data_2kfh_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2kfh _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 . . . . . 0 N--CA 1.454 -0.258 0 CA-C-O 121.12 0.486 . . . . 3.1 111.124 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 6.4 t90 -82.39 106.01 13.92 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 109.333 -0.617 . . . . 0.73 109.333 178.089 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.567 ' O ' ' HG2' ' A' ' 48' ' ' LYS . 9.7 p -67.5 -7.0 5.67 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.546 0 CA-C-N 115.562 -0.744 . . . . 2.1 112.236 -171.812 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 57.9 t -80.7 -24.81 11.02 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-O 120.742 0.306 . . . . 1.76 110.759 178.393 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -74.0 -9.19 79.69 Favored Glycine 0 CA--C 1.519 0.284 0 C-N-CA 120.788 -0.72 . . . . 0.59 113.215 -175.342 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . 0.567 ' HG2' ' O ' ' A' ' 45' ' ' VAL . 18.7 ptmt -74.23 -27.77 60.93 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 117.134 0.467 . . . . 3.11 111.175 -176.651 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 36.9 t0 -125.36 33.25 5.18 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.608 0.718 . . . . 1.66 109.453 -179.671 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . 0.647 ' N ' ' HD2' ' A' ' 51' ' ' PRO . 51.3 tttt -72.65 -43.86 8.97 Favored Pre-proline 0 C--N 1.321 -0.632 0 CA-C-N 115.471 -0.786 . . . . 1.72 112.059 -175.481 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . 0.647 ' HD2' ' N ' ' A' ' 50' ' ' LYS . 1.7 Cg_endo -45.77 -37.07 15.78 Favored 'Trans proline' 0 C--N 1.359 1.082 0 C-N-CA 123.122 2.548 . . . . 1.07 113.184 176.692 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 24.2 m -68.36 -46.61 69.64 Favored 'General case' 0 C--O 1.239 0.54 0 CA-C-O 121.198 0.523 . . . . 1.38 110.304 -179.471 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 5.0 m-85 -75.11 -20.24 59.55 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.867 -0.606 . . . . 1.14 109.423 -178.451 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 7.6 t70 -67.26 -45.23 77.29 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.42 -0.809 . . . . 2.18 110.036 175.128 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 29.4 mt-10 -67.31 -29.17 68.68 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.229 -0.442 . . . . 2.33 110.593 178.715 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 54.0 mt -78.87 -29.42 14.25 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-O 121.386 0.612 . . . . 1.36 110.587 175.792 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . 0.531 ' CE2' ' HB3' ' A' ' 62' ' ' PRO . 72.8 t80 -71.2 -41.08 70.74 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.961 -0.563 . . . . 0.36 110.623 178.765 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . 0.573 ' HA ' ' HG3' ' A' ' 62' ' ' PRO . 2.5 m-85 -78.23 -12.45 60.0 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.917 -0.583 . . . . 1.85 111.656 -176.049 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 3.8 p -91.88 -7.61 48.81 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 120.96 0.409 . . . . 1.12 110.988 178.655 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 89.1 mt -100.77 11.49 39.45 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-N 116.015 -0.539 . . . . 2.02 110.5 177.75 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 24.6 m 65.65 85.28 0.16 Allowed Pre-proline 0 N--CA 1.463 0.213 0 CA-C-N 115.363 -0.835 . . . . 1.87 111.8 178.347 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . 0.573 ' HG3' ' HA ' ' A' ' 58' ' ' TYR . 4.6 Cg_endo -85.59 130.87 3.87 Favored 'Trans proline' 0 N--CA 1.454 -0.795 0 C-N-CA 122.996 2.464 . . . . 0.62 112.162 178.626 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 60.2 t -112.25 108.83 26.51 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 N-CA-C 109.755 -0.461 . . . . 1.76 109.755 177.477 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 92.0 m-20 62.15 30.03 17.65 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.664 -0.698 . . . . 1.82 111.922 178.029 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 94.58 3.38 62.78 Favored Glycine 0 CA--C 1.519 0.296 0 C-N-CA 120.792 -0.718 . . . . 0.51 113.817 173.668 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . 0.522 ' HZ2' ' CG ' ' A' ' 102' ' ' ASP . 55.5 mttm -129.37 150.53 50.69 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 117.135 0.467 . . . . 2.12 110.488 177.555 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 33.7 pt -117.66 159.67 17.72 Favored 'Isoleucine or valine' 0 C--O 1.24 0.605 0 CA-C-O 121.264 0.554 . . . . 1.28 110.455 172.836 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 22.4 p -72.28 151.67 42.64 Favored 'General case' 0 N--CA 1.446 -0.64 0 CA-C-N 114.915 -1.038 . . . . 1.21 110.784 179.046 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -71.05 -10.47 68.63 Favored Glycine 0 C--O 1.222 -0.63 0 C-N-CA 120.744 -0.741 . . . . 0.48 111.609 179.957 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -70.52 -40.85 73.25 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.069 0.461 . . . . 1.13 111.181 178.65 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 30.2 m-80 -81.13 -33.09 33.43 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.971 -0.559 . . . . 1.81 110.34 -178.409 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -62.95 -46.41 87.88 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 109.424 -0.584 . . . . 1.09 109.424 171.558 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . 0.419 ' HA ' ' CZ ' ' B' ' 151' ' ' PHE . 54.6 tttp -52.25 -43.38 64.33 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 115.248 -0.887 . . . . 1.63 110.414 174.671 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . 0.537 ' O ' ' HG2' ' A' ' 78' ' ' LYS . 35.5 ttpt -59.16 -49.91 76.05 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.239 -0.891 . . . . 2.43 111.397 179.037 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 3.1 tp10 -59.32 -47.98 83.35 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.359 0.599 . . . . 1.6 110.514 177.108 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' MET . . . . . 0.713 ' HG3' ' CZ ' ' B' ' 151' ' ' PHE . 70.9 mmm -55.75 -47.09 77.57 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.383 -0.826 . . . . 1.92 111.457 -177.819 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 29.5 m -75.56 -20.7 15.95 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.362 0 N-CA-C 111.702 0.26 . . . . 2.22 111.702 -177.641 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.537 ' HG2' ' O ' ' A' ' 74' ' ' LYS . 24.0 mmtp -72.96 -27.46 61.84 Favored 'General case' 0 CA--C 1.52 -0.196 0 CA-C-O 121.111 0.482 . . . . 3.27 110.151 174.723 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 66.1 m -85.59 5.09 33.22 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.831 -0.622 . . . . 1.42 111.291 179.286 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . 0.635 ' HB3' ' HZ3' ' A' ' 80' ' ' LYS . 5.0 mmmp? 62.9 31.92 16.0 Favored 'General case' 0 C--O 1.235 0.328 0 N-CA-C 113.343 0.868 . . . . 3.49 113.343 170.188 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.413 ' HA ' ' HD3' ' A' ' 82' ' ' PRO . 87.0 mt -87.29 136.54 33.41 Favored Pre-proline 0 C--N 1.322 -0.624 0 C-N-CA 120.651 -0.42 . . . . 1.17 110.335 176.813 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . 0.549 ' O ' ' HG ' ' A' ' 86' ' ' LEU . 32.0 Cg_exo -58.7 152.76 54.14 Favored 'Trans proline' 0 C--N 1.344 0.332 0 C-N-CA 122.795 2.33 . . . . 0.59 111.991 178.261 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . 0.487 ' HA ' HD13 ' A' ' 86' ' ' LEU . 17.6 m120 -55.21 -33.53 63.14 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-N 116.481 -0.327 . . . . 2.37 111.658 -177.088 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 7.3 p -63.78 -46.64 84.31 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.255 0.55 . . . . 1.92 110.674 177.161 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.481 ' O ' HG12 ' A' ' 89' ' ' ILE . 47.8 t -69.1 -32.75 55.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 115.616 -0.72 . . . . 1.15 110.61 -179.871 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.704 HD21 ' HB3' ' A' ' 76' ' ' MET . 79.7 mt -57.58 -46.67 83.72 Favored 'General case' 0 C--O 1.238 0.471 0 CA-C-N 116.119 -0.491 . . . . 1.45 110.098 176.188 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -66.62 -35.39 89.82 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.821 -0.704 . . . . 0.32 111.625 178.282 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 48.3 mmtt -57.21 -52.46 65.23 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-O 120.907 0.384 . . . . 2.37 110.819 175.52 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . 0.488 ' HB ' ' HE1' ' A' ' 76' ' ' MET . 50.6 mm -61.16 -47.0 95.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 115.581 -0.736 . . . . 1.42 110.938 -177.675 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 50.0 t-105 -59.21 -46.87 87.3 Favored 'General case' 0 CA--C 1.53 0.198 0 CA-C-O 120.825 0.345 . . . . 0.38 110.984 179.511 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 17.0 ttmm -54.42 -37.8 65.53 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 115.71 -0.677 . . . . 3.4 112.025 178.319 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.72 HD12 ' HA ' ' A' ' 124' ' ' ALA . 96.9 mt -86.22 -29.95 22.77 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.5 -0.318 . . . . 2.23 111.774 -176.907 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . 0.686 ' HA ' HD21 ' A' ' 108' ' ' LEU . . . -79.57 -42.31 25.29 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 116.458 -0.337 . . . . 1.15 111.868 -175.659 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -102.99 95.14 5.95 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.186 0.517 . . . . 0.79 110.197 -177.994 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 32.3 t -67.47 -40.52 84.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 115.388 -0.824 . . . . 1.23 111.53 -174.27 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 13.2 p-10 -90.0 -20.09 23.68 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.24 -0.437 . . . . 0.96 110.919 -175.994 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . 0.57 ' HB2' ' HZ1' ' A' ' 97' ' ' LYS . 8.0 mtmp? 66.33 60.4 0.62 Allowed 'General case' 0 C--O 1.233 0.21 0 CA-C-N 115.848 -0.615 . . . . 3.53 111.038 177.164 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . 0.419 ' C ' ' H ' ' A' ' 100' ' ' LEU . 11.2 p-10 -94.3 9.57 37.61 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.211 -0.45 . . . . 0.53 110.907 -179.598 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 73.99 -19.03 1.78 Allowed Glycine 0 CA--C 1.519 0.329 0 CA-C-N 116.025 -0.534 . . . . 0.45 113.346 175.592 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.419 ' H ' ' C ' ' A' ' 98' ' ' ASP . 94.7 mt -113.35 151.63 30.99 Favored 'General case' 0 C--N 1.318 -0.775 0 N-CA-C 108.889 -0.782 . . . . 1.72 108.889 178.227 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 58.5 mt -104.04 119.99 40.12 Favored 'General case' 0 C--N 1.318 -0.796 0 C-N-CA 120.414 -0.514 . . . . 1.1 110.519 178.762 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . 0.578 ' HB2' ' HG3' ' A' ' 105' ' ' GLU . 20.6 m-20 -69.38 168.61 14.03 Favored 'General case' 0 CA--C 1.513 -0.46 0 N-CA-C 108.721 -0.844 . . . . 1.72 108.721 171.586 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 12.7 p-10 -59.99 -35.89 76.0 Favored 'General case' 0 C--N 1.317 -0.845 0 N-CA-C 109.612 -0.514 . . . . 1.6 109.612 176.094 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 37.5 mm-40 -65.57 -51.17 61.76 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-N 115.668 -0.697 . . . . 1.66 110.288 176.138 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . 0.578 ' HG3' ' HB2' ' A' ' 102' ' ' ASP . 42.5 mt-10 -64.41 -42.78 95.89 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.75 -0.659 . . . . 0.64 111.074 -174.404 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 90.2 t80 -66.91 -34.89 78.78 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.245 -0.434 . . . . 0.54 110.434 -179.574 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -60.8 -40.4 92.53 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.874 0.368 . . . . 1.09 110.326 175.667 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . 0.686 HD21 ' HA ' ' A' ' 93' ' ' ALA . 6.9 tt -66.45 -50.21 64.11 Favored 'General case' 0 C--O 1.237 0.409 0 CA-C-N 116.217 -0.447 . . . . 1.98 110.094 178.791 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . 0.64 ' O ' HG13 ' A' ' 113' ' ' ILE . . . -54.59 -55.98 23.76 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 115.961 -0.563 . . . . 1.03 110.728 178.072 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' ASN . . . . . 0.604 ' HA ' HD11 ' A' ' 113' ' ' ILE . 0.7 OUTLIER -52.93 -39.91 63.22 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.662 -0.699 . . . . 1.2 111.176 179.98 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' HIS . . . . . 0.424 ' O ' HG22 ' A' ' 115' ' ' VAL . 37.2 t60 -60.54 -53.26 59.65 Favored 'General case' 0 C--O 1.223 -0.295 0 N-CA-C 110.115 -0.328 . . . . 0.65 110.115 178.548 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 92.5 mt -54.87 -42.98 72.73 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-O 120.975 0.417 . . . . 1.21 110.775 179.42 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . 0.64 HG13 ' O ' ' A' ' 109' ' ' ALA . 70.6 mt -57.5 -56.63 14.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 115.542 -0.754 . . . . 1.41 111.488 -179.374 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 114' ' ' LYS . . . . . 0.507 ' HG2' ' O ' ' A' ' 110' ' ' ASN . 63.2 mmtt -69.55 -32.99 72.12 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.69 -0.687 . . . . 4.33 110.644 -174.261 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . 0.471 HG13 ' HB2' ' A' ' 120' ' ' HIS . 51.5 t -62.96 -33.78 62.51 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-N 115.914 -0.585 . . . . 1.77 110.679 174.212 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 3.5 mmmp? -68.27 -37.19 80.46 Favored 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 120.694 -0.402 . . . . 1.86 110.19 173.225 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 98.1 mt -67.66 -27.78 67.14 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.201 -0.454 . . . . 1.53 110.537 177.328 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . 0.401 ' HB2' ' O ' ' A' ' 115' ' ' VAL . 45.8 mt-10 -64.85 -22.41 66.99 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.06 -0.518 . . . . 2.18 111.165 174.819 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 106.28 10.82 28.86 Favored Glycine 0 N--CA 1.445 -0.728 0 C-N-CA 120.417 -0.897 . . . . 1.17 111.854 -176.906 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 120' ' ' HIS . . . . . 0.471 ' HB2' HG13 ' A' ' 115' ' ' VAL . 7.0 m170 -88.6 159.27 17.96 Favored 'General case' 0 C--O 1.235 0.318 0 N-CA-C 109.381 -0.6 . . . . 2.86 109.381 177.32 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 18.2 mt-10 -114.04 163.28 15.37 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 110.285 -0.265 . . . . 2.53 110.285 174.166 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . 0.647 ' H ' HD23 ' A' ' 122' ' ' LEU . 2.2 pt? -106.05 136.39 19.32 Favored Pre-proline 0 C--N 1.326 -0.422 0 CA-C-N 116.494 -0.321 . . . . 1.8 110.588 -176.771 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . 0.428 ' HD3' ' HA ' ' A' ' 122' ' ' LEU . 10.7 Cg_exo -72.13 -14.91 28.95 Favored 'Trans proline' 0 N--CA 1.464 -0.238 0 C-N-CA 122.889 2.393 . . . . 1.72 112.125 177.685 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . 0.72 ' HA ' HD12 ' A' ' 92' ' ' LEU . . . 64.72 18.99 11.69 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 115.417 -0.81 . . . . 1.71 112.106 179.238 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 24.4 t70 -128.45 152.16 48.55 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 108.921 -0.77 . . . . 2.73 108.921 174.767 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . 0.542 ' HG ' HG21 ' A' ' 131' ' ' VAL . 36.3 tp -105.75 105.44 53.0 Favored Pre-proline 0 C--N 1.322 -0.602 0 CA-C-O 120.747 0.308 . . . . 2.28 111.588 -172.645 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 127' ' ' PRO . . . . . 0.426 ' HD2' HD11 ' A' ' 130' ' ' LEU . 71.9 Cg_endo -79.61 155.04 24.12 Favored 'Trans proline' 0 CA--C 1.534 0.508 0 C-N-CA 122.722 2.281 . . . . 1.33 112.059 174.679 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 12.6 Cg_endo -56.7 -26.01 63.24 Favored 'Trans proline' 0 CA--C 1.534 0.504 0 C-N-CA 123.35 2.7 . . . . 1.87 114.32 -174.937 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 32.0 p-80 -87.14 3.34 46.72 Favored 'General case' 0 N--CA 1.462 0.169 0 C-N-CA 120.441 -0.504 . . . . 1.29 111.148 -179.442 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . 0.426 HD11 ' HD2' ' A' ' 127' ' ' PRO . 24.2 mt -110.8 -17.86 13.25 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.453 -0.34 . . . . 1.87 110.615 173.617 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . 0.542 HG21 ' HG ' ' A' ' 126' ' ' LEU . 6.7 t -75.73 122.41 87.02 Favored Pre-proline 0 C--N 1.328 -0.336 0 N-CA-C 109.844 -0.428 . . . . 1.85 109.844 178.832 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_exo -49.58 135.98 33.69 Favored 'Trans proline' 0 C--N 1.344 0.327 0 C-N-CA 122.851 2.367 . . . . 1.02 112.078 177.153 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -51.23 -36.43 56.36 Favored 'Trans proline' 0 C--N 1.344 0.322 0 C-N-CA 123.762 2.974 . . . . 1.39 113.815 -173.818 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 14.6 m -89.34 1.32 55.94 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 112.048 0.388 . . . . 1.79 112.048 -176.783 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 66.0 mttm . . . . . 0 CA--C 1.532 0.278 0 O-C-N 122.313 -0.242 . . . . 1.79 111.198 -179.885 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' B' B ' 149' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.437 -1.243 0 N-CA-C 110.832 -0.907 . . . . 0.92 110.832 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' B' B ' 150' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -73.21 -0.88 9.76 Favored 'Trans proline' 0 CA--C 1.53 0.323 0 C-N-CA 123.249 2.632 . . . . 0.33 112.312 -177.009 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 151' ' ' PHE . . . . . 0.713 ' CZ ' ' HG3' ' A' ' 76' ' ' MET . 46.7 m-85 . . . . . 0 C--N 1.328 -0.346 0 CA-C-N 116.055 -0.52 . . . . 0.75 112.183 -178.617 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 4.1 mp0 . . . . . 0 C--O 1.234 0.276 0 CA-C-O 121.356 0.598 . . . . 3.1 111.887 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' TRP . . . . . 0.527 ' HH2' ' O ' ' A' ' 104' ' ' GLU . 7.7 t90 -70.6 116.12 10.55 Favored 'General case' 0 N--CA 1.45 -0.436 0 CA-C-N 115.191 -0.913 . . . . 0.73 109.025 178.533 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 9.9 p -67.38 -9.61 10.52 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-O 121.14 0.495 . . . . 2.1 111.371 -174.657 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 51.0 t -89.41 -20.76 7.01 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-O 121.262 0.553 . . . . 1.76 110.317 176.866 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . 0.421 ' HA2' ' HG2' ' A' ' 50' ' ' LYS . . . -72.68 -19.34 79.15 Favored Glycine 0 N--CA 1.446 -0.635 0 CA-C-N 115.706 -0.679 . . . . 0.59 112.897 -175.666 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 15.3 ptpt -76.61 -26.1 54.6 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.602 0.239 . . . . 3.11 111.138 -179.182 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -101.2 34.25 2.6 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.023 0.439 . . . . 1.66 109.917 178.259 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . 0.421 ' HG2' ' HA2' ' A' ' 47' ' ' GLY . 0.1 OUTLIER -67.73 -54.16 18.54 Favored Pre-proline 0 C--O 1.214 -0.775 0 CA-C-O 118.256 -0.878 . . . . 1.72 113.156 -175.922 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_exo -42.66 -41.76 8.33 Favored 'Trans proline' 0 C--N 1.358 1.068 0 C-N-CA 122.798 2.332 . . . . 1.07 113.868 -173.245 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 90.7 m -69.97 -44.76 68.79 Favored 'General case' 0 C--O 1.238 0.449 0 CA-C-O 121.1 0.476 . . . . 1.38 111.282 179.404 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 8.6 m-30 -74.23 -23.21 59.14 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.957 0.408 . . . . 1.14 110.045 -177.491 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 84.2 m-20 -70.03 -44.23 69.69 Favored 'General case' 0 CA--C 1.511 -0.532 0 N-CA-C 108.961 -0.755 . . . . 2.18 108.961 175.818 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 10.8 tp10 -57.26 -47.29 81.78 Favored 'General case' 0 N--CA 1.45 -0.444 0 CA-C-N 115.016 -0.993 . . . . 2.33 110.225 178.541 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 39.8 mt -70.79 -37.54 69.14 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 CA-C-N 116.24 -0.437 . . . . 1.36 111.552 -178.273 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . 0.459 ' HD1' ' CD2' ' A' ' 106' ' ' PHE . 86.6 t80 -66.29 -45.3 80.89 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.807 0.337 . . . . 0.36 110.981 -178.689 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . 0.458 ' CE1' ' HD2' ' A' ' 57' ' ' PHE . 21.7 m-85 -79.81 -12.6 59.76 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.592 -0.276 . . . . 1.85 111.429 -174.596 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 11.5 p -88.7 -8.65 54.16 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.716 0.293 . . . . 1.12 111.286 177.406 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.458 ' HB3' ' HB3' ' A' ' 71' ' ' ASN . 35.2 mt -94.69 9.38 39.07 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.665 -0.243 . . . . 2.02 110.988 178.599 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 17.3 m 68.23 87.55 0.11 Allowed Pre-proline 0 CA--C 1.531 0.219 0 O-C-N 123.823 0.702 . . . . 1.87 110.854 -176.374 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -77.3 125.3 7.69 Favored 'Trans proline' 0 N--CA 1.458 -0.582 0 C-N-CA 122.586 2.191 . . . . 0.62 112.199 -179.463 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 12.5 m -115.3 119.35 61.55 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 CA-C-O 121.091 0.472 . . . . 1.76 110.271 177.432 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 65.5 m-20 64.39 22.24 12.7 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-N 115.711 -0.677 . . . . 1.82 110.742 -179.19 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 80.67 15.73 77.16 Favored Glycine 0 CA--C 1.52 0.352 0 C-N-CA 120.961 -0.638 . . . . 0.51 112.579 -178.393 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . 0.74 ' HG2' ' HB3' ' A' ' 102' ' ' ASP . 86.8 mttt -137.37 160.14 39.92 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 109.739 -0.467 . . . . 2.12 109.739 179.812 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . 0.429 HD12 ' HB2' ' A' ' 101' ' ' LEU . 2.8 pp -119.48 158.12 21.18 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 N-CA-C 109.907 -0.405 . . . . 1.28 109.907 172.309 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 63.8 p -89.5 173.11 8.52 Favored 'General case' 0 C--N 1.321 -0.63 0 CA-C-N 116.203 -0.453 . . . . 1.21 110.898 -174.569 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -64.53 -19.29 64.56 Favored Glycine 0 N--CA 1.445 -0.726 0 C-N-CA 120.81 -0.709 . . . . 0.48 111.997 176.962 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -66.61 -46.01 77.24 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.168 0.509 . . . . 1.13 111.154 179.061 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . 0.458 ' HB3' ' HB3' ' A' ' 60' ' ' LEU . 1.7 m120 -77.57 -41.09 40.13 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.654 -0.703 . . . . 1.81 110.128 -175.148 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -62.78 -43.39 98.94 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.862 -0.608 . . . . 1.09 110.263 177.194 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . 0.541 ' O ' HG22 ' A' ' 77' ' ' VAL . 21.3 ttmm -56.96 -47.28 81.08 Favored 'General case' 0 CA--C 1.516 -0.332 0 CA-C-N 116.255 -0.43 . . . . 1.63 109.862 176.358 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 48.8 tttm -52.44 -50.65 62.17 Favored 'General case' 0 N--CA 1.451 -0.386 0 O-C-N 123.908 0.755 . . . . 2.43 111.209 -178.974 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 13.2 tp10 -70.7 -43.37 69.12 Favored 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 120.846 -0.341 . . . . 1.6 111.15 -178.208 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 64.7 mtt -64.34 -38.67 91.85 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 111.656 0.243 . . . . 1.92 111.656 -175.729 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.541 HG22 ' O ' ' A' ' 73' ' ' LYS . 32.9 m -76.31 -28.55 18.34 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.302 0 C-N-CA 120.788 -0.365 . . . . 2.22 110.621 177.271 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.438 ' HB3' ' HE3' ' A' ' 78' ' ' LYS . 19.8 mmmt -64.89 -25.78 68.04 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-N 116.18 -0.464 . . . . 3.27 110.727 173.58 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 20.3 m -75.16 -8.85 57.72 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.585 -0.734 . . . . 1.42 110.512 177.796 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 55.0 mtpt 62.34 42.64 8.95 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-N 115.903 -0.59 . . . . 3.49 111.126 177.38 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.687 ' HB2' HD13 ' A' ' 86' ' ' LEU . 97.5 mt -100.32 169.2 8.25 Favored Pre-proline 0 C--N 1.325 -0.495 0 CA-C-N 115.704 -0.68 . . . . 1.17 109.758 178.307 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . 0.405 ' CD ' ' HB3' ' A' ' 81' ' ' LEU . 2.0 Cg_endo -83.49 132.01 5.73 Favored 'Trans proline' 0 C--N 1.348 0.515 0 C-N-CA 123.274 2.65 . . . . 0.59 112.371 -178.478 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 5.0 p-10 -50.67 -38.67 47.95 Favored 'General case' 0 N--CA 1.472 0.638 0 N-CA-C 113.504 0.927 . . . . 2.37 113.504 -171.532 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 75.7 m -65.79 -34.28 77.81 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 120.892 0.377 . . . . 1.92 110.925 -179.719 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.484 ' O ' HG12 ' A' ' 89' ' ' ILE . 95.6 t -71.12 -39.85 74.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.153 -0.476 . . . . 1.15 109.789 178.485 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.687 HD13 ' HB2' ' A' ' 81' ' ' LEU . 9.8 mp -58.44 -34.83 71.24 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.18 -0.464 . . . . 1.45 110.992 172.39 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -65.66 -38.67 94.81 Favored Glycine 0 N--CA 1.447 -0.612 0 N-CA-C 111.072 -0.811 . . . . 0.32 111.072 176.619 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 70.0 mmtt -63.43 -49.73 72.57 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.147 -0.526 . . . . 2.37 109.968 174.5 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . 0.484 HG12 ' O ' ' A' ' 85' ' ' VAL . 40.8 mm -54.74 -49.82 65.46 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.097 0 CA-C-N 115.711 -0.677 . . . . 1.42 110.699 179.686 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 53.5 t-105 -61.38 -50.55 72.42 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.323 -0.399 . . . . 0.38 111.402 -178.671 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 26.4 ttmt -74.52 -10.76 59.87 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-O 121.009 0.433 . . . . 3.4 111.359 -172.766 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.417 HD13 ' HA ' ' A' ' 124' ' ' ALA . 94.1 mt -94.36 -37.42 11.48 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.336 -0.393 . . . . 2.23 111.08 172.7 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . 0.463 ' HA ' HD21 ' A' ' 108' ' ' LEU . . . -78.81 -36.85 42.08 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.224 -0.444 . . . . 1.15 111.489 -176.787 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 26.7 t0 -81.15 86.83 6.12 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.612 0.72 . . . . 0.79 109.524 177.562 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . 0.412 ' HB ' ' HD3' ' A' ' 135' ' ' LYS . 34.4 t -82.2 -30.74 9.83 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.587 0 CA-C-N 114.839 -1.073 . . . . 1.23 110.352 -174.796 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 43.5 p-10 -86.41 -7.57 58.34 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.22 -0.445 . . . . 0.96 110.655 -179.461 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 88.9 mttt 59.06 44.62 15.85 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-N 115.716 -0.675 . . . . 3.53 111.129 172.974 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . 0.531 ' OD2' ' HB2' ' A' ' 100' ' ' LEU . 6.5 p-10 -107.08 9.06 30.56 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 116.246 -0.434 . . . . 0.53 111.016 -175.872 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 67.58 12.84 62.27 Favored Glycine 0 CA--C 1.518 0.277 0 C-N-CA 121.053 -0.594 . . . . 0.45 112.481 178.746 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.531 ' HB2' ' OD2' ' A' ' 98' ' ' ASP . 87.0 mt -135.77 153.3 51.59 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 109.114 -0.699 . . . . 1.72 109.114 178.817 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . 0.429 ' HB2' HD12 ' A' ' 67' ' ' ILE . 89.9 mt -110.22 111.89 23.5 Favored 'General case' 0 C--N 1.315 -0.928 0 N-CA-C 109.166 -0.679 . . . . 1.1 109.166 175.009 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . 0.74 ' HB3' ' HG2' ' A' ' 66' ' ' LYS . 2.1 p30 -75.99 -174.82 2.81 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 116.233 -0.44 . . . . 1.72 110.672 178.523 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -54.86 -40.33 69.56 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 115.604 -0.726 . . . . 1.6 110.48 -179.215 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . 0.527 ' O ' ' HH2' ' A' ' 44' ' ' TRP . 54.5 mt-10 -73.62 -52.76 12.32 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.992 -0.549 . . . . 1.66 110.253 179.408 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 36.1 mt-10 -63.12 -37.93 89.15 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.238 -0.437 . . . . 0.64 111.753 -173.833 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . 0.459 ' CD2' ' HD1' ' A' ' 57' ' ' PHE . 54.1 t80 -74.86 -34.94 62.35 Favored 'General case' 0 C--N 1.326 -0.436 0 C-N-CA 120.781 -0.368 . . . . 0.54 110.098 -179.533 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -58.61 -42.43 88.13 Favored 'General case' 0 C--O 1.231 0.127 0 N-CA-C 109.714 -0.476 . . . . 1.09 109.714 173.215 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . 0.463 HD21 ' HA ' ' A' ' 93' ' ' ALA . 64.8 tp -62.73 -43.77 97.95 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.842 -0.617 . . . . 1.98 110.557 176.055 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . 0.509 ' O ' HG13 ' A' ' 113' ' ' ILE . . . -57.86 -46.03 85.41 Favored 'General case' 0 C--O 1.225 -0.237 0 CA-C-N 116.251 -0.431 . . . . 1.03 110.869 178.562 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 13.6 m120 -63.4 -36.71 84.61 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 116.5 -0.318 . . . . 1.2 111.146 179.037 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 9.6 t60 -64.4 -37.87 89.04 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 109.615 -0.513 . . . . 0.65 109.615 178.838 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 94.3 mt -72.02 -39.19 69.33 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.793 -0.639 . . . . 1.21 110.742 178.098 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . 0.509 HG13 ' O ' ' A' ' 109' ' ' ALA . 59.4 mt -56.68 -47.54 82.24 Favored 'Isoleucine or valine' 0 C--O 1.233 0.211 0 N-CA-C 109.816 -0.439 . . . . 1.41 109.816 175.247 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 114' ' ' LYS . . . . . 0.555 ' O ' ' HB2' ' A' ' 118' ' ' GLU . 4.6 mmmm -62.38 -44.11 97.23 Favored 'General case' 0 C--O 1.221 -0.413 0 CA-C-N 116.076 -0.511 . . . . 4.33 111.622 179.223 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . 0.521 HG12 ' HB2' ' A' ' 120' ' ' HIS . 42.9 t -58.01 -43.25 84.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-O 120.835 0.35 . . . . 1.77 110.903 178.192 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 116' ' ' LYS . . . . . 0.48 ' HD2' ' HA ' ' A' ' 116' ' ' LYS . 18.3 tptt -65.75 -45.41 82.7 Favored 'General case' 0 N--CA 1.444 -0.754 0 CA-C-N 116.057 -0.519 . . . . 1.86 110.786 -178.982 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 95.7 mt -78.95 -15.75 57.88 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.511 -0.313 . . . . 1.53 111.78 -178.742 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . 0.555 ' HB2' ' O ' ' A' ' 114' ' ' LYS . 2.1 tp10 -79.4 -13.56 59.52 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 109.081 -0.711 . . . . 2.18 109.081 177.063 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 93.78 31.02 8.46 Favored Glycine 0 N--CA 1.452 -0.287 0 CA-C-N 115.236 -0.893 . . . . 1.17 112.318 178.293 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 120' ' ' HIS . . . . . 0.521 ' HB2' HG12 ' A' ' 115' ' ' VAL . 80.8 m-70 -117.09 176.8 4.97 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 109.843 -0.429 . . . . 2.86 109.843 177.644 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 -126.41 155.07 42.75 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 120.789 0.328 . . . . 2.53 110.255 -177.85 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . 0.473 ' HA ' ' HD3' ' A' ' 123' ' ' PRO . 0.7 OUTLIER -116.39 135.64 22.91 Favored Pre-proline 0 C--N 1.324 -0.521 0 N-CA-C 109.807 -0.442 . . . . 1.8 109.807 177.931 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . 0.473 ' HD3' ' HA ' ' A' ' 122' ' ' LEU . 2.9 Cg_exo -76.45 10.31 2.23 Favored 'Trans proline' 0 C--O 1.234 0.315 0 C-N-CA 123.191 2.594 . . . . 1.72 113.393 -175.49 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . 0.417 ' HA ' HD13 ' A' ' 92' ' ' LEU . . . 57.91 27.21 14.33 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-O 121.24 0.543 . . . . 1.71 111.367 -178.89 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 8.2 t70 -132.42 154.67 49.61 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 109.235 -0.654 . . . . 2.73 109.235 -179.887 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 95.2 mt -108.46 101.67 43.78 Favored Pre-proline 0 C--N 1.324 -0.527 0 CA-C-O 120.917 0.389 . . . . 2.28 111.616 -177.078 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 127' ' ' PRO . . . . . 0.62 ' HG2' ' CB ' ' A' ' 130' ' ' LEU . 18.4 Cg_endo -62.64 151.95 80.68 Favored 'Trans proline' 0 CA--C 1.535 0.546 0 C-N-CA 122.821 2.347 . . . . 1.33 111.767 173.344 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -53.11 -35.7 73.83 Favored 'Trans proline' 0 CA--C 1.533 0.461 0 C-N-CA 123.415 2.743 . . . . 1.87 113.622 -175.23 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 11.9 p-80 -86.93 3.26 46.36 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 111.669 0.248 . . . . 1.29 111.669 -178.916 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . 0.62 ' CB ' ' HG2' ' A' ' 127' ' ' PRO . 16.5 tp -115.57 -1.14 12.83 Favored 'General case' 0 N--CA 1.446 -0.655 0 CA-C-O 120.965 0.412 . . . . 1.87 110.279 -177.912 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . 0.404 HG22 ' O ' ' A' ' 127' ' ' PRO . 65.0 t -88.69 129.77 47.6 Favored Pre-proline 0 C--N 1.327 -0.391 0 CA-C-N 115.987 -0.551 . . . . 1.85 110.122 178.598 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 132' ' ' PRO . . . . . 0.401 ' HA ' ' HD3' ' A' ' 133' ' ' PRO . 83.1 Cg_exo -48.31 130.38 20.93 Favored 'Trans proline' 0 C--N 1.348 0.532 0 C-N-CA 122.891 2.394 . . . . 1.02 112.306 177.685 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 133' ' ' PRO . . . . . 0.401 ' HD3' ' HA ' ' A' ' 132' ' ' PRO . 50.6 Cg_exo -54.27 -37.44 88.27 Favored 'Trans proline' 0 C--O 1.232 0.206 0 C-N-CA 123.446 2.764 . . . . 1.39 113.369 -174.296 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 12.8 m -83.99 -2.05 55.85 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.55 -0.295 . . . . 1.79 111.227 -177.05 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 135' ' ' LYS . . . . . 0.412 ' HD3' ' HB ' ' A' ' 95' ' ' VAL . 61.2 mttp . . . . . 0 C--N 1.329 -0.324 0 N-CA-C 112.285 0.476 . . . . 1.79 112.285 -174.702 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 149' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.444 -0.778 0 N-CA-C 111.542 -0.623 . . . . 0.92 111.542 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' B' B ' 150' ' ' PRO . . . . . . . . . . . . . 69.4 Cg_endo -73.86 -8.33 21.16 Favored 'Trans proline' 0 N--CA 1.465 -0.204 0 C-N-CA 122.423 2.082 . . . . 0.33 112.106 -179.228 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 151' ' ' PHE . . . . . 0.418 ' CZ ' ' HA ' ' A' ' 73' ' ' LYS . 36.2 m-85 . . . . . 0 C--N 1.328 -0.332 0 CA-C-N 116.067 -0.515 . . . . 0.75 111.038 178.136 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . 0.453 ' OE2' ' HA ' ' A' ' 45' ' ' VAL . 12.4 tt0 . . . . . 0 C--O 1.237 0.411 0 CA-C-O 120.879 0.371 . . . . 3.1 110.814 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' TRP . . . . . 0.49 ' HH2' ' O ' ' A' ' 104' ' ' GLU . 6.1 t90 -83.39 102.14 11.82 Favored 'General case' 0 N--CA 1.448 -0.545 0 N-CA-C 107.503 -1.295 . . . . 0.73 107.503 168.767 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.453 ' HA ' ' OE2' ' A' ' 43' ' ' GLU . 35.6 m -61.58 -9.66 3.24 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.532 0 N-CA-C 113.011 0.745 . . . . 2.1 113.011 -170.045 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 22.4 t -86.51 -20.17 7.91 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 CA-C-O 121.24 0.543 . . . . 1.76 110.194 177.794 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . 0.546 ' HA2' ' HG3' ' A' ' 50' ' ' LYS . . . -73.27 -25.86 71.97 Favored Glycine 0 N--CA 1.449 -0.45 0 CA-C-N 115.71 -0.677 . . . . 0.59 113.242 -175.145 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 6.4 ptpp? -74.06 -25.32 59.77 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 117.052 0.426 . . . . 3.11 111.051 -178.827 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 24.1 m-20 -105.67 33.75 3.6 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.114 0.483 . . . . 1.66 109.96 179.37 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . 0.546 ' HG3' ' HA2' ' A' ' 47' ' ' GLY . 48.9 mttt -70.16 -43.25 18.32 Favored Pre-proline 0 C--O 1.219 -0.521 0 CA-C-O 118.499 -0.762 . . . . 1.72 112.657 178.042 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . 0.52 ' O ' ' HG3' ' A' ' 55' ' ' GLU . 66.2 Cg_exo -39.64 -48.71 3.44 Favored 'Trans proline' 0 C--N 1.365 1.439 0 C-N-CA 122.82 2.346 . . . . 1.07 113.89 -179.243 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 18.4 m -69.54 -44.8 70.19 Favored 'General case' 0 C--O 1.239 0.509 0 CA-C-O 121.082 0.467 . . . . 1.38 111.148 -177.626 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 9.8 m-30 -70.34 -21.49 62.9 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.873 -0.603 . . . . 1.14 109.854 -178.238 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -74.88 -44.68 47.54 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.95 -0.568 . . . . 2.18 109.734 177.782 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . 0.52 ' HG3' ' O ' ' A' ' 51' ' ' PRO . 72.0 mt-10 -60.6 -29.8 69.44 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.453 -0.794 . . . . 2.33 110.416 178.493 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.458 ' O ' HD13 ' A' ' 60' ' ' LEU . 52.4 mt -84.74 -48.72 16.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 116.148 -0.478 . . . . 1.36 111.225 177.566 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . 0.46 ' HE1' HG12 ' A' ' 67' ' ' ILE . 82.9 t80 -56.24 -37.37 69.65 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 122.99 0.516 . . . . 0.36 111.534 -176.699 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . 0.522 ' HA ' ' HG3' ' A' ' 62' ' ' PRO . 3.1 m-30 -80.44 -10.03 59.75 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.234 -0.439 . . . . 1.85 111.59 -174.487 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 61.4 p -98.13 -2.38 40.12 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.113 0.482 . . . . 1.12 110.646 176.808 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.458 HD13 ' O ' ' A' ' 56' ' ' ILE . 8.9 mp -97.52 12.59 32.87 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.867 -0.606 . . . . 2.02 110.526 179.439 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 44.6 t 64.32 73.5 0.45 Allowed Pre-proline 0 C--O 1.234 0.259 0 CA-C-N 115.595 -0.73 . . . . 1.87 111.407 -179.216 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . 0.522 ' HG3' ' HA ' ' A' ' 58' ' ' TYR . 61.2 Cg_endo -77.26 126.45 8.5 Favored 'Trans proline' 0 C--N 1.347 0.455 0 C-N-CA 122.212 1.942 . . . . 0.62 112.4 178.88 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 15.7 m -109.42 113.1 43.24 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 CA-C-O 121.253 0.549 . . . . 1.76 110.438 177.633 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 95.2 m-20 61.33 34.65 18.35 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 115.617 -0.72 . . . . 1.82 111.178 179.574 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 77.76 21.68 71.15 Favored Glycine 0 C--N 1.331 0.302 0 CA-C-N 115.89 -0.596 . . . . 0.51 112.927 178.243 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 58.4 mttm -141.13 148.96 40.9 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 109.904 -0.406 . . . . 2.12 109.904 -179.015 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . 0.46 HG12 ' HE1' ' A' ' 57' ' ' PHE . 36.9 pt -117.5 160.61 16.92 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 N-CA-C 109.915 -0.402 . . . . 1.28 109.915 171.103 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 54.8 p -86.18 170.71 11.91 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 120.921 0.391 . . . . 1.21 110.623 -177.178 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -65.01 -21.13 67.55 Favored Glycine 0 N--CA 1.446 -0.687 0 C-N-CA 120.962 -0.637 . . . . 0.48 112.36 178.687 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . 0.612 ' O ' ' HG3' ' A' ' 74' ' ' LYS . . . -63.23 -52.42 62.26 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 121.027 0.441 . . . . 1.13 111.181 -179.754 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -71.23 -41.68 69.85 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.848 -0.614 . . . . 1.81 109.93 -175.012 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -61.73 -38.07 86.56 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.472 -0.785 . . . . 1.09 110.604 177.2 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . 0.621 ' HG3' ' HE1' ' B' ' 151' ' ' PHE . 79.9 tttt -64.41 -43.09 95.49 Favored 'General case' 0 CA--C 1.515 -0.37 0 CA-C-N 116.216 -0.447 . . . . 1.63 110.43 178.462 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . 0.612 ' HG3' ' O ' ' A' ' 70' ' ' ALA . 29.1 mtpp -59.33 -44.58 92.59 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.54 0.21 . . . . 2.43 110.472 -179.41 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 14.6 tp10 -61.29 -48.41 81.51 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 116.337 -0.392 . . . . 1.6 110.5 177.283 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' MET . . . . . 0.772 ' HB3' HD22 ' A' ' 86' ' ' LEU . 53.4 mtt -63.55 -33.38 75.46 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.155 0.502 . . . . 1.92 111.289 -179.682 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.501 HG22 ' O ' ' A' ' 73' ' ' LYS . 38.6 t -64.99 -30.8 51.44 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-N 116.123 -0.49 . . . . 2.22 110.087 176.392 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 66.1 mmtt -79.6 -26.81 41.13 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.15 -0.477 . . . . 3.27 111.689 178.906 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 76.9 p -66.14 -14.97 62.7 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 120.867 -0.333 . . . . 1.42 110.501 178.422 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 31.7 mtmm 70.1 18.88 6.94 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-N 115.557 -0.747 . . . . 3.49 111.572 176.135 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.529 ' HB2' HD23 ' A' ' 86' ' ' LEU . 97.0 mt -82.91 144.14 47.4 Favored Pre-proline 0 C--N 1.325 -0.498 0 N-CA-C 109.573 -0.528 . . . . 1.17 109.573 174.363 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 41.2 Cg_exo -57.65 148.07 75.99 Favored 'Trans proline' 0 C--N 1.343 0.245 0 C-N-CA 122.605 2.204 . . . . 0.59 112.369 178.659 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 2.1 m-20 -50.61 -41.82 55.24 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-N 115.852 -0.613 . . . . 2.37 111.293 -179.489 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -57.69 -47.62 81.82 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.942 -0.572 . . . . 1.92 110.878 179.37 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.512 ' O ' HG12 ' A' ' 89' ' ' ILE . 93.8 t -63.2 -37.89 80.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 115.699 -0.682 . . . . 1.15 110.393 -179.761 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.772 HD22 ' HB3' ' A' ' 76' ' ' MET . 75.0 mt -65.73 -36.63 84.14 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.016 -0.538 . . . . 1.45 110.672 179.704 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -65.23 -37.94 94.59 Favored Glycine 0 N--CA 1.449 -0.451 0 N-CA-C 110.857 -0.897 . . . . 0.32 110.857 176.213 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 31.1 mmmt -61.91 -47.43 84.98 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.295 -0.452 . . . . 2.37 109.976 174.739 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . 0.512 HG12 ' O ' ' A' ' 85' ' ' VAL . 28.3 mm -58.97 -46.62 91.43 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.18 0 CA-C-N 115.471 -0.786 . . . . 1.42 110.695 179.403 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 52.5 t-105 -60.09 -47.4 86.05 Favored 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 121.076 -0.25 . . . . 0.38 110.915 -179.064 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 37.4 ttmt -62.91 -24.16 67.71 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 116.41 -0.359 . . . . 3.4 111.319 -178.118 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.711 HD12 ' HA ' ' A' ' 124' ' ' ALA . 91.9 mt -93.38 -29.47 15.58 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.443 -0.344 . . . . 2.23 111.51 179.903 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -85.94 -41.39 14.96 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.58 -0.282 . . . . 1.15 111.35 -177.315 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 39.8 t0 -84.5 79.34 9.61 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 108.858 -0.793 . . . . 0.79 108.858 177.282 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . 0.48 ' HB ' ' HG2' ' A' ' 135' ' ' LYS . 40.5 t -67.56 -37.51 78.91 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-N 115.292 -0.867 . . . . 1.23 111.056 -171.63 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 40.4 p-10 -83.54 -10.1 58.52 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.934 -0.575 . . . . 0.96 110.973 -178.972 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 92.0 mttt 52.16 72.65 0.38 Allowed 'General case' 0 C--O 1.235 0.338 0 O-C-N 123.839 0.712 . . . . 3.53 110.843 179.789 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . 0.413 ' OD2' ' HB2' ' A' ' 100' ' ' LEU . 9.6 p-10 -127.27 9.02 6.64 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 120.916 0.389 . . . . 0.53 110.694 -176.896 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 74.02 0.39 55.96 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.768 -0.729 . . . . 0.45 112.709 177.375 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.413 ' HB2' ' OD2' ' A' ' 98' ' ' ASP . 77.2 mt -128.79 147.41 50.79 Favored 'General case' 0 N--CA 1.446 -0.653 0 N-CA-C 109.417 -0.586 . . . . 1.72 109.417 179.355 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 60.8 mt -105.17 120.1 40.68 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-N 115.992 -0.549 . . . . 1.1 109.912 176.549 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . 0.435 ' HB2' ' HG3' ' A' ' 105' ' ' GLU . 9.8 m-20 -69.6 176.96 3.19 Favored 'General case' 0 CA--C 1.511 -0.533 0 N-CA-C 109.613 -0.514 . . . . 1.72 109.613 174.279 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -56.81 -42.7 80.01 Favored 'General case' 0 C--N 1.317 -0.808 0 N-CA-C 109.552 -0.536 . . . . 1.6 109.552 172.967 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . 0.498 ' HB3' ' HB3' ' A' ' 132' ' ' PRO . 4.7 mp0 -61.94 -53.34 56.99 Favored 'General case' 0 N--CA 1.461 0.115 0 CA-C-N 115.895 -0.593 . . . . 1.66 111.266 173.946 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . 0.435 ' HG3' ' HB2' ' A' ' 102' ' ' ASP . 22.9 mt-10 -67.1 -34.33 77.39 Favored 'General case' 0 C--N 1.327 -0.394 0 C-N-CA 120.947 -0.301 . . . . 0.64 111.471 -169.824 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . 0.436 ' CD1' HD12 ' A' ' 67' ' ' ILE . 84.4 t80 -71.29 -40.67 70.72 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 109.94 -0.393 . . . . 0.54 109.94 176.335 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -57.31 -43.08 82.96 Favored 'General case' 0 N--CA 1.454 -0.239 0 CA-C-O 121.107 0.48 . . . . 1.09 110.393 175.698 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 6.3 tt -60.15 -50.6 73.03 Favored 'General case' 0 C--O 1.236 0.353 0 CA-C-N 115.504 -0.771 . . . . 1.98 110.012 178.428 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . 0.465 ' O ' HG13 ' A' ' 113' ' ' ILE . . . -57.93 -45.38 86.64 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.108 -0.496 . . . . 1.03 110.834 179.245 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -62.77 -34.12 76.58 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.04 -0.527 . . . . 1.2 110.674 -179.71 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 2.3 t60 -70.07 -35.85 74.52 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.197 -0.456 . . . . 0.65 110.358 179.712 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 63.1 mt -68.65 -40.36 80.28 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.16 -0.473 . . . . 1.21 110.077 176.597 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . 0.465 HG13 ' O ' ' A' ' 109' ' ' ALA . 69.3 mt -57.58 -41.9 80.07 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.141 0 CA-C-N 115.959 -0.564 . . . . 1.41 109.636 174.512 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 114' ' ' LYS . . . . . 0.674 ' O ' ' HG2' ' A' ' 118' ' ' GLU . 2.4 mmmt -58.08 -49.04 78.3 Favored 'General case' 0 C--O 1.22 -0.464 0 CA-C-N 115.406 -0.816 . . . . 4.33 110.551 177.335 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . 0.555 HG11 ' HB2' ' A' ' 120' ' ' HIS . 68.2 t -53.6 -40.86 43.9 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 O-C-N 123.408 0.443 . . . . 1.77 111.604 177.63 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 116' ' ' LYS . . . . . 0.407 ' HA ' ' HD3' ' A' ' 116' ' ' LYS . 42.0 mmtt -70.16 -33.54 71.9 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 111.857 0.318 . . . . 1.86 111.857 178.604 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 98.0 mt -71.38 -30.39 66.08 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.185 0.516 . . . . 1.53 110.058 175.414 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . 0.674 ' HG2' ' O ' ' A' ' 114' ' ' LYS . 22.1 mm-40 -67.71 -25.9 65.89 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.345 -0.843 . . . . 2.18 110.127 176.077 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 91.91 35.17 6.89 Favored Glycine 0 N--CA 1.447 -0.573 0 C-N-CA 120.593 -0.813 . . . . 1.17 111.927 -176.65 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 120' ' ' HIS . . . . . 0.555 ' HB2' HG11 ' A' ' 115' ' ' VAL . 97.9 m-70 -119.51 164.82 15.22 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 109.91 -0.404 . . . . 2.86 109.91 177.955 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 42.3 mm-40 -110.59 161.87 15.28 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 116.329 -0.396 . . . . 2.53 110.882 -174.628 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . 0.454 ' H ' HD23 ' A' ' 122' ' ' LEU . 1.7 pt? -124.96 135.44 26.78 Favored Pre-proline 0 C--N 1.323 -0.553 0 CA-C-N 115.795 -0.638 . . . . 1.8 109.492 176.331 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 62.9 Cg_endo -74.33 -1.76 11.43 Favored 'Trans proline' 0 CA--C 1.53 0.279 0 C-N-CA 122.877 2.385 . . . . 1.72 113.557 -175.455 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . 0.711 ' HA ' HD12 ' A' ' 92' ' ' LEU . . . 68.97 18.89 8.35 Favored 'General case' 0 N--CA 1.467 0.38 0 C-N-CA 123.04 0.536 . . . . 1.71 110.769 -175.781 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -117.95 156.57 28.27 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.396 -0.82 . . . . 2.73 109.231 174.765 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . 0.496 HD23 ' HB3' ' A' ' 92' ' ' LEU . 90.8 mt -108.97 104.8 55.92 Favored Pre-proline 0 C--N 1.323 -0.566 0 CA-C-O 120.705 0.288 . . . . 2.28 111.629 -176.858 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 127' ' ' PRO . . . . . 0.481 ' HD2' HD11 ' A' ' 130' ' ' LEU . 51.5 Cg_exo -54.81 146.72 54.42 Favored 'Trans proline' 0 C--O 1.235 0.356 0 C-N-CA 123.015 2.477 . . . . 1.33 111.782 172.023 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 41.3 Cg_endo -67.14 3.14 1.76 Allowed 'Trans proline' 0 N--CA 1.475 0.426 0 C-N-CA 123.24 2.627 . . . . 1.87 114.258 -174.228 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 27.5 p-80 -117.16 7.51 13.02 Favored 'General case' 0 C--N 1.327 -0.382 0 C-N-CA 120.737 -0.385 . . . . 1.29 110.577 177.877 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . 0.481 HD11 ' HD2' ' A' ' 127' ' ' PRO . 23.4 mt -108.08 0.99 22.03 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.833 0.349 . . . . 1.87 111.345 178.785 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 3.5 m -77.31 121.06 83.94 Favored Pre-proline 0 C--N 1.322 -0.613 0 CA-C-N 116.373 -0.376 . . . . 1.85 110.401 173.825 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 132' ' ' PRO . . . . . 0.498 ' HB3' ' HB3' ' A' ' 104' ' ' GLU . 51.4 Cg_exo -53.29 148.64 31.87 Favored 'Trans proline' 0 C--N 1.342 0.205 0 C-N-CA 122.944 2.43 . . . . 1.02 112.094 -179.404 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 133' ' ' PRO . . . . . 0.449 ' HD2' ' HG2' ' A' ' 104' ' ' GLU . 52.3 Cg_exo -55.27 -26.61 52.99 Favored 'Trans proline' 0 C--N 1.344 0.311 0 C-N-CA 122.816 2.344 . . . . 1.39 112.554 -178.61 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 5.9 p -89.71 -13.05 37.71 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.113 -0.494 . . . . 1.79 111.74 -179.32 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 135' ' ' LYS . . . . . 0.48 ' HG2' ' HB ' ' A' ' 95' ' ' VAL . 13.6 mptt . . . . . 0 N--CA 1.464 0.228 0 N-CA-C 111.967 0.358 . . . . 1.79 111.967 -177.746 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 149' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.617 0 N-CA-C 112.081 -0.408 . . . . 0.92 112.081 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' B' B ' 150' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -72.5 -2.25 11.49 Favored 'Trans proline' 0 C--O 1.235 0.345 0 C-N-CA 122.797 2.331 . . . . 0.33 112.238 -179.188 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 151' ' ' PHE . . . . . 0.621 ' HE1' ' HG3' ' A' ' 73' ' ' LYS . 49.3 m-85 . . . . . 0 C--N 1.326 -0.42 0 CA-C-N 116.006 -0.543 . . . . 0.75 111.236 -179.093 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 50.7 mt-10 . . . . . 0 N--CA 1.451 -0.392 0 N-CA-C 109.147 -0.686 . . . . 3.1 109.147 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 1.5 t90 -71.16 107.61 4.27 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 109.444 -0.576 . . . . 0.73 109.444 -176.375 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 31.2 m -66.48 -0.65 0.96 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 115.84 -0.618 . . . . 2.1 111.945 -177.444 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 46.5 t -97.73 -24.08 4.45 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-O 121.219 0.533 . . . . 1.76 109.788 173.875 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . 0.769 ' HA2' ' HG2' ' A' ' 50' ' ' LYS . . . -73.25 -21.21 79.89 Favored Glycine 0 N--CA 1.45 -0.39 0 CA-C-N 115.81 -0.632 . . . . 0.59 112.345 -178.483 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . 0.431 ' HB2' ' HE3' ' A' ' 48' ' ' LYS . 12.3 ptmt -75.13 -25.06 58.15 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 120.863 0.363 . . . . 3.11 110.633 178.847 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -102.67 31.87 3.91 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.205 -0.452 . . . . 1.66 110.004 176.694 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . 0.769 ' HG2' ' HA2' ' A' ' 47' ' ' GLY . 8.1 mmmm -72.82 -50.65 7.11 Favored Pre-proline 0 C--O 1.216 -0.673 0 CA-C-O 118.53 -0.747 . . . . 1.72 112.253 -178.293 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . 0.577 ' HD2' ' N ' ' A' ' 50' ' ' LYS . 1.4 Cg_endo -44.05 -42.01 12.66 Favored 'Trans proline' 0 C--N 1.36 1.181 0 C-N-CA 122.845 2.363 . . . . 1.07 112.593 -177.397 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 9.5 m -69.73 -45.4 68.24 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.952 -0.567 . . . . 1.38 111.119 179.67 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' TYR . . . . . 0.978 ' HH ' ' HA ' ' A' ' 111' ' ' HIS . 12.1 m-30 -76.35 -22.69 54.57 Favored 'General case' 0 C--O 1.219 -0.535 0 CA-C-N 116.486 -0.324 . . . . 1.14 110.607 -175.178 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -73.74 -45.05 54.37 Favored 'General case' 0 C--O 1.237 0.425 0 N-CA-C 108.68 -0.859 . . . . 2.18 108.68 175.418 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 2.2 tp10 -53.61 -42.26 67.53 Favored 'General case' 0 N--CA 1.455 -0.186 0 CA-C-N 114.675 -1.148 . . . . 2.33 110.495 178.2 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 66.1 mt -80.37 -47.09 21.33 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-N 115.668 -0.696 . . . . 1.36 111.341 -179.134 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . 0.488 ' CE1' HG21 ' A' ' 67' ' ' ILE . 86.3 t80 -52.31 -37.2 55.2 Favored 'General case' 0 N--CA 1.468 0.457 0 C-N-CA 122.982 0.513 . . . . 0.36 112.024 -176.076 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . 0.571 ' HA ' ' HG3' ' A' ' 62' ' ' PRO . 18.5 m-30 -77.24 -17.8 58.16 Favored 'General case' 0 C--N 1.326 -0.424 0 C-N-CA 120.743 -0.383 . . . . 1.85 111.421 -174.485 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 41.0 p -85.83 -7.5 58.69 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.283 0.563 . . . . 1.12 110.386 -179.497 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 11.1 mp -95.47 19.16 11.35 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.58 -0.737 . . . . 2.02 110.327 179.16 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 12.7 p 49.61 81.46 0.26 Allowed Pre-proline 0 N--CA 1.465 0.317 0 CA-C-N 115.558 -0.746 . . . . 1.87 111.836 -177.515 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . 0.571 ' HG3' ' HA ' ' A' ' 58' ' ' TYR . 72.6 Cg_endo -84.85 116.9 1.91 Allowed 'Trans proline' 0 N--CA 1.455 -0.767 0 C-N-CA 122.659 2.239 . . . . 0.62 112.555 -177.744 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 18.7 m -88.76 113.46 25.53 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 CA-C-O 121.26 0.553 . . . . 1.76 110.134 178.011 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 11.7 m120 62.98 28.52 16.3 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 115.485 -0.78 . . . . 1.82 111.472 179.4 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 82.01 22.98 58.38 Favored Glycine 0 N--CA 1.454 -0.146 0 C-N-CA 121.072 -0.585 . . . . 0.51 112.326 179.404 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . 0.481 ' HG2' ' HA ' ' A' ' 102' ' ' ASP . 26.8 mtpp -143.28 141.05 30.9 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 109.417 -0.586 . . . . 2.12 109.417 -177.886 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . 0.488 HG21 ' CE1' ' A' ' 57' ' ' PHE . 36.6 pt -108.66 154.77 9.86 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.812 0 CA-C-O 121.184 0.516 . . . . 1.28 110.975 178.456 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' THR . . . . . 0.511 ' HA ' ' CD2' ' A' ' 100' ' ' LEU . 32.2 p -77.6 161.28 27.95 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.171 -0.922 . . . . 1.21 111.082 -179.474 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -63.6 -22.52 66.03 Favored Glycine 0 N--CA 1.444 -0.78 0 C-N-CA 121.05 -0.595 . . . . 0.48 111.796 179.179 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -61.48 -47.52 85.29 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.898 0.38 . . . . 1.13 111.663 178.367 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 46.1 m-80 -81.29 -31.86 33.44 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.176 -0.465 . . . . 1.81 110.976 -175.804 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . 0.505 ' O ' ' HG2' ' A' ' 76' ' ' MET . . . -63.79 -45.21 90.73 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 109.378 -0.601 . . . . 1.09 109.378 173.283 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 60.5 tttp -57.03 -37.9 72.4 Favored 'General case' 0 CA--C 1.52 -0.178 0 CA-C-N 115.24 -0.891 . . . . 1.63 109.889 175.95 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 9.0 tptm -57.28 -57.05 14.32 Favored 'General case' 0 N--CA 1.453 -0.298 0 CA-C-N 115.41 -0.814 . . . . 2.43 110.509 177.968 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . 0.548 ' HA ' ' HG3' ' A' ' 78' ' ' LYS . 5.4 tp10 -64.61 -39.46 93.77 Favored 'General case' 0 C--O 1.237 0.434 0 CA-C-O 121.218 0.532 . . . . 1.6 110.966 -177.168 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' MET . . . . . 0.618 ' HB3' HD22 ' A' ' 86' ' ' LEU . 96.3 mmm -64.91 -29.39 70.33 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.179 0.514 . . . . 1.92 109.882 178.775 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -75.04 -28.32 20.79 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 CA-C-N 115.985 -0.552 . . . . 2.22 110.086 175.672 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.548 ' HG3' ' HA ' ' A' ' 75' ' ' GLU . 3.1 mmmm -68.86 -27.76 66.1 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.802 -0.635 . . . . 3.27 111.211 177.015 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 78.5 p -73.11 -15.67 61.48 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.32 -0.4 . . . . 1.42 111.643 -176.558 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 75.0 mmtt 66.75 16.43 10.38 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-N 115.9 -0.591 . . . . 3.49 111.385 178.98 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.425 ' HB2' HD23 ' A' ' 86' ' ' LEU . 93.0 mt -83.82 150.3 58.72 Favored Pre-proline 0 C--N 1.327 -0.374 0 CA-C-N 116.483 -0.326 . . . . 1.17 111.032 -179.633 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . 0.526 ' O ' ' HG ' ' A' ' 86' ' ' LEU . 51.2 Cg_exo -55.34 148.15 52.75 Favored 'Trans proline' 0 C--N 1.349 0.601 0 C-N-CA 123.113 2.542 . . . . 0.59 112.698 179.47 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 13.7 m120 -61.43 -36.12 79.48 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.939 -0.573 . . . . 2.37 111.448 -174.109 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 15.0 t -66.03 -35.23 79.98 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.949 0.404 . . . . 1.92 110.254 179.243 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 57.4 t -72.29 -37.3 58.18 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.313 0 N-CA-C 109.68 -0.489 . . . . 1.15 109.68 178.905 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.618 HD22 ' HB3' ' A' ' 76' ' ' MET . 62.1 mt -61.48 -39.72 91.94 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.883 -0.599 . . . . 1.45 109.93 176.587 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -67.19 -39.93 92.45 Favored Glycine 0 N--CA 1.45 -0.378 0 N-CA-C 111.672 -0.571 . . . . 0.32 111.672 177.29 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . 0.429 ' O ' ' HG ' ' A' ' 92' ' ' LEU . 29.9 mmmt -58.06 -47.92 81.68 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.996 0.427 . . . . 2.37 110.67 175.69 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . 0.743 HG23 HD12 ' A' ' 112' ' ' LEU . 74.9 mt -65.27 -40.35 88.32 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 115.811 -0.632 . . . . 1.42 110.926 -177.785 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 39.0 t-105 -61.79 -45.16 95.08 Favored 'General case' 0 C--N 1.334 -0.083 0 N-CA-C 110.053 -0.351 . . . . 0.38 110.053 175.392 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 4.9 tppp? -58.19 -28.15 64.53 Favored 'General case' 0 CA--C 1.531 0.232 0 CA-C-N 115.686 -0.688 . . . . 3.4 111.561 -179.554 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.429 ' HG ' ' O ' ' A' ' 88' ' ' LYS . 73.6 mt -92.39 -36.19 13.28 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.708 0.289 . . . . 2.23 111.056 179.396 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -75.22 -42.39 55.59 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.372 -0.377 . . . . 1.15 111.404 -175.458 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 45.2 t0 -86.73 75.45 9.64 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.549 0.69 . . . . 0.79 109.446 178.954 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 42.8 t -63.56 -40.54 89.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 114.927 -1.033 . . . . 1.23 111.255 -174.342 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 30.4 p30 -84.39 -7.47 59.29 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.369 -0.378 . . . . 0.96 111.898 -177.838 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 48.0 mtmt 55.86 74.13 0.4 Allowed 'General case' 0 N--CA 1.466 0.369 0 O-C-N 123.503 0.502 . . . . 3.53 111.541 177.904 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . 0.45 ' OD2' ' HB2' ' A' ' 100' ' ' LEU . 7.3 p-10 -128.85 9.26 5.83 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.869 0.366 . . . . 0.53 111.068 -177.557 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 69.73 -0.65 19.14 Favored Glycine 0 CA--C 1.522 0.487 0 C-N-CA 121.043 -0.598 . . . . 0.45 113.207 176.538 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.511 ' CD2' ' HA ' ' A' ' 68' ' ' THR . 83.8 mt -129.27 137.37 51.02 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 109.128 -0.693 . . . . 1.72 109.128 177.617 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 72.3 mt -90.62 122.44 33.42 Favored 'General case' 0 C--N 1.312 -1.025 0 C-N-CA 120.3 -0.56 . . . . 1.1 109.839 178.685 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . 0.481 ' HA ' ' HG2' ' A' ' 66' ' ' LYS . 23.4 m-20 -69.36 173.97 5.28 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 108.263 -1.014 . . . . 1.72 108.263 173.897 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -55.4 -41.44 72.7 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 121.081 0.467 . . . . 1.6 110.133 173.755 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -72.54 -40.84 66.43 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.96 -0.564 . . . . 1.66 111.406 179.508 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 28.2 mt-10 -70.13 -39.53 75.39 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 120.707 -0.397 . . . . 0.64 111.018 -176.017 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . 0.48 ' CD1' HD13 ' A' ' 67' ' ' ILE . 81.9 t80 -67.07 -37.64 84.37 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 109.952 -0.388 . . . . 0.54 109.952 176.275 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -58.3 -43.91 88.31 Favored 'General case' 0 N--CA 1.452 -0.342 0 CA-C-N 116.147 -0.479 . . . . 1.09 110.406 175.885 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 6.3 tt -60.35 -48.11 83.17 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.154 -0.476 . . . . 1.98 110.098 178.779 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -58.53 -49.47 77.29 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.082 -0.508 . . . . 1.03 110.943 179.063 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' ASN . . . . . 0.413 HD22 ' HG2' ' A' ' 75' ' ' GLU . 0.5 OUTLIER -63.57 -31.42 72.58 Favored 'General case' 0 CA--C 1.519 -0.245 0 CA-C-N 115.915 -0.584 . . . . 1.2 111.201 179.737 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' HIS . . . . . 0.978 ' HA ' ' HH ' ' A' ' 53' ' ' TYR . 32.0 t60 -66.93 -40.57 87.65 Favored 'General case' 0 N--CA 1.453 -0.302 0 N-CA-C 109.952 -0.388 . . . . 0.65 109.952 179.388 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . 0.743 HD12 HG23 ' A' ' 89' ' ' ILE . 98.3 mt -65.29 -39.54 92.66 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.658 -0.246 . . . . 1.21 110.448 177.519 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . 0.517 HD13 ' SD ' ' A' ' 76' ' ' MET . 61.2 mt -60.3 -52.35 62.42 Favored 'Isoleucine or valine' 0 C--O 1.233 0.219 0 CA-C-O 121.104 0.478 . . . . 1.41 110.192 175.424 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 114' ' ' LYS . . . . . 0.533 ' O ' ' HB2' ' A' ' 118' ' ' GLU . 0.4 OUTLIER -65.02 -39.45 93.4 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.492 -0.776 . . . . 4.33 111.075 -174.804 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 51.7 t -69.73 -45.03 78.67 Favored 'Isoleucine or valine' 0 C--O 1.234 0.248 0 CA-C-N 116.639 -0.255 . . . . 1.77 111.567 -178.032 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 35.8 tptt -60.52 -45.76 92.64 Favored 'General case' 0 N--CA 1.454 -0.267 0 CA-C-O 120.981 0.42 . . . . 1.86 110.676 176.92 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 94.4 mt -74.34 -16.06 60.92 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.306 -0.406 . . . . 1.53 111.208 -179.4 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . 0.658 ' HB3' ' HD2' ' A' ' 120' ' ' HIS . 22.6 tt0 -80.02 0.89 29.82 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.914 -0.584 . . . . 2.18 109.664 176.22 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 91.81 15.76 53.59 Favored Glycine 0 N--CA 1.451 -0.319 0 CA-C-N 115.839 -0.619 . . . . 1.17 112.834 175.378 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 120' ' ' HIS . . . . . 0.658 ' HD2' ' HB3' ' A' ' 118' ' ' GLU . 61.6 m-70 -106.08 160.3 15.41 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 110.095 -0.335 . . . . 2.86 110.095 179.903 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 8.0 tp10 -96.63 149.25 22.0 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 121.001 0.429 . . . . 2.53 110.377 179.275 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . 0.427 ' O ' HD11 ' A' ' 122' ' ' LEU . 2.4 pp -114.06 143.67 30.11 Favored Pre-proline 0 C--N 1.321 -0.645 0 CA-C-N 115.92 -0.582 . . . . 1.8 109.767 177.304 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 63.1 Cg_endo -74.09 -12.03 23.43 Favored 'Trans proline' 0 N--CA 1.465 -0.166 0 C-N-CA 122.298 1.998 . . . . 1.72 113.036 -176.372 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . 62.92 18.07 10.53 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-N 115.823 -0.626 . . . . 1.71 110.337 -175.029 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -134.01 176.09 8.89 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.045 -0.98 . . . . 2.73 108.61 175.773 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . 0.456 ' HA ' ' HD2' ' A' ' 127' ' ' PRO . 4.2 tt -113.06 100.37 51.15 Favored Pre-proline 0 C--N 1.322 -0.61 0 C-N-CA 120.786 -0.365 . . . . 2.28 110.542 -178.062 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 127' ' ' PRO . . . . . 0.73 ' HG2' ' HB2' ' A' ' 130' ' ' LEU . 19.5 Cg_endo -58.98 151.17 67.7 Favored 'Trans proline' 0 C--N 1.347 0.496 0 C-N-CA 123.435 2.757 . . . . 1.33 112.645 176.624 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -58.38 -28.63 85.65 Favored 'Trans proline' 0 C--N 1.346 0.446 0 C-N-CA 123.329 2.686 . . . . 1.87 113.315 -175.608 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 4.1 p-80 -91.34 4.9 51.25 Favored 'General case' 0 C--N 1.329 -0.316 0 C-N-CA 120.836 -0.346 . . . . 1.29 111.226 -178.512 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . 0.73 ' HB2' ' HG2' ' A' ' 127' ' ' PRO . 41.7 tp -104.65 -2.95 24.35 Favored 'General case' 0 N--CA 1.444 -0.75 0 CA-C-O 121.185 0.517 . . . . 1.87 110.248 -177.121 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . 0.446 ' HA ' ' HD2' ' A' ' 132' ' ' PRO . 29.9 t -72.84 125.99 90.85 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 115.779 -0.646 . . . . 1.85 109.907 177.562 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 132' ' ' PRO . . . . . 0.446 ' HD2' ' HA ' ' A' ' 131' ' ' VAL . 3.8 Cg_endo -47.69 136.02 21.76 Favored 'Trans proline' 0 C--O 1.236 0.414 0 C-N-CA 123.074 2.516 . . . . 1.02 111.797 176.653 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 23.6 Cg_endo -60.81 -15.34 37.34 Favored 'Trans proline' 0 C--N 1.343 0.288 0 C-N-CA 123.222 2.615 . . . . 1.39 112.633 -174.525 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 19.7 p -90.35 -21.63 21.9 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.166 -0.47 . . . . 1.79 111.366 -179.451 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 62.8 mttt . . . . . 0 C--N 1.327 -0.404 0 CA-C-O 120.782 0.325 . . . . 1.79 111.555 -172.23 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' B' B ' 149' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.445 -0.726 0 N-CA-C 111.712 -0.555 . . . . 0.92 111.712 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' B' B ' 150' ' ' PRO . . . . . . . . . . . . . 91.8 Cg_endo -80.85 -1.52 11.28 Favored 'Trans proline' 0 CA--C 1.532 0.424 0 C-N-CA 123.176 2.584 . . . . 0.33 112.571 -178.631 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 151' ' ' PHE . . . . . 0.566 ' CZ ' ' HG3' ' A' ' 76' ' ' MET . 37.8 m-85 . . . . . 0 C--N 1.329 -0.314 0 CA-C-N 115.996 -0.547 . . . . 0.75 111.327 -178.388 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 16.8 pt-20 . . . . . 0 C--O 1.235 0.296 0 CA-C-O 121.214 0.53 . . . . 3.1 111.386 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' TRP . . . . . 0.436 ' HH2' ' O ' ' A' ' 104' ' ' GLU . 1.3 t90 -86.07 105.15 16.3 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 109.495 -0.557 . . . . 0.73 109.495 -178.612 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 23.6 m -64.82 -11.33 11.01 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.335 0 CA-C-O 121.034 0.445 . . . . 2.1 111.961 -177.292 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.432 HG12 ' HB2' ' A' ' 111' ' ' HIS . 42.1 t -82.04 -16.43 11.89 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 CA-C-O 121.31 0.576 . . . . 1.76 110.261 177.331 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . 0.515 ' HA2' ' HB2' ' A' ' 50' ' ' LYS . . . -74.25 -11.17 82.07 Favored Glycine 0 N--CA 1.446 -0.638 0 CA-C-N 115.684 -0.689 . . . . 0.59 112.701 -178.68 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 17.2 pttt -82.95 -28.44 29.82 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 120.347 -0.541 . . . . 3.11 109.978 -179.041 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 12.9 m-20 -106.77 30.75 5.83 Favored 'General case' 0 CA--C 1.509 -0.622 0 N-CA-C 108.593 -0.892 . . . . 1.66 108.593 176.972 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . 0.531 ' N ' ' HD2' ' A' ' 51' ' ' PRO . 15.0 tttp -92.0 -52.86 0.28 Allowed Pre-proline 0 C--N 1.317 -0.827 0 N-CA-C 112.521 0.563 . . . . 1.72 112.521 -171.207 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . 0.531 ' HD2' ' N ' ' A' ' 50' ' ' LYS . 4.8 Cg_endo -47.03 -39.54 25.46 Favored 'Trans proline' 0 C--N 1.357 0.998 0 C-N-CA 122.738 2.292 . . . . 1.07 112.981 -178.078 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 18.8 m -70.14 -42.77 72.13 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 116.003 -0.544 . . . . 1.38 110.55 -179.485 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 21.3 m-30 -71.74 -22.53 61.6 Favored 'General case' 0 CA--C 1.517 -0.312 0 CA-C-N 116.314 -0.403 . . . . 1.14 110.222 179.558 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 86.8 m-20 -72.96 -36.26 67.09 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.183 -0.462 . . . . 2.18 109.785 176.682 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . 0.464 ' HG3' ' O ' ' A' ' 51' ' ' PRO . 48.1 mt-10 -66.12 -40.75 90.93 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.017 -0.538 . . . . 2.33 110.472 176.659 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 44.8 mt -69.39 -37.38 75.25 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-O 121.582 0.706 . . . . 1.36 109.964 175.781 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . 0.455 ' HE1' HG12 ' A' ' 67' ' ' ILE . 78.2 t80 -59.62 -36.79 77.03 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.171 -0.922 . . . . 0.36 110.971 176.988 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . 0.489 ' HA ' ' HG3' ' A' ' 62' ' ' PRO . 14.2 m-30 -74.35 -23.38 59.01 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.481 -0.327 . . . . 1.85 111.047 -178.689 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 19.0 p -89.76 6.77 40.13 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 120.978 0.418 . . . . 1.12 111.371 -179.15 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 59.9 mt -105.38 5.75 32.04 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.121 -0.49 . . . . 2.02 110.193 173.956 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 19.2 m 66.42 82.7 0.2 Allowed Pre-proline 0 CA--C 1.532 0.276 0 CA-C-N 115.266 -0.879 . . . . 1.87 111.519 178.571 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . 0.489 ' HG3' ' HA ' ' A' ' 58' ' ' TYR . 36.7 Cg_endo -93.53 138.51 1.38 Allowed 'Trans proline' 0 N--CA 1.453 -0.885 0 C-N-CA 123.288 2.659 . . . . 0.62 113.162 -178.837 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 18.9 m -119.42 134.06 64.22 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 115.892 -0.595 . . . . 1.76 109.555 174.816 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 83.6 m-20 59.27 30.65 20.43 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-O 121.015 0.436 . . . . 1.82 110.986 -176.859 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 69.92 25.46 75.55 Favored Glycine 0 C--N 1.332 0.339 0 CA-C-N 115.959 -0.564 . . . . 0.51 112.598 178.47 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . 0.629 ' HA ' ' HA ' ' A' ' 102' ' ' ASP . 3.0 ptpp? -152.13 145.88 25.07 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.055 0.455 . . . . 2.12 111.425 179.528 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . 0.455 HG12 ' HE1' ' A' ' 57' ' ' PHE . 34.3 pt -107.9 142.77 19.73 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-N 116.078 -0.51 . . . . 1.28 109.766 176.887 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' THR . . . . . 0.675 ' HA ' ' HB2' ' A' ' 100' ' ' LEU . 23.2 p -64.51 161.4 17.37 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 116.382 -0.372 . . . . 1.21 110.455 177.638 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -62.3 -12.43 38.44 Favored Glycine 0 N--CA 1.448 -0.548 0 C-N-CA 120.78 -0.724 . . . . 0.48 112.24 -178.634 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . 0.45 ' O ' ' HG3' ' A' ' 74' ' ' LYS . . . -68.16 -50.04 57.09 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.326 0.584 . . . . 1.13 110.63 179.573 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . 0.907 ' HA ' ' HE3' ' A' ' 74' ' ' LYS . 35.0 m-80 -72.92 -38.84 66.71 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.564 -0.743 . . . . 1.81 110.32 -177.758 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -61.94 -41.63 98.17 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.69 -0.686 . . . . 1.09 110.097 176.766 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . 0.506 ' HG3' ' CE1' ' B' ' 151' ' ' PHE . 86.0 tttt -59.21 -43.06 92.29 Favored 'General case' 0 CA--C 1.519 -0.234 0 CA-C-N 115.964 -0.562 . . . . 1.63 110.216 176.639 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . 0.907 ' HE3' ' HA ' ' A' ' 71' ' ' ASN . 8.5 mtmp? -58.24 -42.03 85.45 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-N 116.318 -0.401 . . . . 2.43 111.091 179.114 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 15.4 tp10 -66.74 -44.92 80.24 Favored 'General case' 0 C--O 1.237 0.396 0 CA-C-O 121.476 0.655 . . . . 1.6 110.732 179.154 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' MET . . . . . 0.579 ' HB3' HD21 ' A' ' 86' ' ' LEU . 84.8 mtp -73.11 -21.9 60.66 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.78 -0.645 . . . . 1.92 111.687 -174.423 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 34.5 m -86.21 -12.32 11.08 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.455 0 C-N-CA 120.408 -0.517 . . . . 2.22 110.363 171.054 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.741 ' HG2' ' O ' ' A' ' 74' ' ' LYS . 40.6 mmtm -75.78 -26.93 57.78 Favored 'General case' 0 N--CA 1.469 0.498 0 N-CA-C 110.244 -0.28 . . . . 3.27 110.244 170.439 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -72.88 -11.62 60.66 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-O 120.798 0.332 . . . . 1.42 110.39 172.069 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 73.3 mttt 65.38 24.28 12.03 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-N 115.596 -0.729 . . . . 3.49 112.392 169.63 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.645 ' HB2' HD22 ' A' ' 86' ' ' LEU . 91.6 mt -83.77 161.86 54.57 Favored Pre-proline 0 C--N 1.325 -0.483 0 CA-C-N 116.302 -0.408 . . . . 1.17 110.786 179.763 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . 0.423 ' O ' ' HG ' ' A' ' 86' ' ' LEU . 52.1 Cg_exo -57.73 142.16 95.87 Favored 'Trans proline' 0 C--N 1.349 0.576 0 C-N-CA 123.073 2.515 . . . . 0.59 112.812 177.558 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 31.4 m-80 -59.03 -43.62 91.65 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 115.769 -0.65 . . . . 2.37 111.636 -175.237 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 2.9 p -63.64 -44.7 93.11 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.055 -0.52 . . . . 1.92 111.113 -179.208 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 60.6 t -64.18 -40.6 89.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 115.872 -0.604 . . . . 1.15 110.241 178.886 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.645 HD22 ' HB2' ' A' ' 81' ' ' LEU . 92.3 mt -59.57 -38.43 81.13 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.178 -0.465 . . . . 1.45 110.764 176.529 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -67.38 -37.61 90.57 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.686 -0.769 . . . . 0.32 112.24 178.386 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.21 -43.3 95.42 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 120.766 -0.374 . . . . 2.37 110.081 174.651 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 20.9 mt -62.37 -35.07 67.69 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.312 0 CA-C-N 116.07 -0.513 . . . . 1.42 110.387 175.831 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 71.4 t-105 -57.44 -53.93 52.59 Favored 'General case' 0 N--CA 1.452 -0.342 0 CA-C-O 120.561 0.219 . . . . 0.38 110.623 175.739 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . 0.817 ' HA ' ' HE2' ' A' ' 91' ' ' LYS . 0.6 OUTLIER -69.3 -15.57 63.37 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.989 0.423 . . . . 3.4 111.1 -176.989 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.432 HD23 ' HA ' ' A' ' 124' ' ' ALA . 14.8 tp -88.4 -32.06 18.53 Favored 'General case' 0 N--CA 1.437 -1.09 0 CA-C-O 120.89 0.376 . . . . 2.23 110.006 178.2 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . 0.766 ' HA ' HD13 ' A' ' 108' ' ' LEU . . . -87.89 -42.99 12.13 Favored 'General case' 0 C--O 1.232 0.184 0 CA-C-N 116.451 -0.34 . . . . 1.15 111.583 -179.571 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . 0.555 ' OD2' ' HA ' ' A' ' 97' ' ' LYS . 28.1 t0 -82.81 99.9 9.98 Favored 'General case' 0 C--O 1.236 0.376 0 CA-C-O 121.555 0.693 . . . . 0.79 110.029 179.667 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 45.3 t -83.09 -43.42 18.4 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.739 0 CA-C-N 115.282 -0.872 . . . . 1.23 110.883 -174.512 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 34.6 p-10 -82.63 -10.44 58.95 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.961 -0.563 . . . . 0.96 111.779 -173.666 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . 0.555 ' HA ' ' OD2' ' A' ' 94' ' ' ASP . 42.7 mtpt 57.91 73.0 0.49 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.402 0.62 . . . . 3.53 111.922 178.951 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . 0.486 ' OD2' ' HG ' ' A' ' 100' ' ' LEU . 16.9 p-10 -121.64 9.98 10.28 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 115.395 -0.82 . . . . 0.53 110.196 176.334 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 64.2 18.05 62.27 Favored Glycine 0 C--N 1.333 0.401 0 CA-C-N 115.713 -0.676 . . . . 0.45 112.208 177.706 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.675 ' HB2' ' HA ' ' A' ' 68' ' ' THR . 1.7 pp -155.02 166.32 33.95 Favored 'General case' 0 N--CA 1.444 -0.748 0 N-CA-C 108.468 -0.938 . . . . 1.72 108.468 -179.373 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 87.6 mt -126.44 123.66 38.36 Favored 'General case' 0 C--N 1.322 -0.615 0 C-N-CA 120.832 -0.347 . . . . 1.1 111.228 -173.581 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . 0.629 ' HA ' ' HA ' ' A' ' 66' ' ' LYS . 2.3 p30 -79.75 -177.1 5.73 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 109.31 -0.626 . . . . 1.72 109.31 170.906 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 3.1 p30 -62.12 -29.39 70.3 Favored 'General case' 0 C--N 1.322 -0.63 0 C-N-CA 120.905 -0.318 . . . . 1.6 111.503 -174.694 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . 0.491 ' HB3' ' HB3' ' A' ' 132' ' ' PRO . 78.3 mt-10 -70.97 -56.24 6.62 Favored 'General case' 0 C--O 1.232 0.178 0 N-CA-C 109.823 -0.436 . . . . 1.66 109.823 177.545 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 25.3 mt-10 -65.52 -33.33 75.68 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.838 -0.619 . . . . 0.64 110.977 -174.645 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 90.8 t80 -69.23 -42.96 74.99 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.53 -0.305 . . . . 0.54 110.235 178.13 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -59.95 -39.15 84.6 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-O 121.121 0.486 . . . . 1.09 110.092 176.35 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . 0.766 HD13 ' HA ' ' A' ' 93' ' ' ALA . 2.5 tm? -59.99 -51.69 68.6 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.625 -0.716 . . . . 1.98 109.492 176.862 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . 0.41 ' O ' HG13 ' A' ' 113' ' ' ILE . . . -57.61 -45.37 85.43 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 115.965 -0.562 . . . . 1.03 111.62 179.456 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -69.38 -30.99 69.1 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.741 0.305 . . . . 1.2 111.244 -178.588 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' HIS . . . . . 0.432 ' HB2' HG12 ' A' ' 46' ' ' VAL . 30.3 t60 -64.55 -35.15 80.04 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 108.862 -0.792 . . . . 0.65 108.862 175.426 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . 0.479 ' HA ' HG13 ' A' ' 115' ' ' VAL . 74.8 mt -71.18 -42.63 68.79 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.399 -0.818 . . . . 1.21 110.797 177.303 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . 0.41 HG13 ' O ' ' A' ' 109' ' ' ALA . 24.6 mt -55.52 -50.28 67.51 Favored 'Isoleucine or valine' 0 C--O 1.234 0.26 0 CA-C-O 121.209 0.528 . . . . 1.41 110.44 177.859 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 37.3 ttpt -69.95 -45.4 67.51 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.729 -0.669 . . . . 4.33 110.997 -175.417 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . 0.479 HG13 ' HA ' ' A' ' 112' ' ' LEU . 5.8 p -63.48 -30.61 50.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 120.95 0.405 . . . . 1.77 110.207 -178.557 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 116' ' ' LYS . . . . . 0.463 ' HD2' ' O ' ' A' ' 120' ' ' HIS . 34.6 tptt -69.28 -45.81 68.72 Favored 'General case' 0 N--CA 1.447 -0.61 0 CA-C-N 116.204 -0.453 . . . . 1.86 110.513 176.786 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 93.9 mt -74.56 -16.28 60.82 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.11 -0.496 . . . . 1.53 111.305 -179.198 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -84.47 6.05 25.0 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.594 0.711 . . . . 2.18 109.35 176.52 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 90.34 33.92 8.39 Favored Glycine 0 CA--C 1.518 0.272 0 CA-C-N 115.47 -0.786 . . . . 1.17 113.927 172.666 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 120' ' ' HIS . . . . . 0.463 ' O ' ' HD2' ' A' ' 116' ' ' LYS . 33.4 m-70 -112.62 155.36 24.55 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 117.04 0.42 . . . . 2.86 110.341 175.044 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 7.4 tp10 -111.52 127.98 55.88 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 109.864 -0.421 . . . . 2.53 109.864 179.167 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 2.4 pp -92.86 136.92 24.27 Favored Pre-proline 0 C--N 1.321 -0.637 0 CA-C-O 121.108 0.48 . . . . 1.8 111.761 -174.844 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_endo -73.42 -20.74 20.53 Favored 'Trans proline' 0 C--O 1.234 0.294 0 C-N-CA 123.147 2.564 . . . . 1.72 112.423 179.266 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . 0.432 ' HA ' HD23 ' A' ' 92' ' ' LEU . . . 66.78 18.26 10.66 Favored 'General case' 0 N--CA 1.462 0.138 0 CA-C-N 115.297 -0.865 . . . . 1.71 110.092 -172.712 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 29.0 m-20 -106.14 159.74 15.85 Favored 'General case' 0 CA--C 1.516 -0.341 0 N-CA-C 108.015 -1.105 . . . . 2.73 108.015 172.445 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . 0.431 ' HA ' ' HD2' ' A' ' 127' ' ' PRO . 49.2 tp -114.44 91.98 26.44 Favored Pre-proline 0 C--N 1.322 -0.601 0 C-N-CA 120.609 -0.436 . . . . 2.28 111.713 -176.982 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 127' ' ' PRO . . . . . 0.431 ' HD2' ' HA ' ' A' ' 126' ' ' LEU . 10.9 Cg_endo -58.5 146.45 90.64 Favored 'Trans proline' 0 CA--C 1.535 0.548 0 C-N-CA 122.836 2.357 . . . . 1.33 112.138 171.883 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 128' ' ' PRO . . . . . 0.409 ' HD3' ' HA ' ' A' ' 127' ' ' PRO . 76.0 Cg_exo -51.77 -39.47 67.28 Favored 'Trans proline' 0 C--N 1.346 0.435 0 C-N-CA 123.842 3.028 . . . . 1.87 114.27 -175.31 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 41.6 p-80 -79.0 13.67 1.68 Allowed 'General case' 0 N--CA 1.469 0.513 0 N-CA-C 112.463 0.542 . . . . 1.29 112.463 -175.368 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . 0.407 HD12 ' HG2' ' A' ' 127' ' ' PRO . 41.3 mt -111.8 4.21 18.25 Favored 'General case' 0 C--N 1.324 -0.501 0 C-N-CA 121.181 -0.208 . . . . 1.87 111.131 175.198 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 93.8 t -75.27 126.57 87.68 Favored Pre-proline 0 C--N 1.327 -0.37 0 CA-C-O 120.694 0.283 . . . . 1.85 110.923 -179.788 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 132' ' ' PRO . . . . . 0.491 ' HB3' ' HB3' ' A' ' 104' ' ' GLU . 54.4 Cg_exo -54.88 154.61 20.79 Favored 'Trans proline' 0 CA--C 1.533 0.455 0 C-N-CA 123.472 2.781 . . . . 1.02 113.316 -179.583 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -54.84 -54.55 4.3 Favored 'Trans proline' 0 C--N 1.347 0.468 0 C-N-CA 123.516 2.811 . . . . 1.39 113.987 -175.979 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 72.6 p -84.87 8.04 18.82 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 120.676 -0.41 . . . . 1.79 111.536 -175.464 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 135' ' ' LYS . . . . . 0.488 ' HD2' ' HG2' ' A' ' 132' ' ' PRO . 61.5 mttp . . . . . 0 C--N 1.329 -0.3 0 N-CA-C 111.876 0.324 . . . . 1.79 111.876 -177.411 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 149' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.443 -0.86 0 N-CA-C 111.277 -0.729 . . . . 0.92 111.277 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' B' B ' 150' ' ' PRO . . . . . . . . . . . . . 76.0 Cg_endo -74.77 -8.13 20.01 Favored 'Trans proline' 0 N--CA 1.463 -0.28 0 C-N-CA 122.448 2.099 . . . . 0.33 111.351 -179.187 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 151' ' ' PHE . . . . . 0.506 ' CE1' ' HG3' ' A' ' 73' ' ' LYS . 48.7 m-85 . . . . . 0 C--N 1.327 -0.381 0 CA-C-N 115.904 -0.589 . . . . 0.75 110.952 179.245 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 . . . . . 0 C--O 1.234 0.259 0 N-CA-C 109.404 -0.591 . . . . 3.1 109.404 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' TRP . . . . . 0.488 ' HH2' ' O ' ' A' ' 104' ' ' GLU . 3.2 t90 -85.6 109.41 18.53 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 120.967 0.413 . . . . 0.73 110.095 -178.034 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 11.7 p -63.12 -17.62 19.91 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.433 0 CA-C-N 115.671 -0.695 . . . . 2.1 111.909 -175.822 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.408 HG12 ' HA ' ' A' ' 108' ' ' LEU . 46.9 t -82.06 -22.25 9.79 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-O 121.151 0.5 . . . . 1.76 110.425 179.105 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . 0.685 ' HA2' ' HG3' ' A' ' 50' ' ' LYS . . . -73.31 -11.91 79.74 Favored Glycine 0 CA--C 1.517 0.161 0 CA-C-N 115.739 -0.664 . . . . 0.59 113.481 -173.232 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 21.9 ptmt -77.83 -19.59 54.65 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.854 0.327 . . . . 3.11 111.158 -176.927 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 42.7 t0 -117.35 33.88 5.4 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.863 0.839 . . . . 1.66 109.503 179.956 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . 0.685 ' HG3' ' HA2' ' A' ' 47' ' ' GLY . 24.1 mtpt -69.18 -42.0 20.15 Favored Pre-proline 0 C--O 1.22 -0.454 0 CA-C-N 115.652 -0.704 . . . . 1.72 112.793 -179.601 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_exo -44.21 -41.33 13.06 Favored 'Trans proline' 0 C--N 1.359 1.082 0 C-N-CA 122.202 1.935 . . . . 1.07 112.733 176.699 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 15.4 m -70.44 -45.5 65.69 Favored 'General case' 0 C--O 1.238 0.456 0 CA-C-N 116.203 -0.453 . . . . 1.38 111.156 -179.277 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 7.2 m-85 -74.12 -22.01 59.64 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.534 -0.303 . . . . 1.14 110.589 -176.998 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -76.09 -39.72 54.68 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 108.932 -0.766 . . . . 2.18 108.932 178.007 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 44.4 tt0 -58.38 -47.86 82.48 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.241 -0.89 . . . . 2.33 110.218 175.282 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 55.7 mt -67.45 -52.09 45.36 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 115.644 -0.707 . . . . 1.36 111.384 179.697 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . 0.559 ' HE1' HG12 ' A' ' 67' ' ' ILE . 72.7 t80 -55.65 -32.57 63.3 Favored 'General case' 0 C--N 1.326 -0.435 0 C-N-CA 122.872 0.469 . . . . 0.36 112.017 -176.695 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . 0.433 ' CE1' ' HD2' ' A' ' 57' ' ' PHE . 2.6 m-85 -88.52 -2.23 58.48 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 111.835 0.309 . . . . 1.85 111.835 -176.416 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 79.0 p -100.36 -12.69 19.22 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.18 0.514 . . . . 1.12 109.99 173.476 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 10.4 mp -88.42 6.62 36.64 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.687 -0.688 . . . . 2.02 110.768 177.885 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 52.0 m 62.87 83.6 0.2 Allowed Pre-proline 0 CA--C 1.531 0.212 0 CA-C-N 115.558 -0.746 . . . . 1.87 111.203 -178.6 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 75.2 Cg_endo -83.36 137.16 8.02 Favored 'Trans proline' 0 N--CA 1.458 -0.598 0 C-N-CA 122.763 2.309 . . . . 0.62 112.893 -178.157 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 47.4 t -104.71 103.82 15.89 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 CA-C-N 116.105 -0.498 . . . . 1.76 110.25 178.191 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 93.2 m-20 60.57 25.78 15.47 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-N 116.042 -0.527 . . . . 1.82 111.605 177.497 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 92.54 17.46 45.38 Favored Glycine 0 C--O 1.227 -0.303 0 C-N-CA 120.788 -0.72 . . . . 0.51 112.712 178.533 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . 0.614 ' HA ' ' HA ' ' A' ' 102' ' ' ASP . 59.4 mttm -141.41 134.64 29.42 Favored 'General case' 0 C--N 1.324 -0.532 0 C-N-CA 122.95 0.5 . . . . 2.12 110.242 177.734 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . 0.559 HG12 ' HE1' ' A' ' 57' ' ' PHE . 30.0 pt -103.25 150.57 6.7 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 N-CA-C 110.197 -0.297 . . . . 1.28 110.197 173.321 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 59.3 p -73.62 166.3 23.51 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.272 -0.422 . . . . 1.21 111.078 -176.307 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -68.06 -18.82 71.32 Favored Glycine 0 N--CA 1.447 -0.622 0 C-N-CA 120.801 -0.714 . . . . 0.48 112.162 178.265 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -74.28 -39.52 62.9 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.374 0.607 . . . . 1.13 110.294 176.126 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 12.3 m120 -73.45 -41.36 63.3 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.686 -0.688 . . . . 1.81 109.309 178.771 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -62.05 -37.63 85.68 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.232 -0.895 . . . . 1.09 110.248 174.153 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . 0.427 ' O ' HG21 ' A' ' 77' ' ' VAL . 22.8 ttmm -55.74 -52.02 65.34 Favored 'General case' 0 C--O 1.221 -0.404 0 CA-C-N 115.86 -0.609 . . . . 1.63 109.862 174.66 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . 0.418 ' O ' ' HG2' ' A' ' 78' ' ' LYS . 68.4 mttm -54.95 -46.23 74.99 Favored 'General case' 0 C--N 1.329 -0.321 0 O-C-N 123.38 0.425 . . . . 2.43 111.389 -179.395 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 20.7 tp10 -63.75 -49.72 71.9 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.838 0.352 . . . . 1.6 110.895 -179.401 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' MET . . . . . 0.734 ' HB3' HD23 ' A' ' 86' ' ' LEU . 96.5 mmm -66.54 -27.91 68.12 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.247 0.546 . . . . 1.92 111.285 -178.34 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.427 HG21 ' O ' ' A' ' 73' ' ' LYS . 37.2 t -71.65 -34.53 52.64 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-N 115.907 -0.588 . . . . 2.22 110.044 175.066 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.418 ' HG2' ' O ' ' A' ' 74' ' ' LYS . 29.5 mmmt -69.85 -22.46 63.26 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.925 -0.579 . . . . 3.27 110.277 174.872 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' SER . . . . . 0.44 ' C ' ' HG2' ' A' ' 80' ' ' LYS . 15.7 m -76.02 -4.81 43.33 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.951 -0.568 . . . . 1.42 110.711 178.333 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . 0.44 ' HG2' ' C ' ' A' ' 79' ' ' SER . 18.5 ptmt 47.2 32.6 2.14 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 124.07 0.948 . . . . 3.49 112.863 175.821 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.408 ' HB2' HD21 ' A' ' 86' ' ' LEU . 85.7 mt -97.22 150.16 36.51 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 116.094 -0.503 . . . . 1.17 110.089 176.487 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . 0.496 ' O ' ' HG ' ' A' ' 86' ' ' LEU . 52.9 Cg_exo -55.51 145.39 69.27 Favored 'Trans proline' 0 C--O 1.234 0.293 0 C-N-CA 122.658 2.239 . . . . 0.59 112.347 179.636 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 21.1 p-10 -55.21 -41.71 72.39 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-N 116.35 -0.387 . . . . 2.37 111.693 -177.046 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 9.4 m -55.06 -45.87 75.36 Favored 'General case' 0 N--CA 1.448 -0.542 0 CA-C-N 115.821 -0.627 . . . . 1.92 110.748 177.826 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 80.5 t -72.28 -32.04 41.22 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.177 0 CA-C-N 115.902 -0.59 . . . . 1.15 110.891 -179.821 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.734 HD23 ' HB3' ' A' ' 76' ' ' MET . 80.4 mt -61.78 -43.66 98.42 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 110.079 -0.341 . . . . 1.45 110.079 175.906 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -66.88 -34.35 86.87 Favored Glycine 0 N--CA 1.452 -0.299 0 N-CA-C 111.511 -0.635 . . . . 0.32 111.511 178.09 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . 0.516 ' O ' HD21 ' A' ' 92' ' ' LEU . 35.5 mmtm -58.12 -58.69 7.35 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.946 0.403 . . . . 2.37 110.124 174.189 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 56.0 mt -62.11 -35.22 67.57 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 115.747 -0.661 . . . . 1.42 110.932 -177.483 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 50.7 t-105 -58.02 -49.03 78.28 Favored 'General case' 0 C--O 1.223 -0.325 0 C-N-CA 120.707 -0.397 . . . . 0.38 110.293 175.287 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 20.8 ttmm -61.95 -39.84 93.48 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.298 -0.41 . . . . 3.4 111.7 -177.526 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.819 HD12 ' HG ' ' A' ' 126' ' ' LEU . 4.3 mm? -76.74 -24.55 53.01 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 111.888 0.329 . . . . 2.23 111.888 -179.253 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -93.05 -42.21 9.55 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.648 0.261 . . . . 1.15 111.618 -178.291 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . 0.468 ' OD2' ' HA ' ' A' ' 97' ' ' LYS . 30.8 t0 -82.66 87.16 6.74 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.51 0.671 . . . . 0.79 109.484 179.674 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 47.4 t -80.77 -34.75 14.27 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 CA-C-N 115.197 -0.911 . . . . 1.23 110.718 -174.271 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 48.4 p-10 -82.43 -13.92 55.99 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.503 -0.317 . . . . 0.96 110.453 -179.294 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . 0.468 ' HA ' ' OD2' ' A' ' 94' ' ' ASP . 31.7 mtmm 57.72 54.74 6.03 Favored 'General case' 0 C--O 1.231 0.118 0 O-C-N 123.778 0.674 . . . . 3.53 110.816 173.614 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 16.2 p-10 -110.2 8.66 23.77 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.59 -0.732 . . . . 0.53 110.891 -174.775 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 71.64 7.08 64.19 Favored Glycine 0 N--CA 1.453 -0.205 0 C-N-CA 120.633 -0.794 . . . . 0.45 112.429 179.717 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 4.3 mp -135.04 155.18 51.2 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 109.516 -0.55 . . . . 1.72 109.516 178.143 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 77.7 mt -109.68 114.09 27.4 Favored 'General case' 0 C--N 1.315 -0.933 0 N-CA-C 109.399 -0.593 . . . . 1.1 109.399 175.831 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . 0.614 ' HA ' ' HA ' ' A' ' 66' ' ' LYS . 2.9 p30 -79.87 -176.05 5.24 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.255 -0.429 . . . . 1.72 110.65 179.698 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -55.07 -42.1 72.35 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.826 -0.624 . . . . 1.6 111.277 -178.719 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . 0.488 ' O ' ' HH2' ' A' ' 44' ' ' TRP . 49.9 mt-10 -72.32 -52.78 14.69 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.193 -0.458 . . . . 1.66 110.335 179.728 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 36.6 mt-10 -64.02 -37.77 88.63 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.106 -0.497 . . . . 0.64 111.193 -172.951 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . 0.49 ' CD2' ' HD1' ' A' ' 57' ' ' PHE . 49.5 t80 -74.79 -34.58 62.45 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.412 -0.358 . . . . 0.54 110.3 -179.327 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -60.07 -42.64 94.99 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-O 121.075 0.465 . . . . 1.09 110.003 173.689 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . 0.408 ' HA ' HG12 ' A' ' 46' ' ' VAL . 6.9 tt -62.1 -47.56 84.07 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-N 115.86 -0.609 . . . . 1.98 109.74 176.643 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . 0.499 ' O ' HG13 ' A' ' 113' ' ' ILE . . . -55.82 -52.03 65.41 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 115.885 -0.598 . . . . 1.03 111.195 179.2 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' ASN . . . . . 0.449 HD21 HD11 ' A' ' 113' ' ' ILE . 12.4 m120 -59.13 -35.14 72.95 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-O 120.721 0.296 . . . . 1.2 110.992 179.375 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' HIS . . . . . 0.464 ' O ' HG23 ' A' ' 115' ' ' VAL . 24.8 t60 -64.21 -39.94 95.02 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.282 -0.417 . . . . 0.65 110.193 -179.49 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 59.7 mt -74.85 -34.29 62.26 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.297 -0.41 . . . . 1.21 110.976 178.252 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . 0.499 HG13 ' O ' ' A' ' 109' ' ' ALA . 82.5 mt -59.32 -45.27 93.37 Favored 'Isoleucine or valine' 0 C--O 1.234 0.279 0 CA-C-O 121.242 0.544 . . . . 1.41 109.61 173.955 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 114' ' ' LYS . . . . . 0.415 ' HA ' ' HE3' ' A' ' 114' ' ' LYS . 0.1 OUTLIER -60.54 -42.65 96.95 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.216 -0.902 . . . . 4.33 110.163 177.808 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . 0.57 HG13 ' HB2' ' A' ' 120' ' ' HIS . 40.6 t -53.53 -47.07 60.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.015 -0.539 . . . . 1.77 110.978 176.103 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 27.6 mmmt -69.62 -38.75 77.36 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.403 -0.362 . . . . 1.86 111.246 -179.42 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 94.7 mt -66.51 -29.09 69.11 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.128 0.489 . . . . 1.53 111.009 177.805 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 5.4 tp10 -77.53 -22.11 51.61 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.47 0.652 . . . . 2.18 110.044 178.858 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 99.57 19.71 19.5 Favored Glycine 0 N--CA 1.445 -0.702 0 CA-C-N 115.458 -0.792 . . . . 1.17 112.657 179.919 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 120' ' ' HIS . . . . . 0.57 ' HB2' HG13 ' A' ' 115' ' ' VAL . 29.2 m-70 -97.4 167.07 11.23 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 109.425 -0.583 . . . . 2.86 109.425 175.907 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 7.4 tp10 -114.86 145.77 41.81 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-O 120.717 0.294 . . . . 2.53 110.223 -179.154 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . 0.476 ' HA ' ' HD3' ' A' ' 123' ' ' PRO . 3.1 pp -106.87 139.98 20.92 Favored Pre-proline 0 C--N 1.323 -0.545 0 N-CA-C 109.473 -0.566 . . . . 1.8 109.473 177.133 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . 0.476 ' HD3' ' HA ' ' A' ' 122' ' ' LEU . 9.5 Cg_exo -72.58 0.17 7.95 Favored 'Trans proline' 0 C--O 1.232 0.19 0 C-N-CA 122.743 2.295 . . . . 1.72 113.16 -176.55 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . 58.83 23.67 11.54 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-O 121.202 0.525 . . . . 1.71 110.592 -176.874 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 5.6 t0 -132.27 170.63 14.77 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 108.31 -0.996 . . . . 2.73 108.31 -179.87 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . 0.819 ' HG ' HD12 ' A' ' 92' ' ' LEU . 19.2 mt -116.76 105.93 48.91 Favored Pre-proline 0 C--N 1.321 -0.668 0 N-CA-C 112.116 0.413 . . . . 2.28 112.116 -175.21 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 127' ' ' PRO . . . . . 0.429 ' HD2' ' HB2' ' A' ' 130' ' ' LEU . 12.1 Cg_exo -70.94 147.67 55.81 Favored 'Trans proline' 0 N--CA 1.459 -0.502 0 C-N-CA 122.611 2.207 . . . . 1.33 110.778 169.919 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_exo -50.39 -37.87 51.81 Favored 'Trans proline' 0 CA--C 1.531 0.373 0 C-N-CA 122.944 2.429 . . . . 1.87 113.596 -178.311 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 44.3 p-80 -82.18 3.95 25.25 Favored 'General case' 0 CA--C 1.533 0.306 0 N-CA-C 111.961 0.356 . . . . 1.29 111.961 -178.168 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . 0.429 ' HB2' ' HD2' ' A' ' 127' ' ' PRO . 2.4 mm? -101.06 -20.01 15.55 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.665 0.269 . . . . 1.87 110.582 174.35 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 43.4 t -74.85 126.54 88.24 Favored Pre-proline 0 C--N 1.325 -0.459 0 CA-C-N 116.127 -0.488 . . . . 1.85 110.606 -178.989 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_exo -55.64 134.0 61.39 Favored 'Trans proline' 0 C--N 1.345 0.391 0 C-N-CA 122.587 2.191 . . . . 1.02 111.722 177.224 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -58.31 -23.32 62.31 Favored 'Trans proline' 0 CA--C 1.529 0.256 0 C-N-CA 122.961 2.441 . . . . 1.39 112.955 -176.64 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 5.5 m -82.01 -16.77 49.14 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.413 -0.358 . . . . 1.79 111.304 -179.72 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 6.2 mptt . . . . . 0 C--N 1.33 -0.268 0 N-CA-C 111.776 0.287 . . . . 1.79 111.776 -176.404 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' B' B ' 149' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.443 -0.84 0 N-CA-C 112.395 -0.282 . . . . 0.92 112.395 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' B' B ' 150' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -73.83 -2.14 11.81 Favored 'Trans proline' 0 C--O 1.232 0.191 0 C-N-CA 122.844 2.362 . . . . 0.33 112.318 -178.272 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 151' ' ' PHE . . . . . . . . . . . . . 26.9 m-85 . . . . . 0 C--N 1.326 -0.444 0 CA-C-N 115.961 -0.563 . . . . 0.75 110.409 178.491 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 . . . . . 0 N--CA 1.45 -0.432 0 CA-C-O 121.157 0.503 . . . . 3.1 110.547 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 9.8 t90 -83.44 122.02 27.95 Favored 'General case' 0 C--N 1.318 -0.803 0 N-CA-C 108.796 -0.816 . . . . 0.73 108.796 179.834 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 33.6 m -61.48 -15.9 13.87 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.521 0 N-CA-C 114.316 1.228 . . . . 2.1 114.316 -166.793 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.409 HG21 ' O ' ' A' ' 107' ' ' ALA . 11.5 p -92.45 -14.06 8.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 C-N-CA 120.033 -0.667 . . . . 1.76 110.541 178.346 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -64.55 -25.41 70.17 Favored Glycine 0 CA--C 1.519 0.305 0 C-N-CA 120.964 -0.636 . . . . 0.59 112.955 -177.115 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . 0.491 ' HG3' ' OD2' ' A' ' 49' ' ' ASP . 11.5 ptmm? -76.63 -19.44 57.8 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.599 0.238 . . . . 3.11 111.149 -179.226 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . 0.491 ' OD2' ' HG3' ' A' ' 48' ' ' LYS . 10.5 m-20 -127.14 34.56 4.72 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 109.362 -0.607 . . . . 1.66 109.362 179.571 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . 0.42 ' HG2' ' OD1' ' A' ' 54' ' ' ASP . 56.7 tttm -86.61 -48.13 0.51 Allowed Pre-proline 0 C--N 1.324 -0.541 0 CA-C-N 115.862 -0.608 . . . . 1.72 112.308 -172.725 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . 0.403 ' HD3' ' HB3' ' A' ' 50' ' ' LYS . 84.3 Cg_exo -49.61 -31.22 24.11 Favored 'Trans proline' 0 C--N 1.361 1.202 0 C-N-CA 122.158 1.905 . . . . 1.07 113.003 -179.88 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 11.0 m -70.14 -45.43 66.81 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.252 -0.431 . . . . 1.38 110.502 177.763 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 19.9 m-30 -73.67 -23.25 59.82 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.395 -0.366 . . . . 1.14 110.291 -177.81 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . 0.42 ' OD1' ' HG2' ' A' ' 50' ' ' LYS . 0.9 OUTLIER -72.59 -40.6 66.44 Favored 'General case' 0 CA--C 1.517 -0.305 0 N-CA-C 109.683 -0.488 . . . . 2.18 109.683 174.657 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 2.6 mm-40 -58.76 -36.93 75.18 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.039 -0.528 . . . . 2.33 110.58 176.012 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 35.3 mt -75.65 -40.29 40.31 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-O 121.119 0.485 . . . . 1.36 110.298 177.183 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . 0.41 ' HD2' ' CD1' ' A' ' 58' ' ' TYR . 86.5 t80 -57.1 -38.18 73.01 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.685 -0.689 . . . . 0.36 111.409 179.132 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . 0.506 ' HA ' ' HG3' ' A' ' 62' ' ' PRO . 19.8 m-30 -80.32 -3.77 50.77 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.383 -0.372 . . . . 1.85 111.578 -174.208 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 75.3 p -100.2 -2.4 34.04 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.878 0.371 . . . . 1.12 111.034 179.609 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 74.6 mt -102.09 16.7 25.28 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.393 -0.367 . . . . 2.02 110.615 179.753 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 48.3 t 63.06 80.89 0.24 Allowed Pre-proline 0 CA--C 1.532 0.283 0 CA-C-N 115.53 -0.759 . . . . 1.87 111.237 -179.209 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . 0.575 ' HA ' HG23 ' A' ' 67' ' ' ILE . 6.2 Cg_exo -78.59 143.88 19.4 Favored 'Trans proline' 0 N--CA 1.461 -0.427 0 C-N-CA 122.899 2.399 . . . . 0.62 112.007 178.84 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 16.7 m -122.86 117.43 51.78 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-N 116.284 -0.416 . . . . 1.76 110.191 176.161 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 13.7 m120 62.07 23.35 13.77 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-N 115.984 -0.553 . . . . 1.82 111.182 -179.823 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 90.57 5.77 68.79 Favored Glycine 0 C--O 1.229 -0.201 0 C-N-CA 120.961 -0.638 . . . . 0.51 113.043 178.375 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . 0.614 ' HG2' ' HA ' ' A' ' 102' ' ' ASP . 37.0 mtpt -135.52 157.93 45.64 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 109.952 -0.388 . . . . 2.12 109.952 -178.692 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . 0.575 HG23 ' HA ' ' A' ' 62' ' ' PRO . 48.8 pt -124.95 164.07 24.38 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-O 120.988 0.423 . . . . 1.28 110.943 177.416 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 37.5 p -82.25 165.57 20.31 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.339 -0.846 . . . . 1.21 110.893 179.992 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -72.1 -12.98 76.17 Favored Glycine 0 N--CA 1.447 -0.614 0 C-N-CA 120.988 -0.625 . . . . 0.48 112.56 179.599 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . 0.405 ' O ' ' HG3' ' A' ' 74' ' ' LYS . . . -64.46 -58.97 4.93 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.079 0.466 . . . . 1.13 111.068 -179.216 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 39.4 m-80 -68.89 -38.54 79.72 Favored 'General case' 0 C--O 1.238 0.454 0 CA-C-N 115.809 -0.632 . . . . 1.81 110.451 -178.06 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -59.25 -43.2 92.45 Favored 'General case' 0 N--CA 1.45 -0.425 0 CA-C-N 115.608 -0.723 . . . . 1.09 109.951 176.542 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -62.23 -39.54 93.16 Favored 'General case' 0 C--O 1.224 -0.276 0 CA-C-N 116.362 -0.381 . . . . 1.63 110.906 177.85 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . 0.475 ' O ' HG11 ' A' ' 77' ' ' VAL . 57.6 mtpt -59.14 -33.43 70.87 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-O 121.008 0.432 . . . . 2.43 110.693 178.731 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . 0.467 ' O ' ' HG3' ' A' ' 78' ' ' LYS . 40.9 tt0 -81.34 -50.67 9.22 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 116.172 -0.467 . . . . 1.6 110.368 -179.496 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' MET . . . . . 0.72 ' HB3' HD21 ' A' ' 86' ' ' LEU . 75.1 mmm -57.4 -27.49 62.39 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.803 -0.635 . . . . 1.92 110.327 178.672 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.475 HG11 ' O ' ' A' ' 74' ' ' LYS . 1.5 p -86.95 -28.01 5.8 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.535 0 CA-C-N 115.942 -0.572 . . . . 2.22 110.968 -179.082 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.476 ' C ' ' HD3' ' A' ' 78' ' ' LYS . 0.0 OUTLIER -82.28 -14.38 55.51 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-O 120.886 0.374 . . . . 3.27 110.26 -179.096 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 2.0 p -78.6 4.43 13.53 Favored 'General case' 0 CA--C 1.531 0.214 0 CA-C-N 116.323 -0.399 . . . . 1.42 110.396 170.343 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 52.3 mtpt 63.5 32.81 14.0 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 115.403 -0.817 . . . . 3.49 112.247 172.535 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.635 ' HB2' HD22 ' A' ' 86' ' ' LEU . 88.7 mt -102.17 141.39 22.44 Favored Pre-proline 0 C--N 1.318 -0.778 0 CA-C-N 116.417 -0.356 . . . . 1.17 110.118 176.956 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . 0.524 ' O ' ' HG ' ' A' ' 86' ' ' LEU . 51.7 Cg_exo -56.14 136.74 76.69 Favored 'Trans proline' 0 C--N 1.344 0.306 0 C-N-CA 122.821 2.347 . . . . 0.59 112.706 179.52 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 18.2 p30 -51.93 -34.9 43.79 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-N 115.846 -0.616 . . . . 2.37 112.437 -179.866 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 30.1 m -69.48 -39.07 77.89 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 121.006 0.432 . . . . 1.92 110.608 -179.553 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.408 HG22 ' HB2' ' A' ' 82' ' ' PRO . 58.8 t -67.69 -36.23 75.33 Favored 'Isoleucine or valine' 0 C--O 1.234 0.277 0 N-CA-C 109.325 -0.62 . . . . 1.15 109.325 176.573 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.72 HD21 ' HB3' ' A' ' 76' ' ' MET . 65.4 mt -63.84 -33.47 75.75 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.348 -0.842 . . . . 1.45 109.876 175.807 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -68.58 -38.28 86.07 Favored Glycine 0 N--CA 1.451 -0.363 0 N-CA-C 111.57 -0.612 . . . . 0.32 111.57 178.931 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . 0.409 ' O ' ' HG ' ' A' ' 92' ' ' LEU . 73.1 mmtt -57.7 -52.82 63.86 Favored 'General case' 0 C--O 1.24 0.563 0 CA-C-O 121.638 0.733 . . . . 2.37 109.582 173.814 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . 0.407 HG23 HD12 ' A' ' 112' ' ' LEU . 45.4 mt -65.12 -34.88 73.59 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.453 0 CA-C-N 114.924 -1.034 . . . . 1.42 111.389 -178.148 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' TRP . . . . . 0.455 ' HB2' ' CE2' ' B' ' 151' ' ' PHE . 55.0 t-105 -60.45 -46.09 91.33 Favored 'General case' 0 C--N 1.333 -0.118 0 CA-C-O 120.795 0.331 . . . . 0.38 110.149 175.814 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 30.8 ttpt -66.39 -20.86 66.18 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.846 -0.615 . . . . 3.4 110.807 -178.611 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.749 HD12 ' HA ' ' A' ' 124' ' ' ALA . 82.6 mt -92.35 -31.56 15.3 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.437 -0.347 . . . . 2.23 111.682 177.4 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -86.54 -41.49 14.28 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.506 -0.315 . . . . 1.15 111.835 -174.39 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 36.3 t0 -80.86 81.26 7.16 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 108.982 -0.747 . . . . 0.79 108.982 178.137 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . 0.697 ' HB ' ' HD3' ' A' ' 135' ' ' LYS . 46.2 t -75.35 -34.7 31.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 115.027 -0.988 . . . . 1.23 111.083 -173.519 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . 0.548 ' HB3' ' HE3' ' A' ' 135' ' ' LYS . 15.5 p-10 -82.58 -8.46 59.61 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 109.514 -0.551 . . . . 0.96 109.514 179.05 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 97.0 mttt 49.65 73.06 0.27 Allowed 'General case' 0 C--O 1.235 0.314 0 CA-C-N 115.403 -0.817 . . . . 3.53 111.455 175.229 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . 0.478 ' OD2' ' HB2' ' A' ' 100' ' ' LEU . 9.5 p-10 -134.69 9.5 3.63 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.624 -0.716 . . . . 0.53 111.067 -173.837 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 73.75 -4.64 28.14 Favored Glycine 0 C--N 1.331 0.288 0 C-N-CA 120.791 -0.719 . . . . 0.45 112.407 178.699 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.478 ' HB2' ' OD2' ' A' ' 98' ' ' ASP . 89.2 mt -120.86 154.35 35.93 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 109.051 -0.722 . . . . 1.72 109.051 178.401 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 75.3 mt -108.32 122.77 47.67 Favored 'General case' 0 C--N 1.31 -1.138 0 C-N-CA 120.487 -0.485 . . . . 1.1 110.146 178.011 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . 0.665 ' HB2' ' HG3' ' A' ' 105' ' ' GLU . 16.0 m-20 -68.83 168.36 13.63 Favored 'General case' 0 CA--C 1.512 -0.508 0 N-CA-C 108.113 -1.069 . . . . 1.72 108.113 170.111 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -61.53 -29.82 70.24 Favored 'General case' 0 C--N 1.317 -0.81 0 N-CA-C 109.202 -0.666 . . . . 1.6 109.202 174.527 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 50.7 mt-10 -64.64 -55.52 19.69 Favored 'General case' 0 C--O 1.231 0.092 0 CA-C-N 115.762 -0.654 . . . . 1.66 110.148 173.495 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . 0.665 ' HG3' ' HB2' ' A' ' 102' ' ' ASP . 14.4 mt-10 -62.4 -39.85 94.6 Favored 'General case' 0 N--CA 1.463 0.207 0 CA-C-N 115.454 -0.793 . . . . 0.64 110.956 -173.914 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 79.7 t80 -64.21 -47.86 78.09 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.671 -0.695 . . . . 0.54 110.524 178.193 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . 0.409 ' O ' HG21 ' A' ' 46' ' ' VAL . . . -57.67 -45.61 85.36 Favored 'General case' 0 N--CA 1.454 -0.258 0 CA-C-N 116.278 -0.419 . . . . 1.09 110.754 178.704 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 55.1 tp -59.48 -47.37 85.75 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.486 -0.325 . . . . 1.98 110.735 -179.906 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . 0.578 ' O ' HG12 ' A' ' 113' ' ' ILE . . . -58.61 -46.85 86.14 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.224 -0.444 . . . . 1.03 110.595 177.974 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' ASN . . . . . 0.412 ' O ' ' HB ' ' A' ' 113' ' ' ILE . 0.6 OUTLIER -60.59 -36.5 78.7 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 115.903 -0.589 . . . . 1.2 111.388 179.044 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' HIS . . . . . 0.722 ' O ' HG21 ' A' ' 115' ' ' VAL . 24.8 t60 -62.94 -48.13 80.26 Favored 'General case' 0 CA--C 1.513 -0.449 0 N-CA-C 108.78 -0.822 . . . . 0.65 108.78 177.192 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . 0.407 HD12 HG23 ' A' ' 89' ' ' ILE . 97.8 mt -58.16 -34.64 70.53 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.527 -0.76 . . . . 1.21 110.795 177.521 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . 0.578 HG12 ' O ' ' A' ' 109' ' ' ALA . 36.9 mm -56.46 -52.32 54.11 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.235 0 CA-C-O 121.515 0.674 . . . . 1.41 110.309 173.605 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 18.4 tppt? -63.13 -45.83 90.11 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.016 -0.993 . . . . 4.33 111.523 -177.416 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . 0.722 HG21 ' O ' ' A' ' 111' ' ' HIS . 2.2 t -73.89 -23.82 19.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-O 120.82 0.343 . . . . 1.77 110.294 -176.499 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 14.6 tppt? -64.89 -49.48 70.31 Favored 'General case' 0 CA--C 1.52 -0.175 0 N-CA-C 109.487 -0.56 . . . . 1.86 109.487 170.264 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 86.2 mt -70.41 -15.15 62.81 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.553 -0.749 . . . . 1.53 110.88 -179.804 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 7.2 tp10 -71.35 -16.44 62.43 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.104 0.478 . . . . 2.18 109.784 175.331 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 98.67 23.97 11.46 Favored Glycine 0 N--CA 1.451 -0.36 0 N-CA-C 111.124 -0.79 . . . . 1.17 111.124 179.443 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 18.2 t60 -117.84 121.57 41.09 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 121.122 0.487 . . . . 2.86 110.867 -177.584 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 47.9 mm-40 -83.59 119.88 25.28 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.361 -0.836 . . . . 2.53 110.725 177.55 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . 0.761 ' H ' HD23 ' A' ' 122' ' ' LEU . 1.3 pt? -78.58 139.37 58.87 Favored Pre-proline 0 C--N 1.322 -0.626 0 N-CA-C 109.019 -0.734 . . . . 1.8 109.019 172.948 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . 0.447 ' HD3' ' HA ' ' A' ' 122' ' ' LEU . 7.8 Cg_exo -72.78 10.03 1.16 Allowed 'Trans proline' 0 C--N 1.345 0.374 0 C-N-CA 123.205 2.604 . . . . 1.72 112.792 -176.055 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . 0.749 ' HA ' HD12 ' A' ' 92' ' ' LEU . . . 59.14 29.94 19.61 Favored 'General case' 0 C--O 1.232 0.141 0 CA-C-N 116.239 -0.437 . . . . 1.71 110.946 -179.771 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 37.8 t70 -132.53 156.92 45.95 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.819 -0.628 . . . . 2.73 109.882 -179.688 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . 0.634 ' HG ' HD23 ' A' ' 92' ' ' LEU . 84.3 mt -110.46 103.34 53.94 Favored Pre-proline 0 C--N 1.327 -0.41 0 N-CA-C 112.055 0.391 . . . . 2.28 112.055 -175.814 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 127' ' ' PRO . . . . . 0.481 ' HD2' HD11 ' A' ' 130' ' ' LEU . 56.6 Cg_endo -72.21 161.46 44.48 Favored 'Trans proline' 0 C--O 1.234 0.321 0 C-N-CA 122.803 2.335 . . . . 1.33 111.085 171.249 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 75.5 Cg_exo -50.49 -40.39 54.22 Favored 'Trans proline' 0 C--N 1.346 0.446 0 C-N-CA 123.178 2.585 . . . . 1.87 113.836 -176.672 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 23.4 p-80 -81.29 14.56 2.35 Favored 'General case' 0 CA--C 1.533 0.324 0 N-CA-C 112.828 0.677 . . . . 1.29 112.828 -174.381 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . 0.481 HD11 ' HD2' ' A' ' 127' ' ' PRO . 12.7 mt -114.39 2.41 14.69 Favored 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 120.791 -0.363 . . . . 1.87 111.072 174.69 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 46.3 t -84.39 121.48 75.16 Favored Pre-proline 0 C--N 1.324 -0.539 0 CA-C-N 116.326 -0.397 . . . . 1.85 110.492 -178.455 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 44.7 Cg_exo -56.77 142.75 91.96 Favored 'Trans proline' 0 C--N 1.347 0.484 0 C-N-CA 123.097 2.531 . . . . 1.02 112.804 -179.974 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 11.8 Cg_endo -55.45 -36.16 93.53 Favored 'Trans proline' 0 CA--C 1.531 0.345 0 C-N-CA 123.739 2.959 . . . . 1.39 113.62 -176.682 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 4.4 m -83.82 -9.59 58.66 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.012 0.434 . . . . 1.79 110.885 -178.19 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 135' ' ' LYS . . . . . 0.697 ' HD3' ' HB ' ' A' ' 95' ' ' VAL . 49.5 mttp . . . . . 0 C--N 1.324 -0.511 0 CA-C-N 116.056 -0.52 . . . . 1.79 110.843 -173.867 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 149' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.446 -0.675 0 N-CA-C 111.878 -0.489 . . . . 0.92 111.878 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' B' B ' 150' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -74.72 -2.02 11.91 Favored 'Trans proline' 0 CA--C 1.533 0.465 0 C-N-CA 123.053 2.502 . . . . 0.33 113.159 -176.585 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 151' ' ' PHE . . . . . 0.455 ' CE2' ' HB2' ' A' ' 90' ' ' TRP . 30.2 m-85 . . . . . 0 C--N 1.326 -0.449 0 N-CA-C 112.119 0.414 . . . . 0.75 112.119 -174.344 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 17.9 mm-40 . . . . . 0 C--O 1.233 0.222 0 CA-C-O 120.771 0.319 . . . . 3.1 110.474 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 5.7 t90 -81.91 103.14 11.36 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 109.243 -0.651 . . . . 0.73 109.243 176.912 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.485 ' O ' ' HG2' ' A' ' 48' ' ' LYS . 21.2 m -60.2 -19.86 18.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 N-CA-C 112.978 0.733 . . . . 2.1 112.978 -173.172 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 28.3 t -78.94 -16.79 13.41 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-O 121.177 0.513 . . . . 1.76 110.856 -178.834 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -74.08 -9.54 80.36 Favored Glycine 0 N--CA 1.448 -0.526 0 C-N-CA 120.851 -0.69 . . . . 0.59 113.414 -175.476 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . 0.621 ' HB3' ' HZ3' ' A' ' 48' ' ' LYS . 1.1 ptpm? -83.93 -27.66 28.4 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 117.3 0.55 . . . . 3.11 111.112 -178.787 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 21.5 m-20 -100.6 33.83 2.62 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.824 0.345 . . . . 1.66 110.266 -179.465 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . 0.549 ' N ' ' HD2' ' A' ' 51' ' ' PRO . 14.9 mmtp -69.35 -51.03 17.99 Favored Pre-proline 0 C--N 1.324 -0.53 0 N-CA-C 112.83 0.678 . . . . 1.72 112.83 -177.017 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . 0.586 ' HA ' ' OD2' ' A' ' 54' ' ' ASP . 4.6 Cg_endo -48.34 -42.04 34.69 Favored 'Trans proline' 0 C--N 1.356 0.966 0 C-N-CA 122.707 2.271 . . . . 1.07 113.217 -177.966 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' THR . . . . . 0.474 ' O ' ' HB3' ' A' ' 55' ' ' GLU . 21.9 m -70.93 -39.93 72.36 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.375 0.607 . . . . 1.38 110.932 -179.419 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' TYR . . . . . 0.466 ' HH ' ' HA ' ' A' ' 111' ' ' HIS . 21.2 m-30 -79.25 -22.09 45.23 Favored 'General case' 0 C--N 1.324 -0.51 0 C-N-CA 120.603 -0.439 . . . . 1.14 111.114 -175.857 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . 0.586 ' OD2' ' HA ' ' A' ' 51' ' ' PRO . 0.6 OUTLIER -82.1 -25.48 34.45 Favored 'General case' 0 CA--C 1.52 -0.18 0 N-CA-C 108.945 -0.761 . . . . 2.18 108.945 175.166 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . 0.474 ' HB3' ' O ' ' A' ' 52' ' ' THR . 9.5 tp10 -59.37 -43.14 92.9 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.478 -0.783 . . . . 2.33 109.102 169.598 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.433 HG12 ' O ' ' A' ' 52' ' ' THR . 27.6 mm -76.18 -34.82 26.91 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.331 0 CA-C-N 115.841 -0.618 . . . . 1.36 110.521 178.092 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . 0.488 ' CE2' ' HB3' ' A' ' 62' ' ' PRO . 74.0 t80 -65.72 -46.6 78.32 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.122 -0.49 . . . . 0.36 111.372 -176.725 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 15.1 m-85 -80.33 -7.94 59.28 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.382 -0.372 . . . . 1.85 111.922 -174.493 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 15.5 p -92.65 -4.34 53.44 Favored 'General case' 0 C--N 1.323 -0.572 0 C-N-CA 120.717 -0.393 . . . . 1.12 110.693 177.064 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.454 ' HB3' ' HB3' ' A' ' 71' ' ' ASN . 73.0 mt -108.08 13.24 26.16 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.299 -0.41 . . . . 2.02 111.266 178.026 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 15.8 m 68.53 87.42 0.11 Allowed Pre-proline 0 N--CA 1.469 0.525 0 CA-C-N 116.03 -0.532 . . . . 1.87 112.171 175.698 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . 0.488 ' HB3' ' CE2' ' A' ' 57' ' ' PHE . 5.6 Cg_exo -80.69 138.89 12.18 Favored 'Trans proline' 0 N--CA 1.46 -0.47 0 C-N-CA 122.862 2.375 . . . . 0.62 112.635 178.206 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 11.0 m -127.94 117.83 47.05 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-N 115.819 -0.628 . . . . 1.76 110.216 175.168 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 49.3 m-80 66.39 24.27 10.5 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-N 115.694 -0.684 . . . . 1.82 111.389 178.661 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 92.96 8.15 62.01 Favored Glycine 0 C--N 1.331 0.275 0 C-N-CA 121.018 -0.611 . . . . 0.51 112.788 176.847 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . 0.768 ' HG2' ' HA ' ' A' ' 102' ' ' ASP . 55.1 mtmt -143.28 153.96 43.31 Favored 'General case' 0 C--N 1.326 -0.422 0 C-N-CA 122.381 0.272 . . . . 2.12 110.397 -177.165 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . 0.422 HD11 ' CD1' ' A' ' 106' ' ' PHE . 41.0 pt -110.68 153.92 12.36 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.763 0 N-CA-C 110.011 -0.366 . . . . 1.28 110.011 174.957 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 18.6 p -72.7 152.5 41.65 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.285 -0.416 . . . . 1.21 111.151 179.589 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -61.8 -15.93 49.96 Favored Glycine 0 N--CA 1.448 -0.54 0 C-N-CA 121.071 -0.585 . . . . 0.48 112.947 -179.434 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -60.36 -50.46 73.51 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.133 0.492 . . . . 1.13 111.213 177.636 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . 0.548 ' HA ' ' HD3' ' A' ' 74' ' ' LYS . 39.9 m-80 -74.93 -34.23 62.08 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.826 -0.624 . . . . 1.81 110.38 -175.778 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -61.42 -45.28 94.99 Favored 'General case' 0 N--CA 1.449 -0.489 0 CA-C-N 115.929 -0.578 . . . . 1.09 109.528 173.961 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . 0.584 ' HA ' ' CZ ' ' B' ' 151' ' ' PHE . 54.9 tttp -56.08 -38.43 70.67 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.777 -0.647 . . . . 1.63 110.383 177.296 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . 0.548 ' HD3' ' HA ' ' A' ' 71' ' ' ASN . 26.8 mtpp -65.49 -32.88 74.73 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.952 -0.567 . . . . 2.43 111.256 178.671 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 18.2 tp10 -76.31 -39.39 54.27 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.164 0.507 . . . . 1.6 110.039 177.701 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' MET . . . . . 0.546 ' HB3' HD21 ' A' ' 86' ' ' LEU . 1.1 mpt? -60.71 -36.43 78.78 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 116.378 -0.374 . . . . 1.92 111.471 176.386 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.405 HG23 ' HA ' ' A' ' 74' ' ' LYS . 17.9 m -82.38 -13.88 12.2 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.507 0 C-N-CA 120.701 -0.4 . . . . 2.22 110.978 177.455 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 46.7 mmtt -74.29 -29.74 61.77 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-O 120.867 0.365 . . . . 3.27 111.029 171.396 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -83.9 -13.61 53.09 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.155 -0.475 . . . . 1.42 111.122 -178.931 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 56.2 mttp 68.29 33.01 4.43 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 115.639 -0.709 . . . . 3.49 111.927 171.788 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.713 ' HB2' HD22 ' A' ' 86' ' ' LEU . 97.2 mt -86.32 151.6 53.98 Favored Pre-proline 0 C--N 1.326 -0.453 0 N-CA-C 109.68 -0.489 . . . . 1.17 109.68 175.682 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -54.46 142.91 69.11 Favored 'Trans proline' 0 C--N 1.35 0.628 0 C-N-CA 122.887 2.391 . . . . 0.59 112.65 179.336 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 39.9 m-80 -52.36 -48.05 65.76 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 115.615 -0.72 . . . . 2.37 112.141 -175.61 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' THR . . . . . 0.415 ' O ' ' HD3' ' A' ' 88' ' ' LYS . 38.8 p -63.76 -42.73 97.77 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.912 0.387 . . . . 1.92 110.757 -178.837 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 84.7 t -59.85 -39.24 79.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 115.85 -0.614 . . . . 1.15 110.584 179.247 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.713 HD22 ' HB2' ' A' ' 81' ' ' LEU . 93.6 mt -65.75 -29.37 69.87 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.435 -0.348 . . . . 1.45 110.521 177.333 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -65.77 -41.41 95.73 Favored Glycine 0 CA--C 1.502 -0.753 0 N-CA-C 111.086 -0.806 . . . . 0.32 111.086 175.151 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . 0.415 ' HD3' ' O ' ' A' ' 84' ' ' THR . 2.5 mptp? -75.06 -28.33 60.32 Favored 'General case' 0 N--CA 1.443 -0.808 0 CA-C-N 115.464 -0.368 . . . . 2.37 110.846 178.605 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 16.4 mm -60.15 -49.44 84.08 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.254 0 CA-C-N 116.325 -0.398 . . . . 1.42 110.222 173.153 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' TRP . . . . . 0.41 ' HB2' ' CD2' ' B' ' 151' ' ' PHE . 52.4 t-105 -62.38 -45.33 93.62 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.917 0.389 . . . . 0.38 110.578 178.073 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 17.4 ttmm -54.85 -32.33 60.49 Favored 'General case' 0 C--O 1.237 0.447 0 CA-C-N 115.665 -0.698 . . . . 3.4 111.585 179.276 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.543 HD23 ' HA ' ' A' ' 124' ' ' ALA . 13.0 tp -93.93 -36.92 11.96 Favored 'General case' 0 N--CA 1.442 -0.846 0 CA-C-N 115.906 -0.588 . . . . 2.23 111.782 -176.439 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -81.36 -42.48 20.44 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.753 0.311 . . . . 1.15 111.718 -174.53 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . 0.654 ' OD2' ' HA ' ' A' ' 97' ' ' LYS . 50.0 t0 -78.03 96.72 5.16 Favored 'General case' 0 C--O 1.237 0.417 0 N-CA-C 108.689 -0.856 . . . . 0.79 108.689 178.049 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 38.3 t -68.86 -45.16 81.14 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-N 115.481 -0.781 . . . . 1.23 110.965 -172.497 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 29.0 p-10 -88.6 -17.96 29.04 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 116.092 -0.504 . . . . 0.96 111.694 -176.779 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . 0.654 ' HA ' ' OD2' ' A' ' 94' ' ' ASP . 53.0 mttp 58.07 72.89 0.5 Allowed 'General case' 0 CA--C 1.518 -0.278 0 CA-C-O 122.063 0.935 . . . . 3.53 111.32 177.838 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . 0.413 ' OD2' ' HB2' ' A' ' 100' ' ' LEU . 11.5 p-10 -122.83 9.05 9.41 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 114.589 -1.187 . . . . 0.53 110.868 -173.169 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 78.19 -3.78 60.92 Favored Glycine 0 CA--C 1.52 0.369 0 C-N-CA 121.001 -0.619 . . . . 0.45 112.468 -179.554 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.413 ' HB2' ' OD2' ' A' ' 98' ' ' ASP . 4.6 mp -128.86 166.23 19.47 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 109.726 -0.472 . . . . 1.72 109.726 175.922 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 81.7 mt -123.75 127.52 48.26 Favored 'General case' 0 C--N 1.314 -0.951 0 CA-C-N 116.128 -0.487 . . . . 1.1 109.799 176.999 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . 0.768 ' HA ' ' HG2' ' A' ' 66' ' ' LYS . 2.6 m-20 -69.72 168.42 14.99 Favored 'General case' 0 CA--C 1.509 -0.631 0 N-CA-C 108.799 -0.815 . . . . 1.72 108.799 174.334 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -57.61 -30.28 65.2 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 108.46 -0.941 . . . . 1.6 108.46 171.772 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 6.4 mm-40 -66.97 -58.81 4.23 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-N 115.11 -0.95 . . . . 1.66 111.851 177.195 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . 0.574 ' OE1' ' HE3' ' A' ' 135' ' ' LYS . 2.4 pt-20 -78.91 -18.09 54.44 Favored 'General case' 0 CA--C 1.53 0.187 0 C-N-CA 120.283 -0.567 . . . . 0.64 112.236 -173.822 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . 0.422 ' CD1' HD11 ' A' ' 67' ' ' ILE . 50.3 t80 -76.64 -34.17 58.31 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 109.164 -0.68 . . . . 0.54 109.164 173.603 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -62.23 -44.49 96.44 Favored 'General case' 0 N--CA 1.452 -0.363 0 CA-C-N 115.672 -0.694 . . . . 1.09 109.262 171.663 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . 0.429 ' O ' ' HG ' ' A' ' 112' ' ' LEU . 4.8 tt -60.39 -46.28 90.54 Favored 'General case' 0 CA--C 1.533 0.305 0 CA-C-N 115.491 -0.777 . . . . 1.98 109.847 178.326 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -56.17 -49.65 73.41 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 116.484 -0.326 . . . . 1.03 111.363 178.361 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 22.5 m-80 -65.06 -32.53 74.28 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.423 -0.353 . . . . 1.2 111.31 179.626 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' HIS . . . . . 0.466 ' HA ' ' HH ' ' A' ' 53' ' ' TYR . 11.9 t60 -68.28 -35.59 78.09 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 109.689 -0.485 . . . . 0.65 109.689 178.091 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . 0.429 ' HG ' ' O ' ' A' ' 108' ' ' LEU . 95.8 mt -65.61 -46.88 77.65 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 116.323 -0.398 . . . . 1.21 110.324 175.713 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 62.7 mt -56.7 -45.03 82.63 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.177 0 CA-C-N 115.767 -0.651 . . . . 1.41 109.709 177.254 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 17.1 tppt? -56.85 -49.99 73.78 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.054 -0.975 . . . . 4.33 110.919 178.191 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . 0.649 HG12 ' HB2' ' A' ' 120' ' ' HIS . 45.9 t -58.68 -42.87 86.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.194 -0.457 . . . . 1.77 111.57 -178.716 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 17.5 tppt? -70.02 -41.51 74.19 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 116.628 -0.26 . . . . 1.86 110.698 -179.257 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 74.5 mt -68.61 -30.69 69.48 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.881 0.372 . . . . 1.53 111.04 179.287 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -74.96 -16.7 60.63 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.917 -0.583 . . . . 2.18 110.483 179.696 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 99.25 32.83 5.65 Favored Glycine 0 N--CA 1.449 -0.486 0 C-N-CA 120.744 -0.741 . . . . 1.17 113.02 175.96 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 120' ' ' HIS . . . . . 0.649 ' HB2' HG12 ' A' ' 115' ' ' VAL . 78.4 m-70 -119.54 -179.52 3.9 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 109.79 -0.448 . . . . 2.86 109.79 177.692 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -117.46 149.27 40.85 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 120.956 0.408 . . . . 2.53 111.166 -176.119 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 2.6 pp -108.3 143.53 27.62 Favored Pre-proline 0 C--N 1.324 -0.542 0 CA-C-N 115.516 -0.766 . . . . 1.8 109.784 175.346 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -73.34 -13.9 25.41 Favored 'Trans proline' 0 C--N 1.343 0.261 0 C-N-CA 122.395 2.064 . . . . 1.72 113.164 -176.338 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . 0.543 ' HA ' HD23 ' A' ' 92' ' ' LEU . . . 61.01 17.68 8.18 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 123.162 0.585 . . . . 1.71 111.392 -177.402 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -134.4 163.13 30.36 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 107.817 -1.179 . . . . 2.73 107.817 174.268 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 64.2 mt -109.2 93.88 14.11 Favored Pre-proline 0 C--N 1.322 -0.614 0 CA-C-O 120.724 0.297 . . . . 2.28 111.515 -177.016 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 127' ' ' PRO . . . . . 0.422 ' HD2' HD12 ' A' ' 130' ' ' LEU . 63.5 Cg_endo -75.77 155.67 39.48 Favored 'Trans proline' 0 N--CA 1.459 -0.554 0 C-N-CA 122.571 2.181 . . . . 1.33 111.141 173.667 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 90.0 Cg_exo -44.44 -37.2 10.48 Favored 'Trans proline' 0 CA--C 1.533 0.452 0 C-N-CA 123.478 2.785 . . . . 1.87 114.557 -177.874 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 41.0 p-80 -82.03 10.27 6.9 Favored 'General case' 0 N--CA 1.466 0.339 0 C-N-CA 120.793 -0.363 . . . . 1.29 111.851 -175.503 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . 0.422 HD12 ' HD2' ' A' ' 127' ' ' PRO . 66.6 mt -126.99 1.57 6.57 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.514 0.197 . . . . 1.87 111.48 176.335 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 43.0 t -85.06 122.9 74.09 Favored Pre-proline 0 C--N 1.326 -0.456 0 N-CA-C 110.515 -0.18 . . . . 1.85 110.515 -178.74 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_exo -56.12 129.2 33.58 Favored 'Trans proline' 0 C--N 1.346 0.407 0 C-N-CA 122.99 2.46 . . . . 1.02 112.329 178.881 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 25.4 Cg_exo -62.01 -18.85 63.77 Favored 'Trans proline' 0 C--N 1.345 0.393 0 C-N-CA 122.884 2.39 . . . . 1.39 112.692 -177.131 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 8.4 p -77.24 -21.5 53.66 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 116.061 -0.518 . . . . 1.79 111.72 -179.317 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 135' ' ' LYS . . . . . 0.574 ' HE3' ' OE1' ' A' ' 105' ' ' GLU . 68.4 mttm . . . . . 0 C--N 1.328 -0.328 0 N-CA-C 111.721 0.267 . . . . 1.79 111.721 -175.074 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 149' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.445 -0.75 0 N-CA-C 111.748 -0.541 . . . . 0.92 111.748 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' B' B ' 150' ' ' PRO . . . . . . . . . . . . . 90.0 Cg_endo -80.79 -0.69 10.78 Favored 'Trans proline' 0 N--CA 1.461 -0.389 0 C-N-CA 122.864 2.376 . . . . 0.33 112.319 179.766 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 151' ' ' PHE . . . . . 0.584 ' CZ ' ' HA ' ' A' ' 73' ' ' LYS . 56.7 m-85 . . . . . 0 C--N 1.331 -0.207 0 N-CA-C 112.56 0.578 . . . . 0.75 112.56 -177.554 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 . . . . . 0 N--CA 1.455 -0.193 0 N-CA-C 109.755 -0.461 . . . . 3.1 109.755 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 5.1 t90 -83.11 104.08 13.03 Favored 'General case' 0 N--CA 1.444 -0.764 0 N-CA-C 107.698 -1.223 . . . . 0.73 107.698 168.93 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.41 ' HA ' ' HE3' ' A' ' 48' ' ' LYS . 29.7 m -69.82 4.89 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.234 0 CA-C-O 121.228 0.537 . . . . 2.1 111.628 -175.677 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.417 HG11 ' HA ' ' A' ' 108' ' ' LEU . 42.1 t -103.62 -29.48 2.9 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.818 0 CA-C-N 115.711 -0.677 . . . . 1.76 109.874 172.239 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . 0.522 ' HA2' ' HB2' ' A' ' 50' ' ' LYS . . . -82.89 -10.12 83.47 Favored Glycine 0 N--CA 1.448 -0.54 0 CA-C-N 115.88 -0.6 . . . . 0.59 113.023 -175.528 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . 0.41 ' HE3' ' HA ' ' A' ' 45' ' ' VAL . 17.2 ptpt -81.55 -25.89 35.48 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.772 0.32 . . . . 3.11 110.315 177.145 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 12.0 m-20 -110.11 33.21 4.58 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 108.948 -0.76 . . . . 1.66 108.948 173.577 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . 0.665 ' N ' ' HD2' ' A' ' 51' ' ' PRO . 17.3 ttpp -77.35 -43.04 2.58 Favored Pre-proline 0 C--O 1.219 -0.538 0 CA-C-O 118.633 -0.699 . . . . 1.72 112.067 -174.779 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . 0.665 ' HD2' ' N ' ' A' ' 50' ' ' LYS . 1.3 Cg_endo -44.74 -36.31 10.41 Favored 'Trans proline' 0 C--N 1.362 1.284 0 C-N-CA 123.0 2.467 . . . . 1.07 113.471 178.493 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 13.0 m -69.51 -45.49 68.75 Favored 'General case' 0 C--O 1.238 0.49 0 CA-C-O 121.111 0.481 . . . . 1.38 110.459 178.657 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 21.7 m-85 -70.97 -22.35 62.21 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.027 -0.533 . . . . 1.14 109.92 178.936 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -68.77 -45.03 72.44 Favored 'General case' 0 CA--C 1.513 -0.471 0 CA-C-N 116.163 -0.471 . . . . 2.18 109.856 175.667 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -61.78 -44.85 96.07 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.79 -0.641 . . . . 2.33 109.937 -179.821 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 45.0 mt -65.78 -40.95 89.17 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-N 115.798 -0.637 . . . . 1.36 110.84 177.634 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 77.7 t80 -61.9 -39.34 91.66 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.677 -0.692 . . . . 0.36 111.297 179.397 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 4.1 m-30 -79.79 -22.58 42.93 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.56 -0.291 . . . . 1.85 111.2 -175.573 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 28.2 p -79.57 -10.15 59.75 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.72 0.295 . . . . 1.12 111.446 178.257 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 53.7 mt -88.92 -0.47 57.42 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.566 -0.288 . . . . 2.02 110.246 175.274 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 55.7 m 62.43 81.04 0.24 Allowed Pre-proline 0 CA--C 1.533 0.313 0 O-C-N 123.788 0.68 . . . . 1.87 110.986 -176.86 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -76.61 157.54 36.02 Favored 'Trans proline' 0 N--CA 1.46 -0.482 0 C-N-CA 122.827 2.351 . . . . 0.62 112.307 -179.011 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 15.4 m -123.96 115.64 45.61 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 CA-C-N 116.157 -0.474 . . . . 1.76 110.073 177.231 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 82.6 m-20 63.82 24.71 13.85 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 115.467 -0.788 . . . . 1.82 111.375 179.809 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 88.69 10.52 67.19 Favored Glycine 0 C--N 1.33 0.224 0 C-N-CA 120.992 -0.623 . . . . 0.51 112.957 178.334 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . 0.538 ' HE2' ' OD1' ' A' ' 102' ' ' ASP . 82.2 mttt -136.13 154.45 50.98 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 110.152 -0.314 . . . . 2.12 110.152 179.687 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 40.9 pt -116.77 159.16 16.93 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 C-N-CA 121.109 -0.236 . . . . 1.28 110.397 174.942 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' THR . . . . . 0.497 ' HA ' HD21 ' A' ' 100' ' ' LEU . 44.8 p -80.85 169.85 17.03 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.324 -0.398 . . . . 1.21 110.148 -179.593 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . 0.521 ' O ' ' HB2' ' A' ' 73' ' ' LYS . . . -64.25 -16.98 61.0 Favored Glycine 0 N--CA 1.447 -0.626 0 C-N-CA 120.653 -0.784 . . . . 0.48 112.503 177.314 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -68.86 -46.75 67.68 Favored 'General case' 0 C--O 1.235 0.325 0 CA-C-O 121.219 0.533 . . . . 1.13 111.743 -179.139 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 1.7 m120 -72.71 -43.17 63.35 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.815 -0.629 . . . . 1.81 109.716 -174.575 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -64.1 -35.24 80.09 Favored 'General case' 0 N--CA 1.448 -0.568 0 CA-C-N 115.527 -0.761 . . . . 1.09 110.137 176.061 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . 0.521 ' HB2' ' O ' ' A' ' 69' ' ' GLY . 34.3 tttp -56.23 -45.11 80.11 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 116.13 -0.486 . . . . 1.63 110.194 176.259 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . 0.773 ' O ' ' HG2' ' A' ' 78' ' ' LYS . 45.8 mtpt -67.75 -31.38 71.26 Favored 'General case' 0 C--O 1.217 -0.651 0 CA-C-N 115.601 -0.727 . . . . 2.43 111.041 -178.742 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 13.9 tp10 -71.78 -47.52 52.89 Favored 'General case' 0 C--N 1.314 -0.971 0 CA-C-O 121.531 0.682 . . . . 1.6 109.753 178.52 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' MET . . . . . 0.77 ' HG3' ' HZ ' ' B' ' 151' ' ' PHE . 16.0 mmt -55.52 -42.36 74.42 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.095 -0.957 . . . . 1.92 109.684 175.691 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.622 HG13 ' O ' ' A' ' 74' ' ' LYS . 1.1 p -74.12 -23.27 18.55 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.413 0 CA-C-N 115.276 -0.875 . . . . 2.22 111.301 -177.226 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.773 ' HG2' ' O ' ' A' ' 74' ' ' LYS . 31.8 mmmt -73.56 -28.53 61.9 Favored 'General case' 0 CA--C 1.517 -0.319 0 CA-C-O 121.063 0.459 . . . . 3.27 109.872 176.165 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 45.1 m -81.91 -5.56 58.38 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.781 -0.645 . . . . 1.42 110.439 178.336 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 45.0 mttp 65.51 23.18 11.84 Favored 'General case' 0 N--CA 1.465 0.325 0 CA-C-N 115.418 -0.81 . . . . 3.49 112.03 169.078 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.7 ' HB2' HD21 ' A' ' 86' ' ' LEU . 88.0 mt -85.59 148.65 49.64 Favored Pre-proline 0 C--N 1.322 -0.626 0 CA-C-N 116.413 -0.358 . . . . 1.17 110.216 178.836 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . 0.524 ' O ' ' HG ' ' A' ' 86' ' ' LEU . 50.8 Cg_exo -54.91 137.34 75.46 Favored 'Trans proline' 0 C--N 1.344 0.294 0 C-N-CA 123.105 2.537 . . . . 0.59 112.206 179.043 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . 0.536 ' HA ' HD12 ' A' ' 86' ' ' LEU . 4.6 p30 -60.16 -34.81 74.09 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-N 115.954 -0.566 . . . . 2.37 110.965 -174.225 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 63.3 m -63.39 -40.6 97.65 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.674 -0.694 . . . . 1.92 110.379 177.697 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.462 HG22 ' HB2' ' A' ' 82' ' ' PRO . 52.3 t -71.66 -34.49 52.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 115.835 -0.62 . . . . 1.15 109.862 178.088 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.71 HD23 ' HB3' ' A' ' 76' ' ' MET . 77.1 mt -63.46 -33.9 76.57 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.969 -0.56 . . . . 1.45 110.073 174.728 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -66.78 -38.05 92.78 Favored Glycine 0 N--CA 1.45 -0.423 0 N-CA-C 111.362 -0.695 . . . . 0.32 111.362 176.064 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . 0.412 ' HB2' ' O ' ' A' ' 85' ' ' VAL . 71.7 mmtt -58.15 -49.48 76.87 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 109.974 -0.38 . . . . 2.37 109.974 172.125 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . 0.405 HG12 ' O ' ' A' ' 85' ' ' VAL . 40.3 mm -59.32 -48.4 87.15 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.197 0 CA-C-N 115.752 -0.658 . . . . 1.42 111.294 -179.297 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' TRP . . . . . 0.401 ' HB2' ' HE2' ' B' ' 151' ' ' PHE . 41.8 t-105 -62.83 -45.16 93.9 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.937 0.398 . . . . 0.38 111.087 -178.563 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 21.1 ttpp -64.27 -27.64 69.18 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.06 -0.518 . . . . 3.4 111.285 -176.783 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.432 HD11 ' HG ' ' A' ' 126' ' ' LEU . 14.5 tp -93.9 -48.49 6.25 Favored 'General case' 0 N--CA 1.445 -0.696 0 N-CA-C 112.154 0.427 . . . . 2.23 112.154 -175.946 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -73.3 -41.12 63.95 Favored 'General case' 0 N--CA 1.463 0.21 0 N-CA-C 111.847 0.314 . . . . 1.15 111.847 -174.259 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . 0.616 ' OD2' ' HA ' ' A' ' 97' ' ' LYS . 21.9 t70 -78.08 96.34 5.11 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 108.965 -0.754 . . . . 0.79 108.965 176.089 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 45.7 t -78.31 -36.22 20.51 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 CA-C-N 115.647 -0.706 . . . . 1.23 111.08 -171.516 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 5.7 p30 -83.5 -11.39 57.51 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 116.042 -0.526 . . . . 0.96 112.03 -174.942 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . 0.616 ' HA ' ' OD2' ' A' ' 94' ' ' ASP . 0.0 OUTLIER 59.08 30.89 20.8 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-O 121.26 0.552 . . . . 3.53 111.181 172.981 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . 0.643 ' OD2' ' HB2' ' A' ' 100' ' ' LEU . 8.6 p-10 -86.83 9.8 18.02 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 115.453 -0.794 . . . . 0.53 111.24 -173.564 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 66.9 9.18 52.32 Favored Glycine 0 C--N 1.332 0.331 0 CA-C-N 116.089 -0.505 . . . . 0.45 112.476 -178.987 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.643 ' HB2' ' OD2' ' A' ' 98' ' ' ASP . 72.3 mt -135.18 161.45 35.32 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 109.145 -0.687 . . . . 1.72 109.145 179.955 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 80.1 mt -117.86 125.5 50.64 Favored 'General case' 0 C--N 1.311 -1.09 0 C-N-CA 120.725 -0.39 . . . . 1.1 110.035 176.73 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . 0.538 ' OD1' ' HE2' ' A' ' 66' ' ' LYS . 11.5 m-20 -68.94 172.51 6.5 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 108.111 -1.07 . . . . 1.72 108.111 172.939 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 2.0 p30 -63.16 -32.63 74.07 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 109.186 -0.672 . . . . 1.6 109.186 177.113 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 51.9 mt-10 -72.16 -45.2 61.41 Favored 'General case' 0 N--CA 1.452 -0.336 0 CA-C-N 115.888 -0.596 . . . . 1.66 110.956 175.463 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 29.7 mt-10 -64.89 -39.54 93.69 Favored 'General case' 0 N--CA 1.462 0.156 0 C-N-CA 120.818 -0.353 . . . . 0.64 110.449 -176.996 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 90.2 t80 -65.55 -40.87 93.33 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.298 -0.41 . . . . 0.54 110.173 177.214 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -58.7 -47.42 84.62 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.246 -0.433 . . . . 1.09 110.688 176.158 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . 0.417 ' HA ' HG11 ' A' ' 46' ' ' VAL . 60.4 tp -61.82 -45.94 91.65 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-N 116.32 -0.4 . . . . 1.98 110.972 178.463 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . 0.674 ' O ' HG13 ' A' ' 113' ' ' ILE . . . -56.09 -57.16 13.32 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.052 -0.522 . . . . 1.03 110.549 177.878 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' ASN . . . . . 0.512 ' HA ' HD11 ' A' ' 113' ' ' ILE . 1.1 t-20 -56.31 -36.27 68.5 Favored 'General case' 0 CA--C 1.521 -0.162 0 CA-C-N 116.049 -0.523 . . . . 1.2 111.395 179.684 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 13.3 t60 -63.67 -39.92 95.55 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.159 -0.473 . . . . 0.65 110.174 -179.655 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . 0.4 ' O ' HG11 ' A' ' 115' ' ' VAL . 94.6 mt -74.08 -39.86 63.15 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.27 -0.423 . . . . 1.21 110.498 178.302 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . 0.674 HG13 ' O ' ' A' ' 109' ' ' ALA . 54.0 mt -58.42 -49.53 81.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-O 121.531 0.681 . . . . 1.41 110.361 177.647 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 114' ' ' LYS . . . . . 0.575 ' HE2' HD11 ' A' ' 117' ' ' LEU . 0.0 OUTLIER -71.31 -24.97 62.23 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.403 -0.817 . . . . 4.33 110.827 -177.157 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . 0.4 HG11 ' O ' ' A' ' 112' ' ' LEU . 0.4 OUTLIER -72.78 -33.29 43.58 Favored 'Isoleucine or valine' 0 C--O 1.235 0.306 0 N-CA-C 109.75 -0.463 . . . . 1.77 109.75 177.195 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 116' ' ' LYS . . . . . 0.442 ' HD2' ' O ' ' A' ' 120' ' ' HIS . 19.6 tptp -66.1 -39.5 90.03 Favored 'General case' 0 N--CA 1.442 -0.834 0 CA-C-N 116.125 -0.488 . . . . 1.86 109.929 173.06 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . 0.575 HD11 ' HE2' ' A' ' 114' ' ' LYS . 80.1 mt -65.45 -23.54 66.96 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 116.066 -0.515 . . . . 1.53 110.554 176.508 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 24.6 mm-40 -78.53 -7.01 57.05 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.918 -0.583 . . . . 2.18 111.237 177.878 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 86.22 25.53 36.59 Favored Glycine 0 N--CA 1.448 -0.508 0 C-N-CA 120.652 -0.785 . . . . 1.17 112.154 -179.277 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 120' ' ' HIS . . . . . 0.442 ' O ' ' HD2' ' A' ' 116' ' ' LYS . 97.5 m-70 -109.86 152.04 26.28 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 110.058 -0.349 . . . . 2.86 110.058 178.029 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -108.12 155.75 20.05 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 116.015 -0.539 . . . . 2.53 109.563 176.73 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -118.74 131.73 24.18 Favored Pre-proline 0 C--N 1.321 -0.653 0 CA-C-N 116.478 -0.328 . . . . 1.8 110.33 -177.826 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_endo -71.19 -0.11 7.54 Favored 'Trans proline' 0 C--N 1.345 0.344 0 C-N-CA 123.274 2.649 . . . . 1.72 113.438 -177.051 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . 62.92 21.25 12.75 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-O 121.526 0.679 . . . . 1.71 110.348 -175.405 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -103.74 142.78 33.76 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.107 -0.951 . . . . 2.73 108.53 178.552 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . 0.432 ' HG ' HD11 ' A' ' 92' ' ' LEU . 38.6 mt -115.27 90.96 26.22 Favored Pre-proline 0 C--N 1.321 -0.659 0 C-N-CA 120.943 -0.303 . . . . 2.28 111.32 179.815 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 127' ' ' PRO . . . . . 0.444 ' HD2' HD13 ' A' ' 130' ' ' LEU . 41.7 Cg_endo -71.19 157.84 56.28 Favored 'Trans proline' 0 N--CA 1.46 -0.455 0 C-N-CA 122.678 2.252 . . . . 1.33 111.45 173.248 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 78.1 Cg_exo -52.41 -29.55 39.84 Favored 'Trans proline' 0 CA--C 1.535 0.527 0 C-N-CA 123.271 2.647 . . . . 1.87 114.155 -177.35 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 3.9 p-80 -83.36 1.85 39.25 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 120.476 -0.49 . . . . 1.29 111.495 -178.988 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . 0.444 HD13 ' HD2' ' A' ' 127' ' ' PRO . 26.0 mt -113.98 -7.59 13.12 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 116.846 -0.161 . . . . 1.87 111.304 175.149 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 26.2 m -94.11 139.54 22.58 Favored Pre-proline 0 C--N 1.325 -0.471 0 CA-C-O 120.81 0.338 . . . . 1.85 110.145 177.452 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 132' ' ' PRO . . . . . 0.785 ' HG2' ' HB2' ' A' ' 135' ' ' LYS . 27.7 Cg_endo -63.08 143.95 91.55 Favored 'Trans proline' 0 C--O 1.234 0.285 0 C-N-CA 122.61 2.207 . . . . 1.02 112.217 -178.111 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -54.19 -30.54 61.71 Favored 'Trans proline' 0 C--N 1.345 0.377 0 C-N-CA 123.142 2.562 . . . . 1.39 112.961 179.254 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 50.2 p -75.36 -25.19 57.53 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 121.118 0.485 . . . . 1.79 111.515 -178.097 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 135' ' ' LYS . . . . . 0.785 ' HB2' ' HG2' ' A' ' 132' ' ' PRO . 87.9 mttt . . . . . 0 C--N 1.325 -0.495 0 CA-C-N 116.243 -0.435 . . . . 1.79 110.976 -173.308 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 149' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.446 -0.67 0 N-CA-C 111.541 -0.623 . . . . 0.92 111.541 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' B' B ' 150' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -77.59 -1.84 12.0 Favored 'Trans proline' 0 N--CA 1.463 -0.282 0 C-N-CA 122.753 2.302 . . . . 0.33 112.712 -178.334 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 151' ' ' PHE . . . . . 0.77 ' HZ ' ' HG3' ' A' ' 76' ' ' MET . 48.1 m-85 . . . . . 0 C--N 1.324 -0.508 0 CA-C-N 116.574 -0.284 . . . . 0.75 110.813 -178.448 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 26.9 mt-10 . . . . . 0 C--O 1.235 0.293 0 CA-C-O 120.612 0.244 . . . . 3.1 111.206 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' TRP . . . . . 0.535 ' CE3' ' HD3' ' A' ' 133' ' ' PRO . 5.1 t90 -83.84 111.04 18.85 Favored 'General case' 0 C--N 1.332 -0.191 0 N-CA-C 109.486 -0.561 . . . . 0.73 109.486 179.451 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 12.0 p -60.85 -27.36 41.0 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-N 116.08 -0.509 . . . . 2.1 111.662 -176.911 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 21.5 t -85.17 -11.44 11.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 120.962 0.411 . . . . 1.76 111.438 -177.367 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -66.38 -15.51 63.69 Favored Glycine 0 CA--C 1.518 0.231 0 C-N-CA 120.884 -0.674 . . . . 0.59 113.565 -174.339 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 4.0 ptpp? -91.32 -27.64 18.26 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.787 0.294 . . . . 3.11 111.526 -179.201 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 27.5 m-20 -92.44 32.23 1.23 Allowed 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 120.648 -0.421 . . . . 1.66 110.506 -175.692 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . 0.432 ' HB3' ' HZ2' ' A' ' 50' ' ' LYS . 7.8 mtpm? -79.78 -49.36 1.33 Allowed Pre-proline 0 C--O 1.214 -0.803 0 CA-C-O 118.544 -0.741 . . . . 1.72 112.728 -175.377 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 82.8 Cg_exo -43.1 -37.2 6.4 Favored 'Trans proline' 0 C--N 1.354 0.822 0 C-N-CA 122.156 1.904 . . . . 1.07 113.502 -178.928 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -71.88 -45.97 59.48 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.012 0.434 . . . . 1.38 111.878 179.238 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 12.8 m-85 -79.14 -22.31 45.3 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.508 -0.315 . . . . 1.14 110.153 -175.585 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -70.93 -40.56 72.02 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 108.628 -0.879 . . . . 2.18 108.628 173.553 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 20.6 tp10 -55.18 -48.34 73.94 Favored 'General case' 0 C--O 1.232 0.152 0 CA-C-N 114.988 -1.006 . . . . 2.33 109.923 176.16 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 40.5 mt -71.77 -38.36 65.6 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-N 115.541 -0.754 . . . . 1.36 110.907 178.968 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . 0.423 ' CE1' HG23 ' A' ' 67' ' ' ILE . 58.1 t80 -56.15 -34.96 66.63 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 116.022 -0.535 . . . . 0.36 111.576 -177.773 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 9.8 m-85 -88.81 5.46 43.53 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 112.194 0.442 . . . . 1.85 112.194 -175.871 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 80.4 p -98.98 -17.67 18.19 Favored 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 120.49 -0.484 . . . . 1.12 110.558 175.951 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -93.58 9.59 36.14 Favored 'General case' 0 N--CA 1.462 0.168 0 CA-C-N 116.225 -0.443 . . . . 2.02 110.962 179.257 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 19.0 m 65.27 87.3 0.12 Allowed Pre-proline 0 N--CA 1.466 0.36 0 CA-C-N 115.538 -0.756 . . . . 1.87 111.647 179.061 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . 0.439 ' HA ' HG21 ' A' ' 67' ' ' ILE . 95.3 Cg_endo -88.91 139.52 3.81 Favored 'Trans proline' 0 N--CA 1.456 -0.682 0 C-N-CA 122.754 2.303 . . . . 0.62 113.39 -178.966 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 15.4 m -113.7 117.94 56.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 115.904 -0.589 . . . . 1.76 110.272 176.294 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 93.1 m-20 63.03 23.33 13.94 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 115.837 -0.62 . . . . 1.82 110.827 -178.157 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 78.4 24.69 62.66 Favored Glycine 0 N--CA 1.448 -0.526 0 C-N-CA 120.72 -0.752 . . . . 0.51 112.0 -177.367 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 24.4 mtpp -136.45 140.76 43.36 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 109.428 -0.582 . . . . 2.12 109.428 178.076 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . 0.439 HG21 ' HA ' ' A' ' 62' ' ' PRO . 45.8 pt -115.44 160.03 15.03 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 C-N-CA 120.614 -0.435 . . . . 1.28 110.668 175.286 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 24.0 p -79.26 158.99 27.47 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.664 -0.698 . . . . 1.21 110.867 179.992 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . 0.421 ' O ' ' HB2' ' A' ' 73' ' ' LYS . . . -64.98 -18.06 64.05 Favored Glycine 0 C--O 1.221 -0.656 0 C-N-CA 120.895 -0.669 . . . . 0.48 112.392 179.572 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . 0.484 ' O ' ' HG3' ' A' ' 74' ' ' LYS . . . -62.33 -45.42 93.29 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.072 0.463 . . . . 1.13 111.385 179.818 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 48.1 m-80 -79.59 -34.84 40.42 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.216 -0.447 . . . . 1.81 110.623 -176.494 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -61.62 -39.71 92.26 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 109.368 -0.605 . . . . 1.09 109.368 173.054 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . 0.421 ' HB2' ' O ' ' A' ' 69' ' ' GLY . 78.9 tttt -57.87 -44.32 86.55 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 114.96 -1.018 . . . . 1.63 110.141 176.099 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . 0.715 ' O ' ' HG2' ' A' ' 78' ' ' LYS . 96.0 mttt -55.73 -54.66 41.58 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.726 -0.67 . . . . 2.43 110.926 178.701 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . 0.467 ' HA ' ' OE1' ' A' ' 75' ' ' GLU . 12.6 tp10 -64.34 -40.05 95.11 Favored 'General case' 0 C--O 1.239 0.538 0 CA-C-O 121.125 0.488 . . . . 1.6 111.151 -176.871 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' MET . . . . . 0.838 ' HB3' HD21 ' A' ' 86' ' ' LEU . 18.8 mmt -57.12 -47.05 82.05 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.892 -0.595 . . . . 1.92 111.358 179.607 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 25.4 m -74.29 -18.07 16.93 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.422 0 C-N-CA 120.798 -0.361 . . . . 2.22 111.381 -178.861 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.715 ' HG2' ' O ' ' A' ' 74' ' ' LYS . 46.2 mmtm -76.25 -20.95 56.92 Favored 'General case' 0 N--CA 1.463 0.186 0 CA-C-O 121.265 0.555 . . . . 3.27 109.614 174.322 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 16.9 m -79.68 2.17 23.65 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-N 115.497 -0.774 . . . . 1.42 111.729 -178.174 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . 0.456 ' HZ2' ' HB3' ' A' ' 80' ' ' LYS . 7.3 mtpm? 65.98 22.39 11.26 Favored 'General case' 0 N--CA 1.471 0.575 0 C-N-CA 123.224 0.61 . . . . 3.49 112.196 175.468 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.622 ' HB2' HD22 ' A' ' 86' ' ' LEU . 93.2 mt -95.58 147.18 32.61 Favored Pre-proline 0 C--N 1.325 -0.474 0 N-CA-C 110.012 -0.366 . . . . 1.17 110.012 178.239 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . 0.469 ' O ' ' HG ' ' A' ' 86' ' ' LEU . 1.5 Cg_endo -73.2 156.22 51.33 Favored 'Trans proline' 0 N--CA 1.457 -0.619 0 C-N-CA 122.293 1.995 . . . . 0.59 112.178 -178.885 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 88.6 m-20 -55.16 -38.96 68.96 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-N 115.973 -0.558 . . . . 2.37 111.503 -176.482 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' THR . . . . . 0.593 ' O ' ' HG2' ' A' ' 88' ' ' LYS . 3.1 p -57.55 -51.38 69.72 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.119 -0.491 . . . . 1.92 111.121 178.323 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 93.0 t -63.37 -40.94 90.94 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 115.578 -0.737 . . . . 1.15 110.834 -179.908 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.838 HD21 ' HB3' ' A' ' 76' ' ' MET . 83.5 mt -62.47 -37.37 85.7 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.138 -0.483 . . . . 1.45 110.715 179.199 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -68.61 -35.45 80.91 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.889 -0.672 . . . . 0.32 111.632 178.906 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . 0.593 ' HG2' ' O ' ' A' ' 84' ' ' THR . 74.8 mmtt -61.41 -52.75 63.29 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 109.419 -0.586 . . . . 2.37 109.419 176.064 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . 0.52 HG23 HD11 ' A' ' 112' ' ' LEU . 42.5 mt -62.7 -38.88 82.79 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.374 0 CA-C-N 115.396 -0.82 . . . . 1.42 111.532 -177.093 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 64.7 t-105 -60.97 -45.77 93.44 Favored 'General case' 0 C--N 1.332 -0.19 0 C-N-CA 120.688 -0.405 . . . . 0.38 110.731 177.134 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 39.3 ttpt -66.48 -24.46 66.41 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.295 -0.411 . . . . 3.4 110.879 -177.319 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.446 ' HG ' ' O ' ' A' ' 88' ' ' LYS . 96.2 mt -86.03 -52.05 5.95 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.51 -0.314 . . . . 2.23 111.657 -179.784 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . 0.454 ' HA ' HD22 ' A' ' 108' ' ' LEU . . . -64.86 -38.74 91.98 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.198 -0.455 . . . . 1.15 111.687 -174.093 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . 0.432 ' OD2' ' HA ' ' A' ' 97' ' ' LYS . 25.6 t0 -81.71 97.11 7.77 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 109.44 -0.578 . . . . 0.79 109.44 178.948 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 44.3 t -82.77 -36.86 13.58 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-N 115.119 -0.946 . . . . 1.23 111.376 -173.969 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 1.9 p30 -87.0 -6.4 58.77 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.957 -0.565 . . . . 0.96 111.166 -176.544 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . 0.432 ' HA ' ' OD2' ' A' ' 94' ' ' ASP . 23.9 mmmt 59.95 38.74 20.81 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 115.651 -0.704 . . . . 3.53 110.814 173.35 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 15.9 p-10 -98.52 9.06 44.05 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.131 -0.486 . . . . 0.53 111.602 -173.817 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 66.07 6.72 33.55 Favored Glycine 0 C--N 1.333 0.389 0 C-N-CA 120.867 -0.682 . . . . 0.45 113.016 178.692 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 90.0 mt -131.39 157.4 43.53 Favored 'General case' 0 N--CA 1.446 -0.659 0 N-CA-C 109.575 -0.528 . . . . 1.72 109.575 -178.95 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 83.1 mt -116.23 115.96 26.92 Favored 'General case' 0 C--N 1.315 -0.928 0 C-N-CA 120.669 -0.412 . . . . 1.1 110.481 177.491 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -70.55 173.19 7.33 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 108.672 -0.862 . . . . 1.72 108.672 171.85 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -57.85 -30.54 65.86 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 109.706 -0.479 . . . . 1.6 109.706 175.978 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 38.2 mt-10 -66.31 -56.79 9.47 Favored 'General case' 0 C--O 1.235 0.294 0 CA-C-N 115.762 -0.654 . . . . 1.66 111.192 175.242 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . 0.574 ' CG ' ' HE3' ' A' ' 135' ' ' LYS . 24.4 mt-10 -68.28 -34.93 77.07 Favored 'General case' 0 C--N 1.331 -0.202 0 C-N-CA 121.006 -0.278 . . . . 0.64 110.802 -173.561 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 84.8 t80 -69.15 -35.25 76.14 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 109.889 -0.412 . . . . 0.54 109.889 178.247 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -60.47 -42.15 95.65 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.009 0.433 . . . . 1.09 109.96 175.452 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . 0.454 HD22 ' HA ' ' A' ' 93' ' ' ALA . 53.2 tp -66.62 -45.88 77.68 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.183 -0.462 . . . . 1.98 110.715 177.672 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -57.41 -50.38 73.17 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.24 -0.436 . . . . 1.03 111.172 179.0 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -66.88 -30.61 70.83 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.161 -0.472 . . . . 1.2 110.979 179.349 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' HIS . . . . . 0.448 ' O ' HG23 ' A' ' 115' ' ' VAL . 55.6 t60 -64.51 -44.5 90.7 Favored 'General case' 0 C--O 1.22 -0.476 0 N-CA-C 109.749 -0.463 . . . . 0.65 109.749 177.057 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . 0.52 HD11 HG23 ' A' ' 89' ' ' ILE . 88.3 mt -63.81 -41.11 97.96 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.308 -0.406 . . . . 1.21 110.494 178.534 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 81.2 mt -55.45 -51.76 53.76 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.308 0 CA-C-O 121.166 0.508 . . . . 1.41 110.296 174.092 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 14.3 tptm -60.12 -48.54 81.28 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.329 -0.85 . . . . 4.33 110.809 -179.188 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . 0.478 HG13 ' HB2' ' A' ' 120' ' ' HIS . 54.4 t -62.75 -36.63 76.25 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-N 115.919 -0.582 . . . . 1.77 111.091 -177.736 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 116' ' ' LYS . . . . . 0.418 ' HB3' ' HE3' ' A' ' 116' ' ' LYS . 23.2 mmmt -64.47 -50.88 65.75 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.627 -0.261 . . . . 1.86 110.99 176.245 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 89.9 mt -69.06 -25.26 64.36 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.196 -0.457 . . . . 1.53 110.91 -178.919 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 31.6 tt0 -72.0 -14.78 61.98 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.057 -0.519 . . . . 2.18 110.583 179.504 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 107.47 28.51 4.83 Favored Glycine 0 N--CA 1.446 -0.635 0 C-N-CA 120.434 -0.889 . . . . 1.17 113.042 176.774 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 120' ' ' HIS . . . . . 0.478 ' HB2' HG13 ' A' ' 115' ' ' VAL . 28.6 m-70 -121.38 156.75 31.97 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 109.397 -0.594 . . . . 2.86 109.397 176.276 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -117.1 144.84 44.23 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 110.276 -0.268 . . . . 2.53 110.276 177.327 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . 0.419 HD13 ' O ' ' A' ' 122' ' ' LEU . 2.1 pp -97.39 145.51 29.79 Favored Pre-proline 0 C--N 1.323 -0.569 0 CA-C-N 116.376 -0.374 . . . . 1.8 110.756 -178.379 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 8.2 Cg_exo -73.31 -5.38 17.04 Favored 'Trans proline' 0 N--CA 1.465 -0.163 0 C-N-CA 122.927 2.418 . . . . 1.72 112.636 -178.277 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . 69.9 19.05 7.15 Favored 'General case' 0 N--CA 1.464 0.275 0 O-C-N 123.734 0.646 . . . . 1.71 111.232 -179.265 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 20.7 m-20 -116.52 171.6 7.75 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 109.359 -0.608 . . . . 2.73 109.359 174.543 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 36.3 tp -115.62 97.42 48.73 Favored Pre-proline 0 C--N 1.325 -0.466 0 CA-C-O 120.965 0.412 . . . . 2.28 110.486 177.582 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 127' ' ' PRO . . . . . 0.41 ' HD2' HD11 ' A' ' 130' ' ' LEU . 74.4 Cg_endo -75.97 156.03 38.63 Favored 'Trans proline' 0 CA--C 1.534 0.517 0 C-N-CA 122.962 2.442 . . . . 1.33 112.417 178.232 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 11.3 Cg_endo -54.95 -34.7 87.42 Favored 'Trans proline' 0 C--N 1.347 0.482 0 C-N-CA 123.395 2.73 . . . . 1.87 113.677 -175.76 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 4.4 p-80 -79.96 7.63 8.58 Favored 'General case' 0 N--CA 1.465 0.302 0 C-N-CA 120.811 -0.356 . . . . 1.29 111.76 -177.595 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . 0.41 HD11 ' HD2' ' A' ' 127' ' ' PRO . 29.3 mt -116.98 5.58 12.89 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.533 0.206 . . . . 1.87 111.085 175.121 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 62.8 t -85.3 123.31 73.3 Favored Pre-proline 0 C--N 1.324 -0.51 0 CA-C-N 116.49 -0.323 . . . . 1.85 110.513 178.43 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 132' ' ' PRO . . . . . 0.465 ' HG2' ' HD2' ' A' ' 135' ' ' LYS . 53.6 Cg_exo -54.06 143.33 62.61 Favored 'Trans proline' 0 CA--C 1.534 0.521 0 C-N-CA 123.016 2.478 . . . . 1.02 112.724 179.351 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 133' ' ' PRO . . . . . 0.535 ' HD3' ' CE3' ' A' ' 44' ' ' TRP . 23.7 Cg_exo -62.97 -35.27 67.32 Favored 'Trans proline' 0 C--N 1.347 0.454 0 C-N-CA 122.937 2.424 . . . . 1.39 113.626 -175.005 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 23.2 t -87.44 0.01 56.15 Favored 'General case' 0 C--N 1.323 -0.573 0 C-N-CA 120.707 -0.397 . . . . 1.79 111.249 -175.216 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 135' ' ' LYS . . . . . 0.574 ' HE3' ' CG ' ' A' ' 105' ' ' GLU . 62.6 mttm . . . . . 0 C--N 1.327 -0.4 0 CA-C-O 120.905 0.383 . . . . 1.79 111.342 -176.762 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 149' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.445 -0.752 0 N-CA-C 111.099 -0.8 . . . . 0.92 111.099 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' B' B ' 150' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -74.93 -3.84 14.52 Favored 'Trans proline' 0 CA--C 1.53 0.293 0 C-N-CA 122.991 2.461 . . . . 0.33 113.118 -173.888 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 151' ' ' PHE . . . . . 0.544 ' CZ ' ' HG3' ' A' ' 76' ' ' MET . 61.2 m-85 . . . . . 0 C--N 1.327 -0.396 0 CA-C-O 120.788 0.328 . . . . 0.75 110.955 -179.388 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.758 0 N-CA-C 111.602 -0.599 . . . . 11.39 111.602 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . 0.401 ' HB2' ' HG ' ' A' ' 39' ' ' SER . 9.0 Cg_endo -87.91 113.67 0.85 Allowed 'Trans proline' 0 N--CA 1.452 -0.93 0 C-N-CA 123.2 2.6 . . . . 9.9 112.11 179.263 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -92.34 -48.29 6.74 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.16 -0.473 . . . . 7.72 109.732 177.157 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -84.75 60.67 4.79 Favored Glycine 0 N--CA 1.449 -0.482 0 C-N-CA 121.047 -0.596 . . . . 4.67 111.757 178.975 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' SER . . . . . 0.401 ' HG ' ' HB2' ' A' ' 36' ' ' PRO . 5.6 m -86.77 115.44 24.21 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 110.299 -0.26 . . . . 4.08 110.299 179.698 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 10.9 m-20 -76.75 93.1 3.63 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.315 0.579 . . . . 3.46 110.261 175.853 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 7.0 t70 -125.63 106.87 10.06 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.466 -0.788 . . . . 1.98 108.955 179.858 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 15.0 p -77.47 137.23 22.72 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-O 120.968 0.414 . . . . 2.56 111.128 -174.978 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -66.92 128.81 37.74 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.399 -0.819 . . . . 3.1 111.124 -177.587 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 6.4 t90 -82.39 106.01 13.92 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 109.333 -0.617 . . . . 0.73 109.333 178.089 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.567 ' O ' ' HG2' ' A' ' 48' ' ' LYS . 9.7 p -67.5 -7.0 5.67 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.546 0 CA-C-N 115.562 -0.744 . . . . 2.1 112.236 -171.812 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 57.9 t -80.7 -24.81 11.02 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-O 120.742 0.306 . . . . 1.76 110.759 178.393 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -74.0 -9.19 79.69 Favored Glycine 0 CA--C 1.519 0.284 0 C-N-CA 120.788 -0.72 . . . . 0.59 113.215 -175.342 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . 0.567 ' HG2' ' O ' ' A' ' 45' ' ' VAL . 18.7 ptmt -74.23 -27.77 60.93 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 117.134 0.467 . . . . 3.11 111.175 -176.651 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 36.9 t0 -125.36 33.25 5.18 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.608 0.718 . . . . 1.66 109.453 -179.671 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . 0.647 ' N ' ' HD2' ' A' ' 51' ' ' PRO . 51.3 tttt -72.65 -43.86 8.97 Favored Pre-proline 0 C--N 1.321 -0.632 0 CA-C-N 115.471 -0.786 . . . . 1.72 112.059 -175.481 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . 0.647 ' HD2' ' N ' ' A' ' 50' ' ' LYS . 1.7 Cg_endo -45.77 -37.07 15.78 Favored 'Trans proline' 0 C--N 1.359 1.082 0 C-N-CA 123.122 2.548 . . . . 1.07 113.184 176.692 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 24.2 m -68.36 -46.61 69.64 Favored 'General case' 0 C--O 1.239 0.54 0 CA-C-O 121.198 0.523 . . . . 1.38 110.304 -179.471 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 5.0 m-85 -75.11 -20.24 59.55 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.867 -0.606 . . . . 1.14 109.423 -178.451 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 7.6 t70 -67.26 -45.23 77.29 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.42 -0.809 . . . . 2.18 110.036 175.128 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 29.4 mt-10 -67.31 -29.17 68.68 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.229 -0.442 . . . . 2.33 110.593 178.715 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 54.0 mt -78.87 -29.42 14.25 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-O 121.386 0.612 . . . . 1.36 110.587 175.792 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . 0.531 ' CE2' ' HB3' ' A' ' 62' ' ' PRO . 72.8 t80 -71.2 -41.08 70.74 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.961 -0.563 . . . . 0.36 110.623 178.765 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . 0.573 ' HA ' ' HG3' ' A' ' 62' ' ' PRO . 2.5 m-85 -78.23 -12.45 60.0 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.917 -0.583 . . . . 1.85 111.656 -176.049 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 3.8 p -91.88 -7.61 48.81 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 120.96 0.409 . . . . 1.12 110.988 178.655 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 89.1 mt -100.77 11.49 39.45 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-N 116.015 -0.539 . . . . 2.02 110.5 177.75 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 24.6 m 65.65 85.28 0.16 Allowed Pre-proline 0 N--CA 1.463 0.213 0 CA-C-N 115.363 -0.835 . . . . 1.87 111.8 178.347 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . 0.573 ' HG3' ' HA ' ' A' ' 58' ' ' TYR . 4.6 Cg_endo -85.59 130.87 3.87 Favored 'Trans proline' 0 N--CA 1.454 -0.795 0 C-N-CA 122.996 2.464 . . . . 0.62 112.162 178.626 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 60.2 t -112.25 108.83 26.51 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 N-CA-C 109.755 -0.461 . . . . 1.76 109.755 177.477 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 92.0 m-20 62.15 30.03 17.65 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.664 -0.698 . . . . 1.82 111.922 178.029 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 94.58 3.38 62.78 Favored Glycine 0 CA--C 1.519 0.296 0 C-N-CA 120.792 -0.718 . . . . 0.51 113.817 173.668 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . 0.522 ' HZ2' ' CG ' ' A' ' 102' ' ' ASP . 55.5 mttm -129.37 150.53 50.69 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 117.135 0.467 . . . . 2.12 110.488 177.555 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 33.7 pt -117.66 159.67 17.72 Favored 'Isoleucine or valine' 0 C--O 1.24 0.605 0 CA-C-O 121.264 0.554 . . . . 1.28 110.455 172.836 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 22.4 p -72.28 151.67 42.64 Favored 'General case' 0 N--CA 1.446 -0.64 0 CA-C-N 114.915 -1.038 . . . . 1.21 110.784 179.046 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -71.05 -10.47 68.63 Favored Glycine 0 C--O 1.222 -0.63 0 C-N-CA 120.744 -0.741 . . . . 0.48 111.609 179.957 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -70.52 -40.85 73.25 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.069 0.461 . . . . 1.13 111.181 178.65 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 30.2 m-80 -81.13 -33.09 33.43 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.971 -0.559 . . . . 1.81 110.34 -178.409 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -62.95 -46.41 87.88 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 109.424 -0.584 . . . . 1.09 109.424 171.558 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . 0.419 ' HA ' ' CZ ' ' B' ' 151' ' ' PHE . 54.6 tttp -52.25 -43.38 64.33 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 115.248 -0.887 . . . . 1.63 110.414 174.671 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . 0.537 ' O ' ' HG2' ' A' ' 78' ' ' LYS . 35.5 ttpt -59.16 -49.91 76.05 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.239 -0.891 . . . . 2.43 111.397 179.037 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 3.1 tp10 -59.32 -47.98 83.35 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.359 0.599 . . . . 1.6 110.514 177.108 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' MET . . . . . 0.713 ' HG3' ' CZ ' ' B' ' 151' ' ' PHE . 70.9 mmm -55.75 -47.09 77.57 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.383 -0.826 . . . . 1.92 111.457 -177.819 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 29.5 m -75.56 -20.7 15.95 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.362 0 N-CA-C 111.702 0.26 . . . . 2.22 111.702 -177.641 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.537 ' HG2' ' O ' ' A' ' 74' ' ' LYS . 24.0 mmtp -72.96 -27.46 61.84 Favored 'General case' 0 CA--C 1.52 -0.196 0 CA-C-O 121.111 0.482 . . . . 3.27 110.151 174.723 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 66.1 m -85.59 5.09 33.22 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.831 -0.622 . . . . 1.42 111.291 179.286 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . 0.635 ' HB3' ' HZ3' ' A' ' 80' ' ' LYS . 5.0 mmmp? 62.9 31.92 16.0 Favored 'General case' 0 C--O 1.235 0.328 0 N-CA-C 113.343 0.868 . . . . 3.49 113.343 170.188 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.413 ' HA ' ' HD3' ' A' ' 82' ' ' PRO . 87.0 mt -87.29 136.54 33.41 Favored Pre-proline 0 C--N 1.322 -0.624 0 C-N-CA 120.651 -0.42 . . . . 1.17 110.335 176.813 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . 0.549 ' O ' ' HG ' ' A' ' 86' ' ' LEU . 32.0 Cg_exo -58.7 152.76 54.14 Favored 'Trans proline' 0 C--N 1.344 0.332 0 C-N-CA 122.795 2.33 . . . . 0.59 111.991 178.261 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . 0.487 ' HA ' HD13 ' A' ' 86' ' ' LEU . 17.6 m120 -55.21 -33.53 63.14 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-N 116.481 -0.327 . . . . 2.37 111.658 -177.088 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 7.3 p -63.78 -46.64 84.31 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.255 0.55 . . . . 1.92 110.674 177.161 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.481 ' O ' HG12 ' A' ' 89' ' ' ILE . 47.8 t -69.1 -32.75 55.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 115.616 -0.72 . . . . 1.15 110.61 -179.871 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.704 HD21 ' HB3' ' A' ' 76' ' ' MET . 79.7 mt -57.58 -46.67 83.72 Favored 'General case' 0 C--O 1.238 0.471 0 CA-C-N 116.119 -0.491 . . . . 1.45 110.098 176.188 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -66.62 -35.39 89.82 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.821 -0.704 . . . . 0.32 111.625 178.282 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 48.3 mmtt -57.21 -52.46 65.23 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-O 120.907 0.384 . . . . 2.37 110.819 175.52 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . 0.488 ' HB ' ' HE1' ' A' ' 76' ' ' MET . 50.6 mm -61.16 -47.0 95.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 115.581 -0.736 . . . . 1.42 110.938 -177.675 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 50.0 t-105 -59.21 -46.87 87.3 Favored 'General case' 0 CA--C 1.53 0.198 0 CA-C-O 120.825 0.345 . . . . 0.38 110.984 179.511 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 17.0 ttmm -54.42 -37.8 65.53 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 115.71 -0.677 . . . . 3.4 112.025 178.319 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.72 HD12 ' HA ' ' A' ' 124' ' ' ALA . 96.9 mt -86.22 -29.95 22.77 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.5 -0.318 . . . . 2.23 111.774 -176.907 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . 0.686 ' HA ' HD21 ' A' ' 108' ' ' LEU . . . -79.57 -42.31 25.29 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 116.458 -0.337 . . . . 1.15 111.868 -175.659 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -102.99 95.14 5.95 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.186 0.517 . . . . 0.79 110.197 -177.994 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 32.3 t -67.47 -40.52 84.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 115.388 -0.824 . . . . 1.23 111.53 -174.27 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 13.2 p-10 -90.0 -20.09 23.68 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.24 -0.437 . . . . 0.96 110.919 -175.994 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . 0.57 ' HB2' ' HZ1' ' A' ' 97' ' ' LYS . 8.0 mtmp? 66.33 60.4 0.62 Allowed 'General case' 0 C--O 1.233 0.21 0 CA-C-N 115.848 -0.615 . . . . 3.53 111.038 177.164 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . 0.657 ' OD1' 'CA ' ' A' ' 141' ' ' ' CA' . 11.2 p-10 -94.3 9.57 37.61 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.211 -0.45 . . . . 0.53 110.907 -179.598 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 73.99 -19.03 1.78 Allowed Glycine 0 CA--C 1.519 0.329 0 CA-C-N 116.025 -0.534 . . . . 0.45 113.346 175.592 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.419 ' H ' ' C ' ' A' ' 98' ' ' ASP . 94.7 mt -113.35 151.63 30.99 Favored 'General case' 0 C--N 1.318 -0.775 0 N-CA-C 108.889 -0.782 . . . . 1.72 108.889 178.227 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 58.5 mt -104.04 119.99 40.12 Favored 'General case' 0 C--N 1.318 -0.796 0 C-N-CA 120.414 -0.514 . . . . 1.1 110.519 178.762 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . 0.578 ' HB2' ' HG3' ' A' ' 105' ' ' GLU . 20.6 m-20 -69.38 168.61 14.03 Favored 'General case' 0 CA--C 1.513 -0.46 0 N-CA-C 108.721 -0.844 . . . . 1.72 108.721 171.586 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 12.7 p-10 -59.99 -35.89 76.0 Favored 'General case' 0 C--N 1.317 -0.845 0 N-CA-C 109.612 -0.514 . . . . 1.6 109.612 176.094 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 37.5 mm-40 -65.57 -51.17 61.76 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-N 115.668 -0.697 . . . . 1.66 110.288 176.138 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . 0.578 ' HG3' ' HB2' ' A' ' 102' ' ' ASP . 42.5 mt-10 -64.41 -42.78 95.89 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.75 -0.659 . . . . 0.64 111.074 -174.404 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 90.2 t80 -66.91 -34.89 78.78 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.245 -0.434 . . . . 0.54 110.434 -179.574 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -60.8 -40.4 92.53 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.874 0.368 . . . . 1.09 110.326 175.667 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . 0.686 HD21 ' HA ' ' A' ' 93' ' ' ALA . 6.9 tt -66.45 -50.21 64.11 Favored 'General case' 0 C--O 1.237 0.409 0 CA-C-N 116.217 -0.447 . . . . 1.98 110.094 178.791 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . 0.64 ' O ' HG13 ' A' ' 113' ' ' ILE . . . -54.59 -55.98 23.76 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 115.961 -0.563 . . . . 1.03 110.728 178.072 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' ASN . . . . . 0.604 ' HA ' HD11 ' A' ' 113' ' ' ILE . 0.7 OUTLIER -52.93 -39.91 63.22 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.662 -0.699 . . . . 1.2 111.176 179.98 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' HIS . . . . . 0.424 ' O ' HG22 ' A' ' 115' ' ' VAL . 37.2 t60 -60.54 -53.26 59.65 Favored 'General case' 0 C--O 1.223 -0.295 0 N-CA-C 110.115 -0.328 . . . . 0.65 110.115 178.548 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 92.5 mt -54.87 -42.98 72.73 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-O 120.975 0.417 . . . . 1.21 110.775 179.42 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . 0.64 HG13 ' O ' ' A' ' 109' ' ' ALA . 70.6 mt -57.5 -56.63 14.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 115.542 -0.754 . . . . 1.41 111.488 -179.374 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . 0.507 ' HG2' ' O ' ' A' ' 110' ' ' ASN . 63.2 mmtt -69.55 -32.99 72.12 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.69 -0.687 . . . . 4.33 110.644 -174.261 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . 0.471 HG13 ' HB2' ' A' ' 120' ' ' HIS . 51.5 t -62.96 -33.78 62.51 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-N 115.914 -0.585 . . . . 1.77 110.679 174.212 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 3.5 mmmp? -68.27 -37.19 80.46 Favored 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 120.694 -0.402 . . . . 1.86 110.19 173.225 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 98.1 mt -67.66 -27.78 67.14 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.201 -0.454 . . . . 1.53 110.537 177.328 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . 0.401 ' HB2' ' O ' ' A' ' 115' ' ' VAL . 45.8 mt-10 -64.85 -22.41 66.99 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.06 -0.518 . . . . 2.18 111.165 174.819 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 106.28 10.82 28.86 Favored Glycine 0 N--CA 1.445 -0.728 0 C-N-CA 120.417 -0.897 . . . . 1.17 111.854 -176.906 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' HIS . . . . . 0.471 ' HB2' HG13 ' A' ' 115' ' ' VAL . 7.0 m170 -88.6 159.27 17.96 Favored 'General case' 0 C--O 1.235 0.318 0 N-CA-C 109.381 -0.6 . . . . 2.86 109.381 177.32 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 18.2 mt-10 -114.04 163.28 15.37 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 110.285 -0.265 . . . . 2.53 110.285 174.166 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . 0.647 ' H ' HD23 ' A' ' 122' ' ' LEU . 2.2 pt? -106.05 136.39 19.32 Favored Pre-proline 0 C--N 1.326 -0.422 0 CA-C-N 116.494 -0.321 . . . . 1.8 110.588 -176.771 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . 0.428 ' HD3' ' HA ' ' A' ' 122' ' ' LEU . 10.7 Cg_exo -72.13 -14.91 28.95 Favored 'Trans proline' 0 N--CA 1.464 -0.238 0 C-N-CA 122.889 2.393 . . . . 1.72 112.125 177.685 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . 0.72 ' HA ' HD12 ' A' ' 92' ' ' LEU . . . 64.72 18.99 11.69 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 115.417 -0.81 . . . . 1.71 112.106 179.238 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 24.4 t70 -128.45 152.16 48.55 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 108.921 -0.77 . . . . 2.73 108.921 174.767 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . 0.542 ' HG ' HG21 ' A' ' 131' ' ' VAL . 36.3 tp -105.75 105.44 53.0 Favored Pre-proline 0 C--N 1.322 -0.602 0 CA-C-O 120.747 0.308 . . . . 2.28 111.588 -172.645 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' PRO . . . . . 0.426 ' HD2' HD11 ' A' ' 130' ' ' LEU . 71.9 Cg_endo -79.61 155.04 24.12 Favored 'Trans proline' 0 CA--C 1.534 0.508 0 C-N-CA 122.722 2.281 . . . . 1.33 112.059 174.679 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 12.6 Cg_endo -56.7 -26.01 63.24 Favored 'Trans proline' 0 CA--C 1.534 0.504 0 C-N-CA 123.35 2.7 . . . . 1.87 114.32 -174.937 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 32.0 p-80 -87.14 3.34 46.72 Favored 'General case' 0 N--CA 1.462 0.169 0 C-N-CA 120.441 -0.504 . . . . 1.29 111.148 -179.442 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . 0.426 HD11 ' HD2' ' A' ' 127' ' ' PRO . 24.2 mt -110.8 -17.86 13.25 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.453 -0.34 . . . . 1.87 110.615 173.617 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . 0.542 HG21 ' HG ' ' A' ' 126' ' ' LEU . 6.7 t -75.73 122.41 87.02 Favored Pre-proline 0 C--N 1.328 -0.336 0 N-CA-C 109.844 -0.428 . . . . 1.85 109.844 178.832 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_exo -49.58 135.98 33.69 Favored 'Trans proline' 0 C--N 1.344 0.327 0 C-N-CA 122.851 2.367 . . . . 1.02 112.078 177.153 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 133' ' ' PRO . . . . . 0.475 ' HA ' ' NE ' ' A' ' 136' ' ' ARG . 10.1 Cg_endo -51.23 -36.43 56.36 Favored 'Trans proline' 0 C--N 1.344 0.322 0 C-N-CA 123.762 2.974 . . . . 1.39 113.815 -173.818 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 14.6 m -89.34 1.32 55.94 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 112.048 0.388 . . . . 1.79 112.048 -176.783 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 66.0 mttm -120.4 3.42 10.79 Favored 'General case' 0 CA--C 1.532 0.278 0 O-C-N 122.313 -0.242 . . . . 1.79 111.198 -179.885 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . 0.475 ' NE ' ' HA ' ' A' ' 133' ' ' PRO . 35.7 ptt180 -103.78 151.37 23.13 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 113.037 0.754 . . . . 3.33 113.037 -170.066 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 67.5 mtt180 -127.14 155.35 43.49 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 114.962 -1.017 . . . . 5.15 108.693 170.934 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 34.0 t60 -133.43 111.36 10.68 Favored 'General case' 0 C--N 1.318 -0.77 0 C-N-CA 120.397 -0.521 . . . . 6.71 110.808 170.788 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 74.2 mm-40 . . . . . 0 C--O 1.244 0.809 0 CA-C-O 118.394 -0.813 . . . . 6.15 109.868 176.172 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' B' B ' 143' ' ' PHE . . . . . . . . . . . . . 71.5 t80 . . . . . 0 N--CA 1.478 0.927 0 CA-C-O 120.766 0.317 . . . . 12.46 110.575 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' B' B ' 144' ' ' ASN . . . . . . . . . . . . . 27.7 t-20 -72.12 132.44 44.19 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.1 0.476 . . . . 8.42 111.213 179.643 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 145' ' ' TYR . . . . . . . . . . . . . 72.7 t80 -151.49 139.21 19.76 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.804 -0.634 . . . . 6.88 109.786 -177.864 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 146' ' ' GLU . . . . . . . . . . . . . 2.2 pp20? -119.06 179.97 4.0 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.679 0.276 . . . . 6.61 111.047 -178.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 147' ' ' SER . . . . . . . . . . . . . 33.2 p -121.25 -58.3 1.8 Allowed 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.309 0.576 . . . . 4.05 111.07 -177.935 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 148' ' ' THR . . . . . . . . . . . . . 1.3 p -139.4 32.01 2.1 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.326 -0.852 . . . . 2.41 109.376 -179.76 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 149' ' ' GLY . . . . . . . . . . . . . . . 133.99 158.57 8.62 Favored Glycine 0 N--CA 1.437 -1.243 0 N-CA-C 110.832 -0.907 . . . . 0.92 110.832 -171.318 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 150' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -73.21 -0.88 9.76 Favored 'Trans proline' 0 CA--C 1.53 0.323 0 C-N-CA 123.249 2.632 . . . . 0.33 112.312 -177.009 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 151' ' ' PHE . . . . . 0.713 ' CZ ' ' HG3' ' A' ' 76' ' ' MET . 46.7 m-85 -106.96 -38.55 6.01 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.055 -0.52 . . . . 0.75 112.183 -178.617 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 152' ' ' THR . . . . . . . . . . . . . 4.5 p -87.43 24.01 1.75 Allowed 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 112.372 0.508 . . . . 2.81 112.372 -170.871 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 153' ' ' ALA . . . . . . . . . . . . . . . -72.54 142.82 48.48 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 116.437 -0.347 . . . . 4.4 110.473 178.079 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 154' ' ' LYS . . . . . . . . . . . . . 35.8 mmtp . . . . . 0 C--O 1.25 1.113 0 CA-C-O 118.481 -0.771 . . . . 7.16 110.19 -179.621 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 141' ' ' ' CA' . . . . . 0.657 'CA ' ' OD1' ' A' ' 98' ' ' ASP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.58 0 N-CA-C 112.139 -0.384 . . . . 11.39 112.139 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 16.5 Cg_endo -58.66 -35.59 98.42 Favored 'Trans proline' 0 C--N 1.344 0.307 0 C-N-CA 122.908 2.405 . . . . 9.9 112.308 178.881 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 1.2 tm? -135.98 -71.69 0.46 Allowed 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 109.883 -0.414 . . . . 7.72 109.883 179.668 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 148.06 93.22 0.11 Allowed Glycine 0 N--CA 1.448 -0.533 0 C-N-CA 120.504 -0.855 . . . . 4.67 112.428 -179.009 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 46.3 m -150.53 25.84 0.77 Allowed 'General case' 0 C--N 1.318 -0.764 0 CA-C-O 121.787 0.803 . . . . 4.08 108.849 178.166 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -109.74 108.41 18.77 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 114.597 -1.183 . . . . 3.46 110.569 -172.809 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -76.84 95.38 4.06 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.087 -0.506 . . . . 1.98 111.316 -178.411 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 40.8 t -78.7 119.81 28.53 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 N-CA-C 109.525 -0.546 . . . . 2.56 109.525 174.52 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 4.1 mp0 -66.82 150.04 49.72 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.356 0.598 . . . . 3.1 111.887 -176.501 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' TRP . . . . . 0.527 ' HH2' ' O ' ' A' ' 104' ' ' GLU . 7.7 t90 -70.6 116.12 10.55 Favored 'General case' 0 N--CA 1.45 -0.436 0 CA-C-N 115.191 -0.913 . . . . 0.73 109.025 178.533 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 9.9 p -67.38 -9.61 10.52 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-O 121.14 0.495 . . . . 2.1 111.371 -174.657 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 51.0 t -89.41 -20.76 7.01 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-O 121.262 0.553 . . . . 1.76 110.317 176.866 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . 0.421 ' HA2' ' HG2' ' A' ' 50' ' ' LYS . . . -72.68 -19.34 79.15 Favored Glycine 0 N--CA 1.446 -0.635 0 CA-C-N 115.706 -0.679 . . . . 0.59 112.897 -175.666 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 15.3 ptpt -76.61 -26.1 54.6 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.602 0.239 . . . . 3.11 111.138 -179.182 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -101.2 34.25 2.6 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.023 0.439 . . . . 1.66 109.917 178.259 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . 0.421 ' HG2' ' HA2' ' A' ' 47' ' ' GLY . 0.1 OUTLIER -67.73 -54.16 18.54 Favored Pre-proline 0 C--O 1.214 -0.775 0 CA-C-O 118.256 -0.878 . . . . 1.72 113.156 -175.922 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_exo -42.66 -41.76 8.33 Favored 'Trans proline' 0 C--N 1.358 1.068 0 C-N-CA 122.798 2.332 . . . . 1.07 113.868 -173.245 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 90.7 m -69.97 -44.76 68.79 Favored 'General case' 0 C--O 1.238 0.449 0 CA-C-O 121.1 0.476 . . . . 1.38 111.282 179.404 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 8.6 m-30 -74.23 -23.21 59.14 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.957 0.408 . . . . 1.14 110.045 -177.491 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 84.2 m-20 -70.03 -44.23 69.69 Favored 'General case' 0 CA--C 1.511 -0.532 0 N-CA-C 108.961 -0.755 . . . . 2.18 108.961 175.818 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 10.8 tp10 -57.26 -47.29 81.78 Favored 'General case' 0 N--CA 1.45 -0.444 0 CA-C-N 115.016 -0.993 . . . . 2.33 110.225 178.541 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 39.8 mt -70.79 -37.54 69.14 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 CA-C-N 116.24 -0.437 . . . . 1.36 111.552 -178.273 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . 0.459 ' HD1' ' CD2' ' A' ' 106' ' ' PHE . 86.6 t80 -66.29 -45.3 80.89 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.807 0.337 . . . . 0.36 110.981 -178.689 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . 0.458 ' CE1' ' HD2' ' A' ' 57' ' ' PHE . 21.7 m-85 -79.81 -12.6 59.76 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.592 -0.276 . . . . 1.85 111.429 -174.596 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 11.5 p -88.7 -8.65 54.16 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.716 0.293 . . . . 1.12 111.286 177.406 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.458 ' HB3' ' HB3' ' A' ' 71' ' ' ASN . 35.2 mt -94.69 9.38 39.07 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.665 -0.243 . . . . 2.02 110.988 178.599 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 17.3 m 68.23 87.55 0.11 Allowed Pre-proline 0 CA--C 1.531 0.219 0 O-C-N 123.823 0.702 . . . . 1.87 110.854 -176.374 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -77.3 125.3 7.69 Favored 'Trans proline' 0 N--CA 1.458 -0.582 0 C-N-CA 122.586 2.191 . . . . 0.62 112.199 -179.463 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 12.5 m -115.3 119.35 61.55 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 CA-C-O 121.091 0.472 . . . . 1.76 110.271 177.432 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 65.5 m-20 64.39 22.24 12.7 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-N 115.711 -0.677 . . . . 1.82 110.742 -179.19 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 80.67 15.73 77.16 Favored Glycine 0 CA--C 1.52 0.352 0 C-N-CA 120.961 -0.638 . . . . 0.51 112.579 -178.393 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . 0.74 ' HG2' ' HB3' ' A' ' 102' ' ' ASP . 86.8 mttt -137.37 160.14 39.92 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 109.739 -0.467 . . . . 2.12 109.739 179.812 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . 0.429 HD12 ' HB2' ' A' ' 101' ' ' LEU . 2.8 pp -119.48 158.12 21.18 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 N-CA-C 109.907 -0.405 . . . . 1.28 109.907 172.309 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 63.8 p -89.5 173.11 8.52 Favored 'General case' 0 C--N 1.321 -0.63 0 CA-C-N 116.203 -0.453 . . . . 1.21 110.898 -174.569 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -64.53 -19.29 64.56 Favored Glycine 0 N--CA 1.445 -0.726 0 C-N-CA 120.81 -0.709 . . . . 0.48 111.997 176.962 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -66.61 -46.01 77.24 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.168 0.509 . . . . 1.13 111.154 179.061 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . 0.458 ' HB3' ' HB3' ' A' ' 60' ' ' LEU . 1.7 m120 -77.57 -41.09 40.13 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.654 -0.703 . . . . 1.81 110.128 -175.148 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -62.78 -43.39 98.94 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.862 -0.608 . . . . 1.09 110.263 177.194 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . 0.541 ' O ' HG22 ' A' ' 77' ' ' VAL . 21.3 ttmm -56.96 -47.28 81.08 Favored 'General case' 0 CA--C 1.516 -0.332 0 CA-C-N 116.255 -0.43 . . . . 1.63 109.862 176.358 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 48.8 tttm -52.44 -50.65 62.17 Favored 'General case' 0 N--CA 1.451 -0.386 0 O-C-N 123.908 0.755 . . . . 2.43 111.209 -178.974 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 13.2 tp10 -70.7 -43.37 69.12 Favored 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 120.846 -0.341 . . . . 1.6 111.15 -178.208 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 64.7 mtt -64.34 -38.67 91.85 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 111.656 0.243 . . . . 1.92 111.656 -175.729 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.541 HG22 ' O ' ' A' ' 73' ' ' LYS . 32.9 m -76.31 -28.55 18.34 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.302 0 C-N-CA 120.788 -0.365 . . . . 2.22 110.621 177.271 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.438 ' HB3' ' HE3' ' A' ' 78' ' ' LYS . 19.8 mmmt -64.89 -25.78 68.04 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-N 116.18 -0.464 . . . . 3.27 110.727 173.58 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 20.3 m -75.16 -8.85 57.72 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.585 -0.734 . . . . 1.42 110.512 177.796 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 55.0 mtpt 62.34 42.64 8.95 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-N 115.903 -0.59 . . . . 3.49 111.126 177.38 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.687 ' HB2' HD13 ' A' ' 86' ' ' LEU . 97.5 mt -100.32 169.2 8.25 Favored Pre-proline 0 C--N 1.325 -0.495 0 CA-C-N 115.704 -0.68 . . . . 1.17 109.758 178.307 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . 0.405 ' CD ' ' HB3' ' A' ' 81' ' ' LEU . 2.0 Cg_endo -83.49 132.01 5.73 Favored 'Trans proline' 0 C--N 1.348 0.515 0 C-N-CA 123.274 2.65 . . . . 0.59 112.371 -178.478 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 5.0 p-10 -50.67 -38.67 47.95 Favored 'General case' 0 N--CA 1.472 0.638 0 N-CA-C 113.504 0.927 . . . . 2.37 113.504 -171.532 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 75.7 m -65.79 -34.28 77.81 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 120.892 0.377 . . . . 1.92 110.925 -179.719 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.484 ' O ' HG12 ' A' ' 89' ' ' ILE . 95.6 t -71.12 -39.85 74.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.153 -0.476 . . . . 1.15 109.789 178.485 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.687 HD13 ' HB2' ' A' ' 81' ' ' LEU . 9.8 mp -58.44 -34.83 71.24 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.18 -0.464 . . . . 1.45 110.992 172.39 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -65.66 -38.67 94.81 Favored Glycine 0 N--CA 1.447 -0.612 0 N-CA-C 111.072 -0.811 . . . . 0.32 111.072 176.619 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 70.0 mmtt -63.43 -49.73 72.57 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.147 -0.526 . . . . 2.37 109.968 174.5 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . 0.484 HG12 ' O ' ' A' ' 85' ' ' VAL . 40.8 mm -54.74 -49.82 65.46 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.097 0 CA-C-N 115.711 -0.677 . . . . 1.42 110.699 179.686 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 53.5 t-105 -61.38 -50.55 72.42 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.323 -0.399 . . . . 0.38 111.402 -178.671 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . 0.459 ' HE3' HG22 ' B' ' 152' ' ' THR . 26.4 ttmt -74.52 -10.76 59.87 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-O 121.009 0.433 . . . . 3.4 111.359 -172.766 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.417 HD13 ' HA ' ' A' ' 124' ' ' ALA . 94.1 mt -94.36 -37.42 11.48 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.336 -0.393 . . . . 2.23 111.08 172.7 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . 0.463 ' HA ' HD21 ' A' ' 108' ' ' LEU . . . -78.81 -36.85 42.08 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.224 -0.444 . . . . 1.15 111.489 -176.787 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . 0.638 ' OD1' 'CA ' ' A' ' 141' ' ' ' CA' . 26.7 t0 -81.15 86.83 6.12 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.612 0.72 . . . . 0.79 109.524 177.562 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . 0.412 ' HB ' ' HD3' ' A' ' 135' ' ' LYS . 34.4 t -82.2 -30.74 9.83 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.587 0 CA-C-N 114.839 -1.073 . . . . 1.23 110.352 -174.796 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . 0.595 ' OD1' 'CA ' ' A' ' 141' ' ' ' CA' . 43.5 p-10 -86.41 -7.57 58.34 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.22 -0.445 . . . . 0.96 110.655 -179.461 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 88.9 mttt 59.06 44.62 15.85 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-N 115.716 -0.675 . . . . 3.53 111.129 172.974 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . 0.593 ' OD1' 'CA ' ' A' ' 141' ' ' ' CA' . 6.5 p-10 -107.08 9.06 30.56 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 116.246 -0.434 . . . . 0.53 111.016 -175.872 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 67.58 12.84 62.27 Favored Glycine 0 CA--C 1.518 0.277 0 C-N-CA 121.053 -0.594 . . . . 0.45 112.481 178.746 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.531 ' HB2' ' OD2' ' A' ' 98' ' ' ASP . 87.0 mt -135.77 153.3 51.59 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 109.114 -0.699 . . . . 1.72 109.114 178.817 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . 0.429 ' HB2' HD12 ' A' ' 67' ' ' ILE . 89.9 mt -110.22 111.89 23.5 Favored 'General case' 0 C--N 1.315 -0.928 0 N-CA-C 109.166 -0.679 . . . . 1.1 109.166 175.009 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . 0.74 ' HB3' ' HG2' ' A' ' 66' ' ' LYS . 2.1 p30 -75.99 -174.82 2.81 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 116.233 -0.44 . . . . 1.72 110.672 178.523 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -54.86 -40.33 69.56 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 115.604 -0.726 . . . . 1.6 110.48 -179.215 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . 0.527 ' O ' ' HH2' ' A' ' 44' ' ' TRP . 54.5 mt-10 -73.62 -52.76 12.32 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.992 -0.549 . . . . 1.66 110.253 179.408 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 36.1 mt-10 -63.12 -37.93 89.15 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.238 -0.437 . . . . 0.64 111.753 -173.833 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . 0.459 ' CD2' ' HD1' ' A' ' 57' ' ' PHE . 54.1 t80 -74.86 -34.94 62.35 Favored 'General case' 0 C--N 1.326 -0.436 0 C-N-CA 120.781 -0.368 . . . . 0.54 110.098 -179.533 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -58.61 -42.43 88.13 Favored 'General case' 0 C--O 1.231 0.127 0 N-CA-C 109.714 -0.476 . . . . 1.09 109.714 173.215 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . 0.463 HD21 ' HA ' ' A' ' 93' ' ' ALA . 64.8 tp -62.73 -43.77 97.95 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.842 -0.617 . . . . 1.98 110.557 176.055 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . 0.509 ' O ' HG13 ' A' ' 113' ' ' ILE . . . -57.86 -46.03 85.41 Favored 'General case' 0 C--O 1.225 -0.237 0 CA-C-N 116.251 -0.431 . . . . 1.03 110.869 178.562 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 13.6 m120 -63.4 -36.71 84.61 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 116.5 -0.318 . . . . 1.2 111.146 179.037 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 9.6 t60 -64.4 -37.87 89.04 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 109.615 -0.513 . . . . 0.65 109.615 178.838 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 94.3 mt -72.02 -39.19 69.33 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.793 -0.639 . . . . 1.21 110.742 178.098 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . 0.509 HG13 ' O ' ' A' ' 109' ' ' ALA . 59.4 mt -56.68 -47.54 82.24 Favored 'Isoleucine or valine' 0 C--O 1.233 0.211 0 N-CA-C 109.816 -0.439 . . . . 1.41 109.816 175.247 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . 0.555 ' O ' ' HB2' ' A' ' 118' ' ' GLU . 4.6 mmmm -62.38 -44.11 97.23 Favored 'General case' 0 C--O 1.221 -0.413 0 CA-C-N 116.076 -0.511 . . . . 4.33 111.622 179.223 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . 0.521 HG12 ' HB2' ' A' ' 120' ' ' HIS . 42.9 t -58.01 -43.25 84.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-O 120.835 0.35 . . . . 1.77 110.903 178.192 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . 0.48 ' HD2' ' HA ' ' A' ' 116' ' ' LYS . 18.3 tptt -65.75 -45.41 82.7 Favored 'General case' 0 N--CA 1.444 -0.754 0 CA-C-N 116.057 -0.519 . . . . 1.86 110.786 -178.982 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 95.7 mt -78.95 -15.75 57.88 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.511 -0.313 . . . . 1.53 111.78 -178.742 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . 0.555 ' HB2' ' O ' ' A' ' 114' ' ' LYS . 2.1 tp10 -79.4 -13.56 59.52 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 109.081 -0.711 . . . . 2.18 109.081 177.063 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 93.78 31.02 8.46 Favored Glycine 0 N--CA 1.452 -0.287 0 CA-C-N 115.236 -0.893 . . . . 1.17 112.318 178.293 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' HIS . . . . . 0.521 ' HB2' HG12 ' A' ' 115' ' ' VAL . 80.8 m-70 -117.09 176.8 4.97 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 109.843 -0.429 . . . . 2.86 109.843 177.644 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 -126.41 155.07 42.75 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 120.789 0.328 . . . . 2.53 110.255 -177.85 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . 0.473 ' HA ' ' HD3' ' A' ' 123' ' ' PRO . 0.7 OUTLIER -116.39 135.64 22.91 Favored Pre-proline 0 C--N 1.324 -0.521 0 N-CA-C 109.807 -0.442 . . . . 1.8 109.807 177.931 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . 0.473 ' HD3' ' HA ' ' A' ' 122' ' ' LEU . 2.9 Cg_exo -76.45 10.31 2.23 Favored 'Trans proline' 0 C--O 1.234 0.315 0 C-N-CA 123.191 2.594 . . . . 1.72 113.393 -175.49 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . 0.417 ' HA ' HD13 ' A' ' 92' ' ' LEU . . . 57.91 27.21 14.33 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-O 121.24 0.543 . . . . 1.71 111.367 -178.89 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 8.2 t70 -132.42 154.67 49.61 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 109.235 -0.654 . . . . 2.73 109.235 -179.887 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 95.2 mt -108.46 101.67 43.78 Favored Pre-proline 0 C--N 1.324 -0.527 0 CA-C-O 120.917 0.389 . . . . 2.28 111.616 -177.078 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' PRO . . . . . 0.62 ' HG2' ' CB ' ' A' ' 130' ' ' LEU . 18.4 Cg_endo -62.64 151.95 80.68 Favored 'Trans proline' 0 CA--C 1.535 0.546 0 C-N-CA 122.821 2.347 . . . . 1.33 111.767 173.344 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -53.11 -35.7 73.83 Favored 'Trans proline' 0 CA--C 1.533 0.461 0 C-N-CA 123.415 2.743 . . . . 1.87 113.622 -175.23 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 11.9 p-80 -86.93 3.26 46.36 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 111.669 0.248 . . . . 1.29 111.669 -178.916 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . 0.62 ' CB ' ' HG2' ' A' ' 127' ' ' PRO . 16.5 tp -115.57 -1.14 12.83 Favored 'General case' 0 N--CA 1.446 -0.655 0 CA-C-O 120.965 0.412 . . . . 1.87 110.279 -177.912 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . 0.404 HG22 ' O ' ' A' ' 127' ' ' PRO . 65.0 t -88.69 129.77 47.6 Favored Pre-proline 0 C--N 1.327 -0.391 0 CA-C-N 115.987 -0.551 . . . . 1.85 110.122 178.598 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 132' ' ' PRO . . . . . 0.401 ' HA ' ' HD3' ' A' ' 133' ' ' PRO . 83.1 Cg_exo -48.31 130.38 20.93 Favored 'Trans proline' 0 C--N 1.348 0.532 0 C-N-CA 122.891 2.394 . . . . 1.02 112.306 177.685 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 133' ' ' PRO . . . . . 0.401 ' HD3' ' HA ' ' A' ' 132' ' ' PRO . 50.6 Cg_exo -54.27 -37.44 88.27 Favored 'Trans proline' 0 C--O 1.232 0.206 0 C-N-CA 123.446 2.764 . . . . 1.39 113.369 -174.296 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 12.8 m -83.99 -2.05 55.85 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.55 -0.295 . . . . 1.79 111.227 -177.05 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . 0.412 ' HD3' ' HB ' ' A' ' 95' ' ' VAL . 61.2 mttp -120.24 17.24 12.32 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 112.285 0.476 . . . . 1.79 112.285 -174.702 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 40.4 ptt180 -100.61 145.76 27.98 Favored 'General case' 0 C--N 1.324 -0.523 0 C-N-CA 120.748 -0.381 . . . . 3.33 110.255 177.927 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 33.7 mtp180 -99.22 -176.26 3.25 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.637 0.732 . . . . 5.15 112.59 -175.098 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 31.2 m80 -120.91 140.82 51.31 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 114.707 -1.133 . . . . 6.71 109.178 173.923 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 . . . . . 0 C--O 1.247 0.939 0 CA-C-O 118.218 -0.896 . . . . 6.15 111.157 -179.732 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' B' B ' 143' ' ' PHE . . . . . . . . . . . . . 40.1 m-85 . . . . . 0 N--CA 1.477 0.895 0 CA-C-O 121.19 0.519 . . . . 12.46 111.145 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' B' B ' 144' ' ' ASN . . . . . . . . . . . . . 3.6 p-10 -169.15 168.89 9.69 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 107.797 -1.186 . . . . 8.42 107.797 179.661 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 145' ' ' TYR . . . . . . . . . . . . . 36.0 t80 -103.21 159.3 15.66 Favored 'General case' 0 C--N 1.32 -0.692 0 C-N-CA 120.41 -0.516 . . . . 6.88 109.611 176.007 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 146' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -62.96 -23.3 67.34 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.719 -0.673 . . . . 6.61 111.118 -178.874 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 147' ' ' SER . . . . . . . . . . . . . 36.6 t -98.46 119.54 37.34 Favored 'General case' 0 N--CA 1.447 -0.594 0 CA-C-N 115.86 -0.609 . . . . 4.05 109.417 178.704 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 148' ' ' THR . . . . . . . . . . . . . 2.6 p -105.78 19.5 20.46 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.342 0.591 . . . . 2.41 110.519 178.682 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 149' ' ' GLY . . . . . . . . . . . . . . . 161.29 157.54 8.86 Favored Glycine 0 N--CA 1.444 -0.778 0 CA-C-N 115.578 -0.737 . . . . 0.92 111.542 177.723 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 150' ' ' PRO . . . . . . . . . . . . . 69.4 Cg_endo -73.86 -8.33 21.16 Favored 'Trans proline' 0 N--CA 1.465 -0.204 0 C-N-CA 122.423 2.082 . . . . 0.33 112.106 -179.228 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 151' ' ' PHE . . . . . 0.418 ' CZ ' ' HA ' ' A' ' 73' ' ' LYS . 36.2 m-85 -108.59 -16.71 14.14 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.067 -0.515 . . . . 0.75 111.038 178.136 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 152' ' ' THR . . . . . 0.459 HG22 ' HE3' ' A' ' 91' ' ' LYS . 2.6 t -148.56 131.74 16.41 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.041 0.448 . . . . 2.81 111.935 -167.32 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 153' ' ' ALA . . . . . . . . . . . . . . . -109.76 166.36 10.97 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.899 -0.592 . . . . 4.4 109.806 176.26 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 154' ' ' LYS . . . . . . . . . . . . . 12.4 mptt . . . . . 0 C--O 1.247 0.94 0 CA-C-O 118.25 -0.881 . . . . 7.16 110.366 -177.696 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 141' ' ' ' CA' . . . . . 0.638 'CA ' ' OD1' ' A' ' 94' ' ' ASP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.723 0 N-CA-C 112.372 -0.291 . . . . 11.39 112.372 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 97.1 Cg_endo -84.4 68.78 6.34 Favored 'Trans proline' 0 N--CA 1.46 -0.444 0 C-N-CA 122.795 2.33 . . . . 9.9 112.084 178.414 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.442 ' H ' HD22 ' A' ' 37' ' ' LEU . 2.5 pt? -67.63 -25.12 65.58 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 116.109 -0.496 . . . . 7.72 111.662 -177.659 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -78.43 -48.3 7.49 Favored Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 120.857 -0.687 . . . . 4.67 112.311 -177.848 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 16.5 m 66.58 -75.44 0.06 Allowed 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 122.977 0.511 . . . . 4.08 110.596 -176.889 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -92.59 134.43 35.01 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 109.211 -0.662 . . . . 3.46 109.211 -179.502 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -114.57 138.73 50.28 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 120.646 0.26 . . . . 1.98 111.379 -171.686 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 13.5 p -99.37 144.39 12.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.184 -0.462 . . . . 2.56 110.718 -178.851 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . 0.453 ' OE2' ' HA ' ' A' ' 45' ' ' VAL . 12.4 tt0 -74.01 143.04 45.73 Favored 'General case' 0 C--O 1.237 0.411 0 CA-C-O 120.879 0.371 . . . . 3.1 110.814 179.775 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' TRP . . . . . 0.49 ' HH2' ' O ' ' A' ' 104' ' ' GLU . 6.1 t90 -83.39 102.14 11.82 Favored 'General case' 0 N--CA 1.448 -0.545 0 N-CA-C 107.503 -1.295 . . . . 0.73 107.503 168.767 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.453 ' HA ' ' OE2' ' A' ' 43' ' ' GLU . 35.6 m -61.58 -9.66 3.24 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.532 0 N-CA-C 113.011 0.745 . . . . 2.1 113.011 -170.045 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 22.4 t -86.51 -20.17 7.91 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 CA-C-O 121.24 0.543 . . . . 1.76 110.194 177.794 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . 0.546 ' HA2' ' HG3' ' A' ' 50' ' ' LYS . . . -73.27 -25.86 71.97 Favored Glycine 0 N--CA 1.449 -0.45 0 CA-C-N 115.71 -0.677 . . . . 0.59 113.242 -175.145 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 6.4 ptpp? -74.06 -25.32 59.77 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 117.052 0.426 . . . . 3.11 111.051 -178.827 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 24.1 m-20 -105.67 33.75 3.6 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.114 0.483 . . . . 1.66 109.96 179.37 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . 0.546 ' HG3' ' HA2' ' A' ' 47' ' ' GLY . 48.9 mttt -70.16 -43.25 18.32 Favored Pre-proline 0 C--O 1.219 -0.521 0 CA-C-O 118.499 -0.762 . . . . 1.72 112.657 178.042 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . 0.52 ' O ' ' HG3' ' A' ' 55' ' ' GLU . 66.2 Cg_exo -39.64 -48.71 3.44 Favored 'Trans proline' 0 C--N 1.365 1.439 0 C-N-CA 122.82 2.346 . . . . 1.07 113.89 -179.243 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 18.4 m -69.54 -44.8 70.19 Favored 'General case' 0 C--O 1.239 0.509 0 CA-C-O 121.082 0.467 . . . . 1.38 111.148 -177.626 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 9.8 m-30 -70.34 -21.49 62.9 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.873 -0.603 . . . . 1.14 109.854 -178.238 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -74.88 -44.68 47.54 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.95 -0.568 . . . . 2.18 109.734 177.782 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . 0.52 ' HG3' ' O ' ' A' ' 51' ' ' PRO . 72.0 mt-10 -60.6 -29.8 69.44 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.453 -0.794 . . . . 2.33 110.416 178.493 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.458 ' O ' HD13 ' A' ' 60' ' ' LEU . 52.4 mt -84.74 -48.72 16.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 116.148 -0.478 . . . . 1.36 111.225 177.566 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . 0.46 ' HE1' HG12 ' A' ' 67' ' ' ILE . 82.9 t80 -56.24 -37.37 69.65 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 122.99 0.516 . . . . 0.36 111.534 -176.699 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . 0.522 ' HA ' ' HG3' ' A' ' 62' ' ' PRO . 3.1 m-30 -80.44 -10.03 59.75 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.234 -0.439 . . . . 1.85 111.59 -174.487 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 61.4 p -98.13 -2.38 40.12 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.113 0.482 . . . . 1.12 110.646 176.808 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.458 HD13 ' O ' ' A' ' 56' ' ' ILE . 8.9 mp -97.52 12.59 32.87 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.867 -0.606 . . . . 2.02 110.526 179.439 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 44.6 t 64.32 73.5 0.45 Allowed Pre-proline 0 C--O 1.234 0.259 0 CA-C-N 115.595 -0.73 . . . . 1.87 111.407 -179.216 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . 0.522 ' HG3' ' HA ' ' A' ' 58' ' ' TYR . 61.2 Cg_endo -77.26 126.45 8.5 Favored 'Trans proline' 0 C--N 1.347 0.455 0 C-N-CA 122.212 1.942 . . . . 0.62 112.4 178.88 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 15.7 m -109.42 113.1 43.24 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 CA-C-O 121.253 0.549 . . . . 1.76 110.438 177.633 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 95.2 m-20 61.33 34.65 18.35 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 115.617 -0.72 . . . . 1.82 111.178 179.574 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 77.76 21.68 71.15 Favored Glycine 0 C--N 1.331 0.302 0 CA-C-N 115.89 -0.596 . . . . 0.51 112.927 178.243 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 58.4 mttm -141.13 148.96 40.9 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 109.904 -0.406 . . . . 2.12 109.904 -179.015 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . 0.46 HG12 ' HE1' ' A' ' 57' ' ' PHE . 36.9 pt -117.5 160.61 16.92 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 N-CA-C 109.915 -0.402 . . . . 1.28 109.915 171.103 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 54.8 p -86.18 170.71 11.91 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 120.921 0.391 . . . . 1.21 110.623 -177.178 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -65.01 -21.13 67.55 Favored Glycine 0 N--CA 1.446 -0.687 0 C-N-CA 120.962 -0.637 . . . . 0.48 112.36 178.687 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . 0.612 ' O ' ' HG3' ' A' ' 74' ' ' LYS . . . -63.23 -52.42 62.26 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 121.027 0.441 . . . . 1.13 111.181 -179.754 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -71.23 -41.68 69.85 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.848 -0.614 . . . . 1.81 109.93 -175.012 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -61.73 -38.07 86.56 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.472 -0.785 . . . . 1.09 110.604 177.2 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . 0.621 ' HG3' ' HE1' ' B' ' 151' ' ' PHE . 79.9 tttt -64.41 -43.09 95.49 Favored 'General case' 0 CA--C 1.515 -0.37 0 CA-C-N 116.216 -0.447 . . . . 1.63 110.43 178.462 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . 0.612 ' HG3' ' O ' ' A' ' 70' ' ' ALA . 29.1 mtpp -59.33 -44.58 92.59 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.54 0.21 . . . . 2.43 110.472 -179.41 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 14.6 tp10 -61.29 -48.41 81.51 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 116.337 -0.392 . . . . 1.6 110.5 177.283 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' MET . . . . . 0.772 ' HB3' HD22 ' A' ' 86' ' ' LEU . 53.4 mtt -63.55 -33.38 75.46 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.155 0.502 . . . . 1.92 111.289 -179.682 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.501 HG22 ' O ' ' A' ' 73' ' ' LYS . 38.6 t -64.99 -30.8 51.44 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-N 116.123 -0.49 . . . . 2.22 110.087 176.392 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 66.1 mmtt -79.6 -26.81 41.13 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.15 -0.477 . . . . 3.27 111.689 178.906 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 76.9 p -66.14 -14.97 62.7 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 120.867 -0.333 . . . . 1.42 110.501 178.422 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 31.7 mtmm 70.1 18.88 6.94 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-N 115.557 -0.747 . . . . 3.49 111.572 176.135 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.529 ' HB2' HD23 ' A' ' 86' ' ' LEU . 97.0 mt -82.91 144.14 47.4 Favored Pre-proline 0 C--N 1.325 -0.498 0 N-CA-C 109.573 -0.528 . . . . 1.17 109.573 174.363 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 41.2 Cg_exo -57.65 148.07 75.99 Favored 'Trans proline' 0 C--N 1.343 0.245 0 C-N-CA 122.605 2.204 . . . . 0.59 112.369 178.659 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 2.1 m-20 -50.61 -41.82 55.24 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-N 115.852 -0.613 . . . . 2.37 111.293 -179.489 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -57.69 -47.62 81.82 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.942 -0.572 . . . . 1.92 110.878 179.37 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.512 ' O ' HG12 ' A' ' 89' ' ' ILE . 93.8 t -63.2 -37.89 80.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 115.699 -0.682 . . . . 1.15 110.393 -179.761 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.772 HD22 ' HB3' ' A' ' 76' ' ' MET . 75.0 mt -65.73 -36.63 84.14 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.016 -0.538 . . . . 1.45 110.672 179.704 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -65.23 -37.94 94.59 Favored Glycine 0 N--CA 1.449 -0.451 0 N-CA-C 110.857 -0.897 . . . . 0.32 110.857 176.213 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 31.1 mmmt -61.91 -47.43 84.98 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.295 -0.452 . . . . 2.37 109.976 174.739 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . 0.512 HG12 ' O ' ' A' ' 85' ' ' VAL . 28.3 mm -58.97 -46.62 91.43 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.18 0 CA-C-N 115.471 -0.786 . . . . 1.42 110.695 179.403 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 52.5 t-105 -60.09 -47.4 86.05 Favored 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 121.076 -0.25 . . . . 0.38 110.915 -179.064 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 37.4 ttmt -62.91 -24.16 67.71 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 116.41 -0.359 . . . . 3.4 111.319 -178.118 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.711 HD12 ' HA ' ' A' ' 124' ' ' ALA . 91.9 mt -93.38 -29.47 15.58 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.443 -0.344 . . . . 2.23 111.51 179.903 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -85.94 -41.39 14.96 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.58 -0.282 . . . . 1.15 111.35 -177.315 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . 0.659 ' OD1' 'CA ' ' A' ' 141' ' ' ' CA' . 39.8 t0 -84.5 79.34 9.61 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 108.858 -0.793 . . . . 0.79 108.858 177.282 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . 0.48 ' HB ' ' HG2' ' A' ' 135' ' ' LYS . 40.5 t -67.56 -37.51 78.91 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-N 115.292 -0.867 . . . . 1.23 111.056 -171.63 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . 0.619 ' OD1' 'CA ' ' A' ' 141' ' ' ' CA' . 40.4 p-10 -83.54 -10.1 58.52 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.934 -0.575 . . . . 0.96 110.973 -178.972 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 92.0 mttt 52.16 72.65 0.38 Allowed 'General case' 0 C--O 1.235 0.338 0 O-C-N 123.839 0.712 . . . . 3.53 110.843 179.789 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . 0.634 ' OD1' 'CA ' ' A' ' 141' ' ' ' CA' . 9.6 p-10 -127.27 9.02 6.64 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 120.916 0.389 . . . . 0.53 110.694 -176.896 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 74.02 0.39 55.96 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.768 -0.729 . . . . 0.45 112.709 177.375 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.413 ' HB2' ' OD2' ' A' ' 98' ' ' ASP . 77.2 mt -128.79 147.41 50.79 Favored 'General case' 0 N--CA 1.446 -0.653 0 N-CA-C 109.417 -0.586 . . . . 1.72 109.417 179.355 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 60.8 mt -105.17 120.1 40.68 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-N 115.992 -0.549 . . . . 1.1 109.912 176.549 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . 0.435 ' HB2' ' HG3' ' A' ' 105' ' ' GLU . 9.8 m-20 -69.6 176.96 3.19 Favored 'General case' 0 CA--C 1.511 -0.533 0 N-CA-C 109.613 -0.514 . . . . 1.72 109.613 174.279 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -56.81 -42.7 80.01 Favored 'General case' 0 C--N 1.317 -0.808 0 N-CA-C 109.552 -0.536 . . . . 1.6 109.552 172.967 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . 0.498 ' HB3' ' HB3' ' A' ' 132' ' ' PRO . 4.7 mp0 -61.94 -53.34 56.99 Favored 'General case' 0 N--CA 1.461 0.115 0 CA-C-N 115.895 -0.593 . . . . 1.66 111.266 173.946 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . 0.435 ' HG3' ' HB2' ' A' ' 102' ' ' ASP . 22.9 mt-10 -67.1 -34.33 77.39 Favored 'General case' 0 C--N 1.327 -0.394 0 C-N-CA 120.947 -0.301 . . . . 0.64 111.471 -169.824 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . 0.436 ' CD1' HD12 ' A' ' 67' ' ' ILE . 84.4 t80 -71.29 -40.67 70.72 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 109.94 -0.393 . . . . 0.54 109.94 176.335 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -57.31 -43.08 82.96 Favored 'General case' 0 N--CA 1.454 -0.239 0 CA-C-O 121.107 0.48 . . . . 1.09 110.393 175.698 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 6.3 tt -60.15 -50.6 73.03 Favored 'General case' 0 C--O 1.236 0.353 0 CA-C-N 115.504 -0.771 . . . . 1.98 110.012 178.428 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . 0.465 ' O ' HG13 ' A' ' 113' ' ' ILE . . . -57.93 -45.38 86.64 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.108 -0.496 . . . . 1.03 110.834 179.245 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -62.77 -34.12 76.58 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.04 -0.527 . . . . 1.2 110.674 -179.71 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 2.3 t60 -70.07 -35.85 74.52 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.197 -0.456 . . . . 0.65 110.358 179.712 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 63.1 mt -68.65 -40.36 80.28 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.16 -0.473 . . . . 1.21 110.077 176.597 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . 0.465 HG13 ' O ' ' A' ' 109' ' ' ALA . 69.3 mt -57.58 -41.9 80.07 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.141 0 CA-C-N 115.959 -0.564 . . . . 1.41 109.636 174.512 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . 0.674 ' O ' ' HG2' ' A' ' 118' ' ' GLU . 2.4 mmmt -58.08 -49.04 78.3 Favored 'General case' 0 C--O 1.22 -0.464 0 CA-C-N 115.406 -0.816 . . . . 4.33 110.551 177.335 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . 0.555 HG11 ' HB2' ' A' ' 120' ' ' HIS . 68.2 t -53.6 -40.86 43.9 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 O-C-N 123.408 0.443 . . . . 1.77 111.604 177.63 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . 0.407 ' HA ' ' HD3' ' A' ' 116' ' ' LYS . 42.0 mmtt -70.16 -33.54 71.9 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 111.857 0.318 . . . . 1.86 111.857 178.604 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 98.0 mt -71.38 -30.39 66.08 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.185 0.516 . . . . 1.53 110.058 175.414 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . 0.674 ' HG2' ' O ' ' A' ' 114' ' ' LYS . 22.1 mm-40 -67.71 -25.9 65.89 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.345 -0.843 . . . . 2.18 110.127 176.077 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 91.91 35.17 6.89 Favored Glycine 0 N--CA 1.447 -0.573 0 C-N-CA 120.593 -0.813 . . . . 1.17 111.927 -176.65 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' HIS . . . . . 0.555 ' HB2' HG11 ' A' ' 115' ' ' VAL . 97.9 m-70 -119.51 164.82 15.22 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 109.91 -0.404 . . . . 2.86 109.91 177.955 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 42.3 mm-40 -110.59 161.87 15.28 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 116.329 -0.396 . . . . 2.53 110.882 -174.628 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . 0.454 ' H ' HD23 ' A' ' 122' ' ' LEU . 1.7 pt? -124.96 135.44 26.78 Favored Pre-proline 0 C--N 1.323 -0.553 0 CA-C-N 115.795 -0.638 . . . . 1.8 109.492 176.331 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 62.9 Cg_endo -74.33 -1.76 11.43 Favored 'Trans proline' 0 CA--C 1.53 0.279 0 C-N-CA 122.877 2.385 . . . . 1.72 113.557 -175.455 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . 0.711 ' HA ' HD12 ' A' ' 92' ' ' LEU . . . 68.97 18.89 8.35 Favored 'General case' 0 N--CA 1.467 0.38 0 C-N-CA 123.04 0.536 . . . . 1.71 110.769 -175.781 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -117.95 156.57 28.27 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.396 -0.82 . . . . 2.73 109.231 174.765 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . 0.496 HD23 ' HB3' ' A' ' 92' ' ' LEU . 90.8 mt -108.97 104.8 55.92 Favored Pre-proline 0 C--N 1.323 -0.566 0 CA-C-O 120.705 0.288 . . . . 2.28 111.629 -176.858 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' PRO . . . . . 0.481 ' HD2' HD11 ' A' ' 130' ' ' LEU . 51.5 Cg_exo -54.81 146.72 54.42 Favored 'Trans proline' 0 C--O 1.235 0.356 0 C-N-CA 123.015 2.477 . . . . 1.33 111.782 172.023 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 41.3 Cg_endo -67.14 3.14 1.76 Allowed 'Trans proline' 0 N--CA 1.475 0.426 0 C-N-CA 123.24 2.627 . . . . 1.87 114.258 -174.228 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 27.5 p-80 -117.16 7.51 13.02 Favored 'General case' 0 C--N 1.327 -0.382 0 C-N-CA 120.737 -0.385 . . . . 1.29 110.577 177.877 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . 0.481 HD11 ' HD2' ' A' ' 127' ' ' PRO . 23.4 mt -108.08 0.99 22.03 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.833 0.349 . . . . 1.87 111.345 178.785 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 3.5 m -77.31 121.06 83.94 Favored Pre-proline 0 C--N 1.322 -0.613 0 CA-C-N 116.373 -0.376 . . . . 1.85 110.401 173.825 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 132' ' ' PRO . . . . . 0.498 ' HB3' ' HB3' ' A' ' 104' ' ' GLU . 51.4 Cg_exo -53.29 148.64 31.87 Favored 'Trans proline' 0 C--N 1.342 0.205 0 C-N-CA 122.944 2.43 . . . . 1.02 112.094 -179.404 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 133' ' ' PRO . . . . . 0.449 ' HD2' ' HG2' ' A' ' 104' ' ' GLU . 52.3 Cg_exo -55.27 -26.61 52.99 Favored 'Trans proline' 0 C--N 1.344 0.311 0 C-N-CA 122.816 2.344 . . . . 1.39 112.554 -178.61 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 5.9 p -89.71 -13.05 37.71 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.113 -0.494 . . . . 1.79 111.74 -179.32 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . 0.48 ' HG2' ' HB ' ' A' ' 95' ' ' VAL . 13.6 mptt -111.28 -14.99 13.72 Favored 'General case' 0 N--CA 1.464 0.228 0 N-CA-C 111.967 0.358 . . . . 1.79 111.967 -177.746 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 31.9 ptt180 -75.21 143.38 43.18 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.995 0.426 . . . . 3.33 110.484 -177.774 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 18.9 ttm180 -88.71 100.39 13.09 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.029 0.443 . . . . 5.15 110.7 -177.415 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 52.9 t-80 -107.29 99.46 8.99 Favored 'General case' 0 C--N 1.318 -0.804 0 N-CA-C 109.491 -0.559 . . . . 6.71 109.491 174.687 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 11.8 tp10 . . . . . 0 C--O 1.248 0.981 0 O-C-N 123.943 0.777 . . . . 6.15 109.998 -178.056 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' B' B ' 143' ' ' PHE . . . . . . . . . . . . . 74.0 t80 . . . . . 0 N--CA 1.478 0.947 0 CA-C-O 120.577 0.227 . . . . 12.46 110.444 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' B' B ' 144' ' ' ASN . . . . . . . . . . . . . 8.3 t30 -78.01 99.36 6.05 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.019 0.438 . . . . 8.42 110.52 -179.817 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 145' ' ' TYR . . . . . . . . . . . . . 27.7 p90 -92.76 133.71 35.77 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 116.07 -0.514 . . . . 6.88 109.659 177.453 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 146' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -138.64 -41.25 0.49 Allowed 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 109.831 -0.433 . . . . 6.61 109.831 174.824 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 147' ' ' SER . . . . . . . . . . . . . 11.2 t 68.8 112.45 0.04 OUTLIER 'General case' 0 N--CA 1.463 0.179 0 O-C-N 123.999 0.812 . . . . 4.05 111.319 175.509 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 148' ' ' THR . . . . . . . . . . . . . 2.8 m -113.41 1.6 15.15 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.751 -0.659 . . . . 2.41 110.336 -177.862 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 149' ' ' GLY . . . . . . . . . . . . . . . 168.85 -176.3 43.09 Favored Glycine 0 N--CA 1.447 -0.617 0 C-N-CA 120.647 -0.787 . . . . 0.92 112.081 178.661 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 150' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -72.5 -2.25 11.49 Favored 'Trans proline' 0 C--O 1.235 0.345 0 C-N-CA 122.797 2.331 . . . . 0.33 112.238 -179.188 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 151' ' ' PHE . . . . . 0.621 ' HE1' ' HG3' ' A' ' 73' ' ' LYS . 49.3 m-85 -102.8 1.66 34.48 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.006 -0.543 . . . . 0.75 111.236 -179.093 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 152' ' ' THR . . . . . . . . . . . . . 22.7 p -108.74 24.67 12.75 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.275 0.56 . . . . 2.81 110.041 175.263 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 153' ' ' ALA . . . . . . . . . . . . . . . -120.13 -74.14 0.62 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.623 -0.717 . . . . 4.4 110.051 177.778 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 154' ' ' LYS . . . . . . . . . . . . . 9.7 mptt . . . . . 0 C--O 1.248 0.976 0 CA-C-O 118.041 -0.98 . . . . 7.16 109.674 173.399 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 141' ' ' ' CA' . . . . . 0.659 'CA ' ' OD1' ' A' ' 94' ' ' ASP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.42 ' HA2' ' HD3' ' A' ' 36' ' ' PRO . . . . . . . . 0 N--CA 1.481 1.7 0 N-CA-C 111.658 -0.577 . . . . 11.39 111.658 . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . 0.42 ' HD3' ' HA2' ' A' ' 35' ' ' GLY . 22.7 Cg_exo -65.07 120.59 7.85 Favored 'Trans proline' 0 C--N 1.343 0.28 0 C-N-CA 122.904 2.403 . . . . 9.9 111.99 179.141 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 3.0 pp -106.88 -2.7 21.07 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.27 -0.423 . . . . 7.72 111.253 -179.04 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -85.5 160.89 34.89 Favored Glycine 0 N--CA 1.448 -0.521 0 C-N-CA 120.525 -0.845 . . . . 4.67 112.362 -179.643 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 36.5 p -142.72 142.35 31.96 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 120.567 0.222 . . . . 4.08 110.673 -179.591 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -77.63 92.62 4.12 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 109.923 -0.399 . . . . 3.46 109.923 174.982 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 9.1 m-20 -117.8 127.08 53.54 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.851 -0.613 . . . . 1.98 110.838 -177.986 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.447 HG22 ' HA ' ' A' ' 129' ' ' HIS . 17.9 m -110.46 125.88 67.73 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.727 0 CA-C-N 115.717 -0.674 . . . . 2.56 109.475 174.991 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 50.7 mt-10 -66.79 121.67 15.96 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 109.147 -0.686 . . . . 3.1 109.147 177.523 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 1.5 t90 -71.16 107.61 4.27 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 109.444 -0.576 . . . . 0.73 109.444 -176.375 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 31.2 m -66.48 -0.65 0.96 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 115.84 -0.618 . . . . 2.1 111.945 -177.444 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 46.5 t -97.73 -24.08 4.45 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-O 121.219 0.533 . . . . 1.76 109.788 173.875 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . 0.769 ' HA2' ' HG2' ' A' ' 50' ' ' LYS . . . -73.25 -21.21 79.89 Favored Glycine 0 N--CA 1.45 -0.39 0 CA-C-N 115.81 -0.632 . . . . 0.59 112.345 -178.483 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . 0.431 ' HB2' ' HE3' ' A' ' 48' ' ' LYS . 12.3 ptmt -75.13 -25.06 58.15 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 120.863 0.363 . . . . 3.11 110.633 178.847 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -102.67 31.87 3.91 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.205 -0.452 . . . . 1.66 110.004 176.694 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . 0.769 ' HG2' ' HA2' ' A' ' 47' ' ' GLY . 8.1 mmmm -72.82 -50.65 7.11 Favored Pre-proline 0 C--O 1.216 -0.673 0 CA-C-O 118.53 -0.747 . . . . 1.72 112.253 -178.293 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . 0.577 ' HD2' ' N ' ' A' ' 50' ' ' LYS . 1.4 Cg_endo -44.05 -42.01 12.66 Favored 'Trans proline' 0 C--N 1.36 1.181 0 C-N-CA 122.845 2.363 . . . . 1.07 112.593 -177.397 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 9.5 m -69.73 -45.4 68.24 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.952 -0.567 . . . . 1.38 111.119 179.67 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' TYR . . . . . 0.978 ' HH ' ' HA ' ' A' ' 111' ' ' HIS . 12.1 m-30 -76.35 -22.69 54.57 Favored 'General case' 0 C--O 1.219 -0.535 0 CA-C-N 116.486 -0.324 . . . . 1.14 110.607 -175.178 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -73.74 -45.05 54.37 Favored 'General case' 0 C--O 1.237 0.425 0 N-CA-C 108.68 -0.859 . . . . 2.18 108.68 175.418 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 2.2 tp10 -53.61 -42.26 67.53 Favored 'General case' 0 N--CA 1.455 -0.186 0 CA-C-N 114.675 -1.148 . . . . 2.33 110.495 178.2 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 66.1 mt -80.37 -47.09 21.33 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-N 115.668 -0.696 . . . . 1.36 111.341 -179.134 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . 0.488 ' CE1' HG21 ' A' ' 67' ' ' ILE . 86.3 t80 -52.31 -37.2 55.2 Favored 'General case' 0 N--CA 1.468 0.457 0 C-N-CA 122.982 0.513 . . . . 0.36 112.024 -176.076 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . 0.571 ' HA ' ' HG3' ' A' ' 62' ' ' PRO . 18.5 m-30 -77.24 -17.8 58.16 Favored 'General case' 0 C--N 1.326 -0.424 0 C-N-CA 120.743 -0.383 . . . . 1.85 111.421 -174.485 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 41.0 p -85.83 -7.5 58.69 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.283 0.563 . . . . 1.12 110.386 -179.497 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 11.1 mp -95.47 19.16 11.35 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.58 -0.737 . . . . 2.02 110.327 179.16 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 12.7 p 49.61 81.46 0.26 Allowed Pre-proline 0 N--CA 1.465 0.317 0 CA-C-N 115.558 -0.746 . . . . 1.87 111.836 -177.515 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . 0.571 ' HG3' ' HA ' ' A' ' 58' ' ' TYR . 72.6 Cg_endo -84.85 116.9 1.91 Allowed 'Trans proline' 0 N--CA 1.455 -0.767 0 C-N-CA 122.659 2.239 . . . . 0.62 112.555 -177.744 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 18.7 m -88.76 113.46 25.53 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 CA-C-O 121.26 0.553 . . . . 1.76 110.134 178.011 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 11.7 m120 62.98 28.52 16.3 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 115.485 -0.78 . . . . 1.82 111.472 179.4 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 82.01 22.98 58.38 Favored Glycine 0 N--CA 1.454 -0.146 0 C-N-CA 121.072 -0.585 . . . . 0.51 112.326 179.404 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . 0.481 ' HG2' ' HA ' ' A' ' 102' ' ' ASP . 26.8 mtpp -143.28 141.05 30.9 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 109.417 -0.586 . . . . 2.12 109.417 -177.886 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . 0.488 HG21 ' CE1' ' A' ' 57' ' ' PHE . 36.6 pt -108.66 154.77 9.86 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.812 0 CA-C-O 121.184 0.516 . . . . 1.28 110.975 178.456 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' THR . . . . . 0.511 ' HA ' ' CD2' ' A' ' 100' ' ' LEU . 32.2 p -77.6 161.28 27.95 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.171 -0.922 . . . . 1.21 111.082 -179.474 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -63.6 -22.52 66.03 Favored Glycine 0 N--CA 1.444 -0.78 0 C-N-CA 121.05 -0.595 . . . . 0.48 111.796 179.179 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -61.48 -47.52 85.29 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.898 0.38 . . . . 1.13 111.663 178.367 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 46.1 m-80 -81.29 -31.86 33.44 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.176 -0.465 . . . . 1.81 110.976 -175.804 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . 0.505 ' O ' ' HG2' ' A' ' 76' ' ' MET . . . -63.79 -45.21 90.73 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 109.378 -0.601 . . . . 1.09 109.378 173.283 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 60.5 tttp -57.03 -37.9 72.4 Favored 'General case' 0 CA--C 1.52 -0.178 0 CA-C-N 115.24 -0.891 . . . . 1.63 109.889 175.95 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 9.0 tptm -57.28 -57.05 14.32 Favored 'General case' 0 N--CA 1.453 -0.298 0 CA-C-N 115.41 -0.814 . . . . 2.43 110.509 177.968 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . 0.548 ' HA ' ' HG3' ' A' ' 78' ' ' LYS . 5.4 tp10 -64.61 -39.46 93.77 Favored 'General case' 0 C--O 1.237 0.434 0 CA-C-O 121.218 0.532 . . . . 1.6 110.966 -177.168 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' MET . . . . . 0.618 ' HB3' HD22 ' A' ' 86' ' ' LEU . 96.3 mmm -64.91 -29.39 70.33 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.179 0.514 . . . . 1.92 109.882 178.775 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -75.04 -28.32 20.79 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 CA-C-N 115.985 -0.552 . . . . 2.22 110.086 175.672 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.548 ' HG3' ' HA ' ' A' ' 75' ' ' GLU . 3.1 mmmm -68.86 -27.76 66.1 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.802 -0.635 . . . . 3.27 111.211 177.015 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 78.5 p -73.11 -15.67 61.48 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.32 -0.4 . . . . 1.42 111.643 -176.558 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 75.0 mmtt 66.75 16.43 10.38 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-N 115.9 -0.591 . . . . 3.49 111.385 178.98 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.425 ' HB2' HD23 ' A' ' 86' ' ' LEU . 93.0 mt -83.82 150.3 58.72 Favored Pre-proline 0 C--N 1.327 -0.374 0 CA-C-N 116.483 -0.326 . . . . 1.17 111.032 -179.633 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . 0.526 ' O ' ' HG ' ' A' ' 86' ' ' LEU . 51.2 Cg_exo -55.34 148.15 52.75 Favored 'Trans proline' 0 C--N 1.349 0.601 0 C-N-CA 123.113 2.542 . . . . 0.59 112.698 179.47 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 13.7 m120 -61.43 -36.12 79.48 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.939 -0.573 . . . . 2.37 111.448 -174.109 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 15.0 t -66.03 -35.23 79.98 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.949 0.404 . . . . 1.92 110.254 179.243 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 57.4 t -72.29 -37.3 58.18 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.313 0 N-CA-C 109.68 -0.489 . . . . 1.15 109.68 178.905 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.618 HD22 ' HB3' ' A' ' 76' ' ' MET . 62.1 mt -61.48 -39.72 91.94 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.883 -0.599 . . . . 1.45 109.93 176.587 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -67.19 -39.93 92.45 Favored Glycine 0 N--CA 1.45 -0.378 0 N-CA-C 111.672 -0.571 . . . . 0.32 111.672 177.29 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . 0.429 ' O ' ' HG ' ' A' ' 92' ' ' LEU . 29.9 mmmt -58.06 -47.92 81.68 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.996 0.427 . . . . 2.37 110.67 175.69 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . 0.743 HG23 HD12 ' A' ' 112' ' ' LEU . 74.9 mt -65.27 -40.35 88.32 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 115.811 -0.632 . . . . 1.42 110.926 -177.785 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 39.0 t-105 -61.79 -45.16 95.08 Favored 'General case' 0 C--N 1.334 -0.083 0 N-CA-C 110.053 -0.351 . . . . 0.38 110.053 175.392 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 4.9 tppp? -58.19 -28.15 64.53 Favored 'General case' 0 CA--C 1.531 0.232 0 CA-C-N 115.686 -0.688 . . . . 3.4 111.561 -179.554 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.429 ' HG ' ' O ' ' A' ' 88' ' ' LYS . 73.6 mt -92.39 -36.19 13.28 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.708 0.289 . . . . 2.23 111.056 179.396 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -75.22 -42.39 55.59 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.372 -0.377 . . . . 1.15 111.404 -175.458 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . 0.653 ' OD1' 'CA ' ' A' ' 141' ' ' ' CA' . 45.2 t0 -86.73 75.45 9.64 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.549 0.69 . . . . 0.79 109.446 178.954 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 42.8 t -63.56 -40.54 89.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 114.927 -1.033 . . . . 1.23 111.255 -174.342 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 30.4 p30 -84.39 -7.47 59.29 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.369 -0.378 . . . . 0.96 111.898 -177.838 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 48.0 mtmt 55.86 74.13 0.4 Allowed 'General case' 0 N--CA 1.466 0.369 0 O-C-N 123.503 0.502 . . . . 3.53 111.541 177.904 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . 0.626 ' OD1' 'CA ' ' A' ' 141' ' ' ' CA' . 7.3 p-10 -128.85 9.26 5.83 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.869 0.366 . . . . 0.53 111.068 -177.557 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 69.73 -0.65 19.14 Favored Glycine 0 CA--C 1.522 0.487 0 C-N-CA 121.043 -0.598 . . . . 0.45 113.207 176.538 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.511 ' CD2' ' HA ' ' A' ' 68' ' ' THR . 83.8 mt -129.27 137.37 51.02 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 109.128 -0.693 . . . . 1.72 109.128 177.617 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 72.3 mt -90.62 122.44 33.42 Favored 'General case' 0 C--N 1.312 -1.025 0 C-N-CA 120.3 -0.56 . . . . 1.1 109.839 178.685 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . 0.481 ' HA ' ' HG2' ' A' ' 66' ' ' LYS . 23.4 m-20 -69.36 173.97 5.28 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 108.263 -1.014 . . . . 1.72 108.263 173.897 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -55.4 -41.44 72.7 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 121.081 0.467 . . . . 1.6 110.133 173.755 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -72.54 -40.84 66.43 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.96 -0.564 . . . . 1.66 111.406 179.508 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 28.2 mt-10 -70.13 -39.53 75.39 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 120.707 -0.397 . . . . 0.64 111.018 -176.017 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . 0.48 ' CD1' HD13 ' A' ' 67' ' ' ILE . 81.9 t80 -67.07 -37.64 84.37 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 109.952 -0.388 . . . . 0.54 109.952 176.275 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -58.3 -43.91 88.31 Favored 'General case' 0 N--CA 1.452 -0.342 0 CA-C-N 116.147 -0.479 . . . . 1.09 110.406 175.885 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 6.3 tt -60.35 -48.11 83.17 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.154 -0.476 . . . . 1.98 110.098 178.779 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -58.53 -49.47 77.29 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.082 -0.508 . . . . 1.03 110.943 179.063 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' ASN . . . . . 0.413 HD22 ' HG2' ' A' ' 75' ' ' GLU . 0.5 OUTLIER -63.57 -31.42 72.58 Favored 'General case' 0 CA--C 1.519 -0.245 0 CA-C-N 115.915 -0.584 . . . . 1.2 111.201 179.737 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' HIS . . . . . 0.978 ' HA ' ' HH ' ' A' ' 53' ' ' TYR . 32.0 t60 -66.93 -40.57 87.65 Favored 'General case' 0 N--CA 1.453 -0.302 0 N-CA-C 109.952 -0.388 . . . . 0.65 109.952 179.388 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . 0.743 HD12 HG23 ' A' ' 89' ' ' ILE . 98.3 mt -65.29 -39.54 92.66 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.658 -0.246 . . . . 1.21 110.448 177.519 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . 0.517 HD13 ' SD ' ' A' ' 76' ' ' MET . 61.2 mt -60.3 -52.35 62.42 Favored 'Isoleucine or valine' 0 C--O 1.233 0.219 0 CA-C-O 121.104 0.478 . . . . 1.41 110.192 175.424 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . 0.533 ' O ' ' HB2' ' A' ' 118' ' ' GLU . 0.4 OUTLIER -65.02 -39.45 93.4 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.492 -0.776 . . . . 4.33 111.075 -174.804 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 51.7 t -69.73 -45.03 78.67 Favored 'Isoleucine or valine' 0 C--O 1.234 0.248 0 CA-C-N 116.639 -0.255 . . . . 1.77 111.567 -178.032 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 35.8 tptt -60.52 -45.76 92.64 Favored 'General case' 0 N--CA 1.454 -0.267 0 CA-C-O 120.981 0.42 . . . . 1.86 110.676 176.92 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 94.4 mt -74.34 -16.06 60.92 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.306 -0.406 . . . . 1.53 111.208 -179.4 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . 0.658 ' HB3' ' HD2' ' A' ' 120' ' ' HIS . 22.6 tt0 -80.02 0.89 29.82 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.914 -0.584 . . . . 2.18 109.664 176.22 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 91.81 15.76 53.59 Favored Glycine 0 N--CA 1.451 -0.319 0 CA-C-N 115.839 -0.619 . . . . 1.17 112.834 175.378 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' HIS . . . . . 0.658 ' HD2' ' HB3' ' A' ' 118' ' ' GLU . 61.6 m-70 -106.08 160.3 15.41 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 110.095 -0.335 . . . . 2.86 110.095 179.903 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 8.0 tp10 -96.63 149.25 22.0 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 121.001 0.429 . . . . 2.53 110.377 179.275 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . 0.427 ' O ' HD11 ' A' ' 122' ' ' LEU . 2.4 pp -114.06 143.67 30.11 Favored Pre-proline 0 C--N 1.321 -0.645 0 CA-C-N 115.92 -0.582 . . . . 1.8 109.767 177.304 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 63.1 Cg_endo -74.09 -12.03 23.43 Favored 'Trans proline' 0 N--CA 1.465 -0.166 0 C-N-CA 122.298 1.998 . . . . 1.72 113.036 -176.372 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . 62.92 18.07 10.53 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-N 115.823 -0.626 . . . . 1.71 110.337 -175.029 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -134.01 176.09 8.89 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.045 -0.98 . . . . 2.73 108.61 175.773 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . 0.456 ' HA ' ' HD2' ' A' ' 127' ' ' PRO . 4.2 tt -113.06 100.37 51.15 Favored Pre-proline 0 C--N 1.322 -0.61 0 C-N-CA 120.786 -0.365 . . . . 2.28 110.542 -178.062 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' PRO . . . . . 0.73 ' HG2' ' HB2' ' A' ' 130' ' ' LEU . 19.5 Cg_endo -58.98 151.17 67.7 Favored 'Trans proline' 0 C--N 1.347 0.496 0 C-N-CA 123.435 2.757 . . . . 1.33 112.645 176.624 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -58.38 -28.63 85.65 Favored 'Trans proline' 0 C--N 1.346 0.446 0 C-N-CA 123.329 2.686 . . . . 1.87 113.315 -175.608 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 129' ' ' HIS . . . . . 0.447 ' HA ' HG22 ' A' ' 42' ' ' VAL . 4.1 p-80 -91.34 4.9 51.25 Favored 'General case' 0 C--N 1.329 -0.316 0 C-N-CA 120.836 -0.346 . . . . 1.29 111.226 -178.512 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . 0.73 ' HB2' ' HG2' ' A' ' 127' ' ' PRO . 41.7 tp -104.65 -2.95 24.35 Favored 'General case' 0 N--CA 1.444 -0.75 0 CA-C-O 121.185 0.517 . . . . 1.87 110.248 -177.121 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . 0.446 ' HA ' ' HD2' ' A' ' 132' ' ' PRO . 29.9 t -72.84 125.99 90.85 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 115.779 -0.646 . . . . 1.85 109.907 177.562 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 132' ' ' PRO . . . . . 0.446 ' HD2' ' HA ' ' A' ' 131' ' ' VAL . 3.8 Cg_endo -47.69 136.02 21.76 Favored 'Trans proline' 0 C--O 1.236 0.414 0 C-N-CA 123.074 2.516 . . . . 1.02 111.797 176.653 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 23.6 Cg_endo -60.81 -15.34 37.34 Favored 'Trans proline' 0 C--N 1.343 0.288 0 C-N-CA 123.222 2.615 . . . . 1.39 112.633 -174.525 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 19.7 p -90.35 -21.63 21.9 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.166 -0.47 . . . . 1.79 111.366 -179.451 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 62.8 mttt -119.5 23.34 11.26 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.782 0.325 . . . . 1.79 111.555 -172.23 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 21.1 ptt180 -87.11 132.62 33.78 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.942 0.401 . . . . 3.33 111.504 -178.926 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 15.4 mtm180 -108.35 152.13 25.06 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 109.594 -0.521 . . . . 5.15 109.594 178.625 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 53.2 t-80 -133.59 137.21 45.35 Favored 'General case' 0 C--N 1.323 -0.562 0 C-N-CA 121.228 -0.189 . . . . 6.71 110.539 177.665 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 7.4 tt0 . . . . . 0 C--O 1.25 1.11 0 O-C-N 124.301 1.0 . . . . 6.15 111.245 176.488 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' B' B ' 143' ' ' PHE . . . . . . . . . . . . . 94.3 m-85 . . . . . 0 N--CA 1.483 1.202 0 CA-C-O 120.747 0.308 . . . . 12.46 110.247 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' B' B ' 144' ' ' ASN . . . . . . . . . . . . . 26.6 p-10 -86.48 166.42 15.51 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 109.411 -0.589 . . . . 8.42 109.411 174.34 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 145' ' ' TYR . . . . . . . . . . . . . 62.6 t80 -122.55 107.71 12.31 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.178 0.513 . . . . 6.88 110.001 175.118 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 146' ' ' GLU . . . . . . . . . . . . . 4.8 pt-20 -93.97 157.5 16.08 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.611 -0.722 . . . . 6.61 110.51 -179.578 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 147' ' ' SER . . . . . . . . . . . . . 8.6 p -63.58 151.68 40.88 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.009 -0.542 . . . . 4.05 112.062 -175.297 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 148' ' ' THR . . . . . . . . . . . . . 1.6 m -92.39 1.63 57.12 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.389 0.614 . . . . 2.41 110.37 -177.407 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 149' ' ' GLY . . . . . . . . . . . . . . . 143.67 157.62 7.25 Favored Glycine 0 N--CA 1.445 -0.726 0 CA-C-N 115.72 -0.673 . . . . 0.92 111.712 -179.613 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 150' ' ' PRO . . . . . . . . . . . . . 91.8 Cg_endo -80.85 -1.52 11.28 Favored 'Trans proline' 0 CA--C 1.532 0.424 0 C-N-CA 123.176 2.584 . . . . 0.33 112.571 -178.631 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 151' ' ' PHE . . . . . 0.566 ' CZ ' ' HG3' ' A' ' 76' ' ' MET . 37.8 m-85 -107.2 -58.45 1.94 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.996 -0.547 . . . . 0.75 111.327 -178.388 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 152' ' ' THR . . . . . . . . . . . . . 15.0 t -80.24 153.79 28.31 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.185 0.517 . . . . 2.81 111.4 -174.692 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 153' ' ' ALA . . . . . . . . . . . . . . . -146.84 159.31 43.67 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.718 -0.674 . . . . 4.4 109.529 179.562 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 154' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.245 0.836 0 CA-C-O 118.143 -0.932 . . . . 7.16 110.028 -178.886 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 141' ' ' ' CA' . . . . . 0.653 'CA ' ' OD1' ' A' ' 94' ' ' ASP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.598 0 N-CA-C 111.892 -0.483 . . . . 11.39 111.892 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 92.0 Cg_endo -76.64 10.18 2.34 Favored 'Trans proline' 0 CA--C 1.53 0.322 0 C-N-CA 123.019 2.48 . . . . 9.9 113.003 -178.015 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -123.7 92.37 3.67 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.138 0.494 . . . . 7.72 109.919 179.108 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -94.61 57.56 1.92 Allowed Glycine 0 N--CA 1.447 -0.627 0 CA-C-N 115.712 -0.676 . . . . 4.67 112.465 -176.987 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 8.8 p -87.74 25.88 1.42 Allowed 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.05 0.452 . . . . 4.08 110.85 -179.418 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -86.81 113.08 22.33 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.001 -0.545 . . . . 3.46 110.589 -178.611 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -75.3 127.56 33.42 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.281 -0.418 . . . . 1.98 110.599 179.489 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 16.5 m -98.06 133.75 38.99 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-O 121.009 0.433 . . . . 2.56 111.009 -179.915 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 16.8 pt-20 -66.56 147.41 53.32 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.214 0.53 . . . . 3.1 111.386 -177.499 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' TRP . . . . . 0.436 ' HH2' ' O ' ' A' ' 104' ' ' GLU . 1.3 t90 -86.07 105.15 16.3 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 109.495 -0.557 . . . . 0.73 109.495 -178.612 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 23.6 m -64.82 -11.33 11.01 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.335 0 CA-C-O 121.034 0.445 . . . . 2.1 111.961 -177.292 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.432 HG12 ' HB2' ' A' ' 111' ' ' HIS . 42.1 t -82.04 -16.43 11.89 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 CA-C-O 121.31 0.576 . . . . 1.76 110.261 177.331 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . 0.515 ' HA2' ' HB2' ' A' ' 50' ' ' LYS . . . -74.25 -11.17 82.07 Favored Glycine 0 N--CA 1.446 -0.638 0 CA-C-N 115.684 -0.689 . . . . 0.59 112.701 -178.68 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 17.2 pttt -82.95 -28.44 29.82 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 120.347 -0.541 . . . . 3.11 109.978 -179.041 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 12.9 m-20 -106.77 30.75 5.83 Favored 'General case' 0 CA--C 1.509 -0.622 0 N-CA-C 108.593 -0.892 . . . . 1.66 108.593 176.972 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . 0.531 ' N ' ' HD2' ' A' ' 51' ' ' PRO . 15.0 tttp -92.0 -52.86 0.28 Allowed Pre-proline 0 C--N 1.317 -0.827 0 N-CA-C 112.521 0.563 . . . . 1.72 112.521 -171.207 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . 0.531 ' HD2' ' N ' ' A' ' 50' ' ' LYS . 4.8 Cg_endo -47.03 -39.54 25.46 Favored 'Trans proline' 0 C--N 1.357 0.998 0 C-N-CA 122.738 2.292 . . . . 1.07 112.981 -178.078 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 18.8 m -70.14 -42.77 72.13 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 116.003 -0.544 . . . . 1.38 110.55 -179.485 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 21.3 m-30 -71.74 -22.53 61.6 Favored 'General case' 0 CA--C 1.517 -0.312 0 CA-C-N 116.314 -0.403 . . . . 1.14 110.222 179.558 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 86.8 m-20 -72.96 -36.26 67.09 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.183 -0.462 . . . . 2.18 109.785 176.682 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . 0.464 ' HG3' ' O ' ' A' ' 51' ' ' PRO . 48.1 mt-10 -66.12 -40.75 90.93 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.017 -0.538 . . . . 2.33 110.472 176.659 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 44.8 mt -69.39 -37.38 75.25 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-O 121.582 0.706 . . . . 1.36 109.964 175.781 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . 0.455 ' HE1' HG12 ' A' ' 67' ' ' ILE . 78.2 t80 -59.62 -36.79 77.03 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.171 -0.922 . . . . 0.36 110.971 176.988 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . 0.489 ' HA ' ' HG3' ' A' ' 62' ' ' PRO . 14.2 m-30 -74.35 -23.38 59.01 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.481 -0.327 . . . . 1.85 111.047 -178.689 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 19.0 p -89.76 6.77 40.13 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 120.978 0.418 . . . . 1.12 111.371 -179.15 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 59.9 mt -105.38 5.75 32.04 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.121 -0.49 . . . . 2.02 110.193 173.956 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 19.2 m 66.42 82.7 0.2 Allowed Pre-proline 0 CA--C 1.532 0.276 0 CA-C-N 115.266 -0.879 . . . . 1.87 111.519 178.571 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . 0.489 ' HG3' ' HA ' ' A' ' 58' ' ' TYR . 36.7 Cg_endo -93.53 138.51 1.38 Allowed 'Trans proline' 0 N--CA 1.453 -0.885 0 C-N-CA 123.288 2.659 . . . . 0.62 113.162 -178.837 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 18.9 m -119.42 134.06 64.22 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 115.892 -0.595 . . . . 1.76 109.555 174.816 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 83.6 m-20 59.27 30.65 20.43 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-O 121.015 0.436 . . . . 1.82 110.986 -176.859 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 69.92 25.46 75.55 Favored Glycine 0 C--N 1.332 0.339 0 CA-C-N 115.959 -0.564 . . . . 0.51 112.598 178.47 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . 0.629 ' HA ' ' HA ' ' A' ' 102' ' ' ASP . 3.0 ptpp? -152.13 145.88 25.07 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.055 0.455 . . . . 2.12 111.425 179.528 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . 0.455 HG12 ' HE1' ' A' ' 57' ' ' PHE . 34.3 pt -107.9 142.77 19.73 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-N 116.078 -0.51 . . . . 1.28 109.766 176.887 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' THR . . . . . 0.675 ' HA ' ' HB2' ' A' ' 100' ' ' LEU . 23.2 p -64.51 161.4 17.37 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 116.382 -0.372 . . . . 1.21 110.455 177.638 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -62.3 -12.43 38.44 Favored Glycine 0 N--CA 1.448 -0.548 0 C-N-CA 120.78 -0.724 . . . . 0.48 112.24 -178.634 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . 0.45 ' O ' ' HG3' ' A' ' 74' ' ' LYS . . . -68.16 -50.04 57.09 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.326 0.584 . . . . 1.13 110.63 179.573 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . 0.907 ' HA ' ' HE3' ' A' ' 74' ' ' LYS . 35.0 m-80 -72.92 -38.84 66.71 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.564 -0.743 . . . . 1.81 110.32 -177.758 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -61.94 -41.63 98.17 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.69 -0.686 . . . . 1.09 110.097 176.766 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . 0.506 ' HG3' ' CE1' ' B' ' 151' ' ' PHE . 86.0 tttt -59.21 -43.06 92.29 Favored 'General case' 0 CA--C 1.519 -0.234 0 CA-C-N 115.964 -0.562 . . . . 1.63 110.216 176.639 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . 0.907 ' HE3' ' HA ' ' A' ' 71' ' ' ASN . 8.5 mtmp? -58.24 -42.03 85.45 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-N 116.318 -0.401 . . . . 2.43 111.091 179.114 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 15.4 tp10 -66.74 -44.92 80.24 Favored 'General case' 0 C--O 1.237 0.396 0 CA-C-O 121.476 0.655 . . . . 1.6 110.732 179.154 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' MET . . . . . 0.579 ' HB3' HD21 ' A' ' 86' ' ' LEU . 84.8 mtp -73.11 -21.9 60.66 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.78 -0.645 . . . . 1.92 111.687 -174.423 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 34.5 m -86.21 -12.32 11.08 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.455 0 C-N-CA 120.408 -0.517 . . . . 2.22 110.363 171.054 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.741 ' HG2' ' O ' ' A' ' 74' ' ' LYS . 40.6 mmtm -75.78 -26.93 57.78 Favored 'General case' 0 N--CA 1.469 0.498 0 N-CA-C 110.244 -0.28 . . . . 3.27 110.244 170.439 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -72.88 -11.62 60.66 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-O 120.798 0.332 . . . . 1.42 110.39 172.069 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 73.3 mttt 65.38 24.28 12.03 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-N 115.596 -0.729 . . . . 3.49 112.392 169.63 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.645 ' HB2' HD22 ' A' ' 86' ' ' LEU . 91.6 mt -83.77 161.86 54.57 Favored Pre-proline 0 C--N 1.325 -0.483 0 CA-C-N 116.302 -0.408 . . . . 1.17 110.786 179.763 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . 0.423 ' O ' ' HG ' ' A' ' 86' ' ' LEU . 52.1 Cg_exo -57.73 142.16 95.87 Favored 'Trans proline' 0 C--N 1.349 0.576 0 C-N-CA 123.073 2.515 . . . . 0.59 112.812 177.558 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 31.4 m-80 -59.03 -43.62 91.65 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 115.769 -0.65 . . . . 2.37 111.636 -175.237 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 2.9 p -63.64 -44.7 93.11 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.055 -0.52 . . . . 1.92 111.113 -179.208 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 60.6 t -64.18 -40.6 89.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 115.872 -0.604 . . . . 1.15 110.241 178.886 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.645 HD22 ' HB2' ' A' ' 81' ' ' LEU . 92.3 mt -59.57 -38.43 81.13 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.178 -0.465 . . . . 1.45 110.764 176.529 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -67.38 -37.61 90.57 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.686 -0.769 . . . . 0.32 112.24 178.386 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.21 -43.3 95.42 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 120.766 -0.374 . . . . 2.37 110.081 174.651 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 20.9 mt -62.37 -35.07 67.69 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.312 0 CA-C-N 116.07 -0.513 . . . . 1.42 110.387 175.831 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 71.4 t-105 -57.44 -53.93 52.59 Favored 'General case' 0 N--CA 1.452 -0.342 0 CA-C-O 120.561 0.219 . . . . 0.38 110.623 175.739 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . 0.817 ' HA ' ' HE2' ' A' ' 91' ' ' LYS . 0.6 OUTLIER -69.3 -15.57 63.37 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.989 0.423 . . . . 3.4 111.1 -176.989 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.432 HD23 ' HA ' ' A' ' 124' ' ' ALA . 14.8 tp -88.4 -32.06 18.53 Favored 'General case' 0 N--CA 1.437 -1.09 0 CA-C-O 120.89 0.376 . . . . 2.23 110.006 178.2 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . 0.766 ' HA ' HD13 ' A' ' 108' ' ' LEU . . . -87.89 -42.99 12.13 Favored 'General case' 0 C--O 1.232 0.184 0 CA-C-N 116.451 -0.34 . . . . 1.15 111.583 -179.571 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . 0.641 ' OD1' 'CA ' ' A' ' 141' ' ' ' CA' . 28.1 t0 -82.81 99.9 9.98 Favored 'General case' 0 C--O 1.236 0.376 0 CA-C-O 121.555 0.693 . . . . 0.79 110.029 179.667 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 45.3 t -83.09 -43.42 18.4 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.739 0 CA-C-N 115.282 -0.872 . . . . 1.23 110.883 -174.512 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . 0.592 ' OD1' 'CA ' ' A' ' 141' ' ' ' CA' . 34.6 p-10 -82.63 -10.44 58.95 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.961 -0.563 . . . . 0.96 111.779 -173.666 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . 0.555 ' HA ' ' OD2' ' A' ' 94' ' ' ASP . 42.7 mtpt 57.91 73.0 0.49 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.402 0.62 . . . . 3.53 111.922 178.951 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . 0.582 ' OD1' 'CA ' ' A' ' 141' ' ' ' CA' . 16.9 p-10 -121.64 9.98 10.28 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 115.395 -0.82 . . . . 0.53 110.196 176.334 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 64.2 18.05 62.27 Favored Glycine 0 C--N 1.333 0.401 0 CA-C-N 115.713 -0.676 . . . . 0.45 112.208 177.706 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.675 ' HB2' ' HA ' ' A' ' 68' ' ' THR . 1.7 pp -155.02 166.32 33.95 Favored 'General case' 0 N--CA 1.444 -0.748 0 N-CA-C 108.468 -0.938 . . . . 1.72 108.468 -179.373 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 87.6 mt -126.44 123.66 38.36 Favored 'General case' 0 C--N 1.322 -0.615 0 C-N-CA 120.832 -0.347 . . . . 1.1 111.228 -173.581 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . 0.629 ' HA ' ' HA ' ' A' ' 66' ' ' LYS . 2.3 p30 -79.75 -177.1 5.73 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 109.31 -0.626 . . . . 1.72 109.31 170.906 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 3.1 p30 -62.12 -29.39 70.3 Favored 'General case' 0 C--N 1.322 -0.63 0 C-N-CA 120.905 -0.318 . . . . 1.6 111.503 -174.694 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . 0.491 ' HB3' ' HB3' ' A' ' 132' ' ' PRO . 78.3 mt-10 -70.97 -56.24 6.62 Favored 'General case' 0 C--O 1.232 0.178 0 N-CA-C 109.823 -0.436 . . . . 1.66 109.823 177.545 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 25.3 mt-10 -65.52 -33.33 75.68 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.838 -0.619 . . . . 0.64 110.977 -174.645 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 90.8 t80 -69.23 -42.96 74.99 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.53 -0.305 . . . . 0.54 110.235 178.13 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -59.95 -39.15 84.6 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-O 121.121 0.486 . . . . 1.09 110.092 176.35 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . 0.766 HD13 ' HA ' ' A' ' 93' ' ' ALA . 2.5 tm? -59.99 -51.69 68.6 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.625 -0.716 . . . . 1.98 109.492 176.862 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . 0.41 ' O ' HG13 ' A' ' 113' ' ' ILE . . . -57.61 -45.37 85.43 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 115.965 -0.562 . . . . 1.03 111.62 179.456 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -69.38 -30.99 69.1 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.741 0.305 . . . . 1.2 111.244 -178.588 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' HIS . . . . . 0.432 ' HB2' HG12 ' A' ' 46' ' ' VAL . 30.3 t60 -64.55 -35.15 80.04 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 108.862 -0.792 . . . . 0.65 108.862 175.426 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . 0.479 ' HA ' HG13 ' A' ' 115' ' ' VAL . 74.8 mt -71.18 -42.63 68.79 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.399 -0.818 . . . . 1.21 110.797 177.303 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . 0.41 HG13 ' O ' ' A' ' 109' ' ' ALA . 24.6 mt -55.52 -50.28 67.51 Favored 'Isoleucine or valine' 0 C--O 1.234 0.26 0 CA-C-O 121.209 0.528 . . . . 1.41 110.44 177.859 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 37.3 ttpt -69.95 -45.4 67.51 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.729 -0.669 . . . . 4.33 110.997 -175.417 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . 0.479 HG13 ' HA ' ' A' ' 112' ' ' LEU . 5.8 p -63.48 -30.61 50.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 120.95 0.405 . . . . 1.77 110.207 -178.557 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . 0.463 ' HD2' ' O ' ' A' ' 120' ' ' HIS . 34.6 tptt -69.28 -45.81 68.72 Favored 'General case' 0 N--CA 1.447 -0.61 0 CA-C-N 116.204 -0.453 . . . . 1.86 110.513 176.786 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 93.9 mt -74.56 -16.28 60.82 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.11 -0.496 . . . . 1.53 111.305 -179.198 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -84.47 6.05 25.0 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.594 0.711 . . . . 2.18 109.35 176.52 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 90.34 33.92 8.39 Favored Glycine 0 CA--C 1.518 0.272 0 CA-C-N 115.47 -0.786 . . . . 1.17 113.927 172.666 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' HIS . . . . . 0.463 ' O ' ' HD2' ' A' ' 116' ' ' LYS . 33.4 m-70 -112.62 155.36 24.55 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 117.04 0.42 . . . . 2.86 110.341 175.044 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 7.4 tp10 -111.52 127.98 55.88 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 109.864 -0.421 . . . . 2.53 109.864 179.167 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 2.4 pp -92.86 136.92 24.27 Favored Pre-proline 0 C--N 1.321 -0.637 0 CA-C-O 121.108 0.48 . . . . 1.8 111.761 -174.844 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_endo -73.42 -20.74 20.53 Favored 'Trans proline' 0 C--O 1.234 0.294 0 C-N-CA 123.147 2.564 . . . . 1.72 112.423 179.266 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . 0.432 ' HA ' HD23 ' A' ' 92' ' ' LEU . . . 66.78 18.26 10.66 Favored 'General case' 0 N--CA 1.462 0.138 0 CA-C-N 115.297 -0.865 . . . . 1.71 110.092 -172.712 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 29.0 m-20 -106.14 159.74 15.85 Favored 'General case' 0 CA--C 1.516 -0.341 0 N-CA-C 108.015 -1.105 . . . . 2.73 108.015 172.445 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . 0.431 ' HA ' ' HD2' ' A' ' 127' ' ' PRO . 49.2 tp -114.44 91.98 26.44 Favored Pre-proline 0 C--N 1.322 -0.601 0 C-N-CA 120.609 -0.436 . . . . 2.28 111.713 -176.982 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 127' ' ' PRO . . . . . 0.431 ' HD2' ' HA ' ' A' ' 126' ' ' LEU . 10.9 Cg_endo -58.5 146.45 90.64 Favored 'Trans proline' 0 CA--C 1.535 0.548 0 C-N-CA 122.836 2.357 . . . . 1.33 112.138 171.883 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 128' ' ' PRO . . . . . 0.409 ' HD3' ' HA ' ' A' ' 127' ' ' PRO . 76.0 Cg_exo -51.77 -39.47 67.28 Favored 'Trans proline' 0 C--N 1.346 0.435 0 C-N-CA 123.842 3.028 . . . . 1.87 114.27 -175.31 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 41.6 p-80 -79.0 13.67 1.68 Allowed 'General case' 0 N--CA 1.469 0.513 0 N-CA-C 112.463 0.542 . . . . 1.29 112.463 -175.368 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . 0.407 HD12 ' HG2' ' A' ' 127' ' ' PRO . 41.3 mt -111.8 4.21 18.25 Favored 'General case' 0 C--N 1.324 -0.501 0 C-N-CA 121.181 -0.208 . . . . 1.87 111.131 175.198 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 93.8 t -75.27 126.57 87.68 Favored Pre-proline 0 C--N 1.327 -0.37 0 CA-C-O 120.694 0.283 . . . . 1.85 110.923 -179.788 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 132' ' ' PRO . . . . . 0.491 ' HB3' ' HB3' ' A' ' 104' ' ' GLU . 54.4 Cg_exo -54.88 154.61 20.79 Favored 'Trans proline' 0 CA--C 1.533 0.455 0 C-N-CA 123.472 2.781 . . . . 1.02 113.316 -179.583 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 133' ' ' PRO . . . . . 0.548 ' O ' ' HG2' ' A' ' 136' ' ' ARG . 50.7 Cg_exo -54.84 -54.55 4.3 Favored 'Trans proline' 0 C--N 1.347 0.468 0 C-N-CA 123.516 2.811 . . . . 1.39 113.987 -175.979 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 72.6 p -84.87 8.04 18.82 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 120.676 -0.41 . . . . 1.79 111.536 -175.464 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . 0.488 ' HD2' ' HG2' ' A' ' 132' ' ' PRO . 61.5 mttp -119.65 10.58 11.76 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 111.876 0.324 . . . . 1.79 111.876 -177.411 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . 0.548 ' HG2' ' O ' ' A' ' 133' ' ' PRO . 16.6 ptp180 -99.71 148.68 24.11 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.01 0.433 . . . . 3.33 111.2 -178.647 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 22.6 mmm180 -78.44 111.72 14.74 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.997 -0.547 . . . . 5.15 111.366 -177.32 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 138' ' ' HIS . . . . . 0.464 ' ND1' ' HG2' ' A' ' 139' ' ' GLU . 8.2 p80 -111.1 144.31 40.43 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 108.847 -0.798 . . . . 6.71 108.847 173.684 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . 0.464 ' HG2' ' ND1' ' A' ' 138' ' ' HIS . 17.6 mm-40 . . . . . 0 C--O 1.246 0.907 0 O-C-N 124.653 1.221 . . . . 6.15 109.895 -175.786 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 143' ' ' PHE . . . . . . . . . . . . . 42.8 p90 . . . . . 0 N--CA 1.48 1.063 0 CA-C-O 120.596 0.236 . . . . 12.46 110.603 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' B' B ' 144' ' ' ASN . . . . . . . . . . . . . 9.8 t-20 -142.52 -47.2 0.33 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.275 -0.42 . . . . 8.42 111.329 178.212 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 145' ' ' TYR . . . . . . . . . . . . . 47.5 p90 -129.76 6.09 5.1 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.372 -0.376 . . . . 6.88 111.088 -174.056 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 146' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -56.69 116.55 3.21 Favored 'General case' 0 C--N 1.329 -0.289 0 O-C-N 123.431 0.457 . . . . 6.61 110.578 -172.115 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 147' ' ' SER . . . . . . . . . . . . . 10.7 p -72.44 -68.0 0.51 Allowed 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.702 -0.681 . . . . 4.05 111.629 -175.39 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 148' ' ' THR . . . . . . . . . . . . . 25.1 m -132.86 -40.27 0.95 Allowed 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.909 -0.587 . . . . 2.41 109.651 178.662 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 149' ' ' GLY . . . . . . . . . . . . . . . -160.58 175.9 37.27 Favored Glycine 0 N--CA 1.443 -0.86 0 CA-C-N 115.251 -0.886 . . . . 0.92 111.277 176.0 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 150' ' ' PRO . . . . . . . . . . . . . 76.0 Cg_endo -74.77 -8.13 20.01 Favored 'Trans proline' 0 N--CA 1.463 -0.28 0 C-N-CA 122.448 2.099 . . . . 0.33 111.351 -179.187 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 151' ' ' PHE . . . . . 0.506 ' CE1' ' HG3' ' A' ' 73' ' ' LYS . 48.7 m-85 -89.47 -33.03 16.94 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.904 -0.589 . . . . 0.75 110.952 179.245 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 152' ' ' THR . . . . . . . . . . . . . 17.4 p -77.46 99.01 5.49 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.114 -0.494 . . . . 2.81 111.05 -177.16 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 153' ' ' ALA . . . . . . . . . . . . . . . -138.04 167.23 22.22 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.015 -0.539 . . . . 4.4 110.422 -179.957 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 154' ' ' LYS . . . . . . . . . . . . . 49.9 tptt . . . . . 0 C--O 1.251 1.146 0 CA-C-O 118.496 -0.764 . . . . 7.16 110.689 -178.356 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 141' ' ' ' CA' . . . . . 0.641 'CA ' ' OD1' ' A' ' 94' ' ' ASP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.735 0 N-CA-C 112.085 -0.406 . . . . 11.39 112.085 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 5.5 Cg_exo -78.3 137.79 15.33 Favored 'Trans proline' 0 N--CA 1.461 -0.422 0 C-N-CA 123.292 2.661 . . . . 9.9 112.057 179.522 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 95.0 mt -118.4 -56.34 2.15 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.051 0.453 . . . . 7.72 110.755 -179.837 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -92.22 86.3 1.23 Allowed Glycine 0 N--CA 1.447 -0.604 0 C-N-CA 120.681 -0.771 . . . . 4.67 112.667 -178.482 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 28.3 m 65.94 -170.04 0.2 Allowed 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 122.888 0.475 . . . . 4.08 111.118 177.151 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -100.02 134.05 43.5 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.207 -0.451 . . . . 3.46 110.423 179.69 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -105.1 131.11 53.02 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.047 -0.524 . . . . 1.98 110.736 -177.64 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 13.8 p -123.52 150.64 27.81 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.45 0 CA-C-N 116.175 -0.466 . . . . 2.56 111.345 -178.412 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -84.5 148.47 26.51 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 109.404 -0.591 . . . . 3.1 109.404 174.142 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' TRP . . . . . 0.488 ' HH2' ' O ' ' A' ' 104' ' ' GLU . 3.2 t90 -85.6 109.41 18.53 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 120.967 0.413 . . . . 0.73 110.095 -178.034 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 11.7 p -63.12 -17.62 19.91 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.433 0 CA-C-N 115.671 -0.695 . . . . 2.1 111.909 -175.822 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.408 HG12 ' HA ' ' A' ' 108' ' ' LEU . 46.9 t -82.06 -22.25 9.79 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-O 121.151 0.5 . . . . 1.76 110.425 179.105 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . 0.685 ' HA2' ' HG3' ' A' ' 50' ' ' LYS . . . -73.31 -11.91 79.74 Favored Glycine 0 CA--C 1.517 0.161 0 CA-C-N 115.739 -0.664 . . . . 0.59 113.481 -173.232 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 21.9 ptmt -77.83 -19.59 54.65 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.854 0.327 . . . . 3.11 111.158 -176.927 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 42.7 t0 -117.35 33.88 5.4 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.863 0.839 . . . . 1.66 109.503 179.956 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . 0.685 ' HG3' ' HA2' ' A' ' 47' ' ' GLY . 24.1 mtpt -69.18 -42.0 20.15 Favored Pre-proline 0 C--O 1.22 -0.454 0 CA-C-N 115.652 -0.704 . . . . 1.72 112.793 -179.601 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_exo -44.21 -41.33 13.06 Favored 'Trans proline' 0 C--N 1.359 1.082 0 C-N-CA 122.202 1.935 . . . . 1.07 112.733 176.699 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 15.4 m -70.44 -45.5 65.69 Favored 'General case' 0 C--O 1.238 0.456 0 CA-C-N 116.203 -0.453 . . . . 1.38 111.156 -179.277 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 7.2 m-85 -74.12 -22.01 59.64 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.534 -0.303 . . . . 1.14 110.589 -176.998 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -76.09 -39.72 54.68 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 108.932 -0.766 . . . . 2.18 108.932 178.007 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 44.4 tt0 -58.38 -47.86 82.48 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.241 -0.89 . . . . 2.33 110.218 175.282 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 55.7 mt -67.45 -52.09 45.36 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 115.644 -0.707 . . . . 1.36 111.384 179.697 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . 0.559 ' HE1' HG12 ' A' ' 67' ' ' ILE . 72.7 t80 -55.65 -32.57 63.3 Favored 'General case' 0 C--N 1.326 -0.435 0 C-N-CA 122.872 0.469 . . . . 0.36 112.017 -176.695 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . 0.433 ' CE1' ' HD2' ' A' ' 57' ' ' PHE . 2.6 m-85 -88.52 -2.23 58.48 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 111.835 0.309 . . . . 1.85 111.835 -176.416 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 79.0 p -100.36 -12.69 19.22 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.18 0.514 . . . . 1.12 109.99 173.476 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 10.4 mp -88.42 6.62 36.64 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.687 -0.688 . . . . 2.02 110.768 177.885 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 52.0 m 62.87 83.6 0.2 Allowed Pre-proline 0 CA--C 1.531 0.212 0 CA-C-N 115.558 -0.746 . . . . 1.87 111.203 -178.6 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 75.2 Cg_endo -83.36 137.16 8.02 Favored 'Trans proline' 0 N--CA 1.458 -0.598 0 C-N-CA 122.763 2.309 . . . . 0.62 112.893 -178.157 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 47.4 t -104.71 103.82 15.89 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 CA-C-N 116.105 -0.498 . . . . 1.76 110.25 178.191 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 93.2 m-20 60.57 25.78 15.47 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-N 116.042 -0.527 . . . . 1.82 111.605 177.497 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 92.54 17.46 45.38 Favored Glycine 0 C--O 1.227 -0.303 0 C-N-CA 120.788 -0.72 . . . . 0.51 112.712 178.533 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . 0.614 ' HA ' ' HA ' ' A' ' 102' ' ' ASP . 59.4 mttm -141.41 134.64 29.42 Favored 'General case' 0 C--N 1.324 -0.532 0 C-N-CA 122.95 0.5 . . . . 2.12 110.242 177.734 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . 0.559 HG12 ' HE1' ' A' ' 57' ' ' PHE . 30.0 pt -103.25 150.57 6.7 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 N-CA-C 110.197 -0.297 . . . . 1.28 110.197 173.321 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 59.3 p -73.62 166.3 23.51 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.272 -0.422 . . . . 1.21 111.078 -176.307 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -68.06 -18.82 71.32 Favored Glycine 0 N--CA 1.447 -0.622 0 C-N-CA 120.801 -0.714 . . . . 0.48 112.162 178.265 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -74.28 -39.52 62.9 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.374 0.607 . . . . 1.13 110.294 176.126 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 12.3 m120 -73.45 -41.36 63.3 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.686 -0.688 . . . . 1.81 109.309 178.771 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -62.05 -37.63 85.68 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.232 -0.895 . . . . 1.09 110.248 174.153 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . 0.427 ' O ' HG21 ' A' ' 77' ' ' VAL . 22.8 ttmm -55.74 -52.02 65.34 Favored 'General case' 0 C--O 1.221 -0.404 0 CA-C-N 115.86 -0.609 . . . . 1.63 109.862 174.66 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . 0.418 ' O ' ' HG2' ' A' ' 78' ' ' LYS . 68.4 mttm -54.95 -46.23 74.99 Favored 'General case' 0 C--N 1.329 -0.321 0 O-C-N 123.38 0.425 . . . . 2.43 111.389 -179.395 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 20.7 tp10 -63.75 -49.72 71.9 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.838 0.352 . . . . 1.6 110.895 -179.401 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' MET . . . . . 0.734 ' HB3' HD23 ' A' ' 86' ' ' LEU . 96.5 mmm -66.54 -27.91 68.12 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.247 0.546 . . . . 1.92 111.285 -178.34 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.427 HG21 ' O ' ' A' ' 73' ' ' LYS . 37.2 t -71.65 -34.53 52.64 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-N 115.907 -0.588 . . . . 2.22 110.044 175.066 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.418 ' HG2' ' O ' ' A' ' 74' ' ' LYS . 29.5 mmmt -69.85 -22.46 63.26 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.925 -0.579 . . . . 3.27 110.277 174.872 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' SER . . . . . 0.44 ' C ' ' HG2' ' A' ' 80' ' ' LYS . 15.7 m -76.02 -4.81 43.33 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.951 -0.568 . . . . 1.42 110.711 178.333 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . 0.44 ' HG2' ' C ' ' A' ' 79' ' ' SER . 18.5 ptmt 47.2 32.6 2.14 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 124.07 0.948 . . . . 3.49 112.863 175.821 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.408 ' HB2' HD21 ' A' ' 86' ' ' LEU . 85.7 mt -97.22 150.16 36.51 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 116.094 -0.503 . . . . 1.17 110.089 176.487 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . 0.496 ' O ' ' HG ' ' A' ' 86' ' ' LEU . 52.9 Cg_exo -55.51 145.39 69.27 Favored 'Trans proline' 0 C--O 1.234 0.293 0 C-N-CA 122.658 2.239 . . . . 0.59 112.347 179.636 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 21.1 p-10 -55.21 -41.71 72.39 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-N 116.35 -0.387 . . . . 2.37 111.693 -177.046 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 9.4 m -55.06 -45.87 75.36 Favored 'General case' 0 N--CA 1.448 -0.542 0 CA-C-N 115.821 -0.627 . . . . 1.92 110.748 177.826 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 80.5 t -72.28 -32.04 41.22 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.177 0 CA-C-N 115.902 -0.59 . . . . 1.15 110.891 -179.821 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.734 HD23 ' HB3' ' A' ' 76' ' ' MET . 80.4 mt -61.78 -43.66 98.42 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 110.079 -0.341 . . . . 1.45 110.079 175.906 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -66.88 -34.35 86.87 Favored Glycine 0 N--CA 1.452 -0.299 0 N-CA-C 111.511 -0.635 . . . . 0.32 111.511 178.09 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . 0.516 ' O ' HD21 ' A' ' 92' ' ' LEU . 35.5 mmtm -58.12 -58.69 7.35 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.946 0.403 . . . . 2.37 110.124 174.189 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 56.0 mt -62.11 -35.22 67.57 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 115.747 -0.661 . . . . 1.42 110.932 -177.483 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 50.7 t-105 -58.02 -49.03 78.28 Favored 'General case' 0 C--O 1.223 -0.325 0 C-N-CA 120.707 -0.397 . . . . 0.38 110.293 175.287 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 20.8 ttmm -61.95 -39.84 93.48 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.298 -0.41 . . . . 3.4 111.7 -177.526 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.819 HD12 ' HG ' ' A' ' 126' ' ' LEU . 4.3 mm? -76.74 -24.55 53.01 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 111.888 0.329 . . . . 2.23 111.888 -179.253 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -93.05 -42.21 9.55 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.648 0.261 . . . . 1.15 111.618 -178.291 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . 0.648 ' OD1' 'CA ' ' A' ' 141' ' ' ' CA' . 30.8 t0 -82.66 87.16 6.74 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.51 0.671 . . . . 0.79 109.484 179.674 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 47.4 t -80.77 -34.75 14.27 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 CA-C-N 115.197 -0.911 . . . . 1.23 110.718 -174.271 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . 0.634 ' OD1' 'CA ' ' A' ' 141' ' ' ' CA' . 48.4 p-10 -82.43 -13.92 55.99 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.503 -0.317 . . . . 0.96 110.453 -179.294 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . 0.468 ' HA ' ' OD2' ' A' ' 94' ' ' ASP . 31.7 mtmm 57.72 54.74 6.03 Favored 'General case' 0 C--O 1.231 0.118 0 O-C-N 123.778 0.674 . . . . 3.53 110.816 173.614 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . 0.606 ' OD1' 'CA ' ' A' ' 141' ' ' ' CA' . 16.2 p-10 -110.2 8.66 23.77 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.59 -0.732 . . . . 0.53 110.891 -174.775 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 71.64 7.08 64.19 Favored Glycine 0 N--CA 1.453 -0.205 0 C-N-CA 120.633 -0.794 . . . . 0.45 112.429 179.717 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 4.3 mp -135.04 155.18 51.2 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 109.516 -0.55 . . . . 1.72 109.516 178.143 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 77.7 mt -109.68 114.09 27.4 Favored 'General case' 0 C--N 1.315 -0.933 0 N-CA-C 109.399 -0.593 . . . . 1.1 109.399 175.831 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . 0.614 ' HA ' ' HA ' ' A' ' 66' ' ' LYS . 2.9 p30 -79.87 -176.05 5.24 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.255 -0.429 . . . . 1.72 110.65 179.698 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -55.07 -42.1 72.35 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.826 -0.624 . . . . 1.6 111.277 -178.719 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . 0.488 ' O ' ' HH2' ' A' ' 44' ' ' TRP . 49.9 mt-10 -72.32 -52.78 14.69 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.193 -0.458 . . . . 1.66 110.335 179.728 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 36.6 mt-10 -64.02 -37.77 88.63 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.106 -0.497 . . . . 0.64 111.193 -172.951 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . 0.49 ' CD2' ' HD1' ' A' ' 57' ' ' PHE . 49.5 t80 -74.79 -34.58 62.45 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.412 -0.358 . . . . 0.54 110.3 -179.327 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -60.07 -42.64 94.99 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-O 121.075 0.465 . . . . 1.09 110.003 173.689 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . 0.408 ' HA ' HG12 ' A' ' 46' ' ' VAL . 6.9 tt -62.1 -47.56 84.07 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-N 115.86 -0.609 . . . . 1.98 109.74 176.643 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . 0.499 ' O ' HG13 ' A' ' 113' ' ' ILE . . . -55.82 -52.03 65.41 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 115.885 -0.598 . . . . 1.03 111.195 179.2 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' ASN . . . . . 0.449 HD21 HD11 ' A' ' 113' ' ' ILE . 12.4 m120 -59.13 -35.14 72.95 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-O 120.721 0.296 . . . . 1.2 110.992 179.375 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' HIS . . . . . 0.464 ' O ' HG23 ' A' ' 115' ' ' VAL . 24.8 t60 -64.21 -39.94 95.02 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.282 -0.417 . . . . 0.65 110.193 -179.49 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 59.7 mt -74.85 -34.29 62.26 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.297 -0.41 . . . . 1.21 110.976 178.252 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . 0.499 HG13 ' O ' ' A' ' 109' ' ' ALA . 82.5 mt -59.32 -45.27 93.37 Favored 'Isoleucine or valine' 0 C--O 1.234 0.279 0 CA-C-O 121.242 0.544 . . . . 1.41 109.61 173.955 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . 0.415 ' HA ' ' HE3' ' A' ' 114' ' ' LYS . 0.1 OUTLIER -60.54 -42.65 96.95 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.216 -0.902 . . . . 4.33 110.163 177.808 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . 0.57 HG13 ' HB2' ' A' ' 120' ' ' HIS . 40.6 t -53.53 -47.07 60.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.015 -0.539 . . . . 1.77 110.978 176.103 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 27.6 mmmt -69.62 -38.75 77.36 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.403 -0.362 . . . . 1.86 111.246 -179.42 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 94.7 mt -66.51 -29.09 69.11 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.128 0.489 . . . . 1.53 111.009 177.805 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 5.4 tp10 -77.53 -22.11 51.61 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.47 0.652 . . . . 2.18 110.044 178.858 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 99.57 19.71 19.5 Favored Glycine 0 N--CA 1.445 -0.702 0 CA-C-N 115.458 -0.792 . . . . 1.17 112.657 179.919 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' HIS . . . . . 0.57 ' HB2' HG13 ' A' ' 115' ' ' VAL . 29.2 m-70 -97.4 167.07 11.23 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 109.425 -0.583 . . . . 2.86 109.425 175.907 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 7.4 tp10 -114.86 145.77 41.81 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-O 120.717 0.294 . . . . 2.53 110.223 -179.154 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . 0.476 ' HA ' ' HD3' ' A' ' 123' ' ' PRO . 3.1 pp -106.87 139.98 20.92 Favored Pre-proline 0 C--N 1.323 -0.545 0 N-CA-C 109.473 -0.566 . . . . 1.8 109.473 177.133 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . 0.476 ' HD3' ' HA ' ' A' ' 122' ' ' LEU . 9.5 Cg_exo -72.58 0.17 7.95 Favored 'Trans proline' 0 C--O 1.232 0.19 0 C-N-CA 122.743 2.295 . . . . 1.72 113.16 -176.55 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . 58.83 23.67 11.54 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-O 121.202 0.525 . . . . 1.71 110.592 -176.874 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 5.6 t0 -132.27 170.63 14.77 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 108.31 -0.996 . . . . 2.73 108.31 -179.87 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . 0.819 ' HG ' HD12 ' A' ' 92' ' ' LEU . 19.2 mt -116.76 105.93 48.91 Favored Pre-proline 0 C--N 1.321 -0.668 0 N-CA-C 112.116 0.413 . . . . 2.28 112.116 -175.21 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 127' ' ' PRO . . . . . 0.429 ' HD2' ' HB2' ' A' ' 130' ' ' LEU . 12.1 Cg_exo -70.94 147.67 55.81 Favored 'Trans proline' 0 N--CA 1.459 -0.502 0 C-N-CA 122.611 2.207 . . . . 1.33 110.778 169.919 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_exo -50.39 -37.87 51.81 Favored 'Trans proline' 0 CA--C 1.531 0.373 0 C-N-CA 122.944 2.429 . . . . 1.87 113.596 -178.311 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 44.3 p-80 -82.18 3.95 25.25 Favored 'General case' 0 CA--C 1.533 0.306 0 N-CA-C 111.961 0.356 . . . . 1.29 111.961 -178.168 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . 0.429 ' HB2' ' HD2' ' A' ' 127' ' ' PRO . 2.4 mm? -101.06 -20.01 15.55 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.665 0.269 . . . . 1.87 110.582 174.35 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 43.4 t -74.85 126.54 88.24 Favored Pre-proline 0 C--N 1.325 -0.459 0 CA-C-N 116.127 -0.488 . . . . 1.85 110.606 -178.989 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_exo -55.64 134.0 61.39 Favored 'Trans proline' 0 C--N 1.345 0.391 0 C-N-CA 122.587 2.191 . . . . 1.02 111.722 177.224 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -58.31 -23.32 62.31 Favored 'Trans proline' 0 CA--C 1.529 0.256 0 C-N-CA 122.961 2.441 . . . . 1.39 112.955 -176.64 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 5.5 m -82.01 -16.77 49.14 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.413 -0.358 . . . . 1.79 111.304 -179.72 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 6.2 mptt -119.93 22.11 11.63 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 111.776 0.287 . . . . 1.79 111.776 -176.404 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 33.9 ptt180 -86.99 101.68 13.67 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.662 0.744 . . . . 3.33 112.035 -174.702 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 15.2 tpp180 -132.21 131.7 42.41 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.343 -0.844 . . . . 5.15 109.463 175.343 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 28.0 t60 -85.36 99.65 11.31 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 120.709 0.29 . . . . 6.71 110.528 179.432 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 52.1 mt-10 . . . . . 0 C--O 1.249 1.039 0 CA-C-O 118.616 -0.707 . . . . 6.15 109.93 175.877 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' B' B ' 143' ' ' PHE . . . . . . . . . . . . . 86.1 m-85 . . . . . 0 N--CA 1.479 0.993 0 N-CA-C 110.175 -0.306 . . . . 12.46 110.175 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' B' B ' 144' ' ' ASN . . . . . . . . . . . . . 48.3 t30 -145.61 117.65 8.3 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 109.888 -0.412 . . . . 8.42 109.888 176.498 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 145' ' ' TYR . . . . . . . . . . . . . 12.9 t80 -126.32 100.58 6.34 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.134 0.492 . . . . 6.88 110.106 179.066 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 146' ' ' GLU . . . . . 0.445 ' H ' ' CD ' ' B' ' 146' ' ' GLU . 0.7 OUTLIER -80.63 121.5 25.92 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.652 -0.704 . . . . 6.61 110.486 -179.918 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 147' ' ' SER . . . . . . . . . . . . . 4.9 p -140.56 40.86 1.88 Allowed 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.767 -0.651 . . . . 4.05 110.788 -176.655 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 148' ' ' THR . . . . . 0.523 ' HB ' ' HB ' ' B' ' 152' ' ' THR . 18.0 p -78.64 -33.83 46.93 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.191 -0.459 . . . . 2.41 111.027 -178.059 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 149' ' ' GLY . . . . . . . . . . . . . . . 106.89 160.0 21.7 Favored Glycine 0 N--CA 1.443 -0.84 0 C-N-CA 120.561 -0.828 . . . . 0.92 112.395 177.555 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 150' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -73.83 -2.14 11.81 Favored 'Trans proline' 0 C--O 1.232 0.191 0 C-N-CA 122.844 2.362 . . . . 0.33 112.318 -178.272 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 151' ' ' PHE . . . . . . . . . . . . . 26.9 m-85 -102.84 -27.14 12.84 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.961 -0.563 . . . . 0.75 110.409 178.491 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 152' ' ' THR . . . . . 0.523 ' HB ' ' HB ' ' B' ' 148' ' ' THR . 6.0 m -90.61 -31.76 16.54 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.935 -0.575 . . . . 2.81 110.386 -179.743 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 153' ' ' ALA . . . . . . . . . . . . . . . 67.05 -165.06 0.22 Allowed 'General case' 0 C--O 1.234 0.285 0 CA-C-N 115.363 -0.835 . . . . 4.4 111.661 177.523 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 154' ' ' LYS . . . . . . . . . . . . . 51.2 mtmt . . . . . 0 C--O 1.245 0.846 0 CA-C-O 118.423 -0.798 . . . . 7.16 109.985 -178.732 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 141' ' ' ' CA' . . . . . 0.648 'CA ' ' OD1' ' A' ' 94' ' ' ASP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.797 0 N-CA-C 111.528 -0.629 . . . . 11.39 111.528 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . 0.729 ' HA ' ' HB2' ' A' ' 40' ' ' ASP . 7.6 Cg_exo -72.44 97.15 0.85 Allowed 'Trans proline' 0 N--CA 1.46 -0.441 0 C-N-CA 122.658 2.239 . . . . 9.9 111.3 177.125 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 56.0 tp -109.89 -47.3 3.36 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.13 -0.486 . . . . 7.72 110.211 -178.263 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -90.38 -126.64 3.29 Favored Glycine 0 N--CA 1.446 -0.674 0 N-CA-C 110.617 -0.993 . . . . 4.67 110.617 177.671 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 3.8 t -94.52 40.56 1.09 Allowed 'General case' 0 C--N 1.318 -0.784 0 N-CA-C 109.253 -0.647 . . . . 4.08 109.253 176.832 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . 0.729 ' HB2' ' HA ' ' A' ' 36' ' ' PRO . 13.7 m-20 -76.35 95.1 3.72 Favored 'General case' 0 CA--C 1.519 -0.216 0 CA-C-N 115.506 -0.77 . . . . 3.46 109.887 -179.029 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 9.9 t0 -93.03 90.52 6.95 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 109.536 -0.542 . . . . 1.98 109.536 179.347 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 26.9 m -77.32 146.75 8.03 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-N 115.904 -0.589 . . . . 2.56 110.512 -178.842 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -69.54 136.12 50.95 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 116.088 -0.505 . . . . 3.1 110.547 178.682 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 9.8 t90 -83.44 122.02 27.95 Favored 'General case' 0 C--N 1.318 -0.803 0 N-CA-C 108.796 -0.816 . . . . 0.73 108.796 179.834 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 33.6 m -61.48 -15.9 13.87 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.521 0 N-CA-C 114.316 1.228 . . . . 2.1 114.316 -166.793 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.409 HG21 ' O ' ' A' ' 107' ' ' ALA . 11.5 p -92.45 -14.06 8.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 C-N-CA 120.033 -0.667 . . . . 1.76 110.541 178.346 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -64.55 -25.41 70.17 Favored Glycine 0 CA--C 1.519 0.305 0 C-N-CA 120.964 -0.636 . . . . 0.59 112.955 -177.115 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . 0.491 ' HG3' ' OD2' ' A' ' 49' ' ' ASP . 11.5 ptmm? -76.63 -19.44 57.8 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.599 0.238 . . . . 3.11 111.149 -179.226 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . 0.491 ' OD2' ' HG3' ' A' ' 48' ' ' LYS . 10.5 m-20 -127.14 34.56 4.72 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 109.362 -0.607 . . . . 1.66 109.362 179.571 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . 0.42 ' HG2' ' OD1' ' A' ' 54' ' ' ASP . 56.7 tttm -86.61 -48.13 0.51 Allowed Pre-proline 0 C--N 1.324 -0.541 0 CA-C-N 115.862 -0.608 . . . . 1.72 112.308 -172.725 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . 0.403 ' HD3' ' HB3' ' A' ' 50' ' ' LYS . 84.3 Cg_exo -49.61 -31.22 24.11 Favored 'Trans proline' 0 C--N 1.361 1.202 0 C-N-CA 122.158 1.905 . . . . 1.07 113.003 -179.88 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 11.0 m -70.14 -45.43 66.81 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.252 -0.431 . . . . 1.38 110.502 177.763 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 19.9 m-30 -73.67 -23.25 59.82 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.395 -0.366 . . . . 1.14 110.291 -177.81 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . 0.42 ' OD1' ' HG2' ' A' ' 50' ' ' LYS . 0.9 OUTLIER -72.59 -40.6 66.44 Favored 'General case' 0 CA--C 1.517 -0.305 0 N-CA-C 109.683 -0.488 . . . . 2.18 109.683 174.657 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 2.6 mm-40 -58.76 -36.93 75.18 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.039 -0.528 . . . . 2.33 110.58 176.012 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 35.3 mt -75.65 -40.29 40.31 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-O 121.119 0.485 . . . . 1.36 110.298 177.183 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . 0.41 ' HD2' ' CD1' ' A' ' 58' ' ' TYR . 86.5 t80 -57.1 -38.18 73.01 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.685 -0.689 . . . . 0.36 111.409 179.132 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . 0.506 ' HA ' ' HG3' ' A' ' 62' ' ' PRO . 19.8 m-30 -80.32 -3.77 50.77 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.383 -0.372 . . . . 1.85 111.578 -174.208 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 75.3 p -100.2 -2.4 34.04 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.878 0.371 . . . . 1.12 111.034 179.609 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 74.6 mt -102.09 16.7 25.28 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.393 -0.367 . . . . 2.02 110.615 179.753 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 48.3 t 63.06 80.89 0.24 Allowed Pre-proline 0 CA--C 1.532 0.283 0 CA-C-N 115.53 -0.759 . . . . 1.87 111.237 -179.209 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . 0.575 ' HA ' HG23 ' A' ' 67' ' ' ILE . 6.2 Cg_exo -78.59 143.88 19.4 Favored 'Trans proline' 0 N--CA 1.461 -0.427 0 C-N-CA 122.899 2.399 . . . . 0.62 112.007 178.84 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 16.7 m -122.86 117.43 51.78 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-N 116.284 -0.416 . . . . 1.76 110.191 176.161 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 13.7 m120 62.07 23.35 13.77 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-N 115.984 -0.553 . . . . 1.82 111.182 -179.823 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 90.57 5.77 68.79 Favored Glycine 0 C--O 1.229 -0.201 0 C-N-CA 120.961 -0.638 . . . . 0.51 113.043 178.375 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . 0.614 ' HG2' ' HA ' ' A' ' 102' ' ' ASP . 37.0 mtpt -135.52 157.93 45.64 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 109.952 -0.388 . . . . 2.12 109.952 -178.692 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . 0.575 HG23 ' HA ' ' A' ' 62' ' ' PRO . 48.8 pt -124.95 164.07 24.38 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-O 120.988 0.423 . . . . 1.28 110.943 177.416 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 37.5 p -82.25 165.57 20.31 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.339 -0.846 . . . . 1.21 110.893 179.992 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -72.1 -12.98 76.17 Favored Glycine 0 N--CA 1.447 -0.614 0 C-N-CA 120.988 -0.625 . . . . 0.48 112.56 179.599 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . 0.405 ' O ' ' HG3' ' A' ' 74' ' ' LYS . . . -64.46 -58.97 4.93 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.079 0.466 . . . . 1.13 111.068 -179.216 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 39.4 m-80 -68.89 -38.54 79.72 Favored 'General case' 0 C--O 1.238 0.454 0 CA-C-N 115.809 -0.632 . . . . 1.81 110.451 -178.06 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -59.25 -43.2 92.45 Favored 'General case' 0 N--CA 1.45 -0.425 0 CA-C-N 115.608 -0.723 . . . . 1.09 109.951 176.542 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -62.23 -39.54 93.16 Favored 'General case' 0 C--O 1.224 -0.276 0 CA-C-N 116.362 -0.381 . . . . 1.63 110.906 177.85 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . 0.475 ' O ' HG11 ' A' ' 77' ' ' VAL . 57.6 mtpt -59.14 -33.43 70.87 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-O 121.008 0.432 . . . . 2.43 110.693 178.731 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . 0.467 ' O ' ' HG3' ' A' ' 78' ' ' LYS . 40.9 tt0 -81.34 -50.67 9.22 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 116.172 -0.467 . . . . 1.6 110.368 -179.496 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' MET . . . . . 0.72 ' HB3' HD21 ' A' ' 86' ' ' LEU . 75.1 mmm -57.4 -27.49 62.39 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.803 -0.635 . . . . 1.92 110.327 178.672 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.475 HG11 ' O ' ' A' ' 74' ' ' LYS . 1.5 p -86.95 -28.01 5.8 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.535 0 CA-C-N 115.942 -0.572 . . . . 2.22 110.968 -179.082 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.476 ' C ' ' HD3' ' A' ' 78' ' ' LYS . 0.0 OUTLIER -82.28 -14.38 55.51 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-O 120.886 0.374 . . . . 3.27 110.26 -179.096 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 2.0 p -78.6 4.43 13.53 Favored 'General case' 0 CA--C 1.531 0.214 0 CA-C-N 116.323 -0.399 . . . . 1.42 110.396 170.343 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 52.3 mtpt 63.5 32.81 14.0 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 115.403 -0.817 . . . . 3.49 112.247 172.535 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.635 ' HB2' HD22 ' A' ' 86' ' ' LEU . 88.7 mt -102.17 141.39 22.44 Favored Pre-proline 0 C--N 1.318 -0.778 0 CA-C-N 116.417 -0.356 . . . . 1.17 110.118 176.956 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . 0.524 ' O ' ' HG ' ' A' ' 86' ' ' LEU . 51.7 Cg_exo -56.14 136.74 76.69 Favored 'Trans proline' 0 C--N 1.344 0.306 0 C-N-CA 122.821 2.347 . . . . 0.59 112.706 179.52 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 18.2 p30 -51.93 -34.9 43.79 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-N 115.846 -0.616 . . . . 2.37 112.437 -179.866 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 30.1 m -69.48 -39.07 77.89 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 121.006 0.432 . . . . 1.92 110.608 -179.553 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.408 HG22 ' HB2' ' A' ' 82' ' ' PRO . 58.8 t -67.69 -36.23 75.33 Favored 'Isoleucine or valine' 0 C--O 1.234 0.277 0 N-CA-C 109.325 -0.62 . . . . 1.15 109.325 176.573 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.72 HD21 ' HB3' ' A' ' 76' ' ' MET . 65.4 mt -63.84 -33.47 75.75 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.348 -0.842 . . . . 1.45 109.876 175.807 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -68.58 -38.28 86.07 Favored Glycine 0 N--CA 1.451 -0.363 0 N-CA-C 111.57 -0.612 . . . . 0.32 111.57 178.931 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . 0.409 ' O ' ' HG ' ' A' ' 92' ' ' LEU . 73.1 mmtt -57.7 -52.82 63.86 Favored 'General case' 0 C--O 1.24 0.563 0 CA-C-O 121.638 0.733 . . . . 2.37 109.582 173.814 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . 0.407 HG23 HD12 ' A' ' 112' ' ' LEU . 45.4 mt -65.12 -34.88 73.59 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.453 0 CA-C-N 114.924 -1.034 . . . . 1.42 111.389 -178.148 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' TRP . . . . . 0.455 ' HB2' ' CE2' ' B' ' 151' ' ' PHE . 55.0 t-105 -60.45 -46.09 91.33 Favored 'General case' 0 C--N 1.333 -0.118 0 CA-C-O 120.795 0.331 . . . . 0.38 110.149 175.814 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 30.8 ttpt -66.39 -20.86 66.18 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.846 -0.615 . . . . 3.4 110.807 -178.611 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.749 HD12 ' HA ' ' A' ' 124' ' ' ALA . 82.6 mt -92.35 -31.56 15.3 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.437 -0.347 . . . . 2.23 111.682 177.4 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -86.54 -41.49 14.28 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.506 -0.315 . . . . 1.15 111.835 -174.39 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . 0.65 ' OD1' 'CA ' ' A' ' 141' ' ' ' CA' . 36.3 t0 -80.86 81.26 7.16 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 108.982 -0.747 . . . . 0.79 108.982 178.137 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . 0.697 ' HB ' ' HD3' ' A' ' 135' ' ' LYS . 46.2 t -75.35 -34.7 31.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 115.027 -0.988 . . . . 1.23 111.083 -173.519 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . 0.634 ' OD1' 'CA ' ' A' ' 141' ' ' ' CA' . 15.5 p-10 -82.58 -8.46 59.61 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 109.514 -0.551 . . . . 0.96 109.514 179.05 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 97.0 mttt 49.65 73.06 0.27 Allowed 'General case' 0 C--O 1.235 0.314 0 CA-C-N 115.403 -0.817 . . . . 3.53 111.455 175.229 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . 0.478 ' OD2' ' HB2' ' A' ' 100' ' ' LEU . 9.5 p-10 -134.69 9.5 3.63 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.624 -0.716 . . . . 0.53 111.067 -173.837 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 73.75 -4.64 28.14 Favored Glycine 0 C--N 1.331 0.288 0 C-N-CA 120.791 -0.719 . . . . 0.45 112.407 178.699 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.478 ' HB2' ' OD2' ' A' ' 98' ' ' ASP . 89.2 mt -120.86 154.35 35.93 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 109.051 -0.722 . . . . 1.72 109.051 178.401 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 75.3 mt -108.32 122.77 47.67 Favored 'General case' 0 C--N 1.31 -1.138 0 C-N-CA 120.487 -0.485 . . . . 1.1 110.146 178.011 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . 0.665 ' HB2' ' HG3' ' A' ' 105' ' ' GLU . 16.0 m-20 -68.83 168.36 13.63 Favored 'General case' 0 CA--C 1.512 -0.508 0 N-CA-C 108.113 -1.069 . . . . 1.72 108.113 170.111 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -61.53 -29.82 70.24 Favored 'General case' 0 C--N 1.317 -0.81 0 N-CA-C 109.202 -0.666 . . . . 1.6 109.202 174.527 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 50.7 mt-10 -64.64 -55.52 19.69 Favored 'General case' 0 C--O 1.231 0.092 0 CA-C-N 115.762 -0.654 . . . . 1.66 110.148 173.495 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . 0.665 ' HG3' ' HB2' ' A' ' 102' ' ' ASP . 14.4 mt-10 -62.4 -39.85 94.6 Favored 'General case' 0 N--CA 1.463 0.207 0 CA-C-N 115.454 -0.793 . . . . 0.64 110.956 -173.914 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 79.7 t80 -64.21 -47.86 78.09 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.671 -0.695 . . . . 0.54 110.524 178.193 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . 0.409 ' O ' HG21 ' A' ' 46' ' ' VAL . . . -57.67 -45.61 85.36 Favored 'General case' 0 N--CA 1.454 -0.258 0 CA-C-N 116.278 -0.419 . . . . 1.09 110.754 178.704 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 55.1 tp -59.48 -47.37 85.75 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.486 -0.325 . . . . 1.98 110.735 -179.906 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . 0.578 ' O ' HG12 ' A' ' 113' ' ' ILE . . . -58.61 -46.85 86.14 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.224 -0.444 . . . . 1.03 110.595 177.974 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' ASN . . . . . 0.412 ' O ' ' HB ' ' A' ' 113' ' ' ILE . 0.6 OUTLIER -60.59 -36.5 78.7 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 115.903 -0.589 . . . . 1.2 111.388 179.044 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' HIS . . . . . 0.722 ' O ' HG21 ' A' ' 115' ' ' VAL . 24.8 t60 -62.94 -48.13 80.26 Favored 'General case' 0 CA--C 1.513 -0.449 0 N-CA-C 108.78 -0.822 . . . . 0.65 108.78 177.192 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . 0.407 HD12 HG23 ' A' ' 89' ' ' ILE . 97.8 mt -58.16 -34.64 70.53 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.527 -0.76 . . . . 1.21 110.795 177.521 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . 0.578 HG12 ' O ' ' A' ' 109' ' ' ALA . 36.9 mm -56.46 -52.32 54.11 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.235 0 CA-C-O 121.515 0.674 . . . . 1.41 110.309 173.605 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 18.4 tppt? -63.13 -45.83 90.11 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.016 -0.993 . . . . 4.33 111.523 -177.416 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . 0.722 HG21 ' O ' ' A' ' 111' ' ' HIS . 2.2 t -73.89 -23.82 19.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-O 120.82 0.343 . . . . 1.77 110.294 -176.499 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 14.6 tppt? -64.89 -49.48 70.31 Favored 'General case' 0 CA--C 1.52 -0.175 0 N-CA-C 109.487 -0.56 . . . . 1.86 109.487 170.264 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 86.2 mt -70.41 -15.15 62.81 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.553 -0.749 . . . . 1.53 110.88 -179.804 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 7.2 tp10 -71.35 -16.44 62.43 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.104 0.478 . . . . 2.18 109.784 175.331 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 98.67 23.97 11.46 Favored Glycine 0 N--CA 1.451 -0.36 0 N-CA-C 111.124 -0.79 . . . . 1.17 111.124 179.443 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 18.2 t60 -117.84 121.57 41.09 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 121.122 0.487 . . . . 2.86 110.867 -177.584 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 47.9 mm-40 -83.59 119.88 25.28 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.361 -0.836 . . . . 2.53 110.725 177.55 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . 0.761 ' H ' HD23 ' A' ' 122' ' ' LEU . 1.3 pt? -78.58 139.37 58.87 Favored Pre-proline 0 C--N 1.322 -0.626 0 N-CA-C 109.019 -0.734 . . . . 1.8 109.019 172.948 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . 0.447 ' HD3' ' HA ' ' A' ' 122' ' ' LEU . 7.8 Cg_exo -72.78 10.03 1.16 Allowed 'Trans proline' 0 C--N 1.345 0.374 0 C-N-CA 123.205 2.604 . . . . 1.72 112.792 -176.055 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . 0.749 ' HA ' HD12 ' A' ' 92' ' ' LEU . . . 59.14 29.94 19.61 Favored 'General case' 0 C--O 1.232 0.141 0 CA-C-N 116.239 -0.437 . . . . 1.71 110.946 -179.771 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 37.8 t70 -132.53 156.92 45.95 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.819 -0.628 . . . . 2.73 109.882 -179.688 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . 0.634 ' HG ' HD23 ' A' ' 92' ' ' LEU . 84.3 mt -110.46 103.34 53.94 Favored Pre-proline 0 C--N 1.327 -0.41 0 N-CA-C 112.055 0.391 . . . . 2.28 112.055 -175.814 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 127' ' ' PRO . . . . . 0.481 ' HD2' HD11 ' A' ' 130' ' ' LEU . 56.6 Cg_endo -72.21 161.46 44.48 Favored 'Trans proline' 0 C--O 1.234 0.321 0 C-N-CA 122.803 2.335 . . . . 1.33 111.085 171.249 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 75.5 Cg_exo -50.49 -40.39 54.22 Favored 'Trans proline' 0 C--N 1.346 0.446 0 C-N-CA 123.178 2.585 . . . . 1.87 113.836 -176.672 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 23.4 p-80 -81.29 14.56 2.35 Favored 'General case' 0 CA--C 1.533 0.324 0 N-CA-C 112.828 0.677 . . . . 1.29 112.828 -174.381 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . 0.481 HD11 ' HD2' ' A' ' 127' ' ' PRO . 12.7 mt -114.39 2.41 14.69 Favored 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 120.791 -0.363 . . . . 1.87 111.072 174.69 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 46.3 t -84.39 121.48 75.16 Favored Pre-proline 0 C--N 1.324 -0.539 0 CA-C-N 116.326 -0.397 . . . . 1.85 110.492 -178.455 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 44.7 Cg_exo -56.77 142.75 91.96 Favored 'Trans proline' 0 C--N 1.347 0.484 0 C-N-CA 123.097 2.531 . . . . 1.02 112.804 -179.974 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 133' ' ' PRO . . . . . 0.43 ' O ' ' HG2' ' A' ' 136' ' ' ARG . 11.8 Cg_endo -55.45 -36.16 93.53 Favored 'Trans proline' 0 CA--C 1.531 0.345 0 C-N-CA 123.739 2.959 . . . . 1.39 113.62 -176.682 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 4.4 m -83.82 -9.59 58.66 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.012 0.434 . . . . 1.79 110.885 -178.19 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . 0.697 ' HD3' ' HB ' ' A' ' 95' ' ' VAL . 49.5 mttp -119.67 17.62 12.76 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.056 -0.52 . . . . 1.79 110.843 -173.867 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . 0.43 ' HG2' ' O ' ' A' ' 133' ' ' PRO . 41.0 ptt180 -103.59 142.12 34.86 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.867 0.365 . . . . 3.33 110.621 -179.978 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 55.5 mtm180 -105.67 111.91 24.77 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.301 -0.408 . . . . 5.15 111.501 -179.87 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 61.6 t-80 -132.8 99.18 4.53 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 109.096 -0.705 . . . . 6.71 109.096 170.361 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 . . . . . 0 C--O 1.246 0.914 0 CA-C-O 118.135 -0.936 . . . . 6.15 110.074 -179.006 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' B' B ' 143' ' ' PHE . . . . . . . . . . . . . 92.7 m-85 . . . . . 0 N--CA 1.481 1.088 0 CA-C-O 120.868 0.366 . . . . 12.46 110.423 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' B' B ' 144' ' ' ASN . . . . . 0.456 ' O ' ' HB3' ' B' ' 145' ' ' TYR . 5.8 t-20 -160.2 131.07 5.64 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.465 -0.334 . . . . 8.42 110.293 -175.191 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 145' ' ' TYR . . . . . 0.456 ' HB3' ' O ' ' B' ' 144' ' ' ASN . 64.3 t80 76.91 -30.55 0.18 Allowed 'General case' 0 N--CA 1.478 0.937 0 N-CA-C 112.515 0.561 . . . . 6.88 112.515 173.179 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 146' ' ' GLU . . . . . . . . . . . . . 6.3 mt-10 -56.42 106.9 0.32 Allowed 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 122.935 0.494 . . . . 6.61 111.87 -178.673 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 147' ' ' SER . . . . . . . . . . . . . 79.0 p -98.91 131.06 45.28 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.048 -0.524 . . . . 4.05 109.756 175.883 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 148' ' ' THR . . . . . . . . . . . . . 7.5 p -84.46 -43.43 14.63 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 120.831 0.348 . . . . 2.41 111.734 -177.886 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 149' ' ' GLY . . . . . . . . . . . . . . . -175.28 -178.85 45.44 Favored Glycine 0 N--CA 1.446 -0.675 0 C-N-CA 120.627 -0.797 . . . . 0.92 111.878 -179.212 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 150' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -74.72 -2.02 11.91 Favored 'Trans proline' 0 CA--C 1.533 0.465 0 C-N-CA 123.053 2.502 . . . . 0.33 113.159 -176.585 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 151' ' ' PHE . . . . . 0.455 ' CE2' ' HB2' ' A' ' 90' ' ' TRP . 30.2 m-85 -94.03 -14.02 26.29 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 112.119 0.414 . . . . 0.75 112.119 -174.344 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 152' ' ' THR . . . . . . . . . . . . . 1.2 p -84.06 -15.22 48.26 Favored 'General case' 0 C--N 1.327 -0.395 0 C-N-CA 121.036 -0.266 . . . . 2.81 111.679 179.957 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 153' ' ' ALA . . . . . . . . . . . . . . . 58.86 50.23 8.82 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 115.847 -0.615 . . . . 4.4 111.201 -179.948 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 154' ' ' LYS . . . . . . . . . . . . . 72.0 mmtt . . . . . 0 C--O 1.247 0.969 0 CA-C-N 115.736 -0.665 . . . . 7.16 109.215 178.642 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 141' ' ' ' CA' . . . . . 0.65 'CA ' ' OD1' ' A' ' 94' ' ' ASP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.787 0 N-CA-C 111.576 -0.61 . . . . 11.39 111.576 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 88.4 Cg_endo -83.09 150.14 13.73 Favored 'Trans proline' 0 N--CA 1.464 -0.248 0 C-N-CA 122.448 2.099 . . . . 9.9 112.338 179.179 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 40.8 tp -111.46 -38.0 5.08 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.934 0.397 . . . . 7.72 110.582 177.561 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -159.29 49.03 0.4 Allowed Glycine 0 N--CA 1.449 -0.472 0 C-N-CA 120.439 -0.886 . . . . 4.67 112.173 179.002 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' SER . . . . . 0.456 ' HA ' ' CE1' ' A' ' 138' ' ' HIS . 44.1 m 54.12 74.24 0.34 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.969 0.89 . . . . 4.08 109.589 -175.05 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -75.59 101.01 4.77 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 114.56 -1.2 . . . . 3.46 110.383 -170.021 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -82.38 94.49 7.4 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.519 -0.764 . . . . 1.98 110.264 -176.627 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.432 HG11 ' HA ' ' A' ' 129' ' ' HIS . 13.7 p -96.64 148.25 5.59 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-N 115.829 -0.623 . . . . 2.56 110.922 -177.733 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 17.9 mm-40 -67.47 126.84 30.57 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.861 -0.609 . . . . 3.1 110.474 177.142 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 5.7 t90 -81.91 103.14 11.36 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 109.243 -0.651 . . . . 0.73 109.243 176.912 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.485 ' O ' ' HG2' ' A' ' 48' ' ' LYS . 21.2 m -60.2 -19.86 18.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 N-CA-C 112.978 0.733 . . . . 2.1 112.978 -173.172 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 28.3 t -78.94 -16.79 13.41 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-O 121.177 0.513 . . . . 1.76 110.856 -178.834 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -74.08 -9.54 80.36 Favored Glycine 0 N--CA 1.448 -0.526 0 C-N-CA 120.851 -0.69 . . . . 0.59 113.414 -175.476 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . 0.621 ' HB3' ' HZ3' ' A' ' 48' ' ' LYS . 1.1 ptpm? -83.93 -27.66 28.4 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 117.3 0.55 . . . . 3.11 111.112 -178.787 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 21.5 m-20 -100.6 33.83 2.62 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.824 0.345 . . . . 1.66 110.266 -179.465 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . 0.549 ' N ' ' HD2' ' A' ' 51' ' ' PRO . 14.9 mmtp -69.35 -51.03 17.99 Favored Pre-proline 0 C--N 1.324 -0.53 0 N-CA-C 112.83 0.678 . . . . 1.72 112.83 -177.017 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . 0.586 ' HA ' ' OD2' ' A' ' 54' ' ' ASP . 4.6 Cg_endo -48.34 -42.04 34.69 Favored 'Trans proline' 0 C--N 1.356 0.966 0 C-N-CA 122.707 2.271 . . . . 1.07 113.217 -177.966 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' THR . . . . . 0.474 ' O ' ' HB3' ' A' ' 55' ' ' GLU . 21.9 m -70.93 -39.93 72.36 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.375 0.607 . . . . 1.38 110.932 -179.419 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' TYR . . . . . 0.466 ' HH ' ' HA ' ' A' ' 111' ' ' HIS . 21.2 m-30 -79.25 -22.09 45.23 Favored 'General case' 0 C--N 1.324 -0.51 0 C-N-CA 120.603 -0.439 . . . . 1.14 111.114 -175.857 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . 0.586 ' OD2' ' HA ' ' A' ' 51' ' ' PRO . 0.6 OUTLIER -82.1 -25.48 34.45 Favored 'General case' 0 CA--C 1.52 -0.18 0 N-CA-C 108.945 -0.761 . . . . 2.18 108.945 175.166 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . 0.474 ' HB3' ' O ' ' A' ' 52' ' ' THR . 9.5 tp10 -59.37 -43.14 92.9 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.478 -0.783 . . . . 2.33 109.102 169.598 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.433 HG12 ' O ' ' A' ' 52' ' ' THR . 27.6 mm -76.18 -34.82 26.91 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.331 0 CA-C-N 115.841 -0.618 . . . . 1.36 110.521 178.092 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . 0.488 ' CE2' ' HB3' ' A' ' 62' ' ' PRO . 74.0 t80 -65.72 -46.6 78.32 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.122 -0.49 . . . . 0.36 111.372 -176.725 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 15.1 m-85 -80.33 -7.94 59.28 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.382 -0.372 . . . . 1.85 111.922 -174.493 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 15.5 p -92.65 -4.34 53.44 Favored 'General case' 0 C--N 1.323 -0.572 0 C-N-CA 120.717 -0.393 . . . . 1.12 110.693 177.064 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.454 ' HB3' ' HB3' ' A' ' 71' ' ' ASN . 73.0 mt -108.08 13.24 26.16 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.299 -0.41 . . . . 2.02 111.266 178.026 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 15.8 m 68.53 87.42 0.11 Allowed Pre-proline 0 N--CA 1.469 0.525 0 CA-C-N 116.03 -0.532 . . . . 1.87 112.171 175.698 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . 0.488 ' HB3' ' CE2' ' A' ' 57' ' ' PHE . 5.6 Cg_exo -80.69 138.89 12.18 Favored 'Trans proline' 0 N--CA 1.46 -0.47 0 C-N-CA 122.862 2.375 . . . . 0.62 112.635 178.206 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 11.0 m -127.94 117.83 47.05 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-N 115.819 -0.628 . . . . 1.76 110.216 175.168 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 49.3 m-80 66.39 24.27 10.5 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-N 115.694 -0.684 . . . . 1.82 111.389 178.661 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 92.96 8.15 62.01 Favored Glycine 0 C--N 1.331 0.275 0 C-N-CA 121.018 -0.611 . . . . 0.51 112.788 176.847 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . 0.768 ' HG2' ' HA ' ' A' ' 102' ' ' ASP . 55.1 mtmt -143.28 153.96 43.31 Favored 'General case' 0 C--N 1.326 -0.422 0 C-N-CA 122.381 0.272 . . . . 2.12 110.397 -177.165 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . 0.422 HD11 ' CD1' ' A' ' 106' ' ' PHE . 41.0 pt -110.68 153.92 12.36 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.763 0 N-CA-C 110.011 -0.366 . . . . 1.28 110.011 174.957 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 18.6 p -72.7 152.5 41.65 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.285 -0.416 . . . . 1.21 111.151 179.589 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -61.8 -15.93 49.96 Favored Glycine 0 N--CA 1.448 -0.54 0 C-N-CA 121.071 -0.585 . . . . 0.48 112.947 -179.434 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -60.36 -50.46 73.51 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.133 0.492 . . . . 1.13 111.213 177.636 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . 0.548 ' HA ' ' HD3' ' A' ' 74' ' ' LYS . 39.9 m-80 -74.93 -34.23 62.08 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.826 -0.624 . . . . 1.81 110.38 -175.778 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -61.42 -45.28 94.99 Favored 'General case' 0 N--CA 1.449 -0.489 0 CA-C-N 115.929 -0.578 . . . . 1.09 109.528 173.961 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . 0.584 ' HA ' ' CZ ' ' B' ' 151' ' ' PHE . 54.9 tttp -56.08 -38.43 70.67 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.777 -0.647 . . . . 1.63 110.383 177.296 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . 0.548 ' HD3' ' HA ' ' A' ' 71' ' ' ASN . 26.8 mtpp -65.49 -32.88 74.73 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.952 -0.567 . . . . 2.43 111.256 178.671 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 18.2 tp10 -76.31 -39.39 54.27 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.164 0.507 . . . . 1.6 110.039 177.701 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' MET . . . . . 0.546 ' HB3' HD21 ' A' ' 86' ' ' LEU . 1.1 mpt? -60.71 -36.43 78.78 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 116.378 -0.374 . . . . 1.92 111.471 176.386 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.405 HG23 ' HA ' ' A' ' 74' ' ' LYS . 17.9 m -82.38 -13.88 12.2 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.507 0 C-N-CA 120.701 -0.4 . . . . 2.22 110.978 177.455 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 46.7 mmtt -74.29 -29.74 61.77 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-O 120.867 0.365 . . . . 3.27 111.029 171.396 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -83.9 -13.61 53.09 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.155 -0.475 . . . . 1.42 111.122 -178.931 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 56.2 mttp 68.29 33.01 4.43 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 115.639 -0.709 . . . . 3.49 111.927 171.788 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.713 ' HB2' HD22 ' A' ' 86' ' ' LEU . 97.2 mt -86.32 151.6 53.98 Favored Pre-proline 0 C--N 1.326 -0.453 0 N-CA-C 109.68 -0.489 . . . . 1.17 109.68 175.682 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -54.46 142.91 69.11 Favored 'Trans proline' 0 C--N 1.35 0.628 0 C-N-CA 122.887 2.391 . . . . 0.59 112.65 179.336 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 39.9 m-80 -52.36 -48.05 65.76 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 115.615 -0.72 . . . . 2.37 112.141 -175.61 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' THR . . . . . 0.415 ' O ' ' HD3' ' A' ' 88' ' ' LYS . 38.8 p -63.76 -42.73 97.77 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.912 0.387 . . . . 1.92 110.757 -178.837 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 84.7 t -59.85 -39.24 79.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 115.85 -0.614 . . . . 1.15 110.584 179.247 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.713 HD22 ' HB2' ' A' ' 81' ' ' LEU . 93.6 mt -65.75 -29.37 69.87 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.435 -0.348 . . . . 1.45 110.521 177.333 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . 0.516 ' HA3' ' HA ' ' B' ' 153' ' ' ALA . . . -65.77 -41.41 95.73 Favored Glycine 0 CA--C 1.502 -0.753 0 N-CA-C 111.086 -0.806 . . . . 0.32 111.086 175.151 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . 0.913 ' HD2' ' HB2' ' B' ' 153' ' ' ALA . 2.5 mptp? -75.06 -28.33 60.32 Favored 'General case' 0 N--CA 1.443 -0.808 0 CA-C-N 115.464 -0.368 . . . . 2.37 110.846 178.605 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 16.4 mm -60.15 -49.44 84.08 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.254 0 CA-C-N 116.325 -0.398 . . . . 1.42 110.222 173.153 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' TRP . . . . . 0.41 ' HB2' ' CD2' ' B' ' 151' ' ' PHE . 52.4 t-105 -62.38 -45.33 93.62 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.917 0.389 . . . . 0.38 110.578 178.073 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 17.4 ttmm -54.85 -32.33 60.49 Favored 'General case' 0 C--O 1.237 0.447 0 CA-C-N 115.665 -0.698 . . . . 3.4 111.585 179.276 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.543 HD23 ' HA ' ' A' ' 124' ' ' ALA . 13.0 tp -93.93 -36.92 11.96 Favored 'General case' 0 N--CA 1.442 -0.846 0 CA-C-N 115.906 -0.588 . . . . 2.23 111.782 -176.439 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -81.36 -42.48 20.44 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.753 0.311 . . . . 1.15 111.718 -174.53 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . 0.654 ' OD2' ' HA ' ' A' ' 97' ' ' LYS . 50.0 t0 -78.03 96.72 5.16 Favored 'General case' 0 C--O 1.237 0.417 0 N-CA-C 108.689 -0.856 . . . . 0.79 108.689 178.049 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 38.3 t -68.86 -45.16 81.14 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-N 115.481 -0.781 . . . . 1.23 110.965 -172.497 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 29.0 p-10 -88.6 -17.96 29.04 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 116.092 -0.504 . . . . 0.96 111.694 -176.779 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . 0.654 ' HA ' ' OD2' ' A' ' 94' ' ' ASP . 53.0 mttp 58.07 72.89 0.5 Allowed 'General case' 0 CA--C 1.518 -0.278 0 CA-C-O 122.063 0.935 . . . . 3.53 111.32 177.838 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . 0.628 ' OD1' 'CA ' ' A' ' 141' ' ' ' CA' . 11.5 p-10 -122.83 9.05 9.41 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 114.589 -1.187 . . . . 0.53 110.868 -173.169 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 78.19 -3.78 60.92 Favored Glycine 0 CA--C 1.52 0.369 0 C-N-CA 121.001 -0.619 . . . . 0.45 112.468 -179.554 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.413 ' HB2' ' OD2' ' A' ' 98' ' ' ASP . 4.6 mp -128.86 166.23 19.47 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 109.726 -0.472 . . . . 1.72 109.726 175.922 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 81.7 mt -123.75 127.52 48.26 Favored 'General case' 0 C--N 1.314 -0.951 0 CA-C-N 116.128 -0.487 . . . . 1.1 109.799 176.999 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . 0.768 ' HA ' ' HG2' ' A' ' 66' ' ' LYS . 2.6 m-20 -69.72 168.42 14.99 Favored 'General case' 0 CA--C 1.509 -0.631 0 N-CA-C 108.799 -0.815 . . . . 1.72 108.799 174.334 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -57.61 -30.28 65.2 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 108.46 -0.941 . . . . 1.6 108.46 171.772 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 6.4 mm-40 -66.97 -58.81 4.23 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-N 115.11 -0.95 . . . . 1.66 111.851 177.195 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . 0.574 ' OE1' ' HE3' ' A' ' 135' ' ' LYS . 2.4 pt-20 -78.91 -18.09 54.44 Favored 'General case' 0 CA--C 1.53 0.187 0 C-N-CA 120.283 -0.567 . . . . 0.64 112.236 -173.822 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . 0.422 ' CD1' HD11 ' A' ' 67' ' ' ILE . 50.3 t80 -76.64 -34.17 58.31 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 109.164 -0.68 . . . . 0.54 109.164 173.603 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -62.23 -44.49 96.44 Favored 'General case' 0 N--CA 1.452 -0.363 0 CA-C-N 115.672 -0.694 . . . . 1.09 109.262 171.663 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . 0.429 ' O ' ' HG ' ' A' ' 112' ' ' LEU . 4.8 tt -60.39 -46.28 90.54 Favored 'General case' 0 CA--C 1.533 0.305 0 CA-C-N 115.491 -0.777 . . . . 1.98 109.847 178.326 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -56.17 -49.65 73.41 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 116.484 -0.326 . . . . 1.03 111.363 178.361 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 22.5 m-80 -65.06 -32.53 74.28 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.423 -0.353 . . . . 1.2 111.31 179.626 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' HIS . . . . . 0.466 ' HA ' ' HH ' ' A' ' 53' ' ' TYR . 11.9 t60 -68.28 -35.59 78.09 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 109.689 -0.485 . . . . 0.65 109.689 178.091 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . 0.429 ' HG ' ' O ' ' A' ' 108' ' ' LEU . 95.8 mt -65.61 -46.88 77.65 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 116.323 -0.398 . . . . 1.21 110.324 175.713 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 62.7 mt -56.7 -45.03 82.63 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.177 0 CA-C-N 115.767 -0.651 . . . . 1.41 109.709 177.254 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 17.1 tppt? -56.85 -49.99 73.78 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.054 -0.975 . . . . 4.33 110.919 178.191 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . 0.649 HG12 ' HB2' ' A' ' 120' ' ' HIS . 45.9 t -58.68 -42.87 86.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.194 -0.457 . . . . 1.77 111.57 -178.716 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 17.5 tppt? -70.02 -41.51 74.19 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 116.628 -0.26 . . . . 1.86 110.698 -179.257 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 74.5 mt -68.61 -30.69 69.48 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.881 0.372 . . . . 1.53 111.04 179.287 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -74.96 -16.7 60.63 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.917 -0.583 . . . . 2.18 110.483 179.696 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 99.25 32.83 5.65 Favored Glycine 0 N--CA 1.449 -0.486 0 C-N-CA 120.744 -0.741 . . . . 1.17 113.02 175.96 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' HIS . . . . . 0.649 ' HB2' HG12 ' A' ' 115' ' ' VAL . 78.4 m-70 -119.54 -179.52 3.9 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 109.79 -0.448 . . . . 2.86 109.79 177.692 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -117.46 149.27 40.85 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 120.956 0.408 . . . . 2.53 111.166 -176.119 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 2.6 pp -108.3 143.53 27.62 Favored Pre-proline 0 C--N 1.324 -0.542 0 CA-C-N 115.516 -0.766 . . . . 1.8 109.784 175.346 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -73.34 -13.9 25.41 Favored 'Trans proline' 0 C--N 1.343 0.261 0 C-N-CA 122.395 2.064 . . . . 1.72 113.164 -176.338 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . 0.543 ' HA ' HD23 ' A' ' 92' ' ' LEU . . . 61.01 17.68 8.18 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 123.162 0.585 . . . . 1.71 111.392 -177.402 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -134.4 163.13 30.36 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 107.817 -1.179 . . . . 2.73 107.817 174.268 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 64.2 mt -109.2 93.88 14.11 Favored Pre-proline 0 C--N 1.322 -0.614 0 CA-C-O 120.724 0.297 . . . . 2.28 111.515 -177.016 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 127' ' ' PRO . . . . . 0.422 ' HD2' HD12 ' A' ' 130' ' ' LEU . 63.5 Cg_endo -75.77 155.67 39.48 Favored 'Trans proline' 0 N--CA 1.459 -0.554 0 C-N-CA 122.571 2.181 . . . . 1.33 111.141 173.667 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 90.0 Cg_exo -44.44 -37.2 10.48 Favored 'Trans proline' 0 CA--C 1.533 0.452 0 C-N-CA 123.478 2.785 . . . . 1.87 114.557 -177.874 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 129' ' ' HIS . . . . . 0.432 ' HA ' HG11 ' A' ' 42' ' ' VAL . 41.0 p-80 -82.03 10.27 6.9 Favored 'General case' 0 N--CA 1.466 0.339 0 C-N-CA 120.793 -0.363 . . . . 1.29 111.851 -175.503 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . 0.422 HD12 ' HD2' ' A' ' 127' ' ' PRO . 66.6 mt -126.99 1.57 6.57 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.514 0.197 . . . . 1.87 111.48 176.335 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 43.0 t -85.06 122.9 74.09 Favored Pre-proline 0 C--N 1.326 -0.456 0 N-CA-C 110.515 -0.18 . . . . 1.85 110.515 -178.74 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_exo -56.12 129.2 33.58 Favored 'Trans proline' 0 C--N 1.346 0.407 0 C-N-CA 122.99 2.46 . . . . 1.02 112.329 178.881 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 25.4 Cg_exo -62.01 -18.85 63.77 Favored 'Trans proline' 0 C--N 1.345 0.393 0 C-N-CA 122.884 2.39 . . . . 1.39 112.692 -177.131 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 8.4 p -77.24 -21.5 53.66 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 116.061 -0.518 . . . . 1.79 111.72 -179.317 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . 0.574 ' HE3' ' OE1' ' A' ' 105' ' ' GLU . 68.4 mttm -115.94 0.19 13.0 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 111.721 0.267 . . . . 1.79 111.721 -175.074 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . 0.414 ' HG3' ' O ' ' A' ' 136' ' ' ARG . 36.1 ptt180 -84.74 110.08 18.52 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 121.61 0.719 . . . . 3.33 110.951 -176.364 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 65.6 mtm180 -100.84 130.4 46.85 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.702 -0.681 . . . . 5.15 109.502 174.038 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 138' ' ' HIS . . . . . 0.456 ' CE1' ' HA ' ' A' ' 39' ' ' SER . 5.2 t-80 -117.83 139.68 50.76 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 120.725 0.298 . . . . 6.71 110.761 -174.716 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 . . . . . 0 C--O 1.245 0.865 0 CA-C-O 118.209 -0.901 . . . . 6.15 109.65 -179.639 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' B' B ' 143' ' ' PHE . . . . . . . . . . . . . 98.6 m-85 . . . . . 0 N--CA 1.481 1.085 0 N-CA-C 109.825 -0.435 . . . . 12.46 109.825 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' B' B ' 144' ' ' ASN . . . . . . . . . . . . . 27.0 p-10 -120.17 -8.65 9.69 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 112.22 0.452 . . . . 8.42 112.22 -175.223 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 145' ' ' TYR . . . . . 0.447 ' HH ' ' HG1' ' B' ' 152' ' ' THR . 28.8 p90 -131.24 165.18 23.95 Favored 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 120.688 -0.405 . . . . 6.88 110.578 -177.973 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 146' ' ' GLU . . . . . . . . . . . . . 30.9 tt0 -158.34 27.39 0.24 Allowed 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 122.02 0.914 . . . . 6.61 108.613 177.877 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 147' ' ' SER . . . . . . . . . . . . . 1.4 m -65.3 -14.29 60.43 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 114.556 -1.202 . . . . 4.05 112.295 -172.42 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 148' ' ' THR . . . . . . . . . . . . . 4.7 m -134.92 32.02 3.25 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.796 0.808 . . . . 2.41 109.366 176.795 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 149' ' ' GLY . . . . . . . . . . . . . . . 83.55 -172.49 50.57 Favored Glycine 0 N--CA 1.445 -0.75 0 CA-C-N 115.282 -0.872 . . . . 0.92 111.748 -179.13 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 150' ' ' PRO . . . . . . . . . . . . . 90.0 Cg_endo -80.79 -0.69 10.78 Favored 'Trans proline' 0 N--CA 1.461 -0.389 0 C-N-CA 122.864 2.376 . . . . 0.33 112.319 179.766 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 151' ' ' PHE . . . . . 0.584 ' CZ ' ' HA ' ' A' ' 73' ' ' LYS . 56.7 m-85 -101.28 -47.72 4.62 Favored 'General case' 0 C--N 1.331 -0.207 0 N-CA-C 112.56 0.578 . . . . 0.75 112.56 -177.554 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 152' ' ' THR . . . . . 0.447 ' HG1' ' HH ' ' B' ' 145' ' ' TYR . 81.6 m 72.01 101.59 0.07 Allowed 'General case' 0 CA--C 1.532 0.28 0 CA-C-O 121.57 0.7 . . . . 2.81 109.896 -170.934 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 153' ' ' ALA . . . . . 0.913 ' HB2' ' HD2' ' A' ' 88' ' ' LYS . . . -85.68 -33.78 21.47 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 113.31 0.855 . . . . 4.4 113.31 -169.047 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 154' ' ' LYS . . . . . 0.693 ' HB3' ' HZ1' ' B' ' 154' ' ' LYS . 9.5 mtpm? . . . . . 0 C--O 1.251 1.135 0 CA-C-O 118.423 -0.798 . . . . 7.16 109.789 -169.434 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 141' ' ' ' CA' . . . . . 0.63 'CA ' ' OD1' ' A' ' 94' ' ' ASP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.818 0 N-CA-C 111.972 -0.451 . . . . 11.39 111.972 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 33.2 Cg_exo -61.83 -63.2 0.1 Allowed 'Trans proline' 0 C--N 1.343 0.265 0 C-N-CA 122.751 2.301 . . . . 9.9 112.151 -179.758 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 47.4 tp 51.29 81.14 0.07 Allowed 'General case' 0 N--CA 1.463 0.221 0 O-C-N 123.904 0.752 . . . . 7.72 111.744 178.861 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -178.14 -153.09 10.83 Favored Glycine 0 N--CA 1.446 -0.674 0 C-N-CA 120.759 -0.734 . . . . 4.67 112.312 179.859 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 7.6 p -145.47 143.24 29.9 Favored 'General case' 0 C--N 1.322 -0.598 0 C-N-CA 122.288 0.235 . . . . 4.08 110.443 179.692 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -103.51 114.57 28.94 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.426 -0.352 . . . . 3.46 110.285 178.486 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -105.89 111.08 23.58 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.04 -0.527 . . . . 1.98 109.636 177.33 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 35.8 m -77.17 154.21 5.52 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 CA-C-N 115.355 -0.839 . . . . 2.56 111.813 -173.019 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -68.88 144.3 54.27 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.015 -0.539 . . . . 3.1 109.755 175.072 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 5.1 t90 -83.11 104.08 13.03 Favored 'General case' 0 N--CA 1.444 -0.764 0 N-CA-C 107.698 -1.223 . . . . 0.73 107.698 168.93 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.41 ' HA ' ' HE3' ' A' ' 48' ' ' LYS . 29.7 m -69.82 4.89 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.234 0 CA-C-O 121.228 0.537 . . . . 2.1 111.628 -175.677 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.417 HG11 ' HA ' ' A' ' 108' ' ' LEU . 42.1 t -103.62 -29.48 2.9 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.818 0 CA-C-N 115.711 -0.677 . . . . 1.76 109.874 172.239 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . 0.522 ' HA2' ' HB2' ' A' ' 50' ' ' LYS . . . -82.89 -10.12 83.47 Favored Glycine 0 N--CA 1.448 -0.54 0 CA-C-N 115.88 -0.6 . . . . 0.59 113.023 -175.528 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . 0.41 ' HE3' ' HA ' ' A' ' 45' ' ' VAL . 17.2 ptpt -81.55 -25.89 35.48 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.772 0.32 . . . . 3.11 110.315 177.145 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 12.0 m-20 -110.11 33.21 4.58 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 108.948 -0.76 . . . . 1.66 108.948 173.577 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . 0.665 ' N ' ' HD2' ' A' ' 51' ' ' PRO . 17.3 ttpp -77.35 -43.04 2.58 Favored Pre-proline 0 C--O 1.219 -0.538 0 CA-C-O 118.633 -0.699 . . . . 1.72 112.067 -174.779 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . 0.665 ' HD2' ' N ' ' A' ' 50' ' ' LYS . 1.3 Cg_endo -44.74 -36.31 10.41 Favored 'Trans proline' 0 C--N 1.362 1.284 0 C-N-CA 123.0 2.467 . . . . 1.07 113.471 178.493 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 13.0 m -69.51 -45.49 68.75 Favored 'General case' 0 C--O 1.238 0.49 0 CA-C-O 121.111 0.481 . . . . 1.38 110.459 178.657 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 21.7 m-85 -70.97 -22.35 62.21 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.027 -0.533 . . . . 1.14 109.92 178.936 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -68.77 -45.03 72.44 Favored 'General case' 0 CA--C 1.513 -0.471 0 CA-C-N 116.163 -0.471 . . . . 2.18 109.856 175.667 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -61.78 -44.85 96.07 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.79 -0.641 . . . . 2.33 109.937 -179.821 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 45.0 mt -65.78 -40.95 89.17 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-N 115.798 -0.637 . . . . 1.36 110.84 177.634 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 77.7 t80 -61.9 -39.34 91.66 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.677 -0.692 . . . . 0.36 111.297 179.397 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 4.1 m-30 -79.79 -22.58 42.93 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.56 -0.291 . . . . 1.85 111.2 -175.573 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 28.2 p -79.57 -10.15 59.75 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.72 0.295 . . . . 1.12 111.446 178.257 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 53.7 mt -88.92 -0.47 57.42 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.566 -0.288 . . . . 2.02 110.246 175.274 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 55.7 m 62.43 81.04 0.24 Allowed Pre-proline 0 CA--C 1.533 0.313 0 O-C-N 123.788 0.68 . . . . 1.87 110.986 -176.86 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -76.61 157.54 36.02 Favored 'Trans proline' 0 N--CA 1.46 -0.482 0 C-N-CA 122.827 2.351 . . . . 0.62 112.307 -179.011 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 15.4 m -123.96 115.64 45.61 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 CA-C-N 116.157 -0.474 . . . . 1.76 110.073 177.231 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 82.6 m-20 63.82 24.71 13.85 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 115.467 -0.788 . . . . 1.82 111.375 179.809 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 88.69 10.52 67.19 Favored Glycine 0 C--N 1.33 0.224 0 C-N-CA 120.992 -0.623 . . . . 0.51 112.957 178.334 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . 0.538 ' HE2' ' OD1' ' A' ' 102' ' ' ASP . 82.2 mttt -136.13 154.45 50.98 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 110.152 -0.314 . . . . 2.12 110.152 179.687 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 40.9 pt -116.77 159.16 16.93 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 C-N-CA 121.109 -0.236 . . . . 1.28 110.397 174.942 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' THR . . . . . 0.497 ' HA ' HD21 ' A' ' 100' ' ' LEU . 44.8 p -80.85 169.85 17.03 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.324 -0.398 . . . . 1.21 110.148 -179.593 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . 0.521 ' O ' ' HB2' ' A' ' 73' ' ' LYS . . . -64.25 -16.98 61.0 Favored Glycine 0 N--CA 1.447 -0.626 0 C-N-CA 120.653 -0.784 . . . . 0.48 112.503 177.314 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -68.86 -46.75 67.68 Favored 'General case' 0 C--O 1.235 0.325 0 CA-C-O 121.219 0.533 . . . . 1.13 111.743 -179.139 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 1.7 m120 -72.71 -43.17 63.35 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.815 -0.629 . . . . 1.81 109.716 -174.575 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -64.1 -35.24 80.09 Favored 'General case' 0 N--CA 1.448 -0.568 0 CA-C-N 115.527 -0.761 . . . . 1.09 110.137 176.061 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . 0.521 ' HB2' ' O ' ' A' ' 69' ' ' GLY . 34.3 tttp -56.23 -45.11 80.11 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 116.13 -0.486 . . . . 1.63 110.194 176.259 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . 0.773 ' O ' ' HG2' ' A' ' 78' ' ' LYS . 45.8 mtpt -67.75 -31.38 71.26 Favored 'General case' 0 C--O 1.217 -0.651 0 CA-C-N 115.601 -0.727 . . . . 2.43 111.041 -178.742 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 13.9 tp10 -71.78 -47.52 52.89 Favored 'General case' 0 C--N 1.314 -0.971 0 CA-C-O 121.531 0.682 . . . . 1.6 109.753 178.52 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' MET . . . . . 0.77 ' HG3' ' HZ ' ' B' ' 151' ' ' PHE . 16.0 mmt -55.52 -42.36 74.42 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.095 -0.957 . . . . 1.92 109.684 175.691 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.622 HG13 ' O ' ' A' ' 74' ' ' LYS . 1.1 p -74.12 -23.27 18.55 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.413 0 CA-C-N 115.276 -0.875 . . . . 2.22 111.301 -177.226 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.773 ' HG2' ' O ' ' A' ' 74' ' ' LYS . 31.8 mmmt -73.56 -28.53 61.9 Favored 'General case' 0 CA--C 1.517 -0.319 0 CA-C-O 121.063 0.459 . . . . 3.27 109.872 176.165 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 45.1 m -81.91 -5.56 58.38 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.781 -0.645 . . . . 1.42 110.439 178.336 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 45.0 mttp 65.51 23.18 11.84 Favored 'General case' 0 N--CA 1.465 0.325 0 CA-C-N 115.418 -0.81 . . . . 3.49 112.03 169.078 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.7 ' HB2' HD21 ' A' ' 86' ' ' LEU . 88.0 mt -85.59 148.65 49.64 Favored Pre-proline 0 C--N 1.322 -0.626 0 CA-C-N 116.413 -0.358 . . . . 1.17 110.216 178.836 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . 0.524 ' O ' ' HG ' ' A' ' 86' ' ' LEU . 50.8 Cg_exo -54.91 137.34 75.46 Favored 'Trans proline' 0 C--N 1.344 0.294 0 C-N-CA 123.105 2.537 . . . . 0.59 112.206 179.043 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . 0.536 ' HA ' HD12 ' A' ' 86' ' ' LEU . 4.6 p30 -60.16 -34.81 74.09 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-N 115.954 -0.566 . . . . 2.37 110.965 -174.225 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 63.3 m -63.39 -40.6 97.65 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.674 -0.694 . . . . 1.92 110.379 177.697 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.462 HG22 ' HB2' ' A' ' 82' ' ' PRO . 52.3 t -71.66 -34.49 52.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 115.835 -0.62 . . . . 1.15 109.862 178.088 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.71 HD23 ' HB3' ' A' ' 76' ' ' MET . 77.1 mt -63.46 -33.9 76.57 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.969 -0.56 . . . . 1.45 110.073 174.728 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -66.78 -38.05 92.78 Favored Glycine 0 N--CA 1.45 -0.423 0 N-CA-C 111.362 -0.695 . . . . 0.32 111.362 176.064 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . 0.412 ' HB2' ' O ' ' A' ' 85' ' ' VAL . 71.7 mmtt -58.15 -49.48 76.87 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 109.974 -0.38 . . . . 2.37 109.974 172.125 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . 0.405 HG12 ' O ' ' A' ' 85' ' ' VAL . 40.3 mm -59.32 -48.4 87.15 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.197 0 CA-C-N 115.752 -0.658 . . . . 1.42 111.294 -179.297 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' TRP . . . . . 0.401 ' HB2' ' HE2' ' B' ' 151' ' ' PHE . 41.8 t-105 -62.83 -45.16 93.9 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.937 0.398 . . . . 0.38 111.087 -178.563 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 21.1 ttpp -64.27 -27.64 69.18 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.06 -0.518 . . . . 3.4 111.285 -176.783 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.432 HD11 ' HG ' ' A' ' 126' ' ' LEU . 14.5 tp -93.9 -48.49 6.25 Favored 'General case' 0 N--CA 1.445 -0.696 0 N-CA-C 112.154 0.427 . . . . 2.23 112.154 -175.946 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -73.3 -41.12 63.95 Favored 'General case' 0 N--CA 1.463 0.21 0 N-CA-C 111.847 0.314 . . . . 1.15 111.847 -174.259 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . 0.616 ' OD2' ' HA ' ' A' ' 97' ' ' LYS . 21.9 t70 -78.08 96.34 5.11 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 108.965 -0.754 . . . . 0.79 108.965 176.089 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 45.7 t -78.31 -36.22 20.51 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 CA-C-N 115.647 -0.706 . . . . 1.23 111.08 -171.516 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . 0.607 ' OD1' 'CA ' ' A' ' 141' ' ' ' CA' . 5.7 p30 -83.5 -11.39 57.51 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 116.042 -0.526 . . . . 0.96 112.03 -174.942 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . 0.616 ' HA ' ' OD2' ' A' ' 94' ' ' ASP . 0.0 OUTLIER 59.08 30.89 20.8 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-O 121.26 0.552 . . . . 3.53 111.181 172.981 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . 0.643 ' OD2' ' HB2' ' A' ' 100' ' ' LEU . 8.6 p-10 -86.83 9.8 18.02 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 115.453 -0.794 . . . . 0.53 111.24 -173.564 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 66.9 9.18 52.32 Favored Glycine 0 C--N 1.332 0.331 0 CA-C-N 116.089 -0.505 . . . . 0.45 112.476 -178.987 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.643 ' HB2' ' OD2' ' A' ' 98' ' ' ASP . 72.3 mt -135.18 161.45 35.32 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 109.145 -0.687 . . . . 1.72 109.145 179.955 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 80.1 mt -117.86 125.5 50.64 Favored 'General case' 0 C--N 1.311 -1.09 0 C-N-CA 120.725 -0.39 . . . . 1.1 110.035 176.73 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . 0.538 ' OD1' ' HE2' ' A' ' 66' ' ' LYS . 11.5 m-20 -68.94 172.51 6.5 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 108.111 -1.07 . . . . 1.72 108.111 172.939 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 2.0 p30 -63.16 -32.63 74.07 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 109.186 -0.672 . . . . 1.6 109.186 177.113 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 51.9 mt-10 -72.16 -45.2 61.41 Favored 'General case' 0 N--CA 1.452 -0.336 0 CA-C-N 115.888 -0.596 . . . . 1.66 110.956 175.463 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 29.7 mt-10 -64.89 -39.54 93.69 Favored 'General case' 0 N--CA 1.462 0.156 0 C-N-CA 120.818 -0.353 . . . . 0.64 110.449 -176.996 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 90.2 t80 -65.55 -40.87 93.33 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.298 -0.41 . . . . 0.54 110.173 177.214 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -58.7 -47.42 84.62 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.246 -0.433 . . . . 1.09 110.688 176.158 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . 0.417 ' HA ' HG11 ' A' ' 46' ' ' VAL . 60.4 tp -61.82 -45.94 91.65 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-N 116.32 -0.4 . . . . 1.98 110.972 178.463 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . 0.674 ' O ' HG13 ' A' ' 113' ' ' ILE . . . -56.09 -57.16 13.32 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.052 -0.522 . . . . 1.03 110.549 177.878 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' ASN . . . . . 0.512 ' HA ' HD11 ' A' ' 113' ' ' ILE . 1.1 t-20 -56.31 -36.27 68.5 Favored 'General case' 0 CA--C 1.521 -0.162 0 CA-C-N 116.049 -0.523 . . . . 1.2 111.395 179.684 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 13.3 t60 -63.67 -39.92 95.55 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.159 -0.473 . . . . 0.65 110.174 -179.655 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . 0.4 ' O ' HG11 ' A' ' 115' ' ' VAL . 94.6 mt -74.08 -39.86 63.15 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.27 -0.423 . . . . 1.21 110.498 178.302 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . 0.674 HG13 ' O ' ' A' ' 109' ' ' ALA . 54.0 mt -58.42 -49.53 81.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-O 121.531 0.681 . . . . 1.41 110.361 177.647 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . 0.575 ' HE2' HD11 ' A' ' 117' ' ' LEU . 0.0 OUTLIER -71.31 -24.97 62.23 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.403 -0.817 . . . . 4.33 110.827 -177.157 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . 0.4 HG11 ' O ' ' A' ' 112' ' ' LEU . 0.4 OUTLIER -72.78 -33.29 43.58 Favored 'Isoleucine or valine' 0 C--O 1.235 0.306 0 N-CA-C 109.75 -0.463 . . . . 1.77 109.75 177.195 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . 0.442 ' HD2' ' O ' ' A' ' 120' ' ' HIS . 19.6 tptp -66.1 -39.5 90.03 Favored 'General case' 0 N--CA 1.442 -0.834 0 CA-C-N 116.125 -0.488 . . . . 1.86 109.929 173.06 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . 0.575 HD11 ' HE2' ' A' ' 114' ' ' LYS . 80.1 mt -65.45 -23.54 66.96 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 116.066 -0.515 . . . . 1.53 110.554 176.508 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 24.6 mm-40 -78.53 -7.01 57.05 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.918 -0.583 . . . . 2.18 111.237 177.878 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 86.22 25.53 36.59 Favored Glycine 0 N--CA 1.448 -0.508 0 C-N-CA 120.652 -0.785 . . . . 1.17 112.154 -179.277 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' HIS . . . . . 0.442 ' O ' ' HD2' ' A' ' 116' ' ' LYS . 97.5 m-70 -109.86 152.04 26.28 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 110.058 -0.349 . . . . 2.86 110.058 178.029 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -108.12 155.75 20.05 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 116.015 -0.539 . . . . 2.53 109.563 176.73 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -118.74 131.73 24.18 Favored Pre-proline 0 C--N 1.321 -0.653 0 CA-C-N 116.478 -0.328 . . . . 1.8 110.33 -177.826 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_endo -71.19 -0.11 7.54 Favored 'Trans proline' 0 C--N 1.345 0.344 0 C-N-CA 123.274 2.649 . . . . 1.72 113.438 -177.051 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . 62.92 21.25 12.75 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-O 121.526 0.679 . . . . 1.71 110.348 -175.405 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -103.74 142.78 33.76 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.107 -0.951 . . . . 2.73 108.53 178.552 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . 0.432 ' HG ' HD11 ' A' ' 92' ' ' LEU . 38.6 mt -115.27 90.96 26.22 Favored Pre-proline 0 C--N 1.321 -0.659 0 C-N-CA 120.943 -0.303 . . . . 2.28 111.32 179.815 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 127' ' ' PRO . . . . . 0.444 ' HD2' HD13 ' A' ' 130' ' ' LEU . 41.7 Cg_endo -71.19 157.84 56.28 Favored 'Trans proline' 0 N--CA 1.46 -0.455 0 C-N-CA 122.678 2.252 . . . . 1.33 111.45 173.248 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 78.1 Cg_exo -52.41 -29.55 39.84 Favored 'Trans proline' 0 CA--C 1.535 0.527 0 C-N-CA 123.271 2.647 . . . . 1.87 114.155 -177.35 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 3.9 p-80 -83.36 1.85 39.25 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 120.476 -0.49 . . . . 1.29 111.495 -178.988 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . 0.444 HD13 ' HD2' ' A' ' 127' ' ' PRO . 26.0 mt -113.98 -7.59 13.12 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 116.846 -0.161 . . . . 1.87 111.304 175.149 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 26.2 m -94.11 139.54 22.58 Favored Pre-proline 0 C--N 1.325 -0.471 0 CA-C-O 120.81 0.338 . . . . 1.85 110.145 177.452 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 132' ' ' PRO . . . . . 0.785 ' HG2' ' HB2' ' A' ' 135' ' ' LYS . 27.7 Cg_endo -63.08 143.95 91.55 Favored 'Trans proline' 0 C--O 1.234 0.285 0 C-N-CA 122.61 2.207 . . . . 1.02 112.217 -178.111 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -54.19 -30.54 61.71 Favored 'Trans proline' 0 C--N 1.345 0.377 0 C-N-CA 123.142 2.562 . . . . 1.39 112.961 179.254 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 50.2 p -75.36 -25.19 57.53 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 121.118 0.485 . . . . 1.79 111.515 -178.097 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . 0.785 ' HB2' ' HG2' ' A' ' 132' ' ' PRO . 87.9 mttt -116.71 22.4 12.72 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.243 -0.435 . . . . 1.79 110.976 -173.308 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 11.4 ptp180 -110.42 139.45 45.62 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.96 0.41 . . . . 3.33 111.109 178.949 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 63.5 mtp180 -134.19 120.85 20.56 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.025 -0.534 . . . . 5.15 110.211 173.859 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 84.1 t60 -133.58 104.59 6.44 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.061 0.458 . . . . 6.71 111.199 177.02 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--O 1.247 0.932 0 CA-C-N 115.419 -0.809 . . . . 6.15 109.59 176.673 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 143' ' ' PHE . . . . . . . . . . . . . 86.5 t80 . . . . . 0 N--CA 1.476 0.844 0 N-CA-C 109.96 -0.385 . . . . 12.46 109.96 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' B' B ' 144' ' ' ASN . . . . . . . . . . . . . 51.0 t30 -105.02 142.77 34.22 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.324 -0.398 . . . . 8.42 109.996 -178.566 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 145' ' ' TYR . . . . . 0.522 ' HD2' ' H ' ' B' ' 146' ' ' GLU . 5.9 p90 -142.84 -95.07 0.12 Allowed 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.318 -0.401 . . . . 6.88 110.498 -179.713 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 146' ' ' GLU . . . . . 0.522 ' H ' ' HD2' ' B' ' 145' ' ' TYR . 42.6 mt-10 -130.4 -156.96 0.79 Allowed 'General case' 0 C--N 1.318 -0.782 0 N-CA-C 107.697 -1.223 . . . . 6.61 107.697 173.953 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 147' ' ' SER . . . . . . . . . . . . . 13.2 p -121.6 131.64 54.23 Favored 'General case' 0 C--N 1.319 -0.73 0 C-N-CA 119.785 -0.766 . . . . 4.05 112.396 -176.449 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 148' ' ' THR . . . . . . . . . . . . . 8.0 p -90.95 -43.92 9.68 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.463 -0.79 . . . . 2.41 110.567 175.684 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 149' ' ' GLY . . . . . . . . . . . . . . . 163.26 157.79 9.4 Favored Glycine 0 N--CA 1.446 -0.67 0 CA-C-N 115.403 -0.817 . . . . 0.92 111.541 178.832 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 150' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -77.59 -1.84 12.0 Favored 'Trans proline' 0 N--CA 1.463 -0.282 0 C-N-CA 122.753 2.302 . . . . 0.33 112.712 -178.334 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 151' ' ' PHE . . . . . 0.77 ' HZ ' ' HG3' ' A' ' 76' ' ' MET . 48.1 m-85 -92.14 -57.03 2.85 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.574 -0.284 . . . . 0.75 110.813 -178.448 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 152' ' ' THR . . . . . . . . . . . . . 8.8 t -119.49 133.87 55.49 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 121.317 0.579 . . . . 2.81 111.156 178.654 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 153' ' ' ALA . . . . . . . . . . . . . . . -157.94 10.6 0.18 Allowed 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.449 -0.796 . . . . 4.4 110.189 -179.893 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 154' ' ' LYS . . . . . . . . . . . . . 11.9 tptt . . . . . 0 C--O 1.248 1.011 0 CA-C-O 118.423 -0.799 . . . . 7.16 110.408 -174.704 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 141' ' ' ' CA' . . . . . 0.607 'CA ' ' OD1' ' A' ' 96' ' ' ASP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.734 0 N-CA-C 111.984 -0.446 . . . . 11.39 111.984 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 25.6 Cg_exo -63.95 140.07 71.0 Favored 'Trans proline' 0 C--O 1.234 0.301 0 C-N-CA 122.816 2.344 . . . . 9.9 111.764 177.189 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 81.4 mt -113.18 119.95 39.56 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.1 -0.5 . . . . 7.72 111.17 -175.435 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -168.33 87.58 0.09 OUTLIER Glycine 0 N--CA 1.447 -0.61 0 CA-C-N 115.627 -0.715 . . . . 4.67 111.44 177.823 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 26.6 t -101.51 138.09 38.97 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.768 0.284 . . . . 4.08 110.348 -176.923 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 35.2 t70 -117.7 134.82 54.5 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.473 -0.33 . . . . 3.46 110.487 178.441 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -134.94 146.01 48.71 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.344 -0.389 . . . . 1.98 110.047 -179.456 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 17.9 m -123.9 146.1 29.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 120.757 0.313 . . . . 2.56 111.148 -179.896 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 26.9 mt-10 -68.71 142.83 54.9 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.392 -0.367 . . . . 3.1 111.206 -176.816 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' TRP . . . . . 0.535 ' CE3' ' HD3' ' A' ' 133' ' ' PRO . 5.1 t90 -83.84 111.04 18.85 Favored 'General case' 0 C--N 1.332 -0.191 0 N-CA-C 109.486 -0.561 . . . . 0.73 109.486 179.451 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 12.0 p -60.85 -27.36 41.0 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-N 116.08 -0.509 . . . . 2.1 111.662 -176.911 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 21.5 t -85.17 -11.44 11.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 120.962 0.411 . . . . 1.76 111.438 -177.367 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -66.38 -15.51 63.69 Favored Glycine 0 CA--C 1.518 0.231 0 C-N-CA 120.884 -0.674 . . . . 0.59 113.565 -174.339 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 4.0 ptpp? -91.32 -27.64 18.26 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.787 0.294 . . . . 3.11 111.526 -179.201 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 27.5 m-20 -92.44 32.23 1.23 Allowed 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 120.648 -0.421 . . . . 1.66 110.506 -175.692 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . 0.432 ' HB3' ' HZ2' ' A' ' 50' ' ' LYS . 7.8 mtpm? -79.78 -49.36 1.33 Allowed Pre-proline 0 C--O 1.214 -0.803 0 CA-C-O 118.544 -0.741 . . . . 1.72 112.728 -175.377 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 82.8 Cg_exo -43.1 -37.2 6.4 Favored 'Trans proline' 0 C--N 1.354 0.822 0 C-N-CA 122.156 1.904 . . . . 1.07 113.502 -178.928 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -71.88 -45.97 59.48 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.012 0.434 . . . . 1.38 111.878 179.238 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 12.8 m-85 -79.14 -22.31 45.3 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.508 -0.315 . . . . 1.14 110.153 -175.585 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -70.93 -40.56 72.02 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 108.628 -0.879 . . . . 2.18 108.628 173.553 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 20.6 tp10 -55.18 -48.34 73.94 Favored 'General case' 0 C--O 1.232 0.152 0 CA-C-N 114.988 -1.006 . . . . 2.33 109.923 176.16 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 40.5 mt -71.77 -38.36 65.6 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-N 115.541 -0.754 . . . . 1.36 110.907 178.968 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . 0.423 ' CE1' HG23 ' A' ' 67' ' ' ILE . 58.1 t80 -56.15 -34.96 66.63 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 116.022 -0.535 . . . . 0.36 111.576 -177.773 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 9.8 m-85 -88.81 5.46 43.53 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 112.194 0.442 . . . . 1.85 112.194 -175.871 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 80.4 p -98.98 -17.67 18.19 Favored 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 120.49 -0.484 . . . . 1.12 110.558 175.951 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -93.58 9.59 36.14 Favored 'General case' 0 N--CA 1.462 0.168 0 CA-C-N 116.225 -0.443 . . . . 2.02 110.962 179.257 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 19.0 m 65.27 87.3 0.12 Allowed Pre-proline 0 N--CA 1.466 0.36 0 CA-C-N 115.538 -0.756 . . . . 1.87 111.647 179.061 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . 0.439 ' HA ' HG21 ' A' ' 67' ' ' ILE . 95.3 Cg_endo -88.91 139.52 3.81 Favored 'Trans proline' 0 N--CA 1.456 -0.682 0 C-N-CA 122.754 2.303 . . . . 0.62 113.39 -178.966 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 15.4 m -113.7 117.94 56.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 115.904 -0.589 . . . . 1.76 110.272 176.294 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 93.1 m-20 63.03 23.33 13.94 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 115.837 -0.62 . . . . 1.82 110.827 -178.157 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 78.4 24.69 62.66 Favored Glycine 0 N--CA 1.448 -0.526 0 C-N-CA 120.72 -0.752 . . . . 0.51 112.0 -177.367 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 24.4 mtpp -136.45 140.76 43.36 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 109.428 -0.582 . . . . 2.12 109.428 178.076 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . 0.439 HG21 ' HA ' ' A' ' 62' ' ' PRO . 45.8 pt -115.44 160.03 15.03 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 C-N-CA 120.614 -0.435 . . . . 1.28 110.668 175.286 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 24.0 p -79.26 158.99 27.47 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.664 -0.698 . . . . 1.21 110.867 179.992 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . 0.421 ' O ' ' HB2' ' A' ' 73' ' ' LYS . . . -64.98 -18.06 64.05 Favored Glycine 0 C--O 1.221 -0.656 0 C-N-CA 120.895 -0.669 . . . . 0.48 112.392 179.572 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . 0.484 ' O ' ' HG3' ' A' ' 74' ' ' LYS . . . -62.33 -45.42 93.29 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.072 0.463 . . . . 1.13 111.385 179.818 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 48.1 m-80 -79.59 -34.84 40.42 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.216 -0.447 . . . . 1.81 110.623 -176.494 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -61.62 -39.71 92.26 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 109.368 -0.605 . . . . 1.09 109.368 173.054 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . 0.421 ' HB2' ' O ' ' A' ' 69' ' ' GLY . 78.9 tttt -57.87 -44.32 86.55 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 114.96 -1.018 . . . . 1.63 110.141 176.099 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . 0.715 ' O ' ' HG2' ' A' ' 78' ' ' LYS . 96.0 mttt -55.73 -54.66 41.58 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.726 -0.67 . . . . 2.43 110.926 178.701 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . 0.467 ' HA ' ' OE1' ' A' ' 75' ' ' GLU . 12.6 tp10 -64.34 -40.05 95.11 Favored 'General case' 0 C--O 1.239 0.538 0 CA-C-O 121.125 0.488 . . . . 1.6 111.151 -176.871 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' MET . . . . . 0.838 ' HB3' HD21 ' A' ' 86' ' ' LEU . 18.8 mmt -57.12 -47.05 82.05 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.892 -0.595 . . . . 1.92 111.358 179.607 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 25.4 m -74.29 -18.07 16.93 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.422 0 C-N-CA 120.798 -0.361 . . . . 2.22 111.381 -178.861 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.715 ' HG2' ' O ' ' A' ' 74' ' ' LYS . 46.2 mmtm -76.25 -20.95 56.92 Favored 'General case' 0 N--CA 1.463 0.186 0 CA-C-O 121.265 0.555 . . . . 3.27 109.614 174.322 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 16.9 m -79.68 2.17 23.65 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-N 115.497 -0.774 . . . . 1.42 111.729 -178.174 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . 0.456 ' HZ2' ' HB3' ' A' ' 80' ' ' LYS . 7.3 mtpm? 65.98 22.39 11.26 Favored 'General case' 0 N--CA 1.471 0.575 0 C-N-CA 123.224 0.61 . . . . 3.49 112.196 175.468 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.622 ' HB2' HD22 ' A' ' 86' ' ' LEU . 93.2 mt -95.58 147.18 32.61 Favored Pre-proline 0 C--N 1.325 -0.474 0 N-CA-C 110.012 -0.366 . . . . 1.17 110.012 178.239 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . 0.469 ' O ' ' HG ' ' A' ' 86' ' ' LEU . 1.5 Cg_endo -73.2 156.22 51.33 Favored 'Trans proline' 0 N--CA 1.457 -0.619 0 C-N-CA 122.293 1.995 . . . . 0.59 112.178 -178.885 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 88.6 m-20 -55.16 -38.96 68.96 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-N 115.973 -0.558 . . . . 2.37 111.503 -176.482 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' THR . . . . . 0.593 ' O ' ' HG2' ' A' ' 88' ' ' LYS . 3.1 p -57.55 -51.38 69.72 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.119 -0.491 . . . . 1.92 111.121 178.323 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 93.0 t -63.37 -40.94 90.94 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 115.578 -0.737 . . . . 1.15 110.834 -179.908 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.838 HD21 ' HB3' ' A' ' 76' ' ' MET . 83.5 mt -62.47 -37.37 85.7 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.138 -0.483 . . . . 1.45 110.715 179.199 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -68.61 -35.45 80.91 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.889 -0.672 . . . . 0.32 111.632 178.906 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . 0.593 ' HG2' ' O ' ' A' ' 84' ' ' THR . 74.8 mmtt -61.41 -52.75 63.29 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 109.419 -0.586 . . . . 2.37 109.419 176.064 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . 0.52 HG23 HD11 ' A' ' 112' ' ' LEU . 42.5 mt -62.7 -38.88 82.79 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.374 0 CA-C-N 115.396 -0.82 . . . . 1.42 111.532 -177.093 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 64.7 t-105 -60.97 -45.77 93.44 Favored 'General case' 0 C--N 1.332 -0.19 0 C-N-CA 120.688 -0.405 . . . . 0.38 110.731 177.134 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 39.3 ttpt -66.48 -24.46 66.41 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.295 -0.411 . . . . 3.4 110.879 -177.319 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.446 ' HG ' ' O ' ' A' ' 88' ' ' LYS . 96.2 mt -86.03 -52.05 5.95 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.51 -0.314 . . . . 2.23 111.657 -179.784 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . 0.454 ' HA ' HD22 ' A' ' 108' ' ' LEU . . . -64.86 -38.74 91.98 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.198 -0.455 . . . . 1.15 111.687 -174.093 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . 0.641 ' OD1' 'CA ' ' A' ' 141' ' ' ' CA' . 25.6 t0 -81.71 97.11 7.77 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 109.44 -0.578 . . . . 0.79 109.44 178.948 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 44.3 t -82.77 -36.86 13.58 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-N 115.119 -0.946 . . . . 1.23 111.376 -173.969 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . 0.596 ' OD1' 'CA ' ' A' ' 141' ' ' ' CA' . 1.9 p30 -87.0 -6.4 58.77 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.957 -0.565 . . . . 0.96 111.166 -176.544 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . 0.432 ' HA ' ' OD2' ' A' ' 94' ' ' ASP . 23.9 mmmt 59.95 38.74 20.81 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 115.651 -0.704 . . . . 3.53 110.814 173.35 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . 0.626 ' OD1' 'CA ' ' A' ' 141' ' ' ' CA' . 15.9 p-10 -98.52 9.06 44.05 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.131 -0.486 . . . . 0.53 111.602 -173.817 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 66.07 6.72 33.55 Favored Glycine 0 C--N 1.333 0.389 0 C-N-CA 120.867 -0.682 . . . . 0.45 113.016 178.692 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 90.0 mt -131.39 157.4 43.53 Favored 'General case' 0 N--CA 1.446 -0.659 0 N-CA-C 109.575 -0.528 . . . . 1.72 109.575 -178.95 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 83.1 mt -116.23 115.96 26.92 Favored 'General case' 0 C--N 1.315 -0.928 0 C-N-CA 120.669 -0.412 . . . . 1.1 110.481 177.491 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -70.55 173.19 7.33 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 108.672 -0.862 . . . . 1.72 108.672 171.85 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -57.85 -30.54 65.86 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 109.706 -0.479 . . . . 1.6 109.706 175.978 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 38.2 mt-10 -66.31 -56.79 9.47 Favored 'General case' 0 C--O 1.235 0.294 0 CA-C-N 115.762 -0.654 . . . . 1.66 111.192 175.242 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . 0.574 ' CG ' ' HE3' ' A' ' 135' ' ' LYS . 24.4 mt-10 -68.28 -34.93 77.07 Favored 'General case' 0 C--N 1.331 -0.202 0 C-N-CA 121.006 -0.278 . . . . 0.64 110.802 -173.561 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 84.8 t80 -69.15 -35.25 76.14 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 109.889 -0.412 . . . . 0.54 109.889 178.247 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -60.47 -42.15 95.65 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.009 0.433 . . . . 1.09 109.96 175.452 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . 0.454 HD22 ' HA ' ' A' ' 93' ' ' ALA . 53.2 tp -66.62 -45.88 77.68 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.183 -0.462 . . . . 1.98 110.715 177.672 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -57.41 -50.38 73.17 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.24 -0.436 . . . . 1.03 111.172 179.0 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -66.88 -30.61 70.83 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.161 -0.472 . . . . 1.2 110.979 179.349 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' HIS . . . . . 0.448 ' O ' HG23 ' A' ' 115' ' ' VAL . 55.6 t60 -64.51 -44.5 90.7 Favored 'General case' 0 C--O 1.22 -0.476 0 N-CA-C 109.749 -0.463 . . . . 0.65 109.749 177.057 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . 0.52 HD11 HG23 ' A' ' 89' ' ' ILE . 88.3 mt -63.81 -41.11 97.96 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.308 -0.406 . . . . 1.21 110.494 178.534 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 81.2 mt -55.45 -51.76 53.76 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.308 0 CA-C-O 121.166 0.508 . . . . 1.41 110.296 174.092 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 14.3 tptm -60.12 -48.54 81.28 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.329 -0.85 . . . . 4.33 110.809 -179.188 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . 0.478 HG13 ' HB2' ' A' ' 120' ' ' HIS . 54.4 t -62.75 -36.63 76.25 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-N 115.919 -0.582 . . . . 1.77 111.091 -177.736 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . 0.418 ' HB3' ' HE3' ' A' ' 116' ' ' LYS . 23.2 mmmt -64.47 -50.88 65.75 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.627 -0.261 . . . . 1.86 110.99 176.245 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 89.9 mt -69.06 -25.26 64.36 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.196 -0.457 . . . . 1.53 110.91 -178.919 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 31.6 tt0 -72.0 -14.78 61.98 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.057 -0.519 . . . . 2.18 110.583 179.504 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 107.47 28.51 4.83 Favored Glycine 0 N--CA 1.446 -0.635 0 C-N-CA 120.434 -0.889 . . . . 1.17 113.042 176.774 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' HIS . . . . . 0.478 ' HB2' HG13 ' A' ' 115' ' ' VAL . 28.6 m-70 -121.38 156.75 31.97 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 109.397 -0.594 . . . . 2.86 109.397 176.276 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -117.1 144.84 44.23 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 110.276 -0.268 . . . . 2.53 110.276 177.327 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . 0.419 HD13 ' O ' ' A' ' 122' ' ' LEU . 2.1 pp -97.39 145.51 29.79 Favored Pre-proline 0 C--N 1.323 -0.569 0 CA-C-N 116.376 -0.374 . . . . 1.8 110.756 -178.379 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 8.2 Cg_exo -73.31 -5.38 17.04 Favored 'Trans proline' 0 N--CA 1.465 -0.163 0 C-N-CA 122.927 2.418 . . . . 1.72 112.636 -178.277 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . 69.9 19.05 7.15 Favored 'General case' 0 N--CA 1.464 0.275 0 O-C-N 123.734 0.646 . . . . 1.71 111.232 -179.265 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 20.7 m-20 -116.52 171.6 7.75 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 109.359 -0.608 . . . . 2.73 109.359 174.543 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 36.3 tp -115.62 97.42 48.73 Favored Pre-proline 0 C--N 1.325 -0.466 0 CA-C-O 120.965 0.412 . . . . 2.28 110.486 177.582 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 127' ' ' PRO . . . . . 0.41 ' HD2' HD11 ' A' ' 130' ' ' LEU . 74.4 Cg_endo -75.97 156.03 38.63 Favored 'Trans proline' 0 CA--C 1.534 0.517 0 C-N-CA 122.962 2.442 . . . . 1.33 112.417 178.232 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 11.3 Cg_endo -54.95 -34.7 87.42 Favored 'Trans proline' 0 C--N 1.347 0.482 0 C-N-CA 123.395 2.73 . . . . 1.87 113.677 -175.76 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 4.4 p-80 -79.96 7.63 8.58 Favored 'General case' 0 N--CA 1.465 0.302 0 C-N-CA 120.811 -0.356 . . . . 1.29 111.76 -177.595 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . 0.41 HD11 ' HD2' ' A' ' 127' ' ' PRO . 29.3 mt -116.98 5.58 12.89 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.533 0.206 . . . . 1.87 111.085 175.121 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 62.8 t -85.3 123.31 73.3 Favored Pre-proline 0 C--N 1.324 -0.51 0 CA-C-N 116.49 -0.323 . . . . 1.85 110.513 178.43 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 132' ' ' PRO . . . . . 0.465 ' HG2' ' HD2' ' A' ' 135' ' ' LYS . 53.6 Cg_exo -54.06 143.33 62.61 Favored 'Trans proline' 0 CA--C 1.534 0.521 0 C-N-CA 123.016 2.478 . . . . 1.02 112.724 179.351 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 133' ' ' PRO . . . . . 0.535 ' HD3' ' CE3' ' A' ' 44' ' ' TRP . 23.7 Cg_exo -62.97 -35.27 67.32 Favored 'Trans proline' 0 C--N 1.347 0.454 0 C-N-CA 122.937 2.424 . . . . 1.39 113.626 -175.005 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 23.2 t -87.44 0.01 56.15 Favored 'General case' 0 C--N 1.323 -0.573 0 C-N-CA 120.707 -0.397 . . . . 1.79 111.249 -175.216 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . 0.574 ' HE3' ' CG ' ' A' ' 105' ' ' GLU . 62.6 mttm -119.82 9.67 11.39 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.905 0.383 . . . . 1.79 111.342 -176.762 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . 0.446 ' HG2' ' O ' ' A' ' 133' ' ' PRO . 15.8 ptp180 -103.61 132.62 49.71 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.356 -0.384 . . . . 3.33 110.409 -178.987 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 85.5 mtm180 -142.72 149.98 39.5 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.477 -0.329 . . . . 5.15 110.942 -178.197 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 48.2 m-70 -119.24 100.78 7.53 Favored 'General case' 0 C--N 1.319 -0.72 0 N-CA-C 109.542 -0.54 . . . . 6.71 109.542 171.584 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 16.5 tp10 . . . . . 0 C--O 1.251 1.138 0 CA-C-O 118.194 -0.907 . . . . 6.15 109.999 -178.248 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' B' B ' 143' ' ' PHE . . . . . . . . . . . . . 54.1 t80 . . . . . 0 N--CA 1.482 1.173 0 N-CA-C 110.031 -0.359 . . . . 12.46 110.031 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' B' B ' 144' ' ' ASN . . . . . . . . . . . . . 44.3 t30 -100.52 -28.18 13.03 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.329 0.585 . . . . 8.42 109.447 177.606 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 145' ' ' TYR . . . . . . . . . . . . . 5.6 t80 -96.56 -152.86 0.39 Allowed 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 108.868 -0.79 . . . . 6.88 108.868 179.156 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 146' ' ' GLU . . . . . . . . . . . . . 11.8 mm-40 63.38 36.69 11.34 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-O 121.162 0.506 . . . . 6.61 110.654 179.856 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 147' ' ' SER . . . . . . . . . . . . . 6.7 m -68.79 139.09 55.27 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.704 -0.68 . . . . 4.05 111.435 -178.574 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 148' ' ' THR . . . . . . . . . . . . . 2.0 p -93.44 6.46 48.11 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.497 0.665 . . . . 2.41 110.907 177.268 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 149' ' ' GLY . . . . . . . . . . . . . . . 130.62 155.74 8.38 Favored Glycine 0 N--CA 1.445 -0.752 0 CA-C-N 115.205 -0.907 . . . . 0.92 111.099 179.326 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 150' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -74.93 -3.84 14.52 Favored 'Trans proline' 0 CA--C 1.53 0.293 0 C-N-CA 122.991 2.461 . . . . 0.33 113.118 -173.888 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 151' ' ' PHE . . . . . 0.544 ' CZ ' ' HG3' ' A' ' 76' ' ' MET . 61.2 m-85 -102.13 -6.11 23.67 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.788 0.328 . . . . 0.75 110.955 -179.388 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 152' ' ' THR . . . . . . . . . . . . . 6.6 t -137.98 1.11 2.24 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.2 0.524 . . . . 2.81 110.607 179.951 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 153' ' ' ALA . . . . . . . . . . . . . . . -149.72 101.4 3.06 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.791 -0.64 . . . . 4.4 110.226 178.197 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 154' ' ' LYS . . . . . 0.493 ' HZ2' ' HB3' ' B' ' 154' ' ' LYS . 0.6 OUTLIER . . . . . 0 C--O 1.251 1.141 0 CA-C-N 115.562 -0.744 . . . . 7.16 110.766 178.07 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 141' ' ' ' CA' . . . . . 0.641 'CA ' ' OD1' ' A' ' 94' ' ' ASP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 . . . . . 0 N--CA 1.454 -0.258 0 CA-C-O 121.12 0.486 . . . . 3.1 111.124 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 6.4 t90 -82.39 106.01 13.92 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 109.333 -0.617 . . . . 0.71 109.333 178.089 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.574 ' O ' ' HG2' ' A' ' 48' ' ' LYS . 9.7 p -67.5 -7.0 5.67 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.546 0 CA-C-N 115.562 -0.744 . . . . 1.45 112.236 -171.812 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 57.9 t -80.7 -24.81 11.02 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-O 120.742 0.306 . . . . 1.1 110.759 178.393 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -74.0 -9.19 79.69 Favored Glycine 0 CA--C 1.519 0.284 0 C-N-CA 120.788 -0.72 . . . . 0.59 113.215 -175.342 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 48' ' ' LYS . . . . . 0.574 ' HG2' ' O ' ' A' ' 45' ' ' VAL . 18.7 ptmt -74.23 -27.77 60.93 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 117.134 0.467 . . . . 2.46 111.175 -176.651 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 36.9 t0 -125.36 33.25 5.18 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.608 0.718 . . . . 1.66 109.453 -179.671 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 50' ' ' LYS . . . . . 0.644 ' N ' ' HD2' ' A' ' 51' ' ' PRO . 51.3 tttt -72.65 -43.86 8.97 Favored Pre-proline 0 C--N 1.321 -0.632 0 CA-C-N 115.471 -0.786 . . . . 1.15 112.059 -175.481 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 51' ' ' PRO . . . . . 0.644 ' HD2' ' N ' ' A' ' 50' ' ' LYS . 1.7 Cg_endo -45.77 -37.07 15.78 Favored 'Trans proline' 0 C--N 1.359 1.082 0 C-N-CA 123.122 2.548 . . . . 0.75 113.184 176.692 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 24.2 m -68.36 -46.61 69.64 Favored 'General case' 0 C--O 1.239 0.54 0 CA-C-O 121.198 0.523 . . . . 0.68 110.304 -179.471 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 5.0 m-85 -75.11 -20.24 59.55 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.867 -0.606 . . . . 0.69 109.423 -178.451 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 7.6 t70 -67.26 -45.23 77.29 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.42 -0.809 . . . . 2.18 110.036 175.128 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 29.4 mt-10 -67.31 -29.17 68.68 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.229 -0.442 . . . . 2.33 110.593 178.715 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 54.0 mt -78.87 -29.42 14.25 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-O 121.386 0.612 . . . . 0.64 110.587 175.792 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 57' ' ' PHE . . . . . 0.554 ' CE2' ' HB3' ' A' ' 62' ' ' PRO . 72.8 t80 -71.2 -41.08 70.74 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.961 -0.563 . . . . 0.29 110.623 178.765 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 58' ' ' TYR . . . . . 0.614 ' HA ' ' HG3' ' A' ' 62' ' ' PRO . 2.5 m-85 -78.23 -12.45 60.0 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.917 -0.583 . . . . 1.17 111.656 -176.049 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 3.8 p -91.88 -7.61 48.81 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 120.96 0.409 . . . . 0.44 110.988 178.655 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 89.1 mt -100.77 11.49 39.45 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-N 116.015 -0.539 . . . . 1.37 110.5 177.75 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 24.6 m 65.65 85.28 0.16 Allowed Pre-proline 0 N--CA 1.463 0.213 0 CA-C-N 115.363 -0.835 . . . . 1.24 111.8 178.347 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 62' ' ' PRO . . . . . 0.614 ' HG3' ' HA ' ' A' ' 58' ' ' TYR . 4.6 Cg_endo -85.59 130.87 3.87 Favored 'Trans proline' 0 N--CA 1.454 -0.795 0 C-N-CA 122.996 2.464 . . . . 0.47 112.162 178.626 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 60.2 t -112.25 108.83 26.51 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 N-CA-C 109.755 -0.461 . . . . 1.02 109.755 177.477 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 92.0 m-20 62.15 30.03 17.65 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.664 -0.698 . . . . 1.34 111.922 178.029 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 94.58 3.38 62.78 Favored Glycine 0 CA--C 1.519 0.296 0 C-N-CA 120.792 -0.718 . . . . 0.43 113.817 173.668 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 55.5 mttm -129.37 150.53 50.69 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 117.135 0.467 . . . . 1.48 110.488 177.555 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 33.7 pt -117.66 159.67 17.72 Favored 'Isoleucine or valine' 0 C--O 1.24 0.605 0 CA-C-O 121.264 0.554 . . . . 0.64 110.455 172.836 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 22.4 p -72.28 151.67 42.64 Favored 'General case' 0 N--CA 1.446 -0.64 0 CA-C-N 114.915 -1.038 . . . . 0.55 110.784 179.046 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -71.05 -10.47 68.63 Favored Glycine 0 C--O 1.222 -0.63 0 C-N-CA 120.744 -0.741 . . . . 0.41 111.609 179.957 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -70.52 -40.85 73.25 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.069 0.461 . . . . 0.38 111.181 178.65 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 30.2 m-80 -81.13 -33.09 33.43 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.971 -0.559 . . . . 1.81 110.34 -178.409 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -62.95 -46.41 87.88 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 109.424 -0.584 . . . . 0.39 109.424 171.558 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 73' ' ' LYS . . . . . 0.422 ' HA ' ' CE1' ' B' ' 151' ' ' PHE . 54.6 tttp -52.25 -43.38 64.33 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 115.248 -0.887 . . . . 0.84 110.414 174.671 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 74' ' ' LYS . . . . . 0.54 ' O ' ' HG2' ' A' ' 78' ' ' LYS . 35.5 ttpt -59.16 -49.91 76.05 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.239 -0.891 . . . . 1.95 111.397 179.037 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 3.1 tp10 -59.32 -47.98 83.35 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.359 0.599 . . . . 1.6 110.514 177.108 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 76' ' ' MET . . . . . 0.726 ' HB3' HD22 ' A' ' 86' ' ' LEU . 70.9 mmm -55.75 -47.09 77.57 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.383 -0.826 . . . . 1.24 111.457 -177.819 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 29.5 m -75.56 -20.7 15.95 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.362 0 N-CA-C 111.702 0.26 . . . . 1.57 111.702 -177.641 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.54 ' HG2' ' O ' ' A' ' 74' ' ' LYS . 24.0 mmtp -72.96 -27.46 61.84 Favored 'General case' 0 CA--C 1.52 -0.196 0 CA-C-O 121.111 0.482 . . . . 2.79 110.151 174.723 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 66.1 m -85.59 5.09 33.22 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.831 -0.622 . . . . 1.27 111.291 179.286 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 80' ' ' LYS . . . . . 0.446 ' NZ ' ' HB3' ' A' ' 80' ' ' LYS . 5.0 mmmp? 62.9 31.92 16.0 Favored 'General case' 0 C--O 1.235 0.328 0 N-CA-C 113.343 0.868 . . . . 2.97 113.343 170.188 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.432 ' HA ' ' HD3' ' A' ' 82' ' ' PRO . 87.0 mt -87.29 136.54 33.41 Favored Pre-proline 0 C--N 1.322 -0.624 0 C-N-CA 120.651 -0.42 . . . . 0.52 110.335 176.813 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 82' ' ' PRO . . . . . 0.563 ' O ' ' HG ' ' A' ' 86' ' ' LEU . 32.0 Cg_exo -58.7 152.76 54.14 Favored 'Trans proline' 0 C--N 1.344 0.332 0 C-N-CA 122.795 2.33 . . . . 0.44 111.991 178.261 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 83' ' ' ASN . . . . . 0.551 ' HA ' HD12 ' A' ' 86' ' ' LEU . 17.6 m120 -55.21 -33.53 63.14 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-N 116.481 -0.327 . . . . 1.85 111.658 -177.088 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 7.3 p -63.78 -46.64 84.31 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.255 0.55 . . . . 1.47 110.674 177.161 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.494 ' O ' HG12 ' A' ' 89' ' ' ILE . 47.8 t -69.1 -32.75 55.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 115.616 -0.72 . . . . 0.45 110.61 -179.871 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.726 HD22 ' HB3' ' A' ' 76' ' ' MET . 79.7 mt -57.58 -46.67 83.72 Favored 'General case' 0 C--O 1.238 0.471 0 CA-C-N 116.119 -0.491 . . . . 0.9 110.098 176.188 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -66.62 -35.39 89.82 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.821 -0.704 . . . . 0.32 111.625 178.282 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 48.3 mmtt -57.21 -52.46 65.23 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-O 120.907 0.384 . . . . 1.89 110.819 175.52 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 0.605 ' HB ' ' HE1' ' A' ' 76' ' ' MET . 50.6 mm -61.16 -47.0 95.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 115.581 -0.736 . . . . 0.71 110.938 -177.675 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 50.0 t-105 -59.21 -46.87 87.3 Favored 'General case' 0 CA--C 1.53 0.198 0 CA-C-O 120.825 0.345 . . . . 0.33 110.984 179.511 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 17.0 ttmm -54.42 -37.8 65.53 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 115.71 -0.677 . . . . 2.7 112.025 178.319 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.749 HD11 ' HA ' ' A' ' 124' ' ' ALA . 96.9 mt -86.22 -29.95 22.77 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.5 -0.318 . . . . 1.66 111.774 -176.907 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 93' ' ' ALA . . . . . 0.683 ' HA ' HD22 ' A' ' 108' ' ' LEU . . . -79.57 -42.31 25.29 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 116.458 -0.337 . . . . 0.47 111.868 -175.659 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -102.99 95.14 5.95 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.186 0.517 . . . . 0.79 110.197 -177.994 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 32.3 t -67.47 -40.52 84.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 115.388 -0.824 . . . . 0.61 111.53 -174.27 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 13.2 p-10 -90.0 -20.09 23.68 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.24 -0.437 . . . . 0.96 110.919 -175.994 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 97' ' ' LYS . . . . . 0.513 ' HB2' ' NZ ' ' A' ' 97' ' ' LYS . 8.0 mtmp? 66.33 60.4 0.62 Allowed 'General case' 0 C--O 1.233 0.21 0 CA-C-N 115.848 -0.615 . . . . 2.96 111.038 177.164 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 11.2 p-10 -94.3 9.57 37.61 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.211 -0.45 . . . . 0.43 110.907 -179.598 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 73.99 -19.03 1.78 Allowed Glycine 0 CA--C 1.519 0.329 0 CA-C-N 116.025 -0.534 . . . . 0.44 113.346 175.592 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 94.7 mt -113.35 151.63 30.99 Favored 'General case' 0 C--N 1.318 -0.775 0 N-CA-C 108.889 -0.782 . . . . 1.11 108.889 178.227 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 58.5 mt -104.04 119.99 40.12 Favored 'General case' 0 C--N 1.318 -0.796 0 C-N-CA 120.414 -0.514 . . . . 0.42 110.519 178.762 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 102' ' ' ASP . . . . . 0.579 ' HB2' ' HG3' ' A' ' 105' ' ' GLU . 20.6 m-20 -69.38 168.61 14.03 Favored 'General case' 0 CA--C 1.513 -0.46 0 N-CA-C 108.721 -0.844 . . . . 1.72 108.721 171.586 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 12.7 p-10 -59.99 -35.89 76.0 Favored 'General case' 0 C--N 1.317 -0.845 0 N-CA-C 109.612 -0.514 . . . . 1.6 109.612 176.094 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 37.5 mm-40 -65.57 -51.17 61.76 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-N 115.668 -0.697 . . . . 1.66 110.288 176.138 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 105' ' ' GLU . . . . . 0.579 ' HG3' ' HB2' ' A' ' 102' ' ' ASP . 42.5 mt-10 -64.41 -42.78 95.89 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.75 -0.659 . . . . 0.44 111.074 -174.404 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 90.2 t80 -66.91 -34.89 78.78 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.245 -0.434 . . . . 0.42 110.434 -179.574 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -60.8 -40.4 92.53 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.874 0.368 . . . . 0.22 110.326 175.667 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.683 HD22 ' HA ' ' A' ' 93' ' ' ALA . 6.9 tt -66.45 -50.21 64.11 Favored 'General case' 0 C--O 1.237 0.409 0 CA-C-N 116.217 -0.447 . . . . 1.33 110.094 178.791 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 109' ' ' ALA . . . . . 0.64 ' O ' HG13 ' A' ' 113' ' ' ILE . . . -54.59 -55.98 23.76 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 115.961 -0.563 . . . . 0.32 110.728 178.072 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 110' ' ' ASN . . . . . 0.625 ' HA ' HD12 ' A' ' 113' ' ' ILE . 0.7 OUTLIER -52.93 -39.91 63.22 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.662 -0.699 . . . . 1.2 111.176 179.98 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 111' ' ' HIS . . . . . 0.415 ' O ' HG23 ' A' ' 115' ' ' VAL . 37.2 t60 -60.54 -53.26 59.65 Favored 'General case' 0 C--O 1.223 -0.295 0 N-CA-C 110.115 -0.328 . . . . 0.52 110.115 178.548 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 92.5 mt -54.87 -42.98 72.73 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-O 120.975 0.417 . . . . 0.55 110.775 179.42 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.64 HG13 ' O ' ' A' ' 109' ' ' ALA . 70.6 mt -57.5 -56.63 14.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 115.542 -0.754 . . . . 0.84 111.488 -179.374 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 114' ' ' LYS . . . . . 0.517 ' HG2' ' O ' ' A' ' 110' ' ' ASN . 63.2 mmtt -69.55 -32.99 72.12 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.69 -0.687 . . . . 3.83 110.644 -174.261 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 115' ' ' VAL . . . . . 0.529 HG12 ' HB2' ' A' ' 120' ' ' HIS . 51.5 t -62.96 -33.78 62.51 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-N 115.914 -0.585 . . . . 1.19 110.679 174.212 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 3.5 mmmp? -68.27 -37.19 80.46 Favored 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 120.694 -0.402 . . . . 1.32 110.19 173.225 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 98.1 mt -67.66 -27.78 67.14 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.201 -0.454 . . . . 0.96 110.537 177.328 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 118' ' ' GLU . . . . . 0.408 ' HB2' ' O ' ' A' ' 115' ' ' VAL . 45.8 mt-10 -64.85 -22.41 66.99 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.06 -0.518 . . . . 2.18 111.165 174.819 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 106.28 10.82 28.86 Favored Glycine 0 N--CA 1.445 -0.728 0 C-N-CA 120.417 -0.897 . . . . 1.16 111.854 -176.906 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 120' ' ' HIS . . . . . 0.529 ' HB2' HG12 ' A' ' 115' ' ' VAL . 1.8 m80 -88.6 159.27 17.96 Favored 'General case' 0 C--O 1.235 0.318 0 N-CA-C 109.381 -0.6 . . . . 2.42 109.381 177.32 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 18.2 mt-10 -114.04 163.28 15.37 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 110.285 -0.265 . . . . 2.53 110.285 174.166 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 122' ' ' LEU . . . . . 0.766 ' H ' HD23 ' A' ' 122' ' ' LEU . 2.2 pt? -106.05 136.39 19.32 Favored Pre-proline 0 C--N 1.326 -0.422 0 CA-C-N 116.494 -0.321 . . . . 1.33 110.588 -176.771 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 123' ' ' PRO . . . . . 0.44 ' HD3' ' HA ' ' A' ' 122' ' ' LEU . 10.7 Cg_exo -72.13 -14.91 28.95 Favored 'Trans proline' 0 N--CA 1.464 -0.238 0 C-N-CA 122.889 2.393 . . . . 1.33 112.125 177.685 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 124' ' ' ALA . . . . . 0.749 ' HA ' HD11 ' A' ' 92' ' ' LEU . . . 64.72 18.99 11.69 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 115.417 -0.81 . . . . 1.25 112.106 179.238 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 24.4 t70 -128.45 152.16 48.55 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 108.921 -0.77 . . . . 2.73 108.921 174.767 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 126' ' ' LEU . . . . . 0.527 ' HG ' HG22 ' A' ' 131' ' ' VAL . 36.3 tp -105.75 105.44 53.0 Favored Pre-proline 0 C--N 1.322 -0.602 0 CA-C-O 120.747 0.308 . . . . 1.66 111.588 -172.645 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 127' ' ' PRO . . . . . 0.482 ' HD2' HD12 ' A' ' 130' ' ' LEU . 71.9 Cg_endo -79.61 155.04 24.12 Favored 'Trans proline' 0 CA--C 1.534 0.508 0 C-N-CA 122.722 2.281 . . . . 1.17 112.059 174.679 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 12.6 Cg_endo -56.7 -26.01 63.24 Favored 'Trans proline' 0 CA--C 1.534 0.504 0 C-N-CA 123.35 2.7 . . . . 1.54 114.32 -174.937 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 32.0 p-80 -87.14 3.34 46.72 Favored 'General case' 0 N--CA 1.462 0.169 0 C-N-CA 120.441 -0.504 . . . . 1.07 111.148 -179.442 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 130' ' ' LEU . . . . . 0.482 HD12 ' HD2' ' A' ' 127' ' ' PRO . 24.2 mt -110.8 -17.86 13.25 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.453 -0.34 . . . . 1.36 110.615 173.617 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 131' ' ' VAL . . . . . 0.527 HG22 ' HG ' ' A' ' 126' ' ' LEU . 6.7 t -75.73 122.41 87.02 Favored Pre-proline 0 C--N 1.328 -0.336 0 N-CA-C 109.844 -0.428 . . . . 1.28 109.844 178.832 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_exo -49.58 135.98 33.69 Favored 'Trans proline' 0 C--N 1.344 0.327 0 C-N-CA 122.851 2.367 . . . . 0.81 112.078 177.153 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -51.23 -36.43 56.36 Favored 'Trans proline' 0 C--N 1.344 0.322 0 C-N-CA 123.762 2.974 . . . . 1.17 113.815 -173.818 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 14.6 m -89.34 1.32 55.94 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 112.048 0.388 . . . . 1.6 112.048 -176.783 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 66.0 mttm . . . . . 0 CA--C 1.532 0.278 0 O-C-N 122.313 -0.242 . . . . 1.21 111.198 -179.885 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' B' B ' 149' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.437 -1.243 0 N-CA-C 110.832 -0.907 . . . . 0.48 110.832 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' B' B ' 150' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -73.21 -0.88 9.76 Favored 'Trans proline' 0 CA--C 1.53 0.323 0 C-N-CA 123.249 2.632 . . . . 0.33 112.312 -177.009 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 151' ' ' PHE . . . . . 0.719 ' CZ ' ' HG3' ' A' ' 76' ' ' MET . 46.7 m-85 . . . . . 0 C--N 1.328 -0.346 0 CA-C-N 116.055 -0.52 . . . . 0.75 112.183 -178.617 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 4.1 mp0 . . . . . 0 C--O 1.234 0.276 0 CA-C-O 121.356 0.598 . . . . 3.1 111.887 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 44' ' ' TRP . . . . . 0.523 ' HH2' ' O ' ' A' ' 104' ' ' GLU . 7.7 t90 -70.6 116.12 10.55 Favored 'General case' 0 N--CA 1.45 -0.436 0 CA-C-N 115.191 -0.913 . . . . 0.71 109.025 178.533 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 9.9 p -67.38 -9.61 10.52 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-O 121.14 0.495 . . . . 1.45 111.371 -174.657 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 51.0 t -89.41 -20.76 7.01 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-O 121.262 0.553 . . . . 1.1 110.317 176.866 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 47' ' ' GLY . . . . . 0.438 ' HA2' ' HG2' ' A' ' 50' ' ' LYS . . . -72.68 -19.34 79.15 Favored Glycine 0 N--CA 1.446 -0.635 0 CA-C-N 115.706 -0.679 . . . . 0.59 112.897 -175.666 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 15.3 ptpt -76.61 -26.1 54.6 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.602 0.239 . . . . 2.46 111.138 -179.182 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -101.2 34.25 2.6 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.023 0.439 . . . . 1.66 109.917 178.259 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 50' ' ' LYS . . . . . 0.438 ' HG2' ' HA2' ' A' ' 47' ' ' GLY . 0.1 OUTLIER -67.73 -54.16 18.54 Favored Pre-proline 0 C--O 1.214 -0.775 0 CA-C-O 118.256 -0.878 . . . . 1.15 113.156 -175.922 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_exo -42.66 -41.76 8.33 Favored 'Trans proline' 0 C--N 1.358 1.068 0 C-N-CA 122.798 2.332 . . . . 0.75 113.868 -173.245 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 90.7 m -69.97 -44.76 68.79 Favored 'General case' 0 C--O 1.238 0.449 0 CA-C-O 121.1 0.476 . . . . 0.68 111.282 179.404 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 53' ' ' TYR . . . . . 0.43 ' HB3' HD21 ' A' ' 110' ' ' ASN . 8.6 m-30 -74.23 -23.21 59.14 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.957 0.408 . . . . 0.69 110.045 -177.491 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 84.2 m-20 -70.03 -44.23 69.69 Favored 'General case' 0 CA--C 1.511 -0.532 0 N-CA-C 108.961 -0.755 . . . . 2.18 108.961 175.818 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 10.8 tp10 -57.26 -47.29 81.78 Favored 'General case' 0 N--CA 1.45 -0.444 0 CA-C-N 115.016 -0.993 . . . . 2.33 110.225 178.541 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 39.8 mt -70.79 -37.54 69.14 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 CA-C-N 116.24 -0.437 . . . . 0.64 111.552 -178.273 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 57' ' ' PHE . . . . . 0.461 ' HD2' ' CE1' ' A' ' 58' ' ' TYR . 86.6 t80 -66.29 -45.3 80.89 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.807 0.337 . . . . 0.29 110.981 -178.689 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 58' ' ' TYR . . . . . 0.461 ' CE1' ' HD2' ' A' ' 57' ' ' PHE . 21.7 m-85 -79.81 -12.6 59.76 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.592 -0.276 . . . . 1.17 111.429 -174.596 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 11.5 p -88.7 -8.65 54.16 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.716 0.293 . . . . 0.44 111.286 177.406 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.481 ' HB3' ' HB3' ' A' ' 71' ' ' ASN . 35.2 mt -94.69 9.38 39.07 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.665 -0.243 . . . . 1.37 110.988 178.599 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 17.3 m 68.23 87.55 0.11 Allowed Pre-proline 0 CA--C 1.531 0.219 0 O-C-N 123.823 0.702 . . . . 1.24 110.854 -176.374 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -77.3 125.3 7.69 Favored 'Trans proline' 0 N--CA 1.458 -0.582 0 C-N-CA 122.586 2.191 . . . . 0.47 112.199 -179.463 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 12.5 m -115.3 119.35 61.55 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 CA-C-O 121.091 0.472 . . . . 1.02 110.271 177.432 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 65.5 m-20 64.39 22.24 12.7 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-N 115.711 -0.677 . . . . 1.34 110.742 -179.19 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 80.67 15.73 77.16 Favored Glycine 0 CA--C 1.52 0.352 0 C-N-CA 120.961 -0.638 . . . . 0.43 112.579 -178.393 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 66' ' ' LYS . . . . . 0.751 ' HG2' ' HB3' ' A' ' 102' ' ' ASP . 86.8 mttt -137.37 160.14 39.92 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 109.739 -0.467 . . . . 1.48 109.739 179.812 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 67' ' ' ILE . . . . . 0.454 HD11 ' HB2' ' A' ' 101' ' ' LEU . 2.8 pp -119.48 158.12 21.18 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 N-CA-C 109.907 -0.405 . . . . 0.64 109.907 172.309 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 68' ' ' THR . . . . . 0.401 ' HA ' ' CD2' ' A' ' 100' ' ' LEU . 63.8 p -89.5 173.11 8.52 Favored 'General case' 0 C--N 1.321 -0.63 0 CA-C-N 116.203 -0.453 . . . . 0.55 110.898 -174.569 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -64.53 -19.29 64.56 Favored Glycine 0 N--CA 1.445 -0.726 0 C-N-CA 120.81 -0.709 . . . . 0.41 111.997 176.962 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -66.61 -46.01 77.24 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.168 0.509 . . . . 0.38 111.154 179.061 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 71' ' ' ASN . . . . . 0.481 ' HB3' ' HB3' ' A' ' 60' ' ' LEU . 1.7 m120 -77.57 -41.09 40.13 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.654 -0.703 . . . . 1.81 110.128 -175.148 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -62.78 -43.39 98.94 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.862 -0.608 . . . . 0.39 110.263 177.194 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 73' ' ' LYS . . . . . 0.54 ' O ' HG22 ' A' ' 77' ' ' VAL . 21.3 ttmm -56.96 -47.28 81.08 Favored 'General case' 0 CA--C 1.516 -0.332 0 CA-C-N 116.255 -0.43 . . . . 0.84 109.862 176.358 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 48.8 tttm -52.44 -50.65 62.17 Favored 'General case' 0 N--CA 1.451 -0.386 0 O-C-N 123.908 0.755 . . . . 1.95 111.209 -178.974 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 13.2 tp10 -70.7 -43.37 69.12 Favored 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 120.846 -0.341 . . . . 1.6 111.15 -178.208 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 64.7 mtt -64.34 -38.67 91.85 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 111.656 0.243 . . . . 1.24 111.656 -175.729 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.54 HG22 ' O ' ' A' ' 73' ' ' LYS . 32.9 m -76.31 -28.55 18.34 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.302 0 C-N-CA 120.788 -0.365 . . . . 1.57 110.621 177.271 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.456 ' HB3' ' HE3' ' A' ' 78' ' ' LYS . 19.8 mmmt -64.89 -25.78 68.04 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-N 116.18 -0.464 . . . . 2.79 110.727 173.58 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 20.3 m -75.16 -8.85 57.72 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.585 -0.734 . . . . 1.27 110.512 177.796 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 55.0 mtpt 62.34 42.64 8.95 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-N 115.903 -0.59 . . . . 2.97 111.126 177.38 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.709 ' HB2' HD11 ' A' ' 86' ' ' LEU . 97.5 mt -100.32 169.2 8.25 Favored Pre-proline 0 C--N 1.325 -0.495 0 CA-C-N 115.704 -0.68 . . . . 0.52 109.758 178.307 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 82' ' ' PRO . . . . . 0.407 ' CD ' ' HB3' ' A' ' 81' ' ' LEU . 2.0 Cg_endo -83.49 132.01 5.73 Favored 'Trans proline' 0 C--N 1.348 0.515 0 C-N-CA 123.274 2.65 . . . . 0.44 112.371 -178.478 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 5.0 p-10 -50.67 -38.67 47.95 Favored 'General case' 0 N--CA 1.472 0.638 0 N-CA-C 113.504 0.927 . . . . 1.85 113.504 -171.532 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 84' ' ' THR . . . . . 0.408 ' O ' ' HG2' ' A' ' 88' ' ' LYS . 75.7 m -65.79 -34.28 77.81 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 120.892 0.377 . . . . 1.47 110.925 -179.719 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.502 ' O ' HG12 ' A' ' 89' ' ' ILE . 95.6 t -71.12 -39.85 74.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.153 -0.476 . . . . 0.45 109.789 178.485 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.709 HD11 ' HB2' ' A' ' 81' ' ' LEU . 9.8 mp -58.44 -34.83 71.24 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.18 -0.464 . . . . 0.9 110.992 172.39 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 87' ' ' GLY . . . . . 0.417 ' HA2' ' HB2' ' B' ' 151' ' ' PHE . . . -65.66 -38.67 94.81 Favored Glycine 0 N--CA 1.447 -0.612 0 N-CA-C 111.072 -0.811 . . . . 0.32 111.072 176.619 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 88' ' ' LYS . . . . . 0.408 ' HG2' ' O ' ' A' ' 84' ' ' THR . 70.0 mmtt -63.43 -49.73 72.57 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.147 -0.526 . . . . 1.89 109.968 174.5 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 0.502 HG12 ' O ' ' A' ' 85' ' ' VAL . 40.8 mm -54.74 -49.82 65.46 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.097 0 CA-C-N 115.711 -0.677 . . . . 0.71 110.699 179.686 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 53.5 t-105 -61.38 -50.55 72.42 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.323 -0.399 . . . . 0.33 111.402 -178.671 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 26.4 ttmt -74.52 -10.76 59.87 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-O 121.009 0.433 . . . . 2.7 111.359 -172.766 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.439 HD11 ' HA ' ' A' ' 124' ' ' ALA . 94.1 mt -94.36 -37.42 11.48 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.336 -0.393 . . . . 1.66 111.08 172.7 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 93' ' ' ALA . . . . . 0.474 ' HA ' HD23 ' A' ' 108' ' ' LEU . . . -78.81 -36.85 42.08 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.224 -0.444 . . . . 0.47 111.489 -176.787 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 26.7 t0 -81.15 86.83 6.12 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.612 0.72 . . . . 0.79 109.524 177.562 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.446 ' HB ' ' HD3' ' A' ' 135' ' ' LYS . 34.4 t -82.2 -30.74 9.83 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.587 0 CA-C-N 114.839 -1.073 . . . . 0.61 110.352 -174.796 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 43.5 p-10 -86.41 -7.57 58.34 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.22 -0.445 . . . . 0.96 110.655 -179.461 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 88.9 mttt 59.06 44.62 15.85 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-N 115.716 -0.675 . . . . 2.96 111.129 172.974 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 98' ' ' ASP . . . . . 0.536 ' OD2' ' HB2' ' A' ' 100' ' ' LEU . 6.5 p-10 -107.08 9.06 30.56 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 116.246 -0.434 . . . . 0.43 111.016 -175.872 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 67.58 12.84 62.27 Favored Glycine 0 CA--C 1.518 0.277 0 C-N-CA 121.053 -0.594 . . . . 0.44 112.481 178.746 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.536 ' HB2' ' OD2' ' A' ' 98' ' ' ASP . 87.0 mt -135.77 153.3 51.59 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 109.114 -0.699 . . . . 1.11 109.114 178.817 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.454 ' HB2' HD11 ' A' ' 67' ' ' ILE . 89.9 mt -110.22 111.89 23.5 Favored 'General case' 0 C--N 1.315 -0.928 0 N-CA-C 109.166 -0.679 . . . . 0.42 109.166 175.009 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 102' ' ' ASP . . . . . 0.751 ' HB3' ' HG2' ' A' ' 66' ' ' LYS . 2.1 p30 -75.99 -174.82 2.81 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 116.233 -0.44 . . . . 1.72 110.672 178.523 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -54.86 -40.33 69.56 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 115.604 -0.726 . . . . 1.6 110.48 -179.215 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 104' ' ' GLU . . . . . 0.523 ' O ' ' HH2' ' A' ' 44' ' ' TRP . 54.5 mt-10 -73.62 -52.76 12.32 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.992 -0.549 . . . . 1.66 110.253 179.408 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 36.1 mt-10 -63.12 -37.93 89.15 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.238 -0.437 . . . . 0.44 111.753 -173.833 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 106' ' ' PHE . . . . . 0.456 ' CD2' ' HD1' ' A' ' 57' ' ' PHE . 54.1 t80 -74.86 -34.94 62.35 Favored 'General case' 0 C--N 1.326 -0.436 0 C-N-CA 120.781 -0.368 . . . . 0.42 110.098 -179.533 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -58.61 -42.43 88.13 Favored 'General case' 0 C--O 1.231 0.127 0 N-CA-C 109.714 -0.476 . . . . 0.22 109.714 173.215 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.474 HD23 ' HA ' ' A' ' 93' ' ' ALA . 64.8 tp -62.73 -43.77 97.95 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.842 -0.617 . . . . 1.33 110.557 176.055 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 109' ' ' ALA . . . . . 0.519 ' O ' HG13 ' A' ' 113' ' ' ILE . . . -57.86 -46.03 85.41 Favored 'General case' 0 C--O 1.225 -0.237 0 CA-C-N 116.251 -0.431 . . . . 0.32 110.869 178.562 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 110' ' ' ASN . . . . . 0.43 HD21 ' HB3' ' A' ' 53' ' ' TYR . 93.8 m-20 -63.4 -36.71 84.61 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 116.5 -0.318 . . . . 1.2 111.146 179.037 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 9.6 t60 -64.4 -37.87 89.04 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 109.615 -0.513 . . . . 0.52 109.615 178.838 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 94.3 mt -72.02 -39.19 69.33 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.793 -0.639 . . . . 0.55 110.742 178.098 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.519 HG13 ' O ' ' A' ' 109' ' ' ALA . 59.4 mt -56.68 -47.54 82.24 Favored 'Isoleucine or valine' 0 C--O 1.233 0.211 0 N-CA-C 109.816 -0.439 . . . . 0.84 109.816 175.247 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 114' ' ' LYS . . . . . 0.566 ' O ' ' HB2' ' A' ' 118' ' ' GLU . 4.6 mmmm -62.38 -44.11 97.23 Favored 'General case' 0 C--O 1.221 -0.413 0 CA-C-N 116.076 -0.511 . . . . 3.83 111.622 179.223 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 115' ' ' VAL . . . . . 0.567 HG13 ' HB2' ' A' ' 120' ' ' HIS . 42.9 t -58.01 -43.25 84.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-O 120.835 0.35 . . . . 1.19 110.903 178.192 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 116' ' ' LYS . . . . . 0.472 ' HA ' ' HD2' ' A' ' 116' ' ' LYS . 18.3 tptt -65.75 -45.41 82.7 Favored 'General case' 0 N--CA 1.444 -0.754 0 CA-C-N 116.057 -0.519 . . . . 1.32 110.786 -178.982 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 95.7 mt -78.95 -15.75 57.88 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.511 -0.313 . . . . 0.96 111.78 -178.742 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 118' ' ' GLU . . . . . 0.566 ' HB2' ' O ' ' A' ' 114' ' ' LYS . 2.1 tp10 -79.4 -13.56 59.52 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 109.081 -0.711 . . . . 2.18 109.081 177.063 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 93.78 31.02 8.46 Favored Glycine 0 N--CA 1.452 -0.287 0 CA-C-N 115.236 -0.893 . . . . 1.16 112.318 178.293 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 120' ' ' HIS . . . . . 0.567 ' HB2' HG13 ' A' ' 115' ' ' VAL . 79.8 m80 -117.09 176.8 4.97 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 109.843 -0.429 . . . . 2.42 109.843 177.644 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 -126.41 155.07 42.75 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 120.789 0.328 . . . . 2.53 110.255 -177.85 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 122' ' ' LEU . . . . . 0.481 ' HA ' ' HD3' ' A' ' 123' ' ' PRO . 0.7 OUTLIER -116.39 135.64 22.91 Favored Pre-proline 0 C--N 1.324 -0.521 0 N-CA-C 109.807 -0.442 . . . . 1.33 109.807 177.931 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 123' ' ' PRO . . . . . 0.481 ' HD3' ' HA ' ' A' ' 122' ' ' LEU . 2.9 Cg_exo -76.45 10.31 2.23 Favored 'Trans proline' 0 C--O 1.234 0.315 0 C-N-CA 123.191 2.594 . . . . 1.33 113.393 -175.49 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 124' ' ' ALA . . . . . 0.439 ' HA ' HD11 ' A' ' 92' ' ' LEU . . . 57.91 27.21 14.33 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-O 121.24 0.543 . . . . 1.25 111.367 -178.89 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 8.2 t70 -132.42 154.67 49.61 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 109.235 -0.654 . . . . 2.73 109.235 -179.887 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 95.2 mt -108.46 101.67 43.78 Favored Pre-proline 0 C--N 1.324 -0.527 0 CA-C-O 120.917 0.389 . . . . 1.66 111.616 -177.078 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 127' ' ' PRO . . . . . 0.624 ' HG2' ' HB2' ' A' ' 130' ' ' LEU . 18.4 Cg_endo -62.64 151.95 80.68 Favored 'Trans proline' 0 CA--C 1.535 0.546 0 C-N-CA 122.821 2.347 . . . . 1.17 111.767 173.344 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -53.11 -35.7 73.83 Favored 'Trans proline' 0 CA--C 1.533 0.461 0 C-N-CA 123.415 2.743 . . . . 1.54 113.622 -175.23 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 11.9 p-80 -86.93 3.26 46.36 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 111.669 0.248 . . . . 1.07 111.669 -178.916 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 130' ' ' LEU . . . . . 0.624 ' HB2' ' HG2' ' A' ' 127' ' ' PRO . 16.5 tp -115.57 -1.14 12.83 Favored 'General case' 0 N--CA 1.446 -0.655 0 CA-C-O 120.965 0.412 . . . . 1.36 110.279 -177.912 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 131' ' ' VAL . . . . . 0.413 HG23 ' O ' ' A' ' 127' ' ' PRO . 65.0 t -88.69 129.77 47.6 Favored Pre-proline 0 C--N 1.327 -0.391 0 CA-C-N 115.987 -0.551 . . . . 1.28 110.122 178.598 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 132' ' ' PRO . . . . . 0.463 ' HA ' ' HD3' ' A' ' 133' ' ' PRO . 83.1 Cg_exo -48.31 130.38 20.93 Favored 'Trans proline' 0 C--N 1.348 0.532 0 C-N-CA 122.891 2.394 . . . . 0.81 112.306 177.685 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 133' ' ' PRO . . . . . 0.463 ' HD3' ' HA ' ' A' ' 132' ' ' PRO . 50.6 Cg_exo -54.27 -37.44 88.27 Favored 'Trans proline' 0 C--O 1.232 0.206 0 C-N-CA 123.446 2.764 . . . . 1.17 113.369 -174.296 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 12.8 m -83.99 -2.05 55.85 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.55 -0.295 . . . . 1.6 111.227 -177.05 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 135' ' ' LYS . . . . . 0.446 ' HD3' ' HB ' ' A' ' 95' ' ' VAL . 61.2 mttp . . . . . 0 C--N 1.329 -0.324 0 N-CA-C 112.285 0.476 . . . . 1.21 112.285 -174.702 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 149' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.444 -0.778 0 N-CA-C 111.542 -0.623 . . . . 0.48 111.542 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' B' B ' 150' ' ' PRO . . . . . . . . . . . . . 69.4 Cg_endo -73.86 -8.33 21.16 Favored 'Trans proline' 0 N--CA 1.465 -0.204 0 C-N-CA 122.423 2.082 . . . . 0.33 112.106 -179.228 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 151' ' ' PHE . . . . . 0.43 ' CZ ' ' HA ' ' A' ' 73' ' ' LYS . 36.2 m-85 . . . . . 0 C--N 1.328 -0.332 0 CA-C-N 116.067 -0.515 . . . . 0.75 111.038 178.136 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 43' ' ' GLU . . . . . 0.463 ' OE2' ' HA ' ' A' ' 45' ' ' VAL . 12.4 tt0 . . . . . 0 C--O 1.237 0.411 0 CA-C-O 120.879 0.371 . . . . 3.1 110.814 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' TRP . . . . . 0.487 ' HH2' ' O ' ' A' ' 104' ' ' GLU . 6.1 t90 -83.39 102.14 11.82 Favored 'General case' 0 N--CA 1.448 -0.545 0 N-CA-C 107.503 -1.295 . . . . 0.71 107.503 168.767 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.463 ' HA ' ' OE2' ' A' ' 43' ' ' GLU . 35.6 m -61.58 -9.66 3.24 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.532 0 N-CA-C 113.011 0.745 . . . . 1.45 113.011 -170.045 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 22.4 t -86.51 -20.17 7.91 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 CA-C-O 121.24 0.543 . . . . 1.1 110.194 177.794 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' GLY . . . . . 0.553 ' HA2' ' HG3' ' A' ' 50' ' ' LYS . . . -73.27 -25.86 71.97 Favored Glycine 0 N--CA 1.449 -0.45 0 CA-C-N 115.71 -0.677 . . . . 0.59 113.242 -175.145 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 6.4 ptpp? -74.06 -25.32 59.77 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 117.052 0.426 . . . . 2.46 111.051 -178.827 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 24.1 m-20 -105.67 33.75 3.6 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.114 0.483 . . . . 1.66 109.96 179.37 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 50' ' ' LYS . . . . . 0.553 ' HG3' ' HA2' ' A' ' 47' ' ' GLY . 48.9 mttt -70.16 -43.25 18.32 Favored Pre-proline 0 C--O 1.219 -0.521 0 CA-C-O 118.499 -0.762 . . . . 1.15 112.657 178.042 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 51' ' ' PRO . . . . . 0.512 ' O ' ' HG3' ' A' ' 55' ' ' GLU . 66.2 Cg_exo -39.64 -48.71 3.44 Favored 'Trans proline' 0 C--N 1.365 1.439 0 C-N-CA 122.82 2.346 . . . . 0.75 113.89 -179.243 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 18.4 m -69.54 -44.8 70.19 Favored 'General case' 0 C--O 1.239 0.509 0 CA-C-O 121.082 0.467 . . . . 0.68 111.148 -177.626 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 9.8 m-30 -70.34 -21.49 62.9 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.873 -0.603 . . . . 0.69 109.854 -178.238 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -74.88 -44.68 47.54 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.95 -0.568 . . . . 2.18 109.734 177.782 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 55' ' ' GLU . . . . . 0.512 ' HG3' ' O ' ' A' ' 51' ' ' PRO . 72.0 mt-10 -60.6 -29.8 69.44 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.453 -0.794 . . . . 2.33 110.416 178.493 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.47 ' O ' HD13 ' A' ' 60' ' ' LEU . 52.4 mt -84.74 -48.72 16.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 116.148 -0.478 . . . . 0.64 111.225 177.566 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 57' ' ' PHE . . . . . 0.497 ' HE1' HG12 ' A' ' 67' ' ' ILE . 82.9 t80 -56.24 -37.37 69.65 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 122.99 0.516 . . . . 0.29 111.534 -176.699 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 58' ' ' TYR . . . . . 0.537 ' HA ' ' HG3' ' A' ' 62' ' ' PRO . 3.1 m-30 -80.44 -10.03 59.75 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.234 -0.439 . . . . 1.17 111.59 -174.487 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 61.4 p -98.13 -2.38 40.12 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.113 0.482 . . . . 0.44 110.646 176.808 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.47 HD13 ' O ' ' A' ' 56' ' ' ILE . 8.9 mp -97.52 12.59 32.87 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.867 -0.606 . . . . 1.37 110.526 179.439 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 44.6 t 64.32 73.5 0.45 Allowed Pre-proline 0 C--O 1.234 0.259 0 CA-C-N 115.595 -0.73 . . . . 1.24 111.407 -179.216 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 62' ' ' PRO . . . . . 0.537 ' HG3' ' HA ' ' A' ' 58' ' ' TYR . 61.2 Cg_endo -77.26 126.45 8.5 Favored 'Trans proline' 0 C--N 1.347 0.455 0 C-N-CA 122.212 1.942 . . . . 0.47 112.4 178.88 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 15.7 m -109.42 113.1 43.24 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 CA-C-O 121.253 0.549 . . . . 1.02 110.438 177.633 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 95.2 m-20 61.33 34.65 18.35 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 115.617 -0.72 . . . . 1.34 111.178 179.574 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 77.76 21.68 71.15 Favored Glycine 0 C--N 1.331 0.302 0 CA-C-N 115.89 -0.596 . . . . 0.43 112.927 178.243 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 58.4 mttm -141.13 148.96 40.9 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 109.904 -0.406 . . . . 1.48 109.904 -179.015 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 67' ' ' ILE . . . . . 0.497 HG12 ' HE1' ' A' ' 57' ' ' PHE . 36.9 pt -117.5 160.61 16.92 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 N-CA-C 109.915 -0.402 . . . . 0.64 109.915 171.103 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 54.8 p -86.18 170.71 11.91 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 120.921 0.391 . . . . 0.55 110.623 -177.178 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -65.01 -21.13 67.55 Favored Glycine 0 N--CA 1.446 -0.687 0 C-N-CA 120.962 -0.637 . . . . 0.41 112.36 178.687 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.617 ' O ' ' HG3' ' A' ' 74' ' ' LYS . . . -63.23 -52.42 62.26 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 121.027 0.441 . . . . 0.38 111.181 -179.754 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -71.23 -41.68 69.85 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.848 -0.614 . . . . 1.81 109.93 -175.012 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -61.73 -38.07 86.56 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.472 -0.785 . . . . 0.39 110.604 177.2 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 73' ' ' LYS . . . . . 0.636 ' HG3' ' HE1' ' B' ' 151' ' ' PHE . 79.9 tttt -64.41 -43.09 95.49 Favored 'General case' 0 CA--C 1.515 -0.37 0 CA-C-N 116.216 -0.447 . . . . 0.84 110.43 178.462 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 74' ' ' LYS . . . . . 0.617 ' HG3' ' O ' ' A' ' 70' ' ' ALA . 29.1 mtpp -59.33 -44.58 92.59 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.54 0.21 . . . . 1.95 110.472 -179.41 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 14.6 tp10 -61.29 -48.41 81.51 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 116.337 -0.392 . . . . 1.6 110.5 177.283 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 76' ' ' MET . . . . . 0.846 ' HB3' HD22 ' A' ' 86' ' ' LEU . 53.4 mtt -63.55 -33.38 75.46 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.155 0.502 . . . . 1.24 111.289 -179.682 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.487 HG23 ' O ' ' A' ' 73' ' ' LYS . 38.6 t -64.99 -30.8 51.44 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-N 116.123 -0.49 . . . . 1.57 110.087 176.392 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 66.1 mmtt -79.6 -26.81 41.13 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.15 -0.477 . . . . 2.79 111.689 178.906 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 76.9 p -66.14 -14.97 62.7 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 120.867 -0.333 . . . . 1.27 110.501 178.422 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 31.7 mtmm 70.1 18.88 6.94 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-N 115.557 -0.747 . . . . 2.97 111.572 176.135 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.605 ' HB2' HD21 ' A' ' 86' ' ' LEU . 97.0 mt -82.91 144.14 47.4 Favored Pre-proline 0 C--N 1.325 -0.498 0 N-CA-C 109.573 -0.528 . . . . 0.52 109.573 174.363 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 41.2 Cg_exo -57.65 148.07 75.99 Favored 'Trans proline' 0 C--N 1.343 0.245 0 C-N-CA 122.605 2.204 . . . . 0.44 112.369 178.659 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 2.1 m-20 -50.61 -41.82 55.24 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-N 115.852 -0.613 . . . . 1.85 111.293 -179.489 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -57.69 -47.62 81.82 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.942 -0.572 . . . . 1.47 110.878 179.37 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.529 ' O ' HG12 ' A' ' 89' ' ' ILE . 93.8 t -63.2 -37.89 80.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 115.699 -0.682 . . . . 0.45 110.393 -179.761 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.846 HD22 ' HB3' ' A' ' 76' ' ' MET . 75.0 mt -65.73 -36.63 84.14 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.016 -0.538 . . . . 0.9 110.672 179.704 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -65.23 -37.94 94.59 Favored Glycine 0 N--CA 1.449 -0.451 0 N-CA-C 110.857 -0.897 . . . . 0.32 110.857 176.213 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 31.1 mmmt -61.91 -47.43 84.98 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.295 -0.452 . . . . 1.89 109.976 174.739 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 0.529 HG12 ' O ' ' A' ' 85' ' ' VAL . 28.3 mm -58.97 -46.62 91.43 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.18 0 CA-C-N 115.471 -0.786 . . . . 0.71 110.695 179.403 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 52.5 t-105 -60.09 -47.4 86.05 Favored 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 121.076 -0.25 . . . . 0.33 110.915 -179.064 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 37.4 ttmt -62.91 -24.16 67.71 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 116.41 -0.359 . . . . 2.7 111.319 -178.118 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.728 HD11 ' HA ' ' A' ' 124' ' ' ALA . 91.9 mt -93.38 -29.47 15.58 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.443 -0.344 . . . . 1.66 111.51 179.903 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -85.94 -41.39 14.96 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.58 -0.282 . . . . 0.47 111.35 -177.315 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 39.8 t0 -84.5 79.34 9.61 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 108.858 -0.793 . . . . 0.79 108.858 177.282 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.509 ' HB ' ' HG2' ' A' ' 135' ' ' LYS . 40.5 t -67.56 -37.51 78.91 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-N 115.292 -0.867 . . . . 0.61 111.056 -171.63 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 40.4 p-10 -83.54 -10.1 58.52 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.934 -0.575 . . . . 0.96 110.973 -178.972 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 92.0 mttt 52.16 72.65 0.38 Allowed 'General case' 0 C--O 1.235 0.338 0 O-C-N 123.839 0.712 . . . . 2.96 110.843 179.789 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 98' ' ' ASP . . . . . 0.418 ' OD2' ' HB2' ' A' ' 100' ' ' LEU . 9.6 p-10 -127.27 9.02 6.64 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 120.916 0.389 . . . . 0.43 110.694 -176.896 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 74.02 0.39 55.96 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.768 -0.729 . . . . 0.44 112.709 177.375 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.418 ' HB2' ' OD2' ' A' ' 98' ' ' ASP . 77.2 mt -128.79 147.41 50.79 Favored 'General case' 0 N--CA 1.446 -0.653 0 N-CA-C 109.417 -0.586 . . . . 1.11 109.417 179.355 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 60.8 mt -105.17 120.1 40.68 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-N 115.992 -0.549 . . . . 0.42 109.912 176.549 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 102' ' ' ASP . . . . . 0.444 ' HB2' ' HG3' ' A' ' 105' ' ' GLU . 9.8 m-20 -69.6 176.96 3.19 Favored 'General case' 0 CA--C 1.511 -0.533 0 N-CA-C 109.613 -0.514 . . . . 1.72 109.613 174.279 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -56.81 -42.7 80.01 Favored 'General case' 0 C--N 1.317 -0.808 0 N-CA-C 109.552 -0.536 . . . . 1.6 109.552 172.967 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 104' ' ' GLU . . . . . 0.522 ' HB3' ' HB3' ' A' ' 132' ' ' PRO . 4.7 mp0 -61.94 -53.34 56.99 Favored 'General case' 0 N--CA 1.461 0.115 0 CA-C-N 115.895 -0.593 . . . . 1.66 111.266 173.946 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 105' ' ' GLU . . . . . 0.444 ' HG3' ' HB2' ' A' ' 102' ' ' ASP . 22.9 mt-10 -67.1 -34.33 77.39 Favored 'General case' 0 C--N 1.327 -0.394 0 C-N-CA 120.947 -0.301 . . . . 0.44 111.471 -169.824 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 106' ' ' PHE . . . . . 0.437 ' CD1' HD11 ' A' ' 67' ' ' ILE . 84.4 t80 -71.29 -40.67 70.72 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 109.94 -0.393 . . . . 0.42 109.94 176.335 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -57.31 -43.08 82.96 Favored 'General case' 0 N--CA 1.454 -0.239 0 CA-C-O 121.107 0.48 . . . . 0.22 110.393 175.698 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 6.3 tt -60.15 -50.6 73.03 Favored 'General case' 0 C--O 1.236 0.353 0 CA-C-N 115.504 -0.771 . . . . 1.33 110.012 178.428 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 109' ' ' ALA . . . . . 0.466 ' O ' HG13 ' A' ' 113' ' ' ILE . . . -57.93 -45.38 86.64 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.108 -0.496 . . . . 0.32 110.834 179.245 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 1.8 t30 -62.77 -34.12 76.58 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.04 -0.527 . . . . 1.2 110.674 -179.71 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 2.3 t60 -70.07 -35.85 74.52 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.197 -0.456 . . . . 0.52 110.358 179.712 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 63.1 mt -68.65 -40.36 80.28 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.16 -0.473 . . . . 0.55 110.077 176.597 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.466 HG13 ' O ' ' A' ' 109' ' ' ALA . 69.3 mt -57.58 -41.9 80.07 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.141 0 CA-C-N 115.959 -0.564 . . . . 0.84 109.636 174.512 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 114' ' ' LYS . . . . . 0.685 ' O ' ' HG2' ' A' ' 118' ' ' GLU . 2.4 mmmt -58.08 -49.04 78.3 Favored 'General case' 0 C--O 1.22 -0.464 0 CA-C-N 115.406 -0.816 . . . . 3.83 110.551 177.335 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 115' ' ' VAL . . . . . 0.58 HG13 ' HB2' ' A' ' 120' ' ' HIS . 68.2 t -53.6 -40.86 43.9 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 O-C-N 123.408 0.443 . . . . 1.19 111.604 177.63 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 116' ' ' LYS . . . . . 0.41 ' HA ' ' HD3' ' A' ' 116' ' ' LYS . 42.0 mmtt -70.16 -33.54 71.9 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 111.857 0.318 . . . . 1.32 111.857 178.604 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 98.0 mt -71.38 -30.39 66.08 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.185 0.516 . . . . 0.96 110.058 175.414 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 118' ' ' GLU . . . . . 0.685 ' HG2' ' O ' ' A' ' 114' ' ' LYS . 22.1 mm-40 -67.71 -25.9 65.89 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.345 -0.843 . . . . 2.18 110.127 176.077 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 91.91 35.17 6.89 Favored Glycine 0 N--CA 1.447 -0.573 0 C-N-CA 120.593 -0.813 . . . . 1.16 111.927 -176.65 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 120' ' ' HIS . . . . . 0.58 ' HB2' HG13 ' A' ' 115' ' ' VAL . 54.5 m80 -119.51 164.82 15.22 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 109.91 -0.404 . . . . 2.42 109.91 177.955 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 42.3 mm-40 -110.59 161.87 15.28 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 116.329 -0.396 . . . . 2.53 110.882 -174.628 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 122' ' ' LEU . . . . . 0.513 ' H ' HD23 ' A' ' 122' ' ' LEU . 1.7 pt? -124.96 135.44 26.78 Favored Pre-proline 0 C--N 1.323 -0.553 0 CA-C-N 115.795 -0.638 . . . . 1.33 109.492 176.331 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 62.9 Cg_endo -74.33 -1.76 11.43 Favored 'Trans proline' 0 CA--C 1.53 0.279 0 C-N-CA 122.877 2.385 . . . . 1.33 113.557 -175.455 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 124' ' ' ALA . . . . . 0.728 ' HA ' HD11 ' A' ' 92' ' ' LEU . . . 68.97 18.89 8.35 Favored 'General case' 0 N--CA 1.467 0.38 0 C-N-CA 123.04 0.536 . . . . 1.25 110.769 -175.781 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -117.95 156.57 28.27 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.396 -0.82 . . . . 2.73 109.231 174.765 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 126' ' ' LEU . . . . . 0.51 HD21 ' HB3' ' A' ' 92' ' ' LEU . 90.8 mt -108.97 104.8 55.92 Favored Pre-proline 0 C--N 1.323 -0.566 0 CA-C-O 120.705 0.288 . . . . 1.66 111.629 -176.858 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 127' ' ' PRO . . . . . 0.53 ' HD2' HD12 ' A' ' 130' ' ' LEU . 51.5 Cg_exo -54.81 146.72 54.42 Favored 'Trans proline' 0 C--O 1.235 0.356 0 C-N-CA 123.015 2.477 . . . . 1.17 111.782 172.023 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 41.3 Cg_endo -67.14 3.14 1.76 Allowed 'Trans proline' 0 N--CA 1.475 0.426 0 C-N-CA 123.24 2.627 . . . . 1.54 114.258 -174.228 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 27.5 p-80 -117.16 7.51 13.02 Favored 'General case' 0 C--N 1.327 -0.382 0 C-N-CA 120.737 -0.385 . . . . 1.07 110.577 177.877 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 130' ' ' LEU . . . . . 0.53 HD12 ' HD2' ' A' ' 127' ' ' PRO . 23.4 mt -108.08 0.99 22.03 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.833 0.349 . . . . 1.36 111.345 178.785 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 3.5 m -77.31 121.06 83.94 Favored Pre-proline 0 C--N 1.322 -0.613 0 CA-C-N 116.373 -0.376 . . . . 1.28 110.401 173.825 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 132' ' ' PRO . . . . . 0.522 ' HB3' ' HB3' ' A' ' 104' ' ' GLU . 51.4 Cg_exo -53.29 148.64 31.87 Favored 'Trans proline' 0 C--N 1.342 0.205 0 C-N-CA 122.944 2.43 . . . . 0.81 112.094 -179.404 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 133' ' ' PRO . . . . . 0.484 ' HD2' ' HG2' ' A' ' 104' ' ' GLU . 52.3 Cg_exo -55.27 -26.61 52.99 Favored 'Trans proline' 0 C--N 1.344 0.311 0 C-N-CA 122.816 2.344 . . . . 1.17 112.554 -178.61 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 5.9 p -89.71 -13.05 37.71 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.113 -0.494 . . . . 1.6 111.74 -179.32 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 135' ' ' LYS . . . . . 0.509 ' HG2' ' HB ' ' A' ' 95' ' ' VAL . 13.6 mptt . . . . . 0 N--CA 1.464 0.228 0 N-CA-C 111.967 0.358 . . . . 1.21 111.967 -177.746 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 149' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.617 0 N-CA-C 112.081 -0.408 . . . . 0.48 112.081 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' B' B ' 150' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -72.5 -2.25 11.49 Favored 'Trans proline' 0 C--O 1.235 0.345 0 C-N-CA 122.797 2.331 . . . . 0.33 112.238 -179.188 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 151' ' ' PHE . . . . . 0.636 ' HE1' ' HG3' ' A' ' 73' ' ' LYS . 49.3 m-85 . . . . . 0 C--N 1.326 -0.42 0 CA-C-N 116.006 -0.543 . . . . 0.75 111.236 -179.093 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 50.7 mt-10 . . . . . 0 N--CA 1.451 -0.392 0 N-CA-C 109.147 -0.686 . . . . 3.1 109.147 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 1.5 t90 -71.16 107.61 4.27 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 109.444 -0.576 . . . . 0.71 109.444 -176.375 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 31.2 m -66.48 -0.65 0.96 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 115.84 -0.618 . . . . 1.45 111.945 -177.444 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.416 HG13 ' HB2' ' A' ' 111' ' ' HIS . 46.5 t -97.73 -24.08 4.45 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-O 121.219 0.533 . . . . 1.1 109.788 173.875 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 47' ' ' GLY . . . . . 0.785 ' HA2' ' HG2' ' A' ' 50' ' ' LYS . . . -73.25 -21.21 79.89 Favored Glycine 0 N--CA 1.45 -0.39 0 CA-C-N 115.81 -0.632 . . . . 0.59 112.345 -178.483 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 48' ' ' LYS . . . . . 0.426 ' HB2' ' HE3' ' A' ' 48' ' ' LYS . 12.3 ptmt -75.13 -25.06 58.15 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 120.863 0.363 . . . . 2.46 110.633 178.847 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -102.67 31.87 3.91 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.205 -0.452 . . . . 1.66 110.004 176.694 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 50' ' ' LYS . . . . . 0.785 ' HG2' ' HA2' ' A' ' 47' ' ' GLY . 8.1 mmmm -72.82 -50.65 7.11 Favored Pre-proline 0 C--O 1.216 -0.673 0 CA-C-O 118.53 -0.747 . . . . 1.15 112.253 -178.293 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 51' ' ' PRO . . . . . 0.58 ' HD2' ' N ' ' A' ' 50' ' ' LYS . 1.4 Cg_endo -44.05 -42.01 12.66 Favored 'Trans proline' 0 C--N 1.36 1.181 0 C-N-CA 122.845 2.363 . . . . 0.75 112.593 -177.397 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 9.5 m -69.73 -45.4 68.24 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.952 -0.567 . . . . 0.68 111.119 179.67 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 53' ' ' TYR . . . . . 0.48 ' OH ' ' HA ' ' A' ' 111' ' ' HIS . 12.1 m-30 -76.35 -22.69 54.57 Favored 'General case' 0 C--O 1.219 -0.535 0 CA-C-N 116.486 -0.324 . . . . 0.69 110.607 -175.178 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -73.74 -45.05 54.37 Favored 'General case' 0 C--O 1.237 0.425 0 N-CA-C 108.68 -0.859 . . . . 2.18 108.68 175.418 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 2.2 tp10 -53.61 -42.26 67.53 Favored 'General case' 0 N--CA 1.455 -0.186 0 CA-C-N 114.675 -1.148 . . . . 2.33 110.495 178.2 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 66.1 mt -80.37 -47.09 21.33 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-N 115.668 -0.696 . . . . 0.64 111.341 -179.134 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 57' ' ' PHE . . . . . 0.508 ' HE1' HG12 ' A' ' 67' ' ' ILE . 86.3 t80 -52.31 -37.2 55.2 Favored 'General case' 0 N--CA 1.468 0.457 0 C-N-CA 122.982 0.513 . . . . 0.29 112.024 -176.076 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 58' ' ' TYR . . . . . 0.586 ' HA ' ' HG3' ' A' ' 62' ' ' PRO . 18.5 m-30 -77.24 -17.8 58.16 Favored 'General case' 0 C--N 1.326 -0.424 0 C-N-CA 120.743 -0.383 . . . . 1.17 111.421 -174.485 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 41.0 p -85.83 -7.5 58.69 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.283 0.563 . . . . 0.44 110.386 -179.497 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 11.1 mp -95.47 19.16 11.35 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.58 -0.737 . . . . 1.37 110.327 179.16 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 12.7 p 49.61 81.46 0.26 Allowed Pre-proline 0 N--CA 1.465 0.317 0 CA-C-N 115.558 -0.746 . . . . 1.24 111.836 -177.515 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 62' ' ' PRO . . . . . 0.586 ' HG3' ' HA ' ' A' ' 58' ' ' TYR . 72.6 Cg_endo -84.85 116.9 1.91 Allowed 'Trans proline' 0 N--CA 1.455 -0.767 0 C-N-CA 122.659 2.239 . . . . 0.47 112.555 -177.744 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 18.7 m -88.76 113.46 25.53 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 CA-C-O 121.26 0.553 . . . . 1.02 110.134 178.011 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 75.8 m-20 62.98 28.52 16.3 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 115.485 -0.78 . . . . 1.34 111.472 179.4 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 82.01 22.98 58.38 Favored Glycine 0 N--CA 1.454 -0.146 0 C-N-CA 121.072 -0.585 . . . . 0.43 112.326 179.404 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 66' ' ' LYS . . . . . 0.539 ' HG2' ' HA ' ' A' ' 102' ' ' ASP . 26.8 mtpp -143.28 141.05 30.9 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 109.417 -0.586 . . . . 1.48 109.417 -177.886 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 67' ' ' ILE . . . . . 0.508 HG12 ' HE1' ' A' ' 57' ' ' PHE . 36.6 pt -108.66 154.77 9.86 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.812 0 CA-C-O 121.184 0.516 . . . . 0.64 110.975 178.456 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 68' ' ' THR . . . . . 0.52 ' HA ' ' CD2' ' A' ' 100' ' ' LEU . 32.2 p -77.6 161.28 27.95 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.171 -0.922 . . . . 0.55 111.082 -179.474 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -63.6 -22.52 66.03 Favored Glycine 0 N--CA 1.444 -0.78 0 C-N-CA 121.05 -0.595 . . . . 0.41 111.796 179.179 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -61.48 -47.52 85.29 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.898 0.38 . . . . 0.38 111.663 178.367 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 46.1 m-80 -81.29 -31.86 33.44 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.176 -0.465 . . . . 1.81 110.976 -175.804 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 72' ' ' ALA . . . . . 0.519 ' O ' ' HG2' ' A' ' 76' ' ' MET . . . -63.79 -45.21 90.73 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 109.378 -0.601 . . . . 0.39 109.378 173.283 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 60.5 tttp -57.03 -37.9 72.4 Favored 'General case' 0 CA--C 1.52 -0.178 0 CA-C-N 115.24 -0.891 . . . . 0.84 109.889 175.95 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 74' ' ' LYS . . . . . 0.415 ' O ' ' HG2' ' A' ' 78' ' ' LYS . 9.0 tptm -57.28 -57.05 14.32 Favored 'General case' 0 N--CA 1.453 -0.298 0 CA-C-N 115.41 -0.814 . . . . 1.95 110.509 177.968 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 75' ' ' GLU . . . . . 0.583 ' HA ' ' HG3' ' A' ' 78' ' ' LYS . 5.4 tp10 -64.61 -39.46 93.77 Favored 'General case' 0 C--O 1.237 0.434 0 CA-C-O 121.218 0.532 . . . . 1.6 110.966 -177.168 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 76' ' ' MET . . . . . 0.638 ' HB3' HD22 ' A' ' 86' ' ' LEU . 96.3 mmm -64.91 -29.39 70.33 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.179 0.514 . . . . 1.24 109.882 178.775 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -75.04 -28.32 20.79 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 CA-C-N 115.985 -0.552 . . . . 1.57 110.086 175.672 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.583 ' HG3' ' HA ' ' A' ' 75' ' ' GLU . 3.1 mmmm -68.86 -27.76 66.1 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.802 -0.635 . . . . 2.79 111.211 177.015 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 78.5 p -73.11 -15.67 61.48 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.32 -0.4 . . . . 1.27 111.643 -176.558 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 75.0 mmtt 66.75 16.43 10.38 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-N 115.9 -0.591 . . . . 2.97 111.385 178.98 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.426 ' HB2' HD21 ' A' ' 86' ' ' LEU . 93.0 mt -83.82 150.3 58.72 Favored Pre-proline 0 C--N 1.327 -0.374 0 CA-C-N 116.483 -0.326 . . . . 0.52 111.032 -179.633 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 82' ' ' PRO . . . . . 0.536 ' O ' ' HG ' ' A' ' 86' ' ' LEU . 51.2 Cg_exo -55.34 148.15 52.75 Favored 'Trans proline' 0 C--N 1.349 0.601 0 C-N-CA 123.113 2.542 . . . . 0.44 112.698 179.47 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 82.7 m-20 -61.43 -36.12 79.48 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.939 -0.573 . . . . 1.85 111.448 -174.109 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 15.0 t -66.03 -35.23 79.98 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.949 0.404 . . . . 1.47 110.254 179.243 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 57.4 t -72.29 -37.3 58.18 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.313 0 N-CA-C 109.68 -0.489 . . . . 0.45 109.68 178.905 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.638 HD22 ' HB3' ' A' ' 76' ' ' MET . 62.1 mt -61.48 -39.72 91.94 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.883 -0.599 . . . . 0.9 109.93 176.587 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -67.19 -39.93 92.45 Favored Glycine 0 N--CA 1.45 -0.378 0 N-CA-C 111.672 -0.571 . . . . 0.32 111.672 177.29 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 88' ' ' LYS . . . . . 0.437 ' O ' ' HG ' ' A' ' 92' ' ' LEU . 29.9 mmmt -58.06 -47.92 81.68 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.996 0.427 . . . . 1.89 110.67 175.69 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 0.774 HG23 HD12 ' A' ' 112' ' ' LEU . 74.9 mt -65.27 -40.35 88.32 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 115.811 -0.632 . . . . 0.71 110.926 -177.785 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 39.0 t-105 -61.79 -45.16 95.08 Favored 'General case' 0 C--N 1.334 -0.083 0 N-CA-C 110.053 -0.351 . . . . 0.33 110.053 175.392 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 4.9 tppp? -58.19 -28.15 64.53 Favored 'General case' 0 CA--C 1.531 0.232 0 CA-C-N 115.686 -0.688 . . . . 2.7 111.561 -179.554 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.437 ' HG ' ' O ' ' A' ' 88' ' ' LYS . 73.6 mt -92.39 -36.19 13.28 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.708 0.289 . . . . 1.66 111.056 179.396 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -75.22 -42.39 55.59 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.372 -0.377 . . . . 0.47 111.404 -175.458 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 45.2 t0 -86.73 75.45 9.64 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.549 0.69 . . . . 0.79 109.446 178.954 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 42.8 t -63.56 -40.54 89.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 114.927 -1.033 . . . . 0.61 111.255 -174.342 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 30.4 p30 -84.39 -7.47 59.29 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.369 -0.378 . . . . 0.96 111.898 -177.838 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 48.0 mtmt 55.86 74.13 0.4 Allowed 'General case' 0 N--CA 1.466 0.369 0 O-C-N 123.503 0.502 . . . . 2.96 111.541 177.904 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 98' ' ' ASP . . . . . 0.456 ' OD2' ' HB2' ' A' ' 100' ' ' LEU . 7.3 p-10 -128.85 9.26 5.83 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.869 0.366 . . . . 0.43 111.068 -177.557 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 69.73 -0.65 19.14 Favored Glycine 0 CA--C 1.522 0.487 0 C-N-CA 121.043 -0.598 . . . . 0.44 113.207 176.538 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.52 ' CD2' ' HA ' ' A' ' 68' ' ' THR . 83.8 mt -129.27 137.37 51.02 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 109.128 -0.693 . . . . 1.11 109.128 177.617 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 72.3 mt -90.62 122.44 33.42 Favored 'General case' 0 C--N 1.312 -1.025 0 C-N-CA 120.3 -0.56 . . . . 0.42 109.839 178.685 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 102' ' ' ASP . . . . . 0.539 ' HA ' ' HG2' ' A' ' 66' ' ' LYS . 23.4 m-20 -69.36 173.97 5.28 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 108.263 -1.014 . . . . 1.72 108.263 173.897 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -55.4 -41.44 72.7 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 121.081 0.467 . . . . 1.6 110.133 173.755 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -72.54 -40.84 66.43 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.96 -0.564 . . . . 1.66 111.406 179.508 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 28.2 mt-10 -70.13 -39.53 75.39 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 120.707 -0.397 . . . . 0.44 111.018 -176.017 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 106' ' ' PHE . . . . . 0.491 ' CD1' HD11 ' A' ' 67' ' ' ILE . 81.9 t80 -67.07 -37.64 84.37 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 109.952 -0.388 . . . . 0.42 109.952 176.275 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -58.3 -43.91 88.31 Favored 'General case' 0 N--CA 1.452 -0.342 0 CA-C-N 116.147 -0.479 . . . . 0.22 110.406 175.885 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 6.3 tt -60.35 -48.11 83.17 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.154 -0.476 . . . . 1.33 110.098 178.779 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -58.53 -49.47 77.29 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.082 -0.508 . . . . 0.32 110.943 179.063 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 1.7 m-20 -63.57 -31.42 72.58 Favored 'General case' 0 CA--C 1.519 -0.245 0 CA-C-N 115.915 -0.584 . . . . 1.2 111.201 179.737 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 111' ' ' HIS . . . . . 0.48 ' HA ' ' OH ' ' A' ' 53' ' ' TYR . 32.0 t60 -66.93 -40.57 87.65 Favored 'General case' 0 N--CA 1.453 -0.302 0 N-CA-C 109.952 -0.388 . . . . 0.52 109.952 179.388 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 0.774 HD12 HG23 ' A' ' 89' ' ' ILE . 98.3 mt -65.29 -39.54 92.66 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.658 -0.246 . . . . 0.55 110.448 177.519 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.526 HD11 ' SD ' ' A' ' 76' ' ' MET . 61.2 mt -60.3 -52.35 62.42 Favored 'Isoleucine or valine' 0 C--O 1.233 0.219 0 CA-C-O 121.104 0.478 . . . . 0.84 110.192 175.424 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 114' ' ' LYS . . . . . 0.546 ' O ' ' HB2' ' A' ' 118' ' ' GLU . 0.4 OUTLIER -65.02 -39.45 93.4 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.492 -0.776 . . . . 3.83 111.075 -174.804 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 115' ' ' VAL . . . . . 0.401 HG23 ' O ' ' A' ' 111' ' ' HIS . 51.7 t -69.73 -45.03 78.67 Favored 'Isoleucine or valine' 0 C--O 1.234 0.248 0 CA-C-N 116.639 -0.255 . . . . 1.19 111.567 -178.032 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 35.8 tptt -60.52 -45.76 92.64 Favored 'General case' 0 N--CA 1.454 -0.267 0 CA-C-O 120.981 0.42 . . . . 1.32 110.676 176.92 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 94.4 mt -74.34 -16.06 60.92 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.306 -0.406 . . . . 0.96 111.208 -179.4 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 118' ' ' GLU . . . . . 0.657 ' HB3' ' HD2' ' A' ' 120' ' ' HIS . 22.6 tt0 -80.02 0.89 29.82 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.914 -0.584 . . . . 2.18 109.664 176.22 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 91.81 15.76 53.59 Favored Glycine 0 N--CA 1.451 -0.319 0 CA-C-N 115.839 -0.619 . . . . 1.16 112.834 175.378 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 120' ' ' HIS . . . . . 0.657 ' HD2' ' HB3' ' A' ' 118' ' ' GLU . 61.6 m-70 -106.08 160.3 15.41 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 110.095 -0.335 . . . . 2.42 110.095 179.903 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 8.0 tp10 -96.63 149.25 22.0 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 121.001 0.429 . . . . 2.53 110.377 179.275 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 122' ' ' LEU . . . . . 0.434 HD12 ' O ' ' A' ' 122' ' ' LEU . 2.4 pp -114.06 143.67 30.11 Favored Pre-proline 0 C--N 1.321 -0.645 0 CA-C-N 115.92 -0.582 . . . . 1.33 109.767 177.304 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 63.1 Cg_endo -74.09 -12.03 23.43 Favored 'Trans proline' 0 N--CA 1.465 -0.166 0 C-N-CA 122.298 1.998 . . . . 1.33 113.036 -176.372 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . 62.92 18.07 10.53 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-N 115.823 -0.626 . . . . 1.25 110.337 -175.029 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -134.01 176.09 8.89 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.045 -0.98 . . . . 2.73 108.61 175.773 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 126' ' ' LEU . . . . . 0.469 ' HA ' ' HD2' ' A' ' 127' ' ' PRO . 4.2 tt -113.06 100.37 51.15 Favored Pre-proline 0 C--N 1.322 -0.61 0 C-N-CA 120.786 -0.365 . . . . 1.66 110.542 -178.062 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 127' ' ' PRO . . . . . 0.755 ' HG2' ' HB2' ' A' ' 130' ' ' LEU . 19.5 Cg_endo -58.98 151.17 67.7 Favored 'Trans proline' 0 C--N 1.347 0.496 0 C-N-CA 123.435 2.757 . . . . 1.17 112.645 176.624 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -58.38 -28.63 85.65 Favored 'Trans proline' 0 C--N 1.346 0.446 0 C-N-CA 123.329 2.686 . . . . 1.54 113.315 -175.608 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 9.7 p80 -91.34 4.9 51.25 Favored 'General case' 0 C--N 1.329 -0.316 0 C-N-CA 120.836 -0.346 . . . . 1.07 111.226 -178.512 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 130' ' ' LEU . . . . . 0.755 ' HB2' ' HG2' ' A' ' 127' ' ' PRO . 41.7 tp -104.65 -2.95 24.35 Favored 'General case' 0 N--CA 1.444 -0.75 0 CA-C-O 121.185 0.517 . . . . 1.36 110.248 -177.121 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 131' ' ' VAL . . . . . 0.445 ' HA ' ' HD2' ' A' ' 132' ' ' PRO . 29.9 t -72.84 125.99 90.85 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 115.779 -0.646 . . . . 1.28 109.907 177.562 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 132' ' ' PRO . . . . . 0.445 ' HD2' ' HA ' ' A' ' 131' ' ' VAL . 3.8 Cg_endo -47.69 136.02 21.76 Favored 'Trans proline' 0 C--O 1.236 0.414 0 C-N-CA 123.074 2.516 . . . . 0.81 111.797 176.653 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 23.6 Cg_endo -60.81 -15.34 37.34 Favored 'Trans proline' 0 C--N 1.343 0.288 0 C-N-CA 123.222 2.615 . . . . 1.17 112.633 -174.525 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 19.7 p -90.35 -21.63 21.9 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.166 -0.47 . . . . 1.6 111.366 -179.451 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 62.8 mttt . . . . . 0 C--N 1.327 -0.404 0 CA-C-O 120.782 0.325 . . . . 1.21 111.555 -172.23 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' B' B ' 149' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.445 -0.726 0 N-CA-C 111.712 -0.555 . . . . 0.48 111.712 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' B' B ' 150' ' ' PRO . . . . . . . . . . . . . 91.8 Cg_endo -80.85 -1.52 11.28 Favored 'Trans proline' 0 CA--C 1.532 0.424 0 C-N-CA 123.176 2.584 . . . . 0.33 112.571 -178.631 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 151' ' ' PHE . . . . . 0.571 ' CZ ' ' HG3' ' A' ' 76' ' ' MET . 37.8 m-85 . . . . . 0 C--N 1.329 -0.314 0 CA-C-N 115.996 -0.547 . . . . 0.75 111.327 -178.388 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 16.8 pt-20 . . . . . 0 C--O 1.235 0.296 0 CA-C-O 121.214 0.53 . . . . 3.1 111.386 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 44' ' ' TRP . . . . . 0.433 ' HH2' ' O ' ' A' ' 104' ' ' GLU . 1.3 t90 -86.07 105.15 16.3 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 109.495 -0.557 . . . . 0.71 109.495 -178.612 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 23.6 m -64.82 -11.33 11.01 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.335 0 CA-C-O 121.034 0.445 . . . . 1.45 111.961 -177.292 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.473 HG13 ' HB2' ' A' ' 111' ' ' HIS . 42.1 t -82.04 -16.43 11.89 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 CA-C-O 121.31 0.576 . . . . 1.1 110.261 177.331 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 47' ' ' GLY . . . . . 0.53 ' HA2' ' HB2' ' A' ' 50' ' ' LYS . . . -74.25 -11.17 82.07 Favored Glycine 0 N--CA 1.446 -0.638 0 CA-C-N 115.684 -0.689 . . . . 0.59 112.701 -178.68 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 17.2 pttt -82.95 -28.44 29.82 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 120.347 -0.541 . . . . 2.46 109.978 -179.041 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 12.9 m-20 -106.77 30.75 5.83 Favored 'General case' 0 CA--C 1.509 -0.622 0 N-CA-C 108.593 -0.892 . . . . 1.66 108.593 176.972 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 50' ' ' LYS . . . . . 0.598 ' H ' ' HD2' ' A' ' 51' ' ' PRO . 15.0 tttp -92.0 -52.86 0.28 Allowed Pre-proline 0 C--N 1.317 -0.827 0 N-CA-C 112.521 0.563 . . . . 1.15 112.521 -171.207 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 51' ' ' PRO . . . . . 0.598 ' HD2' ' H ' ' A' ' 50' ' ' LYS . 4.8 Cg_endo -47.03 -39.54 25.46 Favored 'Trans proline' 0 C--N 1.357 0.998 0 C-N-CA 122.738 2.292 . . . . 0.75 112.981 -178.078 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 18.8 m -70.14 -42.77 72.13 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 116.003 -0.544 . . . . 0.68 110.55 -179.485 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 21.3 m-30 -71.74 -22.53 61.6 Favored 'General case' 0 CA--C 1.517 -0.312 0 CA-C-N 116.314 -0.403 . . . . 0.69 110.222 179.558 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 86.8 m-20 -72.96 -36.26 67.09 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.183 -0.462 . . . . 2.18 109.785 176.682 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 55' ' ' GLU . . . . . 0.469 ' HG3' ' O ' ' A' ' 51' ' ' PRO . 48.1 mt-10 -66.12 -40.75 90.93 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.017 -0.538 . . . . 2.33 110.472 176.659 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 44.8 mt -69.39 -37.38 75.25 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-O 121.582 0.706 . . . . 0.64 109.964 175.781 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 57' ' ' PHE . . . . . 0.483 ' HE1' HG12 ' A' ' 67' ' ' ILE . 78.2 t80 -59.62 -36.79 77.03 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.171 -0.922 . . . . 0.29 110.971 176.988 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 58' ' ' TYR . . . . . 0.519 ' HA ' ' HG3' ' A' ' 62' ' ' PRO . 14.2 m-30 -74.35 -23.38 59.01 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.481 -0.327 . . . . 1.17 111.047 -178.689 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 19.0 p -89.76 6.77 40.13 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 120.978 0.418 . . . . 0.44 111.371 -179.15 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 59.9 mt -105.38 5.75 32.04 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.121 -0.49 . . . . 1.37 110.193 173.956 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 19.2 m 66.42 82.7 0.2 Allowed Pre-proline 0 CA--C 1.532 0.276 0 CA-C-N 115.266 -0.879 . . . . 1.24 111.519 178.571 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 62' ' ' PRO . . . . . 0.519 ' HG3' ' HA ' ' A' ' 58' ' ' TYR . 36.7 Cg_endo -93.53 138.51 1.38 Allowed 'Trans proline' 0 N--CA 1.453 -0.885 0 C-N-CA 123.288 2.659 . . . . 0.47 113.162 -178.837 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 18.9 m -119.42 134.06 64.22 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 115.892 -0.595 . . . . 1.02 109.555 174.816 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 83.6 m-20 59.27 30.65 20.43 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-O 121.015 0.436 . . . . 1.34 110.986 -176.859 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 69.92 25.46 75.55 Favored Glycine 0 C--N 1.332 0.339 0 CA-C-N 115.959 -0.564 . . . . 0.43 112.598 178.47 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 66' ' ' LYS . . . . . 0.631 ' HA ' ' HA ' ' A' ' 102' ' ' ASP . 3.0 ptpp? -152.13 145.88 25.07 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.055 0.455 . . . . 1.48 111.425 179.528 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 67' ' ' ILE . . . . . 0.483 HG12 ' HE1' ' A' ' 57' ' ' PHE . 34.3 pt -107.9 142.77 19.73 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-N 116.078 -0.51 . . . . 0.64 109.766 176.887 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 68' ' ' THR . . . . . 0.703 ' HA ' ' HB2' ' A' ' 100' ' ' LEU . 23.2 p -64.51 161.4 17.37 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 116.382 -0.372 . . . . 0.55 110.455 177.638 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -62.3 -12.43 38.44 Favored Glycine 0 N--CA 1.448 -0.548 0 C-N-CA 120.78 -0.724 . . . . 0.41 112.24 -178.634 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.459 ' O ' ' HG3' ' A' ' 74' ' ' LYS . . . -68.16 -50.04 57.09 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.326 0.584 . . . . 0.38 110.63 179.573 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 71' ' ' ASN . . . . . 0.933 ' HA ' ' HE3' ' A' ' 74' ' ' LYS . 35.0 m-80 -72.92 -38.84 66.71 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.564 -0.743 . . . . 1.81 110.32 -177.758 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -61.94 -41.63 98.17 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.69 -0.686 . . . . 0.39 110.097 176.766 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 73' ' ' LYS . . . . . 0.513 ' HG3' ' CE1' ' B' ' 151' ' ' PHE . 86.0 tttt -59.21 -43.06 92.29 Favored 'General case' 0 CA--C 1.519 -0.234 0 CA-C-N 115.964 -0.562 . . . . 0.84 110.216 176.639 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 74' ' ' LYS . . . . . 0.933 ' HE3' ' HA ' ' A' ' 71' ' ' ASN . 8.5 mtmp? -58.24 -42.03 85.45 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-N 116.318 -0.401 . . . . 1.95 111.091 179.114 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 15.4 tp10 -66.74 -44.92 80.24 Favored 'General case' 0 C--O 1.237 0.396 0 CA-C-O 121.476 0.655 . . . . 1.6 110.732 179.154 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 76' ' ' MET . . . . . 0.591 ' HB3' HD22 ' A' ' 86' ' ' LEU . 84.8 mtp -73.11 -21.9 60.66 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.78 -0.645 . . . . 1.24 111.687 -174.423 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.404 HG22 ' O ' ' A' ' 73' ' ' LYS . 34.5 m -86.21 -12.32 11.08 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.455 0 C-N-CA 120.408 -0.517 . . . . 1.57 110.363 171.054 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.75 ' HG2' ' O ' ' A' ' 74' ' ' LYS . 40.6 mmtm -75.78 -26.93 57.78 Favored 'General case' 0 N--CA 1.469 0.498 0 N-CA-C 110.244 -0.28 . . . . 2.79 110.244 170.439 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -72.88 -11.62 60.66 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-O 120.798 0.332 . . . . 1.27 110.39 172.069 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 80' ' ' LYS . . . . . 0.406 ' HG3' ' O ' ' A' ' 78' ' ' LYS . 73.3 mttt 65.38 24.28 12.03 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-N 115.596 -0.729 . . . . 2.97 112.392 169.63 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.627 ' HB2' HD21 ' A' ' 86' ' ' LEU . 91.6 mt -83.77 161.86 54.57 Favored Pre-proline 0 C--N 1.325 -0.483 0 CA-C-N 116.302 -0.408 . . . . 0.52 110.786 179.763 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 82' ' ' PRO . . . . . 0.433 ' O ' ' HG ' ' A' ' 86' ' ' LEU . 52.1 Cg_exo -57.73 142.16 95.87 Favored 'Trans proline' 0 C--N 1.349 0.576 0 C-N-CA 123.073 2.515 . . . . 0.44 112.812 177.558 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 31.4 m-80 -59.03 -43.62 91.65 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 115.769 -0.65 . . . . 1.85 111.636 -175.237 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 2.9 p -63.64 -44.7 93.11 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.055 -0.52 . . . . 1.47 111.113 -179.208 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 60.6 t -64.18 -40.6 89.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 115.872 -0.604 . . . . 0.45 110.241 178.886 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.627 HD21 ' HB2' ' A' ' 81' ' ' LEU . 92.3 mt -59.57 -38.43 81.13 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.178 -0.465 . . . . 0.9 110.764 176.529 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -67.38 -37.61 90.57 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.686 -0.769 . . . . 0.32 112.24 178.386 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.21 -43.3 95.42 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 120.766 -0.374 . . . . 1.89 110.081 174.651 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 20.9 mt -62.37 -35.07 67.69 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.312 0 CA-C-N 116.07 -0.513 . . . . 0.71 110.387 175.831 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 71.4 t-105 -57.44 -53.93 52.59 Favored 'General case' 0 N--CA 1.452 -0.342 0 CA-C-O 120.561 0.219 . . . . 0.33 110.623 175.739 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 91' ' ' LYS . . . . . 0.819 ' HA ' ' HE2' ' A' ' 91' ' ' LYS . 0.6 OUTLIER -69.3 -15.57 63.37 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.989 0.423 . . . . 2.7 111.1 -176.989 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.42 HD22 ' HA ' ' A' ' 124' ' ' ALA . 14.8 tp -88.4 -32.06 18.53 Favored 'General case' 0 N--CA 1.437 -1.09 0 CA-C-O 120.89 0.376 . . . . 1.66 110.006 178.2 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 93' ' ' ALA . . . . . 0.761 ' HA ' HD12 ' A' ' 108' ' ' LEU . . . -87.89 -42.99 12.13 Favored 'General case' 0 C--O 1.232 0.184 0 CA-C-N 116.451 -0.34 . . . . 0.47 111.583 -179.571 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 94' ' ' ASP . . . . . 0.561 ' OD2' ' HA ' ' A' ' 97' ' ' LYS . 28.1 t0 -82.81 99.9 9.98 Favored 'General case' 0 C--O 1.236 0.376 0 CA-C-O 121.555 0.693 . . . . 0.79 110.029 179.667 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 45.3 t -83.09 -43.42 18.4 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.739 0 CA-C-N 115.282 -0.872 . . . . 0.61 110.883 -174.512 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 34.6 p-10 -82.63 -10.44 58.95 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.961 -0.563 . . . . 0.96 111.779 -173.666 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 97' ' ' LYS . . . . . 0.561 ' HA ' ' OD2' ' A' ' 94' ' ' ASP . 42.7 mtpt 57.91 73.0 0.49 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.402 0.62 . . . . 2.96 111.922 178.951 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 98' ' ' ASP . . . . . 0.491 ' OD2' ' HG ' ' A' ' 100' ' ' LEU . 16.9 p-10 -121.64 9.98 10.28 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 115.395 -0.82 . . . . 0.43 110.196 176.334 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 64.2 18.05 62.27 Favored Glycine 0 C--N 1.333 0.401 0 CA-C-N 115.713 -0.676 . . . . 0.44 112.208 177.706 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.703 ' HB2' ' HA ' ' A' ' 68' ' ' THR . 1.7 pp -155.02 166.32 33.95 Favored 'General case' 0 N--CA 1.444 -0.748 0 N-CA-C 108.468 -0.938 . . . . 1.11 108.468 -179.373 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 87.6 mt -126.44 123.66 38.36 Favored 'General case' 0 C--N 1.322 -0.615 0 C-N-CA 120.832 -0.347 . . . . 0.42 111.228 -173.581 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 102' ' ' ASP . . . . . 0.631 ' HA ' ' HA ' ' A' ' 66' ' ' LYS . 2.3 p30 -79.75 -177.1 5.73 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 109.31 -0.626 . . . . 1.72 109.31 170.906 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 3.1 p30 -62.12 -29.39 70.3 Favored 'General case' 0 C--N 1.322 -0.63 0 C-N-CA 120.905 -0.318 . . . . 1.6 111.503 -174.694 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 104' ' ' GLU . . . . . 0.515 ' HB3' ' HB3' ' A' ' 132' ' ' PRO . 78.3 mt-10 -70.97 -56.24 6.62 Favored 'General case' 0 C--O 1.232 0.178 0 N-CA-C 109.823 -0.436 . . . . 1.66 109.823 177.545 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 25.3 mt-10 -65.52 -33.33 75.68 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.838 -0.619 . . . . 0.44 110.977 -174.645 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 90.8 t80 -69.23 -42.96 74.99 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.53 -0.305 . . . . 0.42 110.235 178.13 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -59.95 -39.15 84.6 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-O 121.121 0.486 . . . . 0.22 110.092 176.35 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.761 HD12 ' HA ' ' A' ' 93' ' ' ALA . 2.5 tm? -59.99 -51.69 68.6 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.625 -0.716 . . . . 1.33 109.492 176.862 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 109' ' ' ALA . . . . . 0.429 ' O ' HG13 ' A' ' 113' ' ' ILE . . . -57.61 -45.37 85.43 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 115.965 -0.562 . . . . 0.32 111.62 179.456 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 5.0 m-20 -69.38 -30.99 69.1 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.741 0.305 . . . . 1.2 111.244 -178.588 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 111' ' ' HIS . . . . . 0.473 ' HB2' HG13 ' A' ' 46' ' ' VAL . 30.3 t60 -64.55 -35.15 80.04 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 108.862 -0.792 . . . . 0.52 108.862 175.426 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 0.498 ' HA ' HG12 ' A' ' 115' ' ' VAL . 74.8 mt -71.18 -42.63 68.79 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.399 -0.818 . . . . 0.55 110.797 177.303 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.429 HG13 ' O ' ' A' ' 109' ' ' ALA . 24.6 mt -55.52 -50.28 67.51 Favored 'Isoleucine or valine' 0 C--O 1.234 0.26 0 CA-C-O 121.209 0.528 . . . . 0.84 110.44 177.859 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 37.3 ttpt -69.95 -45.4 67.51 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.729 -0.669 . . . . 3.83 110.997 -175.417 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 115' ' ' VAL . . . . . 0.498 HG12 ' HA ' ' A' ' 112' ' ' LEU . 5.8 p -63.48 -30.61 50.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 120.95 0.405 . . . . 1.19 110.207 -178.557 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 116' ' ' LYS . . . . . 0.477 ' HD2' ' O ' ' A' ' 120' ' ' HIS . 34.6 tptt -69.28 -45.81 68.72 Favored 'General case' 0 N--CA 1.447 -0.61 0 CA-C-N 116.204 -0.453 . . . . 1.32 110.513 176.786 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 93.9 mt -74.56 -16.28 60.82 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.11 -0.496 . . . . 0.96 111.305 -179.198 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -84.47 6.05 25.0 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.594 0.711 . . . . 2.18 109.35 176.52 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 90.34 33.92 8.39 Favored Glycine 0 CA--C 1.518 0.272 0 CA-C-N 115.47 -0.786 . . . . 1.16 113.927 172.666 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 120' ' ' HIS . . . . . 0.477 ' O ' ' HD2' ' A' ' 116' ' ' LYS . 33.4 m-70 -112.62 155.36 24.55 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 117.04 0.42 . . . . 2.42 110.341 175.044 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 7.4 tp10 -111.52 127.98 55.88 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 109.864 -0.421 . . . . 2.53 109.864 179.167 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 122' ' ' LEU . . . . . 0.436 ' H ' ' HG ' ' A' ' 122' ' ' LEU . 2.4 pp -92.86 136.92 24.27 Favored Pre-proline 0 C--N 1.321 -0.637 0 CA-C-O 121.108 0.48 . . . . 1.33 111.761 -174.844 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_endo -73.42 -20.74 20.53 Favored 'Trans proline' 0 C--O 1.234 0.294 0 C-N-CA 123.147 2.564 . . . . 1.33 112.423 179.266 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 124' ' ' ALA . . . . . 0.42 ' HA ' HD22 ' A' ' 92' ' ' LEU . . . 66.78 18.26 10.66 Favored 'General case' 0 N--CA 1.462 0.138 0 CA-C-N 115.297 -0.865 . . . . 1.25 110.092 -172.712 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 29.0 m-20 -106.14 159.74 15.85 Favored 'General case' 0 CA--C 1.516 -0.341 0 N-CA-C 108.015 -1.105 . . . . 2.73 108.015 172.445 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 126' ' ' LEU . . . . . 0.455 ' HA ' ' HD2' ' A' ' 127' ' ' PRO . 49.2 tp -114.44 91.98 26.44 Favored Pre-proline 0 C--N 1.322 -0.601 0 C-N-CA 120.609 -0.436 . . . . 1.66 111.713 -176.982 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 127' ' ' PRO . . . . . 0.458 ' HA ' ' HD3' ' A' ' 128' ' ' PRO . 10.9 Cg_endo -58.5 146.45 90.64 Favored 'Trans proline' 0 CA--C 1.535 0.548 0 C-N-CA 122.836 2.357 . . . . 1.17 112.138 171.883 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 128' ' ' PRO . . . . . 0.458 ' HD3' ' HA ' ' A' ' 127' ' ' PRO . 76.0 Cg_exo -51.77 -39.47 67.28 Favored 'Trans proline' 0 C--N 1.346 0.435 0 C-N-CA 123.842 3.028 . . . . 1.54 114.27 -175.31 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 41.6 p-80 -79.0 13.67 1.68 Allowed 'General case' 0 N--CA 1.469 0.513 0 N-CA-C 112.463 0.542 . . . . 1.07 112.463 -175.368 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 41.3 mt -111.8 4.21 18.25 Favored 'General case' 0 C--N 1.324 -0.501 0 C-N-CA 121.181 -0.208 . . . . 1.36 111.131 175.198 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 93.8 t -75.27 126.57 87.68 Favored Pre-proline 0 C--N 1.327 -0.37 0 CA-C-O 120.694 0.283 . . . . 1.28 110.923 -179.788 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 132' ' ' PRO . . . . . 0.515 ' HB3' ' HB3' ' A' ' 104' ' ' GLU . 54.4 Cg_exo -54.88 154.61 20.79 Favored 'Trans proline' 0 CA--C 1.533 0.455 0 C-N-CA 123.472 2.781 . . . . 0.81 113.316 -179.583 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -54.84 -54.55 4.3 Favored 'Trans proline' 0 C--N 1.347 0.468 0 C-N-CA 123.516 2.811 . . . . 1.17 113.987 -175.979 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 72.6 p -84.87 8.04 18.82 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 120.676 -0.41 . . . . 1.6 111.536 -175.464 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 135' ' ' LYS . . . . . 0.496 ' HD2' ' HG2' ' A' ' 132' ' ' PRO . 61.5 mttp . . . . . 0 C--N 1.329 -0.3 0 N-CA-C 111.876 0.324 . . . . 1.21 111.876 -177.411 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 149' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.443 -0.86 0 N-CA-C 111.277 -0.729 . . . . 0.48 111.277 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' B' B ' 150' ' ' PRO . . . . . . . . . . . . . 76.0 Cg_endo -74.77 -8.13 20.01 Favored 'Trans proline' 0 N--CA 1.463 -0.28 0 C-N-CA 122.448 2.099 . . . . 0.33 111.351 -179.187 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 151' ' ' PHE . . . . . 0.513 ' CE1' ' HG3' ' A' ' 73' ' ' LYS . 48.7 m-85 . . . . . 0 C--N 1.327 -0.381 0 CA-C-N 115.904 -0.589 . . . . 0.75 110.952 179.245 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 . . . . . 0 C--O 1.234 0.259 0 N-CA-C 109.404 -0.591 . . . . 3.1 109.404 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 44' ' ' TRP . . . . . 0.486 ' HH2' ' O ' ' A' ' 104' ' ' GLU . 3.2 t90 -85.6 109.41 18.53 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 120.967 0.413 . . . . 0.71 110.095 -178.034 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 11.7 p -63.12 -17.62 19.91 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.433 0 CA-C-N 115.671 -0.695 . . . . 1.45 111.909 -175.822 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.4 HG11 ' HA ' ' A' ' 108' ' ' LEU . 46.9 t -82.06 -22.25 9.79 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-O 121.151 0.5 . . . . 1.1 110.425 179.105 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 47' ' ' GLY . . . . . 0.711 ' HA2' ' HG3' ' A' ' 50' ' ' LYS . . . -73.31 -11.91 79.74 Favored Glycine 0 CA--C 1.517 0.161 0 CA-C-N 115.739 -0.664 . . . . 0.59 113.481 -173.232 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 21.9 ptmt -77.83 -19.59 54.65 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.854 0.327 . . . . 2.46 111.158 -176.927 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 42.7 t0 -117.35 33.88 5.4 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.863 0.839 . . . . 1.66 109.503 179.956 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 50' ' ' LYS . . . . . 0.711 ' HG3' ' HA2' ' A' ' 47' ' ' GLY . 24.1 mtpt -69.18 -42.0 20.15 Favored Pre-proline 0 C--O 1.22 -0.454 0 CA-C-N 115.652 -0.704 . . . . 1.15 112.793 -179.601 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_exo -44.21 -41.33 13.06 Favored 'Trans proline' 0 C--N 1.359 1.082 0 C-N-CA 122.202 1.935 . . . . 0.75 112.733 176.699 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 15.4 m -70.44 -45.5 65.69 Favored 'General case' 0 C--O 1.238 0.456 0 CA-C-N 116.203 -0.453 . . . . 0.68 111.156 -179.277 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 7.2 m-85 -74.12 -22.01 59.64 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.534 -0.303 . . . . 0.69 110.589 -176.998 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -76.09 -39.72 54.68 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 108.932 -0.766 . . . . 2.18 108.932 178.007 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 44.4 tt0 -58.38 -47.86 82.48 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.241 -0.89 . . . . 2.33 110.218 175.282 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 55.7 mt -67.45 -52.09 45.36 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 115.644 -0.707 . . . . 0.64 111.384 179.697 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 57' ' ' PHE . . . . . 0.583 ' HE1' HG12 ' A' ' 67' ' ' ILE . 72.7 t80 -55.65 -32.57 63.3 Favored 'General case' 0 C--N 1.326 -0.435 0 C-N-CA 122.872 0.469 . . . . 0.29 112.017 -176.695 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 58' ' ' TYR . . . . . 0.434 ' CE1' ' HD2' ' A' ' 57' ' ' PHE . 2.6 m-85 -88.52 -2.23 58.48 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 111.835 0.309 . . . . 1.17 111.835 -176.416 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 79.0 p -100.36 -12.69 19.22 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.18 0.514 . . . . 0.44 109.99 173.476 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 10.4 mp -88.42 6.62 36.64 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.687 -0.688 . . . . 1.37 110.768 177.885 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 52.0 m 62.87 83.6 0.2 Allowed Pre-proline 0 CA--C 1.531 0.212 0 CA-C-N 115.558 -0.746 . . . . 1.24 111.203 -178.6 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 75.2 Cg_endo -83.36 137.16 8.02 Favored 'Trans proline' 0 N--CA 1.458 -0.598 0 C-N-CA 122.763 2.309 . . . . 0.47 112.893 -178.157 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 47.4 t -104.71 103.82 15.89 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 CA-C-N 116.105 -0.498 . . . . 1.02 110.25 178.191 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 93.2 m-20 60.57 25.78 15.47 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-N 116.042 -0.527 . . . . 1.34 111.605 177.497 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 92.54 17.46 45.38 Favored Glycine 0 C--O 1.227 -0.303 0 C-N-CA 120.788 -0.72 . . . . 0.43 112.712 178.533 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 66' ' ' LYS . . . . . 0.636 ' HA ' ' HA ' ' A' ' 102' ' ' ASP . 59.4 mttm -141.41 134.64 29.42 Favored 'General case' 0 C--N 1.324 -0.532 0 C-N-CA 122.95 0.5 . . . . 1.48 110.242 177.734 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 67' ' ' ILE . . . . . 0.583 HG12 ' HE1' ' A' ' 57' ' ' PHE . 30.0 pt -103.25 150.57 6.7 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 N-CA-C 110.197 -0.297 . . . . 0.64 110.197 173.321 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 59.3 p -73.62 166.3 23.51 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.272 -0.422 . . . . 0.55 111.078 -176.307 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -68.06 -18.82 71.32 Favored Glycine 0 N--CA 1.447 -0.622 0 C-N-CA 120.801 -0.714 . . . . 0.41 112.162 178.265 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -74.28 -39.52 62.9 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.374 0.607 . . . . 0.38 110.294 176.126 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 12.3 m120 -73.45 -41.36 63.3 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.686 -0.688 . . . . 1.81 109.309 178.771 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -62.05 -37.63 85.68 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.232 -0.895 . . . . 0.39 110.248 174.153 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 73' ' ' LYS . . . . . 0.452 ' O ' HG23 ' A' ' 77' ' ' VAL . 22.8 ttmm -55.74 -52.02 65.34 Favored 'General case' 0 C--O 1.221 -0.404 0 CA-C-N 115.86 -0.609 . . . . 0.84 109.862 174.66 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 74' ' ' LYS . . . . . 0.438 ' O ' ' HG2' ' A' ' 78' ' ' LYS . 68.4 mttm -54.95 -46.23 74.99 Favored 'General case' 0 C--N 1.329 -0.321 0 O-C-N 123.38 0.425 . . . . 1.95 111.389 -179.395 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 20.7 tp10 -63.75 -49.72 71.9 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.838 0.352 . . . . 1.6 110.895 -179.401 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 76' ' ' MET . . . . . 0.748 ' HB3' HD22 ' A' ' 86' ' ' LEU . 96.5 mmm -66.54 -27.91 68.12 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.247 0.546 . . . . 1.24 111.285 -178.34 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.452 HG23 ' O ' ' A' ' 73' ' ' LYS . 37.2 t -71.65 -34.53 52.64 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-N 115.907 -0.588 . . . . 1.57 110.044 175.066 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.438 ' HG2' ' O ' ' A' ' 74' ' ' LYS . 29.5 mmmt -69.85 -22.46 63.26 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.925 -0.579 . . . . 2.79 110.277 174.872 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 79' ' ' SER . . . . . 0.449 ' C ' ' HG2' ' A' ' 80' ' ' LYS . 15.7 m -76.02 -4.81 43.33 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.951 -0.568 . . . . 1.27 110.711 178.333 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 80' ' ' LYS . . . . . 0.449 ' HG2' ' C ' ' A' ' 79' ' ' SER . 18.5 ptmt 47.2 32.6 2.14 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 124.07 0.948 . . . . 2.97 112.863 175.821 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.4 ' HB2' HD21 ' A' ' 86' ' ' LEU . 85.7 mt -97.22 150.16 36.51 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 116.094 -0.503 . . . . 0.52 110.089 176.487 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 82' ' ' PRO . . . . . 0.508 ' O ' ' HG ' ' A' ' 86' ' ' LEU . 52.9 Cg_exo -55.51 145.39 69.27 Favored 'Trans proline' 0 C--O 1.234 0.293 0 C-N-CA 122.658 2.239 . . . . 0.44 112.347 179.636 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 21.1 p-10 -55.21 -41.71 72.39 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-N 116.35 -0.387 . . . . 1.85 111.693 -177.046 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 9.4 m -55.06 -45.87 75.36 Favored 'General case' 0 N--CA 1.448 -0.542 0 CA-C-N 115.821 -0.627 . . . . 1.47 110.748 177.826 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 80.5 t -72.28 -32.04 41.22 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.177 0 CA-C-N 115.902 -0.59 . . . . 0.45 110.891 -179.821 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.748 HD22 ' HB3' ' A' ' 76' ' ' MET . 80.4 mt -61.78 -43.66 98.42 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 110.079 -0.341 . . . . 0.9 110.079 175.906 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -66.88 -34.35 86.87 Favored Glycine 0 N--CA 1.452 -0.299 0 N-CA-C 111.511 -0.635 . . . . 0.32 111.511 178.09 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 88' ' ' LYS . . . . . 0.489 ' O ' HD23 ' A' ' 92' ' ' LEU . 35.5 mmtm -58.12 -58.69 7.35 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.946 0.403 . . . . 1.89 110.124 174.189 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 56.0 mt -62.11 -35.22 67.57 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 115.747 -0.661 . . . . 0.71 110.932 -177.483 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 50.7 t-105 -58.02 -49.03 78.28 Favored 'General case' 0 C--O 1.223 -0.325 0 C-N-CA 120.707 -0.397 . . . . 0.33 110.293 175.287 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 20.8 ttmm -61.95 -39.84 93.48 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.298 -0.41 . . . . 2.7 111.7 -177.526 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.83 HD12 ' HG ' ' A' ' 126' ' ' LEU . 4.3 mm? -76.74 -24.55 53.01 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 111.888 0.329 . . . . 1.66 111.888 -179.253 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -93.05 -42.21 9.55 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.648 0.261 . . . . 0.47 111.618 -178.291 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 94' ' ' ASP . . . . . 0.476 ' OD2' ' HA ' ' A' ' 97' ' ' LYS . 30.8 t0 -82.66 87.16 6.74 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.51 0.671 . . . . 0.79 109.484 179.674 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 47.4 t -80.77 -34.75 14.27 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 CA-C-N 115.197 -0.911 . . . . 0.61 110.718 -174.271 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 48.4 p-10 -82.43 -13.92 55.99 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.503 -0.317 . . . . 0.96 110.453 -179.294 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 97' ' ' LYS . . . . . 0.476 ' HA ' ' OD2' ' A' ' 94' ' ' ASP . 31.7 mtmm 57.72 54.74 6.03 Favored 'General case' 0 C--O 1.231 0.118 0 O-C-N 123.778 0.674 . . . . 2.96 110.816 173.614 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 98' ' ' ASP . . . . . 0.413 ' O ' HD12 ' A' ' 100' ' ' LEU . 16.2 p-10 -110.2 8.66 23.77 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.59 -0.732 . . . . 0.43 110.891 -174.775 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 71.64 7.08 64.19 Favored Glycine 0 N--CA 1.453 -0.205 0 C-N-CA 120.633 -0.794 . . . . 0.44 112.429 179.717 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.413 HD12 ' O ' ' A' ' 98' ' ' ASP . 4.3 mp -135.04 155.18 51.2 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 109.516 -0.55 . . . . 1.11 109.516 178.143 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 77.7 mt -109.68 114.09 27.4 Favored 'General case' 0 C--N 1.315 -0.933 0 N-CA-C 109.399 -0.593 . . . . 0.42 109.399 175.831 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 102' ' ' ASP . . . . . 0.636 ' HA ' ' HA ' ' A' ' 66' ' ' LYS . 2.9 p30 -79.87 -176.05 5.24 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.255 -0.429 . . . . 1.72 110.65 179.698 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -55.07 -42.1 72.35 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.826 -0.624 . . . . 1.6 111.277 -178.719 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 104' ' ' GLU . . . . . 0.486 ' O ' ' HH2' ' A' ' 44' ' ' TRP . 49.9 mt-10 -72.32 -52.78 14.69 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.193 -0.458 . . . . 1.66 110.335 179.728 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 36.6 mt-10 -64.02 -37.77 88.63 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.106 -0.497 . . . . 0.44 111.193 -172.951 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 106' ' ' PHE . . . . . 0.488 ' CD2' ' HD1' ' A' ' 57' ' ' PHE . 49.5 t80 -74.79 -34.58 62.45 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.412 -0.358 . . . . 0.42 110.3 -179.327 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -60.07 -42.64 94.99 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-O 121.075 0.465 . . . . 0.22 110.003 173.689 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.4 ' HA ' HG11 ' A' ' 46' ' ' VAL . 6.9 tt -62.1 -47.56 84.07 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-N 115.86 -0.609 . . . . 1.33 109.74 176.643 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 109' ' ' ALA . . . . . 0.5 ' O ' HG13 ' A' ' 113' ' ' ILE . . . -55.82 -52.03 65.41 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 115.885 -0.598 . . . . 0.32 111.195 179.2 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 92.7 m-20 -59.13 -35.14 72.95 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-O 120.721 0.296 . . . . 1.2 110.992 179.375 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 111' ' ' HIS . . . . . 0.478 ' O ' HG23 ' A' ' 115' ' ' VAL . 24.8 t60 -64.21 -39.94 95.02 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.282 -0.417 . . . . 0.52 110.193 -179.49 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 59.7 mt -74.85 -34.29 62.26 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.297 -0.41 . . . . 0.55 110.976 178.252 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.5 HG13 ' O ' ' A' ' 109' ' ' ALA . 82.5 mt -59.32 -45.27 93.37 Favored 'Isoleucine or valine' 0 C--O 1.234 0.279 0 CA-C-O 121.242 0.544 . . . . 0.84 109.61 173.955 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 114' ' ' LYS . . . . . 0.431 ' HA ' ' HE3' ' A' ' 114' ' ' LYS . 0.1 OUTLIER -60.54 -42.65 96.95 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.216 -0.902 . . . . 3.83 110.163 177.808 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 115' ' ' VAL . . . . . 0.635 HG13 ' HB2' ' A' ' 120' ' ' HIS . 40.6 t -53.53 -47.07 60.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.015 -0.539 . . . . 1.19 110.978 176.103 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 27.6 mmmt -69.62 -38.75 77.36 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.403 -0.362 . . . . 1.32 111.246 -179.42 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 94.7 mt -66.51 -29.09 69.11 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.128 0.489 . . . . 0.96 111.009 177.805 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 5.4 tp10 -77.53 -22.11 51.61 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.47 0.652 . . . . 2.18 110.044 178.858 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 99.57 19.71 19.5 Favored Glycine 0 N--CA 1.445 -0.702 0 CA-C-N 115.458 -0.792 . . . . 1.16 112.657 179.919 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 120' ' ' HIS . . . . . 0.635 ' HB2' HG13 ' A' ' 115' ' ' VAL . 29.2 m-70 -97.4 167.07 11.23 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 109.425 -0.583 . . . . 2.42 109.425 175.907 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 7.4 tp10 -114.86 145.77 41.81 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-O 120.717 0.294 . . . . 2.53 110.223 -179.154 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 122' ' ' LEU . . . . . 0.496 ' HA ' ' HD3' ' A' ' 123' ' ' PRO . 3.1 pp -106.87 139.98 20.92 Favored Pre-proline 0 C--N 1.323 -0.545 0 N-CA-C 109.473 -0.566 . . . . 1.33 109.473 177.133 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 123' ' ' PRO . . . . . 0.496 ' HD3' ' HA ' ' A' ' 122' ' ' LEU . 9.5 Cg_exo -72.58 0.17 7.95 Favored 'Trans proline' 0 C--O 1.232 0.19 0 C-N-CA 122.743 2.295 . . . . 1.33 113.16 -176.55 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . 58.83 23.67 11.54 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-O 121.202 0.525 . . . . 1.25 110.592 -176.874 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 5.6 t0 -132.27 170.63 14.77 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 108.31 -0.996 . . . . 2.73 108.31 -179.87 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 126' ' ' LEU . . . . . 0.83 ' HG ' HD12 ' A' ' 92' ' ' LEU . 19.2 mt -116.76 105.93 48.91 Favored Pre-proline 0 C--N 1.321 -0.668 0 N-CA-C 112.116 0.413 . . . . 1.66 112.116 -175.21 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 127' ' ' PRO . . . . . 0.423 ' HD2' ' HB2' ' A' ' 130' ' ' LEU . 12.1 Cg_exo -70.94 147.67 55.81 Favored 'Trans proline' 0 N--CA 1.459 -0.502 0 C-N-CA 122.611 2.207 . . . . 1.17 110.778 169.919 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_exo -50.39 -37.87 51.81 Favored 'Trans proline' 0 CA--C 1.531 0.373 0 C-N-CA 122.944 2.429 . . . . 1.54 113.596 -178.311 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 44.3 p-80 -82.18 3.95 25.25 Favored 'General case' 0 CA--C 1.533 0.306 0 N-CA-C 111.961 0.356 . . . . 1.07 111.961 -178.168 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 130' ' ' LEU . . . . . 0.423 ' HB2' ' HD2' ' A' ' 127' ' ' PRO . 2.4 mm? -101.06 -20.01 15.55 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.665 0.269 . . . . 1.36 110.582 174.35 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 43.4 t -74.85 126.54 88.24 Favored Pre-proline 0 C--N 1.325 -0.459 0 CA-C-N 116.127 -0.488 . . . . 1.28 110.606 -178.989 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_exo -55.64 134.0 61.39 Favored 'Trans proline' 0 C--N 1.345 0.391 0 C-N-CA 122.587 2.191 . . . . 0.81 111.722 177.224 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -58.31 -23.32 62.31 Favored 'Trans proline' 0 CA--C 1.529 0.256 0 C-N-CA 122.961 2.441 . . . . 1.17 112.955 -176.64 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 5.5 m -82.01 -16.77 49.14 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.413 -0.358 . . . . 1.6 111.304 -179.72 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 6.2 mptt . . . . . 0 C--N 1.33 -0.268 0 N-CA-C 111.776 0.287 . . . . 1.21 111.776 -176.404 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' B' B ' 149' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.443 -0.84 0 N-CA-C 112.395 -0.282 . . . . 0.48 112.395 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' B' B ' 150' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -73.83 -2.14 11.81 Favored 'Trans proline' 0 C--O 1.232 0.191 0 C-N-CA 122.844 2.362 . . . . 0.33 112.318 -178.272 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 151' ' ' PHE . . . . . . . . . . . . . 26.9 m-85 . . . . . 0 C--N 1.326 -0.444 0 CA-C-N 115.961 -0.563 . . . . 0.75 110.409 178.491 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 . . . . . 0 N--CA 1.45 -0.432 0 CA-C-O 121.157 0.503 . . . . 3.1 110.547 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 9.8 t90 -83.44 122.02 27.95 Favored 'General case' 0 C--N 1.318 -0.803 0 N-CA-C 108.796 -0.816 . . . . 0.71 108.796 179.834 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 33.6 m -61.48 -15.9 13.87 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.521 0 N-CA-C 114.316 1.228 . . . . 1.45 114.316 -166.793 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.469 HG23 ' HB2' ' A' ' 111' ' ' HIS . 11.5 p -92.45 -14.06 8.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 C-N-CA 120.033 -0.667 . . . . 1.1 110.541 178.346 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -64.55 -25.41 70.17 Favored Glycine 0 CA--C 1.519 0.305 0 C-N-CA 120.964 -0.636 . . . . 0.59 112.955 -177.115 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 48' ' ' LYS . . . . . 0.5 ' HG3' ' OD2' ' A' ' 49' ' ' ASP . 11.5 ptmm? -76.63 -19.44 57.8 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.599 0.238 . . . . 2.46 111.149 -179.226 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 49' ' ' ASP . . . . . 0.5 ' OD2' ' HG3' ' A' ' 48' ' ' LYS . 10.5 m-20 -127.14 34.56 4.72 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 109.362 -0.607 . . . . 1.66 109.362 179.571 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 50' ' ' LYS . . . . . 0.436 ' HG2' ' OD1' ' A' ' 54' ' ' ASP . 56.7 tttm -86.61 -48.13 0.51 Allowed Pre-proline 0 C--N 1.324 -0.541 0 CA-C-N 115.862 -0.608 . . . . 1.15 112.308 -172.725 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 51' ' ' PRO . . . . . 0.411 ' HD3' ' HB3' ' A' ' 50' ' ' LYS . 84.3 Cg_exo -49.61 -31.22 24.11 Favored 'Trans proline' 0 C--N 1.361 1.202 0 C-N-CA 122.158 1.905 . . . . 0.75 113.003 -179.88 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 11.0 m -70.14 -45.43 66.81 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.252 -0.431 . . . . 0.68 110.502 177.763 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 19.9 m-30 -73.67 -23.25 59.82 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.395 -0.366 . . . . 0.69 110.291 -177.81 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 54' ' ' ASP . . . . . 0.436 ' OD1' ' HG2' ' A' ' 50' ' ' LYS . 0.9 OUTLIER -72.59 -40.6 66.44 Favored 'General case' 0 CA--C 1.517 -0.305 0 N-CA-C 109.683 -0.488 . . . . 2.18 109.683 174.657 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 2.6 mm-40 -58.76 -36.93 75.18 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.039 -0.528 . . . . 2.33 110.58 176.012 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 35.3 mt -75.65 -40.29 40.31 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-O 121.119 0.485 . . . . 0.64 110.298 177.183 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 57' ' ' PHE . . . . . 0.411 ' HD2' ' CD1' ' A' ' 58' ' ' TYR . 86.5 t80 -57.1 -38.18 73.01 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.685 -0.689 . . . . 0.29 111.409 179.132 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 58' ' ' TYR . . . . . 0.546 ' HA ' ' HG3' ' A' ' 62' ' ' PRO . 19.8 m-30 -80.32 -3.77 50.77 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.383 -0.372 . . . . 1.17 111.578 -174.208 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 75.3 p -100.2 -2.4 34.04 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.878 0.371 . . . . 0.44 111.034 179.609 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 74.6 mt -102.09 16.7 25.28 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.393 -0.367 . . . . 1.37 110.615 179.753 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 48.3 t 63.06 80.89 0.24 Allowed Pre-proline 0 CA--C 1.532 0.283 0 CA-C-N 115.53 -0.759 . . . . 1.24 111.237 -179.209 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 62' ' ' PRO . . . . . 0.578 ' HA ' HG22 ' A' ' 67' ' ' ILE . 6.2 Cg_exo -78.59 143.88 19.4 Favored 'Trans proline' 0 N--CA 1.461 -0.427 0 C-N-CA 122.899 2.399 . . . . 0.47 112.007 178.84 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 16.7 m -122.86 117.43 51.78 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-N 116.284 -0.416 . . . . 1.02 110.191 176.161 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 88.2 m-20 62.07 23.35 13.77 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-N 115.984 -0.553 . . . . 1.34 111.182 -179.823 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 90.57 5.77 68.79 Favored Glycine 0 C--O 1.229 -0.201 0 C-N-CA 120.961 -0.638 . . . . 0.43 113.043 178.375 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 66' ' ' LYS . . . . . 0.645 ' HG2' ' HA ' ' A' ' 102' ' ' ASP . 37.0 mtpt -135.52 157.93 45.64 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 109.952 -0.388 . . . . 1.48 109.952 -178.692 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 67' ' ' ILE . . . . . 0.578 HG22 ' HA ' ' A' ' 62' ' ' PRO . 48.8 pt -124.95 164.07 24.38 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-O 120.988 0.423 . . . . 0.64 110.943 177.416 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 68' ' ' THR . . . . . 0.409 ' HA ' HD23 ' A' ' 100' ' ' LEU . 37.5 p -82.25 165.57 20.31 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.339 -0.846 . . . . 0.55 110.893 179.992 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -72.1 -12.98 76.17 Favored Glycine 0 N--CA 1.447 -0.614 0 C-N-CA 120.988 -0.625 . . . . 0.41 112.56 179.599 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.413 ' O ' ' HG3' ' A' ' 74' ' ' LYS . . . -64.46 -58.97 4.93 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.079 0.466 . . . . 0.38 111.068 -179.216 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 39.4 m-80 -68.89 -38.54 79.72 Favored 'General case' 0 C--O 1.238 0.454 0 CA-C-N 115.809 -0.632 . . . . 1.81 110.451 -178.06 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -59.25 -43.2 92.45 Favored 'General case' 0 N--CA 1.45 -0.425 0 CA-C-N 115.608 -0.723 . . . . 0.39 109.951 176.542 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -62.23 -39.54 93.16 Favored 'General case' 0 C--O 1.224 -0.276 0 CA-C-N 116.362 -0.381 . . . . 0.84 110.906 177.85 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 74' ' ' LYS . . . . . 0.464 ' O ' HG12 ' A' ' 77' ' ' VAL . 57.6 mtpt -59.14 -33.43 70.87 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-O 121.008 0.432 . . . . 1.95 110.693 178.731 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 75' ' ' GLU . . . . . 0.478 ' O ' ' HG3' ' A' ' 78' ' ' LYS . 40.9 tt0 -81.34 -50.67 9.22 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 116.172 -0.467 . . . . 1.6 110.368 -179.496 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 76' ' ' MET . . . . . 0.749 ' HB3' HD22 ' A' ' 86' ' ' LEU . 75.1 mmm -57.4 -27.49 62.39 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.803 -0.635 . . . . 1.24 110.327 178.672 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.464 HG12 ' O ' ' A' ' 74' ' ' LYS . 1.5 p -86.95 -28.01 5.8 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.535 0 CA-C-N 115.942 -0.572 . . . . 1.57 110.968 -179.082 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.478 ' HG3' ' O ' ' A' ' 75' ' ' GLU . 0.0 OUTLIER -82.28 -14.38 55.51 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-O 120.886 0.374 . . . . 2.79 110.26 -179.096 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 2.0 p -78.6 4.43 13.53 Favored 'General case' 0 CA--C 1.531 0.214 0 CA-C-N 116.323 -0.399 . . . . 1.27 110.396 170.343 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 52.3 mtpt 63.5 32.81 14.0 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 115.403 -0.817 . . . . 2.97 112.247 172.535 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.671 ' HB2' HD21 ' A' ' 86' ' ' LEU . 88.7 mt -102.17 141.39 22.44 Favored Pre-proline 0 C--N 1.318 -0.778 0 CA-C-N 116.417 -0.356 . . . . 0.52 110.118 176.956 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 82' ' ' PRO . . . . . 0.537 ' O ' ' HG ' ' A' ' 86' ' ' LEU . 51.7 Cg_exo -56.14 136.74 76.69 Favored 'Trans proline' 0 C--N 1.344 0.306 0 C-N-CA 122.821 2.347 . . . . 0.44 112.706 179.52 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 83' ' ' ASN . . . . . 0.411 ' HA ' HD12 ' A' ' 86' ' ' LEU . 18.2 p30 -51.93 -34.9 43.79 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-N 115.846 -0.616 . . . . 1.85 112.437 -179.866 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 30.1 m -69.48 -39.07 77.89 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 121.006 0.432 . . . . 1.47 110.608 -179.553 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.414 HG23 ' HB2' ' A' ' 82' ' ' PRO . 58.8 t -67.69 -36.23 75.33 Favored 'Isoleucine or valine' 0 C--O 1.234 0.277 0 N-CA-C 109.325 -0.62 . . . . 0.45 109.325 176.573 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.749 HD22 ' HB3' ' A' ' 76' ' ' MET . 65.4 mt -63.84 -33.47 75.75 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.348 -0.842 . . . . 0.9 109.876 175.807 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -68.58 -38.28 86.07 Favored Glycine 0 N--CA 1.451 -0.363 0 N-CA-C 111.57 -0.612 . . . . 0.32 111.57 178.931 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 88' ' ' LYS . . . . . 0.418 ' O ' ' HG ' ' A' ' 92' ' ' LEU . 73.1 mmtt -57.7 -52.82 63.86 Favored 'General case' 0 C--O 1.24 0.563 0 CA-C-O 121.638 0.733 . . . . 1.89 109.582 173.814 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 0.43 HG23 HD12 ' A' ' 112' ' ' LEU . 45.4 mt -65.12 -34.88 73.59 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.453 0 CA-C-N 114.924 -1.034 . . . . 0.71 111.389 -178.148 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 90' ' ' TRP . . . . . 0.462 ' HB2' ' CE2' ' B' ' 151' ' ' PHE . 55.0 t-105 -60.45 -46.09 91.33 Favored 'General case' 0 C--N 1.333 -0.118 0 CA-C-O 120.795 0.331 . . . . 0.33 110.149 175.814 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 30.8 ttpt -66.39 -20.86 66.18 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.846 -0.615 . . . . 2.7 110.807 -178.611 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.782 HD11 ' HA ' ' A' ' 124' ' ' ALA . 82.6 mt -92.35 -31.56 15.3 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.437 -0.347 . . . . 1.66 111.682 177.4 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -86.54 -41.49 14.28 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.506 -0.315 . . . . 0.47 111.835 -174.39 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 36.3 t0 -80.86 81.26 7.16 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 108.982 -0.747 . . . . 0.79 108.982 178.137 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.714 ' HB ' ' HD3' ' A' ' 135' ' ' LYS . 46.2 t -75.35 -34.7 31.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 115.027 -0.988 . . . . 0.61 111.083 -173.519 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 96' ' ' ASP . . . . . 0.545 ' HB3' ' HE3' ' A' ' 135' ' ' LYS . 15.5 p-10 -82.58 -8.46 59.61 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 109.514 -0.551 . . . . 0.96 109.514 179.05 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 97.0 mttt 49.65 73.06 0.27 Allowed 'General case' 0 C--O 1.235 0.314 0 CA-C-N 115.403 -0.817 . . . . 2.96 111.455 175.229 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 98' ' ' ASP . . . . . 0.484 ' OD2' ' HB2' ' A' ' 100' ' ' LEU . 9.5 p-10 -134.69 9.5 3.63 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.624 -0.716 . . . . 0.43 111.067 -173.837 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 73.75 -4.64 28.14 Favored Glycine 0 C--N 1.331 0.288 0 C-N-CA 120.791 -0.719 . . . . 0.44 112.407 178.699 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.484 ' HB2' ' OD2' ' A' ' 98' ' ' ASP . 89.2 mt -120.86 154.35 35.93 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 109.051 -0.722 . . . . 1.11 109.051 178.401 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 75.3 mt -108.32 122.77 47.67 Favored 'General case' 0 C--N 1.31 -1.138 0 C-N-CA 120.487 -0.485 . . . . 0.42 110.146 178.011 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 102' ' ' ASP . . . . . 0.674 ' HB2' ' HG3' ' A' ' 105' ' ' GLU . 16.0 m-20 -68.83 168.36 13.63 Favored 'General case' 0 CA--C 1.512 -0.508 0 N-CA-C 108.113 -1.069 . . . . 1.72 108.113 170.111 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -61.53 -29.82 70.24 Favored 'General case' 0 C--N 1.317 -0.81 0 N-CA-C 109.202 -0.666 . . . . 1.6 109.202 174.527 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 50.7 mt-10 -64.64 -55.52 19.69 Favored 'General case' 0 C--O 1.231 0.092 0 CA-C-N 115.762 -0.654 . . . . 1.66 110.148 173.495 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 105' ' ' GLU . . . . . 0.674 ' HG3' ' HB2' ' A' ' 102' ' ' ASP . 14.4 mt-10 -62.4 -39.85 94.6 Favored 'General case' 0 N--CA 1.463 0.207 0 CA-C-N 115.454 -0.793 . . . . 0.44 110.956 -173.914 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 79.7 t80 -64.21 -47.86 78.09 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.671 -0.695 . . . . 0.42 110.524 178.193 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -57.67 -45.61 85.36 Favored 'General case' 0 N--CA 1.454 -0.258 0 CA-C-N 116.278 -0.419 . . . . 0.22 110.754 178.704 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 55.1 tp -59.48 -47.37 85.75 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.486 -0.325 . . . . 1.33 110.735 -179.906 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 109' ' ' ALA . . . . . 0.579 ' O ' HG12 ' A' ' 113' ' ' ILE . . . -58.61 -46.85 86.14 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.224 -0.444 . . . . 0.32 110.595 177.974 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 110' ' ' ASN . . . . . 0.437 ' HA ' HG12 ' A' ' 113' ' ' ILE . 0.6 OUTLIER -60.59 -36.5 78.7 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 115.903 -0.589 . . . . 1.2 111.388 179.044 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 111' ' ' HIS . . . . . 0.731 ' O ' HG23 ' A' ' 115' ' ' VAL . 24.8 t60 -62.94 -48.13 80.26 Favored 'General case' 0 CA--C 1.513 -0.449 0 N-CA-C 108.78 -0.822 . . . . 0.52 108.78 177.192 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 0.43 HD12 HG23 ' A' ' 89' ' ' ILE . 97.8 mt -58.16 -34.64 70.53 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.527 -0.76 . . . . 0.55 110.795 177.521 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.579 HG12 ' O ' ' A' ' 109' ' ' ALA . 36.9 mm -56.46 -52.32 54.11 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.235 0 CA-C-O 121.515 0.674 . . . . 0.84 110.309 173.605 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 18.4 tppt? -63.13 -45.83 90.11 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.016 -0.993 . . . . 3.83 111.523 -177.416 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 115' ' ' VAL . . . . . 0.731 HG23 ' O ' ' A' ' 111' ' ' HIS . 2.2 t -73.89 -23.82 19.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-O 120.82 0.343 . . . . 1.19 110.294 -176.499 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 14.6 tppt? -64.89 -49.48 70.31 Favored 'General case' 0 CA--C 1.52 -0.175 0 N-CA-C 109.487 -0.56 . . . . 1.32 109.487 170.264 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 86.2 mt -70.41 -15.15 62.81 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.553 -0.749 . . . . 0.96 110.88 -179.804 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 7.2 tp10 -71.35 -16.44 62.43 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.104 0.478 . . . . 2.18 109.784 175.331 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 98.67 23.97 11.46 Favored Glycine 0 N--CA 1.451 -0.36 0 N-CA-C 111.124 -0.79 . . . . 1.16 111.124 179.443 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 3.8 t-80 -117.84 121.57 41.09 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 121.122 0.487 . . . . 2.42 110.867 -177.584 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 47.9 mm-40 -83.59 119.88 25.28 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.361 -0.836 . . . . 2.53 110.725 177.55 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 122' ' ' LEU . . . . . 0.821 ' H ' HD23 ' A' ' 122' ' ' LEU . 1.3 pt? -78.58 139.37 58.87 Favored Pre-proline 0 C--N 1.322 -0.626 0 N-CA-C 109.019 -0.734 . . . . 1.33 109.019 172.948 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 123' ' ' PRO . . . . . 0.455 ' HD3' ' HA ' ' A' ' 122' ' ' LEU . 7.8 Cg_exo -72.78 10.03 1.16 Allowed 'Trans proline' 0 C--N 1.345 0.374 0 C-N-CA 123.205 2.604 . . . . 1.33 112.792 -176.055 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 124' ' ' ALA . . . . . 0.782 ' HA ' HD11 ' A' ' 92' ' ' LEU . . . 59.14 29.94 19.61 Favored 'General case' 0 C--O 1.232 0.141 0 CA-C-N 116.239 -0.437 . . . . 1.25 110.946 -179.771 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 37.8 t70 -132.53 156.92 45.95 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.819 -0.628 . . . . 2.73 109.882 -179.688 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 126' ' ' LEU . . . . . 0.659 ' HG ' HD22 ' A' ' 92' ' ' LEU . 84.3 mt -110.46 103.34 53.94 Favored Pre-proline 0 C--N 1.327 -0.41 0 N-CA-C 112.055 0.391 . . . . 1.66 112.055 -175.814 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 127' ' ' PRO . . . . . 0.539 ' HD2' HD12 ' A' ' 130' ' ' LEU . 56.6 Cg_endo -72.21 161.46 44.48 Favored 'Trans proline' 0 C--O 1.234 0.321 0 C-N-CA 122.803 2.335 . . . . 1.17 111.085 171.249 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 75.5 Cg_exo -50.49 -40.39 54.22 Favored 'Trans proline' 0 C--N 1.346 0.446 0 C-N-CA 123.178 2.585 . . . . 1.54 113.836 -176.672 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 23.4 p-80 -81.29 14.56 2.35 Favored 'General case' 0 CA--C 1.533 0.324 0 N-CA-C 112.828 0.677 . . . . 1.07 112.828 -174.381 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 130' ' ' LEU . . . . . 0.539 HD12 ' HD2' ' A' ' 127' ' ' PRO . 12.7 mt -114.39 2.41 14.69 Favored 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 120.791 -0.363 . . . . 1.36 111.072 174.69 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 46.3 t -84.39 121.48 75.16 Favored Pre-proline 0 C--N 1.324 -0.539 0 CA-C-N 116.326 -0.397 . . . . 1.28 110.492 -178.455 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 44.7 Cg_exo -56.77 142.75 91.96 Favored 'Trans proline' 0 C--N 1.347 0.484 0 C-N-CA 123.097 2.531 . . . . 0.81 112.804 -179.974 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 11.8 Cg_endo -55.45 -36.16 93.53 Favored 'Trans proline' 0 CA--C 1.531 0.345 0 C-N-CA 123.739 2.959 . . . . 1.17 113.62 -176.682 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 4.4 m -83.82 -9.59 58.66 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.012 0.434 . . . . 1.6 110.885 -178.19 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 135' ' ' LYS . . . . . 0.714 ' HD3' ' HB ' ' A' ' 95' ' ' VAL . 49.5 mttp . . . . . 0 C--N 1.324 -0.511 0 CA-C-N 116.056 -0.52 . . . . 1.21 110.843 -173.867 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 149' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.446 -0.675 0 N-CA-C 111.878 -0.489 . . . . 0.48 111.878 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' B' B ' 150' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -74.72 -2.02 11.91 Favored 'Trans proline' 0 CA--C 1.533 0.465 0 C-N-CA 123.053 2.502 . . . . 0.33 113.159 -176.585 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 151' ' ' PHE . . . . . 0.462 ' CE2' ' HB2' ' A' ' 90' ' ' TRP . 30.2 m-85 . . . . . 0 C--N 1.326 -0.449 0 N-CA-C 112.119 0.414 . . . . 0.75 112.119 -174.344 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 17.9 mm-40 . . . . . 0 C--O 1.233 0.222 0 CA-C-O 120.771 0.319 . . . . 3.1 110.474 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 5.7 t90 -81.91 103.14 11.36 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 109.243 -0.651 . . . . 0.71 109.243 176.912 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.493 ' O ' ' HG2' ' A' ' 48' ' ' LYS . 21.2 m -60.2 -19.86 18.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 N-CA-C 112.978 0.733 . . . . 1.45 112.978 -173.172 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 28.3 t -78.94 -16.79 13.41 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-O 121.177 0.513 . . . . 1.1 110.856 -178.834 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -74.08 -9.54 80.36 Favored Glycine 0 N--CA 1.448 -0.526 0 C-N-CA 120.851 -0.69 . . . . 0.59 113.414 -175.476 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 48' ' ' LYS . . . . . 0.493 ' HG2' ' O ' ' A' ' 45' ' ' VAL . 1.1 ptpm? -83.93 -27.66 28.4 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 117.3 0.55 . . . . 2.46 111.112 -178.787 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 21.5 m-20 -100.6 33.83 2.62 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.824 0.345 . . . . 1.66 110.266 -179.465 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 50' ' ' LYS . . . . . 0.554 ' N ' ' HD2' ' A' ' 51' ' ' PRO . 14.9 mmtp -69.35 -51.03 17.99 Favored Pre-proline 0 C--N 1.324 -0.53 0 N-CA-C 112.83 0.678 . . . . 1.15 112.83 -177.017 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 51' ' ' PRO . . . . . 0.643 ' HA ' ' OD2' ' A' ' 54' ' ' ASP . 4.6 Cg_endo -48.34 -42.04 34.69 Favored 'Trans proline' 0 C--N 1.356 0.966 0 C-N-CA 122.707 2.271 . . . . 0.75 113.217 -177.966 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 52' ' ' THR . . . . . 0.486 ' O ' ' HB3' ' A' ' 55' ' ' GLU . 21.9 m -70.93 -39.93 72.36 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.375 0.607 . . . . 0.68 110.932 -179.419 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 21.2 m-30 -79.25 -22.09 45.23 Favored 'General case' 0 C--N 1.324 -0.51 0 C-N-CA 120.603 -0.439 . . . . 0.69 111.114 -175.857 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 54' ' ' ASP . . . . . 0.643 ' OD2' ' HA ' ' A' ' 51' ' ' PRO . 0.6 OUTLIER -82.1 -25.48 34.45 Favored 'General case' 0 CA--C 1.52 -0.18 0 N-CA-C 108.945 -0.761 . . . . 2.18 108.945 175.166 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 55' ' ' GLU . . . . . 0.486 ' HB3' ' O ' ' A' ' 52' ' ' THR . 9.5 tp10 -59.37 -43.14 92.9 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.478 -0.783 . . . . 2.33 109.102 169.598 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.447 HG12 ' O ' ' A' ' 52' ' ' THR . 27.6 mm -76.18 -34.82 26.91 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.331 0 CA-C-N 115.841 -0.618 . . . . 0.64 110.521 178.092 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 57' ' ' PHE . . . . . 0.509 ' CE2' ' HB3' ' A' ' 62' ' ' PRO . 74.0 t80 -65.72 -46.6 78.32 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.122 -0.49 . . . . 0.29 111.372 -176.725 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 58' ' ' TYR . . . . . 0.428 ' HA ' ' HG3' ' A' ' 62' ' ' PRO . 15.1 m-85 -80.33 -7.94 59.28 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.382 -0.372 . . . . 1.17 111.922 -174.493 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 15.5 p -92.65 -4.34 53.44 Favored 'General case' 0 C--N 1.323 -0.572 0 C-N-CA 120.717 -0.393 . . . . 0.44 110.693 177.064 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.466 ' HB3' ' HB3' ' A' ' 71' ' ' ASN . 73.0 mt -108.08 13.24 26.16 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.299 -0.41 . . . . 1.37 111.266 178.026 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 15.8 m 68.53 87.42 0.11 Allowed Pre-proline 0 N--CA 1.469 0.525 0 CA-C-N 116.03 -0.532 . . . . 1.24 112.171 175.698 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 62' ' ' PRO . . . . . 0.509 ' HB3' ' CE2' ' A' ' 57' ' ' PHE . 5.6 Cg_exo -80.69 138.89 12.18 Favored 'Trans proline' 0 N--CA 1.46 -0.47 0 C-N-CA 122.862 2.375 . . . . 0.47 112.635 178.206 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 11.0 m -127.94 117.83 47.05 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-N 115.819 -0.628 . . . . 1.02 110.216 175.168 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 49.3 m-80 66.39 24.27 10.5 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-N 115.694 -0.684 . . . . 1.34 111.389 178.661 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 92.96 8.15 62.01 Favored Glycine 0 C--N 1.331 0.275 0 C-N-CA 121.018 -0.611 . . . . 0.43 112.788 176.847 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 66' ' ' LYS . . . . . 0.804 ' HG2' ' HA ' ' A' ' 102' ' ' ASP . 55.1 mtmt -143.28 153.96 43.31 Favored 'General case' 0 C--N 1.326 -0.422 0 C-N-CA 122.381 0.272 . . . . 1.48 110.397 -177.165 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 67' ' ' ILE . . . . . 0.449 HD11 ' CD1' ' A' ' 106' ' ' PHE . 41.0 pt -110.68 153.92 12.36 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.763 0 N-CA-C 110.011 -0.366 . . . . 0.64 110.011 174.957 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 18.6 p -72.7 152.5 41.65 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.285 -0.416 . . . . 0.55 111.151 179.589 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -61.8 -15.93 49.96 Favored Glycine 0 N--CA 1.448 -0.54 0 C-N-CA 121.071 -0.585 . . . . 0.41 112.947 -179.434 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -60.36 -50.46 73.51 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.133 0.492 . . . . 0.38 111.213 177.636 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 71' ' ' ASN . . . . . 0.559 ' HA ' ' HD3' ' A' ' 74' ' ' LYS . 39.9 m-80 -74.93 -34.23 62.08 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.826 -0.624 . . . . 1.81 110.38 -175.778 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -61.42 -45.28 94.99 Favored 'General case' 0 N--CA 1.449 -0.489 0 CA-C-N 115.929 -0.578 . . . . 0.39 109.528 173.961 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 73' ' ' LYS . . . . . 0.594 ' HA ' ' CZ ' ' B' ' 151' ' ' PHE . 54.9 tttp -56.08 -38.43 70.67 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.777 -0.647 . . . . 0.84 110.383 177.296 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 74' ' ' LYS . . . . . 0.559 ' HD3' ' HA ' ' A' ' 71' ' ' ASN . 26.8 mtpp -65.49 -32.88 74.73 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.952 -0.567 . . . . 1.95 111.256 178.671 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 18.2 tp10 -76.31 -39.39 54.27 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.164 0.507 . . . . 1.6 110.039 177.701 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 76' ' ' MET . . . . . 0.517 ' HB3' HD22 ' A' ' 86' ' ' LEU . 1.1 mpt? -60.71 -36.43 78.78 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 116.378 -0.374 . . . . 1.24 111.471 176.386 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.426 HG22 ' HA ' ' A' ' 74' ' ' LYS . 17.9 m -82.38 -13.88 12.2 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.507 0 C-N-CA 120.701 -0.4 . . . . 1.57 110.978 177.455 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 46.7 mmtt -74.29 -29.74 61.77 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-O 120.867 0.365 . . . . 2.79 111.029 171.396 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -83.9 -13.61 53.09 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.155 -0.475 . . . . 1.27 111.122 -178.931 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 56.2 mttp 68.29 33.01 4.43 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 115.639 -0.709 . . . . 2.97 111.927 171.788 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.715 ' HB2' HD21 ' A' ' 86' ' ' LEU . 97.2 mt -86.32 151.6 53.98 Favored Pre-proline 0 C--N 1.326 -0.453 0 N-CA-C 109.68 -0.489 . . . . 0.52 109.68 175.682 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -54.46 142.91 69.11 Favored 'Trans proline' 0 C--N 1.35 0.628 0 C-N-CA 122.887 2.391 . . . . 0.44 112.65 179.336 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 39.9 m-80 -52.36 -48.05 65.76 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 115.615 -0.72 . . . . 1.85 112.141 -175.61 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 84' ' ' THR . . . . . 0.436 ' O ' ' HD3' ' A' ' 88' ' ' LYS . 38.8 p -63.76 -42.73 97.77 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.912 0.387 . . . . 1.47 110.757 -178.837 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 84.7 t -59.85 -39.24 79.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 115.85 -0.614 . . . . 0.45 110.584 179.247 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.715 HD21 ' HB2' ' A' ' 81' ' ' LEU . 93.6 mt -65.75 -29.37 69.87 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.435 -0.348 . . . . 0.9 110.521 177.333 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -65.77 -41.41 95.73 Favored Glycine 0 CA--C 1.502 -0.753 0 N-CA-C 111.086 -0.806 . . . . 0.32 111.086 175.151 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 88' ' ' LYS . . . . . 0.436 ' HD3' ' O ' ' A' ' 84' ' ' THR . 2.5 mptp? -75.06 -28.33 60.32 Favored 'General case' 0 N--CA 1.443 -0.808 0 CA-C-N 115.464 -0.368 . . . . 1.89 110.846 178.605 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 16.4 mm -60.15 -49.44 84.08 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.254 0 CA-C-N 116.325 -0.398 . . . . 0.71 110.222 173.153 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 90' ' ' TRP . . . . . 0.424 ' HB2' ' CD2' ' B' ' 151' ' ' PHE . 52.4 t-105 -62.38 -45.33 93.62 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.917 0.389 . . . . 0.33 110.578 178.073 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 17.4 ttmm -54.85 -32.33 60.49 Favored 'General case' 0 C--O 1.237 0.447 0 CA-C-N 115.665 -0.698 . . . . 2.7 111.585 179.276 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.559 HD22 ' HA ' ' A' ' 124' ' ' ALA . 13.0 tp -93.93 -36.92 11.96 Favored 'General case' 0 N--CA 1.442 -0.846 0 CA-C-N 115.906 -0.588 . . . . 1.66 111.782 -176.439 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -81.36 -42.48 20.44 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.753 0.311 . . . . 0.47 111.718 -174.53 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 94' ' ' ASP . . . . . 0.654 ' OD2' ' HA ' ' A' ' 97' ' ' LYS . 50.0 t0 -78.03 96.72 5.16 Favored 'General case' 0 C--O 1.237 0.417 0 N-CA-C 108.689 -0.856 . . . . 0.79 108.689 178.049 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 38.3 t -68.86 -45.16 81.14 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-N 115.481 -0.781 . . . . 0.61 110.965 -172.497 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 29.0 p-10 -88.6 -17.96 29.04 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 116.092 -0.504 . . . . 0.96 111.694 -176.779 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 97' ' ' LYS . . . . . 0.654 ' HA ' ' OD2' ' A' ' 94' ' ' ASP . 53.0 mttp 58.07 72.89 0.5 Allowed 'General case' 0 CA--C 1.518 -0.278 0 CA-C-O 122.063 0.935 . . . . 2.96 111.32 177.838 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 98' ' ' ASP . . . . . 0.417 ' OD2' ' HB2' ' A' ' 100' ' ' LEU . 11.5 p-10 -122.83 9.05 9.41 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 114.589 -1.187 . . . . 0.43 110.868 -173.169 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 78.19 -3.78 60.92 Favored Glycine 0 CA--C 1.52 0.369 0 C-N-CA 121.001 -0.619 . . . . 0.44 112.468 -179.554 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.417 ' HB2' ' OD2' ' A' ' 98' ' ' ASP . 4.6 mp -128.86 166.23 19.47 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 109.726 -0.472 . . . . 1.11 109.726 175.922 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 81.7 mt -123.75 127.52 48.26 Favored 'General case' 0 C--N 1.314 -0.951 0 CA-C-N 116.128 -0.487 . . . . 0.42 109.799 176.999 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 102' ' ' ASP . . . . . 0.804 ' HA ' ' HG2' ' A' ' 66' ' ' LYS . 2.6 m-20 -69.72 168.42 14.99 Favored 'General case' 0 CA--C 1.509 -0.631 0 N-CA-C 108.799 -0.815 . . . . 1.72 108.799 174.334 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -57.61 -30.28 65.2 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 108.46 -0.941 . . . . 1.6 108.46 171.772 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 6.4 mm-40 -66.97 -58.81 4.23 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-N 115.11 -0.95 . . . . 1.66 111.851 177.195 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 105' ' ' GLU . . . . . 0.581 ' OE1' ' HE3' ' A' ' 135' ' ' LYS . 2.4 pt-20 -78.91 -18.09 54.44 Favored 'General case' 0 CA--C 1.53 0.187 0 C-N-CA 120.283 -0.567 . . . . 0.44 112.236 -173.822 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 106' ' ' PHE . . . . . 0.449 ' CD1' HD11 ' A' ' 67' ' ' ILE . 50.3 t80 -76.64 -34.17 58.31 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 109.164 -0.68 . . . . 0.42 109.164 173.603 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -62.23 -44.49 96.44 Favored 'General case' 0 N--CA 1.452 -0.363 0 CA-C-N 115.672 -0.694 . . . . 0.22 109.262 171.663 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.435 ' O ' ' HG ' ' A' ' 112' ' ' LEU . 4.8 tt -60.39 -46.28 90.54 Favored 'General case' 0 CA--C 1.533 0.305 0 CA-C-N 115.491 -0.777 . . . . 1.33 109.847 178.326 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -56.17 -49.65 73.41 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 116.484 -0.326 . . . . 0.32 111.363 178.361 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 22.5 m-80 -65.06 -32.53 74.28 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.423 -0.353 . . . . 1.2 111.31 179.626 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 111' ' ' HIS . . . . . 0.408 ' O ' HG23 ' A' ' 115' ' ' VAL . 11.9 t60 -68.28 -35.59 78.09 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 109.689 -0.485 . . . . 0.52 109.689 178.091 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 0.435 ' HG ' ' O ' ' A' ' 108' ' ' LEU . 95.8 mt -65.61 -46.88 77.65 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 116.323 -0.398 . . . . 0.55 110.324 175.713 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 62.7 mt -56.7 -45.03 82.63 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.177 0 CA-C-N 115.767 -0.651 . . . . 0.84 109.709 177.254 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 17.1 tppt? -56.85 -49.99 73.78 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.054 -0.975 . . . . 3.83 110.919 178.191 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 115' ' ' VAL . . . . . 0.621 HG13 ' HB2' ' A' ' 120' ' ' HIS . 45.9 t -58.68 -42.87 86.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.194 -0.457 . . . . 1.19 111.57 -178.716 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 17.5 tppt? -70.02 -41.51 74.19 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 116.628 -0.26 . . . . 1.32 110.698 -179.257 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 74.5 mt -68.61 -30.69 69.48 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.881 0.372 . . . . 0.96 111.04 179.287 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -74.96 -16.7 60.63 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.917 -0.583 . . . . 2.18 110.483 179.696 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 99.25 32.83 5.65 Favored Glycine 0 N--CA 1.449 -0.486 0 C-N-CA 120.744 -0.741 . . . . 1.16 113.02 175.96 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 120' ' ' HIS . . . . . 0.621 ' HB2' HG13 ' A' ' 115' ' ' VAL . 78.4 m-70 -119.54 -179.52 3.9 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 109.79 -0.448 . . . . 2.42 109.79 177.692 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -117.46 149.27 40.85 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 120.956 0.408 . . . . 2.53 111.166 -176.119 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 2.6 pp -108.3 143.53 27.62 Favored Pre-proline 0 C--N 1.324 -0.542 0 CA-C-N 115.516 -0.766 . . . . 1.33 109.784 175.346 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -73.34 -13.9 25.41 Favored 'Trans proline' 0 C--N 1.343 0.261 0 C-N-CA 122.395 2.064 . . . . 1.33 113.164 -176.338 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 124' ' ' ALA . . . . . 0.559 ' HA ' HD22 ' A' ' 92' ' ' LEU . . . 61.01 17.68 8.18 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 123.162 0.585 . . . . 1.25 111.392 -177.402 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -134.4 163.13 30.36 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 107.817 -1.179 . . . . 2.73 107.817 174.268 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 64.2 mt -109.2 93.88 14.11 Favored Pre-proline 0 C--N 1.322 -0.614 0 CA-C-O 120.724 0.297 . . . . 1.66 111.515 -177.016 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 127' ' ' PRO . . . . . 0.432 ' HD2' HD12 ' A' ' 130' ' ' LEU . 63.5 Cg_endo -75.77 155.67 39.48 Favored 'Trans proline' 0 N--CA 1.459 -0.554 0 C-N-CA 122.571 2.181 . . . . 1.17 111.141 173.667 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 90.0 Cg_exo -44.44 -37.2 10.48 Favored 'Trans proline' 0 CA--C 1.533 0.452 0 C-N-CA 123.478 2.785 . . . . 1.54 114.557 -177.874 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 41.0 p-80 -82.03 10.27 6.9 Favored 'General case' 0 N--CA 1.466 0.339 0 C-N-CA 120.793 -0.363 . . . . 1.07 111.851 -175.503 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 130' ' ' LEU . . . . . 0.432 HD12 ' HD2' ' A' ' 127' ' ' PRO . 66.6 mt -126.99 1.57 6.57 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.514 0.197 . . . . 1.36 111.48 176.335 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 43.0 t -85.06 122.9 74.09 Favored Pre-proline 0 C--N 1.326 -0.456 0 N-CA-C 110.515 -0.18 . . . . 1.28 110.515 -178.74 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 132' ' ' PRO . . . . . 0.407 ' HA ' ' HD3' ' A' ' 133' ' ' PRO . 47.9 Cg_exo -56.12 129.2 33.58 Favored 'Trans proline' 0 C--N 1.346 0.407 0 C-N-CA 122.99 2.46 . . . . 0.81 112.329 178.881 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 133' ' ' PRO . . . . . 0.407 ' HD3' ' HA ' ' A' ' 132' ' ' PRO . 25.4 Cg_exo -62.01 -18.85 63.77 Favored 'Trans proline' 0 C--N 1.345 0.393 0 C-N-CA 122.884 2.39 . . . . 1.17 112.692 -177.131 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 8.4 p -77.24 -21.5 53.66 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 116.061 -0.518 . . . . 1.6 111.72 -179.317 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 135' ' ' LYS . . . . . 0.581 ' HE3' ' OE1' ' A' ' 105' ' ' GLU . 68.4 mttm . . . . . 0 C--N 1.328 -0.328 0 N-CA-C 111.721 0.267 . . . . 1.21 111.721 -175.074 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 149' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.445 -0.75 0 N-CA-C 111.748 -0.541 . . . . 0.48 111.748 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' B' B ' 150' ' ' PRO . . . . . . . . . . . . . 90.0 Cg_endo -80.79 -0.69 10.78 Favored 'Trans proline' 0 N--CA 1.461 -0.389 0 C-N-CA 122.864 2.376 . . . . 0.33 112.319 179.766 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 151' ' ' PHE . . . . . 0.594 ' CZ ' ' HA ' ' A' ' 73' ' ' LYS . 56.7 m-85 . . . . . 0 C--N 1.331 -0.207 0 N-CA-C 112.56 0.578 . . . . 0.75 112.56 -177.554 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 . . . . . 0 N--CA 1.455 -0.193 0 N-CA-C 109.755 -0.461 . . . . 3.1 109.755 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 5.1 t90 -83.11 104.08 13.03 Favored 'General case' 0 N--CA 1.444 -0.764 0 N-CA-C 107.698 -1.223 . . . . 0.71 107.698 168.93 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.422 ' HA ' ' HE3' ' A' ' 48' ' ' LYS . 29.7 m -69.82 4.89 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.234 0 CA-C-O 121.228 0.537 . . . . 1.45 111.628 -175.677 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.49 HG11 ' HA ' ' A' ' 108' ' ' LEU . 42.1 t -103.62 -29.48 2.9 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.818 0 CA-C-N 115.711 -0.677 . . . . 1.1 109.874 172.239 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 47' ' ' GLY . . . . . 0.524 ' HA2' ' HB2' ' A' ' 50' ' ' LYS . . . -82.89 -10.12 83.47 Favored Glycine 0 N--CA 1.448 -0.54 0 CA-C-N 115.88 -0.6 . . . . 0.59 113.023 -175.528 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 48' ' ' LYS . . . . . 0.422 ' HE3' ' HA ' ' A' ' 45' ' ' VAL . 17.2 ptpt -81.55 -25.89 35.48 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.772 0.32 . . . . 2.46 110.315 177.145 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 12.0 m-20 -110.11 33.21 4.58 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 108.948 -0.76 . . . . 1.66 108.948 173.577 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 50' ' ' LYS . . . . . 0.667 ' N ' ' HD2' ' A' ' 51' ' ' PRO . 17.3 ttpp -77.35 -43.04 2.58 Favored Pre-proline 0 C--O 1.219 -0.538 0 CA-C-O 118.633 -0.699 . . . . 1.15 112.067 -174.779 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 51' ' ' PRO . . . . . 0.667 ' HD2' ' N ' ' A' ' 50' ' ' LYS . 1.3 Cg_endo -44.74 -36.31 10.41 Favored 'Trans proline' 0 C--N 1.362 1.284 0 C-N-CA 123.0 2.467 . . . . 0.75 113.471 178.493 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 13.0 m -69.51 -45.49 68.75 Favored 'General case' 0 C--O 1.238 0.49 0 CA-C-O 121.111 0.481 . . . . 0.68 110.459 178.657 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 21.7 m-85 -70.97 -22.35 62.21 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.027 -0.533 . . . . 0.69 109.92 178.936 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -68.77 -45.03 72.44 Favored 'General case' 0 CA--C 1.513 -0.471 0 CA-C-N 116.163 -0.471 . . . . 2.18 109.856 175.667 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -61.78 -44.85 96.07 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.79 -0.641 . . . . 2.33 109.937 -179.821 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 45.0 mt -65.78 -40.95 89.17 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-N 115.798 -0.637 . . . . 0.64 110.84 177.634 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 77.7 t80 -61.9 -39.34 91.66 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.677 -0.692 . . . . 0.29 111.297 179.397 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 4.1 m-30 -79.79 -22.58 42.93 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.56 -0.291 . . . . 1.17 111.2 -175.573 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 28.2 p -79.57 -10.15 59.75 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.72 0.295 . . . . 0.44 111.446 178.257 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 53.7 mt -88.92 -0.47 57.42 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.566 -0.288 . . . . 1.37 110.246 175.274 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 55.7 m 62.43 81.04 0.24 Allowed Pre-proline 0 CA--C 1.533 0.313 0 O-C-N 123.788 0.68 . . . . 1.24 110.986 -176.86 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -76.61 157.54 36.02 Favored 'Trans proline' 0 N--CA 1.46 -0.482 0 C-N-CA 122.827 2.351 . . . . 0.47 112.307 -179.011 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 15.4 m -123.96 115.64 45.61 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 CA-C-N 116.157 -0.474 . . . . 1.02 110.073 177.231 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 82.6 m-20 63.82 24.71 13.85 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 115.467 -0.788 . . . . 1.34 111.375 179.809 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 88.69 10.52 67.19 Favored Glycine 0 C--N 1.33 0.224 0 C-N-CA 120.992 -0.623 . . . . 0.43 112.957 178.334 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 66' ' ' LYS . . . . . 0.537 ' HE2' ' OD1' ' A' ' 102' ' ' ASP . 82.2 mttt -136.13 154.45 50.98 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 110.152 -0.314 . . . . 1.48 110.152 179.687 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 40.9 pt -116.77 159.16 16.93 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 C-N-CA 121.109 -0.236 . . . . 0.64 110.397 174.942 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 68' ' ' THR . . . . . 0.518 ' HA ' HD23 ' A' ' 100' ' ' LEU . 44.8 p -80.85 169.85 17.03 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.324 -0.398 . . . . 0.55 110.148 -179.593 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 69' ' ' GLY . . . . . 0.541 ' O ' ' HB2' ' A' ' 73' ' ' LYS . . . -64.25 -16.98 61.0 Favored Glycine 0 N--CA 1.447 -0.626 0 C-N-CA 120.653 -0.784 . . . . 0.41 112.503 177.314 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -68.86 -46.75 67.68 Favored 'General case' 0 C--O 1.235 0.325 0 CA-C-O 121.219 0.533 . . . . 0.38 111.743 -179.139 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 1.7 m120 -72.71 -43.17 63.35 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.815 -0.629 . . . . 1.81 109.716 -174.575 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -64.1 -35.24 80.09 Favored 'General case' 0 N--CA 1.448 -0.568 0 CA-C-N 115.527 -0.761 . . . . 0.39 110.137 176.061 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 73' ' ' LYS . . . . . 0.541 ' HB2' ' O ' ' A' ' 69' ' ' GLY . 34.3 tttp -56.23 -45.11 80.11 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 116.13 -0.486 . . . . 0.84 110.194 176.259 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 74' ' ' LYS . . . . . 0.781 ' O ' ' HG2' ' A' ' 78' ' ' LYS . 45.8 mtpt -67.75 -31.38 71.26 Favored 'General case' 0 C--O 1.217 -0.651 0 CA-C-N 115.601 -0.727 . . . . 1.95 111.041 -178.742 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 13.9 tp10 -71.78 -47.52 52.89 Favored 'General case' 0 C--N 1.314 -0.971 0 CA-C-O 121.531 0.682 . . . . 1.6 109.753 178.52 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 76' ' ' MET . . . . . 0.779 ' HG3' ' HZ ' ' B' ' 151' ' ' PHE . 16.0 mmt -55.52 -42.36 74.42 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.095 -0.957 . . . . 1.24 109.684 175.691 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.64 HG12 ' O ' ' A' ' 74' ' ' LYS . 1.1 p -74.12 -23.27 18.55 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.413 0 CA-C-N 115.276 -0.875 . . . . 1.57 111.301 -177.226 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.781 ' HG2' ' O ' ' A' ' 74' ' ' LYS . 31.8 mmmt -73.56 -28.53 61.9 Favored 'General case' 0 CA--C 1.517 -0.319 0 CA-C-O 121.063 0.459 . . . . 2.79 109.872 176.165 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 45.1 m -81.91 -5.56 58.38 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.781 -0.645 . . . . 1.27 110.439 178.336 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 45.0 mttp 65.51 23.18 11.84 Favored 'General case' 0 N--CA 1.465 0.325 0 CA-C-N 115.418 -0.81 . . . . 2.97 112.03 169.078 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.714 ' HB2' HD21 ' A' ' 86' ' ' LEU . 88.0 mt -85.59 148.65 49.64 Favored Pre-proline 0 C--N 1.322 -0.626 0 CA-C-N 116.413 -0.358 . . . . 0.52 110.216 178.836 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 82' ' ' PRO . . . . . 0.534 ' O ' ' HG ' ' A' ' 86' ' ' LEU . 50.8 Cg_exo -54.91 137.34 75.46 Favored 'Trans proline' 0 C--N 1.344 0.294 0 C-N-CA 123.105 2.537 . . . . 0.44 112.206 179.043 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 83' ' ' ASN . . . . . 0.513 ' HA ' HD12 ' A' ' 86' ' ' LEU . 4.6 p30 -60.16 -34.81 74.09 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-N 115.954 -0.566 . . . . 1.85 110.965 -174.225 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 63.3 m -63.39 -40.6 97.65 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.674 -0.694 . . . . 1.47 110.379 177.697 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.455 HG23 ' HB2' ' A' ' 82' ' ' PRO . 52.3 t -71.66 -34.49 52.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 115.835 -0.62 . . . . 0.45 109.862 178.088 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.716 HD22 ' HB3' ' A' ' 76' ' ' MET . 77.1 mt -63.46 -33.9 76.57 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.969 -0.56 . . . . 0.9 110.073 174.728 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -66.78 -38.05 92.78 Favored Glycine 0 N--CA 1.45 -0.423 0 N-CA-C 111.362 -0.695 . . . . 0.32 111.362 176.064 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 88' ' ' LYS . . . . . 0.418 ' HB2' ' O ' ' A' ' 85' ' ' VAL . 71.7 mmtt -58.15 -49.48 76.87 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 109.974 -0.38 . . . . 1.89 109.974 172.125 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 0.423 HG12 ' O ' ' A' ' 85' ' ' VAL . 40.3 mm -59.32 -48.4 87.15 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.197 0 CA-C-N 115.752 -0.658 . . . . 0.71 111.294 -179.297 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 90' ' ' TRP . . . . . 0.414 ' HB2' ' HE2' ' B' ' 151' ' ' PHE . 41.8 t-105 -62.83 -45.16 93.9 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.937 0.398 . . . . 0.33 111.087 -178.563 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 21.1 ttpp -64.27 -27.64 69.18 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.06 -0.518 . . . . 2.7 111.285 -176.783 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.43 HD11 ' HG ' ' A' ' 126' ' ' LEU . 14.5 tp -93.9 -48.49 6.25 Favored 'General case' 0 N--CA 1.445 -0.696 0 N-CA-C 112.154 0.427 . . . . 1.66 112.154 -175.946 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -73.3 -41.12 63.95 Favored 'General case' 0 N--CA 1.463 0.21 0 N-CA-C 111.847 0.314 . . . . 0.47 111.847 -174.259 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 94' ' ' ASP . . . . . 0.622 ' OD2' ' HA ' ' A' ' 97' ' ' LYS . 21.9 t70 -78.08 96.34 5.11 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 108.965 -0.754 . . . . 0.79 108.965 176.089 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 45.7 t -78.31 -36.22 20.51 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 CA-C-N 115.647 -0.706 . . . . 0.61 111.08 -171.516 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 5.7 p30 -83.5 -11.39 57.51 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 116.042 -0.526 . . . . 0.96 112.03 -174.942 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 97' ' ' LYS . . . . . 0.622 ' HA ' ' OD2' ' A' ' 94' ' ' ASP . 0.0 OUTLIER 59.08 30.89 20.8 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-O 121.26 0.552 . . . . 2.96 111.181 172.981 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 98' ' ' ASP . . . . . 0.643 ' OD2' ' HB2' ' A' ' 100' ' ' LEU . 8.6 p-10 -86.83 9.8 18.02 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 115.453 -0.794 . . . . 0.43 111.24 -173.564 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 66.9 9.18 52.32 Favored Glycine 0 C--N 1.332 0.331 0 CA-C-N 116.089 -0.505 . . . . 0.44 112.476 -178.987 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.643 ' HB2' ' OD2' ' A' ' 98' ' ' ASP . 72.3 mt -135.18 161.45 35.32 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 109.145 -0.687 . . . . 1.11 109.145 179.955 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 80.1 mt -117.86 125.5 50.64 Favored 'General case' 0 C--N 1.311 -1.09 0 C-N-CA 120.725 -0.39 . . . . 0.42 110.035 176.73 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 102' ' ' ASP . . . . . 0.537 ' OD1' ' HE2' ' A' ' 66' ' ' LYS . 11.5 m-20 -68.94 172.51 6.5 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 108.111 -1.07 . . . . 1.72 108.111 172.939 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 2.0 p30 -63.16 -32.63 74.07 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 109.186 -0.672 . . . . 1.6 109.186 177.113 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 51.9 mt-10 -72.16 -45.2 61.41 Favored 'General case' 0 N--CA 1.452 -0.336 0 CA-C-N 115.888 -0.596 . . . . 1.66 110.956 175.463 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 29.7 mt-10 -64.89 -39.54 93.69 Favored 'General case' 0 N--CA 1.462 0.156 0 C-N-CA 120.818 -0.353 . . . . 0.44 110.449 -176.996 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 90.2 t80 -65.55 -40.87 93.33 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.298 -0.41 . . . . 0.42 110.173 177.214 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -58.7 -47.42 84.62 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.246 -0.433 . . . . 0.22 110.688 176.158 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.49 ' HA ' HG11 ' A' ' 46' ' ' VAL . 60.4 tp -61.82 -45.94 91.65 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-N 116.32 -0.4 . . . . 1.33 110.972 178.463 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 109' ' ' ALA . . . . . 0.677 ' O ' HG13 ' A' ' 113' ' ' ILE . . . -56.09 -57.16 13.32 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.052 -0.522 . . . . 0.32 110.549 177.878 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 110' ' ' ASN . . . . . 0.515 ' HA ' HD12 ' A' ' 113' ' ' ILE . 1.1 t-20 -56.31 -36.27 68.5 Favored 'General case' 0 CA--C 1.521 -0.162 0 CA-C-N 116.049 -0.523 . . . . 1.2 111.395 179.684 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 13.3 t60 -63.67 -39.92 95.55 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.159 -0.473 . . . . 0.52 110.174 -179.655 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 0.418 ' O ' HG12 ' A' ' 115' ' ' VAL . 94.6 mt -74.08 -39.86 63.15 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.27 -0.423 . . . . 0.55 110.498 178.302 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.677 HG13 ' O ' ' A' ' 109' ' ' ALA . 54.0 mt -58.42 -49.53 81.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-O 121.531 0.681 . . . . 0.84 110.361 177.647 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 114' ' ' LYS . . . . . 0.614 ' HE2' HD12 ' A' ' 117' ' ' LEU . 0.0 OUTLIER -71.31 -24.97 62.23 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.403 -0.817 . . . . 3.83 110.827 -177.157 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 115' ' ' VAL . . . . . 0.418 HG12 ' O ' ' A' ' 112' ' ' LEU . 0.4 OUTLIER -72.78 -33.29 43.58 Favored 'Isoleucine or valine' 0 C--O 1.235 0.306 0 N-CA-C 109.75 -0.463 . . . . 1.19 109.75 177.195 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 116' ' ' LYS . . . . . 0.458 ' HD2' ' O ' ' A' ' 120' ' ' HIS . 19.6 tptp -66.1 -39.5 90.03 Favored 'General case' 0 N--CA 1.442 -0.834 0 CA-C-N 116.125 -0.488 . . . . 1.32 109.929 173.06 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 117' ' ' LEU . . . . . 0.614 HD12 ' HE2' ' A' ' 114' ' ' LYS . 80.1 mt -65.45 -23.54 66.96 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 116.066 -0.515 . . . . 0.96 110.554 176.508 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 24.6 mm-40 -78.53 -7.01 57.05 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.918 -0.583 . . . . 2.18 111.237 177.878 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 86.22 25.53 36.59 Favored Glycine 0 N--CA 1.448 -0.508 0 C-N-CA 120.652 -0.785 . . . . 1.16 112.154 -179.277 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 120' ' ' HIS . . . . . 0.458 ' O ' ' HD2' ' A' ' 116' ' ' LYS . 63.7 m80 -109.86 152.04 26.28 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 110.058 -0.349 . . . . 2.42 110.058 178.029 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -108.12 155.75 20.05 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 116.015 -0.539 . . . . 2.53 109.563 176.73 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -118.74 131.73 24.18 Favored Pre-proline 0 C--N 1.321 -0.653 0 CA-C-N 116.478 -0.328 . . . . 1.33 110.33 -177.826 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_endo -71.19 -0.11 7.54 Favored 'Trans proline' 0 C--N 1.345 0.344 0 C-N-CA 123.274 2.649 . . . . 1.33 113.438 -177.051 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . 62.92 21.25 12.75 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-O 121.526 0.679 . . . . 1.25 110.348 -175.405 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -103.74 142.78 33.76 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.107 -0.951 . . . . 2.73 108.53 178.552 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 126' ' ' LEU . . . . . 0.43 ' HG ' HD11 ' A' ' 92' ' ' LEU . 38.6 mt -115.27 90.96 26.22 Favored Pre-proline 0 C--N 1.321 -0.659 0 C-N-CA 120.943 -0.303 . . . . 1.66 111.32 179.815 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 127' ' ' PRO . . . . . 0.497 ' HD2' HD12 ' A' ' 130' ' ' LEU . 41.7 Cg_endo -71.19 157.84 56.28 Favored 'Trans proline' 0 N--CA 1.46 -0.455 0 C-N-CA 122.678 2.252 . . . . 1.17 111.45 173.248 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 128' ' ' PRO . . . . . 0.436 ' HA ' HG22 ' A' ' 131' ' ' VAL . 78.1 Cg_exo -52.41 -29.55 39.84 Favored 'Trans proline' 0 CA--C 1.535 0.527 0 C-N-CA 123.271 2.647 . . . . 1.54 114.155 -177.35 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 12.2 p80 -83.36 1.85 39.25 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 120.476 -0.49 . . . . 1.07 111.495 -178.988 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 130' ' ' LEU . . . . . 0.497 HD12 ' HD2' ' A' ' 127' ' ' PRO . 26.0 mt -113.98 -7.59 13.12 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 116.846 -0.161 . . . . 1.36 111.304 175.149 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 131' ' ' VAL . . . . . 0.436 HG22 ' HA ' ' A' ' 128' ' ' PRO . 26.2 m -94.11 139.54 22.58 Favored Pre-proline 0 C--N 1.325 -0.471 0 CA-C-O 120.81 0.338 . . . . 1.28 110.145 177.452 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 132' ' ' PRO . . . . . 0.798 ' HG2' ' HB2' ' A' ' 135' ' ' LYS . 27.7 Cg_endo -63.08 143.95 91.55 Favored 'Trans proline' 0 C--O 1.234 0.285 0 C-N-CA 122.61 2.207 . . . . 0.81 112.217 -178.111 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -54.19 -30.54 61.71 Favored 'Trans proline' 0 C--N 1.345 0.377 0 C-N-CA 123.142 2.562 . . . . 1.17 112.961 179.254 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 50.2 p -75.36 -25.19 57.53 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 121.118 0.485 . . . . 1.6 111.515 -178.097 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 135' ' ' LYS . . . . . 0.798 ' HB2' ' HG2' ' A' ' 132' ' ' PRO . 87.9 mttt . . . . . 0 C--N 1.325 -0.495 0 CA-C-N 116.243 -0.435 . . . . 1.21 110.976 -173.308 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 149' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.446 -0.67 0 N-CA-C 111.541 -0.623 . . . . 0.48 111.541 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' B' B ' 150' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -77.59 -1.84 12.0 Favored 'Trans proline' 0 N--CA 1.463 -0.282 0 C-N-CA 122.753 2.302 . . . . 0.33 112.712 -178.334 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 151' ' ' PHE . . . . . 0.779 ' HZ ' ' HG3' ' A' ' 76' ' ' MET . 48.1 m-85 . . . . . 0 C--N 1.324 -0.508 0 CA-C-N 116.574 -0.284 . . . . 0.75 110.813 -178.448 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 26.9 mt-10 . . . . . 0 C--O 1.235 0.293 0 CA-C-O 120.612 0.244 . . . . 3.1 111.206 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 44' ' ' TRP . . . . . 0.553 ' CE3' ' HD3' ' A' ' 133' ' ' PRO . 5.1 t90 -83.84 111.04 18.85 Favored 'General case' 0 C--N 1.332 -0.191 0 N-CA-C 109.486 -0.561 . . . . 0.71 109.486 179.451 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 12.0 p -60.85 -27.36 41.0 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-N 116.08 -0.509 . . . . 1.45 111.662 -176.911 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 21.5 t -85.17 -11.44 11.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 120.962 0.411 . . . . 1.1 111.438 -177.367 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -66.38 -15.51 63.69 Favored Glycine 0 CA--C 1.518 0.231 0 C-N-CA 120.884 -0.674 . . . . 0.59 113.565 -174.339 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 4.0 ptpp? -91.32 -27.64 18.26 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.787 0.294 . . . . 2.46 111.526 -179.201 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 27.5 m-20 -92.44 32.23 1.23 Allowed 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 120.648 -0.421 . . . . 1.66 110.506 -175.692 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 7.8 mtpm? -79.78 -49.36 1.33 Allowed Pre-proline 0 C--O 1.214 -0.803 0 CA-C-O 118.544 -0.741 . . . . 1.15 112.728 -175.377 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 82.8 Cg_exo -43.1 -37.2 6.4 Favored 'Trans proline' 0 C--N 1.354 0.822 0 C-N-CA 122.156 1.904 . . . . 0.75 113.502 -178.928 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -71.88 -45.97 59.48 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.012 0.434 . . . . 0.68 111.878 179.238 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 12.8 m-85 -79.14 -22.31 45.3 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.508 -0.315 . . . . 0.69 110.153 -175.585 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -70.93 -40.56 72.02 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 108.628 -0.879 . . . . 2.18 108.628 173.553 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 20.6 tp10 -55.18 -48.34 73.94 Favored 'General case' 0 C--O 1.232 0.152 0 CA-C-N 114.988 -1.006 . . . . 2.33 109.923 176.16 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 40.5 mt -71.77 -38.36 65.6 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-N 115.541 -0.754 . . . . 0.64 110.907 178.968 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 57' ' ' PHE . . . . . 0.424 ' CE1' HG23 ' A' ' 67' ' ' ILE . 58.1 t80 -56.15 -34.96 66.63 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 116.022 -0.535 . . . . 0.29 111.576 -177.773 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 9.8 m-85 -88.81 5.46 43.53 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 112.194 0.442 . . . . 1.17 112.194 -175.871 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 80.4 p -98.98 -17.67 18.19 Favored 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 120.49 -0.484 . . . . 0.44 110.558 175.951 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.44 HD13 ' HA ' ' A' ' 60' ' ' LEU . 3.3 mm? -93.58 9.59 36.14 Favored 'General case' 0 N--CA 1.462 0.168 0 CA-C-N 116.225 -0.443 . . . . 1.37 110.962 179.257 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 19.0 m 65.27 87.3 0.12 Allowed Pre-proline 0 N--CA 1.466 0.36 0 CA-C-N 115.538 -0.756 . . . . 1.24 111.647 179.061 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 95.3 Cg_endo -88.91 139.52 3.81 Favored 'Trans proline' 0 N--CA 1.456 -0.682 0 C-N-CA 122.754 2.303 . . . . 0.47 113.39 -178.966 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 15.4 m -113.7 117.94 56.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 115.904 -0.589 . . . . 1.02 110.272 176.294 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 93.1 m-20 63.03 23.33 13.94 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 115.837 -0.62 . . . . 1.34 110.827 -178.157 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 78.4 24.69 62.66 Favored Glycine 0 N--CA 1.448 -0.526 0 C-N-CA 120.72 -0.752 . . . . 0.43 112.0 -177.367 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 24.4 mtpp -136.45 140.76 43.36 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 109.428 -0.582 . . . . 1.48 109.428 178.076 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 67' ' ' ILE . . . . . 0.424 HG23 ' CE1' ' A' ' 57' ' ' PHE . 45.8 pt -115.44 160.03 15.03 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 C-N-CA 120.614 -0.435 . . . . 0.64 110.668 175.286 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 68' ' ' THR . . . . . 0.401 ' HA ' HD23 ' A' ' 100' ' ' LEU . 24.0 p -79.26 158.99 27.47 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.664 -0.698 . . . . 0.55 110.867 179.992 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 69' ' ' GLY . . . . . 0.44 ' O ' ' HB2' ' A' ' 73' ' ' LYS . . . -64.98 -18.06 64.05 Favored Glycine 0 C--O 1.221 -0.656 0 C-N-CA 120.895 -0.669 . . . . 0.41 112.392 179.572 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.489 ' O ' ' HG3' ' A' ' 74' ' ' LYS . . . -62.33 -45.42 93.29 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.072 0.463 . . . . 0.38 111.385 179.818 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 48.1 m-80 -79.59 -34.84 40.42 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.216 -0.447 . . . . 1.81 110.623 -176.494 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -61.62 -39.71 92.26 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 109.368 -0.605 . . . . 0.39 109.368 173.054 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 73' ' ' LYS . . . . . 0.44 ' HB2' ' O ' ' A' ' 69' ' ' GLY . 78.9 tttt -57.87 -44.32 86.55 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 114.96 -1.018 . . . . 0.84 110.141 176.099 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 74' ' ' LYS . . . . . 0.731 ' O ' ' HG2' ' A' ' 78' ' ' LYS . 96.0 mttt -55.73 -54.66 41.58 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.726 -0.67 . . . . 1.95 110.926 178.701 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 75' ' ' GLU . . . . . 0.473 ' HA ' ' OE1' ' A' ' 75' ' ' GLU . 12.6 tp10 -64.34 -40.05 95.11 Favored 'General case' 0 C--O 1.239 0.538 0 CA-C-O 121.125 0.488 . . . . 1.6 111.151 -176.871 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 76' ' ' MET . . . . . 0.83 ' HB3' HD22 ' A' ' 86' ' ' LEU . 18.8 mmt -57.12 -47.05 82.05 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.892 -0.595 . . . . 1.24 111.358 179.607 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 25.4 m -74.29 -18.07 16.93 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.422 0 C-N-CA 120.798 -0.361 . . . . 1.57 111.381 -178.861 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.731 ' HG2' ' O ' ' A' ' 74' ' ' LYS . 46.2 mmtm -76.25 -20.95 56.92 Favored 'General case' 0 N--CA 1.463 0.186 0 CA-C-O 121.265 0.555 . . . . 2.79 109.614 174.322 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 16.9 m -79.68 2.17 23.65 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-N 115.497 -0.774 . . . . 1.27 111.729 -178.174 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 7.3 mtpm? 65.98 22.39 11.26 Favored 'General case' 0 N--CA 1.471 0.575 0 C-N-CA 123.224 0.61 . . . . 2.97 112.196 175.468 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.64 ' HB2' HD21 ' A' ' 86' ' ' LEU . 93.2 mt -95.58 147.18 32.61 Favored Pre-proline 0 C--N 1.325 -0.474 0 N-CA-C 110.012 -0.366 . . . . 0.52 110.012 178.239 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 82' ' ' PRO . . . . . 0.484 ' O ' ' HG ' ' A' ' 86' ' ' LEU . 1.5 Cg_endo -73.2 156.22 51.33 Favored 'Trans proline' 0 N--CA 1.457 -0.619 0 C-N-CA 122.293 1.995 . . . . 0.44 112.178 -178.885 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 88.6 m-20 -55.16 -38.96 68.96 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-N 115.973 -0.558 . . . . 1.85 111.503 -176.482 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 84' ' ' THR . . . . . 0.599 ' O ' ' HG2' ' A' ' 88' ' ' LYS . 3.1 p -57.55 -51.38 69.72 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.119 -0.491 . . . . 1.47 111.121 178.323 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 93.0 t -63.37 -40.94 90.94 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 115.578 -0.737 . . . . 0.45 110.834 -179.908 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.83 HD22 ' HB3' ' A' ' 76' ' ' MET . 83.5 mt -62.47 -37.37 85.7 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.138 -0.483 . . . . 0.9 110.715 179.199 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -68.61 -35.45 80.91 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.889 -0.672 . . . . 0.32 111.632 178.906 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 88' ' ' LYS . . . . . 0.599 ' HG2' ' O ' ' A' ' 84' ' ' THR . 74.8 mmtt -61.41 -52.75 63.29 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 109.419 -0.586 . . . . 1.89 109.419 176.064 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 0.523 HG23 HD12 ' A' ' 112' ' ' LEU . 42.5 mt -62.7 -38.88 82.79 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.374 0 CA-C-N 115.396 -0.82 . . . . 0.71 111.532 -177.093 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 64.7 t-105 -60.97 -45.77 93.44 Favored 'General case' 0 C--N 1.332 -0.19 0 C-N-CA 120.688 -0.405 . . . . 0.33 110.731 177.134 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 39.3 ttpt -66.48 -24.46 66.41 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.295 -0.411 . . . . 2.7 110.879 -177.319 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.455 ' HG ' ' O ' ' A' ' 88' ' ' LYS . 96.2 mt -86.03 -52.05 5.95 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.51 -0.314 . . . . 1.66 111.657 -179.784 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 93' ' ' ALA . . . . . 0.436 ' HA ' HD23 ' A' ' 108' ' ' LEU . . . -64.86 -38.74 91.98 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.198 -0.455 . . . . 0.47 111.687 -174.093 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 94' ' ' ASP . . . . . 0.439 ' OD2' ' HA ' ' A' ' 97' ' ' LYS . 25.6 t0 -81.71 97.11 7.77 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 109.44 -0.578 . . . . 0.79 109.44 178.948 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 44.3 t -82.77 -36.86 13.58 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-N 115.119 -0.946 . . . . 0.61 111.376 -173.969 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 1.9 p30 -87.0 -6.4 58.77 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.957 -0.565 . . . . 0.96 111.166 -176.544 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 97' ' ' LYS . . . . . 0.439 ' HA ' ' OD2' ' A' ' 94' ' ' ASP . 23.9 mmmt 59.95 38.74 20.81 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 115.651 -0.704 . . . . 2.96 110.814 173.35 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 15.9 p-10 -98.52 9.06 44.05 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.131 -0.486 . . . . 0.43 111.602 -173.817 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 66.07 6.72 33.55 Favored Glycine 0 C--N 1.333 0.389 0 C-N-CA 120.867 -0.682 . . . . 0.44 113.016 178.692 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.401 HD23 ' HA ' ' A' ' 68' ' ' THR . 90.0 mt -131.39 157.4 43.53 Favored 'General case' 0 N--CA 1.446 -0.659 0 N-CA-C 109.575 -0.528 . . . . 1.11 109.575 -178.95 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 83.1 mt -116.23 115.96 26.92 Favored 'General case' 0 C--N 1.315 -0.928 0 C-N-CA 120.669 -0.412 . . . . 0.42 110.481 177.491 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -70.55 173.19 7.33 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 108.672 -0.862 . . . . 1.72 108.672 171.85 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -57.85 -30.54 65.86 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 109.706 -0.479 . . . . 1.6 109.706 175.978 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 38.2 mt-10 -66.31 -56.79 9.47 Favored 'General case' 0 C--O 1.235 0.294 0 CA-C-N 115.762 -0.654 . . . . 1.66 111.192 175.242 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 105' ' ' GLU . . . . . 0.582 ' CG ' ' HE3' ' A' ' 135' ' ' LYS . 24.4 mt-10 -68.28 -34.93 77.07 Favored 'General case' 0 C--N 1.331 -0.202 0 C-N-CA 121.006 -0.278 . . . . 0.44 110.802 -173.561 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 84.8 t80 -69.15 -35.25 76.14 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 109.889 -0.412 . . . . 0.42 109.889 178.247 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -60.47 -42.15 95.65 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.009 0.433 . . . . 0.22 109.96 175.452 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.436 HD23 ' HA ' ' A' ' 93' ' ' ALA . 53.2 tp -66.62 -45.88 77.68 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.183 -0.462 . . . . 1.33 110.715 177.672 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -57.41 -50.38 73.17 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.24 -0.436 . . . . 0.32 111.172 179.0 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 4.1 m-20 -66.88 -30.61 70.83 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.161 -0.472 . . . . 1.2 110.979 179.349 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 111' ' ' HIS . . . . . 0.467 ' O ' HG23 ' A' ' 115' ' ' VAL . 55.6 t60 -64.51 -44.5 90.7 Favored 'General case' 0 C--O 1.22 -0.476 0 N-CA-C 109.749 -0.463 . . . . 0.52 109.749 177.057 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 0.523 HD12 HG23 ' A' ' 89' ' ' ILE . 88.3 mt -63.81 -41.11 97.96 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.308 -0.406 . . . . 0.55 110.494 178.534 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 81.2 mt -55.45 -51.76 53.76 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.308 0 CA-C-O 121.166 0.508 . . . . 0.84 110.296 174.092 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 114' ' ' LYS . . . . . 0.401 ' HA ' ' HD2' ' A' ' 114' ' ' LYS . 14.3 tptm -60.12 -48.54 81.28 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.329 -0.85 . . . . 3.83 110.809 -179.188 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 115' ' ' VAL . . . . . 0.498 HG12 ' HB2' ' A' ' 120' ' ' HIS . 54.4 t -62.75 -36.63 76.25 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-N 115.919 -0.582 . . . . 1.19 111.091 -177.736 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 116' ' ' LYS . . . . . 0.411 ' HE3' ' HB3' ' A' ' 116' ' ' LYS . 23.2 mmmt -64.47 -50.88 65.75 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.627 -0.261 . . . . 1.32 110.99 176.245 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 89.9 mt -69.06 -25.26 64.36 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.196 -0.457 . . . . 0.96 110.91 -178.919 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 31.6 tt0 -72.0 -14.78 61.98 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.057 -0.519 . . . . 2.18 110.583 179.504 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 107.47 28.51 4.83 Favored Glycine 0 N--CA 1.446 -0.635 0 C-N-CA 120.434 -0.889 . . . . 1.16 113.042 176.774 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 120' ' ' HIS . . . . . 0.498 ' HB2' HG12 ' A' ' 115' ' ' VAL . 28.6 m-70 -121.38 156.75 31.97 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 109.397 -0.594 . . . . 2.42 109.397 176.276 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -117.1 144.84 44.23 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 110.276 -0.268 . . . . 2.53 110.276 177.327 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 122' ' ' LEU . . . . . 0.448 ' H ' ' HG ' ' A' ' 122' ' ' LEU . 2.1 pp -97.39 145.51 29.79 Favored Pre-proline 0 C--N 1.323 -0.569 0 CA-C-N 116.376 -0.374 . . . . 1.33 110.756 -178.379 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 8.2 Cg_exo -73.31 -5.38 17.04 Favored 'Trans proline' 0 N--CA 1.465 -0.163 0 C-N-CA 122.927 2.418 . . . . 1.33 112.636 -178.277 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . 69.9 19.05 7.15 Favored 'General case' 0 N--CA 1.464 0.275 0 O-C-N 123.734 0.646 . . . . 1.25 111.232 -179.265 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 20.7 m-20 -116.52 171.6 7.75 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 109.359 -0.608 . . . . 2.73 109.359 174.543 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 36.3 tp -115.62 97.42 48.73 Favored Pre-proline 0 C--N 1.325 -0.466 0 CA-C-O 120.965 0.412 . . . . 1.66 110.486 177.582 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 127' ' ' PRO . . . . . 0.432 ' HD2' HD12 ' A' ' 130' ' ' LEU . 74.4 Cg_endo -75.97 156.03 38.63 Favored 'Trans proline' 0 CA--C 1.534 0.517 0 C-N-CA 122.962 2.442 . . . . 1.17 112.417 178.232 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 11.3 Cg_endo -54.95 -34.7 87.42 Favored 'Trans proline' 0 C--N 1.347 0.482 0 C-N-CA 123.395 2.73 . . . . 1.54 113.677 -175.76 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 12.7 p80 -79.96 7.63 8.58 Favored 'General case' 0 N--CA 1.465 0.302 0 C-N-CA 120.811 -0.356 . . . . 1.07 111.76 -177.595 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 130' ' ' LEU . . . . . 0.432 HD12 ' HD2' ' A' ' 127' ' ' PRO . 29.3 mt -116.98 5.58 12.89 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.533 0.206 . . . . 1.36 111.085 175.121 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 62.8 t -85.3 123.31 73.3 Favored Pre-proline 0 C--N 1.324 -0.51 0 CA-C-N 116.49 -0.323 . . . . 1.28 110.513 178.43 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 132' ' ' PRO . . . . . 0.483 ' HA ' ' HD3' ' A' ' 133' ' ' PRO . 53.6 Cg_exo -54.06 143.33 62.61 Favored 'Trans proline' 0 CA--C 1.534 0.521 0 C-N-CA 123.016 2.478 . . . . 0.81 112.724 179.351 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 133' ' ' PRO . . . . . 0.553 ' HD3' ' CE3' ' A' ' 44' ' ' TRP . 23.7 Cg_exo -62.97 -35.27 67.32 Favored 'Trans proline' 0 C--N 1.347 0.454 0 C-N-CA 122.937 2.424 . . . . 1.17 113.626 -175.005 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 23.2 t -87.44 0.01 56.15 Favored 'General case' 0 C--N 1.323 -0.573 0 C-N-CA 120.707 -0.397 . . . . 1.6 111.249 -175.216 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 135' ' ' LYS . . . . . 0.582 ' HE3' ' CG ' ' A' ' 105' ' ' GLU . 62.6 mttm . . . . . 0 C--N 1.327 -0.4 0 CA-C-O 120.905 0.383 . . . . 1.21 111.342 -176.762 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 149' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.445 -0.752 0 N-CA-C 111.099 -0.8 . . . . 0.48 111.099 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' B' B ' 150' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -74.93 -3.84 14.52 Favored 'Trans proline' 0 CA--C 1.53 0.293 0 C-N-CA 122.991 2.461 . . . . 0.33 113.118 -173.888 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 151' ' ' PHE . . . . . 0.551 ' CZ ' ' HG3' ' A' ' 76' ' ' MET . 61.2 m-85 . . . . . 0 C--N 1.327 -0.396 0 CA-C-O 120.788 0.328 . . . . 0.75 110.955 -179.388 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.758 0 N-CA-C 111.602 -0.599 . . . . 10.97 111.602 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 9.0 Cg_endo -87.91 113.67 0.85 Allowed 'Trans proline' 0 N--CA 1.452 -0.93 0 C-N-CA 123.2 2.6 . . . . 9.0 112.11 179.263 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -92.34 -48.29 6.74 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.16 -0.473 . . . . 7.42 109.732 177.157 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -84.75 60.67 4.79 Favored Glycine 0 N--CA 1.449 -0.482 0 C-N-CA 121.047 -0.596 . . . . 4.46 111.757 178.975 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 5.6 m -86.77 115.44 24.21 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 110.299 -0.26 . . . . 3.97 110.299 179.698 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 10.9 m-20 -76.75 93.1 3.63 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.315 0.579 . . . . 3.46 110.261 175.853 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 7.0 t70 -125.63 106.87 10.06 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.466 -0.788 . . . . 1.93 108.955 179.858 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 15.0 p -77.47 137.23 22.72 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-O 120.968 0.414 . . . . 1.85 111.128 -174.978 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -66.92 128.81 37.74 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.399 -0.819 . . . . 3.1 111.124 -177.587 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 6.4 t90 -82.39 106.01 13.92 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 109.333 -0.617 . . . . 0.71 109.333 178.089 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.574 ' O ' ' HG2' ' A' ' 48' ' ' LYS . 9.7 p -67.5 -7.0 5.67 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.546 0 CA-C-N 115.562 -0.744 . . . . 1.45 112.236 -171.812 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 57.9 t -80.7 -24.81 11.02 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-O 120.742 0.306 . . . . 1.1 110.759 178.393 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -74.0 -9.19 79.69 Favored Glycine 0 CA--C 1.519 0.284 0 C-N-CA 120.788 -0.72 . . . . 0.59 113.215 -175.342 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' LYS . . . . . 0.574 ' HG2' ' O ' ' A' ' 45' ' ' VAL . 18.7 ptmt -74.23 -27.77 60.93 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 117.134 0.467 . . . . 2.46 111.175 -176.651 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 36.9 t0 -125.36 33.25 5.18 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.608 0.718 . . . . 1.66 109.453 -179.671 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 0.644 ' N ' ' HD2' ' A' ' 51' ' ' PRO . 51.3 tttt -72.65 -43.86 8.97 Favored Pre-proline 0 C--N 1.321 -0.632 0 CA-C-N 115.471 -0.786 . . . . 1.15 112.059 -175.481 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.644 ' HD2' ' N ' ' A' ' 50' ' ' LYS . 1.7 Cg_endo -45.77 -37.07 15.78 Favored 'Trans proline' 0 C--N 1.359 1.082 0 C-N-CA 123.122 2.548 . . . . 0.75 113.184 176.692 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 24.2 m -68.36 -46.61 69.64 Favored 'General case' 0 C--O 1.239 0.54 0 CA-C-O 121.198 0.523 . . . . 0.68 110.304 -179.471 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 5.0 m-85 -75.11 -20.24 59.55 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.867 -0.606 . . . . 0.69 109.423 -178.451 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 7.6 t70 -67.26 -45.23 77.29 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.42 -0.809 . . . . 2.18 110.036 175.128 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 29.4 mt-10 -67.31 -29.17 68.68 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.229 -0.442 . . . . 2.33 110.593 178.715 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 54.0 mt -78.87 -29.42 14.25 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-O 121.386 0.612 . . . . 0.64 110.587 175.792 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' PHE . . . . . 0.554 ' CE2' ' HB3' ' A' ' 62' ' ' PRO . 72.8 t80 -71.2 -41.08 70.74 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.961 -0.563 . . . . 0.29 110.623 178.765 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 58' ' ' TYR . . . . . 0.614 ' HA ' ' HG3' ' A' ' 62' ' ' PRO . 2.5 m-85 -78.23 -12.45 60.0 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.917 -0.583 . . . . 1.17 111.656 -176.049 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 3.8 p -91.88 -7.61 48.81 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 120.96 0.409 . . . . 0.44 110.988 178.655 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 89.1 mt -100.77 11.49 39.45 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-N 116.015 -0.539 . . . . 1.37 110.5 177.75 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 24.6 m 65.65 85.28 0.16 Allowed Pre-proline 0 N--CA 1.463 0.213 0 CA-C-N 115.363 -0.835 . . . . 1.24 111.8 178.347 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' PRO . . . . . 0.614 ' HG3' ' HA ' ' A' ' 58' ' ' TYR . 4.6 Cg_endo -85.59 130.87 3.87 Favored 'Trans proline' 0 N--CA 1.454 -0.795 0 C-N-CA 122.996 2.464 . . . . 0.47 112.162 178.626 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 60.2 t -112.25 108.83 26.51 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 N-CA-C 109.755 -0.461 . . . . 1.02 109.755 177.477 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 92.0 m-20 62.15 30.03 17.65 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.664 -0.698 . . . . 1.34 111.922 178.029 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 94.58 3.38 62.78 Favored Glycine 0 CA--C 1.519 0.296 0 C-N-CA 120.792 -0.718 . . . . 0.43 113.817 173.668 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 55.5 mttm -129.37 150.53 50.69 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 117.135 0.467 . . . . 1.48 110.488 177.555 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 33.7 pt -117.66 159.67 17.72 Favored 'Isoleucine or valine' 0 C--O 1.24 0.605 0 CA-C-O 121.264 0.554 . . . . 0.64 110.455 172.836 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 22.4 p -72.28 151.67 42.64 Favored 'General case' 0 N--CA 1.446 -0.64 0 CA-C-N 114.915 -1.038 . . . . 0.55 110.784 179.046 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -71.05 -10.47 68.63 Favored Glycine 0 C--O 1.222 -0.63 0 C-N-CA 120.744 -0.741 . . . . 0.41 111.609 179.957 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -70.52 -40.85 73.25 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.069 0.461 . . . . 0.38 111.181 178.65 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 30.2 m-80 -81.13 -33.09 33.43 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.971 -0.559 . . . . 1.81 110.34 -178.409 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -62.95 -46.41 87.88 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 109.424 -0.584 . . . . 0.39 109.424 171.558 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' LYS . . . . . 0.422 ' HA ' ' CE1' ' B' ' 151' ' ' PHE . 54.6 tttp -52.25 -43.38 64.33 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 115.248 -0.887 . . . . 0.84 110.414 174.671 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 74' ' ' LYS . . . . . 0.54 ' O ' ' HG2' ' A' ' 78' ' ' LYS . 35.5 ttpt -59.16 -49.91 76.05 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.239 -0.891 . . . . 1.95 111.397 179.037 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 3.1 tp10 -59.32 -47.98 83.35 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.359 0.599 . . . . 1.6 110.514 177.108 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' MET . . . . . 0.726 ' HB3' HD22 ' A' ' 86' ' ' LEU . 70.9 mmm -55.75 -47.09 77.57 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.383 -0.826 . . . . 1.24 111.457 -177.819 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 29.5 m -75.56 -20.7 15.95 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.362 0 N-CA-C 111.702 0.26 . . . . 1.57 111.702 -177.641 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.54 ' HG2' ' O ' ' A' ' 74' ' ' LYS . 24.0 mmtp -72.96 -27.46 61.84 Favored 'General case' 0 CA--C 1.52 -0.196 0 CA-C-O 121.111 0.482 . . . . 2.79 110.151 174.723 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 66.1 m -85.59 5.09 33.22 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.831 -0.622 . . . . 1.27 111.291 179.286 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 80' ' ' LYS . . . . . 0.446 ' NZ ' ' HB3' ' A' ' 80' ' ' LYS . 5.0 mmmp? 62.9 31.92 16.0 Favored 'General case' 0 C--O 1.235 0.328 0 N-CA-C 113.343 0.868 . . . . 2.97 113.343 170.188 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.432 ' HA ' ' HD3' ' A' ' 82' ' ' PRO . 87.0 mt -87.29 136.54 33.41 Favored Pre-proline 0 C--N 1.322 -0.624 0 C-N-CA 120.651 -0.42 . . . . 0.52 110.335 176.813 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 82' ' ' PRO . . . . . 0.563 ' O ' ' HG ' ' A' ' 86' ' ' LEU . 32.0 Cg_exo -58.7 152.76 54.14 Favored 'Trans proline' 0 C--N 1.344 0.332 0 C-N-CA 122.795 2.33 . . . . 0.44 111.991 178.261 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 83' ' ' ASN . . . . . 0.551 ' HA ' HD12 ' A' ' 86' ' ' LEU . 17.6 m120 -55.21 -33.53 63.14 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-N 116.481 -0.327 . . . . 1.85 111.658 -177.088 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 7.3 p -63.78 -46.64 84.31 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.255 0.55 . . . . 1.47 110.674 177.161 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.494 ' O ' HG12 ' A' ' 89' ' ' ILE . 47.8 t -69.1 -32.75 55.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 115.616 -0.72 . . . . 0.45 110.61 -179.871 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.726 HD22 ' HB3' ' A' ' 76' ' ' MET . 79.7 mt -57.58 -46.67 83.72 Favored 'General case' 0 C--O 1.238 0.471 0 CA-C-N 116.119 -0.491 . . . . 0.9 110.098 176.188 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -66.62 -35.39 89.82 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.821 -0.704 . . . . 0.32 111.625 178.282 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 48.3 mmtt -57.21 -52.46 65.23 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-O 120.907 0.384 . . . . 1.89 110.819 175.52 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.605 ' HB ' ' HE1' ' A' ' 76' ' ' MET . 50.6 mm -61.16 -47.0 95.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 115.581 -0.736 . . . . 0.71 110.938 -177.675 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 50.0 t-105 -59.21 -46.87 87.3 Favored 'General case' 0 CA--C 1.53 0.198 0 CA-C-O 120.825 0.345 . . . . 0.33 110.984 179.511 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 17.0 ttmm -54.42 -37.8 65.53 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 115.71 -0.677 . . . . 2.7 112.025 178.319 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.749 HD11 ' HA ' ' A' ' 124' ' ' ALA . 96.9 mt -86.22 -29.95 22.77 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.5 -0.318 . . . . 1.66 111.774 -176.907 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 93' ' ' ALA . . . . . 0.683 ' HA ' HD22 ' A' ' 108' ' ' LEU . . . -79.57 -42.31 25.29 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 116.458 -0.337 . . . . 0.47 111.868 -175.659 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -102.99 95.14 5.95 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.186 0.517 . . . . 0.79 110.197 -177.994 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 32.3 t -67.47 -40.52 84.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 115.388 -0.824 . . . . 0.61 111.53 -174.27 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 13.2 p-10 -90.0 -20.09 23.68 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.24 -0.437 . . . . 0.96 110.919 -175.994 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 0.513 ' HB2' ' NZ ' ' A' ' 97' ' ' LYS . 8.0 mtmp? 66.33 60.4 0.62 Allowed 'General case' 0 C--O 1.233 0.21 0 CA-C-N 115.848 -0.615 . . . . 2.96 111.038 177.164 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 98' ' ' ASP . . . . . 0.657 ' OD1' 'CA ' ' A' ' 141' ' ' ' CA' . 11.2 p-10 -94.3 9.57 37.61 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.211 -0.45 . . . . 0.43 110.907 -179.598 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 73.99 -19.03 1.78 Allowed Glycine 0 CA--C 1.519 0.329 0 CA-C-N 116.025 -0.534 . . . . 0.44 113.346 175.592 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 94.7 mt -113.35 151.63 30.99 Favored 'General case' 0 C--N 1.318 -0.775 0 N-CA-C 108.889 -0.782 . . . . 1.11 108.889 178.227 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 58.5 mt -104.04 119.99 40.12 Favored 'General case' 0 C--N 1.318 -0.796 0 C-N-CA 120.414 -0.514 . . . . 0.42 110.519 178.762 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 102' ' ' ASP . . . . . 0.579 ' HB2' ' HG3' ' A' ' 105' ' ' GLU . 20.6 m-20 -69.38 168.61 14.03 Favored 'General case' 0 CA--C 1.513 -0.46 0 N-CA-C 108.721 -0.844 . . . . 1.72 108.721 171.586 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 12.7 p-10 -59.99 -35.89 76.0 Favored 'General case' 0 C--N 1.317 -0.845 0 N-CA-C 109.612 -0.514 . . . . 1.6 109.612 176.094 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 37.5 mm-40 -65.57 -51.17 61.76 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-N 115.668 -0.697 . . . . 1.66 110.288 176.138 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 105' ' ' GLU . . . . . 0.579 ' HG3' ' HB2' ' A' ' 102' ' ' ASP . 42.5 mt-10 -64.41 -42.78 95.89 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.75 -0.659 . . . . 0.44 111.074 -174.404 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 90.2 t80 -66.91 -34.89 78.78 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.245 -0.434 . . . . 0.42 110.434 -179.574 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -60.8 -40.4 92.53 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.874 0.368 . . . . 0.22 110.326 175.667 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.683 HD22 ' HA ' ' A' ' 93' ' ' ALA . 6.9 tt -66.45 -50.21 64.11 Favored 'General case' 0 C--O 1.237 0.409 0 CA-C-N 116.217 -0.447 . . . . 1.33 110.094 178.791 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 109' ' ' ALA . . . . . 0.64 ' O ' HG13 ' A' ' 113' ' ' ILE . . . -54.59 -55.98 23.76 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 115.961 -0.563 . . . . 0.32 110.728 178.072 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 110' ' ' ASN . . . . . 0.625 ' HA ' HD12 ' A' ' 113' ' ' ILE . 0.7 OUTLIER -52.93 -39.91 63.22 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.662 -0.699 . . . . 1.2 111.176 179.98 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 111' ' ' HIS . . . . . 0.415 ' O ' HG23 ' A' ' 115' ' ' VAL . 37.2 t60 -60.54 -53.26 59.65 Favored 'General case' 0 C--O 1.223 -0.295 0 N-CA-C 110.115 -0.328 . . . . 0.52 110.115 178.548 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 92.5 mt -54.87 -42.98 72.73 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-O 120.975 0.417 . . . . 0.55 110.775 179.42 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.64 HG13 ' O ' ' A' ' 109' ' ' ALA . 70.6 mt -57.5 -56.63 14.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 115.542 -0.754 . . . . 0.84 111.488 -179.374 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 114' ' ' LYS . . . . . 0.517 ' HG2' ' O ' ' A' ' 110' ' ' ASN . 63.2 mmtt -69.55 -32.99 72.12 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.69 -0.687 . . . . 3.83 110.644 -174.261 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.529 HG12 ' HB2' ' A' ' 120' ' ' HIS . 51.5 t -62.96 -33.78 62.51 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-N 115.914 -0.585 . . . . 1.19 110.679 174.212 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 3.5 mmmp? -68.27 -37.19 80.46 Favored 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 120.694 -0.402 . . . . 1.32 110.19 173.225 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 98.1 mt -67.66 -27.78 67.14 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.201 -0.454 . . . . 0.96 110.537 177.328 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 118' ' ' GLU . . . . . 0.408 ' HB2' ' O ' ' A' ' 115' ' ' VAL . 45.8 mt-10 -64.85 -22.41 66.99 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.06 -0.518 . . . . 2.18 111.165 174.819 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 106.28 10.82 28.86 Favored Glycine 0 N--CA 1.445 -0.728 0 C-N-CA 120.417 -0.897 . . . . 1.16 111.854 -176.906 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 120' ' ' HIS . . . . . 0.529 ' HB2' HG12 ' A' ' 115' ' ' VAL . 1.8 m80 -88.6 159.27 17.96 Favored 'General case' 0 C--O 1.235 0.318 0 N-CA-C 109.381 -0.6 . . . . 2.42 109.381 177.32 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 18.2 mt-10 -114.04 163.28 15.37 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 110.285 -0.265 . . . . 2.53 110.285 174.166 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 122' ' ' LEU . . . . . 0.766 ' H ' HD23 ' A' ' 122' ' ' LEU . 2.2 pt? -106.05 136.39 19.32 Favored Pre-proline 0 C--N 1.326 -0.422 0 CA-C-N 116.494 -0.321 . . . . 1.33 110.588 -176.771 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 123' ' ' PRO . . . . . 0.44 ' HD3' ' HA ' ' A' ' 122' ' ' LEU . 10.7 Cg_exo -72.13 -14.91 28.95 Favored 'Trans proline' 0 N--CA 1.464 -0.238 0 C-N-CA 122.889 2.393 . . . . 1.33 112.125 177.685 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 124' ' ' ALA . . . . . 0.749 ' HA ' HD11 ' A' ' 92' ' ' LEU . . . 64.72 18.99 11.69 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 115.417 -0.81 . . . . 1.25 112.106 179.238 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 24.4 t70 -128.45 152.16 48.55 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 108.921 -0.77 . . . . 2.73 108.921 174.767 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 126' ' ' LEU . . . . . 0.527 ' HG ' HG22 ' A' ' 131' ' ' VAL . 36.3 tp -105.75 105.44 53.0 Favored Pre-proline 0 C--N 1.322 -0.602 0 CA-C-O 120.747 0.308 . . . . 1.66 111.588 -172.645 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 127' ' ' PRO . . . . . 0.482 ' HD2' HD12 ' A' ' 130' ' ' LEU . 71.9 Cg_endo -79.61 155.04 24.12 Favored 'Trans proline' 0 CA--C 1.534 0.508 0 C-N-CA 122.722 2.281 . . . . 1.17 112.059 174.679 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 12.6 Cg_endo -56.7 -26.01 63.24 Favored 'Trans proline' 0 CA--C 1.534 0.504 0 C-N-CA 123.35 2.7 . . . . 1.54 114.32 -174.937 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 32.0 p-80 -87.14 3.34 46.72 Favored 'General case' 0 N--CA 1.462 0.169 0 C-N-CA 120.441 -0.504 . . . . 1.07 111.148 -179.442 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 130' ' ' LEU . . . . . 0.482 HD12 ' HD2' ' A' ' 127' ' ' PRO . 24.2 mt -110.8 -17.86 13.25 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.453 -0.34 . . . . 1.36 110.615 173.617 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 131' ' ' VAL . . . . . 0.527 HG22 ' HG ' ' A' ' 126' ' ' LEU . 6.7 t -75.73 122.41 87.02 Favored Pre-proline 0 C--N 1.328 -0.336 0 N-CA-C 109.844 -0.428 . . . . 1.28 109.844 178.832 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_exo -49.58 135.98 33.69 Favored 'Trans proline' 0 C--N 1.344 0.327 0 C-N-CA 122.851 2.367 . . . . 0.81 112.078 177.153 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 133' ' ' PRO . . . . . 0.475 ' HA ' ' NE ' ' A' ' 136' ' ' ARG . 10.1 Cg_endo -51.23 -36.43 56.36 Favored 'Trans proline' 0 C--N 1.344 0.322 0 C-N-CA 123.762 2.974 . . . . 1.17 113.815 -173.818 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 14.6 m -89.34 1.32 55.94 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 112.048 0.388 . . . . 1.6 112.048 -176.783 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 66.0 mttm -120.4 3.42 10.79 Favored 'General case' 0 CA--C 1.532 0.278 0 O-C-N 122.313 -0.242 . . . . 1.21 111.198 -179.885 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 136' ' ' ARG . . . . . 0.475 ' NE ' ' HA ' ' A' ' 133' ' ' PRO . 35.7 ptt180 -103.78 151.37 23.13 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 113.037 0.754 . . . . 2.76 113.037 -170.066 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 67.5 mtt180 -127.14 155.35 43.49 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 114.962 -1.017 . . . . 4.54 108.693 170.934 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 34.0 t60 -133.43 111.36 10.68 Favored 'General case' 0 C--N 1.318 -0.77 0 C-N-CA 120.397 -0.521 . . . . 5.95 110.808 170.788 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 74.2 mm-40 . . . . . 0 C--O 1.244 0.809 0 CA-C-O 118.394 -0.813 . . . . 6.15 109.868 176.172 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' B' B ' 143' ' ' PHE . . . . . . . . . . . . . 71.5 t80 . . . . . 0 N--CA 1.478 0.927 0 CA-C-O 120.766 0.317 . . . . 11.86 110.575 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' B' B ' 144' ' ' ASN . . . . . . . . . . . . . 27.7 t-20 -72.12 132.44 44.19 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.1 0.476 . . . . 8.14 111.213 179.643 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 145' ' ' TYR . . . . . . . . . . . . . 72.7 t80 -151.49 139.21 19.76 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.804 -0.634 . . . . 6.71 109.786 -177.864 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 146' ' ' GLU . . . . . . . . . . . . . 2.2 pp20? -119.06 179.97 4.0 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.679 0.276 . . . . 6.61 111.047 -178.987 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 147' ' ' SER . . . . . . . . . . . . . 33.2 p -121.25 -58.3 1.8 Allowed 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.309 0.576 . . . . 3.65 111.07 -177.935 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 148' ' ' THR . . . . . . . . . . . . . 1.3 p -139.4 32.01 2.1 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.326 -0.852 . . . . 1.79 109.376 -179.76 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 149' ' ' GLY . . . . . . . . . . . . . . . 133.99 158.57 8.62 Favored Glycine 0 N--CA 1.437 -1.243 0 N-CA-C 110.832 -0.907 . . . . 0.48 110.832 -171.318 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 150' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -73.21 -0.88 9.76 Favored 'Trans proline' 0 CA--C 1.53 0.323 0 C-N-CA 123.249 2.632 . . . . 0.33 112.312 -177.009 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 151' ' ' PHE . . . . . 0.719 ' CZ ' ' HG3' ' A' ' 76' ' ' MET . 46.7 m-85 -106.96 -38.55 6.01 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.055 -0.52 . . . . 0.75 112.183 -178.617 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 152' ' ' THR . . . . . . . . . . . . . 4.5 p -87.43 24.01 1.75 Allowed 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 112.372 0.508 . . . . 2.22 112.372 -170.871 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 153' ' ' ALA . . . . . . . . . . . . . . . -72.54 142.82 48.48 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 116.437 -0.347 . . . . 4.4 110.473 178.079 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 154' ' ' LYS . . . . . . . . . . . . . 35.8 mmtp . . . . . 0 C--O 1.25 1.113 0 CA-C-O 118.481 -0.771 . . . . 6.75 110.19 -179.621 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 141' ' ' ' CA' . . . . . 0.657 'CA ' ' OD1' ' A' ' 98' ' ' ASP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.58 0 N-CA-C 112.139 -0.384 . . . . 10.97 112.139 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 16.5 Cg_endo -58.66 -35.59 98.42 Favored 'Trans proline' 0 C--N 1.344 0.307 0 C-N-CA 122.908 2.405 . . . . 9.0 112.308 178.881 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 1.2 tm? -135.98 -71.69 0.46 Allowed 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 109.883 -0.414 . . . . 7.42 109.883 179.668 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 148.06 93.22 0.11 Allowed Glycine 0 N--CA 1.448 -0.533 0 C-N-CA 120.504 -0.855 . . . . 4.46 112.428 -179.009 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 46.3 m -150.53 25.84 0.77 Allowed 'General case' 0 C--N 1.318 -0.764 0 CA-C-O 121.787 0.803 . . . . 3.97 108.849 178.166 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -109.74 108.41 18.77 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 114.597 -1.183 . . . . 3.46 110.569 -172.809 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -76.84 95.38 4.06 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.087 -0.506 . . . . 1.93 111.316 -178.411 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 40.8 t -78.7 119.81 28.53 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 N-CA-C 109.525 -0.546 . . . . 1.85 109.525 174.52 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 4.1 mp0 -66.82 150.04 49.72 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.356 0.598 . . . . 3.1 111.887 -176.501 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' TRP . . . . . 0.523 ' HH2' ' O ' ' A' ' 104' ' ' GLU . 7.7 t90 -70.6 116.12 10.55 Favored 'General case' 0 N--CA 1.45 -0.436 0 CA-C-N 115.191 -0.913 . . . . 0.71 109.025 178.533 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 9.9 p -67.38 -9.61 10.52 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-O 121.14 0.495 . . . . 1.45 111.371 -174.657 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 51.0 t -89.41 -20.76 7.01 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-O 121.262 0.553 . . . . 1.1 110.317 176.866 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' GLY . . . . . 0.438 ' HA2' ' HG2' ' A' ' 50' ' ' LYS . . . -72.68 -19.34 79.15 Favored Glycine 0 N--CA 1.446 -0.635 0 CA-C-N 115.706 -0.679 . . . . 0.59 112.897 -175.666 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 15.3 ptpt -76.61 -26.1 54.6 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.602 0.239 . . . . 2.46 111.138 -179.182 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -101.2 34.25 2.6 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.023 0.439 . . . . 1.66 109.917 178.259 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 0.438 ' HG2' ' HA2' ' A' ' 47' ' ' GLY . 0.1 OUTLIER -67.73 -54.16 18.54 Favored Pre-proline 0 C--O 1.214 -0.775 0 CA-C-O 118.256 -0.878 . . . . 1.15 113.156 -175.922 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_exo -42.66 -41.76 8.33 Favored 'Trans proline' 0 C--N 1.358 1.068 0 C-N-CA 122.798 2.332 . . . . 0.75 113.868 -173.245 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 90.7 m -69.97 -44.76 68.79 Favored 'General case' 0 C--O 1.238 0.449 0 CA-C-O 121.1 0.476 . . . . 0.68 111.282 179.404 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' TYR . . . . . 0.43 ' HB3' HD21 ' A' ' 110' ' ' ASN . 8.6 m-30 -74.23 -23.21 59.14 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.957 0.408 . . . . 0.69 110.045 -177.491 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 84.2 m-20 -70.03 -44.23 69.69 Favored 'General case' 0 CA--C 1.511 -0.532 0 N-CA-C 108.961 -0.755 . . . . 2.18 108.961 175.818 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 10.8 tp10 -57.26 -47.29 81.78 Favored 'General case' 0 N--CA 1.45 -0.444 0 CA-C-N 115.016 -0.993 . . . . 2.33 110.225 178.541 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 39.8 mt -70.79 -37.54 69.14 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 CA-C-N 116.24 -0.437 . . . . 0.64 111.552 -178.273 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' PHE . . . . . 0.461 ' HD2' ' CE1' ' A' ' 58' ' ' TYR . 86.6 t80 -66.29 -45.3 80.89 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.807 0.337 . . . . 0.29 110.981 -178.689 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 58' ' ' TYR . . . . . 0.461 ' CE1' ' HD2' ' A' ' 57' ' ' PHE . 21.7 m-85 -79.81 -12.6 59.76 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.592 -0.276 . . . . 1.17 111.429 -174.596 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 11.5 p -88.7 -8.65 54.16 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.716 0.293 . . . . 0.44 111.286 177.406 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.481 ' HB3' ' HB3' ' A' ' 71' ' ' ASN . 35.2 mt -94.69 9.38 39.07 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.665 -0.243 . . . . 1.37 110.988 178.599 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 17.3 m 68.23 87.55 0.11 Allowed Pre-proline 0 CA--C 1.531 0.219 0 O-C-N 123.823 0.702 . . . . 1.24 110.854 -176.374 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -77.3 125.3 7.69 Favored 'Trans proline' 0 N--CA 1.458 -0.582 0 C-N-CA 122.586 2.191 . . . . 0.47 112.199 -179.463 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 12.5 m -115.3 119.35 61.55 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 CA-C-O 121.091 0.472 . . . . 1.02 110.271 177.432 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 65.5 m-20 64.39 22.24 12.7 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-N 115.711 -0.677 . . . . 1.34 110.742 -179.19 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 80.67 15.73 77.16 Favored Glycine 0 CA--C 1.52 0.352 0 C-N-CA 120.961 -0.638 . . . . 0.43 112.579 -178.393 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 0.751 ' HG2' ' HB3' ' A' ' 102' ' ' ASP . 86.8 mttt -137.37 160.14 39.92 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 109.739 -0.467 . . . . 1.48 109.739 179.812 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 67' ' ' ILE . . . . . 0.454 HD11 ' HB2' ' A' ' 101' ' ' LEU . 2.8 pp -119.48 158.12 21.18 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 N-CA-C 109.907 -0.405 . . . . 0.64 109.907 172.309 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 68' ' ' THR . . . . . 0.401 ' HA ' ' CD2' ' A' ' 100' ' ' LEU . 63.8 p -89.5 173.11 8.52 Favored 'General case' 0 C--N 1.321 -0.63 0 CA-C-N 116.203 -0.453 . . . . 0.55 110.898 -174.569 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -64.53 -19.29 64.56 Favored Glycine 0 N--CA 1.445 -0.726 0 C-N-CA 120.81 -0.709 . . . . 0.41 111.997 176.962 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -66.61 -46.01 77.24 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.168 0.509 . . . . 0.38 111.154 179.061 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' ASN . . . . . 0.481 ' HB3' ' HB3' ' A' ' 60' ' ' LEU . 1.7 m120 -77.57 -41.09 40.13 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.654 -0.703 . . . . 1.81 110.128 -175.148 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -62.78 -43.39 98.94 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.862 -0.608 . . . . 0.39 110.263 177.194 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' LYS . . . . . 0.54 ' O ' HG22 ' A' ' 77' ' ' VAL . 21.3 ttmm -56.96 -47.28 81.08 Favored 'General case' 0 CA--C 1.516 -0.332 0 CA-C-N 116.255 -0.43 . . . . 0.84 109.862 176.358 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 48.8 tttm -52.44 -50.65 62.17 Favored 'General case' 0 N--CA 1.451 -0.386 0 O-C-N 123.908 0.755 . . . . 1.95 111.209 -178.974 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 13.2 tp10 -70.7 -43.37 69.12 Favored 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 120.846 -0.341 . . . . 1.6 111.15 -178.208 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 64.7 mtt -64.34 -38.67 91.85 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 111.656 0.243 . . . . 1.24 111.656 -175.729 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.54 HG22 ' O ' ' A' ' 73' ' ' LYS . 32.9 m -76.31 -28.55 18.34 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.302 0 C-N-CA 120.788 -0.365 . . . . 1.57 110.621 177.271 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.456 ' HB3' ' HE3' ' A' ' 78' ' ' LYS . 19.8 mmmt -64.89 -25.78 68.04 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-N 116.18 -0.464 . . . . 2.79 110.727 173.58 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 20.3 m -75.16 -8.85 57.72 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.585 -0.734 . . . . 1.27 110.512 177.796 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 55.0 mtpt 62.34 42.64 8.95 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-N 115.903 -0.59 . . . . 2.97 111.126 177.38 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.709 ' HB2' HD11 ' A' ' 86' ' ' LEU . 97.5 mt -100.32 169.2 8.25 Favored Pre-proline 0 C--N 1.325 -0.495 0 CA-C-N 115.704 -0.68 . . . . 0.52 109.758 178.307 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 82' ' ' PRO . . . . . 0.407 ' CD ' ' HB3' ' A' ' 81' ' ' LEU . 2.0 Cg_endo -83.49 132.01 5.73 Favored 'Trans proline' 0 C--N 1.348 0.515 0 C-N-CA 123.274 2.65 . . . . 0.44 112.371 -178.478 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 5.0 p-10 -50.67 -38.67 47.95 Favored 'General case' 0 N--CA 1.472 0.638 0 N-CA-C 113.504 0.927 . . . . 1.85 113.504 -171.532 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 84' ' ' THR . . . . . 0.408 ' O ' ' HG2' ' A' ' 88' ' ' LYS . 75.7 m -65.79 -34.28 77.81 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 120.892 0.377 . . . . 1.47 110.925 -179.719 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.502 ' O ' HG12 ' A' ' 89' ' ' ILE . 95.6 t -71.12 -39.85 74.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.153 -0.476 . . . . 0.45 109.789 178.485 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.709 HD11 ' HB2' ' A' ' 81' ' ' LEU . 9.8 mp -58.44 -34.83 71.24 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.18 -0.464 . . . . 0.9 110.992 172.39 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 87' ' ' GLY . . . . . 0.417 ' HA2' ' HB2' ' B' ' 151' ' ' PHE . . . -65.66 -38.67 94.81 Favored Glycine 0 N--CA 1.447 -0.612 0 N-CA-C 111.072 -0.811 . . . . 0.32 111.072 176.619 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 88' ' ' LYS . . . . . 0.408 ' HG2' ' O ' ' A' ' 84' ' ' THR . 70.0 mmtt -63.43 -49.73 72.57 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.147 -0.526 . . . . 1.89 109.968 174.5 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.502 HG12 ' O ' ' A' ' 85' ' ' VAL . 40.8 mm -54.74 -49.82 65.46 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.097 0 CA-C-N 115.711 -0.677 . . . . 0.71 110.699 179.686 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 53.5 t-105 -61.38 -50.55 72.42 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.323 -0.399 . . . . 0.33 111.402 -178.671 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 91' ' ' LYS . . . . . 0.452 ' HE3' HG21 ' B' ' 152' ' ' THR . 26.4 ttmt -74.52 -10.76 59.87 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-O 121.009 0.433 . . . . 2.7 111.359 -172.766 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.439 HD11 ' HA ' ' A' ' 124' ' ' ALA . 94.1 mt -94.36 -37.42 11.48 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.336 -0.393 . . . . 1.66 111.08 172.7 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 93' ' ' ALA . . . . . 0.474 ' HA ' HD23 ' A' ' 108' ' ' LEU . . . -78.81 -36.85 42.08 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.224 -0.444 . . . . 0.47 111.489 -176.787 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 94' ' ' ASP . . . . . 0.638 ' OD1' 'CA ' ' A' ' 141' ' ' ' CA' . 26.7 t0 -81.15 86.83 6.12 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.612 0.72 . . . . 0.79 109.524 177.562 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.446 ' HB ' ' HD3' ' A' ' 135' ' ' LYS . 34.4 t -82.2 -30.74 9.83 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.587 0 CA-C-N 114.839 -1.073 . . . . 0.61 110.352 -174.796 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 96' ' ' ASP . . . . . 0.595 ' OD1' 'CA ' ' A' ' 141' ' ' ' CA' . 43.5 p-10 -86.41 -7.57 58.34 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.22 -0.445 . . . . 0.96 110.655 -179.461 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 88.9 mttt 59.06 44.62 15.85 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-N 115.716 -0.675 . . . . 2.96 111.129 172.974 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 98' ' ' ASP . . . . . 0.593 ' OD1' 'CA ' ' A' ' 141' ' ' ' CA' . 6.5 p-10 -107.08 9.06 30.56 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 116.246 -0.434 . . . . 0.43 111.016 -175.872 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 67.58 12.84 62.27 Favored Glycine 0 CA--C 1.518 0.277 0 C-N-CA 121.053 -0.594 . . . . 0.44 112.481 178.746 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.536 ' HB2' ' OD2' ' A' ' 98' ' ' ASP . 87.0 mt -135.77 153.3 51.59 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 109.114 -0.699 . . . . 1.11 109.114 178.817 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.454 ' HB2' HD11 ' A' ' 67' ' ' ILE . 89.9 mt -110.22 111.89 23.5 Favored 'General case' 0 C--N 1.315 -0.928 0 N-CA-C 109.166 -0.679 . . . . 0.42 109.166 175.009 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 102' ' ' ASP . . . . . 0.751 ' HB3' ' HG2' ' A' ' 66' ' ' LYS . 2.1 p30 -75.99 -174.82 2.81 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 116.233 -0.44 . . . . 1.72 110.672 178.523 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -54.86 -40.33 69.56 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 115.604 -0.726 . . . . 1.6 110.48 -179.215 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 104' ' ' GLU . . . . . 0.523 ' O ' ' HH2' ' A' ' 44' ' ' TRP . 54.5 mt-10 -73.62 -52.76 12.32 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.992 -0.549 . . . . 1.66 110.253 179.408 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 36.1 mt-10 -63.12 -37.93 89.15 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.238 -0.437 . . . . 0.44 111.753 -173.833 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 106' ' ' PHE . . . . . 0.456 ' CD2' ' HD1' ' A' ' 57' ' ' PHE . 54.1 t80 -74.86 -34.94 62.35 Favored 'General case' 0 C--N 1.326 -0.436 0 C-N-CA 120.781 -0.368 . . . . 0.42 110.098 -179.533 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -58.61 -42.43 88.13 Favored 'General case' 0 C--O 1.231 0.127 0 N-CA-C 109.714 -0.476 . . . . 0.22 109.714 173.215 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.474 HD23 ' HA ' ' A' ' 93' ' ' ALA . 64.8 tp -62.73 -43.77 97.95 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.842 -0.617 . . . . 1.33 110.557 176.055 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 109' ' ' ALA . . . . . 0.519 ' O ' HG13 ' A' ' 113' ' ' ILE . . . -57.86 -46.03 85.41 Favored 'General case' 0 C--O 1.225 -0.237 0 CA-C-N 116.251 -0.431 . . . . 0.32 110.869 178.562 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 110' ' ' ASN . . . . . 0.43 HD21 ' HB3' ' A' ' 53' ' ' TYR . 93.8 m-20 -63.4 -36.71 84.61 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 116.5 -0.318 . . . . 1.2 111.146 179.037 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 9.6 t60 -64.4 -37.87 89.04 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 109.615 -0.513 . . . . 0.52 109.615 178.838 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 94.3 mt -72.02 -39.19 69.33 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.793 -0.639 . . . . 0.55 110.742 178.098 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.519 HG13 ' O ' ' A' ' 109' ' ' ALA . 59.4 mt -56.68 -47.54 82.24 Favored 'Isoleucine or valine' 0 C--O 1.233 0.211 0 N-CA-C 109.816 -0.439 . . . . 0.84 109.816 175.247 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 114' ' ' LYS . . . . . 0.566 ' O ' ' HB2' ' A' ' 118' ' ' GLU . 4.6 mmmm -62.38 -44.11 97.23 Favored 'General case' 0 C--O 1.221 -0.413 0 CA-C-N 116.076 -0.511 . . . . 3.83 111.622 179.223 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.567 HG13 ' HB2' ' A' ' 120' ' ' HIS . 42.9 t -58.01 -43.25 84.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-O 120.835 0.35 . . . . 1.19 110.903 178.192 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 116' ' ' LYS . . . . . 0.472 ' HA ' ' HD2' ' A' ' 116' ' ' LYS . 18.3 tptt -65.75 -45.41 82.7 Favored 'General case' 0 N--CA 1.444 -0.754 0 CA-C-N 116.057 -0.519 . . . . 1.32 110.786 -178.982 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 95.7 mt -78.95 -15.75 57.88 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.511 -0.313 . . . . 0.96 111.78 -178.742 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 118' ' ' GLU . . . . . 0.566 ' HB2' ' O ' ' A' ' 114' ' ' LYS . 2.1 tp10 -79.4 -13.56 59.52 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 109.081 -0.711 . . . . 2.18 109.081 177.063 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 93.78 31.02 8.46 Favored Glycine 0 N--CA 1.452 -0.287 0 CA-C-N 115.236 -0.893 . . . . 1.16 112.318 178.293 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 120' ' ' HIS . . . . . 0.567 ' HB2' HG13 ' A' ' 115' ' ' VAL . 79.8 m80 -117.09 176.8 4.97 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 109.843 -0.429 . . . . 2.42 109.843 177.644 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 -126.41 155.07 42.75 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 120.789 0.328 . . . . 2.53 110.255 -177.85 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 122' ' ' LEU . . . . . 0.481 ' HA ' ' HD3' ' A' ' 123' ' ' PRO . 0.7 OUTLIER -116.39 135.64 22.91 Favored Pre-proline 0 C--N 1.324 -0.521 0 N-CA-C 109.807 -0.442 . . . . 1.33 109.807 177.931 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 123' ' ' PRO . . . . . 0.481 ' HD3' ' HA ' ' A' ' 122' ' ' LEU . 2.9 Cg_exo -76.45 10.31 2.23 Favored 'Trans proline' 0 C--O 1.234 0.315 0 C-N-CA 123.191 2.594 . . . . 1.33 113.393 -175.49 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 124' ' ' ALA . . . . . 0.439 ' HA ' HD11 ' A' ' 92' ' ' LEU . . . 57.91 27.21 14.33 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-O 121.24 0.543 . . . . 1.25 111.367 -178.89 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 8.2 t70 -132.42 154.67 49.61 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 109.235 -0.654 . . . . 2.73 109.235 -179.887 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 95.2 mt -108.46 101.67 43.78 Favored Pre-proline 0 C--N 1.324 -0.527 0 CA-C-O 120.917 0.389 . . . . 1.66 111.616 -177.078 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 127' ' ' PRO . . . . . 0.624 ' HG2' ' HB2' ' A' ' 130' ' ' LEU . 18.4 Cg_endo -62.64 151.95 80.68 Favored 'Trans proline' 0 CA--C 1.535 0.546 0 C-N-CA 122.821 2.347 . . . . 1.17 111.767 173.344 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -53.11 -35.7 73.83 Favored 'Trans proline' 0 CA--C 1.533 0.461 0 C-N-CA 123.415 2.743 . . . . 1.54 113.622 -175.23 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 11.9 p-80 -86.93 3.26 46.36 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 111.669 0.248 . . . . 1.07 111.669 -178.916 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 130' ' ' LEU . . . . . 0.624 ' HB2' ' HG2' ' A' ' 127' ' ' PRO . 16.5 tp -115.57 -1.14 12.83 Favored 'General case' 0 N--CA 1.446 -0.655 0 CA-C-O 120.965 0.412 . . . . 1.36 110.279 -177.912 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 131' ' ' VAL . . . . . 0.413 HG23 ' O ' ' A' ' 127' ' ' PRO . 65.0 t -88.69 129.77 47.6 Favored Pre-proline 0 C--N 1.327 -0.391 0 CA-C-N 115.987 -0.551 . . . . 1.28 110.122 178.598 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 132' ' ' PRO . . . . . 0.463 ' HA ' ' HD3' ' A' ' 133' ' ' PRO . 83.1 Cg_exo -48.31 130.38 20.93 Favored 'Trans proline' 0 C--N 1.348 0.532 0 C-N-CA 122.891 2.394 . . . . 0.81 112.306 177.685 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 133' ' ' PRO . . . . . 0.463 ' HD3' ' HA ' ' A' ' 132' ' ' PRO . 50.6 Cg_exo -54.27 -37.44 88.27 Favored 'Trans proline' 0 C--O 1.232 0.206 0 C-N-CA 123.446 2.764 . . . . 1.17 113.369 -174.296 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 12.8 m -83.99 -2.05 55.85 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.55 -0.295 . . . . 1.6 111.227 -177.05 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 135' ' ' LYS . . . . . 0.446 ' HD3' ' HB ' ' A' ' 95' ' ' VAL . 61.2 mttp -120.24 17.24 12.32 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 112.285 0.476 . . . . 1.21 112.285 -174.702 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 40.4 ptt180 -100.61 145.76 27.98 Favored 'General case' 0 C--N 1.324 -0.523 0 C-N-CA 120.748 -0.381 . . . . 2.76 110.255 177.927 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 33.7 mtp180 -99.22 -176.26 3.25 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.637 0.732 . . . . 4.54 112.59 -175.098 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 31.2 m80 -120.91 140.82 51.31 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 114.707 -1.133 . . . . 5.95 109.178 173.923 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 . . . . . 0 C--O 1.247 0.939 0 CA-C-O 118.218 -0.896 . . . . 6.15 111.157 -179.732 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' B' B ' 143' ' ' PHE . . . . . . . . . . . . . 40.1 m-85 . . . . . 0 N--CA 1.477 0.895 0 CA-C-O 121.19 0.519 . . . . 11.86 111.145 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' B' B ' 144' ' ' ASN . . . . . . . . . . . . . 3.6 p-10 -169.15 168.89 9.69 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 107.797 -1.186 . . . . 8.14 107.797 179.661 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 145' ' ' TYR . . . . . 0.437 ' HD2' ' H ' ' B' ' 147' ' ' SER . 36.0 t80 -103.21 159.3 15.66 Favored 'General case' 0 C--N 1.32 -0.692 0 C-N-CA 120.41 -0.516 . . . . 6.71 109.611 176.007 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 146' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -62.96 -23.3 67.34 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.719 -0.673 . . . . 6.61 111.118 -178.874 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 147' ' ' SER . . . . . 0.437 ' H ' ' HD2' ' B' ' 145' ' ' TYR . 36.6 t -98.46 119.54 37.34 Favored 'General case' 0 N--CA 1.447 -0.594 0 CA-C-N 115.86 -0.609 . . . . 3.65 109.417 178.704 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 148' ' ' THR . . . . . . . . . . . . . 2.6 p -105.78 19.5 20.46 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.342 0.591 . . . . 1.79 110.519 178.682 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 149' ' ' GLY . . . . . . . . . . . . . . . 161.29 157.54 8.86 Favored Glycine 0 N--CA 1.444 -0.778 0 CA-C-N 115.578 -0.737 . . . . 0.48 111.542 177.723 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 150' ' ' PRO . . . . . . . . . . . . . 69.4 Cg_endo -73.86 -8.33 21.16 Favored 'Trans proline' 0 N--CA 1.465 -0.204 0 C-N-CA 122.423 2.082 . . . . 0.33 112.106 -179.228 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 151' ' ' PHE . . . . . 0.43 ' CZ ' ' HA ' ' A' ' 73' ' ' LYS . 36.2 m-85 -108.59 -16.71 14.14 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.067 -0.515 . . . . 0.75 111.038 178.136 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 152' ' ' THR . . . . . 0.452 HG21 ' HE3' ' A' ' 91' ' ' LYS . 2.6 t -148.56 131.74 16.41 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.041 0.448 . . . . 2.22 111.935 -167.32 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 153' ' ' ALA . . . . . . . . . . . . . . . -109.76 166.36 10.97 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.899 -0.592 . . . . 4.4 109.806 176.26 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 154' ' ' LYS . . . . . . . . . . . . . 12.4 mptt . . . . . 0 C--O 1.247 0.94 0 CA-C-O 118.25 -0.881 . . . . 6.75 110.366 -177.696 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 141' ' ' ' CA' . . . . . 0.638 'CA ' ' OD1' ' A' ' 94' ' ' ASP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.723 0 N-CA-C 112.372 -0.291 . . . . 10.97 112.372 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 97.1 Cg_endo -84.4 68.78 6.34 Favored 'Trans proline' 0 N--CA 1.46 -0.444 0 C-N-CA 122.795 2.33 . . . . 9.0 112.084 178.414 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.488 ' H ' HD23 ' A' ' 37' ' ' LEU . 2.5 pt? -67.63 -25.12 65.58 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 116.109 -0.496 . . . . 7.42 111.662 -177.659 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -78.43 -48.3 7.49 Favored Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 120.857 -0.687 . . . . 4.46 112.311 -177.848 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 16.5 m 66.58 -75.44 0.06 Allowed 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 122.977 0.511 . . . . 3.97 110.596 -176.889 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -92.59 134.43 35.01 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 109.211 -0.662 . . . . 3.46 109.211 -179.502 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -114.57 138.73 50.28 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 120.646 0.26 . . . . 1.93 111.379 -171.686 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 13.5 p -99.37 144.39 12.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.184 -0.462 . . . . 1.85 110.718 -178.851 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.463 ' OE2' ' HA ' ' A' ' 45' ' ' VAL . 12.4 tt0 -74.01 143.04 45.73 Favored 'General case' 0 C--O 1.237 0.411 0 CA-C-O 120.879 0.371 . . . . 3.1 110.814 179.775 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 44' ' ' TRP . . . . . 0.487 ' HH2' ' O ' ' A' ' 104' ' ' GLU . 6.1 t90 -83.39 102.14 11.82 Favored 'General case' 0 N--CA 1.448 -0.545 0 N-CA-C 107.503 -1.295 . . . . 0.71 107.503 168.767 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.463 ' HA ' ' OE2' ' A' ' 43' ' ' GLU . 35.6 m -61.58 -9.66 3.24 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.532 0 N-CA-C 113.011 0.745 . . . . 1.45 113.011 -170.045 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 22.4 t -86.51 -20.17 7.91 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 CA-C-O 121.24 0.543 . . . . 1.1 110.194 177.794 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' GLY . . . . . 0.553 ' HA2' ' HG3' ' A' ' 50' ' ' LYS . . . -73.27 -25.86 71.97 Favored Glycine 0 N--CA 1.449 -0.45 0 CA-C-N 115.71 -0.677 . . . . 0.59 113.242 -175.145 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 6.4 ptpp? -74.06 -25.32 59.77 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 117.052 0.426 . . . . 2.46 111.051 -178.827 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 24.1 m-20 -105.67 33.75 3.6 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.114 0.483 . . . . 1.66 109.96 179.37 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 0.553 ' HG3' ' HA2' ' A' ' 47' ' ' GLY . 48.9 mttt -70.16 -43.25 18.32 Favored Pre-proline 0 C--O 1.219 -0.521 0 CA-C-O 118.499 -0.762 . . . . 1.15 112.657 178.042 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.512 ' O ' ' HG3' ' A' ' 55' ' ' GLU . 66.2 Cg_exo -39.64 -48.71 3.44 Favored 'Trans proline' 0 C--N 1.365 1.439 0 C-N-CA 122.82 2.346 . . . . 0.75 113.89 -179.243 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 18.4 m -69.54 -44.8 70.19 Favored 'General case' 0 C--O 1.239 0.509 0 CA-C-O 121.082 0.467 . . . . 0.68 111.148 -177.626 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 9.8 m-30 -70.34 -21.49 62.9 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.873 -0.603 . . . . 0.69 109.854 -178.238 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -74.88 -44.68 47.54 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.95 -0.568 . . . . 2.18 109.734 177.782 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.512 ' HG3' ' O ' ' A' ' 51' ' ' PRO . 72.0 mt-10 -60.6 -29.8 69.44 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.453 -0.794 . . . . 2.33 110.416 178.493 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.47 ' O ' HD13 ' A' ' 60' ' ' LEU . 52.4 mt -84.74 -48.72 16.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 116.148 -0.478 . . . . 0.64 111.225 177.566 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 57' ' ' PHE . . . . . 0.497 ' HE1' HG12 ' A' ' 67' ' ' ILE . 82.9 t80 -56.24 -37.37 69.65 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 122.99 0.516 . . . . 0.29 111.534 -176.699 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 58' ' ' TYR . . . . . 0.537 ' HA ' ' HG3' ' A' ' 62' ' ' PRO . 3.1 m-30 -80.44 -10.03 59.75 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.234 -0.439 . . . . 1.17 111.59 -174.487 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 61.4 p -98.13 -2.38 40.12 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.113 0.482 . . . . 0.44 110.646 176.808 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.47 HD13 ' O ' ' A' ' 56' ' ' ILE . 8.9 mp -97.52 12.59 32.87 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.867 -0.606 . . . . 1.37 110.526 179.439 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 44.6 t 64.32 73.5 0.45 Allowed Pre-proline 0 C--O 1.234 0.259 0 CA-C-N 115.595 -0.73 . . . . 1.24 111.407 -179.216 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' PRO . . . . . 0.537 ' HG3' ' HA ' ' A' ' 58' ' ' TYR . 61.2 Cg_endo -77.26 126.45 8.5 Favored 'Trans proline' 0 C--N 1.347 0.455 0 C-N-CA 122.212 1.942 . . . . 0.47 112.4 178.88 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 15.7 m -109.42 113.1 43.24 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 CA-C-O 121.253 0.549 . . . . 1.02 110.438 177.633 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 95.2 m-20 61.33 34.65 18.35 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 115.617 -0.72 . . . . 1.34 111.178 179.574 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 77.76 21.68 71.15 Favored Glycine 0 C--N 1.331 0.302 0 CA-C-N 115.89 -0.596 . . . . 0.43 112.927 178.243 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 58.4 mttm -141.13 148.96 40.9 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 109.904 -0.406 . . . . 1.48 109.904 -179.015 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' ILE . . . . . 0.497 HG12 ' HE1' ' A' ' 57' ' ' PHE . 36.9 pt -117.5 160.61 16.92 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 N-CA-C 109.915 -0.402 . . . . 0.64 109.915 171.103 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 54.8 p -86.18 170.71 11.91 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 120.921 0.391 . . . . 0.55 110.623 -177.178 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -65.01 -21.13 67.55 Favored Glycine 0 N--CA 1.446 -0.687 0 C-N-CA 120.962 -0.637 . . . . 0.41 112.36 178.687 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.617 ' O ' ' HG3' ' A' ' 74' ' ' LYS . . . -63.23 -52.42 62.26 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 121.027 0.441 . . . . 0.38 111.181 -179.754 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -71.23 -41.68 69.85 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.848 -0.614 . . . . 1.81 109.93 -175.012 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -61.73 -38.07 86.56 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.472 -0.785 . . . . 0.39 110.604 177.2 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' LYS . . . . . 0.636 ' HG3' ' HE1' ' B' ' 151' ' ' PHE . 79.9 tttt -64.41 -43.09 95.49 Favored 'General case' 0 CA--C 1.515 -0.37 0 CA-C-N 116.216 -0.447 . . . . 0.84 110.43 178.462 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 74' ' ' LYS . . . . . 0.617 ' HG3' ' O ' ' A' ' 70' ' ' ALA . 29.1 mtpp -59.33 -44.58 92.59 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.54 0.21 . . . . 1.95 110.472 -179.41 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 14.6 tp10 -61.29 -48.41 81.51 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 116.337 -0.392 . . . . 1.6 110.5 177.283 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 76' ' ' MET . . . . . 0.846 ' HB3' HD22 ' A' ' 86' ' ' LEU . 53.4 mtt -63.55 -33.38 75.46 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.155 0.502 . . . . 1.24 111.289 -179.682 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.487 HG23 ' O ' ' A' ' 73' ' ' LYS . 38.6 t -64.99 -30.8 51.44 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-N 116.123 -0.49 . . . . 1.57 110.087 176.392 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 66.1 mmtt -79.6 -26.81 41.13 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.15 -0.477 . . . . 2.79 111.689 178.906 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 76.9 p -66.14 -14.97 62.7 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 120.867 -0.333 . . . . 1.27 110.501 178.422 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 31.7 mtmm 70.1 18.88 6.94 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-N 115.557 -0.747 . . . . 2.97 111.572 176.135 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.605 ' HB2' HD21 ' A' ' 86' ' ' LEU . 97.0 mt -82.91 144.14 47.4 Favored Pre-proline 0 C--N 1.325 -0.498 0 N-CA-C 109.573 -0.528 . . . . 0.52 109.573 174.363 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 41.2 Cg_exo -57.65 148.07 75.99 Favored 'Trans proline' 0 C--N 1.343 0.245 0 C-N-CA 122.605 2.204 . . . . 0.44 112.369 178.659 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 2.1 m-20 -50.61 -41.82 55.24 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-N 115.852 -0.613 . . . . 1.85 111.293 -179.489 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -57.69 -47.62 81.82 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.942 -0.572 . . . . 1.47 110.878 179.37 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.529 ' O ' HG12 ' A' ' 89' ' ' ILE . 93.8 t -63.2 -37.89 80.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 115.699 -0.682 . . . . 0.45 110.393 -179.761 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.846 HD22 ' HB3' ' A' ' 76' ' ' MET . 75.0 mt -65.73 -36.63 84.14 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.016 -0.538 . . . . 0.9 110.672 179.704 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -65.23 -37.94 94.59 Favored Glycine 0 N--CA 1.449 -0.451 0 N-CA-C 110.857 -0.897 . . . . 0.32 110.857 176.213 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 31.1 mmmt -61.91 -47.43 84.98 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.295 -0.452 . . . . 1.89 109.976 174.739 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.529 HG12 ' O ' ' A' ' 85' ' ' VAL . 28.3 mm -58.97 -46.62 91.43 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.18 0 CA-C-N 115.471 -0.786 . . . . 0.71 110.695 179.403 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 52.5 t-105 -60.09 -47.4 86.05 Favored 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 121.076 -0.25 . . . . 0.33 110.915 -179.064 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 37.4 ttmt -62.91 -24.16 67.71 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 116.41 -0.359 . . . . 2.7 111.319 -178.118 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.728 HD11 ' HA ' ' A' ' 124' ' ' ALA . 91.9 mt -93.38 -29.47 15.58 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.443 -0.344 . . . . 1.66 111.51 179.903 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -85.94 -41.39 14.96 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.58 -0.282 . . . . 0.47 111.35 -177.315 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 94' ' ' ASP . . . . . 0.659 ' OD1' 'CA ' ' A' ' 141' ' ' ' CA' . 39.8 t0 -84.5 79.34 9.61 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 108.858 -0.793 . . . . 0.79 108.858 177.282 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.509 ' HB ' ' HG2' ' A' ' 135' ' ' LYS . 40.5 t -67.56 -37.51 78.91 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-N 115.292 -0.867 . . . . 0.61 111.056 -171.63 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 96' ' ' ASP . . . . . 0.619 ' OD1' 'CA ' ' A' ' 141' ' ' ' CA' . 40.4 p-10 -83.54 -10.1 58.52 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.934 -0.575 . . . . 0.96 110.973 -178.972 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 92.0 mttt 52.16 72.65 0.38 Allowed 'General case' 0 C--O 1.235 0.338 0 O-C-N 123.839 0.712 . . . . 2.96 110.843 179.789 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 98' ' ' ASP . . . . . 0.634 ' OD1' 'CA ' ' A' ' 141' ' ' ' CA' . 9.6 p-10 -127.27 9.02 6.64 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 120.916 0.389 . . . . 0.43 110.694 -176.896 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 74.02 0.39 55.96 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.768 -0.729 . . . . 0.44 112.709 177.375 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.418 ' HB2' ' OD2' ' A' ' 98' ' ' ASP . 77.2 mt -128.79 147.41 50.79 Favored 'General case' 0 N--CA 1.446 -0.653 0 N-CA-C 109.417 -0.586 . . . . 1.11 109.417 179.355 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 60.8 mt -105.17 120.1 40.68 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-N 115.992 -0.549 . . . . 0.42 109.912 176.549 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 102' ' ' ASP . . . . . 0.444 ' HB2' ' HG3' ' A' ' 105' ' ' GLU . 9.8 m-20 -69.6 176.96 3.19 Favored 'General case' 0 CA--C 1.511 -0.533 0 N-CA-C 109.613 -0.514 . . . . 1.72 109.613 174.279 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -56.81 -42.7 80.01 Favored 'General case' 0 C--N 1.317 -0.808 0 N-CA-C 109.552 -0.536 . . . . 1.6 109.552 172.967 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 104' ' ' GLU . . . . . 0.522 ' HB3' ' HB3' ' A' ' 132' ' ' PRO . 4.7 mp0 -61.94 -53.34 56.99 Favored 'General case' 0 N--CA 1.461 0.115 0 CA-C-N 115.895 -0.593 . . . . 1.66 111.266 173.946 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 105' ' ' GLU . . . . . 0.444 ' HG3' ' HB2' ' A' ' 102' ' ' ASP . 22.9 mt-10 -67.1 -34.33 77.39 Favored 'General case' 0 C--N 1.327 -0.394 0 C-N-CA 120.947 -0.301 . . . . 0.44 111.471 -169.824 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 106' ' ' PHE . . . . . 0.437 ' CD1' HD11 ' A' ' 67' ' ' ILE . 84.4 t80 -71.29 -40.67 70.72 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 109.94 -0.393 . . . . 0.42 109.94 176.335 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -57.31 -43.08 82.96 Favored 'General case' 0 N--CA 1.454 -0.239 0 CA-C-O 121.107 0.48 . . . . 0.22 110.393 175.698 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 6.3 tt -60.15 -50.6 73.03 Favored 'General case' 0 C--O 1.236 0.353 0 CA-C-N 115.504 -0.771 . . . . 1.33 110.012 178.428 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 109' ' ' ALA . . . . . 0.466 ' O ' HG13 ' A' ' 113' ' ' ILE . . . -57.93 -45.38 86.64 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.108 -0.496 . . . . 0.32 110.834 179.245 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 1.8 t30 -62.77 -34.12 76.58 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.04 -0.527 . . . . 1.2 110.674 -179.71 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 2.3 t60 -70.07 -35.85 74.52 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.197 -0.456 . . . . 0.52 110.358 179.712 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 63.1 mt -68.65 -40.36 80.28 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.16 -0.473 . . . . 0.55 110.077 176.597 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.466 HG13 ' O ' ' A' ' 109' ' ' ALA . 69.3 mt -57.58 -41.9 80.07 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.141 0 CA-C-N 115.959 -0.564 . . . . 0.84 109.636 174.512 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 114' ' ' LYS . . . . . 0.685 ' O ' ' HG2' ' A' ' 118' ' ' GLU . 2.4 mmmt -58.08 -49.04 78.3 Favored 'General case' 0 C--O 1.22 -0.464 0 CA-C-N 115.406 -0.816 . . . . 3.83 110.551 177.335 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.58 HG13 ' HB2' ' A' ' 120' ' ' HIS . 68.2 t -53.6 -40.86 43.9 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 O-C-N 123.408 0.443 . . . . 1.19 111.604 177.63 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 116' ' ' LYS . . . . . 0.41 ' HA ' ' HD3' ' A' ' 116' ' ' LYS . 42.0 mmtt -70.16 -33.54 71.9 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 111.857 0.318 . . . . 1.32 111.857 178.604 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 98.0 mt -71.38 -30.39 66.08 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.185 0.516 . . . . 0.96 110.058 175.414 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 118' ' ' GLU . . . . . 0.685 ' HG2' ' O ' ' A' ' 114' ' ' LYS . 22.1 mm-40 -67.71 -25.9 65.89 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.345 -0.843 . . . . 2.18 110.127 176.077 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 91.91 35.17 6.89 Favored Glycine 0 N--CA 1.447 -0.573 0 C-N-CA 120.593 -0.813 . . . . 1.16 111.927 -176.65 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 120' ' ' HIS . . . . . 0.58 ' HB2' HG13 ' A' ' 115' ' ' VAL . 54.5 m80 -119.51 164.82 15.22 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 109.91 -0.404 . . . . 2.42 109.91 177.955 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 42.3 mm-40 -110.59 161.87 15.28 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 116.329 -0.396 . . . . 2.53 110.882 -174.628 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 122' ' ' LEU . . . . . 0.513 ' H ' HD23 ' A' ' 122' ' ' LEU . 1.7 pt? -124.96 135.44 26.78 Favored Pre-proline 0 C--N 1.323 -0.553 0 CA-C-N 115.795 -0.638 . . . . 1.33 109.492 176.331 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 62.9 Cg_endo -74.33 -1.76 11.43 Favored 'Trans proline' 0 CA--C 1.53 0.279 0 C-N-CA 122.877 2.385 . . . . 1.33 113.557 -175.455 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 124' ' ' ALA . . . . . 0.728 ' HA ' HD11 ' A' ' 92' ' ' LEU . . . 68.97 18.89 8.35 Favored 'General case' 0 N--CA 1.467 0.38 0 C-N-CA 123.04 0.536 . . . . 1.25 110.769 -175.781 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -117.95 156.57 28.27 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.396 -0.82 . . . . 2.73 109.231 174.765 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 126' ' ' LEU . . . . . 0.51 HD21 ' HB3' ' A' ' 92' ' ' LEU . 90.8 mt -108.97 104.8 55.92 Favored Pre-proline 0 C--N 1.323 -0.566 0 CA-C-O 120.705 0.288 . . . . 1.66 111.629 -176.858 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 127' ' ' PRO . . . . . 0.53 ' HD2' HD12 ' A' ' 130' ' ' LEU . 51.5 Cg_exo -54.81 146.72 54.42 Favored 'Trans proline' 0 C--O 1.235 0.356 0 C-N-CA 123.015 2.477 . . . . 1.17 111.782 172.023 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 41.3 Cg_endo -67.14 3.14 1.76 Allowed 'Trans proline' 0 N--CA 1.475 0.426 0 C-N-CA 123.24 2.627 . . . . 1.54 114.258 -174.228 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 27.5 p-80 -117.16 7.51 13.02 Favored 'General case' 0 C--N 1.327 -0.382 0 C-N-CA 120.737 -0.385 . . . . 1.07 110.577 177.877 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 130' ' ' LEU . . . . . 0.53 HD12 ' HD2' ' A' ' 127' ' ' PRO . 23.4 mt -108.08 0.99 22.03 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.833 0.349 . . . . 1.36 111.345 178.785 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 3.5 m -77.31 121.06 83.94 Favored Pre-proline 0 C--N 1.322 -0.613 0 CA-C-N 116.373 -0.376 . . . . 1.28 110.401 173.825 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 132' ' ' PRO . . . . . 0.522 ' HB3' ' HB3' ' A' ' 104' ' ' GLU . 51.4 Cg_exo -53.29 148.64 31.87 Favored 'Trans proline' 0 C--N 1.342 0.205 0 C-N-CA 122.944 2.43 . . . . 0.81 112.094 -179.404 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 133' ' ' PRO . . . . . 0.484 ' HD2' ' HG2' ' A' ' 104' ' ' GLU . 52.3 Cg_exo -55.27 -26.61 52.99 Favored 'Trans proline' 0 C--N 1.344 0.311 0 C-N-CA 122.816 2.344 . . . . 1.17 112.554 -178.61 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 5.9 p -89.71 -13.05 37.71 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.113 -0.494 . . . . 1.6 111.74 -179.32 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 135' ' ' LYS . . . . . 0.509 ' HG2' ' HB ' ' A' ' 95' ' ' VAL . 13.6 mptt -111.28 -14.99 13.72 Favored 'General case' 0 N--CA 1.464 0.228 0 N-CA-C 111.967 0.358 . . . . 1.21 111.967 -177.746 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 31.9 ptt180 -75.21 143.38 43.18 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.995 0.426 . . . . 2.76 110.484 -177.774 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 18.9 ttm180 -88.71 100.39 13.09 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.029 0.443 . . . . 4.54 110.7 -177.415 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 52.9 t-80 -107.29 99.46 8.99 Favored 'General case' 0 C--N 1.318 -0.804 0 N-CA-C 109.491 -0.559 . . . . 5.95 109.491 174.687 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 11.8 tp10 . . . . . 0 C--O 1.248 0.981 0 O-C-N 123.943 0.777 . . . . 6.15 109.998 -178.056 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' B' B ' 143' ' ' PHE . . . . . . . . . . . . . 74.0 t80 . . . . . 0 N--CA 1.478 0.947 0 CA-C-O 120.577 0.227 . . . . 11.86 110.444 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' B' B ' 144' ' ' ASN . . . . . . . . . . . . . 8.3 t30 -78.01 99.36 6.05 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.019 0.438 . . . . 8.14 110.52 -179.817 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 145' ' ' TYR . . . . . . . . . . . . . 27.7 p90 -92.76 133.71 35.77 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 116.07 -0.514 . . . . 6.71 109.659 177.453 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 146' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -138.64 -41.25 0.49 Allowed 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 109.831 -0.433 . . . . 6.61 109.831 174.824 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 147' ' ' SER . . . . . . . . . . . . . 11.2 t 68.8 112.45 0.04 OUTLIER 'General case' 0 N--CA 1.463 0.179 0 O-C-N 123.999 0.812 . . . . 3.65 111.319 175.509 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 148' ' ' THR . . . . . . . . . . . . . 2.8 m -113.41 1.6 15.15 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.751 -0.659 . . . . 1.79 110.336 -177.862 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 149' ' ' GLY . . . . . . . . . . . . . . . 168.85 -176.3 43.09 Favored Glycine 0 N--CA 1.447 -0.617 0 C-N-CA 120.647 -0.787 . . . . 0.48 112.081 178.661 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 150' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -72.5 -2.25 11.49 Favored 'Trans proline' 0 C--O 1.235 0.345 0 C-N-CA 122.797 2.331 . . . . 0.33 112.238 -179.188 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 151' ' ' PHE . . . . . 0.636 ' HE1' ' HG3' ' A' ' 73' ' ' LYS . 49.3 m-85 -102.8 1.66 34.48 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.006 -0.543 . . . . 0.75 111.236 -179.093 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 152' ' ' THR . . . . . . . . . . . . . 22.7 p -108.74 24.67 12.75 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.275 0.56 . . . . 2.22 110.041 175.263 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 153' ' ' ALA . . . . . . . . . . . . . . . -120.13 -74.14 0.62 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.623 -0.717 . . . . 4.4 110.051 177.778 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 154' ' ' LYS . . . . . . . . . . . . . 9.7 mptt . . . . . 0 C--O 1.248 0.976 0 CA-C-O 118.041 -0.98 . . . . 6.75 109.674 173.399 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 141' ' ' ' CA' . . . . . 0.659 'CA ' ' OD1' ' A' ' 94' ' ' ASP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.428 ' HA2' ' HD3' ' A' ' 36' ' ' PRO . . . . . . . . 0 N--CA 1.481 1.7 0 N-CA-C 111.658 -0.577 . . . . 10.97 111.658 . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' PRO . . . . . 0.428 ' HD3' ' HA2' ' A' ' 35' ' ' GLY . 22.7 Cg_exo -65.07 120.59 7.85 Favored 'Trans proline' 0 C--N 1.343 0.28 0 C-N-CA 122.904 2.403 . . . . 9.0 111.99 179.141 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 3.0 pp -106.88 -2.7 21.07 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.27 -0.423 . . . . 7.42 111.253 -179.04 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -85.5 160.89 34.89 Favored Glycine 0 N--CA 1.448 -0.521 0 C-N-CA 120.525 -0.845 . . . . 4.46 112.362 -179.643 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 36.5 p -142.72 142.35 31.96 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 120.567 0.222 . . . . 3.97 110.673 -179.591 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -77.63 92.62 4.12 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 109.923 -0.399 . . . . 3.46 109.923 174.982 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 9.1 m-20 -117.8 127.08 53.54 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.851 -0.613 . . . . 1.93 110.838 -177.986 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.458 HG21 ' HA ' ' A' ' 129' ' ' HIS . 17.9 m -110.46 125.88 67.73 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.727 0 CA-C-N 115.717 -0.674 . . . . 1.85 109.475 174.991 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 50.7 mt-10 -66.79 121.67 15.96 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 109.147 -0.686 . . . . 3.1 109.147 177.523 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 1.5 t90 -71.16 107.61 4.27 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 109.444 -0.576 . . . . 0.71 109.444 -176.375 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 31.2 m -66.48 -0.65 0.96 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 115.84 -0.618 . . . . 1.45 111.945 -177.444 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.416 HG13 ' HB2' ' A' ' 111' ' ' HIS . 46.5 t -97.73 -24.08 4.45 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-O 121.219 0.533 . . . . 1.1 109.788 173.875 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 47' ' ' GLY . . . . . 0.785 ' HA2' ' HG2' ' A' ' 50' ' ' LYS . . . -73.25 -21.21 79.89 Favored Glycine 0 N--CA 1.45 -0.39 0 CA-C-N 115.81 -0.632 . . . . 0.59 112.345 -178.483 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 48' ' ' LYS . . . . . 0.426 ' HB2' ' HE3' ' A' ' 48' ' ' LYS . 12.3 ptmt -75.13 -25.06 58.15 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 120.863 0.363 . . . . 2.46 110.633 178.847 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -102.67 31.87 3.91 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.205 -0.452 . . . . 1.66 110.004 176.694 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 0.785 ' HG2' ' HA2' ' A' ' 47' ' ' GLY . 8.1 mmmm -72.82 -50.65 7.11 Favored Pre-proline 0 C--O 1.216 -0.673 0 CA-C-O 118.53 -0.747 . . . . 1.15 112.253 -178.293 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.58 ' HD2' ' N ' ' A' ' 50' ' ' LYS . 1.4 Cg_endo -44.05 -42.01 12.66 Favored 'Trans proline' 0 C--N 1.36 1.181 0 C-N-CA 122.845 2.363 . . . . 0.75 112.593 -177.397 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 9.5 m -69.73 -45.4 68.24 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.952 -0.567 . . . . 0.68 111.119 179.67 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' TYR . . . . . 0.48 ' OH ' ' HA ' ' A' ' 111' ' ' HIS . 12.1 m-30 -76.35 -22.69 54.57 Favored 'General case' 0 C--O 1.219 -0.535 0 CA-C-N 116.486 -0.324 . . . . 0.69 110.607 -175.178 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -73.74 -45.05 54.37 Favored 'General case' 0 C--O 1.237 0.425 0 N-CA-C 108.68 -0.859 . . . . 2.18 108.68 175.418 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 2.2 tp10 -53.61 -42.26 67.53 Favored 'General case' 0 N--CA 1.455 -0.186 0 CA-C-N 114.675 -1.148 . . . . 2.33 110.495 178.2 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 66.1 mt -80.37 -47.09 21.33 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-N 115.668 -0.696 . . . . 0.64 111.341 -179.134 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' PHE . . . . . 0.508 ' HE1' HG12 ' A' ' 67' ' ' ILE . 86.3 t80 -52.31 -37.2 55.2 Favored 'General case' 0 N--CA 1.468 0.457 0 C-N-CA 122.982 0.513 . . . . 0.29 112.024 -176.076 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 58' ' ' TYR . . . . . 0.586 ' HA ' ' HG3' ' A' ' 62' ' ' PRO . 18.5 m-30 -77.24 -17.8 58.16 Favored 'General case' 0 C--N 1.326 -0.424 0 C-N-CA 120.743 -0.383 . . . . 1.17 111.421 -174.485 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 41.0 p -85.83 -7.5 58.69 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.283 0.563 . . . . 0.44 110.386 -179.497 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 11.1 mp -95.47 19.16 11.35 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.58 -0.737 . . . . 1.37 110.327 179.16 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 12.7 p 49.61 81.46 0.26 Allowed Pre-proline 0 N--CA 1.465 0.317 0 CA-C-N 115.558 -0.746 . . . . 1.24 111.836 -177.515 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' PRO . . . . . 0.586 ' HG3' ' HA ' ' A' ' 58' ' ' TYR . 72.6 Cg_endo -84.85 116.9 1.91 Allowed 'Trans proline' 0 N--CA 1.455 -0.767 0 C-N-CA 122.659 2.239 . . . . 0.47 112.555 -177.744 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 18.7 m -88.76 113.46 25.53 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 CA-C-O 121.26 0.553 . . . . 1.02 110.134 178.011 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 75.8 m-20 62.98 28.52 16.3 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 115.485 -0.78 . . . . 1.34 111.472 179.4 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 82.01 22.98 58.38 Favored Glycine 0 N--CA 1.454 -0.146 0 C-N-CA 121.072 -0.585 . . . . 0.43 112.326 179.404 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 0.539 ' HG2' ' HA ' ' A' ' 102' ' ' ASP . 26.8 mtpp -143.28 141.05 30.9 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 109.417 -0.586 . . . . 1.48 109.417 -177.886 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 67' ' ' ILE . . . . . 0.508 HG12 ' HE1' ' A' ' 57' ' ' PHE . 36.6 pt -108.66 154.77 9.86 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.812 0 CA-C-O 121.184 0.516 . . . . 0.64 110.975 178.456 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 68' ' ' THR . . . . . 0.52 ' HA ' ' CD2' ' A' ' 100' ' ' LEU . 32.2 p -77.6 161.28 27.95 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.171 -0.922 . . . . 0.55 111.082 -179.474 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -63.6 -22.52 66.03 Favored Glycine 0 N--CA 1.444 -0.78 0 C-N-CA 121.05 -0.595 . . . . 0.41 111.796 179.179 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -61.48 -47.52 85.29 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.898 0.38 . . . . 0.38 111.663 178.367 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 46.1 m-80 -81.29 -31.86 33.44 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.176 -0.465 . . . . 1.81 110.976 -175.804 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 0.519 ' O ' ' HG2' ' A' ' 76' ' ' MET . . . -63.79 -45.21 90.73 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 109.378 -0.601 . . . . 0.39 109.378 173.283 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 60.5 tttp -57.03 -37.9 72.4 Favored 'General case' 0 CA--C 1.52 -0.178 0 CA-C-N 115.24 -0.891 . . . . 0.84 109.889 175.95 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 74' ' ' LYS . . . . . 0.415 ' O ' ' HG2' ' A' ' 78' ' ' LYS . 9.0 tptm -57.28 -57.05 14.32 Favored 'General case' 0 N--CA 1.453 -0.298 0 CA-C-N 115.41 -0.814 . . . . 1.95 110.509 177.968 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 75' ' ' GLU . . . . . 0.583 ' HA ' ' HG3' ' A' ' 78' ' ' LYS . 5.4 tp10 -64.61 -39.46 93.77 Favored 'General case' 0 C--O 1.237 0.434 0 CA-C-O 121.218 0.532 . . . . 1.6 110.966 -177.168 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 76' ' ' MET . . . . . 0.638 ' HB3' HD22 ' A' ' 86' ' ' LEU . 96.3 mmm -64.91 -29.39 70.33 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.179 0.514 . . . . 1.24 109.882 178.775 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -75.04 -28.32 20.79 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 CA-C-N 115.985 -0.552 . . . . 1.57 110.086 175.672 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.583 ' HG3' ' HA ' ' A' ' 75' ' ' GLU . 3.1 mmmm -68.86 -27.76 66.1 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.802 -0.635 . . . . 2.79 111.211 177.015 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 78.5 p -73.11 -15.67 61.48 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.32 -0.4 . . . . 1.27 111.643 -176.558 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 75.0 mmtt 66.75 16.43 10.38 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-N 115.9 -0.591 . . . . 2.97 111.385 178.98 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.426 ' HB2' HD21 ' A' ' 86' ' ' LEU . 93.0 mt -83.82 150.3 58.72 Favored Pre-proline 0 C--N 1.327 -0.374 0 CA-C-N 116.483 -0.326 . . . . 0.52 111.032 -179.633 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 82' ' ' PRO . . . . . 0.536 ' O ' ' HG ' ' A' ' 86' ' ' LEU . 51.2 Cg_exo -55.34 148.15 52.75 Favored 'Trans proline' 0 C--N 1.349 0.601 0 C-N-CA 123.113 2.542 . . . . 0.44 112.698 179.47 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 82.7 m-20 -61.43 -36.12 79.48 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.939 -0.573 . . . . 1.85 111.448 -174.109 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 15.0 t -66.03 -35.23 79.98 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.949 0.404 . . . . 1.47 110.254 179.243 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 57.4 t -72.29 -37.3 58.18 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.313 0 N-CA-C 109.68 -0.489 . . . . 0.45 109.68 178.905 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.638 HD22 ' HB3' ' A' ' 76' ' ' MET . 62.1 mt -61.48 -39.72 91.94 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.883 -0.599 . . . . 0.9 109.93 176.587 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -67.19 -39.93 92.45 Favored Glycine 0 N--CA 1.45 -0.378 0 N-CA-C 111.672 -0.571 . . . . 0.32 111.672 177.29 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 88' ' ' LYS . . . . . 0.437 ' O ' ' HG ' ' A' ' 92' ' ' LEU . 29.9 mmmt -58.06 -47.92 81.68 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.996 0.427 . . . . 1.89 110.67 175.69 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.774 HG23 HD12 ' A' ' 112' ' ' LEU . 74.9 mt -65.27 -40.35 88.32 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 115.811 -0.632 . . . . 0.71 110.926 -177.785 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 39.0 t-105 -61.79 -45.16 95.08 Favored 'General case' 0 C--N 1.334 -0.083 0 N-CA-C 110.053 -0.351 . . . . 0.33 110.053 175.392 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 4.9 tppp? -58.19 -28.15 64.53 Favored 'General case' 0 CA--C 1.531 0.232 0 CA-C-N 115.686 -0.688 . . . . 2.7 111.561 -179.554 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.437 ' HG ' ' O ' ' A' ' 88' ' ' LYS . 73.6 mt -92.39 -36.19 13.28 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.708 0.289 . . . . 1.66 111.056 179.396 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -75.22 -42.39 55.59 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.372 -0.377 . . . . 0.47 111.404 -175.458 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 94' ' ' ASP . . . . . 0.653 ' OD1' 'CA ' ' A' ' 141' ' ' ' CA' . 45.2 t0 -86.73 75.45 9.64 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.549 0.69 . . . . 0.79 109.446 178.954 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 42.8 t -63.56 -40.54 89.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 114.927 -1.033 . . . . 0.61 111.255 -174.342 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 30.4 p30 -84.39 -7.47 59.29 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.369 -0.378 . . . . 0.96 111.898 -177.838 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 48.0 mtmt 55.86 74.13 0.4 Allowed 'General case' 0 N--CA 1.466 0.369 0 O-C-N 123.503 0.502 . . . . 2.96 111.541 177.904 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 98' ' ' ASP . . . . . 0.626 ' OD1' 'CA ' ' A' ' 141' ' ' ' CA' . 7.3 p-10 -128.85 9.26 5.83 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.869 0.366 . . . . 0.43 111.068 -177.557 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 69.73 -0.65 19.14 Favored Glycine 0 CA--C 1.522 0.487 0 C-N-CA 121.043 -0.598 . . . . 0.44 113.207 176.538 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.52 ' CD2' ' HA ' ' A' ' 68' ' ' THR . 83.8 mt -129.27 137.37 51.02 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 109.128 -0.693 . . . . 1.11 109.128 177.617 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 72.3 mt -90.62 122.44 33.42 Favored 'General case' 0 C--N 1.312 -1.025 0 C-N-CA 120.3 -0.56 . . . . 0.42 109.839 178.685 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 102' ' ' ASP . . . . . 0.539 ' HA ' ' HG2' ' A' ' 66' ' ' LYS . 23.4 m-20 -69.36 173.97 5.28 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 108.263 -1.014 . . . . 1.72 108.263 173.897 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -55.4 -41.44 72.7 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 121.081 0.467 . . . . 1.6 110.133 173.755 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -72.54 -40.84 66.43 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.96 -0.564 . . . . 1.66 111.406 179.508 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 28.2 mt-10 -70.13 -39.53 75.39 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 120.707 -0.397 . . . . 0.44 111.018 -176.017 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 106' ' ' PHE . . . . . 0.491 ' CD1' HD11 ' A' ' 67' ' ' ILE . 81.9 t80 -67.07 -37.64 84.37 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 109.952 -0.388 . . . . 0.42 109.952 176.275 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -58.3 -43.91 88.31 Favored 'General case' 0 N--CA 1.452 -0.342 0 CA-C-N 116.147 -0.479 . . . . 0.22 110.406 175.885 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 6.3 tt -60.35 -48.11 83.17 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.154 -0.476 . . . . 1.33 110.098 178.779 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -58.53 -49.47 77.29 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.082 -0.508 . . . . 0.32 110.943 179.063 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 1.7 m-20 -63.57 -31.42 72.58 Favored 'General case' 0 CA--C 1.519 -0.245 0 CA-C-N 115.915 -0.584 . . . . 1.2 111.201 179.737 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 111' ' ' HIS . . . . . 0.48 ' HA ' ' OH ' ' A' ' 53' ' ' TYR . 32.0 t60 -66.93 -40.57 87.65 Favored 'General case' 0 N--CA 1.453 -0.302 0 N-CA-C 109.952 -0.388 . . . . 0.52 109.952 179.388 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.774 HD12 HG23 ' A' ' 89' ' ' ILE . 98.3 mt -65.29 -39.54 92.66 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.658 -0.246 . . . . 0.55 110.448 177.519 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.526 HD11 ' SD ' ' A' ' 76' ' ' MET . 61.2 mt -60.3 -52.35 62.42 Favored 'Isoleucine or valine' 0 C--O 1.233 0.219 0 CA-C-O 121.104 0.478 . . . . 0.84 110.192 175.424 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 114' ' ' LYS . . . . . 0.546 ' O ' ' HB2' ' A' ' 118' ' ' GLU . 0.4 OUTLIER -65.02 -39.45 93.4 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.492 -0.776 . . . . 3.83 111.075 -174.804 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.401 HG23 ' O ' ' A' ' 111' ' ' HIS . 51.7 t -69.73 -45.03 78.67 Favored 'Isoleucine or valine' 0 C--O 1.234 0.248 0 CA-C-N 116.639 -0.255 . . . . 1.19 111.567 -178.032 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 35.8 tptt -60.52 -45.76 92.64 Favored 'General case' 0 N--CA 1.454 -0.267 0 CA-C-O 120.981 0.42 . . . . 1.32 110.676 176.92 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 94.4 mt -74.34 -16.06 60.92 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.306 -0.406 . . . . 0.96 111.208 -179.4 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 118' ' ' GLU . . . . . 0.657 ' HB3' ' HD2' ' A' ' 120' ' ' HIS . 22.6 tt0 -80.02 0.89 29.82 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.914 -0.584 . . . . 2.18 109.664 176.22 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 91.81 15.76 53.59 Favored Glycine 0 N--CA 1.451 -0.319 0 CA-C-N 115.839 -0.619 . . . . 1.16 112.834 175.378 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 120' ' ' HIS . . . . . 0.657 ' HD2' ' HB3' ' A' ' 118' ' ' GLU . 61.6 m-70 -106.08 160.3 15.41 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 110.095 -0.335 . . . . 2.42 110.095 179.903 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 8.0 tp10 -96.63 149.25 22.0 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 121.001 0.429 . . . . 2.53 110.377 179.275 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 122' ' ' LEU . . . . . 0.434 HD12 ' O ' ' A' ' 122' ' ' LEU . 2.4 pp -114.06 143.67 30.11 Favored Pre-proline 0 C--N 1.321 -0.645 0 CA-C-N 115.92 -0.582 . . . . 1.33 109.767 177.304 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 63.1 Cg_endo -74.09 -12.03 23.43 Favored 'Trans proline' 0 N--CA 1.465 -0.166 0 C-N-CA 122.298 1.998 . . . . 1.33 113.036 -176.372 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . 62.92 18.07 10.53 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-N 115.823 -0.626 . . . . 1.25 110.337 -175.029 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -134.01 176.09 8.89 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.045 -0.98 . . . . 2.73 108.61 175.773 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 126' ' ' LEU . . . . . 0.469 ' HA ' ' HD2' ' A' ' 127' ' ' PRO . 4.2 tt -113.06 100.37 51.15 Favored Pre-proline 0 C--N 1.322 -0.61 0 C-N-CA 120.786 -0.365 . . . . 1.66 110.542 -178.062 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 127' ' ' PRO . . . . . 0.755 ' HG2' ' HB2' ' A' ' 130' ' ' LEU . 19.5 Cg_endo -58.98 151.17 67.7 Favored 'Trans proline' 0 C--N 1.347 0.496 0 C-N-CA 123.435 2.757 . . . . 1.17 112.645 176.624 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -58.38 -28.63 85.65 Favored 'Trans proline' 0 C--N 1.346 0.446 0 C-N-CA 123.329 2.686 . . . . 1.54 113.315 -175.608 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 129' ' ' HIS . . . . . 0.458 ' HA ' HG21 ' A' ' 42' ' ' VAL . 9.7 p80 -91.34 4.9 51.25 Favored 'General case' 0 C--N 1.329 -0.316 0 C-N-CA 120.836 -0.346 . . . . 1.07 111.226 -178.512 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 130' ' ' LEU . . . . . 0.755 ' HB2' ' HG2' ' A' ' 127' ' ' PRO . 41.7 tp -104.65 -2.95 24.35 Favored 'General case' 0 N--CA 1.444 -0.75 0 CA-C-O 121.185 0.517 . . . . 1.36 110.248 -177.121 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 131' ' ' VAL . . . . . 0.445 ' HA ' ' HD2' ' A' ' 132' ' ' PRO . 29.9 t -72.84 125.99 90.85 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 115.779 -0.646 . . . . 1.28 109.907 177.562 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 132' ' ' PRO . . . . . 0.445 ' HD2' ' HA ' ' A' ' 131' ' ' VAL . 3.8 Cg_endo -47.69 136.02 21.76 Favored 'Trans proline' 0 C--O 1.236 0.414 0 C-N-CA 123.074 2.516 . . . . 0.81 111.797 176.653 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 23.6 Cg_endo -60.81 -15.34 37.34 Favored 'Trans proline' 0 C--N 1.343 0.288 0 C-N-CA 123.222 2.615 . . . . 1.17 112.633 -174.525 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 19.7 p -90.35 -21.63 21.9 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.166 -0.47 . . . . 1.6 111.366 -179.451 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 62.8 mttt -119.5 23.34 11.26 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.782 0.325 . . . . 1.21 111.555 -172.23 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 21.1 ptt180 -87.11 132.62 33.78 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.942 0.401 . . . . 2.76 111.504 -178.926 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 15.4 mtm180 -108.35 152.13 25.06 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 109.594 -0.521 . . . . 4.54 109.594 178.625 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 53.2 t-80 -133.59 137.21 45.35 Favored 'General case' 0 C--N 1.323 -0.562 0 C-N-CA 121.228 -0.189 . . . . 5.95 110.539 177.665 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 7.4 tt0 . . . . . 0 C--O 1.25 1.11 0 O-C-N 124.301 1.0 . . . . 6.15 111.245 176.488 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' B' B ' 143' ' ' PHE . . . . . . . . . . . . . 94.3 m-85 . . . . . 0 N--CA 1.483 1.202 0 CA-C-O 120.747 0.308 . . . . 11.86 110.247 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' B' B ' 144' ' ' ASN . . . . . . . . . . . . . 26.6 p-10 -86.48 166.42 15.51 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 109.411 -0.589 . . . . 8.14 109.411 174.34 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 145' ' ' TYR . . . . . . . . . . . . . 62.6 t80 -122.55 107.71 12.31 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.178 0.513 . . . . 6.71 110.001 175.118 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 146' ' ' GLU . . . . . 0.459 ' H ' ' HG2' ' B' ' 146' ' ' GLU . 4.8 pt-20 -93.97 157.5 16.08 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.611 -0.722 . . . . 6.61 110.51 -179.578 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 147' ' ' SER . . . . . . . . . . . . . 8.6 p -63.58 151.68 40.88 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.009 -0.542 . . . . 3.65 112.062 -175.297 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 148' ' ' THR . . . . . . . . . . . . . 1.6 m -92.39 1.63 57.12 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.389 0.614 . . . . 1.79 110.37 -177.407 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 149' ' ' GLY . . . . . . . . . . . . . . . 143.67 157.62 7.25 Favored Glycine 0 N--CA 1.445 -0.726 0 CA-C-N 115.72 -0.673 . . . . 0.48 111.712 -179.613 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 150' ' ' PRO . . . . . . . . . . . . . 91.8 Cg_endo -80.85 -1.52 11.28 Favored 'Trans proline' 0 CA--C 1.532 0.424 0 C-N-CA 123.176 2.584 . . . . 0.33 112.571 -178.631 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 151' ' ' PHE . . . . . 0.571 ' CZ ' ' HG3' ' A' ' 76' ' ' MET . 37.8 m-85 -107.2 -58.45 1.94 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.996 -0.547 . . . . 0.75 111.327 -178.388 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 152' ' ' THR . . . . . . . . . . . . . 15.0 t -80.24 153.79 28.31 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.185 0.517 . . . . 2.22 111.4 -174.692 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 153' ' ' ALA . . . . . . . . . . . . . . . -146.84 159.31 43.67 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.718 -0.674 . . . . 4.4 109.529 179.562 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 154' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.245 0.836 0 CA-C-O 118.143 -0.932 . . . . 6.75 110.028 -178.886 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 141' ' ' ' CA' . . . . . 0.653 'CA ' ' OD1' ' A' ' 94' ' ' ASP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.598 0 N-CA-C 111.892 -0.483 . . . . 10.97 111.892 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 92.0 Cg_endo -76.64 10.18 2.34 Favored 'Trans proline' 0 CA--C 1.53 0.322 0 C-N-CA 123.019 2.48 . . . . 9.0 113.003 -178.015 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -123.7 92.37 3.67 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.138 0.494 . . . . 7.42 109.919 179.108 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -94.61 57.56 1.92 Allowed Glycine 0 N--CA 1.447 -0.627 0 CA-C-N 115.712 -0.676 . . . . 4.46 112.465 -176.987 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 8.8 p -87.74 25.88 1.42 Allowed 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.05 0.452 . . . . 3.97 110.85 -179.418 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -86.81 113.08 22.33 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.001 -0.545 . . . . 3.46 110.589 -178.611 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -75.3 127.56 33.42 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.281 -0.418 . . . . 1.93 110.599 179.489 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 16.5 m -98.06 133.75 38.99 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-O 121.009 0.433 . . . . 1.85 111.009 -179.915 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 16.8 pt-20 -66.56 147.41 53.32 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.214 0.53 . . . . 3.1 111.386 -177.499 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' TRP . . . . . 0.433 ' HH2' ' O ' ' A' ' 104' ' ' GLU . 1.3 t90 -86.07 105.15 16.3 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 109.495 -0.557 . . . . 0.71 109.495 -178.612 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 23.6 m -64.82 -11.33 11.01 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.335 0 CA-C-O 121.034 0.445 . . . . 1.45 111.961 -177.292 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.473 HG13 ' HB2' ' A' ' 111' ' ' HIS . 42.1 t -82.04 -16.43 11.89 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 CA-C-O 121.31 0.576 . . . . 1.1 110.261 177.331 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 47' ' ' GLY . . . . . 0.53 ' HA2' ' HB2' ' A' ' 50' ' ' LYS . . . -74.25 -11.17 82.07 Favored Glycine 0 N--CA 1.446 -0.638 0 CA-C-N 115.684 -0.689 . . . . 0.59 112.701 -178.68 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 17.2 pttt -82.95 -28.44 29.82 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 120.347 -0.541 . . . . 2.46 109.978 -179.041 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 12.9 m-20 -106.77 30.75 5.83 Favored 'General case' 0 CA--C 1.509 -0.622 0 N-CA-C 108.593 -0.892 . . . . 1.66 108.593 176.972 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 0.598 ' H ' ' HD2' ' A' ' 51' ' ' PRO . 15.0 tttp -92.0 -52.86 0.28 Allowed Pre-proline 0 C--N 1.317 -0.827 0 N-CA-C 112.521 0.563 . . . . 1.15 112.521 -171.207 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.598 ' HD2' ' H ' ' A' ' 50' ' ' LYS . 4.8 Cg_endo -47.03 -39.54 25.46 Favored 'Trans proline' 0 C--N 1.357 0.998 0 C-N-CA 122.738 2.292 . . . . 0.75 112.981 -178.078 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 18.8 m -70.14 -42.77 72.13 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 116.003 -0.544 . . . . 0.68 110.55 -179.485 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 21.3 m-30 -71.74 -22.53 61.6 Favored 'General case' 0 CA--C 1.517 -0.312 0 CA-C-N 116.314 -0.403 . . . . 0.69 110.222 179.558 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 86.8 m-20 -72.96 -36.26 67.09 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.183 -0.462 . . . . 2.18 109.785 176.682 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.469 ' HG3' ' O ' ' A' ' 51' ' ' PRO . 48.1 mt-10 -66.12 -40.75 90.93 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.017 -0.538 . . . . 2.33 110.472 176.659 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 44.8 mt -69.39 -37.38 75.25 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-O 121.582 0.706 . . . . 0.64 109.964 175.781 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' PHE . . . . . 0.483 ' HE1' HG12 ' A' ' 67' ' ' ILE . 78.2 t80 -59.62 -36.79 77.03 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.171 -0.922 . . . . 0.29 110.971 176.988 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 58' ' ' TYR . . . . . 0.519 ' HA ' ' HG3' ' A' ' 62' ' ' PRO . 14.2 m-30 -74.35 -23.38 59.01 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.481 -0.327 . . . . 1.17 111.047 -178.689 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 19.0 p -89.76 6.77 40.13 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 120.978 0.418 . . . . 0.44 111.371 -179.15 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 59.9 mt -105.38 5.75 32.04 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.121 -0.49 . . . . 1.37 110.193 173.956 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 19.2 m 66.42 82.7 0.2 Allowed Pre-proline 0 CA--C 1.532 0.276 0 CA-C-N 115.266 -0.879 . . . . 1.24 111.519 178.571 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' PRO . . . . . 0.519 ' HG3' ' HA ' ' A' ' 58' ' ' TYR . 36.7 Cg_endo -93.53 138.51 1.38 Allowed 'Trans proline' 0 N--CA 1.453 -0.885 0 C-N-CA 123.288 2.659 . . . . 0.47 113.162 -178.837 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 18.9 m -119.42 134.06 64.22 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 115.892 -0.595 . . . . 1.02 109.555 174.816 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 83.6 m-20 59.27 30.65 20.43 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-O 121.015 0.436 . . . . 1.34 110.986 -176.859 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 69.92 25.46 75.55 Favored Glycine 0 C--N 1.332 0.339 0 CA-C-N 115.959 -0.564 . . . . 0.43 112.598 178.47 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 0.631 ' HA ' ' HA ' ' A' ' 102' ' ' ASP . 3.0 ptpp? -152.13 145.88 25.07 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.055 0.455 . . . . 1.48 111.425 179.528 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 67' ' ' ILE . . . . . 0.483 HG12 ' HE1' ' A' ' 57' ' ' PHE . 34.3 pt -107.9 142.77 19.73 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-N 116.078 -0.51 . . . . 0.64 109.766 176.887 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 68' ' ' THR . . . . . 0.703 ' HA ' ' HB2' ' A' ' 100' ' ' LEU . 23.2 p -64.51 161.4 17.37 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 116.382 -0.372 . . . . 0.55 110.455 177.638 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -62.3 -12.43 38.44 Favored Glycine 0 N--CA 1.448 -0.548 0 C-N-CA 120.78 -0.724 . . . . 0.41 112.24 -178.634 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.459 ' O ' ' HG3' ' A' ' 74' ' ' LYS . . . -68.16 -50.04 57.09 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.326 0.584 . . . . 0.38 110.63 179.573 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 71' ' ' ASN . . . . . 0.933 ' HA ' ' HE3' ' A' ' 74' ' ' LYS . 35.0 m-80 -72.92 -38.84 66.71 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.564 -0.743 . . . . 1.81 110.32 -177.758 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -61.94 -41.63 98.17 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.69 -0.686 . . . . 0.39 110.097 176.766 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' LYS . . . . . 0.513 ' HG3' ' CE1' ' B' ' 151' ' ' PHE . 86.0 tttt -59.21 -43.06 92.29 Favored 'General case' 0 CA--C 1.519 -0.234 0 CA-C-N 115.964 -0.562 . . . . 0.84 110.216 176.639 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 74' ' ' LYS . . . . . 0.933 ' HE3' ' HA ' ' A' ' 71' ' ' ASN . 8.5 mtmp? -58.24 -42.03 85.45 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-N 116.318 -0.401 . . . . 1.95 111.091 179.114 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 15.4 tp10 -66.74 -44.92 80.24 Favored 'General case' 0 C--O 1.237 0.396 0 CA-C-O 121.476 0.655 . . . . 1.6 110.732 179.154 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 76' ' ' MET . . . . . 0.591 ' HB3' HD22 ' A' ' 86' ' ' LEU . 84.8 mtp -73.11 -21.9 60.66 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.78 -0.645 . . . . 1.24 111.687 -174.423 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.404 HG22 ' O ' ' A' ' 73' ' ' LYS . 34.5 m -86.21 -12.32 11.08 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.455 0 C-N-CA 120.408 -0.517 . . . . 1.57 110.363 171.054 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.75 ' HG2' ' O ' ' A' ' 74' ' ' LYS . 40.6 mmtm -75.78 -26.93 57.78 Favored 'General case' 0 N--CA 1.469 0.498 0 N-CA-C 110.244 -0.28 . . . . 2.79 110.244 170.439 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -72.88 -11.62 60.66 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-O 120.798 0.332 . . . . 1.27 110.39 172.069 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 80' ' ' LYS . . . . . 0.406 ' HG3' ' O ' ' A' ' 78' ' ' LYS . 73.3 mttt 65.38 24.28 12.03 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-N 115.596 -0.729 . . . . 2.97 112.392 169.63 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.627 ' HB2' HD21 ' A' ' 86' ' ' LEU . 91.6 mt -83.77 161.86 54.57 Favored Pre-proline 0 C--N 1.325 -0.483 0 CA-C-N 116.302 -0.408 . . . . 0.52 110.786 179.763 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 82' ' ' PRO . . . . . 0.433 ' O ' ' HG ' ' A' ' 86' ' ' LEU . 52.1 Cg_exo -57.73 142.16 95.87 Favored 'Trans proline' 0 C--N 1.349 0.576 0 C-N-CA 123.073 2.515 . . . . 0.44 112.812 177.558 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 31.4 m-80 -59.03 -43.62 91.65 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 115.769 -0.65 . . . . 1.85 111.636 -175.237 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 2.9 p -63.64 -44.7 93.11 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.055 -0.52 . . . . 1.47 111.113 -179.208 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 60.6 t -64.18 -40.6 89.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 115.872 -0.604 . . . . 0.45 110.241 178.886 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.627 HD21 ' HB2' ' A' ' 81' ' ' LEU . 92.3 mt -59.57 -38.43 81.13 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.178 -0.465 . . . . 0.9 110.764 176.529 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -67.38 -37.61 90.57 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.686 -0.769 . . . . 0.32 112.24 178.386 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.21 -43.3 95.42 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 120.766 -0.374 . . . . 1.89 110.081 174.651 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 20.9 mt -62.37 -35.07 67.69 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.312 0 CA-C-N 116.07 -0.513 . . . . 0.71 110.387 175.831 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 71.4 t-105 -57.44 -53.93 52.59 Favored 'General case' 0 N--CA 1.452 -0.342 0 CA-C-O 120.561 0.219 . . . . 0.33 110.623 175.739 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 91' ' ' LYS . . . . . 0.819 ' HA ' ' HE2' ' A' ' 91' ' ' LYS . 0.6 OUTLIER -69.3 -15.57 63.37 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.989 0.423 . . . . 2.7 111.1 -176.989 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.42 HD22 ' HA ' ' A' ' 124' ' ' ALA . 14.8 tp -88.4 -32.06 18.53 Favored 'General case' 0 N--CA 1.437 -1.09 0 CA-C-O 120.89 0.376 . . . . 1.66 110.006 178.2 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 93' ' ' ALA . . . . . 0.761 ' HA ' HD12 ' A' ' 108' ' ' LEU . . . -87.89 -42.99 12.13 Favored 'General case' 0 C--O 1.232 0.184 0 CA-C-N 116.451 -0.34 . . . . 0.47 111.583 -179.571 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 94' ' ' ASP . . . . . 0.641 ' OD1' 'CA ' ' A' ' 141' ' ' ' CA' . 28.1 t0 -82.81 99.9 9.98 Favored 'General case' 0 C--O 1.236 0.376 0 CA-C-O 121.555 0.693 . . . . 0.79 110.029 179.667 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 45.3 t -83.09 -43.42 18.4 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.739 0 CA-C-N 115.282 -0.872 . . . . 0.61 110.883 -174.512 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 96' ' ' ASP . . . . . 0.592 ' OD1' 'CA ' ' A' ' 141' ' ' ' CA' . 34.6 p-10 -82.63 -10.44 58.95 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.961 -0.563 . . . . 0.96 111.779 -173.666 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 0.561 ' HA ' ' OD2' ' A' ' 94' ' ' ASP . 42.7 mtpt 57.91 73.0 0.49 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.402 0.62 . . . . 2.96 111.922 178.951 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 98' ' ' ASP . . . . . 0.582 ' OD1' 'CA ' ' A' ' 141' ' ' ' CA' . 16.9 p-10 -121.64 9.98 10.28 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 115.395 -0.82 . . . . 0.43 110.196 176.334 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 64.2 18.05 62.27 Favored Glycine 0 C--N 1.333 0.401 0 CA-C-N 115.713 -0.676 . . . . 0.44 112.208 177.706 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.703 ' HB2' ' HA ' ' A' ' 68' ' ' THR . 1.7 pp -155.02 166.32 33.95 Favored 'General case' 0 N--CA 1.444 -0.748 0 N-CA-C 108.468 -0.938 . . . . 1.11 108.468 -179.373 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 87.6 mt -126.44 123.66 38.36 Favored 'General case' 0 C--N 1.322 -0.615 0 C-N-CA 120.832 -0.347 . . . . 0.42 111.228 -173.581 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 102' ' ' ASP . . . . . 0.631 ' HA ' ' HA ' ' A' ' 66' ' ' LYS . 2.3 p30 -79.75 -177.1 5.73 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 109.31 -0.626 . . . . 1.72 109.31 170.906 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 3.1 p30 -62.12 -29.39 70.3 Favored 'General case' 0 C--N 1.322 -0.63 0 C-N-CA 120.905 -0.318 . . . . 1.6 111.503 -174.694 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 104' ' ' GLU . . . . . 0.515 ' HB3' ' HB3' ' A' ' 132' ' ' PRO . 78.3 mt-10 -70.97 -56.24 6.62 Favored 'General case' 0 C--O 1.232 0.178 0 N-CA-C 109.823 -0.436 . . . . 1.66 109.823 177.545 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 25.3 mt-10 -65.52 -33.33 75.68 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.838 -0.619 . . . . 0.44 110.977 -174.645 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 90.8 t80 -69.23 -42.96 74.99 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.53 -0.305 . . . . 0.42 110.235 178.13 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -59.95 -39.15 84.6 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-O 121.121 0.486 . . . . 0.22 110.092 176.35 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.761 HD12 ' HA ' ' A' ' 93' ' ' ALA . 2.5 tm? -59.99 -51.69 68.6 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.625 -0.716 . . . . 1.33 109.492 176.862 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 109' ' ' ALA . . . . . 0.429 ' O ' HG13 ' A' ' 113' ' ' ILE . . . -57.61 -45.37 85.43 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 115.965 -0.562 . . . . 0.32 111.62 179.456 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 5.0 m-20 -69.38 -30.99 69.1 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.741 0.305 . . . . 1.2 111.244 -178.588 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 111' ' ' HIS . . . . . 0.473 ' HB2' HG13 ' A' ' 46' ' ' VAL . 30.3 t60 -64.55 -35.15 80.04 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 108.862 -0.792 . . . . 0.52 108.862 175.426 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.498 ' HA ' HG12 ' A' ' 115' ' ' VAL . 74.8 mt -71.18 -42.63 68.79 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.399 -0.818 . . . . 0.55 110.797 177.303 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.429 HG13 ' O ' ' A' ' 109' ' ' ALA . 24.6 mt -55.52 -50.28 67.51 Favored 'Isoleucine or valine' 0 C--O 1.234 0.26 0 CA-C-O 121.209 0.528 . . . . 0.84 110.44 177.859 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 37.3 ttpt -69.95 -45.4 67.51 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.729 -0.669 . . . . 3.83 110.997 -175.417 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.498 HG12 ' HA ' ' A' ' 112' ' ' LEU . 5.8 p -63.48 -30.61 50.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 120.95 0.405 . . . . 1.19 110.207 -178.557 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 116' ' ' LYS . . . . . 0.477 ' HD2' ' O ' ' A' ' 120' ' ' HIS . 34.6 tptt -69.28 -45.81 68.72 Favored 'General case' 0 N--CA 1.447 -0.61 0 CA-C-N 116.204 -0.453 . . . . 1.32 110.513 176.786 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 93.9 mt -74.56 -16.28 60.82 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.11 -0.496 . . . . 0.96 111.305 -179.198 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -84.47 6.05 25.0 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.594 0.711 . . . . 2.18 109.35 176.52 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 90.34 33.92 8.39 Favored Glycine 0 CA--C 1.518 0.272 0 CA-C-N 115.47 -0.786 . . . . 1.16 113.927 172.666 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 120' ' ' HIS . . . . . 0.477 ' O ' ' HD2' ' A' ' 116' ' ' LYS . 33.4 m-70 -112.62 155.36 24.55 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 117.04 0.42 . . . . 2.42 110.341 175.044 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 7.4 tp10 -111.52 127.98 55.88 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 109.864 -0.421 . . . . 2.53 109.864 179.167 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 122' ' ' LEU . . . . . 0.436 ' H ' ' HG ' ' A' ' 122' ' ' LEU . 2.4 pp -92.86 136.92 24.27 Favored Pre-proline 0 C--N 1.321 -0.637 0 CA-C-O 121.108 0.48 . . . . 1.33 111.761 -174.844 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_endo -73.42 -20.74 20.53 Favored 'Trans proline' 0 C--O 1.234 0.294 0 C-N-CA 123.147 2.564 . . . . 1.33 112.423 179.266 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 124' ' ' ALA . . . . . 0.42 ' HA ' HD22 ' A' ' 92' ' ' LEU . . . 66.78 18.26 10.66 Favored 'General case' 0 N--CA 1.462 0.138 0 CA-C-N 115.297 -0.865 . . . . 1.25 110.092 -172.712 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 29.0 m-20 -106.14 159.74 15.85 Favored 'General case' 0 CA--C 1.516 -0.341 0 N-CA-C 108.015 -1.105 . . . . 2.73 108.015 172.445 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 126' ' ' LEU . . . . . 0.455 ' HA ' ' HD2' ' A' ' 127' ' ' PRO . 49.2 tp -114.44 91.98 26.44 Favored Pre-proline 0 C--N 1.322 -0.601 0 C-N-CA 120.609 -0.436 . . . . 1.66 111.713 -176.982 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 127' ' ' PRO . . . . . 0.458 ' HA ' ' HD3' ' A' ' 128' ' ' PRO . 10.9 Cg_endo -58.5 146.45 90.64 Favored 'Trans proline' 0 CA--C 1.535 0.548 0 C-N-CA 122.836 2.357 . . . . 1.17 112.138 171.883 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 128' ' ' PRO . . . . . 0.458 ' HD3' ' HA ' ' A' ' 127' ' ' PRO . 76.0 Cg_exo -51.77 -39.47 67.28 Favored 'Trans proline' 0 C--N 1.346 0.435 0 C-N-CA 123.842 3.028 . . . . 1.54 114.27 -175.31 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 41.6 p-80 -79.0 13.67 1.68 Allowed 'General case' 0 N--CA 1.469 0.513 0 N-CA-C 112.463 0.542 . . . . 1.07 112.463 -175.368 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 41.3 mt -111.8 4.21 18.25 Favored 'General case' 0 C--N 1.324 -0.501 0 C-N-CA 121.181 -0.208 . . . . 1.36 111.131 175.198 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 93.8 t -75.27 126.57 87.68 Favored Pre-proline 0 C--N 1.327 -0.37 0 CA-C-O 120.694 0.283 . . . . 1.28 110.923 -179.788 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 132' ' ' PRO . . . . . 0.515 ' HB3' ' HB3' ' A' ' 104' ' ' GLU . 54.4 Cg_exo -54.88 154.61 20.79 Favored 'Trans proline' 0 CA--C 1.533 0.455 0 C-N-CA 123.472 2.781 . . . . 0.81 113.316 -179.583 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 133' ' ' PRO . . . . . 0.562 ' O ' ' HG2' ' A' ' 136' ' ' ARG . 50.7 Cg_exo -54.84 -54.55 4.3 Favored 'Trans proline' 0 C--N 1.347 0.468 0 C-N-CA 123.516 2.811 . . . . 1.17 113.987 -175.979 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 72.6 p -84.87 8.04 18.82 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 120.676 -0.41 . . . . 1.6 111.536 -175.464 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 135' ' ' LYS . . . . . 0.496 ' HD2' ' HG2' ' A' ' 132' ' ' PRO . 61.5 mttp -119.65 10.58 11.76 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 111.876 0.324 . . . . 1.21 111.876 -177.411 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 136' ' ' ARG . . . . . 0.562 ' HG2' ' O ' ' A' ' 133' ' ' PRO . 16.6 ptp180 -99.71 148.68 24.11 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.01 0.433 . . . . 2.76 111.2 -178.647 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 22.6 mmm180 -78.44 111.72 14.74 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.997 -0.547 . . . . 4.54 111.366 -177.32 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 138' ' ' HIS . . . . . 0.469 ' ND1' ' HG2' ' A' ' 139' ' ' GLU . 8.2 p80 -111.1 144.31 40.43 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 108.847 -0.798 . . . . 5.95 108.847 173.684 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 139' ' ' GLU . . . . . 0.469 ' HG2' ' ND1' ' A' ' 138' ' ' HIS . 17.6 mm-40 . . . . . 0 C--O 1.246 0.907 0 O-C-N 124.653 1.221 . . . . 6.15 109.895 -175.786 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 143' ' ' PHE . . . . . . . . . . . . . 42.8 p90 . . . . . 0 N--CA 1.48 1.063 0 CA-C-O 120.596 0.236 . . . . 11.86 110.603 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' B' B ' 144' ' ' ASN . . . . . . . . . . . . . 9.8 t-20 -142.52 -47.2 0.33 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.275 -0.42 . . . . 8.14 111.329 178.212 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 145' ' ' TYR . . . . . . . . . . . . . 47.5 p90 -129.76 6.09 5.1 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.372 -0.376 . . . . 6.71 111.088 -174.056 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 146' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -56.69 116.55 3.21 Favored 'General case' 0 C--N 1.329 -0.289 0 O-C-N 123.431 0.457 . . . . 6.61 110.578 -172.115 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 147' ' ' SER . . . . . . . . . . . . . 10.7 p -72.44 -68.0 0.51 Allowed 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.702 -0.681 . . . . 3.65 111.629 -175.39 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 148' ' ' THR . . . . . . . . . . . . . 25.1 m -132.86 -40.27 0.95 Allowed 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.909 -0.587 . . . . 1.79 109.651 178.662 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 149' ' ' GLY . . . . . . . . . . . . . . . -160.58 175.9 37.27 Favored Glycine 0 N--CA 1.443 -0.86 0 CA-C-N 115.251 -0.886 . . . . 0.48 111.277 176.0 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 150' ' ' PRO . . . . . . . . . . . . . 76.0 Cg_endo -74.77 -8.13 20.01 Favored 'Trans proline' 0 N--CA 1.463 -0.28 0 C-N-CA 122.448 2.099 . . . . 0.33 111.351 -179.187 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 151' ' ' PHE . . . . . 0.513 ' CE1' ' HG3' ' A' ' 73' ' ' LYS . 48.7 m-85 -89.47 -33.03 16.94 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.904 -0.589 . . . . 0.75 110.952 179.245 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 152' ' ' THR . . . . . . . . . . . . . 17.4 p -77.46 99.01 5.49 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.114 -0.494 . . . . 2.22 111.05 -177.16 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 153' ' ' ALA . . . . . . . . . . . . . . . -138.04 167.23 22.22 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.015 -0.539 . . . . 4.4 110.422 -179.957 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 154' ' ' LYS . . . . . . . . . . . . . 49.9 tptt . . . . . 0 C--O 1.251 1.146 0 CA-C-O 118.496 -0.764 . . . . 6.75 110.689 -178.356 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 141' ' ' ' CA' . . . . . 0.641 'CA ' ' OD1' ' A' ' 94' ' ' ASP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.401 ' HA2' ' HD3' ' A' ' 36' ' ' PRO . . . . . . . . 0 N--CA 1.482 1.735 0 N-CA-C 112.085 -0.406 . . . . 10.97 112.085 . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' PRO . . . . . 0.401 ' HD3' ' HA2' ' A' ' 35' ' ' GLY . 5.5 Cg_exo -78.3 137.79 15.33 Favored 'Trans proline' 0 N--CA 1.461 -0.422 0 C-N-CA 123.292 2.661 . . . . 9.0 112.057 179.522 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 95.0 mt -118.4 -56.34 2.15 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.051 0.453 . . . . 7.42 110.755 -179.837 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -92.22 86.3 1.23 Allowed Glycine 0 N--CA 1.447 -0.604 0 C-N-CA 120.681 -0.771 . . . . 4.46 112.667 -178.482 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 28.3 m 65.94 -170.04 0.2 Allowed 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 122.888 0.475 . . . . 3.97 111.118 177.151 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -100.02 134.05 43.5 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.207 -0.451 . . . . 3.46 110.423 179.69 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -105.1 131.11 53.02 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.047 -0.524 . . . . 1.93 110.736 -177.64 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 13.8 p -123.52 150.64 27.81 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.45 0 CA-C-N 116.175 -0.466 . . . . 1.85 111.345 -178.412 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -84.5 148.47 26.51 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 109.404 -0.591 . . . . 3.1 109.404 174.142 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' TRP . . . . . 0.486 ' HH2' ' O ' ' A' ' 104' ' ' GLU . 3.2 t90 -85.6 109.41 18.53 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 120.967 0.413 . . . . 0.71 110.095 -178.034 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 11.7 p -63.12 -17.62 19.91 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.433 0 CA-C-N 115.671 -0.695 . . . . 1.45 111.909 -175.822 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.4 HG11 ' HA ' ' A' ' 108' ' ' LEU . 46.9 t -82.06 -22.25 9.79 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-O 121.151 0.5 . . . . 1.1 110.425 179.105 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 47' ' ' GLY . . . . . 0.711 ' HA2' ' HG3' ' A' ' 50' ' ' LYS . . . -73.31 -11.91 79.74 Favored Glycine 0 CA--C 1.517 0.161 0 CA-C-N 115.739 -0.664 . . . . 0.59 113.481 -173.232 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 21.9 ptmt -77.83 -19.59 54.65 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.854 0.327 . . . . 2.46 111.158 -176.927 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 42.7 t0 -117.35 33.88 5.4 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.863 0.839 . . . . 1.66 109.503 179.956 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 0.711 ' HG3' ' HA2' ' A' ' 47' ' ' GLY . 24.1 mtpt -69.18 -42.0 20.15 Favored Pre-proline 0 C--O 1.22 -0.454 0 CA-C-N 115.652 -0.704 . . . . 1.15 112.793 -179.601 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_exo -44.21 -41.33 13.06 Favored 'Trans proline' 0 C--N 1.359 1.082 0 C-N-CA 122.202 1.935 . . . . 0.75 112.733 176.699 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 15.4 m -70.44 -45.5 65.69 Favored 'General case' 0 C--O 1.238 0.456 0 CA-C-N 116.203 -0.453 . . . . 0.68 111.156 -179.277 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 7.2 m-85 -74.12 -22.01 59.64 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.534 -0.303 . . . . 0.69 110.589 -176.998 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -76.09 -39.72 54.68 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 108.932 -0.766 . . . . 2.18 108.932 178.007 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 44.4 tt0 -58.38 -47.86 82.48 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.241 -0.89 . . . . 2.33 110.218 175.282 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 55.7 mt -67.45 -52.09 45.36 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 115.644 -0.707 . . . . 0.64 111.384 179.697 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' PHE . . . . . 0.583 ' HE1' HG12 ' A' ' 67' ' ' ILE . 72.7 t80 -55.65 -32.57 63.3 Favored 'General case' 0 C--N 1.326 -0.435 0 C-N-CA 122.872 0.469 . . . . 0.29 112.017 -176.695 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 58' ' ' TYR . . . . . 0.434 ' CE1' ' HD2' ' A' ' 57' ' ' PHE . 2.6 m-85 -88.52 -2.23 58.48 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 111.835 0.309 . . . . 1.17 111.835 -176.416 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 79.0 p -100.36 -12.69 19.22 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.18 0.514 . . . . 0.44 109.99 173.476 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 10.4 mp -88.42 6.62 36.64 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.687 -0.688 . . . . 1.37 110.768 177.885 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 52.0 m 62.87 83.6 0.2 Allowed Pre-proline 0 CA--C 1.531 0.212 0 CA-C-N 115.558 -0.746 . . . . 1.24 111.203 -178.6 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 75.2 Cg_endo -83.36 137.16 8.02 Favored 'Trans proline' 0 N--CA 1.458 -0.598 0 C-N-CA 122.763 2.309 . . . . 0.47 112.893 -178.157 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 47.4 t -104.71 103.82 15.89 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 CA-C-N 116.105 -0.498 . . . . 1.02 110.25 178.191 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 93.2 m-20 60.57 25.78 15.47 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-N 116.042 -0.527 . . . . 1.34 111.605 177.497 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 92.54 17.46 45.38 Favored Glycine 0 C--O 1.227 -0.303 0 C-N-CA 120.788 -0.72 . . . . 0.43 112.712 178.533 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 0.636 ' HA ' ' HA ' ' A' ' 102' ' ' ASP . 59.4 mttm -141.41 134.64 29.42 Favored 'General case' 0 C--N 1.324 -0.532 0 C-N-CA 122.95 0.5 . . . . 1.48 110.242 177.734 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 67' ' ' ILE . . . . . 0.583 HG12 ' HE1' ' A' ' 57' ' ' PHE . 30.0 pt -103.25 150.57 6.7 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 N-CA-C 110.197 -0.297 . . . . 0.64 110.197 173.321 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 59.3 p -73.62 166.3 23.51 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.272 -0.422 . . . . 0.55 111.078 -176.307 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -68.06 -18.82 71.32 Favored Glycine 0 N--CA 1.447 -0.622 0 C-N-CA 120.801 -0.714 . . . . 0.41 112.162 178.265 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -74.28 -39.52 62.9 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.374 0.607 . . . . 0.38 110.294 176.126 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 12.3 m120 -73.45 -41.36 63.3 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.686 -0.688 . . . . 1.81 109.309 178.771 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -62.05 -37.63 85.68 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.232 -0.895 . . . . 0.39 110.248 174.153 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' LYS . . . . . 0.452 ' O ' HG23 ' A' ' 77' ' ' VAL . 22.8 ttmm -55.74 -52.02 65.34 Favored 'General case' 0 C--O 1.221 -0.404 0 CA-C-N 115.86 -0.609 . . . . 0.84 109.862 174.66 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 74' ' ' LYS . . . . . 0.438 ' O ' ' HG2' ' A' ' 78' ' ' LYS . 68.4 mttm -54.95 -46.23 74.99 Favored 'General case' 0 C--N 1.329 -0.321 0 O-C-N 123.38 0.425 . . . . 1.95 111.389 -179.395 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 20.7 tp10 -63.75 -49.72 71.9 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.838 0.352 . . . . 1.6 110.895 -179.401 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 76' ' ' MET . . . . . 0.748 ' HB3' HD22 ' A' ' 86' ' ' LEU . 96.5 mmm -66.54 -27.91 68.12 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.247 0.546 . . . . 1.24 111.285 -178.34 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.452 HG23 ' O ' ' A' ' 73' ' ' LYS . 37.2 t -71.65 -34.53 52.64 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-N 115.907 -0.588 . . . . 1.57 110.044 175.066 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.438 ' HG2' ' O ' ' A' ' 74' ' ' LYS . 29.5 mmmt -69.85 -22.46 63.26 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.925 -0.579 . . . . 2.79 110.277 174.872 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 79' ' ' SER . . . . . 0.449 ' C ' ' HG2' ' A' ' 80' ' ' LYS . 15.7 m -76.02 -4.81 43.33 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.951 -0.568 . . . . 1.27 110.711 178.333 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 80' ' ' LYS . . . . . 0.449 ' HG2' ' C ' ' A' ' 79' ' ' SER . 18.5 ptmt 47.2 32.6 2.14 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 124.07 0.948 . . . . 2.97 112.863 175.821 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.4 ' HB2' HD21 ' A' ' 86' ' ' LEU . 85.7 mt -97.22 150.16 36.51 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 116.094 -0.503 . . . . 0.52 110.089 176.487 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 82' ' ' PRO . . . . . 0.508 ' O ' ' HG ' ' A' ' 86' ' ' LEU . 52.9 Cg_exo -55.51 145.39 69.27 Favored 'Trans proline' 0 C--O 1.234 0.293 0 C-N-CA 122.658 2.239 . . . . 0.44 112.347 179.636 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 21.1 p-10 -55.21 -41.71 72.39 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-N 116.35 -0.387 . . . . 1.85 111.693 -177.046 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 9.4 m -55.06 -45.87 75.36 Favored 'General case' 0 N--CA 1.448 -0.542 0 CA-C-N 115.821 -0.627 . . . . 1.47 110.748 177.826 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 80.5 t -72.28 -32.04 41.22 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.177 0 CA-C-N 115.902 -0.59 . . . . 0.45 110.891 -179.821 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.748 HD22 ' HB3' ' A' ' 76' ' ' MET . 80.4 mt -61.78 -43.66 98.42 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 110.079 -0.341 . . . . 0.9 110.079 175.906 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -66.88 -34.35 86.87 Favored Glycine 0 N--CA 1.452 -0.299 0 N-CA-C 111.511 -0.635 . . . . 0.32 111.511 178.09 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 88' ' ' LYS . . . . . 0.489 ' O ' HD23 ' A' ' 92' ' ' LEU . 35.5 mmtm -58.12 -58.69 7.35 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.946 0.403 . . . . 1.89 110.124 174.189 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 56.0 mt -62.11 -35.22 67.57 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 115.747 -0.661 . . . . 0.71 110.932 -177.483 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 50.7 t-105 -58.02 -49.03 78.28 Favored 'General case' 0 C--O 1.223 -0.325 0 C-N-CA 120.707 -0.397 . . . . 0.33 110.293 175.287 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 20.8 ttmm -61.95 -39.84 93.48 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.298 -0.41 . . . . 2.7 111.7 -177.526 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.83 HD12 ' HG ' ' A' ' 126' ' ' LEU . 4.3 mm? -76.74 -24.55 53.01 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 111.888 0.329 . . . . 1.66 111.888 -179.253 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -93.05 -42.21 9.55 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.648 0.261 . . . . 0.47 111.618 -178.291 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 94' ' ' ASP . . . . . 0.648 ' OD1' 'CA ' ' A' ' 141' ' ' ' CA' . 30.8 t0 -82.66 87.16 6.74 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.51 0.671 . . . . 0.79 109.484 179.674 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 47.4 t -80.77 -34.75 14.27 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 CA-C-N 115.197 -0.911 . . . . 0.61 110.718 -174.271 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 96' ' ' ASP . . . . . 0.634 ' OD1' 'CA ' ' A' ' 141' ' ' ' CA' . 48.4 p-10 -82.43 -13.92 55.99 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.503 -0.317 . . . . 0.96 110.453 -179.294 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 0.476 ' HA ' ' OD2' ' A' ' 94' ' ' ASP . 31.7 mtmm 57.72 54.74 6.03 Favored 'General case' 0 C--O 1.231 0.118 0 O-C-N 123.778 0.674 . . . . 2.96 110.816 173.614 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 98' ' ' ASP . . . . . 0.606 ' OD1' 'CA ' ' A' ' 141' ' ' ' CA' . 16.2 p-10 -110.2 8.66 23.77 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.59 -0.732 . . . . 0.43 110.891 -174.775 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 71.64 7.08 64.19 Favored Glycine 0 N--CA 1.453 -0.205 0 C-N-CA 120.633 -0.794 . . . . 0.44 112.429 179.717 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.413 HD12 ' O ' ' A' ' 98' ' ' ASP . 4.3 mp -135.04 155.18 51.2 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 109.516 -0.55 . . . . 1.11 109.516 178.143 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 77.7 mt -109.68 114.09 27.4 Favored 'General case' 0 C--N 1.315 -0.933 0 N-CA-C 109.399 -0.593 . . . . 0.42 109.399 175.831 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 102' ' ' ASP . . . . . 0.636 ' HA ' ' HA ' ' A' ' 66' ' ' LYS . 2.9 p30 -79.87 -176.05 5.24 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.255 -0.429 . . . . 1.72 110.65 179.698 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -55.07 -42.1 72.35 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.826 -0.624 . . . . 1.6 111.277 -178.719 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 104' ' ' GLU . . . . . 0.486 ' O ' ' HH2' ' A' ' 44' ' ' TRP . 49.9 mt-10 -72.32 -52.78 14.69 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.193 -0.458 . . . . 1.66 110.335 179.728 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 36.6 mt-10 -64.02 -37.77 88.63 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.106 -0.497 . . . . 0.44 111.193 -172.951 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 106' ' ' PHE . . . . . 0.488 ' CD2' ' HD1' ' A' ' 57' ' ' PHE . 49.5 t80 -74.79 -34.58 62.45 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.412 -0.358 . . . . 0.42 110.3 -179.327 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -60.07 -42.64 94.99 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-O 121.075 0.465 . . . . 0.22 110.003 173.689 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.4 ' HA ' HG11 ' A' ' 46' ' ' VAL . 6.9 tt -62.1 -47.56 84.07 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-N 115.86 -0.609 . . . . 1.33 109.74 176.643 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 109' ' ' ALA . . . . . 0.5 ' O ' HG13 ' A' ' 113' ' ' ILE . . . -55.82 -52.03 65.41 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 115.885 -0.598 . . . . 0.32 111.195 179.2 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 92.7 m-20 -59.13 -35.14 72.95 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-O 120.721 0.296 . . . . 1.2 110.992 179.375 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 111' ' ' HIS . . . . . 0.478 ' O ' HG23 ' A' ' 115' ' ' VAL . 24.8 t60 -64.21 -39.94 95.02 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.282 -0.417 . . . . 0.52 110.193 -179.49 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 59.7 mt -74.85 -34.29 62.26 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.297 -0.41 . . . . 0.55 110.976 178.252 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.5 HG13 ' O ' ' A' ' 109' ' ' ALA . 82.5 mt -59.32 -45.27 93.37 Favored 'Isoleucine or valine' 0 C--O 1.234 0.279 0 CA-C-O 121.242 0.544 . . . . 0.84 109.61 173.955 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 114' ' ' LYS . . . . . 0.431 ' HA ' ' HE3' ' A' ' 114' ' ' LYS . 0.1 OUTLIER -60.54 -42.65 96.95 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.216 -0.902 . . . . 3.83 110.163 177.808 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.635 HG13 ' HB2' ' A' ' 120' ' ' HIS . 40.6 t -53.53 -47.07 60.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.015 -0.539 . . . . 1.19 110.978 176.103 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 27.6 mmmt -69.62 -38.75 77.36 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.403 -0.362 . . . . 1.32 111.246 -179.42 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 94.7 mt -66.51 -29.09 69.11 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.128 0.489 . . . . 0.96 111.009 177.805 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 5.4 tp10 -77.53 -22.11 51.61 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.47 0.652 . . . . 2.18 110.044 178.858 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 99.57 19.71 19.5 Favored Glycine 0 N--CA 1.445 -0.702 0 CA-C-N 115.458 -0.792 . . . . 1.16 112.657 179.919 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 120' ' ' HIS . . . . . 0.635 ' HB2' HG13 ' A' ' 115' ' ' VAL . 29.2 m-70 -97.4 167.07 11.23 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 109.425 -0.583 . . . . 2.42 109.425 175.907 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 7.4 tp10 -114.86 145.77 41.81 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-O 120.717 0.294 . . . . 2.53 110.223 -179.154 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 122' ' ' LEU . . . . . 0.496 ' HA ' ' HD3' ' A' ' 123' ' ' PRO . 3.1 pp -106.87 139.98 20.92 Favored Pre-proline 0 C--N 1.323 -0.545 0 N-CA-C 109.473 -0.566 . . . . 1.33 109.473 177.133 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 123' ' ' PRO . . . . . 0.496 ' HD3' ' HA ' ' A' ' 122' ' ' LEU . 9.5 Cg_exo -72.58 0.17 7.95 Favored 'Trans proline' 0 C--O 1.232 0.19 0 C-N-CA 122.743 2.295 . . . . 1.33 113.16 -176.55 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . 58.83 23.67 11.54 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-O 121.202 0.525 . . . . 1.25 110.592 -176.874 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 5.6 t0 -132.27 170.63 14.77 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 108.31 -0.996 . . . . 2.73 108.31 -179.87 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 126' ' ' LEU . . . . . 0.83 ' HG ' HD12 ' A' ' 92' ' ' LEU . 19.2 mt -116.76 105.93 48.91 Favored Pre-proline 0 C--N 1.321 -0.668 0 N-CA-C 112.116 0.413 . . . . 1.66 112.116 -175.21 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 127' ' ' PRO . . . . . 0.423 ' HD2' ' HB2' ' A' ' 130' ' ' LEU . 12.1 Cg_exo -70.94 147.67 55.81 Favored 'Trans proline' 0 N--CA 1.459 -0.502 0 C-N-CA 122.611 2.207 . . . . 1.17 110.778 169.919 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_exo -50.39 -37.87 51.81 Favored 'Trans proline' 0 CA--C 1.531 0.373 0 C-N-CA 122.944 2.429 . . . . 1.54 113.596 -178.311 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 44.3 p-80 -82.18 3.95 25.25 Favored 'General case' 0 CA--C 1.533 0.306 0 N-CA-C 111.961 0.356 . . . . 1.07 111.961 -178.168 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 130' ' ' LEU . . . . . 0.423 ' HB2' ' HD2' ' A' ' 127' ' ' PRO . 2.4 mm? -101.06 -20.01 15.55 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.665 0.269 . . . . 1.36 110.582 174.35 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 43.4 t -74.85 126.54 88.24 Favored Pre-proline 0 C--N 1.325 -0.459 0 CA-C-N 116.127 -0.488 . . . . 1.28 110.606 -178.989 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_exo -55.64 134.0 61.39 Favored 'Trans proline' 0 C--N 1.345 0.391 0 C-N-CA 122.587 2.191 . . . . 0.81 111.722 177.224 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -58.31 -23.32 62.31 Favored 'Trans proline' 0 CA--C 1.529 0.256 0 C-N-CA 122.961 2.441 . . . . 1.17 112.955 -176.64 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 5.5 m -82.01 -16.77 49.14 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.413 -0.358 . . . . 1.6 111.304 -179.72 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 6.2 mptt -119.93 22.11 11.63 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 111.776 0.287 . . . . 1.21 111.776 -176.404 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 33.9 ptt180 -86.99 101.68 13.67 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.662 0.744 . . . . 2.76 112.035 -174.702 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 15.2 tpp180 -132.21 131.7 42.41 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.343 -0.844 . . . . 4.54 109.463 175.343 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 28.0 t60 -85.36 99.65 11.31 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 120.709 0.29 . . . . 5.95 110.528 179.432 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 52.1 mt-10 . . . . . 0 C--O 1.249 1.039 0 CA-C-O 118.616 -0.707 . . . . 6.15 109.93 175.877 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' B' B ' 143' ' ' PHE . . . . . . . . . . . . . 86.1 m-85 . . . . . 0 N--CA 1.479 0.993 0 N-CA-C 110.175 -0.306 . . . . 11.86 110.175 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' B' B ' 144' ' ' ASN . . . . . . . . . . . . . 48.3 t30 -145.61 117.65 8.3 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 109.888 -0.412 . . . . 8.14 109.888 176.498 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 145' ' ' TYR . . . . . . . . . . . . . 12.9 t80 -126.32 100.58 6.34 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.134 0.492 . . . . 6.71 110.106 179.066 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 146' ' ' GLU . . . . . 0.545 ' CD ' ' H ' ' B' ' 146' ' ' GLU . 0.7 OUTLIER -80.63 121.5 25.92 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.652 -0.704 . . . . 6.61 110.486 -179.918 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 147' ' ' SER . . . . . . . . . . . . . 4.9 p -140.56 40.86 1.88 Allowed 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.767 -0.651 . . . . 3.65 110.788 -176.655 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 148' ' ' THR . . . . . 0.533 ' HB ' ' HB ' ' B' ' 152' ' ' THR . 18.0 p -78.64 -33.83 46.93 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.191 -0.459 . . . . 1.79 111.027 -178.059 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 149' ' ' GLY . . . . . . . . . . . . . . . 106.89 160.0 21.7 Favored Glycine 0 N--CA 1.443 -0.84 0 C-N-CA 120.561 -0.828 . . . . 0.48 112.395 177.555 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 150' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -73.83 -2.14 11.81 Favored 'Trans proline' 0 C--O 1.232 0.191 0 C-N-CA 122.844 2.362 . . . . 0.33 112.318 -178.272 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 151' ' ' PHE . . . . . . . . . . . . . 26.9 m-85 -102.84 -27.14 12.84 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.961 -0.563 . . . . 0.75 110.409 178.491 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 152' ' ' THR . . . . . 0.533 ' HB ' ' HB ' ' B' ' 148' ' ' THR . 6.0 m -90.61 -31.76 16.54 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.935 -0.575 . . . . 2.22 110.386 -179.743 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 153' ' ' ALA . . . . . . . . . . . . . . . 67.05 -165.06 0.22 Allowed 'General case' 0 C--O 1.234 0.285 0 CA-C-N 115.363 -0.835 . . . . 4.4 111.661 177.523 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 154' ' ' LYS . . . . . . . . . . . . . 51.2 mtmt . . . . . 0 C--O 1.245 0.846 0 CA-C-O 118.423 -0.798 . . . . 6.75 109.985 -178.732 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 141' ' ' ' CA' . . . . . 0.648 'CA ' ' OD1' ' A' ' 94' ' ' ASP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.406 ' HA3' ' HD3' ' A' ' 36' ' ' PRO . . . . . . . . 0 N--CA 1.483 1.797 0 N-CA-C 111.528 -0.629 . . . . 10.97 111.528 . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' PRO . . . . . 0.742 ' HA ' ' HB2' ' A' ' 40' ' ' ASP . 7.6 Cg_exo -72.44 97.15 0.85 Allowed 'Trans proline' 0 N--CA 1.46 -0.441 0 C-N-CA 122.658 2.239 . . . . 9.0 111.3 177.125 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 56.0 tp -109.89 -47.3 3.36 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.13 -0.486 . . . . 7.42 110.211 -178.263 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -90.38 -126.64 3.29 Favored Glycine 0 N--CA 1.446 -0.674 0 N-CA-C 110.617 -0.993 . . . . 4.46 110.617 177.671 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 3.8 t -94.52 40.56 1.09 Allowed 'General case' 0 C--N 1.318 -0.784 0 N-CA-C 109.253 -0.647 . . . . 3.97 109.253 176.832 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' ASP . . . . . 0.742 ' HB2' ' HA ' ' A' ' 36' ' ' PRO . 13.7 m-20 -76.35 95.1 3.72 Favored 'General case' 0 CA--C 1.519 -0.216 0 CA-C-N 115.506 -0.77 . . . . 3.46 109.887 -179.029 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 9.9 t0 -93.03 90.52 6.95 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 109.536 -0.542 . . . . 1.93 109.536 179.347 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 26.9 m -77.32 146.75 8.03 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-N 115.904 -0.589 . . . . 1.85 110.512 -178.842 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -69.54 136.12 50.95 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 116.088 -0.505 . . . . 3.1 110.547 178.682 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 9.8 t90 -83.44 122.02 27.95 Favored 'General case' 0 C--N 1.318 -0.803 0 N-CA-C 108.796 -0.816 . . . . 0.71 108.796 179.834 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 33.6 m -61.48 -15.9 13.87 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.521 0 N-CA-C 114.316 1.228 . . . . 1.45 114.316 -166.793 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.469 HG23 ' HB2' ' A' ' 111' ' ' HIS . 11.5 p -92.45 -14.06 8.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 C-N-CA 120.033 -0.667 . . . . 1.1 110.541 178.346 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -64.55 -25.41 70.17 Favored Glycine 0 CA--C 1.519 0.305 0 C-N-CA 120.964 -0.636 . . . . 0.59 112.955 -177.115 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' LYS . . . . . 0.5 ' HG3' ' OD2' ' A' ' 49' ' ' ASP . 11.5 ptmm? -76.63 -19.44 57.8 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.599 0.238 . . . . 2.46 111.149 -179.226 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 49' ' ' ASP . . . . . 0.5 ' OD2' ' HG3' ' A' ' 48' ' ' LYS . 10.5 m-20 -127.14 34.56 4.72 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 109.362 -0.607 . . . . 1.66 109.362 179.571 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 0.436 ' HG2' ' OD1' ' A' ' 54' ' ' ASP . 56.7 tttm -86.61 -48.13 0.51 Allowed Pre-proline 0 C--N 1.324 -0.541 0 CA-C-N 115.862 -0.608 . . . . 1.15 112.308 -172.725 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.411 ' HD3' ' HB3' ' A' ' 50' ' ' LYS . 84.3 Cg_exo -49.61 -31.22 24.11 Favored 'Trans proline' 0 C--N 1.361 1.202 0 C-N-CA 122.158 1.905 . . . . 0.75 113.003 -179.88 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 11.0 m -70.14 -45.43 66.81 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.252 -0.431 . . . . 0.68 110.502 177.763 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 19.9 m-30 -73.67 -23.25 59.82 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.395 -0.366 . . . . 0.69 110.291 -177.81 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' ASP . . . . . 0.436 ' OD1' ' HG2' ' A' ' 50' ' ' LYS . 0.9 OUTLIER -72.59 -40.6 66.44 Favored 'General case' 0 CA--C 1.517 -0.305 0 N-CA-C 109.683 -0.488 . . . . 2.18 109.683 174.657 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 2.6 mm-40 -58.76 -36.93 75.18 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.039 -0.528 . . . . 2.33 110.58 176.012 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 35.3 mt -75.65 -40.29 40.31 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-O 121.119 0.485 . . . . 0.64 110.298 177.183 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' PHE . . . . . 0.411 ' HD2' ' CD1' ' A' ' 58' ' ' TYR . 86.5 t80 -57.1 -38.18 73.01 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.685 -0.689 . . . . 0.29 111.409 179.132 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 58' ' ' TYR . . . . . 0.546 ' HA ' ' HG3' ' A' ' 62' ' ' PRO . 19.8 m-30 -80.32 -3.77 50.77 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.383 -0.372 . . . . 1.17 111.578 -174.208 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 75.3 p -100.2 -2.4 34.04 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.878 0.371 . . . . 0.44 111.034 179.609 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 74.6 mt -102.09 16.7 25.28 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.393 -0.367 . . . . 1.37 110.615 179.753 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 48.3 t 63.06 80.89 0.24 Allowed Pre-proline 0 CA--C 1.532 0.283 0 CA-C-N 115.53 -0.759 . . . . 1.24 111.237 -179.209 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' PRO . . . . . 0.578 ' HA ' HG22 ' A' ' 67' ' ' ILE . 6.2 Cg_exo -78.59 143.88 19.4 Favored 'Trans proline' 0 N--CA 1.461 -0.427 0 C-N-CA 122.899 2.399 . . . . 0.47 112.007 178.84 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 16.7 m -122.86 117.43 51.78 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-N 116.284 -0.416 . . . . 1.02 110.191 176.161 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 88.2 m-20 62.07 23.35 13.77 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-N 115.984 -0.553 . . . . 1.34 111.182 -179.823 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 90.57 5.77 68.79 Favored Glycine 0 C--O 1.229 -0.201 0 C-N-CA 120.961 -0.638 . . . . 0.43 113.043 178.375 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 0.645 ' HG2' ' HA ' ' A' ' 102' ' ' ASP . 37.0 mtpt -135.52 157.93 45.64 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 109.952 -0.388 . . . . 1.48 109.952 -178.692 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 67' ' ' ILE . . . . . 0.578 HG22 ' HA ' ' A' ' 62' ' ' PRO . 48.8 pt -124.95 164.07 24.38 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-O 120.988 0.423 . . . . 0.64 110.943 177.416 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 68' ' ' THR . . . . . 0.409 ' HA ' HD23 ' A' ' 100' ' ' LEU . 37.5 p -82.25 165.57 20.31 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.339 -0.846 . . . . 0.55 110.893 179.992 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -72.1 -12.98 76.17 Favored Glycine 0 N--CA 1.447 -0.614 0 C-N-CA 120.988 -0.625 . . . . 0.41 112.56 179.599 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.413 ' O ' ' HG3' ' A' ' 74' ' ' LYS . . . -64.46 -58.97 4.93 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.079 0.466 . . . . 0.38 111.068 -179.216 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 39.4 m-80 -68.89 -38.54 79.72 Favored 'General case' 0 C--O 1.238 0.454 0 CA-C-N 115.809 -0.632 . . . . 1.81 110.451 -178.06 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -59.25 -43.2 92.45 Favored 'General case' 0 N--CA 1.45 -0.425 0 CA-C-N 115.608 -0.723 . . . . 0.39 109.951 176.542 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -62.23 -39.54 93.16 Favored 'General case' 0 C--O 1.224 -0.276 0 CA-C-N 116.362 -0.381 . . . . 0.84 110.906 177.85 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 74' ' ' LYS . . . . . 0.464 ' O ' HG12 ' A' ' 77' ' ' VAL . 57.6 mtpt -59.14 -33.43 70.87 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-O 121.008 0.432 . . . . 1.95 110.693 178.731 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 75' ' ' GLU . . . . . 0.478 ' O ' ' HG3' ' A' ' 78' ' ' LYS . 40.9 tt0 -81.34 -50.67 9.22 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 116.172 -0.467 . . . . 1.6 110.368 -179.496 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 76' ' ' MET . . . . . 0.749 ' HB3' HD22 ' A' ' 86' ' ' LEU . 75.1 mmm -57.4 -27.49 62.39 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.803 -0.635 . . . . 1.24 110.327 178.672 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.464 HG12 ' O ' ' A' ' 74' ' ' LYS . 1.5 p -86.95 -28.01 5.8 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.535 0 CA-C-N 115.942 -0.572 . . . . 1.57 110.968 -179.082 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.478 ' HG3' ' O ' ' A' ' 75' ' ' GLU . 0.0 OUTLIER -82.28 -14.38 55.51 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-O 120.886 0.374 . . . . 2.79 110.26 -179.096 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 2.0 p -78.6 4.43 13.53 Favored 'General case' 0 CA--C 1.531 0.214 0 CA-C-N 116.323 -0.399 . . . . 1.27 110.396 170.343 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 52.3 mtpt 63.5 32.81 14.0 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 115.403 -0.817 . . . . 2.97 112.247 172.535 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.671 ' HB2' HD21 ' A' ' 86' ' ' LEU . 88.7 mt -102.17 141.39 22.44 Favored Pre-proline 0 C--N 1.318 -0.778 0 CA-C-N 116.417 -0.356 . . . . 0.52 110.118 176.956 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 82' ' ' PRO . . . . . 0.537 ' O ' ' HG ' ' A' ' 86' ' ' LEU . 51.7 Cg_exo -56.14 136.74 76.69 Favored 'Trans proline' 0 C--N 1.344 0.306 0 C-N-CA 122.821 2.347 . . . . 0.44 112.706 179.52 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 83' ' ' ASN . . . . . 0.411 ' HA ' HD12 ' A' ' 86' ' ' LEU . 18.2 p30 -51.93 -34.9 43.79 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-N 115.846 -0.616 . . . . 1.85 112.437 -179.866 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 30.1 m -69.48 -39.07 77.89 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 121.006 0.432 . . . . 1.47 110.608 -179.553 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.414 HG23 ' HB2' ' A' ' 82' ' ' PRO . 58.8 t -67.69 -36.23 75.33 Favored 'Isoleucine or valine' 0 C--O 1.234 0.277 0 N-CA-C 109.325 -0.62 . . . . 0.45 109.325 176.573 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.749 HD22 ' HB3' ' A' ' 76' ' ' MET . 65.4 mt -63.84 -33.47 75.75 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.348 -0.842 . . . . 0.9 109.876 175.807 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -68.58 -38.28 86.07 Favored Glycine 0 N--CA 1.451 -0.363 0 N-CA-C 111.57 -0.612 . . . . 0.32 111.57 178.931 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 88' ' ' LYS . . . . . 0.418 ' O ' ' HG ' ' A' ' 92' ' ' LEU . 73.1 mmtt -57.7 -52.82 63.86 Favored 'General case' 0 C--O 1.24 0.563 0 CA-C-O 121.638 0.733 . . . . 1.89 109.582 173.814 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.43 HG23 HD12 ' A' ' 112' ' ' LEU . 45.4 mt -65.12 -34.88 73.59 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.453 0 CA-C-N 114.924 -1.034 . . . . 0.71 111.389 -178.148 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 90' ' ' TRP . . . . . 0.462 ' HB2' ' CE2' ' B' ' 151' ' ' PHE . 55.0 t-105 -60.45 -46.09 91.33 Favored 'General case' 0 C--N 1.333 -0.118 0 CA-C-O 120.795 0.331 . . . . 0.33 110.149 175.814 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 30.8 ttpt -66.39 -20.86 66.18 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.846 -0.615 . . . . 2.7 110.807 -178.611 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.782 HD11 ' HA ' ' A' ' 124' ' ' ALA . 82.6 mt -92.35 -31.56 15.3 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.437 -0.347 . . . . 1.66 111.682 177.4 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -86.54 -41.49 14.28 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.506 -0.315 . . . . 0.47 111.835 -174.39 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 94' ' ' ASP . . . . . 0.65 ' OD1' 'CA ' ' A' ' 141' ' ' ' CA' . 36.3 t0 -80.86 81.26 7.16 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 108.982 -0.747 . . . . 0.79 108.982 178.137 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.714 ' HB ' ' HD3' ' A' ' 135' ' ' LYS . 46.2 t -75.35 -34.7 31.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 115.027 -0.988 . . . . 0.61 111.083 -173.519 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 96' ' ' ASP . . . . . 0.634 ' OD1' 'CA ' ' A' ' 141' ' ' ' CA' . 15.5 p-10 -82.58 -8.46 59.61 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 109.514 -0.551 . . . . 0.96 109.514 179.05 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 97.0 mttt 49.65 73.06 0.27 Allowed 'General case' 0 C--O 1.235 0.314 0 CA-C-N 115.403 -0.817 . . . . 2.96 111.455 175.229 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 98' ' ' ASP . . . . . 0.484 ' OD2' ' HB2' ' A' ' 100' ' ' LEU . 9.5 p-10 -134.69 9.5 3.63 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.624 -0.716 . . . . 0.43 111.067 -173.837 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 73.75 -4.64 28.14 Favored Glycine 0 C--N 1.331 0.288 0 C-N-CA 120.791 -0.719 . . . . 0.44 112.407 178.699 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.484 ' HB2' ' OD2' ' A' ' 98' ' ' ASP . 89.2 mt -120.86 154.35 35.93 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 109.051 -0.722 . . . . 1.11 109.051 178.401 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 75.3 mt -108.32 122.77 47.67 Favored 'General case' 0 C--N 1.31 -1.138 0 C-N-CA 120.487 -0.485 . . . . 0.42 110.146 178.011 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 102' ' ' ASP . . . . . 0.674 ' HB2' ' HG3' ' A' ' 105' ' ' GLU . 16.0 m-20 -68.83 168.36 13.63 Favored 'General case' 0 CA--C 1.512 -0.508 0 N-CA-C 108.113 -1.069 . . . . 1.72 108.113 170.111 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -61.53 -29.82 70.24 Favored 'General case' 0 C--N 1.317 -0.81 0 N-CA-C 109.202 -0.666 . . . . 1.6 109.202 174.527 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 50.7 mt-10 -64.64 -55.52 19.69 Favored 'General case' 0 C--O 1.231 0.092 0 CA-C-N 115.762 -0.654 . . . . 1.66 110.148 173.495 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 105' ' ' GLU . . . . . 0.674 ' HG3' ' HB2' ' A' ' 102' ' ' ASP . 14.4 mt-10 -62.4 -39.85 94.6 Favored 'General case' 0 N--CA 1.463 0.207 0 CA-C-N 115.454 -0.793 . . . . 0.44 110.956 -173.914 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 79.7 t80 -64.21 -47.86 78.09 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.671 -0.695 . . . . 0.42 110.524 178.193 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -57.67 -45.61 85.36 Favored 'General case' 0 N--CA 1.454 -0.258 0 CA-C-N 116.278 -0.419 . . . . 0.22 110.754 178.704 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 55.1 tp -59.48 -47.37 85.75 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.486 -0.325 . . . . 1.33 110.735 -179.906 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 109' ' ' ALA . . . . . 0.579 ' O ' HG12 ' A' ' 113' ' ' ILE . . . -58.61 -46.85 86.14 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.224 -0.444 . . . . 0.32 110.595 177.974 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 110' ' ' ASN . . . . . 0.437 ' HA ' HG12 ' A' ' 113' ' ' ILE . 0.6 OUTLIER -60.59 -36.5 78.7 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 115.903 -0.589 . . . . 1.2 111.388 179.044 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 111' ' ' HIS . . . . . 0.731 ' O ' HG23 ' A' ' 115' ' ' VAL . 24.8 t60 -62.94 -48.13 80.26 Favored 'General case' 0 CA--C 1.513 -0.449 0 N-CA-C 108.78 -0.822 . . . . 0.52 108.78 177.192 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.43 HD12 HG23 ' A' ' 89' ' ' ILE . 97.8 mt -58.16 -34.64 70.53 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.527 -0.76 . . . . 0.55 110.795 177.521 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.579 HG12 ' O ' ' A' ' 109' ' ' ALA . 36.9 mm -56.46 -52.32 54.11 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.235 0 CA-C-O 121.515 0.674 . . . . 0.84 110.309 173.605 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 18.4 tppt? -63.13 -45.83 90.11 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.016 -0.993 . . . . 3.83 111.523 -177.416 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.731 HG23 ' O ' ' A' ' 111' ' ' HIS . 2.2 t -73.89 -23.82 19.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-O 120.82 0.343 . . . . 1.19 110.294 -176.499 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 14.6 tppt? -64.89 -49.48 70.31 Favored 'General case' 0 CA--C 1.52 -0.175 0 N-CA-C 109.487 -0.56 . . . . 1.32 109.487 170.264 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 86.2 mt -70.41 -15.15 62.81 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.553 -0.749 . . . . 0.96 110.88 -179.804 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 7.2 tp10 -71.35 -16.44 62.43 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.104 0.478 . . . . 2.18 109.784 175.331 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 98.67 23.97 11.46 Favored Glycine 0 N--CA 1.451 -0.36 0 N-CA-C 111.124 -0.79 . . . . 1.16 111.124 179.443 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 3.8 t-80 -117.84 121.57 41.09 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 121.122 0.487 . . . . 2.42 110.867 -177.584 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 47.9 mm-40 -83.59 119.88 25.28 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.361 -0.836 . . . . 2.53 110.725 177.55 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 122' ' ' LEU . . . . . 0.821 ' H ' HD23 ' A' ' 122' ' ' LEU . 1.3 pt? -78.58 139.37 58.87 Favored Pre-proline 0 C--N 1.322 -0.626 0 N-CA-C 109.019 -0.734 . . . . 1.33 109.019 172.948 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 123' ' ' PRO . . . . . 0.455 ' HD3' ' HA ' ' A' ' 122' ' ' LEU . 7.8 Cg_exo -72.78 10.03 1.16 Allowed 'Trans proline' 0 C--N 1.345 0.374 0 C-N-CA 123.205 2.604 . . . . 1.33 112.792 -176.055 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 124' ' ' ALA . . . . . 0.782 ' HA ' HD11 ' A' ' 92' ' ' LEU . . . 59.14 29.94 19.61 Favored 'General case' 0 C--O 1.232 0.141 0 CA-C-N 116.239 -0.437 . . . . 1.25 110.946 -179.771 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 37.8 t70 -132.53 156.92 45.95 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.819 -0.628 . . . . 2.73 109.882 -179.688 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 126' ' ' LEU . . . . . 0.659 ' HG ' HD22 ' A' ' 92' ' ' LEU . 84.3 mt -110.46 103.34 53.94 Favored Pre-proline 0 C--N 1.327 -0.41 0 N-CA-C 112.055 0.391 . . . . 1.66 112.055 -175.814 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 127' ' ' PRO . . . . . 0.539 ' HD2' HD12 ' A' ' 130' ' ' LEU . 56.6 Cg_endo -72.21 161.46 44.48 Favored 'Trans proline' 0 C--O 1.234 0.321 0 C-N-CA 122.803 2.335 . . . . 1.17 111.085 171.249 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 75.5 Cg_exo -50.49 -40.39 54.22 Favored 'Trans proline' 0 C--N 1.346 0.446 0 C-N-CA 123.178 2.585 . . . . 1.54 113.836 -176.672 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 23.4 p-80 -81.29 14.56 2.35 Favored 'General case' 0 CA--C 1.533 0.324 0 N-CA-C 112.828 0.677 . . . . 1.07 112.828 -174.381 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 130' ' ' LEU . . . . . 0.539 HD12 ' HD2' ' A' ' 127' ' ' PRO . 12.7 mt -114.39 2.41 14.69 Favored 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 120.791 -0.363 . . . . 1.36 111.072 174.69 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 46.3 t -84.39 121.48 75.16 Favored Pre-proline 0 C--N 1.324 -0.539 0 CA-C-N 116.326 -0.397 . . . . 1.28 110.492 -178.455 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 44.7 Cg_exo -56.77 142.75 91.96 Favored 'Trans proline' 0 C--N 1.347 0.484 0 C-N-CA 123.097 2.531 . . . . 0.81 112.804 -179.974 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 133' ' ' PRO . . . . . 0.445 ' O ' ' HG2' ' A' ' 136' ' ' ARG . 11.8 Cg_endo -55.45 -36.16 93.53 Favored 'Trans proline' 0 CA--C 1.531 0.345 0 C-N-CA 123.739 2.959 . . . . 1.17 113.62 -176.682 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 4.4 m -83.82 -9.59 58.66 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.012 0.434 . . . . 1.6 110.885 -178.19 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 135' ' ' LYS . . . . . 0.714 ' HD3' ' HB ' ' A' ' 95' ' ' VAL . 49.5 mttp -119.67 17.62 12.76 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.056 -0.52 . . . . 1.21 110.843 -173.867 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 136' ' ' ARG . . . . . 0.445 ' HG2' ' O ' ' A' ' 133' ' ' PRO . 41.0 ptt180 -103.59 142.12 34.86 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.867 0.365 . . . . 2.76 110.621 -179.978 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 55.5 mtm180 -105.67 111.91 24.77 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.301 -0.408 . . . . 4.54 111.501 -179.87 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 61.6 t-80 -132.8 99.18 4.53 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 109.096 -0.705 . . . . 5.95 109.096 170.361 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 . . . . . 0 C--O 1.246 0.914 0 CA-C-O 118.135 -0.936 . . . . 6.15 110.074 -179.006 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' B' B ' 143' ' ' PHE . . . . . 0.411 ' N ' ' OE2' ' B' ' 146' ' ' GLU . 92.7 m-85 . . . . . 0 N--CA 1.481 1.088 0 CA-C-O 120.868 0.366 . . . . 11.86 110.423 . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 144' ' ' ASN . . . . . 0.465 ' O ' ' HB3' ' B' ' 145' ' ' TYR . 5.8 t-20 -160.2 131.07 5.64 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.465 -0.334 . . . . 8.14 110.293 -175.191 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 145' ' ' TYR . . . . . 0.465 ' HB3' ' O ' ' B' ' 144' ' ' ASN . 64.3 t80 76.91 -30.55 0.18 Allowed 'General case' 0 N--CA 1.478 0.937 0 N-CA-C 112.515 0.561 . . . . 6.71 112.515 173.179 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 146' ' ' GLU . . . . . 0.411 ' OE2' ' N ' ' B' ' 143' ' ' PHE . 6.3 mt-10 -56.42 106.9 0.32 Allowed 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 122.935 0.494 . . . . 6.61 111.87 -178.673 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 147' ' ' SER . . . . . . . . . . . . . 79.0 p -98.91 131.06 45.28 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.048 -0.524 . . . . 3.65 109.756 175.883 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 148' ' ' THR . . . . . . . . . . . . . 7.5 p -84.46 -43.43 14.63 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 120.831 0.348 . . . . 1.79 111.734 -177.886 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 149' ' ' GLY . . . . . . . . . . . . . . . -175.28 -178.85 45.44 Favored Glycine 0 N--CA 1.446 -0.675 0 C-N-CA 120.627 -0.797 . . . . 0.48 111.878 -179.212 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 150' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -74.72 -2.02 11.91 Favored 'Trans proline' 0 CA--C 1.533 0.465 0 C-N-CA 123.053 2.502 . . . . 0.33 113.159 -176.585 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 151' ' ' PHE . . . . . 0.462 ' CE2' ' HB2' ' A' ' 90' ' ' TRP . 30.2 m-85 -94.03 -14.02 26.29 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 112.119 0.414 . . . . 0.75 112.119 -174.344 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 152' ' ' THR . . . . . 0.408 ' HB ' ' HG2' ' B' ' 154' ' ' LYS . 1.2 p -84.06 -15.22 48.26 Favored 'General case' 0 C--N 1.327 -0.395 0 C-N-CA 121.036 -0.266 . . . . 2.22 111.679 179.957 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 153' ' ' ALA . . . . . . . . . . . . . . . 58.86 50.23 8.82 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 115.847 -0.615 . . . . 4.4 111.201 -179.948 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 154' ' ' LYS . . . . . 0.408 ' HG2' ' HB ' ' B' ' 152' ' ' THR . 72.0 mmtt . . . . . 0 C--O 1.247 0.969 0 CA-C-N 115.736 -0.665 . . . . 6.75 109.215 178.642 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 141' ' ' ' CA' . . . . . 0.65 'CA ' ' OD1' ' A' ' 94' ' ' ASP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.787 0 N-CA-C 111.576 -0.61 . . . . 10.97 111.576 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 88.4 Cg_endo -83.09 150.14 13.73 Favored 'Trans proline' 0 N--CA 1.464 -0.248 0 C-N-CA 122.448 2.099 . . . . 9.0 112.338 179.179 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 40.8 tp -111.46 -38.0 5.08 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.934 0.397 . . . . 7.42 110.582 177.561 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -159.29 49.03 0.4 Allowed Glycine 0 N--CA 1.449 -0.472 0 C-N-CA 120.439 -0.886 . . . . 4.46 112.173 179.002 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' SER . . . . . 0.461 ' HA ' ' CE1' ' A' ' 138' ' ' HIS . 44.1 m 54.12 74.24 0.34 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.969 0.89 . . . . 3.97 109.589 -175.05 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -75.59 101.01 4.77 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 114.56 -1.2 . . . . 3.46 110.383 -170.021 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -82.38 94.49 7.4 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.519 -0.764 . . . . 1.93 110.264 -176.627 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.436 HG11 ' HA ' ' A' ' 129' ' ' HIS . 13.7 p -96.64 148.25 5.59 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-N 115.829 -0.623 . . . . 1.85 110.922 -177.733 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 17.9 mm-40 -67.47 126.84 30.57 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.861 -0.609 . . . . 3.1 110.474 177.142 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 5.7 t90 -81.91 103.14 11.36 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 109.243 -0.651 . . . . 0.71 109.243 176.912 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.493 ' O ' ' HG2' ' A' ' 48' ' ' LYS . 21.2 m -60.2 -19.86 18.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 N-CA-C 112.978 0.733 . . . . 1.45 112.978 -173.172 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 28.3 t -78.94 -16.79 13.41 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-O 121.177 0.513 . . . . 1.1 110.856 -178.834 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -74.08 -9.54 80.36 Favored Glycine 0 N--CA 1.448 -0.526 0 C-N-CA 120.851 -0.69 . . . . 0.59 113.414 -175.476 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' LYS . . . . . 0.493 ' HG2' ' O ' ' A' ' 45' ' ' VAL . 1.1 ptpm? -83.93 -27.66 28.4 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 117.3 0.55 . . . . 2.46 111.112 -178.787 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 21.5 m-20 -100.6 33.83 2.62 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.824 0.345 . . . . 1.66 110.266 -179.465 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 0.554 ' N ' ' HD2' ' A' ' 51' ' ' PRO . 14.9 mmtp -69.35 -51.03 17.99 Favored Pre-proline 0 C--N 1.324 -0.53 0 N-CA-C 112.83 0.678 . . . . 1.15 112.83 -177.017 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.643 ' HA ' ' OD2' ' A' ' 54' ' ' ASP . 4.6 Cg_endo -48.34 -42.04 34.69 Favored 'Trans proline' 0 C--N 1.356 0.966 0 C-N-CA 122.707 2.271 . . . . 0.75 113.217 -177.966 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 52' ' ' THR . . . . . 0.486 ' O ' ' HB3' ' A' ' 55' ' ' GLU . 21.9 m -70.93 -39.93 72.36 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.375 0.607 . . . . 0.68 110.932 -179.419 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 21.2 m-30 -79.25 -22.09 45.23 Favored 'General case' 0 C--N 1.324 -0.51 0 C-N-CA 120.603 -0.439 . . . . 0.69 111.114 -175.857 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' ASP . . . . . 0.643 ' OD2' ' HA ' ' A' ' 51' ' ' PRO . 0.6 OUTLIER -82.1 -25.48 34.45 Favored 'General case' 0 CA--C 1.52 -0.18 0 N-CA-C 108.945 -0.761 . . . . 2.18 108.945 175.166 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.486 ' HB3' ' O ' ' A' ' 52' ' ' THR . 9.5 tp10 -59.37 -43.14 92.9 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.478 -0.783 . . . . 2.33 109.102 169.598 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.447 HG12 ' O ' ' A' ' 52' ' ' THR . 27.6 mm -76.18 -34.82 26.91 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.331 0 CA-C-N 115.841 -0.618 . . . . 0.64 110.521 178.092 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 57' ' ' PHE . . . . . 0.509 ' CE2' ' HB3' ' A' ' 62' ' ' PRO . 74.0 t80 -65.72 -46.6 78.32 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.122 -0.49 . . . . 0.29 111.372 -176.725 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 58' ' ' TYR . . . . . 0.428 ' HA ' ' HG3' ' A' ' 62' ' ' PRO . 15.1 m-85 -80.33 -7.94 59.28 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.382 -0.372 . . . . 1.17 111.922 -174.493 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 15.5 p -92.65 -4.34 53.44 Favored 'General case' 0 C--N 1.323 -0.572 0 C-N-CA 120.717 -0.393 . . . . 0.44 110.693 177.064 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.466 ' HB3' ' HB3' ' A' ' 71' ' ' ASN . 73.0 mt -108.08 13.24 26.16 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.299 -0.41 . . . . 1.37 111.266 178.026 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 15.8 m 68.53 87.42 0.11 Allowed Pre-proline 0 N--CA 1.469 0.525 0 CA-C-N 116.03 -0.532 . . . . 1.24 112.171 175.698 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' PRO . . . . . 0.509 ' HB3' ' CE2' ' A' ' 57' ' ' PHE . 5.6 Cg_exo -80.69 138.89 12.18 Favored 'Trans proline' 0 N--CA 1.46 -0.47 0 C-N-CA 122.862 2.375 . . . . 0.47 112.635 178.206 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 11.0 m -127.94 117.83 47.05 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-N 115.819 -0.628 . . . . 1.02 110.216 175.168 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 49.3 m-80 66.39 24.27 10.5 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-N 115.694 -0.684 . . . . 1.34 111.389 178.661 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 92.96 8.15 62.01 Favored Glycine 0 C--N 1.331 0.275 0 C-N-CA 121.018 -0.611 . . . . 0.43 112.788 176.847 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 0.804 ' HG2' ' HA ' ' A' ' 102' ' ' ASP . 55.1 mtmt -143.28 153.96 43.31 Favored 'General case' 0 C--N 1.326 -0.422 0 C-N-CA 122.381 0.272 . . . . 1.48 110.397 -177.165 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 67' ' ' ILE . . . . . 0.449 HD11 ' CD1' ' A' ' 106' ' ' PHE . 41.0 pt -110.68 153.92 12.36 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.763 0 N-CA-C 110.011 -0.366 . . . . 0.64 110.011 174.957 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 18.6 p -72.7 152.5 41.65 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.285 -0.416 . . . . 0.55 111.151 179.589 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -61.8 -15.93 49.96 Favored Glycine 0 N--CA 1.448 -0.54 0 C-N-CA 121.071 -0.585 . . . . 0.41 112.947 -179.434 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -60.36 -50.46 73.51 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.133 0.492 . . . . 0.38 111.213 177.636 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' ASN . . . . . 0.559 ' HA ' ' HD3' ' A' ' 74' ' ' LYS . 39.9 m-80 -74.93 -34.23 62.08 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.826 -0.624 . . . . 1.81 110.38 -175.778 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -61.42 -45.28 94.99 Favored 'General case' 0 N--CA 1.449 -0.489 0 CA-C-N 115.929 -0.578 . . . . 0.39 109.528 173.961 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 73' ' ' LYS . . . . . 0.594 ' HA ' ' CZ ' ' B' ' 151' ' ' PHE . 54.9 tttp -56.08 -38.43 70.67 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.777 -0.647 . . . . 0.84 110.383 177.296 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 74' ' ' LYS . . . . . 0.559 ' HD3' ' HA ' ' A' ' 71' ' ' ASN . 26.8 mtpp -65.49 -32.88 74.73 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.952 -0.567 . . . . 1.95 111.256 178.671 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 18.2 tp10 -76.31 -39.39 54.27 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.164 0.507 . . . . 1.6 110.039 177.701 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 76' ' ' MET . . . . . 0.517 ' HB3' HD22 ' A' ' 86' ' ' LEU . 1.1 mpt? -60.71 -36.43 78.78 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 116.378 -0.374 . . . . 1.24 111.471 176.386 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.426 HG22 ' HA ' ' A' ' 74' ' ' LYS . 17.9 m -82.38 -13.88 12.2 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.507 0 C-N-CA 120.701 -0.4 . . . . 1.57 110.978 177.455 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 46.7 mmtt -74.29 -29.74 61.77 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-O 120.867 0.365 . . . . 2.79 111.029 171.396 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -83.9 -13.61 53.09 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.155 -0.475 . . . . 1.27 111.122 -178.931 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 56.2 mttp 68.29 33.01 4.43 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 115.639 -0.709 . . . . 2.97 111.927 171.788 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.715 ' HB2' HD21 ' A' ' 86' ' ' LEU . 97.2 mt -86.32 151.6 53.98 Favored Pre-proline 0 C--N 1.326 -0.453 0 N-CA-C 109.68 -0.489 . . . . 0.52 109.68 175.682 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -54.46 142.91 69.11 Favored 'Trans proline' 0 C--N 1.35 0.628 0 C-N-CA 122.887 2.391 . . . . 0.44 112.65 179.336 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 39.9 m-80 -52.36 -48.05 65.76 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 115.615 -0.72 . . . . 1.85 112.141 -175.61 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 84' ' ' THR . . . . . 0.436 ' O ' ' HD3' ' A' ' 88' ' ' LYS . 38.8 p -63.76 -42.73 97.77 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.912 0.387 . . . . 1.47 110.757 -178.837 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 84.7 t -59.85 -39.24 79.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 115.85 -0.614 . . . . 0.45 110.584 179.247 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.715 HD21 ' HB2' ' A' ' 81' ' ' LEU . 93.6 mt -65.75 -29.37 69.87 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.435 -0.348 . . . . 0.9 110.521 177.333 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 87' ' ' GLY . . . . . 0.492 ' HA3' ' HA ' ' B' ' 153' ' ' ALA . . . -65.77 -41.41 95.73 Favored Glycine 0 CA--C 1.502 -0.753 0 N-CA-C 111.086 -0.806 . . . . 0.32 111.086 175.151 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 88' ' ' LYS . . . . . 0.911 ' HD2' ' HB1' ' B' ' 153' ' ' ALA . 2.5 mptp? -75.06 -28.33 60.32 Favored 'General case' 0 N--CA 1.443 -0.808 0 CA-C-N 115.464 -0.368 . . . . 1.89 110.846 178.605 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 16.4 mm -60.15 -49.44 84.08 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.254 0 CA-C-N 116.325 -0.398 . . . . 0.71 110.222 173.153 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 90' ' ' TRP . . . . . 0.424 ' HB2' ' CD2' ' B' ' 151' ' ' PHE . 52.4 t-105 -62.38 -45.33 93.62 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.917 0.389 . . . . 0.33 110.578 178.073 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 17.4 ttmm -54.85 -32.33 60.49 Favored 'General case' 0 C--O 1.237 0.447 0 CA-C-N 115.665 -0.698 . . . . 2.7 111.585 179.276 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.559 HD22 ' HA ' ' A' ' 124' ' ' ALA . 13.0 tp -93.93 -36.92 11.96 Favored 'General case' 0 N--CA 1.442 -0.846 0 CA-C-N 115.906 -0.588 . . . . 1.66 111.782 -176.439 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -81.36 -42.48 20.44 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.753 0.311 . . . . 0.47 111.718 -174.53 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 94' ' ' ASP . . . . . 0.654 ' OD2' ' HA ' ' A' ' 97' ' ' LYS . 50.0 t0 -78.03 96.72 5.16 Favored 'General case' 0 C--O 1.237 0.417 0 N-CA-C 108.689 -0.856 . . . . 0.79 108.689 178.049 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 38.3 t -68.86 -45.16 81.14 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-N 115.481 -0.781 . . . . 0.61 110.965 -172.497 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 29.0 p-10 -88.6 -17.96 29.04 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 116.092 -0.504 . . . . 0.96 111.694 -176.779 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 0.654 ' HA ' ' OD2' ' A' ' 94' ' ' ASP . 53.0 mttp 58.07 72.89 0.5 Allowed 'General case' 0 CA--C 1.518 -0.278 0 CA-C-O 122.063 0.935 . . . . 2.96 111.32 177.838 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 98' ' ' ASP . . . . . 0.628 ' OD1' 'CA ' ' A' ' 141' ' ' ' CA' . 11.5 p-10 -122.83 9.05 9.41 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 114.589 -1.187 . . . . 0.43 110.868 -173.169 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 78.19 -3.78 60.92 Favored Glycine 0 CA--C 1.52 0.369 0 C-N-CA 121.001 -0.619 . . . . 0.44 112.468 -179.554 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.417 ' HB2' ' OD2' ' A' ' 98' ' ' ASP . 4.6 mp -128.86 166.23 19.47 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 109.726 -0.472 . . . . 1.11 109.726 175.922 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 81.7 mt -123.75 127.52 48.26 Favored 'General case' 0 C--N 1.314 -0.951 0 CA-C-N 116.128 -0.487 . . . . 0.42 109.799 176.999 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 102' ' ' ASP . . . . . 0.804 ' HA ' ' HG2' ' A' ' 66' ' ' LYS . 2.6 m-20 -69.72 168.42 14.99 Favored 'General case' 0 CA--C 1.509 -0.631 0 N-CA-C 108.799 -0.815 . . . . 1.72 108.799 174.334 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -57.61 -30.28 65.2 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 108.46 -0.941 . . . . 1.6 108.46 171.772 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 6.4 mm-40 -66.97 -58.81 4.23 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-N 115.11 -0.95 . . . . 1.66 111.851 177.195 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 105' ' ' GLU . . . . . 0.581 ' OE1' ' HE3' ' A' ' 135' ' ' LYS . 2.4 pt-20 -78.91 -18.09 54.44 Favored 'General case' 0 CA--C 1.53 0.187 0 C-N-CA 120.283 -0.567 . . . . 0.44 112.236 -173.822 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 106' ' ' PHE . . . . . 0.449 ' CD1' HD11 ' A' ' 67' ' ' ILE . 50.3 t80 -76.64 -34.17 58.31 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 109.164 -0.68 . . . . 0.42 109.164 173.603 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -62.23 -44.49 96.44 Favored 'General case' 0 N--CA 1.452 -0.363 0 CA-C-N 115.672 -0.694 . . . . 0.22 109.262 171.663 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.435 ' O ' ' HG ' ' A' ' 112' ' ' LEU . 4.8 tt -60.39 -46.28 90.54 Favored 'General case' 0 CA--C 1.533 0.305 0 CA-C-N 115.491 -0.777 . . . . 1.33 109.847 178.326 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -56.17 -49.65 73.41 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 116.484 -0.326 . . . . 0.32 111.363 178.361 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 22.5 m-80 -65.06 -32.53 74.28 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.423 -0.353 . . . . 1.2 111.31 179.626 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 111' ' ' HIS . . . . . 0.408 ' O ' HG23 ' A' ' 115' ' ' VAL . 11.9 t60 -68.28 -35.59 78.09 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 109.689 -0.485 . . . . 0.52 109.689 178.091 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.435 ' HG ' ' O ' ' A' ' 108' ' ' LEU . 95.8 mt -65.61 -46.88 77.65 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 116.323 -0.398 . . . . 0.55 110.324 175.713 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 62.7 mt -56.7 -45.03 82.63 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.177 0 CA-C-N 115.767 -0.651 . . . . 0.84 109.709 177.254 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 17.1 tppt? -56.85 -49.99 73.78 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.054 -0.975 . . . . 3.83 110.919 178.191 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.621 HG13 ' HB2' ' A' ' 120' ' ' HIS . 45.9 t -58.68 -42.87 86.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.194 -0.457 . . . . 1.19 111.57 -178.716 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 17.5 tppt? -70.02 -41.51 74.19 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 116.628 -0.26 . . . . 1.32 110.698 -179.257 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 74.5 mt -68.61 -30.69 69.48 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.881 0.372 . . . . 0.96 111.04 179.287 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -74.96 -16.7 60.63 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.917 -0.583 . . . . 2.18 110.483 179.696 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 99.25 32.83 5.65 Favored Glycine 0 N--CA 1.449 -0.486 0 C-N-CA 120.744 -0.741 . . . . 1.16 113.02 175.96 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 120' ' ' HIS . . . . . 0.621 ' HB2' HG13 ' A' ' 115' ' ' VAL . 78.4 m-70 -119.54 -179.52 3.9 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 109.79 -0.448 . . . . 2.42 109.79 177.692 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -117.46 149.27 40.85 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 120.956 0.408 . . . . 2.53 111.166 -176.119 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 2.6 pp -108.3 143.53 27.62 Favored Pre-proline 0 C--N 1.324 -0.542 0 CA-C-N 115.516 -0.766 . . . . 1.33 109.784 175.346 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -73.34 -13.9 25.41 Favored 'Trans proline' 0 C--N 1.343 0.261 0 C-N-CA 122.395 2.064 . . . . 1.33 113.164 -176.338 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 124' ' ' ALA . . . . . 0.559 ' HA ' HD22 ' A' ' 92' ' ' LEU . . . 61.01 17.68 8.18 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 123.162 0.585 . . . . 1.25 111.392 -177.402 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -134.4 163.13 30.36 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 107.817 -1.179 . . . . 2.73 107.817 174.268 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 64.2 mt -109.2 93.88 14.11 Favored Pre-proline 0 C--N 1.322 -0.614 0 CA-C-O 120.724 0.297 . . . . 1.66 111.515 -177.016 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 127' ' ' PRO . . . . . 0.432 ' HD2' HD12 ' A' ' 130' ' ' LEU . 63.5 Cg_endo -75.77 155.67 39.48 Favored 'Trans proline' 0 N--CA 1.459 -0.554 0 C-N-CA 122.571 2.181 . . . . 1.17 111.141 173.667 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 90.0 Cg_exo -44.44 -37.2 10.48 Favored 'Trans proline' 0 CA--C 1.533 0.452 0 C-N-CA 123.478 2.785 . . . . 1.54 114.557 -177.874 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 129' ' ' HIS . . . . . 0.436 ' HA ' HG11 ' A' ' 42' ' ' VAL . 41.0 p-80 -82.03 10.27 6.9 Favored 'General case' 0 N--CA 1.466 0.339 0 C-N-CA 120.793 -0.363 . . . . 1.07 111.851 -175.503 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 130' ' ' LEU . . . . . 0.432 HD12 ' HD2' ' A' ' 127' ' ' PRO . 66.6 mt -126.99 1.57 6.57 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.514 0.197 . . . . 1.36 111.48 176.335 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 43.0 t -85.06 122.9 74.09 Favored Pre-proline 0 C--N 1.326 -0.456 0 N-CA-C 110.515 -0.18 . . . . 1.28 110.515 -178.74 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 132' ' ' PRO . . . . . 0.407 ' HA ' ' HD3' ' A' ' 133' ' ' PRO . 47.9 Cg_exo -56.12 129.2 33.58 Favored 'Trans proline' 0 C--N 1.346 0.407 0 C-N-CA 122.99 2.46 . . . . 0.81 112.329 178.881 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 133' ' ' PRO . . . . . 0.408 ' HA ' ' HG2' ' A' ' 136' ' ' ARG . 25.4 Cg_exo -62.01 -18.85 63.77 Favored 'Trans proline' 0 C--N 1.345 0.393 0 C-N-CA 122.884 2.39 . . . . 1.17 112.692 -177.131 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 8.4 p -77.24 -21.5 53.66 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 116.061 -0.518 . . . . 1.6 111.72 -179.317 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 135' ' ' LYS . . . . . 0.581 ' HE3' ' OE1' ' A' ' 105' ' ' GLU . 68.4 mttm -115.94 0.19 13.0 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 111.721 0.267 . . . . 1.21 111.721 -175.074 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 136' ' ' ARG . . . . . 0.425 ' HG3' ' O ' ' A' ' 136' ' ' ARG . 36.1 ptt180 -84.74 110.08 18.52 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 121.61 0.719 . . . . 2.76 110.951 -176.364 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 65.6 mtm180 -100.84 130.4 46.85 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.702 -0.681 . . . . 4.54 109.502 174.038 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 138' ' ' HIS . . . . . 0.461 ' CE1' ' HA ' ' A' ' 39' ' ' SER . 5.2 t-80 -117.83 139.68 50.76 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 120.725 0.298 . . . . 5.95 110.761 -174.716 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 . . . . . 0 C--O 1.245 0.865 0 CA-C-O 118.209 -0.901 . . . . 6.15 109.65 -179.639 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' B' B ' 143' ' ' PHE . . . . . . . . . . . . . 98.6 m-85 . . . . . 0 N--CA 1.481 1.085 0 N-CA-C 109.825 -0.435 . . . . 11.86 109.825 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' B' B ' 144' ' ' ASN . . . . . . . . . . . . . 27.0 p-10 -120.17 -8.65 9.69 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 112.22 0.452 . . . . 8.14 112.22 -175.223 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 145' ' ' TYR . . . . . . . . . . . . . 28.8 p90 -131.24 165.18 23.95 Favored 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 120.688 -0.405 . . . . 6.71 110.578 -177.973 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 146' ' ' GLU . . . . . . . . . . . . . 30.9 tt0 -158.34 27.39 0.24 Allowed 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 122.02 0.914 . . . . 6.61 108.613 177.877 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 147' ' ' SER . . . . . . . . . . . . . 1.4 m -65.3 -14.29 60.43 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 114.556 -1.202 . . . . 3.65 112.295 -172.42 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 148' ' ' THR . . . . . 0.403 ' HB ' ' HA ' ' B' ' 152' ' ' THR . 4.7 m -134.92 32.02 3.25 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.796 0.808 . . . . 1.79 109.366 176.795 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 149' ' ' GLY . . . . . . . . . . . . . . . 83.55 -172.49 50.57 Favored Glycine 0 N--CA 1.445 -0.75 0 CA-C-N 115.282 -0.872 . . . . 0.48 111.748 -179.13 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 150' ' ' PRO . . . . . . . . . . . . . 90.0 Cg_endo -80.79 -0.69 10.78 Favored 'Trans proline' 0 N--CA 1.461 -0.389 0 C-N-CA 122.864 2.376 . . . . 0.33 112.319 179.766 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 151' ' ' PHE . . . . . 0.594 ' CZ ' ' HA ' ' A' ' 73' ' ' LYS . 56.7 m-85 -101.28 -47.72 4.62 Favored 'General case' 0 C--N 1.331 -0.207 0 N-CA-C 112.56 0.578 . . . . 0.75 112.56 -177.554 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 152' ' ' THR . . . . . 0.415 ' HB ' ' O ' ' B' ' 151' ' ' PHE . 81.6 m 72.01 101.59 0.07 Allowed 'General case' 0 CA--C 1.532 0.28 0 CA-C-O 121.57 0.7 . . . . 2.22 109.896 -170.934 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 153' ' ' ALA . . . . . 0.911 ' HB1' ' HD2' ' A' ' 88' ' ' LYS . . . -85.68 -33.78 21.47 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 113.31 0.855 . . . . 4.4 113.31 -169.047 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 154' ' ' LYS . . . . . 0.446 ' NZ ' ' HB3' ' B' ' 154' ' ' LYS . 9.5 mtpm? . . . . . 0 C--O 1.251 1.135 0 CA-C-O 118.423 -0.798 . . . . 6.75 109.789 -169.434 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 141' ' ' ' CA' . . . . . 0.63 'CA ' ' OD1' ' A' ' 94' ' ' ASP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.818 0 N-CA-C 111.972 -0.451 . . . . 10.97 111.972 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 33.2 Cg_exo -61.83 -63.2 0.1 Allowed 'Trans proline' 0 C--N 1.343 0.265 0 C-N-CA 122.751 2.301 . . . . 9.0 112.151 -179.758 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 47.4 tp 51.29 81.14 0.07 Allowed 'General case' 0 N--CA 1.463 0.221 0 O-C-N 123.904 0.752 . . . . 7.42 111.744 178.861 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -178.14 -153.09 10.83 Favored Glycine 0 N--CA 1.446 -0.674 0 C-N-CA 120.759 -0.734 . . . . 4.46 112.312 179.859 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 7.6 p -145.47 143.24 29.9 Favored 'General case' 0 C--N 1.322 -0.598 0 C-N-CA 122.288 0.235 . . . . 3.97 110.443 179.692 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -103.51 114.57 28.94 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.426 -0.352 . . . . 3.46 110.285 178.486 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -105.89 111.08 23.58 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.04 -0.527 . . . . 1.93 109.636 177.33 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 35.8 m -77.17 154.21 5.52 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 CA-C-N 115.355 -0.839 . . . . 1.85 111.813 -173.019 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -68.88 144.3 54.27 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.015 -0.539 . . . . 3.1 109.755 175.072 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 5.1 t90 -83.11 104.08 13.03 Favored 'General case' 0 N--CA 1.444 -0.764 0 N-CA-C 107.698 -1.223 . . . . 0.71 107.698 168.93 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.422 ' HA ' ' HE3' ' A' ' 48' ' ' LYS . 29.7 m -69.82 4.89 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.234 0 CA-C-O 121.228 0.537 . . . . 1.45 111.628 -175.677 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.49 HG11 ' HA ' ' A' ' 108' ' ' LEU . 42.1 t -103.62 -29.48 2.9 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.818 0 CA-C-N 115.711 -0.677 . . . . 1.1 109.874 172.239 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 47' ' ' GLY . . . . . 0.524 ' HA2' ' HB2' ' A' ' 50' ' ' LYS . . . -82.89 -10.12 83.47 Favored Glycine 0 N--CA 1.448 -0.54 0 CA-C-N 115.88 -0.6 . . . . 0.59 113.023 -175.528 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 48' ' ' LYS . . . . . 0.422 ' HE3' ' HA ' ' A' ' 45' ' ' VAL . 17.2 ptpt -81.55 -25.89 35.48 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.772 0.32 . . . . 2.46 110.315 177.145 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 12.0 m-20 -110.11 33.21 4.58 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 108.948 -0.76 . . . . 1.66 108.948 173.577 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 0.667 ' N ' ' HD2' ' A' ' 51' ' ' PRO . 17.3 ttpp -77.35 -43.04 2.58 Favored Pre-proline 0 C--O 1.219 -0.538 0 CA-C-O 118.633 -0.699 . . . . 1.15 112.067 -174.779 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.667 ' HD2' ' N ' ' A' ' 50' ' ' LYS . 1.3 Cg_endo -44.74 -36.31 10.41 Favored 'Trans proline' 0 C--N 1.362 1.284 0 C-N-CA 123.0 2.467 . . . . 0.75 113.471 178.493 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 13.0 m -69.51 -45.49 68.75 Favored 'General case' 0 C--O 1.238 0.49 0 CA-C-O 121.111 0.481 . . . . 0.68 110.459 178.657 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 21.7 m-85 -70.97 -22.35 62.21 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.027 -0.533 . . . . 0.69 109.92 178.936 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -68.77 -45.03 72.44 Favored 'General case' 0 CA--C 1.513 -0.471 0 CA-C-N 116.163 -0.471 . . . . 2.18 109.856 175.667 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -61.78 -44.85 96.07 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.79 -0.641 . . . . 2.33 109.937 -179.821 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 45.0 mt -65.78 -40.95 89.17 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-N 115.798 -0.637 . . . . 0.64 110.84 177.634 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 77.7 t80 -61.9 -39.34 91.66 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.677 -0.692 . . . . 0.29 111.297 179.397 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 4.1 m-30 -79.79 -22.58 42.93 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.56 -0.291 . . . . 1.17 111.2 -175.573 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 28.2 p -79.57 -10.15 59.75 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.72 0.295 . . . . 0.44 111.446 178.257 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 53.7 mt -88.92 -0.47 57.42 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.566 -0.288 . . . . 1.37 110.246 175.274 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 55.7 m 62.43 81.04 0.24 Allowed Pre-proline 0 CA--C 1.533 0.313 0 O-C-N 123.788 0.68 . . . . 1.24 110.986 -176.86 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -76.61 157.54 36.02 Favored 'Trans proline' 0 N--CA 1.46 -0.482 0 C-N-CA 122.827 2.351 . . . . 0.47 112.307 -179.011 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 15.4 m -123.96 115.64 45.61 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 CA-C-N 116.157 -0.474 . . . . 1.02 110.073 177.231 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 82.6 m-20 63.82 24.71 13.85 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 115.467 -0.788 . . . . 1.34 111.375 179.809 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 88.69 10.52 67.19 Favored Glycine 0 C--N 1.33 0.224 0 C-N-CA 120.992 -0.623 . . . . 0.43 112.957 178.334 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 0.537 ' HE2' ' OD1' ' A' ' 102' ' ' ASP . 82.2 mttt -136.13 154.45 50.98 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 110.152 -0.314 . . . . 1.48 110.152 179.687 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 40.9 pt -116.77 159.16 16.93 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 C-N-CA 121.109 -0.236 . . . . 0.64 110.397 174.942 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' THR . . . . . 0.518 ' HA ' HD23 ' A' ' 100' ' ' LEU . 44.8 p -80.85 169.85 17.03 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.324 -0.398 . . . . 0.55 110.148 -179.593 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 69' ' ' GLY . . . . . 0.541 ' O ' ' HB2' ' A' ' 73' ' ' LYS . . . -64.25 -16.98 61.0 Favored Glycine 0 N--CA 1.447 -0.626 0 C-N-CA 120.653 -0.784 . . . . 0.41 112.503 177.314 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -68.86 -46.75 67.68 Favored 'General case' 0 C--O 1.235 0.325 0 CA-C-O 121.219 0.533 . . . . 0.38 111.743 -179.139 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 1.7 m120 -72.71 -43.17 63.35 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.815 -0.629 . . . . 1.81 109.716 -174.575 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -64.1 -35.24 80.09 Favored 'General case' 0 N--CA 1.448 -0.568 0 CA-C-N 115.527 -0.761 . . . . 0.39 110.137 176.061 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' LYS . . . . . 0.541 ' HB2' ' O ' ' A' ' 69' ' ' GLY . 34.3 tttp -56.23 -45.11 80.11 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 116.13 -0.486 . . . . 0.84 110.194 176.259 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 74' ' ' LYS . . . . . 0.781 ' O ' ' HG2' ' A' ' 78' ' ' LYS . 45.8 mtpt -67.75 -31.38 71.26 Favored 'General case' 0 C--O 1.217 -0.651 0 CA-C-N 115.601 -0.727 . . . . 1.95 111.041 -178.742 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 13.9 tp10 -71.78 -47.52 52.89 Favored 'General case' 0 C--N 1.314 -0.971 0 CA-C-O 121.531 0.682 . . . . 1.6 109.753 178.52 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 76' ' ' MET . . . . . 0.779 ' HG3' ' HZ ' ' B' ' 151' ' ' PHE . 16.0 mmt -55.52 -42.36 74.42 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.095 -0.957 . . . . 1.24 109.684 175.691 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.64 HG12 ' O ' ' A' ' 74' ' ' LYS . 1.1 p -74.12 -23.27 18.55 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.413 0 CA-C-N 115.276 -0.875 . . . . 1.57 111.301 -177.226 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.781 ' HG2' ' O ' ' A' ' 74' ' ' LYS . 31.8 mmmt -73.56 -28.53 61.9 Favored 'General case' 0 CA--C 1.517 -0.319 0 CA-C-O 121.063 0.459 . . . . 2.79 109.872 176.165 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 45.1 m -81.91 -5.56 58.38 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.781 -0.645 . . . . 1.27 110.439 178.336 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 45.0 mttp 65.51 23.18 11.84 Favored 'General case' 0 N--CA 1.465 0.325 0 CA-C-N 115.418 -0.81 . . . . 2.97 112.03 169.078 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.714 ' HB2' HD21 ' A' ' 86' ' ' LEU . 88.0 mt -85.59 148.65 49.64 Favored Pre-proline 0 C--N 1.322 -0.626 0 CA-C-N 116.413 -0.358 . . . . 0.52 110.216 178.836 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 82' ' ' PRO . . . . . 0.534 ' O ' ' HG ' ' A' ' 86' ' ' LEU . 50.8 Cg_exo -54.91 137.34 75.46 Favored 'Trans proline' 0 C--N 1.344 0.294 0 C-N-CA 123.105 2.537 . . . . 0.44 112.206 179.043 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 83' ' ' ASN . . . . . 0.513 ' HA ' HD12 ' A' ' 86' ' ' LEU . 4.6 p30 -60.16 -34.81 74.09 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-N 115.954 -0.566 . . . . 1.85 110.965 -174.225 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 63.3 m -63.39 -40.6 97.65 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.674 -0.694 . . . . 1.47 110.379 177.697 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.455 HG23 ' HB2' ' A' ' 82' ' ' PRO . 52.3 t -71.66 -34.49 52.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 115.835 -0.62 . . . . 0.45 109.862 178.088 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.716 HD22 ' HB3' ' A' ' 76' ' ' MET . 77.1 mt -63.46 -33.9 76.57 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.969 -0.56 . . . . 0.9 110.073 174.728 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -66.78 -38.05 92.78 Favored Glycine 0 N--CA 1.45 -0.423 0 N-CA-C 111.362 -0.695 . . . . 0.32 111.362 176.064 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 88' ' ' LYS . . . . . 0.418 ' HB2' ' O ' ' A' ' 85' ' ' VAL . 71.7 mmtt -58.15 -49.48 76.87 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 109.974 -0.38 . . . . 1.89 109.974 172.125 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.423 HG12 ' O ' ' A' ' 85' ' ' VAL . 40.3 mm -59.32 -48.4 87.15 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.197 0 CA-C-N 115.752 -0.658 . . . . 0.71 111.294 -179.297 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 90' ' ' TRP . . . . . 0.414 ' HB2' ' HE2' ' B' ' 151' ' ' PHE . 41.8 t-105 -62.83 -45.16 93.9 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.937 0.398 . . . . 0.33 111.087 -178.563 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 21.1 ttpp -64.27 -27.64 69.18 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.06 -0.518 . . . . 2.7 111.285 -176.783 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.43 HD11 ' HG ' ' A' ' 126' ' ' LEU . 14.5 tp -93.9 -48.49 6.25 Favored 'General case' 0 N--CA 1.445 -0.696 0 N-CA-C 112.154 0.427 . . . . 1.66 112.154 -175.946 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -73.3 -41.12 63.95 Favored 'General case' 0 N--CA 1.463 0.21 0 N-CA-C 111.847 0.314 . . . . 0.47 111.847 -174.259 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 94' ' ' ASP . . . . . 0.622 ' OD2' ' HA ' ' A' ' 97' ' ' LYS . 21.9 t70 -78.08 96.34 5.11 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 108.965 -0.754 . . . . 0.79 108.965 176.089 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 45.7 t -78.31 -36.22 20.51 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 CA-C-N 115.647 -0.706 . . . . 0.61 111.08 -171.516 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 96' ' ' ASP . . . . . 0.607 ' OD1' 'CA ' ' A' ' 141' ' ' ' CA' . 5.7 p30 -83.5 -11.39 57.51 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 116.042 -0.526 . . . . 0.96 112.03 -174.942 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 0.622 ' HA ' ' OD2' ' A' ' 94' ' ' ASP . 0.0 OUTLIER 59.08 30.89 20.8 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-O 121.26 0.552 . . . . 2.96 111.181 172.981 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 98' ' ' ASP . . . . . 0.643 ' OD2' ' HB2' ' A' ' 100' ' ' LEU . 8.6 p-10 -86.83 9.8 18.02 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 115.453 -0.794 . . . . 0.43 111.24 -173.564 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 66.9 9.18 52.32 Favored Glycine 0 C--N 1.332 0.331 0 CA-C-N 116.089 -0.505 . . . . 0.44 112.476 -178.987 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.643 ' HB2' ' OD2' ' A' ' 98' ' ' ASP . 72.3 mt -135.18 161.45 35.32 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 109.145 -0.687 . . . . 1.11 109.145 179.955 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 80.1 mt -117.86 125.5 50.64 Favored 'General case' 0 C--N 1.311 -1.09 0 C-N-CA 120.725 -0.39 . . . . 0.42 110.035 176.73 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 102' ' ' ASP . . . . . 0.537 ' OD1' ' HE2' ' A' ' 66' ' ' LYS . 11.5 m-20 -68.94 172.51 6.5 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 108.111 -1.07 . . . . 1.72 108.111 172.939 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 2.0 p30 -63.16 -32.63 74.07 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 109.186 -0.672 . . . . 1.6 109.186 177.113 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 51.9 mt-10 -72.16 -45.2 61.41 Favored 'General case' 0 N--CA 1.452 -0.336 0 CA-C-N 115.888 -0.596 . . . . 1.66 110.956 175.463 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 29.7 mt-10 -64.89 -39.54 93.69 Favored 'General case' 0 N--CA 1.462 0.156 0 C-N-CA 120.818 -0.353 . . . . 0.44 110.449 -176.996 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 90.2 t80 -65.55 -40.87 93.33 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.298 -0.41 . . . . 0.42 110.173 177.214 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -58.7 -47.42 84.62 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.246 -0.433 . . . . 0.22 110.688 176.158 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.49 ' HA ' HG11 ' A' ' 46' ' ' VAL . 60.4 tp -61.82 -45.94 91.65 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-N 116.32 -0.4 . . . . 1.33 110.972 178.463 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 109' ' ' ALA . . . . . 0.677 ' O ' HG13 ' A' ' 113' ' ' ILE . . . -56.09 -57.16 13.32 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.052 -0.522 . . . . 0.32 110.549 177.878 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 110' ' ' ASN . . . . . 0.515 ' HA ' HD12 ' A' ' 113' ' ' ILE . 1.1 t-20 -56.31 -36.27 68.5 Favored 'General case' 0 CA--C 1.521 -0.162 0 CA-C-N 116.049 -0.523 . . . . 1.2 111.395 179.684 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 13.3 t60 -63.67 -39.92 95.55 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.159 -0.473 . . . . 0.52 110.174 -179.655 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.418 ' O ' HG12 ' A' ' 115' ' ' VAL . 94.6 mt -74.08 -39.86 63.15 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.27 -0.423 . . . . 0.55 110.498 178.302 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.677 HG13 ' O ' ' A' ' 109' ' ' ALA . 54.0 mt -58.42 -49.53 81.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-O 121.531 0.681 . . . . 0.84 110.361 177.647 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 114' ' ' LYS . . . . . 0.614 ' HE2' HD12 ' A' ' 117' ' ' LEU . 0.0 OUTLIER -71.31 -24.97 62.23 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.403 -0.817 . . . . 3.83 110.827 -177.157 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.418 HG12 ' O ' ' A' ' 112' ' ' LEU . 0.4 OUTLIER -72.78 -33.29 43.58 Favored 'Isoleucine or valine' 0 C--O 1.235 0.306 0 N-CA-C 109.75 -0.463 . . . . 1.19 109.75 177.195 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 116' ' ' LYS . . . . . 0.458 ' HD2' ' O ' ' A' ' 120' ' ' HIS . 19.6 tptp -66.1 -39.5 90.03 Favored 'General case' 0 N--CA 1.442 -0.834 0 CA-C-N 116.125 -0.488 . . . . 1.32 109.929 173.06 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 117' ' ' LEU . . . . . 0.614 HD12 ' HE2' ' A' ' 114' ' ' LYS . 80.1 mt -65.45 -23.54 66.96 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 116.066 -0.515 . . . . 0.96 110.554 176.508 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 24.6 mm-40 -78.53 -7.01 57.05 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.918 -0.583 . . . . 2.18 111.237 177.878 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 86.22 25.53 36.59 Favored Glycine 0 N--CA 1.448 -0.508 0 C-N-CA 120.652 -0.785 . . . . 1.16 112.154 -179.277 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 120' ' ' HIS . . . . . 0.458 ' O ' ' HD2' ' A' ' 116' ' ' LYS . 63.7 m80 -109.86 152.04 26.28 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 110.058 -0.349 . . . . 2.42 110.058 178.029 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -108.12 155.75 20.05 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 116.015 -0.539 . . . . 2.53 109.563 176.73 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -118.74 131.73 24.18 Favored Pre-proline 0 C--N 1.321 -0.653 0 CA-C-N 116.478 -0.328 . . . . 1.33 110.33 -177.826 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_endo -71.19 -0.11 7.54 Favored 'Trans proline' 0 C--N 1.345 0.344 0 C-N-CA 123.274 2.649 . . . . 1.33 113.438 -177.051 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . 62.92 21.25 12.75 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-O 121.526 0.679 . . . . 1.25 110.348 -175.405 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -103.74 142.78 33.76 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.107 -0.951 . . . . 2.73 108.53 178.552 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 126' ' ' LEU . . . . . 0.43 ' HG ' HD11 ' A' ' 92' ' ' LEU . 38.6 mt -115.27 90.96 26.22 Favored Pre-proline 0 C--N 1.321 -0.659 0 C-N-CA 120.943 -0.303 . . . . 1.66 111.32 179.815 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 127' ' ' PRO . . . . . 0.497 ' HD2' HD12 ' A' ' 130' ' ' LEU . 41.7 Cg_endo -71.19 157.84 56.28 Favored 'Trans proline' 0 N--CA 1.46 -0.455 0 C-N-CA 122.678 2.252 . . . . 1.17 111.45 173.248 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 128' ' ' PRO . . . . . 0.436 ' HA ' HG22 ' A' ' 131' ' ' VAL . 78.1 Cg_exo -52.41 -29.55 39.84 Favored 'Trans proline' 0 CA--C 1.535 0.527 0 C-N-CA 123.271 2.647 . . . . 1.54 114.155 -177.35 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 12.2 p80 -83.36 1.85 39.25 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 120.476 -0.49 . . . . 1.07 111.495 -178.988 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 130' ' ' LEU . . . . . 0.497 HD12 ' HD2' ' A' ' 127' ' ' PRO . 26.0 mt -113.98 -7.59 13.12 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 116.846 -0.161 . . . . 1.36 111.304 175.149 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 131' ' ' VAL . . . . . 0.436 HG22 ' HA ' ' A' ' 128' ' ' PRO . 26.2 m -94.11 139.54 22.58 Favored Pre-proline 0 C--N 1.325 -0.471 0 CA-C-O 120.81 0.338 . . . . 1.28 110.145 177.452 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 132' ' ' PRO . . . . . 0.798 ' HG2' ' HB2' ' A' ' 135' ' ' LYS . 27.7 Cg_endo -63.08 143.95 91.55 Favored 'Trans proline' 0 C--O 1.234 0.285 0 C-N-CA 122.61 2.207 . . . . 0.81 112.217 -178.111 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -54.19 -30.54 61.71 Favored 'Trans proline' 0 C--N 1.345 0.377 0 C-N-CA 123.142 2.562 . . . . 1.17 112.961 179.254 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 50.2 p -75.36 -25.19 57.53 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 121.118 0.485 . . . . 1.6 111.515 -178.097 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 135' ' ' LYS . . . . . 0.798 ' HB2' ' HG2' ' A' ' 132' ' ' PRO . 87.9 mttt -116.71 22.4 12.72 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.243 -0.435 . . . . 1.21 110.976 -173.308 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 11.4 ptp180 -110.42 139.45 45.62 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.96 0.41 . . . . 2.76 111.109 178.949 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 63.5 mtp180 -134.19 120.85 20.56 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.025 -0.534 . . . . 4.54 110.211 173.859 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 84.1 t60 -133.58 104.59 6.44 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.061 0.458 . . . . 5.95 111.199 177.02 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--O 1.247 0.932 0 CA-C-N 115.419 -0.809 . . . . 6.15 109.59 176.673 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 143' ' ' PHE . . . . . . . . . . . . . 86.5 t80 . . . . . 0 N--CA 1.476 0.844 0 N-CA-C 109.96 -0.385 . . . . 11.86 109.96 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' B' B ' 144' ' ' ASN . . . . . . . . . . . . . 51.0 t30 -105.02 142.77 34.22 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.324 -0.398 . . . . 8.14 109.996 -178.566 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 145' ' ' TYR . . . . . 0.633 ' HD2' ' H ' ' B' ' 146' ' ' GLU . 5.9 p90 -142.84 -95.07 0.12 Allowed 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.318 -0.401 . . . . 6.71 110.498 -179.713 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 146' ' ' GLU . . . . . 0.633 ' H ' ' HD2' ' B' ' 145' ' ' TYR . 42.6 mt-10 -130.4 -156.96 0.79 Allowed 'General case' 0 C--N 1.318 -0.782 0 N-CA-C 107.697 -1.223 . . . . 6.61 107.697 173.953 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 147' ' ' SER . . . . . . . . . . . . . 13.2 p -121.6 131.64 54.23 Favored 'General case' 0 C--N 1.319 -0.73 0 C-N-CA 119.785 -0.766 . . . . 3.65 112.396 -176.449 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 148' ' ' THR . . . . . . . . . . . . . 8.0 p -90.95 -43.92 9.68 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.463 -0.79 . . . . 1.79 110.567 175.684 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 149' ' ' GLY . . . . . . . . . . . . . . . 163.26 157.79 9.4 Favored Glycine 0 N--CA 1.446 -0.67 0 CA-C-N 115.403 -0.817 . . . . 0.48 111.541 178.832 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 150' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -77.59 -1.84 12.0 Favored 'Trans proline' 0 N--CA 1.463 -0.282 0 C-N-CA 122.753 2.302 . . . . 0.33 112.712 -178.334 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 151' ' ' PHE . . . . . 0.779 ' HZ ' ' HG3' ' A' ' 76' ' ' MET . 48.1 m-85 -92.14 -57.03 2.85 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.574 -0.284 . . . . 0.75 110.813 -178.448 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 152' ' ' THR . . . . . . . . . . . . . 8.8 t -119.49 133.87 55.49 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 121.317 0.579 . . . . 2.22 111.156 178.654 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 153' ' ' ALA . . . . . . . . . . . . . . . -157.94 10.6 0.18 Allowed 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.449 -0.796 . . . . 4.4 110.189 -179.893 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 154' ' ' LYS . . . . . . . . . . . . . 11.9 tptt . . . . . 0 C--O 1.248 1.011 0 CA-C-O 118.423 -0.799 . . . . 6.75 110.408 -174.704 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 141' ' ' ' CA' . . . . . 0.607 'CA ' ' OD1' ' A' ' 96' ' ' ASP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.734 0 N-CA-C 111.984 -0.446 . . . . 10.97 111.984 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 25.6 Cg_exo -63.95 140.07 71.0 Favored 'Trans proline' 0 C--O 1.234 0.301 0 C-N-CA 122.816 2.344 . . . . 9.0 111.764 177.189 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 81.4 mt -113.18 119.95 39.56 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.1 -0.5 . . . . 7.42 111.17 -175.435 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -168.33 87.58 0.09 OUTLIER Glycine 0 N--CA 1.447 -0.61 0 CA-C-N 115.627 -0.715 . . . . 4.46 111.44 177.823 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 26.6 t -101.51 138.09 38.97 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.768 0.284 . . . . 3.97 110.348 -176.923 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 35.2 t70 -117.7 134.82 54.5 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.473 -0.33 . . . . 3.46 110.487 178.441 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -134.94 146.01 48.71 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.344 -0.389 . . . . 1.93 110.047 -179.456 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 17.9 m -123.9 146.1 29.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 120.757 0.313 . . . . 1.85 111.148 -179.896 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 26.9 mt-10 -68.71 142.83 54.9 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.392 -0.367 . . . . 3.1 111.206 -176.816 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' TRP . . . . . 0.553 ' CE3' ' HD3' ' A' ' 133' ' ' PRO . 5.1 t90 -83.84 111.04 18.85 Favored 'General case' 0 C--N 1.332 -0.191 0 N-CA-C 109.486 -0.561 . . . . 0.71 109.486 179.451 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 12.0 p -60.85 -27.36 41.0 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-N 116.08 -0.509 . . . . 1.45 111.662 -176.911 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 21.5 t -85.17 -11.44 11.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 120.962 0.411 . . . . 1.1 111.438 -177.367 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -66.38 -15.51 63.69 Favored Glycine 0 CA--C 1.518 0.231 0 C-N-CA 120.884 -0.674 . . . . 0.59 113.565 -174.339 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 4.0 ptpp? -91.32 -27.64 18.26 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.787 0.294 . . . . 2.46 111.526 -179.201 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 27.5 m-20 -92.44 32.23 1.23 Allowed 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 120.648 -0.421 . . . . 1.66 110.506 -175.692 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 7.8 mtpm? -79.78 -49.36 1.33 Allowed Pre-proline 0 C--O 1.214 -0.803 0 CA-C-O 118.544 -0.741 . . . . 1.15 112.728 -175.377 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 82.8 Cg_exo -43.1 -37.2 6.4 Favored 'Trans proline' 0 C--N 1.354 0.822 0 C-N-CA 122.156 1.904 . . . . 0.75 113.502 -178.928 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -71.88 -45.97 59.48 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.012 0.434 . . . . 0.68 111.878 179.238 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 12.8 m-85 -79.14 -22.31 45.3 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.508 -0.315 . . . . 0.69 110.153 -175.585 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -70.93 -40.56 72.02 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 108.628 -0.879 . . . . 2.18 108.628 173.553 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 20.6 tp10 -55.18 -48.34 73.94 Favored 'General case' 0 C--O 1.232 0.152 0 CA-C-N 114.988 -1.006 . . . . 2.33 109.923 176.16 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 40.5 mt -71.77 -38.36 65.6 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-N 115.541 -0.754 . . . . 0.64 110.907 178.968 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' PHE . . . . . 0.424 ' CE1' HG23 ' A' ' 67' ' ' ILE . 58.1 t80 -56.15 -34.96 66.63 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 116.022 -0.535 . . . . 0.29 111.576 -177.773 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 9.8 m-85 -88.81 5.46 43.53 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 112.194 0.442 . . . . 1.17 112.194 -175.871 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 80.4 p -98.98 -17.67 18.19 Favored 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 120.49 -0.484 . . . . 0.44 110.558 175.951 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.44 HD13 ' HA ' ' A' ' 60' ' ' LEU . 3.3 mm? -93.58 9.59 36.14 Favored 'General case' 0 N--CA 1.462 0.168 0 CA-C-N 116.225 -0.443 . . . . 1.37 110.962 179.257 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 19.0 m 65.27 87.3 0.12 Allowed Pre-proline 0 N--CA 1.466 0.36 0 CA-C-N 115.538 -0.756 . . . . 1.24 111.647 179.061 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 95.3 Cg_endo -88.91 139.52 3.81 Favored 'Trans proline' 0 N--CA 1.456 -0.682 0 C-N-CA 122.754 2.303 . . . . 0.47 113.39 -178.966 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 15.4 m -113.7 117.94 56.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 115.904 -0.589 . . . . 1.02 110.272 176.294 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 93.1 m-20 63.03 23.33 13.94 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 115.837 -0.62 . . . . 1.34 110.827 -178.157 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 78.4 24.69 62.66 Favored Glycine 0 N--CA 1.448 -0.526 0 C-N-CA 120.72 -0.752 . . . . 0.43 112.0 -177.367 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 24.4 mtpp -136.45 140.76 43.36 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 109.428 -0.582 . . . . 1.48 109.428 178.076 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 67' ' ' ILE . . . . . 0.424 HG23 ' CE1' ' A' ' 57' ' ' PHE . 45.8 pt -115.44 160.03 15.03 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 C-N-CA 120.614 -0.435 . . . . 0.64 110.668 175.286 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 68' ' ' THR . . . . . 0.401 ' HA ' HD23 ' A' ' 100' ' ' LEU . 24.0 p -79.26 158.99 27.47 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.664 -0.698 . . . . 0.55 110.867 179.992 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 69' ' ' GLY . . . . . 0.44 ' O ' ' HB2' ' A' ' 73' ' ' LYS . . . -64.98 -18.06 64.05 Favored Glycine 0 C--O 1.221 -0.656 0 C-N-CA 120.895 -0.669 . . . . 0.41 112.392 179.572 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.489 ' O ' ' HG3' ' A' ' 74' ' ' LYS . . . -62.33 -45.42 93.29 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.072 0.463 . . . . 0.38 111.385 179.818 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 48.1 m-80 -79.59 -34.84 40.42 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.216 -0.447 . . . . 1.81 110.623 -176.494 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -61.62 -39.71 92.26 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 109.368 -0.605 . . . . 0.39 109.368 173.054 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' LYS . . . . . 0.44 ' HB2' ' O ' ' A' ' 69' ' ' GLY . 78.9 tttt -57.87 -44.32 86.55 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 114.96 -1.018 . . . . 0.84 110.141 176.099 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 74' ' ' LYS . . . . . 0.731 ' O ' ' HG2' ' A' ' 78' ' ' LYS . 96.0 mttt -55.73 -54.66 41.58 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.726 -0.67 . . . . 1.95 110.926 178.701 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 75' ' ' GLU . . . . . 0.473 ' HA ' ' OE1' ' A' ' 75' ' ' GLU . 12.6 tp10 -64.34 -40.05 95.11 Favored 'General case' 0 C--O 1.239 0.538 0 CA-C-O 121.125 0.488 . . . . 1.6 111.151 -176.871 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 76' ' ' MET . . . . . 0.83 ' HB3' HD22 ' A' ' 86' ' ' LEU . 18.8 mmt -57.12 -47.05 82.05 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.892 -0.595 . . . . 1.24 111.358 179.607 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 25.4 m -74.29 -18.07 16.93 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.422 0 C-N-CA 120.798 -0.361 . . . . 1.57 111.381 -178.861 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.731 ' HG2' ' O ' ' A' ' 74' ' ' LYS . 46.2 mmtm -76.25 -20.95 56.92 Favored 'General case' 0 N--CA 1.463 0.186 0 CA-C-O 121.265 0.555 . . . . 2.79 109.614 174.322 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 16.9 m -79.68 2.17 23.65 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-N 115.497 -0.774 . . . . 1.27 111.729 -178.174 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 7.3 mtpm? 65.98 22.39 11.26 Favored 'General case' 0 N--CA 1.471 0.575 0 C-N-CA 123.224 0.61 . . . . 2.97 112.196 175.468 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.64 ' HB2' HD21 ' A' ' 86' ' ' LEU . 93.2 mt -95.58 147.18 32.61 Favored Pre-proline 0 C--N 1.325 -0.474 0 N-CA-C 110.012 -0.366 . . . . 0.52 110.012 178.239 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 82' ' ' PRO . . . . . 0.484 ' O ' ' HG ' ' A' ' 86' ' ' LEU . 1.5 Cg_endo -73.2 156.22 51.33 Favored 'Trans proline' 0 N--CA 1.457 -0.619 0 C-N-CA 122.293 1.995 . . . . 0.44 112.178 -178.885 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 88.6 m-20 -55.16 -38.96 68.96 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-N 115.973 -0.558 . . . . 1.85 111.503 -176.482 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 84' ' ' THR . . . . . 0.599 ' O ' ' HG2' ' A' ' 88' ' ' LYS . 3.1 p -57.55 -51.38 69.72 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.119 -0.491 . . . . 1.47 111.121 178.323 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 93.0 t -63.37 -40.94 90.94 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 115.578 -0.737 . . . . 0.45 110.834 -179.908 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.83 HD22 ' HB3' ' A' ' 76' ' ' MET . 83.5 mt -62.47 -37.37 85.7 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.138 -0.483 . . . . 0.9 110.715 179.199 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -68.61 -35.45 80.91 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.889 -0.672 . . . . 0.32 111.632 178.906 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 88' ' ' LYS . . . . . 0.599 ' HG2' ' O ' ' A' ' 84' ' ' THR . 74.8 mmtt -61.41 -52.75 63.29 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 109.419 -0.586 . . . . 1.89 109.419 176.064 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.523 HG23 HD12 ' A' ' 112' ' ' LEU . 42.5 mt -62.7 -38.88 82.79 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.374 0 CA-C-N 115.396 -0.82 . . . . 0.71 111.532 -177.093 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 64.7 t-105 -60.97 -45.77 93.44 Favored 'General case' 0 C--N 1.332 -0.19 0 C-N-CA 120.688 -0.405 . . . . 0.33 110.731 177.134 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 39.3 ttpt -66.48 -24.46 66.41 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.295 -0.411 . . . . 2.7 110.879 -177.319 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.455 ' HG ' ' O ' ' A' ' 88' ' ' LYS . 96.2 mt -86.03 -52.05 5.95 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.51 -0.314 . . . . 1.66 111.657 -179.784 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 93' ' ' ALA . . . . . 0.436 ' HA ' HD23 ' A' ' 108' ' ' LEU . . . -64.86 -38.74 91.98 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.198 -0.455 . . . . 0.47 111.687 -174.093 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 94' ' ' ASP . . . . . 0.641 ' OD1' 'CA ' ' A' ' 141' ' ' ' CA' . 25.6 t0 -81.71 97.11 7.77 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 109.44 -0.578 . . . . 0.79 109.44 178.948 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 44.3 t -82.77 -36.86 13.58 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-N 115.119 -0.946 . . . . 0.61 111.376 -173.969 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 96' ' ' ASP . . . . . 0.596 ' OD1' 'CA ' ' A' ' 141' ' ' ' CA' . 1.9 p30 -87.0 -6.4 58.77 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.957 -0.565 . . . . 0.96 111.166 -176.544 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 0.439 ' HA ' ' OD2' ' A' ' 94' ' ' ASP . 23.9 mmmt 59.95 38.74 20.81 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 115.651 -0.704 . . . . 2.96 110.814 173.35 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 98' ' ' ASP . . . . . 0.626 ' OD1' 'CA ' ' A' ' 141' ' ' ' CA' . 15.9 p-10 -98.52 9.06 44.05 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.131 -0.486 . . . . 0.43 111.602 -173.817 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 66.07 6.72 33.55 Favored Glycine 0 C--N 1.333 0.389 0 C-N-CA 120.867 -0.682 . . . . 0.44 113.016 178.692 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.401 HD23 ' HA ' ' A' ' 68' ' ' THR . 90.0 mt -131.39 157.4 43.53 Favored 'General case' 0 N--CA 1.446 -0.659 0 N-CA-C 109.575 -0.528 . . . . 1.11 109.575 -178.95 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 83.1 mt -116.23 115.96 26.92 Favored 'General case' 0 C--N 1.315 -0.928 0 C-N-CA 120.669 -0.412 . . . . 0.42 110.481 177.491 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -70.55 173.19 7.33 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 108.672 -0.862 . . . . 1.72 108.672 171.85 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -57.85 -30.54 65.86 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 109.706 -0.479 . . . . 1.6 109.706 175.978 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 38.2 mt-10 -66.31 -56.79 9.47 Favored 'General case' 0 C--O 1.235 0.294 0 CA-C-N 115.762 -0.654 . . . . 1.66 111.192 175.242 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 105' ' ' GLU . . . . . 0.582 ' CG ' ' HE3' ' A' ' 135' ' ' LYS . 24.4 mt-10 -68.28 -34.93 77.07 Favored 'General case' 0 C--N 1.331 -0.202 0 C-N-CA 121.006 -0.278 . . . . 0.44 110.802 -173.561 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 84.8 t80 -69.15 -35.25 76.14 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 109.889 -0.412 . . . . 0.42 109.889 178.247 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -60.47 -42.15 95.65 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.009 0.433 . . . . 0.22 109.96 175.452 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.436 HD23 ' HA ' ' A' ' 93' ' ' ALA . 53.2 tp -66.62 -45.88 77.68 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.183 -0.462 . . . . 1.33 110.715 177.672 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -57.41 -50.38 73.17 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.24 -0.436 . . . . 0.32 111.172 179.0 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 4.1 m-20 -66.88 -30.61 70.83 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.161 -0.472 . . . . 1.2 110.979 179.349 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 111' ' ' HIS . . . . . 0.467 ' O ' HG23 ' A' ' 115' ' ' VAL . 55.6 t60 -64.51 -44.5 90.7 Favored 'General case' 0 C--O 1.22 -0.476 0 N-CA-C 109.749 -0.463 . . . . 0.52 109.749 177.057 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.523 HD12 HG23 ' A' ' 89' ' ' ILE . 88.3 mt -63.81 -41.11 97.96 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.308 -0.406 . . . . 0.55 110.494 178.534 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 81.2 mt -55.45 -51.76 53.76 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.308 0 CA-C-O 121.166 0.508 . . . . 0.84 110.296 174.092 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 114' ' ' LYS . . . . . 0.401 ' HA ' ' HD2' ' A' ' 114' ' ' LYS . 14.3 tptm -60.12 -48.54 81.28 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.329 -0.85 . . . . 3.83 110.809 -179.188 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.498 HG12 ' HB2' ' A' ' 120' ' ' HIS . 54.4 t -62.75 -36.63 76.25 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-N 115.919 -0.582 . . . . 1.19 111.091 -177.736 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 116' ' ' LYS . . . . . 0.411 ' HE3' ' HB3' ' A' ' 116' ' ' LYS . 23.2 mmmt -64.47 -50.88 65.75 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.627 -0.261 . . . . 1.32 110.99 176.245 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 89.9 mt -69.06 -25.26 64.36 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.196 -0.457 . . . . 0.96 110.91 -178.919 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 31.6 tt0 -72.0 -14.78 61.98 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.057 -0.519 . . . . 2.18 110.583 179.504 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 107.47 28.51 4.83 Favored Glycine 0 N--CA 1.446 -0.635 0 C-N-CA 120.434 -0.889 . . . . 1.16 113.042 176.774 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 120' ' ' HIS . . . . . 0.498 ' HB2' HG12 ' A' ' 115' ' ' VAL . 28.6 m-70 -121.38 156.75 31.97 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 109.397 -0.594 . . . . 2.42 109.397 176.276 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -117.1 144.84 44.23 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 110.276 -0.268 . . . . 2.53 110.276 177.327 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 122' ' ' LEU . . . . . 0.448 ' H ' ' HG ' ' A' ' 122' ' ' LEU . 2.1 pp -97.39 145.51 29.79 Favored Pre-proline 0 C--N 1.323 -0.569 0 CA-C-N 116.376 -0.374 . . . . 1.33 110.756 -178.379 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 8.2 Cg_exo -73.31 -5.38 17.04 Favored 'Trans proline' 0 N--CA 1.465 -0.163 0 C-N-CA 122.927 2.418 . . . . 1.33 112.636 -178.277 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . 69.9 19.05 7.15 Favored 'General case' 0 N--CA 1.464 0.275 0 O-C-N 123.734 0.646 . . . . 1.25 111.232 -179.265 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 20.7 m-20 -116.52 171.6 7.75 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 109.359 -0.608 . . . . 2.73 109.359 174.543 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 36.3 tp -115.62 97.42 48.73 Favored Pre-proline 0 C--N 1.325 -0.466 0 CA-C-O 120.965 0.412 . . . . 1.66 110.486 177.582 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 127' ' ' PRO . . . . . 0.432 ' HD2' HD12 ' A' ' 130' ' ' LEU . 74.4 Cg_endo -75.97 156.03 38.63 Favored 'Trans proline' 0 CA--C 1.534 0.517 0 C-N-CA 122.962 2.442 . . . . 1.17 112.417 178.232 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 11.3 Cg_endo -54.95 -34.7 87.42 Favored 'Trans proline' 0 C--N 1.347 0.482 0 C-N-CA 123.395 2.73 . . . . 1.54 113.677 -175.76 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 12.7 p80 -79.96 7.63 8.58 Favored 'General case' 0 N--CA 1.465 0.302 0 C-N-CA 120.811 -0.356 . . . . 1.07 111.76 -177.595 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 130' ' ' LEU . . . . . 0.432 HD12 ' HD2' ' A' ' 127' ' ' PRO . 29.3 mt -116.98 5.58 12.89 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.533 0.206 . . . . 1.36 111.085 175.121 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 62.8 t -85.3 123.31 73.3 Favored Pre-proline 0 C--N 1.324 -0.51 0 CA-C-N 116.49 -0.323 . . . . 1.28 110.513 178.43 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 132' ' ' PRO . . . . . 0.483 ' HA ' ' HD3' ' A' ' 133' ' ' PRO . 53.6 Cg_exo -54.06 143.33 62.61 Favored 'Trans proline' 0 CA--C 1.534 0.521 0 C-N-CA 123.016 2.478 . . . . 0.81 112.724 179.351 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 133' ' ' PRO . . . . . 0.553 ' HD3' ' CE3' ' A' ' 44' ' ' TRP . 23.7 Cg_exo -62.97 -35.27 67.32 Favored 'Trans proline' 0 C--N 1.347 0.454 0 C-N-CA 122.937 2.424 . . . . 1.17 113.626 -175.005 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 23.2 t -87.44 0.01 56.15 Favored 'General case' 0 C--N 1.323 -0.573 0 C-N-CA 120.707 -0.397 . . . . 1.6 111.249 -175.216 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 135' ' ' LYS . . . . . 0.582 ' HE3' ' CG ' ' A' ' 105' ' ' GLU . 62.6 mttm -119.82 9.67 11.39 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.905 0.383 . . . . 1.21 111.342 -176.762 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 136' ' ' ARG . . . . . 0.467 ' HG2' ' O ' ' A' ' 133' ' ' PRO . 15.8 ptp180 -103.61 132.62 49.71 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.356 -0.384 . . . . 2.76 110.409 -178.987 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 85.5 mtm180 -142.72 149.98 39.5 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.477 -0.329 . . . . 4.54 110.942 -178.197 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 48.2 m-70 -119.24 100.78 7.53 Favored 'General case' 0 C--N 1.319 -0.72 0 N-CA-C 109.542 -0.54 . . . . 5.95 109.542 171.584 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 16.5 tp10 . . . . . 0 C--O 1.251 1.138 0 CA-C-O 118.194 -0.907 . . . . 6.15 109.999 -178.248 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' B' B ' 143' ' ' PHE . . . . . . . . . . . . . 54.1 t80 . . . . . 0 N--CA 1.482 1.173 0 N-CA-C 110.031 -0.359 . . . . 11.86 110.031 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' B' B ' 144' ' ' ASN . . . . . . . . . . . . . 44.3 t30 -100.52 -28.18 13.03 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.329 0.585 . . . . 8.14 109.447 177.606 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 145' ' ' TYR . . . . . . . . . . . . . 5.6 t80 -96.56 -152.86 0.39 Allowed 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 108.868 -0.79 . . . . 6.71 108.868 179.156 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 146' ' ' GLU . . . . . . . . . . . . . 11.8 mm-40 63.38 36.69 11.34 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-O 121.162 0.506 . . . . 6.61 110.654 179.856 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 147' ' ' SER . . . . . . . . . . . . . 6.7 m -68.79 139.09 55.27 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.704 -0.68 . . . . 3.65 111.435 -178.574 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 148' ' ' THR . . . . . . . . . . . . . 2.0 p -93.44 6.46 48.11 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.497 0.665 . . . . 1.79 110.907 177.268 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 149' ' ' GLY . . . . . . . . . . . . . . . 130.62 155.74 8.38 Favored Glycine 0 N--CA 1.445 -0.752 0 CA-C-N 115.205 -0.907 . . . . 0.48 111.099 179.326 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 150' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -74.93 -3.84 14.52 Favored 'Trans proline' 0 CA--C 1.53 0.293 0 C-N-CA 122.991 2.461 . . . . 0.33 113.118 -173.888 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 151' ' ' PHE . . . . . 0.551 ' CZ ' ' HG3' ' A' ' 76' ' ' MET . 61.2 m-85 -102.13 -6.11 23.67 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.788 0.328 . . . . 0.75 110.955 -179.388 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 152' ' ' THR . . . . . . . . . . . . . 6.6 t -137.98 1.11 2.24 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.2 0.524 . . . . 2.22 110.607 179.951 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 153' ' ' ALA . . . . . . . . . . . . . . . -149.72 101.4 3.06 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.791 -0.64 . . . . 4.4 110.226 178.197 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 154' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--O 1.251 1.141 0 CA-C-N 115.562 -0.744 . . . . 6.75 110.766 178.07 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 141' ' ' ' CA' . . . . . 0.641 'CA ' ' OD1' ' A' ' 94' ' ' ASP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 . . . . . 0 N--CA 1.454 -0.258 0 CA-C-O 121.12 0.486 . . . . 3.1000000000000001 111.124 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 6.4 t90 -82.39 106.01 13.92 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 109.333 -0.617 . . . . 0.70999999999999996 109.333 178.089 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.574 ' O ' ' HG2' ' A' ' 48' ' ' LYS . 9.7 p -67.5 -7.0 5.67 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.546 0 CA-C-N 115.562 -0.744 . . . . 1.45 112.236 -171.812 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 57.9 t -80.7 -24.81 11.02 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-O 120.742 0.306 . . . . 1.1000000000000001 110.759 178.393 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -74.0 -9.19 79.69 Favored Glycine 0 CA--C 1.519 0.284 0 C-N-CA 120.788 -0.72 . . . . 0.58999999999999997 113.215 -175.342 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . 0.574 ' HG2' ' O ' ' A' ' 45' ' ' VAL . 18.7 ptmt -74.23 -27.77 60.93 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 117.134 0.467 . . . . 2.46 111.175 -176.651 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 36.9 t0 -125.36 33.25 5.18 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.608 0.718 . . . . 1.6599999999999999 109.453 -179.671 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . 0.644 ' N ' ' HD2' ' A' ' 51' ' ' PRO . 51.3 tttt -72.65 -43.86 8.97 Favored Pre-proline 0 C--N 1.321 -0.632 0 CA-C-N 115.471 -0.786 . . . . 1.1499999999999999 112.059 -175.481 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . 0.644 ' HD2' ' N ' ' A' ' 50' ' ' LYS . 1.7 Cg_endo -45.77 -37.07 15.78 Favored 'Trans proline' 0 C--N 1.359 1.082 0 C-N-CA 123.122 2.548 . . . . 0.75 113.184 176.692 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 24.2 m -68.36 -46.61 69.64 Favored 'General case' 0 C--O 1.239 0.54 0 CA-C-O 121.198 0.523 . . . . 0.68000000000000005 110.304 -179.471 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 5.0 m-85 -75.11 -20.24 59.55 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.867 -0.606 . . . . 0.68999999999999995 109.423 -178.451 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 7.6 t70 -67.26 -45.23 77.29 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.42 -0.809 . . . . 2.1800000000000002 110.036 175.128 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 29.4 mt-10 -67.31 -29.17 68.68 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.229 -0.442 . . . . 2.3300000000000001 110.593 178.715 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 54.0 mt -78.87 -29.42 14.25 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-O 121.386 0.612 . . . . 0.64000000000000001 110.587 175.792 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . 0.554 ' CE2' ' HB3' ' A' ' 62' ' ' PRO . 72.8 t80 -71.2 -41.08 70.74 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.961 -0.563 . . . . 0.28999999999999998 110.623 178.765 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . 0.614 ' HA ' ' HG3' ' A' ' 62' ' ' PRO . 2.5 m-85 -78.23 -12.45 60.0 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.917 -0.583 . . . . 1.1699999999999999 111.656 -176.049 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 3.8 p -91.88 -7.61 48.81 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 120.96 0.409 . . . . 0.44 110.988 178.655 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 89.1 mt -100.77 11.49 39.45 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-N 116.015 -0.539 . . . . 1.3700000000000001 110.5 177.75 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 24.6 m 65.65 85.28 0.16 Allowed Pre-proline 0 N--CA 1.463 0.213 0 CA-C-N 115.363 -0.835 . . . . 1.24 111.8 178.347 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . 0.614 ' HG3' ' HA ' ' A' ' 58' ' ' TYR . 4.6 Cg_endo -85.59 130.87 3.87 Favored 'Trans proline' 0 N--CA 1.454 -0.795 0 C-N-CA 122.996 2.464 . . . . 0.46999999999999997 112.162 178.626 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 60.2 t -112.25 108.83 26.51 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 N-CA-C 109.755 -0.461 . . . . 1.02 109.755 177.477 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 92.0 m-20 62.15 30.03 17.65 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.664 -0.698 . . . . 1.3400000000000001 111.922 178.029 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 94.58 3.38 62.78 Favored Glycine 0 CA--C 1.519 0.296 0 C-N-CA 120.792 -0.718 . . . . 0.42999999999999999 113.817 173.668 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 55.5 mttm -129.37 150.53 50.69 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 117.135 0.467 . . . . 1.48 110.488 177.555 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 33.7 pt -117.66 159.67 17.72 Favored 'Isoleucine or valine' 0 C--O 1.24 0.605 0 CA-C-O 121.264 0.554 . . . . 0.64000000000000001 110.455 172.836 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 22.4 p -72.28 151.67 42.64 Favored 'General case' 0 N--CA 1.446 -0.64 0 CA-C-N 114.915 -1.038 . . . . 0.55000000000000004 110.784 179.046 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -71.05 -10.47 68.63 Favored Glycine 0 C--O 1.222 -0.63 0 C-N-CA 120.744 -0.741 . . . . 0.40999999999999998 111.609 179.957 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -70.52 -40.85 73.25 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.069 0.461 . . . . 0.38 111.181 178.65 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 30.2 m-80 -81.13 -33.09 33.43 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.971 -0.559 . . . . 1.8100000000000001 110.34 -178.409 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -62.95 -46.41 87.88 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 109.424 -0.584 . . . . 0.39000000000000001 109.424 171.558 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . 0.422 ' HA ' ' CE1' ' B' ' 151' ' ' PHE . 54.6 tttp -52.25 -43.38 64.33 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 115.248 -0.887 . . . . 0.83999999999999997 110.414 174.671 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . 0.54 ' O ' ' HG2' ' A' ' 78' ' ' LYS . 35.5 ttpt -59.16 -49.91 76.05 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.239 -0.891 . . . . 1.95 111.397 179.037 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 3.1 tp10 -59.32 -47.98 83.35 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.359 0.599 . . . . 1.6000000000000001 110.514 177.108 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' MET . . . . . 0.726 ' HB3' HD22 ' A' ' 86' ' ' LEU . 70.9 mmm -55.75 -47.09 77.57 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.383 -0.826 . . . . 1.24 111.457 -177.819 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 29.5 m -75.56 -20.7 15.95 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.362 0 N-CA-C 111.702 0.26 . . . . 1.5700000000000001 111.702 -177.641 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.54 ' HG2' ' O ' ' A' ' 74' ' ' LYS . 24.0 mmtp -72.96 -27.46 61.84 Favored 'General case' 0 CA--C 1.52 -0.196 0 CA-C-O 121.111 0.482 . . . . 2.79 110.151 174.723 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 66.1 m -85.59 5.09 33.22 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.831 -0.622 . . . . 1.27 111.291 179.286 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . 0.446 ' NZ ' ' HB3' ' A' ' 80' ' ' LYS . 5.0 mmmp? 62.9 31.92 16.0 Favored 'General case' 0 C--O 1.235 0.328 0 N-CA-C 113.343 0.868 . . . . 2.9700000000000002 113.343 170.188 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.432 ' HA ' ' HD3' ' A' ' 82' ' ' PRO . 87.0 mt -87.29 136.54 33.41 Favored Pre-proline 0 C--N 1.322 -0.624 0 C-N-CA 120.651 -0.42 . . . . 0.52000000000000002 110.335 176.813 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . 0.563 ' O ' ' HG ' ' A' ' 86' ' ' LEU . 32.0 Cg_exo -58.7 152.76 54.14 Favored 'Trans proline' 0 C--N 1.344 0.332 0 C-N-CA 122.795 2.33 . . . . 0.44 111.991 178.261 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . 0.551 ' HA ' HD12 ' A' ' 86' ' ' LEU . 17.6 m120 -55.21 -33.53 63.14 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-N 116.481 -0.327 . . . . 1.8500000000000001 111.658 -177.088 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 7.3 p -63.78 -46.64 84.31 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.255 0.55 . . . . 1.47 110.674 177.161 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.494 ' O ' HG12 ' A' ' 89' ' ' ILE . 47.8 t -69.1 -32.75 55.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 115.616 -0.72 . . . . 0.45000000000000001 110.61 -179.871 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.726 HD22 ' HB3' ' A' ' 76' ' ' MET . 79.7 mt -57.58 -46.67 83.72 Favored 'General case' 0 C--O 1.238 0.471 0 CA-C-N 116.119 -0.491 . . . . 0.90000000000000002 110.098 176.188 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -66.62 -35.39 89.82 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.821 -0.704 . . . . 0.32000000000000001 111.625 178.282 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 48.3 mmtt -57.21 -52.46 65.23 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-O 120.907 0.384 . . . . 1.8899999999999999 110.819 175.52 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 0.605 ' HB ' ' HE1' ' A' ' 76' ' ' MET . 50.6 mm -61.16 -47.0 95.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 115.581 -0.736 . . . . 0.70999999999999996 110.938 -177.675 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 50.0 t-105 -59.21 -46.87 87.3 Favored 'General case' 0 CA--C 1.53 0.198 0 CA-C-O 120.825 0.345 . . . . 0.33000000000000002 110.984 179.511 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 17.0 ttmm -54.42 -37.8 65.53 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 115.71 -0.677 . . . . 2.7000000000000002 112.025 178.319 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.749 HD11 ' HA ' ' A' ' 124' ' ' ALA . 96.9 mt -86.22 -29.95 22.77 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.5 -0.318 . . . . 1.6599999999999999 111.774 -176.907 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . 0.683 ' HA ' HD22 ' A' ' 108' ' ' LEU . . . -79.57 -42.31 25.29 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 116.458 -0.337 . . . . 0.46999999999999997 111.868 -175.659 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -102.99 95.14 5.95 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.186 0.517 . . . . 0.79000000000000004 110.197 -177.994 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 32.3 t -67.47 -40.52 84.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 115.388 -0.824 . . . . 0.60999999999999999 111.53 -174.27 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 13.2 p-10 -90.0 -20.09 23.68 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.24 -0.437 . . . . 0.95999999999999996 110.919 -175.994 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . 0.513 ' NZ ' ' HB2' ' A' ' 97' ' ' LYS . 8.0 mtmp? 66.33 60.4 0.62 Allowed 'General case' 0 C--O 1.233 0.21 0 CA-C-N 115.848 -0.615 . . . . 2.96 111.038 177.164 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 11.2 p-10 -94.3 9.57 37.61 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.211 -0.45 . . . . 0.42999999999999999 110.907 -179.598 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 73.99 -19.03 1.78 Allowed Glycine 0 CA--C 1.519 0.329 0 CA-C-N 116.025 -0.534 . . . . 0.44 113.346 175.592 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 94.7 mt -113.35 151.63 30.99 Favored 'General case' 0 C--N 1.318 -0.775 0 N-CA-C 108.889 -0.782 . . . . 1.1100000000000001 108.889 178.227 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 58.5 mt -104.04 119.99 40.12 Favored 'General case' 0 C--N 1.318 -0.796 0 C-N-CA 120.414 -0.514 . . . . 0.41999999999999998 110.519 178.762 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . 0.579 ' HB2' ' HG3' ' A' ' 105' ' ' GLU . 20.6 m-20 -69.38 168.61 14.03 Favored 'General case' 0 CA--C 1.513 -0.46 0 N-CA-C 108.721 -0.844 . . . . 1.72 108.721 171.586 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 12.7 p-10 -59.99 -35.89 76.0 Favored 'General case' 0 C--N 1.317 -0.845 0 N-CA-C 109.612 -0.514 . . . . 1.6000000000000001 109.612 176.094 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 37.5 mm-40 -65.57 -51.17 61.76 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-N 115.668 -0.697 . . . . 1.6599999999999999 110.288 176.138 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . 0.579 ' HG3' ' HB2' ' A' ' 102' ' ' ASP . 42.5 mt-10 -64.41 -42.78 95.89 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.75 -0.659 . . . . 0.44 111.074 -174.404 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 90.2 t80 -66.91 -34.89 78.78 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.245 -0.434 . . . . 0.41999999999999998 110.434 -179.574 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -60.8 -40.4 92.53 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.874 0.368 . . . . 0.22 110.326 175.667 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.683 HD22 ' HA ' ' A' ' 93' ' ' ALA . 6.9 tt -66.45 -50.21 64.11 Favored 'General case' 0 C--O 1.237 0.409 0 CA-C-N 116.217 -0.447 . . . . 1.3300000000000001 110.094 178.791 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . 0.64 ' O ' HG13 ' A' ' 113' ' ' ILE . . . -54.59 -55.98 23.76 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 115.961 -0.563 . . . . 0.32000000000000001 110.728 178.072 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' ASN . . . . . 0.625 ' HA ' HD12 ' A' ' 113' ' ' ILE . 0.7 OUTLIER -52.93 -39.91 63.22 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.662 -0.699 . . . . 1.2 111.176 179.98 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' HIS . . . . . 0.415 ' O ' HG23 ' A' ' 115' ' ' VAL . 37.2 t60 -60.54 -53.26 59.65 Favored 'General case' 0 C--O 1.223 -0.295 0 N-CA-C 110.115 -0.328 . . . . 0.52000000000000002 110.115 178.548 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 92.5 mt -54.87 -42.98 72.73 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-O 120.975 0.417 . . . . 0.55000000000000004 110.775 179.42 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.64 HG13 ' O ' ' A' ' 109' ' ' ALA . 70.6 mt -57.5 -56.63 14.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 115.542 -0.754 . . . . 0.83999999999999997 111.488 -179.374 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 114' ' ' LYS . . . . . 0.517 ' HG2' ' O ' ' A' ' 110' ' ' ASN . 63.2 mmtt -69.55 -32.99 72.12 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.69 -0.687 . . . . 3.8300000000000001 110.644 -174.261 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . 0.529 HG12 ' HB2' ' A' ' 120' ' ' HIS . 51.5 t -62.96 -33.78 62.51 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-N 115.914 -0.585 . . . . 1.1899999999999999 110.679 174.212 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 3.5 mmmp? -68.27 -37.19 80.46 Favored 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 120.694 -0.402 . . . . 1.3200000000000001 110.19 173.225 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 98.1 mt -67.66 -27.78 67.14 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.201 -0.454 . . . . 0.95999999999999996 110.537 177.328 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . 0.408 ' HB2' ' O ' ' A' ' 115' ' ' VAL . 45.8 mt-10 -64.85 -22.41 66.99 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.06 -0.518 . . . . 2.1800000000000002 111.165 174.819 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 106.28 10.82 28.86 Favored Glycine 0 N--CA 1.445 -0.728 0 C-N-CA 120.417 -0.897 . . . . 1.1599999999999999 111.854 -176.906 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 120' ' ' HIS . . . . . 0.529 ' HB2' HG12 ' A' ' 115' ' ' VAL . 7.0 m170 -88.6 159.27 17.96 Favored 'General case' 0 C--O 1.235 0.318 0 N-CA-C 109.381 -0.6 . . . . 2.4199999999999999 109.381 177.32 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 18.2 mt-10 -114.04 163.28 15.37 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 110.285 -0.265 . . . . 2.5299999999999998 110.285 174.166 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . 0.766 ' H ' HD23 ' A' ' 122' ' ' LEU . 2.2 pt? -106.05 136.39 19.32 Favored Pre-proline 0 C--N 1.326 -0.422 0 CA-C-N 116.494 -0.321 . . . . 1.3300000000000001 110.588 -176.771 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . 0.44 ' HD3' ' HA ' ' A' ' 122' ' ' LEU . 10.7 Cg_exo -72.13 -14.91 28.95 Favored 'Trans proline' 0 N--CA 1.464 -0.238 0 C-N-CA 122.889 2.393 . . . . 1.3300000000000001 112.125 177.685 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . 0.749 ' HA ' HD11 ' A' ' 92' ' ' LEU . . . 64.72 18.99 11.69 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 115.417 -0.81 . . . . 1.25 112.106 179.238 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 24.4 t70 -128.45 152.16 48.55 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 108.921 -0.77 . . . . 2.73 108.921 174.767 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . 0.527 ' HG ' HG22 ' A' ' 131' ' ' VAL . 36.3 tp -105.75 105.44 53.0 Favored Pre-proline 0 C--N 1.322 -0.602 0 CA-C-O 120.747 0.308 . . . . 1.6599999999999999 111.588 -172.645 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 127' ' ' PRO . . . . . 0.482 ' HD2' HD12 ' A' ' 130' ' ' LEU . 71.9 Cg_endo -79.61 155.04 24.12 Favored 'Trans proline' 0 CA--C 1.534 0.508 0 C-N-CA 122.722 2.281 . . . . 1.1699999999999999 112.059 174.679 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 12.6 Cg_endo -56.7 -26.01 63.24 Favored 'Trans proline' 0 CA--C 1.534 0.504 0 C-N-CA 123.35 2.7 . . . . 1.54 114.32 -174.937 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 32.0 p-80 -87.14 3.34 46.72 Favored 'General case' 0 N--CA 1.462 0.169 0 C-N-CA 120.441 -0.504 . . . . 1.0700000000000001 111.148 -179.442 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . 0.482 HD12 ' HD2' ' A' ' 127' ' ' PRO . 24.2 mt -110.8 -17.86 13.25 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.453 -0.34 . . . . 1.3600000000000001 110.615 173.617 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . 0.527 HG22 ' HG ' ' A' ' 126' ' ' LEU . 6.7 t -75.73 122.41 87.02 Favored Pre-proline 0 C--N 1.328 -0.336 0 N-CA-C 109.844 -0.428 . . . . 1.28 109.844 178.832 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_exo -49.58 135.98 33.69 Favored 'Trans proline' 0 C--N 1.344 0.327 0 C-N-CA 122.851 2.367 . . . . 0.81000000000000005 112.078 177.153 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -51.23 -36.43 56.36 Favored 'Trans proline' 0 C--N 1.344 0.322 0 C-N-CA 123.762 2.974 . . . . 1.1699999999999999 113.815 -173.818 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 14.6 m -89.34 1.32 55.94 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 112.048 0.388 . . . . 1.6000000000000001 112.048 -176.783 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 66.0 mttm . . . . . 0 CA--C 1.532 0.278 0 O-C-N 122.313 -0.242 . . . . 1.21 111.198 -179.885 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' B' B ' 149' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.437 -1.243 0 N-CA-C 110.832 -0.907 . . . . 0.47999999999999998 110.832 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' B' B ' 150' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -73.21 -0.88 9.76 Favored 'Trans proline' 0 CA--C 1.53 0.323 0 C-N-CA 123.249 2.632 . . . . 0.33000000000000002 112.312 -177.009 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 151' ' ' PHE . . . . . 0.719 ' CZ ' ' HG3' ' A' ' 76' ' ' MET . 46.7 m-85 . . . . . 0 C--N 1.328 -0.346 0 CA-C-N 116.055 -0.52 . . . . 0.75 112.183 -178.617 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 4.1 mp0 . . . . . 0 C--O 1.234 0.276 0 CA-C-O 121.356 0.598 . . . . 3.1000000000000001 111.887 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' TRP . . . . . 0.523 ' HH2' ' O ' ' A' ' 104' ' ' GLU . 7.7 t90 -70.6 116.12 10.55 Favored 'General case' 0 N--CA 1.45 -0.436 0 CA-C-N 115.191 -0.913 . . . . 0.70999999999999996 109.025 178.533 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 9.9 p -67.38 -9.61 10.52 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-O 121.14 0.495 . . . . 1.45 111.371 -174.657 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 51.0 t -89.41 -20.76 7.01 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-O 121.262 0.553 . . . . 1.1000000000000001 110.317 176.866 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . 0.438 ' HA2' ' HG2' ' A' ' 50' ' ' LYS . . . -72.68 -19.34 79.15 Favored Glycine 0 N--CA 1.446 -0.635 0 CA-C-N 115.706 -0.679 . . . . 0.58999999999999997 112.897 -175.666 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 15.3 ptpt -76.61 -26.1 54.6 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.602 0.239 . . . . 2.46 111.138 -179.182 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -101.2 34.25 2.6 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.023 0.439 . . . . 1.6599999999999999 109.917 178.259 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . 0.438 ' HG2' ' HA2' ' A' ' 47' ' ' GLY . 0.1 OUTLIER -67.73 -54.16 18.54 Favored Pre-proline 0 C--O 1.214 -0.775 0 CA-C-O 118.256 -0.878 . . . . 1.1499999999999999 113.156 -175.922 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_exo -42.66 -41.76 8.33 Favored 'Trans proline' 0 C--N 1.358 1.068 0 C-N-CA 122.798 2.332 . . . . 0.75 113.868 -173.245 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 90.7 m -69.97 -44.76 68.79 Favored 'General case' 0 C--O 1.238 0.449 0 CA-C-O 121.1 0.476 . . . . 0.68000000000000005 111.282 179.404 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 8.6 m-30 -74.23 -23.21 59.14 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.957 0.408 . . . . 0.68999999999999995 110.045 -177.491 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 84.2 m-20 -70.03 -44.23 69.69 Favored 'General case' 0 CA--C 1.511 -0.532 0 N-CA-C 108.961 -0.755 . . . . 2.1800000000000002 108.961 175.818 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 10.8 tp10 -57.26 -47.29 81.78 Favored 'General case' 0 N--CA 1.45 -0.444 0 CA-C-N 115.016 -0.993 . . . . 2.3300000000000001 110.225 178.541 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 39.8 mt -70.79 -37.54 69.14 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 CA-C-N 116.24 -0.437 . . . . 0.64000000000000001 111.552 -178.273 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . 0.461 ' HD2' ' CE1' ' A' ' 58' ' ' TYR . 86.6 t80 -66.29 -45.3 80.89 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.807 0.337 . . . . 0.28999999999999998 110.981 -178.689 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . 0.461 ' CE1' ' HD2' ' A' ' 57' ' ' PHE . 21.7 m-85 -79.81 -12.6 59.76 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.592 -0.276 . . . . 1.1699999999999999 111.429 -174.596 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 11.5 p -88.7 -8.65 54.16 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.716 0.293 . . . . 0.44 111.286 177.406 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.481 ' HB3' ' HB3' ' A' ' 71' ' ' ASN . 35.2 mt -94.69 9.38 39.07 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.665 -0.243 . . . . 1.3700000000000001 110.988 178.599 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 17.3 m 68.23 87.55 0.11 Allowed Pre-proline 0 CA--C 1.531 0.219 0 O-C-N 123.823 0.702 . . . . 1.24 110.854 -176.374 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -77.3 125.3 7.69 Favored 'Trans proline' 0 N--CA 1.458 -0.582 0 C-N-CA 122.586 2.191 . . . . 0.46999999999999997 112.199 -179.463 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 12.5 m -115.3 119.35 61.55 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 CA-C-O 121.091 0.472 . . . . 1.02 110.271 177.432 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 65.5 m-20 64.39 22.24 12.7 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-N 115.711 -0.677 . . . . 1.3400000000000001 110.742 -179.19 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 80.67 15.73 77.16 Favored Glycine 0 CA--C 1.52 0.352 0 C-N-CA 120.961 -0.638 . . . . 0.42999999999999999 112.579 -178.393 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . 0.751 ' HG2' ' HB3' ' A' ' 102' ' ' ASP . 86.8 mttt -137.37 160.14 39.92 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 109.739 -0.467 . . . . 1.48 109.739 179.812 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . 0.454 HD11 ' HB2' ' A' ' 101' ' ' LEU . 2.8 pp -119.48 158.12 21.18 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 N-CA-C 109.907 -0.405 . . . . 0.64000000000000001 109.907 172.309 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . 0.401 ' HA ' ' CD2' ' A' ' 100' ' ' LEU . 63.8 p -89.5 173.11 8.52 Favored 'General case' 0 C--N 1.321 -0.63 0 CA-C-N 116.203 -0.453 . . . . 0.55000000000000004 110.898 -174.569 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -64.53 -19.29 64.56 Favored Glycine 0 N--CA 1.445 -0.726 0 C-N-CA 120.81 -0.709 . . . . 0.40999999999999998 111.997 176.962 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -66.61 -46.01 77.24 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.168 0.509 . . . . 0.38 111.154 179.061 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . 0.481 ' HB3' ' HB3' ' A' ' 60' ' ' LEU . 1.7 m120 -77.57 -41.09 40.13 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.654 -0.703 . . . . 1.8100000000000001 110.128 -175.148 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -62.78 -43.39 98.94 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.862 -0.608 . . . . 0.39000000000000001 110.263 177.194 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . 0.54 ' O ' HG22 ' A' ' 77' ' ' VAL . 21.3 ttmm -56.96 -47.28 81.08 Favored 'General case' 0 CA--C 1.516 -0.332 0 CA-C-N 116.255 -0.43 . . . . 0.83999999999999997 109.862 176.358 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 48.8 tttm -52.44 -50.65 62.17 Favored 'General case' 0 N--CA 1.451 -0.386 0 O-C-N 123.908 0.755 . . . . 1.95 111.209 -178.974 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 13.2 tp10 -70.7 -43.37 69.12 Favored 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 120.846 -0.341 . . . . 1.6000000000000001 111.15 -178.208 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 64.7 mtt -64.34 -38.67 91.85 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 111.656 0.243 . . . . 1.24 111.656 -175.729 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.54 HG22 ' O ' ' A' ' 73' ' ' LYS . 32.9 m -76.31 -28.55 18.34 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.302 0 C-N-CA 120.788 -0.365 . . . . 1.5700000000000001 110.621 177.271 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.456 ' HB3' ' HE3' ' A' ' 78' ' ' LYS . 19.8 mmmt -64.89 -25.78 68.04 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-N 116.18 -0.464 . . . . 2.79 110.727 173.58 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 20.3 m -75.16 -8.85 57.72 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.585 -0.734 . . . . 1.27 110.512 177.796 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 55.0 mtpt 62.34 42.64 8.95 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-N 115.903 -0.59 . . . . 2.9700000000000002 111.126 177.38 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.709 ' HB2' HD11 ' A' ' 86' ' ' LEU . 97.5 mt -100.32 169.2 8.25 Favored Pre-proline 0 C--N 1.325 -0.495 0 CA-C-N 115.704 -0.68 . . . . 0.52000000000000002 109.758 178.307 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . 0.407 ' CD ' ' HB3' ' A' ' 81' ' ' LEU . 2.0 Cg_endo -83.49 132.01 5.73 Favored 'Trans proline' 0 C--N 1.348 0.515 0 C-N-CA 123.274 2.65 . . . . 0.44 112.371 -178.478 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 5.0 p-10 -50.67 -38.67 47.95 Favored 'General case' 0 N--CA 1.472 0.638 0 N-CA-C 113.504 0.927 . . . . 1.8500000000000001 113.504 -171.532 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . 0.408 ' O ' ' HG2' ' A' ' 88' ' ' LYS . 75.7 m -65.79 -34.28 77.81 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 120.892 0.377 . . . . 1.47 110.925 -179.719 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.502 ' O ' HG12 ' A' ' 89' ' ' ILE . 95.6 t -71.12 -39.85 74.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.153 -0.476 . . . . 0.45000000000000001 109.789 178.485 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.709 HD11 ' HB2' ' A' ' 81' ' ' LEU . 9.8 mp -58.44 -34.83 71.24 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.18 -0.464 . . . . 0.90000000000000002 110.992 172.39 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . 0.417 ' HA2' ' HB2' ' B' ' 151' ' ' PHE . . . -65.66 -38.67 94.81 Favored Glycine 0 N--CA 1.447 -0.612 0 N-CA-C 111.072 -0.811 . . . . 0.32000000000000001 111.072 176.619 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . 0.408 ' HG2' ' O ' ' A' ' 84' ' ' THR . 70.0 mmtt -63.43 -49.73 72.57 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.147 -0.526 . . . . 1.8899999999999999 109.968 174.5 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 0.502 HG12 ' O ' ' A' ' 85' ' ' VAL . 40.8 mm -54.74 -49.82 65.46 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.097 0 CA-C-N 115.711 -0.677 . . . . 0.70999999999999996 110.699 179.686 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 53.5 t-105 -61.38 -50.55 72.42 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.323 -0.399 . . . . 0.33000000000000002 111.402 -178.671 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 26.4 ttmt -74.52 -10.76 59.87 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-O 121.009 0.433 . . . . 2.7000000000000002 111.359 -172.766 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.439 HD11 ' HA ' ' A' ' 124' ' ' ALA . 94.1 mt -94.36 -37.42 11.48 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.336 -0.393 . . . . 1.6599999999999999 111.08 172.7 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . 0.474 ' HA ' HD23 ' A' ' 108' ' ' LEU . . . -78.81 -36.85 42.08 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.224 -0.444 . . . . 0.46999999999999997 111.489 -176.787 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 26.7 t0 -81.15 86.83 6.12 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.612 0.72 . . . . 0.79000000000000004 109.524 177.562 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.446 ' HB ' ' HD3' ' A' ' 135' ' ' LYS . 34.4 t -82.2 -30.74 9.83 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.587 0 CA-C-N 114.839 -1.073 . . . . 0.60999999999999999 110.352 -174.796 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 43.5 p-10 -86.41 -7.57 58.34 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.22 -0.445 . . . . 0.95999999999999996 110.655 -179.461 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 88.9 mttt 59.06 44.62 15.85 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-N 115.716 -0.675 . . . . 2.96 111.129 172.974 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . 0.536 ' OD2' ' HB2' ' A' ' 100' ' ' LEU . 6.5 p-10 -107.08 9.06 30.56 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 116.246 -0.434 . . . . 0.42999999999999999 111.016 -175.872 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 67.58 12.84 62.27 Favored Glycine 0 CA--C 1.518 0.277 0 C-N-CA 121.053 -0.594 . . . . 0.44 112.481 178.746 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.536 ' HB2' ' OD2' ' A' ' 98' ' ' ASP . 87.0 mt -135.77 153.3 51.59 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 109.114 -0.699 . . . . 1.1100000000000001 109.114 178.817 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.454 ' HB2' HD11 ' A' ' 67' ' ' ILE . 89.9 mt -110.22 111.89 23.5 Favored 'General case' 0 C--N 1.315 -0.928 0 N-CA-C 109.166 -0.679 . . . . 0.41999999999999998 109.166 175.009 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . 0.751 ' HB3' ' HG2' ' A' ' 66' ' ' LYS . 2.1 p30 -75.99 -174.82 2.81 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 116.233 -0.44 . . . . 1.72 110.672 178.523 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -54.86 -40.33 69.56 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 115.604 -0.726 . . . . 1.6000000000000001 110.48 -179.215 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . 0.523 ' O ' ' HH2' ' A' ' 44' ' ' TRP . 54.5 mt-10 -73.62 -52.76 12.32 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.992 -0.549 . . . . 1.6599999999999999 110.253 179.408 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 36.1 mt-10 -63.12 -37.93 89.15 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.238 -0.437 . . . . 0.44 111.753 -173.833 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . 0.456 ' CD2' ' HD1' ' A' ' 57' ' ' PHE . 54.1 t80 -74.86 -34.94 62.35 Favored 'General case' 0 C--N 1.326 -0.436 0 C-N-CA 120.781 -0.368 . . . . 0.41999999999999998 110.098 -179.533 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -58.61 -42.43 88.13 Favored 'General case' 0 C--O 1.231 0.127 0 N-CA-C 109.714 -0.476 . . . . 0.22 109.714 173.215 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.474 HD23 ' HA ' ' A' ' 93' ' ' ALA . 64.8 tp -62.73 -43.77 97.95 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.842 -0.617 . . . . 1.3300000000000001 110.557 176.055 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . 0.519 ' O ' HG13 ' A' ' 113' ' ' ILE . . . -57.86 -46.03 85.41 Favored 'General case' 0 C--O 1.225 -0.237 0 CA-C-N 116.251 -0.431 . . . . 0.32000000000000001 110.869 178.562 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' ASN . . . . . 0.434 HD22 HD12 ' A' ' 113' ' ' ILE . 13.6 m120 -63.4 -36.71 84.61 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 116.5 -0.318 . . . . 1.2 111.146 179.037 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 9.6 t60 -64.4 -37.87 89.04 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 109.615 -0.513 . . . . 0.52000000000000002 109.615 178.838 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 94.3 mt -72.02 -39.19 69.33 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.793 -0.639 . . . . 0.55000000000000004 110.742 178.098 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.519 HG13 ' O ' ' A' ' 109' ' ' ALA . 59.4 mt -56.68 -47.54 82.24 Favored 'Isoleucine or valine' 0 C--O 1.233 0.211 0 N-CA-C 109.816 -0.439 . . . . 0.83999999999999997 109.816 175.247 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 114' ' ' LYS . . . . . 0.566 ' O ' ' HB2' ' A' ' 118' ' ' GLU . 4.6 mmmm -62.38 -44.11 97.23 Favored 'General case' 0 C--O 1.221 -0.413 0 CA-C-N 116.076 -0.511 . . . . 3.8300000000000001 111.622 179.223 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . 0.567 HG13 ' HB2' ' A' ' 120' ' ' HIS . 42.9 t -58.01 -43.25 84.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-O 120.835 0.35 . . . . 1.1899999999999999 110.903 178.192 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 116' ' ' LYS . . . . . 0.472 ' HA ' ' HD2' ' A' ' 116' ' ' LYS . 18.3 tptt -65.75 -45.41 82.7 Favored 'General case' 0 N--CA 1.444 -0.754 0 CA-C-N 116.057 -0.519 . . . . 1.3200000000000001 110.786 -178.982 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 95.7 mt -78.95 -15.75 57.88 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.511 -0.313 . . . . 0.95999999999999996 111.78 -178.742 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . 0.566 ' HB2' ' O ' ' A' ' 114' ' ' LYS . 2.1 tp10 -79.4 -13.56 59.52 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 109.081 -0.711 . . . . 2.1800000000000002 109.081 177.063 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 93.78 31.02 8.46 Favored Glycine 0 N--CA 1.452 -0.287 0 CA-C-N 115.236 -0.893 . . . . 1.1599999999999999 112.318 178.293 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 120' ' ' HIS . . . . . 0.567 ' HB2' HG13 ' A' ' 115' ' ' VAL . 80.8 m-70 -117.09 176.8 4.97 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 109.843 -0.429 . . . . 2.4199999999999999 109.843 177.644 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 -126.41 155.07 42.75 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 120.789 0.328 . . . . 2.5299999999999998 110.255 -177.85 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . 0.481 ' HA ' ' HD3' ' A' ' 123' ' ' PRO . 0.7 OUTLIER -116.39 135.64 22.91 Favored Pre-proline 0 C--N 1.324 -0.521 0 N-CA-C 109.807 -0.442 . . . . 1.3300000000000001 109.807 177.931 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . 0.481 ' HD3' ' HA ' ' A' ' 122' ' ' LEU . 2.9 Cg_exo -76.45 10.31 2.23 Favored 'Trans proline' 0 C--O 1.234 0.315 0 C-N-CA 123.191 2.594 . . . . 1.3300000000000001 113.393 -175.49 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . 0.439 ' HA ' HD11 ' A' ' 92' ' ' LEU . . . 57.91 27.21 14.33 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-O 121.24 0.543 . . . . 1.25 111.367 -178.89 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 8.2 t70 -132.42 154.67 49.61 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 109.235 -0.654 . . . . 2.73 109.235 -179.887 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 95.2 mt -108.46 101.67 43.78 Favored Pre-proline 0 C--N 1.324 -0.527 0 CA-C-O 120.917 0.389 . . . . 1.6599999999999999 111.616 -177.078 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 127' ' ' PRO . . . . . 0.624 ' HG2' ' HB2' ' A' ' 130' ' ' LEU . 18.4 Cg_endo -62.64 151.95 80.68 Favored 'Trans proline' 0 CA--C 1.535 0.546 0 C-N-CA 122.821 2.347 . . . . 1.1699999999999999 111.767 173.344 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -53.11 -35.7 73.83 Favored 'Trans proline' 0 CA--C 1.533 0.461 0 C-N-CA 123.415 2.743 . . . . 1.54 113.622 -175.23 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 11.9 p-80 -86.93 3.26 46.36 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 111.669 0.248 . . . . 1.0700000000000001 111.669 -178.916 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . 0.624 ' HB2' ' HG2' ' A' ' 127' ' ' PRO . 16.5 tp -115.57 -1.14 12.83 Favored 'General case' 0 N--CA 1.446 -0.655 0 CA-C-O 120.965 0.412 . . . . 1.3600000000000001 110.279 -177.912 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . 0.413 HG23 ' O ' ' A' ' 127' ' ' PRO . 65.0 t -88.69 129.77 47.6 Favored Pre-proline 0 C--N 1.327 -0.391 0 CA-C-N 115.987 -0.551 . . . . 1.28 110.122 178.598 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 132' ' ' PRO . . . . . 0.463 ' HA ' ' HD3' ' A' ' 133' ' ' PRO . 83.1 Cg_exo -48.31 130.38 20.93 Favored 'Trans proline' 0 C--N 1.348 0.532 0 C-N-CA 122.891 2.394 . . . . 0.81000000000000005 112.306 177.685 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 133' ' ' PRO . . . . . 0.463 ' HD3' ' HA ' ' A' ' 132' ' ' PRO . 50.6 Cg_exo -54.27 -37.44 88.27 Favored 'Trans proline' 0 C--O 1.232 0.206 0 C-N-CA 123.446 2.764 . . . . 1.1699999999999999 113.369 -174.296 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 12.8 m -83.99 -2.05 55.85 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.55 -0.295 . . . . 1.6000000000000001 111.227 -177.05 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 135' ' ' LYS . . . . . 0.446 ' HD3' ' HB ' ' A' ' 95' ' ' VAL . 61.2 mttp . . . . . 0 C--N 1.329 -0.324 0 N-CA-C 112.285 0.476 . . . . 1.21 112.285 -174.702 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 149' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.444 -0.778 0 N-CA-C 111.542 -0.623 . . . . 0.47999999999999998 111.542 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' B' B ' 150' ' ' PRO . . . . . . . . . . . . . 69.4 Cg_endo -73.86 -8.33 21.16 Favored 'Trans proline' 0 N--CA 1.465 -0.204 0 C-N-CA 122.423 2.082 . . . . 0.33000000000000002 112.106 -179.228 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 151' ' ' PHE . . . . . 0.43 ' CZ ' ' HA ' ' A' ' 73' ' ' LYS . 36.2 m-85 . . . . . 0 C--N 1.328 -0.332 0 CA-C-N 116.067 -0.515 . . . . 0.75 111.038 178.136 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . 0.463 ' OE2' ' HA ' ' A' ' 45' ' ' VAL . 12.4 tt0 . . . . . 0 C--O 1.237 0.411 0 CA-C-O 120.879 0.371 . . . . 3.1000000000000001 110.814 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' TRP . . . . . 0.487 ' HH2' ' O ' ' A' ' 104' ' ' GLU . 6.1 t90 -83.39 102.14 11.82 Favored 'General case' 0 N--CA 1.448 -0.545 0 N-CA-C 107.503 -1.295 . . . . 0.70999999999999996 107.503 168.767 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.463 ' HA ' ' OE2' ' A' ' 43' ' ' GLU . 35.6 m -61.58 -9.66 3.24 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.532 0 N-CA-C 113.011 0.745 . . . . 1.45 113.011 -170.045 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 22.4 t -86.51 -20.17 7.91 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 CA-C-O 121.24 0.543 . . . . 1.1000000000000001 110.194 177.794 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . 0.553 ' HA2' ' HG3' ' A' ' 50' ' ' LYS . . . -73.27 -25.86 71.97 Favored Glycine 0 N--CA 1.449 -0.45 0 CA-C-N 115.71 -0.677 . . . . 0.58999999999999997 113.242 -175.145 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 6.4 ptpp? -74.06 -25.32 59.77 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 117.052 0.426 . . . . 2.46 111.051 -178.827 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 24.1 m-20 -105.67 33.75 3.6 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.114 0.483 . . . . 1.6599999999999999 109.96 179.37 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . 0.553 ' HG3' ' HA2' ' A' ' 47' ' ' GLY . 48.9 mttt -70.16 -43.25 18.32 Favored Pre-proline 0 C--O 1.219 -0.521 0 CA-C-O 118.499 -0.762 . . . . 1.1499999999999999 112.657 178.042 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . 0.512 ' O ' ' HG3' ' A' ' 55' ' ' GLU . 66.2 Cg_exo -39.64 -48.71 3.44 Favored 'Trans proline' 0 C--N 1.365 1.439 0 C-N-CA 122.82 2.346 . . . . 0.75 113.89 -179.243 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 18.4 m -69.54 -44.8 70.19 Favored 'General case' 0 C--O 1.239 0.509 0 CA-C-O 121.082 0.467 . . . . 0.68000000000000005 111.148 -177.626 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 9.8 m-30 -70.34 -21.49 62.9 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.873 -0.603 . . . . 0.68999999999999995 109.854 -178.238 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -74.88 -44.68 47.54 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.95 -0.568 . . . . 2.1800000000000002 109.734 177.782 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . 0.512 ' HG3' ' O ' ' A' ' 51' ' ' PRO . 72.0 mt-10 -60.6 -29.8 69.44 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.453 -0.794 . . . . 2.3300000000000001 110.416 178.493 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.47 ' O ' HD13 ' A' ' 60' ' ' LEU . 52.4 mt -84.74 -48.72 16.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 116.148 -0.478 . . . . 0.64000000000000001 111.225 177.566 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . 0.497 ' HE1' HG12 ' A' ' 67' ' ' ILE . 82.9 t80 -56.24 -37.37 69.65 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 122.99 0.516 . . . . 0.28999999999999998 111.534 -176.699 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . 0.537 ' HA ' ' HG3' ' A' ' 62' ' ' PRO . 3.1 m-30 -80.44 -10.03 59.75 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.234 -0.439 . . . . 1.1699999999999999 111.59 -174.487 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 61.4 p -98.13 -2.38 40.12 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.113 0.482 . . . . 0.44 110.646 176.808 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.47 HD13 ' O ' ' A' ' 56' ' ' ILE . 8.9 mp -97.52 12.59 32.87 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.867 -0.606 . . . . 1.3700000000000001 110.526 179.439 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 44.6 t 64.32 73.5 0.45 Allowed Pre-proline 0 C--O 1.234 0.259 0 CA-C-N 115.595 -0.73 . . . . 1.24 111.407 -179.216 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . 0.537 ' HG3' ' HA ' ' A' ' 58' ' ' TYR . 61.2 Cg_endo -77.26 126.45 8.5 Favored 'Trans proline' 0 C--N 1.347 0.455 0 C-N-CA 122.212 1.942 . . . . 0.46999999999999997 112.4 178.88 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 15.7 m -109.42 113.1 43.24 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 CA-C-O 121.253 0.549 . . . . 1.02 110.438 177.633 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 95.2 m-20 61.33 34.65 18.35 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 115.617 -0.72 . . . . 1.3400000000000001 111.178 179.574 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 77.76 21.68 71.15 Favored Glycine 0 C--N 1.331 0.302 0 CA-C-N 115.89 -0.596 . . . . 0.42999999999999999 112.927 178.243 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 58.4 mttm -141.13 148.96 40.9 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 109.904 -0.406 . . . . 1.48 109.904 -179.015 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . 0.497 HG12 ' HE1' ' A' ' 57' ' ' PHE . 36.9 pt -117.5 160.61 16.92 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 N-CA-C 109.915 -0.402 . . . . 0.64000000000000001 109.915 171.103 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 54.8 p -86.18 170.71 11.91 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 120.921 0.391 . . . . 0.55000000000000004 110.623 -177.178 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -65.01 -21.13 67.55 Favored Glycine 0 N--CA 1.446 -0.687 0 C-N-CA 120.962 -0.637 . . . . 0.40999999999999998 112.36 178.687 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.617 ' O ' ' HG3' ' A' ' 74' ' ' LYS . . . -63.23 -52.42 62.26 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 121.027 0.441 . . . . 0.38 111.181 -179.754 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -71.23 -41.68 69.85 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.848 -0.614 . . . . 1.8100000000000001 109.93 -175.012 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -61.73 -38.07 86.56 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.472 -0.785 . . . . 0.39000000000000001 110.604 177.2 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . 0.636 ' HG3' ' HE1' ' B' ' 151' ' ' PHE . 79.9 tttt -64.41 -43.09 95.49 Favored 'General case' 0 CA--C 1.515 -0.37 0 CA-C-N 116.216 -0.447 . . . . 0.83999999999999997 110.43 178.462 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . 0.617 ' HG3' ' O ' ' A' ' 70' ' ' ALA . 29.1 mtpp -59.33 -44.58 92.59 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.54 0.21 . . . . 1.95 110.472 -179.41 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 14.6 tp10 -61.29 -48.41 81.51 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 116.337 -0.392 . . . . 1.6000000000000001 110.5 177.283 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' MET . . . . . 0.846 ' HB3' HD22 ' A' ' 86' ' ' LEU . 53.4 mtt -63.55 -33.38 75.46 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.155 0.502 . . . . 1.24 111.289 -179.682 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.487 HG23 ' O ' ' A' ' 73' ' ' LYS . 38.6 t -64.99 -30.8 51.44 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-N 116.123 -0.49 . . . . 1.5700000000000001 110.087 176.392 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 66.1 mmtt -79.6 -26.81 41.13 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.15 -0.477 . . . . 2.79 111.689 178.906 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 76.9 p -66.14 -14.97 62.7 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 120.867 -0.333 . . . . 1.27 110.501 178.422 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 31.7 mtmm 70.1 18.88 6.94 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-N 115.557 -0.747 . . . . 2.9700000000000002 111.572 176.135 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.605 ' HB2' HD21 ' A' ' 86' ' ' LEU . 97.0 mt -82.91 144.14 47.4 Favored Pre-proline 0 C--N 1.325 -0.498 0 N-CA-C 109.573 -0.528 . . . . 0.52000000000000002 109.573 174.363 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 41.2 Cg_exo -57.65 148.07 75.99 Favored 'Trans proline' 0 C--N 1.343 0.245 0 C-N-CA 122.605 2.204 . . . . 0.44 112.369 178.659 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 2.1 m-20 -50.61 -41.82 55.24 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-N 115.852 -0.613 . . . . 1.8500000000000001 111.293 -179.489 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -57.69 -47.62 81.82 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.942 -0.572 . . . . 1.47 110.878 179.37 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.529 ' O ' HG12 ' A' ' 89' ' ' ILE . 93.8 t -63.2 -37.89 80.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 115.699 -0.682 . . . . 0.45000000000000001 110.393 -179.761 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.846 HD22 ' HB3' ' A' ' 76' ' ' MET . 75.0 mt -65.73 -36.63 84.14 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.016 -0.538 . . . . 0.90000000000000002 110.672 179.704 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -65.23 -37.94 94.59 Favored Glycine 0 N--CA 1.449 -0.451 0 N-CA-C 110.857 -0.897 . . . . 0.32000000000000001 110.857 176.213 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 31.1 mmmt -61.91 -47.43 84.98 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.295 -0.452 . . . . 1.8899999999999999 109.976 174.739 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 0.529 HG12 ' O ' ' A' ' 85' ' ' VAL . 28.3 mm -58.97 -46.62 91.43 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.18 0 CA-C-N 115.471 -0.786 . . . . 0.70999999999999996 110.695 179.403 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 52.5 t-105 -60.09 -47.4 86.05 Favored 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 121.076 -0.25 . . . . 0.33000000000000002 110.915 -179.064 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 37.4 ttmt -62.91 -24.16 67.71 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 116.41 -0.359 . . . . 2.7000000000000002 111.319 -178.118 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.728 HD11 ' HA ' ' A' ' 124' ' ' ALA . 91.9 mt -93.38 -29.47 15.58 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.443 -0.344 . . . . 1.6599999999999999 111.51 179.903 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -85.94 -41.39 14.96 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.58 -0.282 . . . . 0.46999999999999997 111.35 -177.315 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 39.8 t0 -84.5 79.34 9.61 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 108.858 -0.793 . . . . 0.79000000000000004 108.858 177.282 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.509 ' HB ' ' HG2' ' A' ' 135' ' ' LYS . 40.5 t -67.56 -37.51 78.91 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-N 115.292 -0.867 . . . . 0.60999999999999999 111.056 -171.63 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 40.4 p-10 -83.54 -10.1 58.52 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.934 -0.575 . . . . 0.95999999999999996 110.973 -178.972 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 92.0 mttt 52.16 72.65 0.38 Allowed 'General case' 0 C--O 1.235 0.338 0 O-C-N 123.839 0.712 . . . . 2.96 110.843 179.789 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . 0.418 ' OD2' ' HB2' ' A' ' 100' ' ' LEU . 9.6 p-10 -127.27 9.02 6.64 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 120.916 0.389 . . . . 0.42999999999999999 110.694 -176.896 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 74.02 0.39 55.96 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.768 -0.729 . . . . 0.44 112.709 177.375 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.418 ' HB2' ' OD2' ' A' ' 98' ' ' ASP . 77.2 mt -128.79 147.41 50.79 Favored 'General case' 0 N--CA 1.446 -0.653 0 N-CA-C 109.417 -0.586 . . . . 1.1100000000000001 109.417 179.355 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 60.8 mt -105.17 120.1 40.68 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-N 115.992 -0.549 . . . . 0.41999999999999998 109.912 176.549 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . 0.444 ' HB2' ' HG3' ' A' ' 105' ' ' GLU . 9.8 m-20 -69.6 176.96 3.19 Favored 'General case' 0 CA--C 1.511 -0.533 0 N-CA-C 109.613 -0.514 . . . . 1.72 109.613 174.279 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -56.81 -42.7 80.01 Favored 'General case' 0 C--N 1.317 -0.808 0 N-CA-C 109.552 -0.536 . . . . 1.6000000000000001 109.552 172.967 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . 0.522 ' HB3' ' HB3' ' A' ' 132' ' ' PRO . 4.7 mp0 -61.94 -53.34 56.99 Favored 'General case' 0 N--CA 1.461 0.115 0 CA-C-N 115.895 -0.593 . . . . 1.6599999999999999 111.266 173.946 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . 0.444 ' HG3' ' HB2' ' A' ' 102' ' ' ASP . 22.9 mt-10 -67.1 -34.33 77.39 Favored 'General case' 0 C--N 1.327 -0.394 0 C-N-CA 120.947 -0.301 . . . . 0.44 111.471 -169.824 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . 0.437 ' CD1' HD11 ' A' ' 67' ' ' ILE . 84.4 t80 -71.29 -40.67 70.72 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 109.94 -0.393 . . . . 0.41999999999999998 109.94 176.335 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -57.31 -43.08 82.96 Favored 'General case' 0 N--CA 1.454 -0.239 0 CA-C-O 121.107 0.48 . . . . 0.22 110.393 175.698 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 6.3 tt -60.15 -50.6 73.03 Favored 'General case' 0 C--O 1.236 0.353 0 CA-C-N 115.504 -0.771 . . . . 1.3300000000000001 110.012 178.428 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . 0.466 ' O ' HG13 ' A' ' 113' ' ' ILE . . . -57.93 -45.38 86.64 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.108 -0.496 . . . . 0.32000000000000001 110.834 179.245 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -62.77 -34.12 76.58 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.04 -0.527 . . . . 1.2 110.674 -179.71 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 2.3 t60 -70.07 -35.85 74.52 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.197 -0.456 . . . . 0.52000000000000002 110.358 179.712 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 63.1 mt -68.65 -40.36 80.28 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.16 -0.473 . . . . 0.55000000000000004 110.077 176.597 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.466 HG13 ' O ' ' A' ' 109' ' ' ALA . 69.3 mt -57.58 -41.9 80.07 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.141 0 CA-C-N 115.959 -0.564 . . . . 0.83999999999999997 109.636 174.512 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 114' ' ' LYS . . . . . 0.685 ' O ' ' HG2' ' A' ' 118' ' ' GLU . 2.4 mmmt -58.08 -49.04 78.3 Favored 'General case' 0 C--O 1.22 -0.464 0 CA-C-N 115.406 -0.816 . . . . 3.8300000000000001 110.551 177.335 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . 0.58 HG13 ' HB2' ' A' ' 120' ' ' HIS . 68.2 t -53.6 -40.86 43.9 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 O-C-N 123.408 0.443 . . . . 1.1899999999999999 111.604 177.63 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 116' ' ' LYS . . . . . 0.41 ' HA ' ' HD3' ' A' ' 116' ' ' LYS . 42.0 mmtt -70.16 -33.54 71.9 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 111.857 0.318 . . . . 1.3200000000000001 111.857 178.604 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 98.0 mt -71.38 -30.39 66.08 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.185 0.516 . . . . 0.95999999999999996 110.058 175.414 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . 0.685 ' HG2' ' O ' ' A' ' 114' ' ' LYS . 22.1 mm-40 -67.71 -25.9 65.89 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.345 -0.843 . . . . 2.1800000000000002 110.127 176.077 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 91.91 35.17 6.89 Favored Glycine 0 N--CA 1.447 -0.573 0 C-N-CA 120.593 -0.813 . . . . 1.1599999999999999 111.927 -176.65 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 120' ' ' HIS . . . . . 0.58 ' HB2' HG13 ' A' ' 115' ' ' VAL . 97.9 m-70 -119.51 164.82 15.22 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 109.91 -0.404 . . . . 2.4199999999999999 109.91 177.955 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 42.3 mm-40 -110.59 161.87 15.28 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 116.329 -0.396 . . . . 2.5299999999999998 110.882 -174.628 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . 0.513 ' H ' HD23 ' A' ' 122' ' ' LEU . 1.7 pt? -124.96 135.44 26.78 Favored Pre-proline 0 C--N 1.323 -0.553 0 CA-C-N 115.795 -0.638 . . . . 1.3300000000000001 109.492 176.331 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 62.9 Cg_endo -74.33 -1.76 11.43 Favored 'Trans proline' 0 CA--C 1.53 0.279 0 C-N-CA 122.877 2.385 . . . . 1.3300000000000001 113.557 -175.455 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . 0.728 ' HA ' HD11 ' A' ' 92' ' ' LEU . . . 68.97 18.89 8.35 Favored 'General case' 0 N--CA 1.467 0.38 0 C-N-CA 123.04 0.536 . . . . 1.25 110.769 -175.781 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -117.95 156.57 28.27 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.396 -0.82 . . . . 2.73 109.231 174.765 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . 0.51 HD21 ' HB3' ' A' ' 92' ' ' LEU . 90.8 mt -108.97 104.8 55.92 Favored Pre-proline 0 C--N 1.323 -0.566 0 CA-C-O 120.705 0.288 . . . . 1.6599999999999999 111.629 -176.858 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 127' ' ' PRO . . . . . 0.53 ' HD2' HD12 ' A' ' 130' ' ' LEU . 51.5 Cg_exo -54.81 146.72 54.42 Favored 'Trans proline' 0 C--O 1.235 0.356 0 C-N-CA 123.015 2.477 . . . . 1.1699999999999999 111.782 172.023 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 41.3 Cg_endo -67.14 3.14 1.76 Allowed 'Trans proline' 0 N--CA 1.475 0.426 0 C-N-CA 123.24 2.627 . . . . 1.54 114.258 -174.228 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 27.5 p-80 -117.16 7.51 13.02 Favored 'General case' 0 C--N 1.327 -0.382 0 C-N-CA 120.737 -0.385 . . . . 1.0700000000000001 110.577 177.877 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . 0.53 HD12 ' HD2' ' A' ' 127' ' ' PRO . 23.4 mt -108.08 0.99 22.03 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.833 0.349 . . . . 1.3600000000000001 111.345 178.785 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 3.5 m -77.31 121.06 83.94 Favored Pre-proline 0 C--N 1.322 -0.613 0 CA-C-N 116.373 -0.376 . . . . 1.28 110.401 173.825 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 132' ' ' PRO . . . . . 0.522 ' HB3' ' HB3' ' A' ' 104' ' ' GLU . 51.4 Cg_exo -53.29 148.64 31.87 Favored 'Trans proline' 0 C--N 1.342 0.205 0 C-N-CA 122.944 2.43 . . . . 0.81000000000000005 112.094 -179.404 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 133' ' ' PRO . . . . . 0.484 ' HD2' ' HG2' ' A' ' 104' ' ' GLU . 52.3 Cg_exo -55.27 -26.61 52.99 Favored 'Trans proline' 0 C--N 1.344 0.311 0 C-N-CA 122.816 2.344 . . . . 1.1699999999999999 112.554 -178.61 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 5.9 p -89.71 -13.05 37.71 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.113 -0.494 . . . . 1.6000000000000001 111.74 -179.32 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 135' ' ' LYS . . . . . 0.509 ' HG2' ' HB ' ' A' ' 95' ' ' VAL . 13.6 mptt . . . . . 0 N--CA 1.464 0.228 0 N-CA-C 111.967 0.358 . . . . 1.21 111.967 -177.746 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 149' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.617 0 N-CA-C 112.081 -0.408 . . . . 0.47999999999999998 112.081 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' B' B ' 150' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -72.5 -2.25 11.49 Favored 'Trans proline' 0 C--O 1.235 0.345 0 C-N-CA 122.797 2.331 . . . . 0.33000000000000002 112.238 -179.188 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 151' ' ' PHE . . . . . 0.636 ' HE1' ' HG3' ' A' ' 73' ' ' LYS . 49.3 m-85 . . . . . 0 C--N 1.326 -0.42 0 CA-C-N 116.006 -0.543 . . . . 0.75 111.236 -179.093 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 50.7 mt-10 . . . . . 0 N--CA 1.451 -0.392 0 N-CA-C 109.147 -0.686 . . . . 3.1000000000000001 109.147 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 1.5 t90 -71.16 107.61 4.27 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 109.444 -0.576 . . . . 0.70999999999999996 109.444 -176.375 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 31.2 m -66.48 -0.65 0.96 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 115.84 -0.618 . . . . 1.45 111.945 -177.444 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.416 HG13 ' HB2' ' A' ' 111' ' ' HIS . 46.5 t -97.73 -24.08 4.45 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-O 121.219 0.533 . . . . 1.1000000000000001 109.788 173.875 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . 0.785 ' HA2' ' HG2' ' A' ' 50' ' ' LYS . . . -73.25 -21.21 79.89 Favored Glycine 0 N--CA 1.45 -0.39 0 CA-C-N 115.81 -0.632 . . . . 0.58999999999999997 112.345 -178.483 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . 0.426 ' HB2' ' HE3' ' A' ' 48' ' ' LYS . 12.3 ptmt -75.13 -25.06 58.15 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 120.863 0.363 . . . . 2.46 110.633 178.847 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -102.67 31.87 3.91 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.205 -0.452 . . . . 1.6599999999999999 110.004 176.694 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . 0.785 ' HG2' ' HA2' ' A' ' 47' ' ' GLY . 8.1 mmmm -72.82 -50.65 7.11 Favored Pre-proline 0 C--O 1.216 -0.673 0 CA-C-O 118.53 -0.747 . . . . 1.1499999999999999 112.253 -178.293 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . 0.58 ' HD2' ' N ' ' A' ' 50' ' ' LYS . 1.4 Cg_endo -44.05 -42.01 12.66 Favored 'Trans proline' 0 C--N 1.36 1.181 0 C-N-CA 122.845 2.363 . . . . 0.75 112.593 -177.397 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 9.5 m -69.73 -45.4 68.24 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.952 -0.567 . . . . 0.68000000000000005 111.119 179.67 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' TYR . . . . . 0.48 ' OH ' ' HA ' ' A' ' 111' ' ' HIS . 12.1 m-30 -76.35 -22.69 54.57 Favored 'General case' 0 C--O 1.219 -0.535 0 CA-C-N 116.486 -0.324 . . . . 0.68999999999999995 110.607 -175.178 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -73.74 -45.05 54.37 Favored 'General case' 0 C--O 1.237 0.425 0 N-CA-C 108.68 -0.859 . . . . 2.1800000000000002 108.68 175.418 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 2.2 tp10 -53.61 -42.26 67.53 Favored 'General case' 0 N--CA 1.455 -0.186 0 CA-C-N 114.675 -1.148 . . . . 2.3300000000000001 110.495 178.2 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 66.1 mt -80.37 -47.09 21.33 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-N 115.668 -0.696 . . . . 0.64000000000000001 111.341 -179.134 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . 0.508 ' HE1' HG12 ' A' ' 67' ' ' ILE . 86.3 t80 -52.31 -37.2 55.2 Favored 'General case' 0 N--CA 1.468 0.457 0 C-N-CA 122.982 0.513 . . . . 0.28999999999999998 112.024 -176.076 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . 0.586 ' HA ' ' HG3' ' A' ' 62' ' ' PRO . 18.5 m-30 -77.24 -17.8 58.16 Favored 'General case' 0 C--N 1.326 -0.424 0 C-N-CA 120.743 -0.383 . . . . 1.1699999999999999 111.421 -174.485 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 41.0 p -85.83 -7.5 58.69 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.283 0.563 . . . . 0.44 110.386 -179.497 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 11.1 mp -95.47 19.16 11.35 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.58 -0.737 . . . . 1.3700000000000001 110.327 179.16 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 12.7 p 49.61 81.46 0.26 Allowed Pre-proline 0 N--CA 1.465 0.317 0 CA-C-N 115.558 -0.746 . . . . 1.24 111.836 -177.515 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . 0.586 ' HG3' ' HA ' ' A' ' 58' ' ' TYR . 72.6 Cg_endo -84.85 116.9 1.91 Allowed 'Trans proline' 0 N--CA 1.455 -0.767 0 C-N-CA 122.659 2.239 . . . . 0.46999999999999997 112.555 -177.744 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 18.7 m -88.76 113.46 25.53 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 CA-C-O 121.26 0.553 . . . . 1.02 110.134 178.011 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 11.7 m120 62.98 28.52 16.3 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 115.485 -0.78 . . . . 1.3400000000000001 111.472 179.4 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 82.01 22.98 58.38 Favored Glycine 0 N--CA 1.454 -0.146 0 C-N-CA 121.072 -0.585 . . . . 0.42999999999999999 112.326 179.404 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . 0.539 ' HG2' ' HA ' ' A' ' 102' ' ' ASP . 26.8 mtpp -143.28 141.05 30.9 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 109.417 -0.586 . . . . 1.48 109.417 -177.886 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . 0.508 HG12 ' HE1' ' A' ' 57' ' ' PHE . 36.6 pt -108.66 154.77 9.86 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.812 0 CA-C-O 121.184 0.516 . . . . 0.64000000000000001 110.975 178.456 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . 0.52 ' HA ' ' CD2' ' A' ' 100' ' ' LEU . 32.2 p -77.6 161.28 27.95 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.171 -0.922 . . . . 0.55000000000000004 111.082 -179.474 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -63.6 -22.52 66.03 Favored Glycine 0 N--CA 1.444 -0.78 0 C-N-CA 121.05 -0.595 . . . . 0.40999999999999998 111.796 179.179 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -61.48 -47.52 85.29 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.898 0.38 . . . . 0.38 111.663 178.367 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 46.1 m-80 -81.29 -31.86 33.44 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.176 -0.465 . . . . 1.8100000000000001 110.976 -175.804 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . 0.519 ' O ' ' HG2' ' A' ' 76' ' ' MET . . . -63.79 -45.21 90.73 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 109.378 -0.601 . . . . 0.39000000000000001 109.378 173.283 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 60.5 tttp -57.03 -37.9 72.4 Favored 'General case' 0 CA--C 1.52 -0.178 0 CA-C-N 115.24 -0.891 . . . . 0.83999999999999997 109.889 175.95 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . 0.415 ' O ' ' HG2' ' A' ' 78' ' ' LYS . 9.0 tptm -57.28 -57.05 14.32 Favored 'General case' 0 N--CA 1.453 -0.298 0 CA-C-N 115.41 -0.814 . . . . 1.95 110.509 177.968 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . 0.583 ' HA ' ' HG3' ' A' ' 78' ' ' LYS . 5.4 tp10 -64.61 -39.46 93.77 Favored 'General case' 0 C--O 1.237 0.434 0 CA-C-O 121.218 0.532 . . . . 1.6000000000000001 110.966 -177.168 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' MET . . . . . 0.638 ' HB3' HD22 ' A' ' 86' ' ' LEU . 96.3 mmm -64.91 -29.39 70.33 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.179 0.514 . . . . 1.24 109.882 178.775 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -75.04 -28.32 20.79 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 CA-C-N 115.985 -0.552 . . . . 1.5700000000000001 110.086 175.672 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.583 ' HG3' ' HA ' ' A' ' 75' ' ' GLU . 3.1 mmmm -68.86 -27.76 66.1 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.802 -0.635 . . . . 2.79 111.211 177.015 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 78.5 p -73.11 -15.67 61.48 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.32 -0.4 . . . . 1.27 111.643 -176.558 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 75.0 mmtt 66.75 16.43 10.38 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-N 115.9 -0.591 . . . . 2.9700000000000002 111.385 178.98 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.426 ' HB2' HD21 ' A' ' 86' ' ' LEU . 93.0 mt -83.82 150.3 58.72 Favored Pre-proline 0 C--N 1.327 -0.374 0 CA-C-N 116.483 -0.326 . . . . 0.52000000000000002 111.032 -179.633 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . 0.536 ' O ' ' HG ' ' A' ' 86' ' ' LEU . 51.2 Cg_exo -55.34 148.15 52.75 Favored 'Trans proline' 0 C--N 1.349 0.601 0 C-N-CA 123.113 2.542 . . . . 0.44 112.698 179.47 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 13.7 m120 -61.43 -36.12 79.48 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.939 -0.573 . . . . 1.8500000000000001 111.448 -174.109 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 15.0 t -66.03 -35.23 79.98 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.949 0.404 . . . . 1.47 110.254 179.243 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 57.4 t -72.29 -37.3 58.18 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.313 0 N-CA-C 109.68 -0.489 . . . . 0.45000000000000001 109.68 178.905 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.638 HD22 ' HB3' ' A' ' 76' ' ' MET . 62.1 mt -61.48 -39.72 91.94 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.883 -0.599 . . . . 0.90000000000000002 109.93 176.587 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -67.19 -39.93 92.45 Favored Glycine 0 N--CA 1.45 -0.378 0 N-CA-C 111.672 -0.571 . . . . 0.32000000000000001 111.672 177.29 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . 0.437 ' O ' ' HG ' ' A' ' 92' ' ' LEU . 29.9 mmmt -58.06 -47.92 81.68 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.996 0.427 . . . . 1.8899999999999999 110.67 175.69 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 0.774 HG23 HD12 ' A' ' 112' ' ' LEU . 74.9 mt -65.27 -40.35 88.32 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 115.811 -0.632 . . . . 0.70999999999999996 110.926 -177.785 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 39.0 t-105 -61.79 -45.16 95.08 Favored 'General case' 0 C--N 1.334 -0.083 0 N-CA-C 110.053 -0.351 . . . . 0.33000000000000002 110.053 175.392 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 4.9 tppp? -58.19 -28.15 64.53 Favored 'General case' 0 CA--C 1.531 0.232 0 CA-C-N 115.686 -0.688 . . . . 2.7000000000000002 111.561 -179.554 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.437 ' HG ' ' O ' ' A' ' 88' ' ' LYS . 73.6 mt -92.39 -36.19 13.28 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.708 0.289 . . . . 1.6599999999999999 111.056 179.396 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -75.22 -42.39 55.59 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.372 -0.377 . . . . 0.46999999999999997 111.404 -175.458 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 45.2 t0 -86.73 75.45 9.64 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.549 0.69 . . . . 0.79000000000000004 109.446 178.954 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 42.8 t -63.56 -40.54 89.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 114.927 -1.033 . . . . 0.60999999999999999 111.255 -174.342 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 30.4 p30 -84.39 -7.47 59.29 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.369 -0.378 . . . . 0.95999999999999996 111.898 -177.838 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 48.0 mtmt 55.86 74.13 0.4 Allowed 'General case' 0 N--CA 1.466 0.369 0 O-C-N 123.503 0.502 . . . . 2.96 111.541 177.904 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . 0.456 ' OD2' ' HB2' ' A' ' 100' ' ' LEU . 7.3 p-10 -128.85 9.26 5.83 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.869 0.366 . . . . 0.42999999999999999 111.068 -177.557 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 69.73 -0.65 19.14 Favored Glycine 0 CA--C 1.522 0.487 0 C-N-CA 121.043 -0.598 . . . . 0.44 113.207 176.538 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.52 ' CD2' ' HA ' ' A' ' 68' ' ' THR . 83.8 mt -129.27 137.37 51.02 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 109.128 -0.693 . . . . 1.1100000000000001 109.128 177.617 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 72.3 mt -90.62 122.44 33.42 Favored 'General case' 0 C--N 1.312 -1.025 0 C-N-CA 120.3 -0.56 . . . . 0.41999999999999998 109.839 178.685 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . 0.539 ' HA ' ' HG2' ' A' ' 66' ' ' LYS . 23.4 m-20 -69.36 173.97 5.28 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 108.263 -1.014 . . . . 1.72 108.263 173.897 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -55.4 -41.44 72.7 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 121.081 0.467 . . . . 1.6000000000000001 110.133 173.755 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -72.54 -40.84 66.43 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.96 -0.564 . . . . 1.6599999999999999 111.406 179.508 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 28.2 mt-10 -70.13 -39.53 75.39 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 120.707 -0.397 . . . . 0.44 111.018 -176.017 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . 0.491 ' CD1' HD11 ' A' ' 67' ' ' ILE . 81.9 t80 -67.07 -37.64 84.37 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 109.952 -0.388 . . . . 0.41999999999999998 109.952 176.275 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -58.3 -43.91 88.31 Favored 'General case' 0 N--CA 1.452 -0.342 0 CA-C-N 116.147 -0.479 . . . . 0.22 110.406 175.885 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 6.3 tt -60.35 -48.11 83.17 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.154 -0.476 . . . . 1.3300000000000001 110.098 178.779 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -58.53 -49.47 77.29 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.082 -0.508 . . . . 0.32000000000000001 110.943 179.063 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' ASN . . . . . 0.471 HD21 ' HG2' ' A' ' 75' ' ' GLU . 0.5 OUTLIER -63.57 -31.42 72.58 Favored 'General case' 0 CA--C 1.519 -0.245 0 CA-C-N 115.915 -0.584 . . . . 1.2 111.201 179.737 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' HIS . . . . . 0.48 ' HA ' ' OH ' ' A' ' 53' ' ' TYR . 32.0 t60 -66.93 -40.57 87.65 Favored 'General case' 0 N--CA 1.453 -0.302 0 N-CA-C 109.952 -0.388 . . . . 0.52000000000000002 109.952 179.388 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 0.774 HD12 HG23 ' A' ' 89' ' ' ILE . 98.3 mt -65.29 -39.54 92.66 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.658 -0.246 . . . . 0.55000000000000004 110.448 177.519 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.526 HD11 ' SD ' ' A' ' 76' ' ' MET . 61.2 mt -60.3 -52.35 62.42 Favored 'Isoleucine or valine' 0 C--O 1.233 0.219 0 CA-C-O 121.104 0.478 . . . . 0.83999999999999997 110.192 175.424 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 114' ' ' LYS . . . . . 0.546 ' O ' ' HB2' ' A' ' 118' ' ' GLU . 0.4 OUTLIER -65.02 -39.45 93.4 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.492 -0.776 . . . . 3.8300000000000001 111.075 -174.804 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . 0.401 HG23 ' O ' ' A' ' 111' ' ' HIS . 51.7 t -69.73 -45.03 78.67 Favored 'Isoleucine or valine' 0 C--O 1.234 0.248 0 CA-C-N 116.639 -0.255 . . . . 1.1899999999999999 111.567 -178.032 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 35.8 tptt -60.52 -45.76 92.64 Favored 'General case' 0 N--CA 1.454 -0.267 0 CA-C-O 120.981 0.42 . . . . 1.3200000000000001 110.676 176.92 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 94.4 mt -74.34 -16.06 60.92 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.306 -0.406 . . . . 0.95999999999999996 111.208 -179.4 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . 0.657 ' HB3' ' HD2' ' A' ' 120' ' ' HIS . 22.6 tt0 -80.02 0.89 29.82 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.914 -0.584 . . . . 2.1800000000000002 109.664 176.22 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 91.81 15.76 53.59 Favored Glycine 0 N--CA 1.451 -0.319 0 CA-C-N 115.839 -0.619 . . . . 1.1599999999999999 112.834 175.378 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 120' ' ' HIS . . . . . 0.657 ' HD2' ' HB3' ' A' ' 118' ' ' GLU . 61.6 m-70 -106.08 160.3 15.41 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 110.095 -0.335 . . . . 2.4199999999999999 110.095 179.903 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 8.0 tp10 -96.63 149.25 22.0 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 121.001 0.429 . . . . 2.5299999999999998 110.377 179.275 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . 0.434 ' O ' HD12 ' A' ' 122' ' ' LEU . 2.4 pp -114.06 143.67 30.11 Favored Pre-proline 0 C--N 1.321 -0.645 0 CA-C-N 115.92 -0.582 . . . . 1.3300000000000001 109.767 177.304 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 63.1 Cg_endo -74.09 -12.03 23.43 Favored 'Trans proline' 0 N--CA 1.465 -0.166 0 C-N-CA 122.298 1.998 . . . . 1.3300000000000001 113.036 -176.372 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . 62.92 18.07 10.53 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-N 115.823 -0.626 . . . . 1.25 110.337 -175.029 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -134.01 176.09 8.89 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.045 -0.98 . . . . 2.73 108.61 175.773 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . 0.469 ' HA ' ' HD2' ' A' ' 127' ' ' PRO . 4.2 tt -113.06 100.37 51.15 Favored Pre-proline 0 C--N 1.322 -0.61 0 C-N-CA 120.786 -0.365 . . . . 1.6599999999999999 110.542 -178.062 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 127' ' ' PRO . . . . . 0.755 ' HG2' ' HB2' ' A' ' 130' ' ' LEU . 19.5 Cg_endo -58.98 151.17 67.7 Favored 'Trans proline' 0 C--N 1.347 0.496 0 C-N-CA 123.435 2.757 . . . . 1.1699999999999999 112.645 176.624 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -58.38 -28.63 85.65 Favored 'Trans proline' 0 C--N 1.346 0.446 0 C-N-CA 123.329 2.686 . . . . 1.54 113.315 -175.608 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 4.1 p-80 -91.34 4.9 51.25 Favored 'General case' 0 C--N 1.329 -0.316 0 C-N-CA 120.836 -0.346 . . . . 1.0700000000000001 111.226 -178.512 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . 0.755 ' HB2' ' HG2' ' A' ' 127' ' ' PRO . 41.7 tp -104.65 -2.95 24.35 Favored 'General case' 0 N--CA 1.444 -0.75 0 CA-C-O 121.185 0.517 . . . . 1.3600000000000001 110.248 -177.121 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . 0.445 ' HA ' ' HD2' ' A' ' 132' ' ' PRO . 29.9 t -72.84 125.99 90.85 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 115.779 -0.646 . . . . 1.28 109.907 177.562 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 132' ' ' PRO . . . . . 0.445 ' HD2' ' HA ' ' A' ' 131' ' ' VAL . 3.8 Cg_endo -47.69 136.02 21.76 Favored 'Trans proline' 0 C--O 1.236 0.414 0 C-N-CA 123.074 2.516 . . . . 0.81000000000000005 111.797 176.653 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 23.6 Cg_endo -60.81 -15.34 37.34 Favored 'Trans proline' 0 C--N 1.343 0.288 0 C-N-CA 123.222 2.615 . . . . 1.1699999999999999 112.633 -174.525 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 19.7 p -90.35 -21.63 21.9 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.166 -0.47 . . . . 1.6000000000000001 111.366 -179.451 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 62.8 mttt . . . . . 0 C--N 1.327 -0.404 0 CA-C-O 120.782 0.325 . . . . 1.21 111.555 -172.23 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' B' B ' 149' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.445 -0.726 0 N-CA-C 111.712 -0.555 . . . . 0.47999999999999998 111.712 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' B' B ' 150' ' ' PRO . . . . . . . . . . . . . 91.8 Cg_endo -80.85 -1.52 11.28 Favored 'Trans proline' 0 CA--C 1.532 0.424 0 C-N-CA 123.176 2.584 . . . . 0.33000000000000002 112.571 -178.631 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 151' ' ' PHE . . . . . 0.571 ' CZ ' ' HG3' ' A' ' 76' ' ' MET . 37.8 m-85 . . . . . 0 C--N 1.329 -0.314 0 CA-C-N 115.996 -0.547 . . . . 0.75 111.327 -178.388 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 16.8 pt-20 . . . . . 0 C--O 1.235 0.296 0 CA-C-O 121.214 0.53 . . . . 3.1000000000000001 111.386 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' TRP . . . . . 0.433 ' HH2' ' O ' ' A' ' 104' ' ' GLU . 1.3 t90 -86.07 105.15 16.3 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 109.495 -0.557 . . . . 0.70999999999999996 109.495 -178.612 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 23.6 m -64.82 -11.33 11.01 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.335 0 CA-C-O 121.034 0.445 . . . . 1.45 111.961 -177.292 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.473 HG13 ' HB2' ' A' ' 111' ' ' HIS . 42.1 t -82.04 -16.43 11.89 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 CA-C-O 121.31 0.576 . . . . 1.1000000000000001 110.261 177.331 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . 0.53 ' HA2' ' HB2' ' A' ' 50' ' ' LYS . . . -74.25 -11.17 82.07 Favored Glycine 0 N--CA 1.446 -0.638 0 CA-C-N 115.684 -0.689 . . . . 0.58999999999999997 112.701 -178.68 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 17.2 pttt -82.95 -28.44 29.82 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 120.347 -0.541 . . . . 2.46 109.978 -179.041 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 12.9 m-20 -106.77 30.75 5.83 Favored 'General case' 0 CA--C 1.509 -0.622 0 N-CA-C 108.593 -0.892 . . . . 1.6599999999999999 108.593 176.972 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . 0.598 ' H ' ' HD2' ' A' ' 51' ' ' PRO . 15.0 tttp -92.0 -52.86 0.28 Allowed Pre-proline 0 C--N 1.317 -0.827 0 N-CA-C 112.521 0.563 . . . . 1.1499999999999999 112.521 -171.207 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . 0.598 ' HD2' ' H ' ' A' ' 50' ' ' LYS . 4.8 Cg_endo -47.03 -39.54 25.46 Favored 'Trans proline' 0 C--N 1.357 0.998 0 C-N-CA 122.738 2.292 . . . . 0.75 112.981 -178.078 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 18.8 m -70.14 -42.77 72.13 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 116.003 -0.544 . . . . 0.68000000000000005 110.55 -179.485 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 21.3 m-30 -71.74 -22.53 61.6 Favored 'General case' 0 CA--C 1.517 -0.312 0 CA-C-N 116.314 -0.403 . . . . 0.68999999999999995 110.222 179.558 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 86.8 m-20 -72.96 -36.26 67.09 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.183 -0.462 . . . . 2.1800000000000002 109.785 176.682 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . 0.469 ' HG3' ' O ' ' A' ' 51' ' ' PRO . 48.1 mt-10 -66.12 -40.75 90.93 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.017 -0.538 . . . . 2.3300000000000001 110.472 176.659 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 44.8 mt -69.39 -37.38 75.25 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-O 121.582 0.706 . . . . 0.64000000000000001 109.964 175.781 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . 0.483 ' HE1' HG12 ' A' ' 67' ' ' ILE . 78.2 t80 -59.62 -36.79 77.03 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.171 -0.922 . . . . 0.28999999999999998 110.971 176.988 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . 0.519 ' HA ' ' HG3' ' A' ' 62' ' ' PRO . 14.2 m-30 -74.35 -23.38 59.01 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.481 -0.327 . . . . 1.1699999999999999 111.047 -178.689 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 19.0 p -89.76 6.77 40.13 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 120.978 0.418 . . . . 0.44 111.371 -179.15 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 59.9 mt -105.38 5.75 32.04 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.121 -0.49 . . . . 1.3700000000000001 110.193 173.956 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 19.2 m 66.42 82.7 0.2 Allowed Pre-proline 0 CA--C 1.532 0.276 0 CA-C-N 115.266 -0.879 . . . . 1.24 111.519 178.571 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . 0.519 ' HG3' ' HA ' ' A' ' 58' ' ' TYR . 36.7 Cg_endo -93.53 138.51 1.38 Allowed 'Trans proline' 0 N--CA 1.453 -0.885 0 C-N-CA 123.288 2.659 . . . . 0.46999999999999997 113.162 -178.837 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 18.9 m -119.42 134.06 64.22 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 115.892 -0.595 . . . . 1.02 109.555 174.816 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 83.6 m-20 59.27 30.65 20.43 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-O 121.015 0.436 . . . . 1.3400000000000001 110.986 -176.859 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 69.92 25.46 75.55 Favored Glycine 0 C--N 1.332 0.339 0 CA-C-N 115.959 -0.564 . . . . 0.42999999999999999 112.598 178.47 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . 0.631 ' HA ' ' HA ' ' A' ' 102' ' ' ASP . 3.0 ptpp? -152.13 145.88 25.07 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.055 0.455 . . . . 1.48 111.425 179.528 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . 0.483 HG12 ' HE1' ' A' ' 57' ' ' PHE . 34.3 pt -107.9 142.77 19.73 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-N 116.078 -0.51 . . . . 0.64000000000000001 109.766 176.887 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . 0.703 ' HA ' ' HB2' ' A' ' 100' ' ' LEU . 23.2 p -64.51 161.4 17.37 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 116.382 -0.372 . . . . 0.55000000000000004 110.455 177.638 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -62.3 -12.43 38.44 Favored Glycine 0 N--CA 1.448 -0.548 0 C-N-CA 120.78 -0.724 . . . . 0.40999999999999998 112.24 -178.634 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.459 ' O ' ' HG3' ' A' ' 74' ' ' LYS . . . -68.16 -50.04 57.09 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.326 0.584 . . . . 0.38 110.63 179.573 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . 0.933 ' HA ' ' HE3' ' A' ' 74' ' ' LYS . 35.0 m-80 -72.92 -38.84 66.71 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.564 -0.743 . . . . 1.8100000000000001 110.32 -177.758 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -61.94 -41.63 98.17 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.69 -0.686 . . . . 0.39000000000000001 110.097 176.766 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . 0.513 ' HG3' ' CE1' ' B' ' 151' ' ' PHE . 86.0 tttt -59.21 -43.06 92.29 Favored 'General case' 0 CA--C 1.519 -0.234 0 CA-C-N 115.964 -0.562 . . . . 0.83999999999999997 110.216 176.639 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . 0.933 ' HE3' ' HA ' ' A' ' 71' ' ' ASN . 8.5 mtmp? -58.24 -42.03 85.45 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-N 116.318 -0.401 . . . . 1.95 111.091 179.114 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 15.4 tp10 -66.74 -44.92 80.24 Favored 'General case' 0 C--O 1.237 0.396 0 CA-C-O 121.476 0.655 . . . . 1.6000000000000001 110.732 179.154 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' MET . . . . . 0.591 ' HB3' HD22 ' A' ' 86' ' ' LEU . 84.8 mtp -73.11 -21.9 60.66 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.78 -0.645 . . . . 1.24 111.687 -174.423 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.404 HG22 ' O ' ' A' ' 73' ' ' LYS . 34.5 m -86.21 -12.32 11.08 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.455 0 C-N-CA 120.408 -0.517 . . . . 1.5700000000000001 110.363 171.054 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.75 ' HG2' ' O ' ' A' ' 74' ' ' LYS . 40.6 mmtm -75.78 -26.93 57.78 Favored 'General case' 0 N--CA 1.469 0.498 0 N-CA-C 110.244 -0.28 . . . . 2.79 110.244 170.439 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -72.88 -11.62 60.66 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-O 120.798 0.332 . . . . 1.27 110.39 172.069 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . 0.406 ' HG3' ' O ' ' A' ' 78' ' ' LYS . 73.3 mttt 65.38 24.28 12.03 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-N 115.596 -0.729 . . . . 2.9700000000000002 112.392 169.63 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.627 ' HB2' HD21 ' A' ' 86' ' ' LEU . 91.6 mt -83.77 161.86 54.57 Favored Pre-proline 0 C--N 1.325 -0.483 0 CA-C-N 116.302 -0.408 . . . . 0.52000000000000002 110.786 179.763 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . 0.433 ' O ' ' HG ' ' A' ' 86' ' ' LEU . 52.1 Cg_exo -57.73 142.16 95.87 Favored 'Trans proline' 0 C--N 1.349 0.576 0 C-N-CA 123.073 2.515 . . . . 0.44 112.812 177.558 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 31.4 m-80 -59.03 -43.62 91.65 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 115.769 -0.65 . . . . 1.8500000000000001 111.636 -175.237 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 2.9 p -63.64 -44.7 93.11 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.055 -0.52 . . . . 1.47 111.113 -179.208 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 60.6 t -64.18 -40.6 89.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 115.872 -0.604 . . . . 0.45000000000000001 110.241 178.886 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.627 HD21 ' HB2' ' A' ' 81' ' ' LEU . 92.3 mt -59.57 -38.43 81.13 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.178 -0.465 . . . . 0.90000000000000002 110.764 176.529 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -67.38 -37.61 90.57 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.686 -0.769 . . . . 0.32000000000000001 112.24 178.386 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.21 -43.3 95.42 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 120.766 -0.374 . . . . 1.8899999999999999 110.081 174.651 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 20.9 mt -62.37 -35.07 67.69 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.312 0 CA-C-N 116.07 -0.513 . . . . 0.70999999999999996 110.387 175.831 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 71.4 t-105 -57.44 -53.93 52.59 Favored 'General case' 0 N--CA 1.452 -0.342 0 CA-C-O 120.561 0.219 . . . . 0.33000000000000002 110.623 175.739 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . 0.819 ' HE2' ' HA ' ' A' ' 91' ' ' LYS . 0.6 OUTLIER -69.3 -15.57 63.37 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.989 0.423 . . . . 2.7000000000000002 111.1 -176.989 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.42 HD22 ' HA ' ' A' ' 124' ' ' ALA . 14.8 tp -88.4 -32.06 18.53 Favored 'General case' 0 N--CA 1.437 -1.09 0 CA-C-O 120.89 0.376 . . . . 1.6599999999999999 110.006 178.2 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . 0.761 ' HA ' HD12 ' A' ' 108' ' ' LEU . . . -87.89 -42.99 12.13 Favored 'General case' 0 C--O 1.232 0.184 0 CA-C-N 116.451 -0.34 . . . . 0.46999999999999997 111.583 -179.571 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . 0.561 ' OD2' ' HA ' ' A' ' 97' ' ' LYS . 28.1 t0 -82.81 99.9 9.98 Favored 'General case' 0 C--O 1.236 0.376 0 CA-C-O 121.555 0.693 . . . . 0.79000000000000004 110.029 179.667 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 45.3 t -83.09 -43.42 18.4 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.739 0 CA-C-N 115.282 -0.872 . . . . 0.60999999999999999 110.883 -174.512 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 34.6 p-10 -82.63 -10.44 58.95 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.961 -0.563 . . . . 0.95999999999999996 111.779 -173.666 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . 0.561 ' HA ' ' OD2' ' A' ' 94' ' ' ASP . 42.7 mtpt 57.91 73.0 0.49 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.402 0.62 . . . . 2.96 111.922 178.951 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . 0.491 ' OD2' ' HG ' ' A' ' 100' ' ' LEU . 16.9 p-10 -121.64 9.98 10.28 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 115.395 -0.82 . . . . 0.42999999999999999 110.196 176.334 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 64.2 18.05 62.27 Favored Glycine 0 C--N 1.333 0.401 0 CA-C-N 115.713 -0.676 . . . . 0.44 112.208 177.706 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.703 ' HB2' ' HA ' ' A' ' 68' ' ' THR . 1.7 pp -155.02 166.32 33.95 Favored 'General case' 0 N--CA 1.444 -0.748 0 N-CA-C 108.468 -0.938 . . . . 1.1100000000000001 108.468 -179.373 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 87.6 mt -126.44 123.66 38.36 Favored 'General case' 0 C--N 1.322 -0.615 0 C-N-CA 120.832 -0.347 . . . . 0.41999999999999998 111.228 -173.581 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . 0.631 ' HA ' ' HA ' ' A' ' 66' ' ' LYS . 2.3 p30 -79.75 -177.1 5.73 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 109.31 -0.626 . . . . 1.72 109.31 170.906 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 3.1 p30 -62.12 -29.39 70.3 Favored 'General case' 0 C--N 1.322 -0.63 0 C-N-CA 120.905 -0.318 . . . . 1.6000000000000001 111.503 -174.694 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . 0.515 ' HB3' ' HB3' ' A' ' 132' ' ' PRO . 78.3 mt-10 -70.97 -56.24 6.62 Favored 'General case' 0 C--O 1.232 0.178 0 N-CA-C 109.823 -0.436 . . . . 1.6599999999999999 109.823 177.545 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 25.3 mt-10 -65.52 -33.33 75.68 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.838 -0.619 . . . . 0.44 110.977 -174.645 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 90.8 t80 -69.23 -42.96 74.99 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.53 -0.305 . . . . 0.41999999999999998 110.235 178.13 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -59.95 -39.15 84.6 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-O 121.121 0.486 . . . . 0.22 110.092 176.35 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.761 HD12 ' HA ' ' A' ' 93' ' ' ALA . 2.5 tm? -59.99 -51.69 68.6 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.625 -0.716 . . . . 1.3300000000000001 109.492 176.862 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . 0.429 ' O ' HG13 ' A' ' 113' ' ' ILE . . . -57.61 -45.37 85.43 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 115.965 -0.562 . . . . 0.32000000000000001 111.62 179.456 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -69.38 -30.99 69.1 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.741 0.305 . . . . 1.2 111.244 -178.588 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' HIS . . . . . 0.473 ' HB2' HG13 ' A' ' 46' ' ' VAL . 30.3 t60 -64.55 -35.15 80.04 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 108.862 -0.792 . . . . 0.52000000000000002 108.862 175.426 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 0.498 ' HA ' HG12 ' A' ' 115' ' ' VAL . 74.8 mt -71.18 -42.63 68.79 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.399 -0.818 . . . . 0.55000000000000004 110.797 177.303 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.429 HG13 ' O ' ' A' ' 109' ' ' ALA . 24.6 mt -55.52 -50.28 67.51 Favored 'Isoleucine or valine' 0 C--O 1.234 0.26 0 CA-C-O 121.209 0.528 . . . . 0.83999999999999997 110.44 177.859 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 37.3 ttpt -69.95 -45.4 67.51 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.729 -0.669 . . . . 3.8300000000000001 110.997 -175.417 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . 0.498 HG12 ' HA ' ' A' ' 112' ' ' LEU . 5.8 p -63.48 -30.61 50.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 120.95 0.405 . . . . 1.1899999999999999 110.207 -178.557 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 116' ' ' LYS . . . . . 0.477 ' HD2' ' O ' ' A' ' 120' ' ' HIS . 34.6 tptt -69.28 -45.81 68.72 Favored 'General case' 0 N--CA 1.447 -0.61 0 CA-C-N 116.204 -0.453 . . . . 1.3200000000000001 110.513 176.786 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 93.9 mt -74.56 -16.28 60.82 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.11 -0.496 . . . . 0.95999999999999996 111.305 -179.198 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -84.47 6.05 25.0 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.594 0.711 . . . . 2.1800000000000002 109.35 176.52 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 90.34 33.92 8.39 Favored Glycine 0 CA--C 1.518 0.272 0 CA-C-N 115.47 -0.786 . . . . 1.1599999999999999 113.927 172.666 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 120' ' ' HIS . . . . . 0.477 ' O ' ' HD2' ' A' ' 116' ' ' LYS . 33.4 m-70 -112.62 155.36 24.55 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 117.04 0.42 . . . . 2.4199999999999999 110.341 175.044 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 7.4 tp10 -111.52 127.98 55.88 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 109.864 -0.421 . . . . 2.5299999999999998 109.864 179.167 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . 0.436 ' H ' ' HG ' ' A' ' 122' ' ' LEU . 2.4 pp -92.86 136.92 24.27 Favored Pre-proline 0 C--N 1.321 -0.637 0 CA-C-O 121.108 0.48 . . . . 1.3300000000000001 111.761 -174.844 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_endo -73.42 -20.74 20.53 Favored 'Trans proline' 0 C--O 1.234 0.294 0 C-N-CA 123.147 2.564 . . . . 1.3300000000000001 112.423 179.266 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . 0.42 ' HA ' HD22 ' A' ' 92' ' ' LEU . . . 66.78 18.26 10.66 Favored 'General case' 0 N--CA 1.462 0.138 0 CA-C-N 115.297 -0.865 . . . . 1.25 110.092 -172.712 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 29.0 m-20 -106.14 159.74 15.85 Favored 'General case' 0 CA--C 1.516 -0.341 0 N-CA-C 108.015 -1.105 . . . . 2.73 108.015 172.445 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . 0.455 ' HA ' ' HD2' ' A' ' 127' ' ' PRO . 49.2 tp -114.44 91.98 26.44 Favored Pre-proline 0 C--N 1.322 -0.601 0 C-N-CA 120.609 -0.436 . . . . 1.6599999999999999 111.713 -176.982 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 127' ' ' PRO . . . . . 0.458 ' HA ' ' HD3' ' A' ' 128' ' ' PRO . 10.9 Cg_endo -58.5 146.45 90.64 Favored 'Trans proline' 0 CA--C 1.535 0.548 0 C-N-CA 122.836 2.357 . . . . 1.1699999999999999 112.138 171.883 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 128' ' ' PRO . . . . . 0.458 ' HD3' ' HA ' ' A' ' 127' ' ' PRO . 76.0 Cg_exo -51.77 -39.47 67.28 Favored 'Trans proline' 0 C--N 1.346 0.435 0 C-N-CA 123.842 3.028 . . . . 1.54 114.27 -175.31 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 41.6 p-80 -79.0 13.67 1.68 Allowed 'General case' 0 N--CA 1.469 0.513 0 N-CA-C 112.463 0.542 . . . . 1.0700000000000001 112.463 -175.368 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 41.3 mt -111.8 4.21 18.25 Favored 'General case' 0 C--N 1.324 -0.501 0 C-N-CA 121.181 -0.208 . . . . 1.3600000000000001 111.131 175.198 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 93.8 t -75.27 126.57 87.68 Favored Pre-proline 0 C--N 1.327 -0.37 0 CA-C-O 120.694 0.283 . . . . 1.28 110.923 -179.788 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 132' ' ' PRO . . . . . 0.515 ' HB3' ' HB3' ' A' ' 104' ' ' GLU . 54.4 Cg_exo -54.88 154.61 20.79 Favored 'Trans proline' 0 CA--C 1.533 0.455 0 C-N-CA 123.472 2.781 . . . . 0.81000000000000005 113.316 -179.583 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -54.84 -54.55 4.3 Favored 'Trans proline' 0 C--N 1.347 0.468 0 C-N-CA 123.516 2.811 . . . . 1.1699999999999999 113.987 -175.979 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 72.6 p -84.87 8.04 18.82 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 120.676 -0.41 . . . . 1.6000000000000001 111.536 -175.464 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 135' ' ' LYS . . . . . 0.496 ' HD2' ' HG2' ' A' ' 132' ' ' PRO . 61.5 mttp . . . . . 0 C--N 1.329 -0.3 0 N-CA-C 111.876 0.324 . . . . 1.21 111.876 -177.411 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 149' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.443 -0.86 0 N-CA-C 111.277 -0.729 . . . . 0.47999999999999998 111.277 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' B' B ' 150' ' ' PRO . . . . . . . . . . . . . 76.0 Cg_endo -74.77 -8.13 20.01 Favored 'Trans proline' 0 N--CA 1.463 -0.28 0 C-N-CA 122.448 2.099 . . . . 0.33000000000000002 111.351 -179.187 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 151' ' ' PHE . . . . . 0.513 ' CE1' ' HG3' ' A' ' 73' ' ' LYS . 48.7 m-85 . . . . . 0 C--N 1.327 -0.381 0 CA-C-N 115.904 -0.589 . . . . 0.75 110.952 179.245 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 . . . . . 0 C--O 1.234 0.259 0 N-CA-C 109.404 -0.591 . . . . 3.1000000000000001 109.404 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' TRP . . . . . 0.486 ' HH2' ' O ' ' A' ' 104' ' ' GLU . 3.2 t90 -85.6 109.41 18.53 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 120.967 0.413 . . . . 0.70999999999999996 110.095 -178.034 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 11.7 p -63.12 -17.62 19.91 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.433 0 CA-C-N 115.671 -0.695 . . . . 1.45 111.909 -175.822 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.4 HG11 ' HA ' ' A' ' 108' ' ' LEU . 46.9 t -82.06 -22.25 9.79 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-O 121.151 0.5 . . . . 1.1000000000000001 110.425 179.105 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . 0.711 ' HA2' ' HG3' ' A' ' 50' ' ' LYS . . . -73.31 -11.91 79.74 Favored Glycine 0 CA--C 1.517 0.161 0 CA-C-N 115.739 -0.664 . . . . 0.58999999999999997 113.481 -173.232 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 21.9 ptmt -77.83 -19.59 54.65 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.854 0.327 . . . . 2.46 111.158 -176.927 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 42.7 t0 -117.35 33.88 5.4 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.863 0.839 . . . . 1.6599999999999999 109.503 179.956 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . 0.711 ' HG3' ' HA2' ' A' ' 47' ' ' GLY . 24.1 mtpt -69.18 -42.0 20.15 Favored Pre-proline 0 C--O 1.22 -0.454 0 CA-C-N 115.652 -0.704 . . . . 1.1499999999999999 112.793 -179.601 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_exo -44.21 -41.33 13.06 Favored 'Trans proline' 0 C--N 1.359 1.082 0 C-N-CA 122.202 1.935 . . . . 0.75 112.733 176.699 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 15.4 m -70.44 -45.5 65.69 Favored 'General case' 0 C--O 1.238 0.456 0 CA-C-N 116.203 -0.453 . . . . 0.68000000000000005 111.156 -179.277 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 7.2 m-85 -74.12 -22.01 59.64 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.534 -0.303 . . . . 0.68999999999999995 110.589 -176.998 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -76.09 -39.72 54.68 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 108.932 -0.766 . . . . 2.1800000000000002 108.932 178.007 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 44.4 tt0 -58.38 -47.86 82.48 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.241 -0.89 . . . . 2.3300000000000001 110.218 175.282 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 55.7 mt -67.45 -52.09 45.36 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 115.644 -0.707 . . . . 0.64000000000000001 111.384 179.697 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . 0.583 ' HE1' HG12 ' A' ' 67' ' ' ILE . 72.7 t80 -55.65 -32.57 63.3 Favored 'General case' 0 C--N 1.326 -0.435 0 C-N-CA 122.872 0.469 . . . . 0.28999999999999998 112.017 -176.695 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . 0.434 ' CE1' ' HD2' ' A' ' 57' ' ' PHE . 2.6 m-85 -88.52 -2.23 58.48 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 111.835 0.309 . . . . 1.1699999999999999 111.835 -176.416 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 79.0 p -100.36 -12.69 19.22 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.18 0.514 . . . . 0.44 109.99 173.476 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 10.4 mp -88.42 6.62 36.64 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.687 -0.688 . . . . 1.3700000000000001 110.768 177.885 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 52.0 m 62.87 83.6 0.2 Allowed Pre-proline 0 CA--C 1.531 0.212 0 CA-C-N 115.558 -0.746 . . . . 1.24 111.203 -178.6 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 75.2 Cg_endo -83.36 137.16 8.02 Favored 'Trans proline' 0 N--CA 1.458 -0.598 0 C-N-CA 122.763 2.309 . . . . 0.46999999999999997 112.893 -178.157 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 47.4 t -104.71 103.82 15.89 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 CA-C-N 116.105 -0.498 . . . . 1.02 110.25 178.191 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 93.2 m-20 60.57 25.78 15.47 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-N 116.042 -0.527 . . . . 1.3400000000000001 111.605 177.497 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 92.54 17.46 45.38 Favored Glycine 0 C--O 1.227 -0.303 0 C-N-CA 120.788 -0.72 . . . . 0.42999999999999999 112.712 178.533 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . 0.636 ' HA ' ' HA ' ' A' ' 102' ' ' ASP . 59.4 mttm -141.41 134.64 29.42 Favored 'General case' 0 C--N 1.324 -0.532 0 C-N-CA 122.95 0.5 . . . . 1.48 110.242 177.734 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . 0.583 HG12 ' HE1' ' A' ' 57' ' ' PHE . 30.0 pt -103.25 150.57 6.7 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 N-CA-C 110.197 -0.297 . . . . 0.64000000000000001 110.197 173.321 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 59.3 p -73.62 166.3 23.51 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.272 -0.422 . . . . 0.55000000000000004 111.078 -176.307 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -68.06 -18.82 71.32 Favored Glycine 0 N--CA 1.447 -0.622 0 C-N-CA 120.801 -0.714 . . . . 0.40999999999999998 112.162 178.265 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -74.28 -39.52 62.9 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.374 0.607 . . . . 0.38 110.294 176.126 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 12.3 m120 -73.45 -41.36 63.3 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.686 -0.688 . . . . 1.8100000000000001 109.309 178.771 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -62.05 -37.63 85.68 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.232 -0.895 . . . . 0.39000000000000001 110.248 174.153 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . 0.452 ' O ' HG23 ' A' ' 77' ' ' VAL . 22.8 ttmm -55.74 -52.02 65.34 Favored 'General case' 0 C--O 1.221 -0.404 0 CA-C-N 115.86 -0.609 . . . . 0.83999999999999997 109.862 174.66 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . 0.438 ' O ' ' HG2' ' A' ' 78' ' ' LYS . 68.4 mttm -54.95 -46.23 74.99 Favored 'General case' 0 C--N 1.329 -0.321 0 O-C-N 123.38 0.425 . . . . 1.95 111.389 -179.395 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 20.7 tp10 -63.75 -49.72 71.9 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.838 0.352 . . . . 1.6000000000000001 110.895 -179.401 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' MET . . . . . 0.748 ' HB3' HD22 ' A' ' 86' ' ' LEU . 96.5 mmm -66.54 -27.91 68.12 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.247 0.546 . . . . 1.24 111.285 -178.34 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.452 HG23 ' O ' ' A' ' 73' ' ' LYS . 37.2 t -71.65 -34.53 52.64 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-N 115.907 -0.588 . . . . 1.5700000000000001 110.044 175.066 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.438 ' HG2' ' O ' ' A' ' 74' ' ' LYS . 29.5 mmmt -69.85 -22.46 63.26 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.925 -0.579 . . . . 2.79 110.277 174.872 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . 0.449 ' C ' ' HG2' ' A' ' 80' ' ' LYS . 15.7 m -76.02 -4.81 43.33 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.951 -0.568 . . . . 1.27 110.711 178.333 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . 0.449 ' HG2' ' C ' ' A' ' 79' ' ' SER . 18.5 ptmt 47.2 32.6 2.14 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 124.07 0.948 . . . . 2.9700000000000002 112.863 175.821 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.4 ' HB2' HD21 ' A' ' 86' ' ' LEU . 85.7 mt -97.22 150.16 36.51 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 116.094 -0.503 . . . . 0.52000000000000002 110.089 176.487 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . 0.508 ' O ' ' HG ' ' A' ' 86' ' ' LEU . 52.9 Cg_exo -55.51 145.39 69.27 Favored 'Trans proline' 0 C--O 1.234 0.293 0 C-N-CA 122.658 2.239 . . . . 0.44 112.347 179.636 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 21.1 p-10 -55.21 -41.71 72.39 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-N 116.35 -0.387 . . . . 1.8500000000000001 111.693 -177.046 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 9.4 m -55.06 -45.87 75.36 Favored 'General case' 0 N--CA 1.448 -0.542 0 CA-C-N 115.821 -0.627 . . . . 1.47 110.748 177.826 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 80.5 t -72.28 -32.04 41.22 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.177 0 CA-C-N 115.902 -0.59 . . . . 0.45000000000000001 110.891 -179.821 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.748 HD22 ' HB3' ' A' ' 76' ' ' MET . 80.4 mt -61.78 -43.66 98.42 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 110.079 -0.341 . . . . 0.90000000000000002 110.079 175.906 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -66.88 -34.35 86.87 Favored Glycine 0 N--CA 1.452 -0.299 0 N-CA-C 111.511 -0.635 . . . . 0.32000000000000001 111.511 178.09 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . 0.489 ' O ' HD23 ' A' ' 92' ' ' LEU . 35.5 mmtm -58.12 -58.69 7.35 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.946 0.403 . . . . 1.8899999999999999 110.124 174.189 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 56.0 mt -62.11 -35.22 67.57 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 115.747 -0.661 . . . . 0.70999999999999996 110.932 -177.483 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 50.7 t-105 -58.02 -49.03 78.28 Favored 'General case' 0 C--O 1.223 -0.325 0 C-N-CA 120.707 -0.397 . . . . 0.33000000000000002 110.293 175.287 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 20.8 ttmm -61.95 -39.84 93.48 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.298 -0.41 . . . . 2.7000000000000002 111.7 -177.526 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.83 HD12 ' HG ' ' A' ' 126' ' ' LEU . 4.3 mm? -76.74 -24.55 53.01 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 111.888 0.329 . . . . 1.6599999999999999 111.888 -179.253 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -93.05 -42.21 9.55 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.648 0.261 . . . . 0.46999999999999997 111.618 -178.291 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . 0.476 ' OD2' ' HA ' ' A' ' 97' ' ' LYS . 30.8 t0 -82.66 87.16 6.74 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.51 0.671 . . . . 0.79000000000000004 109.484 179.674 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 47.4 t -80.77 -34.75 14.27 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 CA-C-N 115.197 -0.911 . . . . 0.60999999999999999 110.718 -174.271 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 48.4 p-10 -82.43 -13.92 55.99 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.503 -0.317 . . . . 0.95999999999999996 110.453 -179.294 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . 0.476 ' HA ' ' OD2' ' A' ' 94' ' ' ASP . 31.7 mtmm 57.72 54.74 6.03 Favored 'General case' 0 C--O 1.231 0.118 0 O-C-N 123.778 0.674 . . . . 2.96 110.816 173.614 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . 0.413 ' O ' HD12 ' A' ' 100' ' ' LEU . 16.2 p-10 -110.2 8.66 23.77 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.59 -0.732 . . . . 0.42999999999999999 110.891 -174.775 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 71.64 7.08 64.19 Favored Glycine 0 N--CA 1.453 -0.205 0 C-N-CA 120.633 -0.794 . . . . 0.44 112.429 179.717 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.413 HD12 ' O ' ' A' ' 98' ' ' ASP . 4.3 mp -135.04 155.18 51.2 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 109.516 -0.55 . . . . 1.1100000000000001 109.516 178.143 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 77.7 mt -109.68 114.09 27.4 Favored 'General case' 0 C--N 1.315 -0.933 0 N-CA-C 109.399 -0.593 . . . . 0.41999999999999998 109.399 175.831 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . 0.636 ' HA ' ' HA ' ' A' ' 66' ' ' LYS . 2.9 p30 -79.87 -176.05 5.24 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.255 -0.429 . . . . 1.72 110.65 179.698 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -55.07 -42.1 72.35 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.826 -0.624 . . . . 1.6000000000000001 111.277 -178.719 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . 0.486 ' O ' ' HH2' ' A' ' 44' ' ' TRP . 49.9 mt-10 -72.32 -52.78 14.69 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.193 -0.458 . . . . 1.6599999999999999 110.335 179.728 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 36.6 mt-10 -64.02 -37.77 88.63 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.106 -0.497 . . . . 0.44 111.193 -172.951 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . 0.488 ' CD2' ' HD1' ' A' ' 57' ' ' PHE . 49.5 t80 -74.79 -34.58 62.45 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.412 -0.358 . . . . 0.41999999999999998 110.3 -179.327 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -60.07 -42.64 94.99 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-O 121.075 0.465 . . . . 0.22 110.003 173.689 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.4 ' HA ' HG11 ' A' ' 46' ' ' VAL . 6.9 tt -62.1 -47.56 84.07 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-N 115.86 -0.609 . . . . 1.3300000000000001 109.74 176.643 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . 0.5 ' O ' HG13 ' A' ' 113' ' ' ILE . . . -55.82 -52.03 65.41 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 115.885 -0.598 . . . . 0.32000000000000001 111.195 179.2 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' ASN . . . . . 0.515 HD22 HD12 ' A' ' 113' ' ' ILE . 12.4 m120 -59.13 -35.14 72.95 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-O 120.721 0.296 . . . . 1.2 110.992 179.375 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' HIS . . . . . 0.478 ' O ' HG23 ' A' ' 115' ' ' VAL . 24.8 t60 -64.21 -39.94 95.02 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.282 -0.417 . . . . 0.52000000000000002 110.193 -179.49 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 59.7 mt -74.85 -34.29 62.26 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.297 -0.41 . . . . 0.55000000000000004 110.976 178.252 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.515 HD12 HD22 ' A' ' 110' ' ' ASN . 82.5 mt -59.32 -45.27 93.37 Favored 'Isoleucine or valine' 0 C--O 1.234 0.279 0 CA-C-O 121.242 0.544 . . . . 0.83999999999999997 109.61 173.955 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 114' ' ' LYS . . . . . 0.431 ' HA ' ' HE3' ' A' ' 114' ' ' LYS . 0.1 OUTLIER -60.54 -42.65 96.95 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.216 -0.902 . . . . 3.8300000000000001 110.163 177.808 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . 0.635 HG13 ' HB2' ' A' ' 120' ' ' HIS . 40.6 t -53.53 -47.07 60.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.015 -0.539 . . . . 1.1899999999999999 110.978 176.103 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 27.6 mmmt -69.62 -38.75 77.36 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.403 -0.362 . . . . 1.3200000000000001 111.246 -179.42 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 94.7 mt -66.51 -29.09 69.11 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.128 0.489 . . . . 0.95999999999999996 111.009 177.805 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 5.4 tp10 -77.53 -22.11 51.61 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.47 0.652 . . . . 2.1800000000000002 110.044 178.858 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 99.57 19.71 19.5 Favored Glycine 0 N--CA 1.445 -0.702 0 CA-C-N 115.458 -0.792 . . . . 1.1599999999999999 112.657 179.919 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 120' ' ' HIS . . . . . 0.635 ' HB2' HG13 ' A' ' 115' ' ' VAL . 29.2 m-70 -97.4 167.07 11.23 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 109.425 -0.583 . . . . 2.4199999999999999 109.425 175.907 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 7.4 tp10 -114.86 145.77 41.81 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-O 120.717 0.294 . . . . 2.5299999999999998 110.223 -179.154 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . 0.496 ' HA ' ' HD3' ' A' ' 123' ' ' PRO . 3.1 pp -106.87 139.98 20.92 Favored Pre-proline 0 C--N 1.323 -0.545 0 N-CA-C 109.473 -0.566 . . . . 1.3300000000000001 109.473 177.133 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . 0.496 ' HD3' ' HA ' ' A' ' 122' ' ' LEU . 9.5 Cg_exo -72.58 0.17 7.95 Favored 'Trans proline' 0 C--O 1.232 0.19 0 C-N-CA 122.743 2.295 . . . . 1.3300000000000001 113.16 -176.55 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . 58.83 23.67 11.54 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-O 121.202 0.525 . . . . 1.25 110.592 -176.874 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 5.6 t0 -132.27 170.63 14.77 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 108.31 -0.996 . . . . 2.73 108.31 -179.87 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . 0.83 ' HG ' HD12 ' A' ' 92' ' ' LEU . 19.2 mt -116.76 105.93 48.91 Favored Pre-proline 0 C--N 1.321 -0.668 0 N-CA-C 112.116 0.413 . . . . 1.6599999999999999 112.116 -175.21 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 127' ' ' PRO . . . . . 0.423 ' HD2' ' HB2' ' A' ' 130' ' ' LEU . 12.1 Cg_exo -70.94 147.67 55.81 Favored 'Trans proline' 0 N--CA 1.459 -0.502 0 C-N-CA 122.611 2.207 . . . . 1.1699999999999999 110.778 169.919 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_exo -50.39 -37.87 51.81 Favored 'Trans proline' 0 CA--C 1.531 0.373 0 C-N-CA 122.944 2.429 . . . . 1.54 113.596 -178.311 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 44.3 p-80 -82.18 3.95 25.25 Favored 'General case' 0 CA--C 1.533 0.306 0 N-CA-C 111.961 0.356 . . . . 1.0700000000000001 111.961 -178.168 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . 0.423 ' HB2' ' HD2' ' A' ' 127' ' ' PRO . 2.4 mm? -101.06 -20.01 15.55 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.665 0.269 . . . . 1.3600000000000001 110.582 174.35 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 43.4 t -74.85 126.54 88.24 Favored Pre-proline 0 C--N 1.325 -0.459 0 CA-C-N 116.127 -0.488 . . . . 1.28 110.606 -178.989 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_exo -55.64 134.0 61.39 Favored 'Trans proline' 0 C--N 1.345 0.391 0 C-N-CA 122.587 2.191 . . . . 0.81000000000000005 111.722 177.224 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -58.31 -23.32 62.31 Favored 'Trans proline' 0 CA--C 1.529 0.256 0 C-N-CA 122.961 2.441 . . . . 1.1699999999999999 112.955 -176.64 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 5.5 m -82.01 -16.77 49.14 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.413 -0.358 . . . . 1.6000000000000001 111.304 -179.72 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 6.2 mptt . . . . . 0 C--N 1.33 -0.268 0 N-CA-C 111.776 0.287 . . . . 1.21 111.776 -176.404 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' B' B ' 149' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.443 -0.84 0 N-CA-C 112.395 -0.282 . . . . 0.47999999999999998 112.395 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' B' B ' 150' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -73.83 -2.14 11.81 Favored 'Trans proline' 0 C--O 1.232 0.191 0 C-N-CA 122.844 2.362 . . . . 0.33000000000000002 112.318 -178.272 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 151' ' ' PHE . . . . . . . . . . . . . 26.9 m-85 . . . . . 0 C--N 1.326 -0.444 0 CA-C-N 115.961 -0.563 . . . . 0.75 110.409 178.491 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 . . . . . 0 N--CA 1.45 -0.432 0 CA-C-O 121.157 0.503 . . . . 3.1000000000000001 110.547 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 9.8 t90 -83.44 122.02 27.95 Favored 'General case' 0 C--N 1.318 -0.803 0 N-CA-C 108.796 -0.816 . . . . 0.70999999999999996 108.796 179.834 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 33.6 m -61.48 -15.9 13.87 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.521 0 N-CA-C 114.316 1.228 . . . . 1.45 114.316 -166.793 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.469 HG23 ' HB2' ' A' ' 111' ' ' HIS . 11.5 p -92.45 -14.06 8.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 C-N-CA 120.033 -0.667 . . . . 1.1000000000000001 110.541 178.346 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -64.55 -25.41 70.17 Favored Glycine 0 CA--C 1.519 0.305 0 C-N-CA 120.964 -0.636 . . . . 0.58999999999999997 112.955 -177.115 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . 0.5 ' HG3' ' OD2' ' A' ' 49' ' ' ASP . 11.5 ptmm? -76.63 -19.44 57.8 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.599 0.238 . . . . 2.46 111.149 -179.226 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . 0.5 ' OD2' ' HG3' ' A' ' 48' ' ' LYS . 10.5 m-20 -127.14 34.56 4.72 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 109.362 -0.607 . . . . 1.6599999999999999 109.362 179.571 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . 0.436 ' HG2' ' OD1' ' A' ' 54' ' ' ASP . 56.7 tttm -86.61 -48.13 0.51 Allowed Pre-proline 0 C--N 1.324 -0.541 0 CA-C-N 115.862 -0.608 . . . . 1.1499999999999999 112.308 -172.725 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . 0.411 ' HD3' ' HB3' ' A' ' 50' ' ' LYS . 84.3 Cg_exo -49.61 -31.22 24.11 Favored 'Trans proline' 0 C--N 1.361 1.202 0 C-N-CA 122.158 1.905 . . . . 0.75 113.003 -179.88 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 11.0 m -70.14 -45.43 66.81 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.252 -0.431 . . . . 0.68000000000000005 110.502 177.763 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 19.9 m-30 -73.67 -23.25 59.82 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.395 -0.366 . . . . 0.68999999999999995 110.291 -177.81 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . 0.436 ' OD1' ' HG2' ' A' ' 50' ' ' LYS . 0.9 OUTLIER -72.59 -40.6 66.44 Favored 'General case' 0 CA--C 1.517 -0.305 0 N-CA-C 109.683 -0.488 . . . . 2.1800000000000002 109.683 174.657 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 2.6 mm-40 -58.76 -36.93 75.18 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.039 -0.528 . . . . 2.3300000000000001 110.58 176.012 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 35.3 mt -75.65 -40.29 40.31 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-O 121.119 0.485 . . . . 0.64000000000000001 110.298 177.183 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . 0.411 ' HD2' ' CD1' ' A' ' 58' ' ' TYR . 86.5 t80 -57.1 -38.18 73.01 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.685 -0.689 . . . . 0.28999999999999998 111.409 179.132 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . 0.546 ' HA ' ' HG3' ' A' ' 62' ' ' PRO . 19.8 m-30 -80.32 -3.77 50.77 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.383 -0.372 . . . . 1.1699999999999999 111.578 -174.208 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 75.3 p -100.2 -2.4 34.04 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.878 0.371 . . . . 0.44 111.034 179.609 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 74.6 mt -102.09 16.7 25.28 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.393 -0.367 . . . . 1.3700000000000001 110.615 179.753 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 48.3 t 63.06 80.89 0.24 Allowed Pre-proline 0 CA--C 1.532 0.283 0 CA-C-N 115.53 -0.759 . . . . 1.24 111.237 -179.209 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . 0.578 ' HA ' HG22 ' A' ' 67' ' ' ILE . 6.2 Cg_exo -78.59 143.88 19.4 Favored 'Trans proline' 0 N--CA 1.461 -0.427 0 C-N-CA 122.899 2.399 . . . . 0.46999999999999997 112.007 178.84 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 16.7 m -122.86 117.43 51.78 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-N 116.284 -0.416 . . . . 1.02 110.191 176.161 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 13.7 m120 62.07 23.35 13.77 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-N 115.984 -0.553 . . . . 1.3400000000000001 111.182 -179.823 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 90.57 5.77 68.79 Favored Glycine 0 C--O 1.229 -0.201 0 C-N-CA 120.961 -0.638 . . . . 0.42999999999999999 113.043 178.375 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . 0.645 ' HG2' ' HA ' ' A' ' 102' ' ' ASP . 37.0 mtpt -135.52 157.93 45.64 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 109.952 -0.388 . . . . 1.48 109.952 -178.692 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . 0.578 HG22 ' HA ' ' A' ' 62' ' ' PRO . 48.8 pt -124.95 164.07 24.38 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-O 120.988 0.423 . . . . 0.64000000000000001 110.943 177.416 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . 0.409 ' HA ' HD23 ' A' ' 100' ' ' LEU . 37.5 p -82.25 165.57 20.31 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.339 -0.846 . . . . 0.55000000000000004 110.893 179.992 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -72.1 -12.98 76.17 Favored Glycine 0 N--CA 1.447 -0.614 0 C-N-CA 120.988 -0.625 . . . . 0.40999999999999998 112.56 179.599 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.413 ' O ' ' HG3' ' A' ' 74' ' ' LYS . . . -64.46 -58.97 4.93 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.079 0.466 . . . . 0.38 111.068 -179.216 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 39.4 m-80 -68.89 -38.54 79.72 Favored 'General case' 0 C--O 1.238 0.454 0 CA-C-N 115.809 -0.632 . . . . 1.8100000000000001 110.451 -178.06 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -59.25 -43.2 92.45 Favored 'General case' 0 N--CA 1.45 -0.425 0 CA-C-N 115.608 -0.723 . . . . 0.39000000000000001 109.951 176.542 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -62.23 -39.54 93.16 Favored 'General case' 0 C--O 1.224 -0.276 0 CA-C-N 116.362 -0.381 . . . . 0.83999999999999997 110.906 177.85 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . 0.464 ' O ' HG12 ' A' ' 77' ' ' VAL . 57.6 mtpt -59.14 -33.43 70.87 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-O 121.008 0.432 . . . . 1.95 110.693 178.731 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . 0.478 ' O ' ' HG3' ' A' ' 78' ' ' LYS . 40.9 tt0 -81.34 -50.67 9.22 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 116.172 -0.467 . . . . 1.6000000000000001 110.368 -179.496 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' MET . . . . . 0.749 ' HB3' HD22 ' A' ' 86' ' ' LEU . 75.1 mmm -57.4 -27.49 62.39 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.803 -0.635 . . . . 1.24 110.327 178.672 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.464 HG12 ' O ' ' A' ' 74' ' ' LYS . 1.5 p -86.95 -28.01 5.8 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.535 0 CA-C-N 115.942 -0.572 . . . . 1.5700000000000001 110.968 -179.082 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.478 ' HG3' ' O ' ' A' ' 75' ' ' GLU . 0.0 OUTLIER -82.28 -14.38 55.51 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-O 120.886 0.374 . . . . 2.79 110.26 -179.096 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 2.0 p -78.6 4.43 13.53 Favored 'General case' 0 CA--C 1.531 0.214 0 CA-C-N 116.323 -0.399 . . . . 1.27 110.396 170.343 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 52.3 mtpt 63.5 32.81 14.0 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 115.403 -0.817 . . . . 2.9700000000000002 112.247 172.535 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.671 ' HB2' HD21 ' A' ' 86' ' ' LEU . 88.7 mt -102.17 141.39 22.44 Favored Pre-proline 0 C--N 1.318 -0.778 0 CA-C-N 116.417 -0.356 . . . . 0.52000000000000002 110.118 176.956 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . 0.537 ' O ' ' HG ' ' A' ' 86' ' ' LEU . 51.7 Cg_exo -56.14 136.74 76.69 Favored 'Trans proline' 0 C--N 1.344 0.306 0 C-N-CA 122.821 2.347 . . . . 0.44 112.706 179.52 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . 0.411 ' HA ' HD12 ' A' ' 86' ' ' LEU . 18.2 p30 -51.93 -34.9 43.79 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-N 115.846 -0.616 . . . . 1.8500000000000001 112.437 -179.866 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 30.1 m -69.48 -39.07 77.89 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 121.006 0.432 . . . . 1.47 110.608 -179.553 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.414 HG23 ' HB2' ' A' ' 82' ' ' PRO . 58.8 t -67.69 -36.23 75.33 Favored 'Isoleucine or valine' 0 C--O 1.234 0.277 0 N-CA-C 109.325 -0.62 . . . . 0.45000000000000001 109.325 176.573 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.749 HD22 ' HB3' ' A' ' 76' ' ' MET . 65.4 mt -63.84 -33.47 75.75 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.348 -0.842 . . . . 0.90000000000000002 109.876 175.807 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -68.58 -38.28 86.07 Favored Glycine 0 N--CA 1.451 -0.363 0 N-CA-C 111.57 -0.612 . . . . 0.32000000000000001 111.57 178.931 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . 0.418 ' O ' ' HG ' ' A' ' 92' ' ' LEU . 73.1 mmtt -57.7 -52.82 63.86 Favored 'General case' 0 C--O 1.24 0.563 0 CA-C-O 121.638 0.733 . . . . 1.8899999999999999 109.582 173.814 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 0.43 HG23 HD12 ' A' ' 112' ' ' LEU . 45.4 mt -65.12 -34.88 73.59 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.453 0 CA-C-N 114.924 -1.034 . . . . 0.70999999999999996 111.389 -178.148 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' TRP . . . . . 0.462 ' HB2' ' CE2' ' B' ' 151' ' ' PHE . 55.0 t-105 -60.45 -46.09 91.33 Favored 'General case' 0 C--N 1.333 -0.118 0 CA-C-O 120.795 0.331 . . . . 0.33000000000000002 110.149 175.814 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 30.8 ttpt -66.39 -20.86 66.18 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.846 -0.615 . . . . 2.7000000000000002 110.807 -178.611 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.782 HD11 ' HA ' ' A' ' 124' ' ' ALA . 82.6 mt -92.35 -31.56 15.3 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.437 -0.347 . . . . 1.6599999999999999 111.682 177.4 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -86.54 -41.49 14.28 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.506 -0.315 . . . . 0.46999999999999997 111.835 -174.39 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 36.3 t0 -80.86 81.26 7.16 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 108.982 -0.747 . . . . 0.79000000000000004 108.982 178.137 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.714 ' HB ' ' HD3' ' A' ' 135' ' ' LYS . 46.2 t -75.35 -34.7 31.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 115.027 -0.988 . . . . 0.60999999999999999 111.083 -173.519 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . 0.545 ' HB3' ' HE3' ' A' ' 135' ' ' LYS . 15.5 p-10 -82.58 -8.46 59.61 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 109.514 -0.551 . . . . 0.95999999999999996 109.514 179.05 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 97.0 mttt 49.65 73.06 0.27 Allowed 'General case' 0 C--O 1.235 0.314 0 CA-C-N 115.403 -0.817 . . . . 2.96 111.455 175.229 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . 0.484 ' OD2' ' HB2' ' A' ' 100' ' ' LEU . 9.5 p-10 -134.69 9.5 3.63 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.624 -0.716 . . . . 0.42999999999999999 111.067 -173.837 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 73.75 -4.64 28.14 Favored Glycine 0 C--N 1.331 0.288 0 C-N-CA 120.791 -0.719 . . . . 0.44 112.407 178.699 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.484 ' HB2' ' OD2' ' A' ' 98' ' ' ASP . 89.2 mt -120.86 154.35 35.93 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 109.051 -0.722 . . . . 1.1100000000000001 109.051 178.401 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 75.3 mt -108.32 122.77 47.67 Favored 'General case' 0 C--N 1.31 -1.138 0 C-N-CA 120.487 -0.485 . . . . 0.41999999999999998 110.146 178.011 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . 0.674 ' HB2' ' HG3' ' A' ' 105' ' ' GLU . 16.0 m-20 -68.83 168.36 13.63 Favored 'General case' 0 CA--C 1.512 -0.508 0 N-CA-C 108.113 -1.069 . . . . 1.72 108.113 170.111 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -61.53 -29.82 70.24 Favored 'General case' 0 C--N 1.317 -0.81 0 N-CA-C 109.202 -0.666 . . . . 1.6000000000000001 109.202 174.527 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 50.7 mt-10 -64.64 -55.52 19.69 Favored 'General case' 0 C--O 1.231 0.092 0 CA-C-N 115.762 -0.654 . . . . 1.6599999999999999 110.148 173.495 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . 0.674 ' HG3' ' HB2' ' A' ' 102' ' ' ASP . 14.4 mt-10 -62.4 -39.85 94.6 Favored 'General case' 0 N--CA 1.463 0.207 0 CA-C-N 115.454 -0.793 . . . . 0.44 110.956 -173.914 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 79.7 t80 -64.21 -47.86 78.09 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.671 -0.695 . . . . 0.41999999999999998 110.524 178.193 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -57.67 -45.61 85.36 Favored 'General case' 0 N--CA 1.454 -0.258 0 CA-C-N 116.278 -0.419 . . . . 0.22 110.754 178.704 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 55.1 tp -59.48 -47.37 85.75 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.486 -0.325 . . . . 1.3300000000000001 110.735 -179.906 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . 0.579 ' O ' HG12 ' A' ' 113' ' ' ILE . . . -58.61 -46.85 86.14 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.224 -0.444 . . . . 0.32000000000000001 110.595 177.974 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' ASN . . . . . 0.437 ' HA ' HG12 ' A' ' 113' ' ' ILE . 0.6 OUTLIER -60.59 -36.5 78.7 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 115.903 -0.589 . . . . 1.2 111.388 179.044 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' HIS . . . . . 0.731 ' O ' HG23 ' A' ' 115' ' ' VAL . 24.8 t60 -62.94 -48.13 80.26 Favored 'General case' 0 CA--C 1.513 -0.449 0 N-CA-C 108.78 -0.822 . . . . 0.52000000000000002 108.78 177.192 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 0.43 HD12 HG23 ' A' ' 89' ' ' ILE . 97.8 mt -58.16 -34.64 70.53 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.527 -0.76 . . . . 0.55000000000000004 110.795 177.521 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.579 HG12 ' O ' ' A' ' 109' ' ' ALA . 36.9 mm -56.46 -52.32 54.11 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.235 0 CA-C-O 121.515 0.674 . . . . 0.83999999999999997 110.309 173.605 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 18.4 tppt? -63.13 -45.83 90.11 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.016 -0.993 . . . . 3.8300000000000001 111.523 -177.416 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . 0.731 HG23 ' O ' ' A' ' 111' ' ' HIS . 2.2 t -73.89 -23.82 19.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-O 120.82 0.343 . . . . 1.1899999999999999 110.294 -176.499 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 14.6 tppt? -64.89 -49.48 70.31 Favored 'General case' 0 CA--C 1.52 -0.175 0 N-CA-C 109.487 -0.56 . . . . 1.3200000000000001 109.487 170.264 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 86.2 mt -70.41 -15.15 62.81 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.553 -0.749 . . . . 0.95999999999999996 110.88 -179.804 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 7.2 tp10 -71.35 -16.44 62.43 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.104 0.478 . . . . 2.1800000000000002 109.784 175.331 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 98.67 23.97 11.46 Favored Glycine 0 N--CA 1.451 -0.36 0 N-CA-C 111.124 -0.79 . . . . 1.1599999999999999 111.124 179.443 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 18.2 t60 -117.84 121.57 41.09 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 121.122 0.487 . . . . 2.4199999999999999 110.867 -177.584 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 47.9 mm-40 -83.59 119.88 25.28 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.361 -0.836 . . . . 2.5299999999999998 110.725 177.55 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . 0.821 ' H ' HD23 ' A' ' 122' ' ' LEU . 1.3 pt? -78.58 139.37 58.87 Favored Pre-proline 0 C--N 1.322 -0.626 0 N-CA-C 109.019 -0.734 . . . . 1.3300000000000001 109.019 172.948 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . 0.455 ' HD3' ' HA ' ' A' ' 122' ' ' LEU . 7.8 Cg_exo -72.78 10.03 1.16 Allowed 'Trans proline' 0 C--N 1.345 0.374 0 C-N-CA 123.205 2.604 . . . . 1.3300000000000001 112.792 -176.055 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . 0.782 ' HA ' HD11 ' A' ' 92' ' ' LEU . . . 59.14 29.94 19.61 Favored 'General case' 0 C--O 1.232 0.141 0 CA-C-N 116.239 -0.437 . . . . 1.25 110.946 -179.771 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 37.8 t70 -132.53 156.92 45.95 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.819 -0.628 . . . . 2.73 109.882 -179.688 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . 0.659 ' HG ' HD22 ' A' ' 92' ' ' LEU . 84.3 mt -110.46 103.34 53.94 Favored Pre-proline 0 C--N 1.327 -0.41 0 N-CA-C 112.055 0.391 . . . . 1.6599999999999999 112.055 -175.814 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 127' ' ' PRO . . . . . 0.539 ' HD2' HD12 ' A' ' 130' ' ' LEU . 56.6 Cg_endo -72.21 161.46 44.48 Favored 'Trans proline' 0 C--O 1.234 0.321 0 C-N-CA 122.803 2.335 . . . . 1.1699999999999999 111.085 171.249 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 75.5 Cg_exo -50.49 -40.39 54.22 Favored 'Trans proline' 0 C--N 1.346 0.446 0 C-N-CA 123.178 2.585 . . . . 1.54 113.836 -176.672 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 23.4 p-80 -81.29 14.56 2.35 Favored 'General case' 0 CA--C 1.533 0.324 0 N-CA-C 112.828 0.677 . . . . 1.0700000000000001 112.828 -174.381 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . 0.539 HD12 ' HD2' ' A' ' 127' ' ' PRO . 12.7 mt -114.39 2.41 14.69 Favored 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 120.791 -0.363 . . . . 1.3600000000000001 111.072 174.69 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 46.3 t -84.39 121.48 75.16 Favored Pre-proline 0 C--N 1.324 -0.539 0 CA-C-N 116.326 -0.397 . . . . 1.28 110.492 -178.455 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 44.7 Cg_exo -56.77 142.75 91.96 Favored 'Trans proline' 0 C--N 1.347 0.484 0 C-N-CA 123.097 2.531 . . . . 0.81000000000000005 112.804 -179.974 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 11.8 Cg_endo -55.45 -36.16 93.53 Favored 'Trans proline' 0 CA--C 1.531 0.345 0 C-N-CA 123.739 2.959 . . . . 1.1699999999999999 113.62 -176.682 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 4.4 m -83.82 -9.59 58.66 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.012 0.434 . . . . 1.6000000000000001 110.885 -178.19 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 135' ' ' LYS . . . . . 0.714 ' HD3' ' HB ' ' A' ' 95' ' ' VAL . 49.5 mttp . . . . . 0 C--N 1.324 -0.511 0 CA-C-N 116.056 -0.52 . . . . 1.21 110.843 -173.867 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 149' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.446 -0.675 0 N-CA-C 111.878 -0.489 . . . . 0.47999999999999998 111.878 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' B' B ' 150' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -74.72 -2.02 11.91 Favored 'Trans proline' 0 CA--C 1.533 0.465 0 C-N-CA 123.053 2.502 . . . . 0.33000000000000002 113.159 -176.585 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 151' ' ' PHE . . . . . 0.462 ' CE2' ' HB2' ' A' ' 90' ' ' TRP . 30.2 m-85 . . . . . 0 C--N 1.326 -0.449 0 N-CA-C 112.119 0.414 . . . . 0.75 112.119 -174.344 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 17.9 mm-40 . . . . . 0 C--O 1.233 0.222 0 CA-C-O 120.771 0.319 . . . . 3.1000000000000001 110.474 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 5.7 t90 -81.91 103.14 11.36 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 109.243 -0.651 . . . . 0.70999999999999996 109.243 176.912 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.493 ' O ' ' HG2' ' A' ' 48' ' ' LYS . 21.2 m -60.2 -19.86 18.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 N-CA-C 112.978 0.733 . . . . 1.45 112.978 -173.172 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 28.3 t -78.94 -16.79 13.41 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-O 121.177 0.513 . . . . 1.1000000000000001 110.856 -178.834 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -74.08 -9.54 80.36 Favored Glycine 0 N--CA 1.448 -0.526 0 C-N-CA 120.851 -0.69 . . . . 0.58999999999999997 113.414 -175.476 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . 0.493 ' HG2' ' O ' ' A' ' 45' ' ' VAL . 1.1 ptpm? -83.93 -27.66 28.4 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 117.3 0.55 . . . . 2.46 111.112 -178.787 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 21.5 m-20 -100.6 33.83 2.62 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.824 0.345 . . . . 1.6599999999999999 110.266 -179.465 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . 0.554 ' N ' ' HD2' ' A' ' 51' ' ' PRO . 14.9 mmtp -69.35 -51.03 17.99 Favored Pre-proline 0 C--N 1.324 -0.53 0 N-CA-C 112.83 0.678 . . . . 1.1499999999999999 112.83 -177.017 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . 0.643 ' HA ' ' OD2' ' A' ' 54' ' ' ASP . 4.6 Cg_endo -48.34 -42.04 34.69 Favored 'Trans proline' 0 C--N 1.356 0.966 0 C-N-CA 122.707 2.271 . . . . 0.75 113.217 -177.966 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . 0.486 ' O ' ' HB3' ' A' ' 55' ' ' GLU . 21.9 m -70.93 -39.93 72.36 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.375 0.607 . . . . 0.68000000000000005 110.932 -179.419 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 21.2 m-30 -79.25 -22.09 45.23 Favored 'General case' 0 C--N 1.324 -0.51 0 C-N-CA 120.603 -0.439 . . . . 0.68999999999999995 111.114 -175.857 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . 0.643 ' OD2' ' HA ' ' A' ' 51' ' ' PRO . 0.6 OUTLIER -82.1 -25.48 34.45 Favored 'General case' 0 CA--C 1.52 -0.18 0 N-CA-C 108.945 -0.761 . . . . 2.1800000000000002 108.945 175.166 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . 0.486 ' HB3' ' O ' ' A' ' 52' ' ' THR . 9.5 tp10 -59.37 -43.14 92.9 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.478 -0.783 . . . . 2.3300000000000001 109.102 169.598 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.447 HG12 ' O ' ' A' ' 52' ' ' THR . 27.6 mm -76.18 -34.82 26.91 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.331 0 CA-C-N 115.841 -0.618 . . . . 0.64000000000000001 110.521 178.092 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . 0.509 ' CE2' ' HB3' ' A' ' 62' ' ' PRO . 74.0 t80 -65.72 -46.6 78.32 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.122 -0.49 . . . . 0.28999999999999998 111.372 -176.725 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . 0.428 ' HA ' ' HG3' ' A' ' 62' ' ' PRO . 15.1 m-85 -80.33 -7.94 59.28 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.382 -0.372 . . . . 1.1699999999999999 111.922 -174.493 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 15.5 p -92.65 -4.34 53.44 Favored 'General case' 0 C--N 1.323 -0.572 0 C-N-CA 120.717 -0.393 . . . . 0.44 110.693 177.064 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.466 ' HB3' ' HB3' ' A' ' 71' ' ' ASN . 73.0 mt -108.08 13.24 26.16 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.299 -0.41 . . . . 1.3700000000000001 111.266 178.026 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 15.8 m 68.53 87.42 0.11 Allowed Pre-proline 0 N--CA 1.469 0.525 0 CA-C-N 116.03 -0.532 . . . . 1.24 112.171 175.698 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . 0.509 ' HB3' ' CE2' ' A' ' 57' ' ' PHE . 5.6 Cg_exo -80.69 138.89 12.18 Favored 'Trans proline' 0 N--CA 1.46 -0.47 0 C-N-CA 122.862 2.375 . . . . 0.46999999999999997 112.635 178.206 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 11.0 m -127.94 117.83 47.05 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-N 115.819 -0.628 . . . . 1.02 110.216 175.168 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 49.3 m-80 66.39 24.27 10.5 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-N 115.694 -0.684 . . . . 1.3400000000000001 111.389 178.661 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 92.96 8.15 62.01 Favored Glycine 0 C--N 1.331 0.275 0 C-N-CA 121.018 -0.611 . . . . 0.42999999999999999 112.788 176.847 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . 0.804 ' HG2' ' HA ' ' A' ' 102' ' ' ASP . 55.1 mtmt -143.28 153.96 43.31 Favored 'General case' 0 C--N 1.326 -0.422 0 C-N-CA 122.381 0.272 . . . . 1.48 110.397 -177.165 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . 0.449 HD11 ' CD1' ' A' ' 106' ' ' PHE . 41.0 pt -110.68 153.92 12.36 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.763 0 N-CA-C 110.011 -0.366 . . . . 0.64000000000000001 110.011 174.957 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 18.6 p -72.7 152.5 41.65 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.285 -0.416 . . . . 0.55000000000000004 111.151 179.589 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -61.8 -15.93 49.96 Favored Glycine 0 N--CA 1.448 -0.54 0 C-N-CA 121.071 -0.585 . . . . 0.40999999999999998 112.947 -179.434 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -60.36 -50.46 73.51 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.133 0.492 . . . . 0.38 111.213 177.636 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . 0.559 ' HA ' ' HD3' ' A' ' 74' ' ' LYS . 39.9 m-80 -74.93 -34.23 62.08 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.826 -0.624 . . . . 1.8100000000000001 110.38 -175.778 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -61.42 -45.28 94.99 Favored 'General case' 0 N--CA 1.449 -0.489 0 CA-C-N 115.929 -0.578 . . . . 0.39000000000000001 109.528 173.961 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . 0.594 ' HA ' ' CZ ' ' B' ' 151' ' ' PHE . 54.9 tttp -56.08 -38.43 70.67 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.777 -0.647 . . . . 0.83999999999999997 110.383 177.296 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . 0.559 ' HD3' ' HA ' ' A' ' 71' ' ' ASN . 26.8 mtpp -65.49 -32.88 74.73 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.952 -0.567 . . . . 1.95 111.256 178.671 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 18.2 tp10 -76.31 -39.39 54.27 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.164 0.507 . . . . 1.6000000000000001 110.039 177.701 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' MET . . . . . 0.517 ' HB3' HD22 ' A' ' 86' ' ' LEU . 1.1 mpt? -60.71 -36.43 78.78 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 116.378 -0.374 . . . . 1.24 111.471 176.386 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.426 HG22 ' HA ' ' A' ' 74' ' ' LYS . 17.9 m -82.38 -13.88 12.2 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.507 0 C-N-CA 120.701 -0.4 . . . . 1.5700000000000001 110.978 177.455 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 46.7 mmtt -74.29 -29.74 61.77 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-O 120.867 0.365 . . . . 2.79 111.029 171.396 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -83.9 -13.61 53.09 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.155 -0.475 . . . . 1.27 111.122 -178.931 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 56.2 mttp 68.29 33.01 4.43 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 115.639 -0.709 . . . . 2.9700000000000002 111.927 171.788 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.715 ' HB2' HD21 ' A' ' 86' ' ' LEU . 97.2 mt -86.32 151.6 53.98 Favored Pre-proline 0 C--N 1.326 -0.453 0 N-CA-C 109.68 -0.489 . . . . 0.52000000000000002 109.68 175.682 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -54.46 142.91 69.11 Favored 'Trans proline' 0 C--N 1.35 0.628 0 C-N-CA 122.887 2.391 . . . . 0.44 112.65 179.336 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 39.9 m-80 -52.36 -48.05 65.76 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 115.615 -0.72 . . . . 1.8500000000000001 112.141 -175.61 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . 0.436 ' O ' ' HD3' ' A' ' 88' ' ' LYS . 38.8 p -63.76 -42.73 97.77 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.912 0.387 . . . . 1.47 110.757 -178.837 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 84.7 t -59.85 -39.24 79.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 115.85 -0.614 . . . . 0.45000000000000001 110.584 179.247 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.715 HD21 ' HB2' ' A' ' 81' ' ' LEU . 93.6 mt -65.75 -29.37 69.87 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.435 -0.348 . . . . 0.90000000000000002 110.521 177.333 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -65.77 -41.41 95.73 Favored Glycine 0 CA--C 1.502 -0.753 0 N-CA-C 111.086 -0.806 . . . . 0.32000000000000001 111.086 175.151 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . 0.436 ' HD3' ' O ' ' A' ' 84' ' ' THR . 2.5 mptp? -75.06 -28.33 60.32 Favored 'General case' 0 N--CA 1.443 -0.808 0 CA-C-N 115.464 -0.368 . . . . 1.8899999999999999 110.846 178.605 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 16.4 mm -60.15 -49.44 84.08 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.254 0 CA-C-N 116.325 -0.398 . . . . 0.70999999999999996 110.222 173.153 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' TRP . . . . . 0.424 ' HB2' ' CD2' ' B' ' 151' ' ' PHE . 52.4 t-105 -62.38 -45.33 93.62 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.917 0.389 . . . . 0.33000000000000002 110.578 178.073 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 17.4 ttmm -54.85 -32.33 60.49 Favored 'General case' 0 C--O 1.237 0.447 0 CA-C-N 115.665 -0.698 . . . . 2.7000000000000002 111.585 179.276 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.559 HD22 ' HA ' ' A' ' 124' ' ' ALA . 13.0 tp -93.93 -36.92 11.96 Favored 'General case' 0 N--CA 1.442 -0.846 0 CA-C-N 115.906 -0.588 . . . . 1.6599999999999999 111.782 -176.439 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -81.36 -42.48 20.44 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.753 0.311 . . . . 0.46999999999999997 111.718 -174.53 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . 0.654 ' OD2' ' HA ' ' A' ' 97' ' ' LYS . 50.0 t0 -78.03 96.72 5.16 Favored 'General case' 0 C--O 1.237 0.417 0 N-CA-C 108.689 -0.856 . . . . 0.79000000000000004 108.689 178.049 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 38.3 t -68.86 -45.16 81.14 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-N 115.481 -0.781 . . . . 0.60999999999999999 110.965 -172.497 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 29.0 p-10 -88.6 -17.96 29.04 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 116.092 -0.504 . . . . 0.95999999999999996 111.694 -176.779 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . 0.654 ' HA ' ' OD2' ' A' ' 94' ' ' ASP . 53.0 mttp 58.07 72.89 0.5 Allowed 'General case' 0 CA--C 1.518 -0.278 0 CA-C-O 122.063 0.935 . . . . 2.96 111.32 177.838 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . 0.417 ' OD2' ' HB2' ' A' ' 100' ' ' LEU . 11.5 p-10 -122.83 9.05 9.41 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 114.589 -1.187 . . . . 0.42999999999999999 110.868 -173.169 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 78.19 -3.78 60.92 Favored Glycine 0 CA--C 1.52 0.369 0 C-N-CA 121.001 -0.619 . . . . 0.44 112.468 -179.554 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.417 ' HB2' ' OD2' ' A' ' 98' ' ' ASP . 4.6 mp -128.86 166.23 19.47 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 109.726 -0.472 . . . . 1.1100000000000001 109.726 175.922 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 81.7 mt -123.75 127.52 48.26 Favored 'General case' 0 C--N 1.314 -0.951 0 CA-C-N 116.128 -0.487 . . . . 0.41999999999999998 109.799 176.999 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . 0.804 ' HA ' ' HG2' ' A' ' 66' ' ' LYS . 2.6 m-20 -69.72 168.42 14.99 Favored 'General case' 0 CA--C 1.509 -0.631 0 N-CA-C 108.799 -0.815 . . . . 1.72 108.799 174.334 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -57.61 -30.28 65.2 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 108.46 -0.941 . . . . 1.6000000000000001 108.46 171.772 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 6.4 mm-40 -66.97 -58.81 4.23 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-N 115.11 -0.95 . . . . 1.6599999999999999 111.851 177.195 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . 0.581 ' OE1' ' HE3' ' A' ' 135' ' ' LYS . 2.4 pt-20 -78.91 -18.09 54.44 Favored 'General case' 0 CA--C 1.53 0.187 0 C-N-CA 120.283 -0.567 . . . . 0.44 112.236 -173.822 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . 0.449 ' CD1' HD11 ' A' ' 67' ' ' ILE . 50.3 t80 -76.64 -34.17 58.31 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 109.164 -0.68 . . . . 0.41999999999999998 109.164 173.603 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -62.23 -44.49 96.44 Favored 'General case' 0 N--CA 1.452 -0.363 0 CA-C-N 115.672 -0.694 . . . . 0.22 109.262 171.663 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.435 ' O ' ' HG ' ' A' ' 112' ' ' LEU . 4.8 tt -60.39 -46.28 90.54 Favored 'General case' 0 CA--C 1.533 0.305 0 CA-C-N 115.491 -0.777 . . . . 1.3300000000000001 109.847 178.326 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -56.17 -49.65 73.41 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 116.484 -0.326 . . . . 0.32000000000000001 111.363 178.361 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 22.5 m-80 -65.06 -32.53 74.28 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.423 -0.353 . . . . 1.2 111.31 179.626 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' HIS . . . . . 0.408 ' O ' HG23 ' A' ' 115' ' ' VAL . 11.9 t60 -68.28 -35.59 78.09 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 109.689 -0.485 . . . . 0.52000000000000002 109.689 178.091 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 0.435 ' HG ' ' O ' ' A' ' 108' ' ' LEU . 95.8 mt -65.61 -46.88 77.65 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 116.323 -0.398 . . . . 0.55000000000000004 110.324 175.713 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 62.7 mt -56.7 -45.03 82.63 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.177 0 CA-C-N 115.767 -0.651 . . . . 0.83999999999999997 109.709 177.254 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 17.1 tppt? -56.85 -49.99 73.78 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.054 -0.975 . . . . 3.8300000000000001 110.919 178.191 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . 0.621 HG13 ' HB2' ' A' ' 120' ' ' HIS . 45.9 t -58.68 -42.87 86.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.194 -0.457 . . . . 1.1899999999999999 111.57 -178.716 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 17.5 tppt? -70.02 -41.51 74.19 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 116.628 -0.26 . . . . 1.3200000000000001 110.698 -179.257 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 74.5 mt -68.61 -30.69 69.48 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.881 0.372 . . . . 0.95999999999999996 111.04 179.287 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -74.96 -16.7 60.63 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.917 -0.583 . . . . 2.1800000000000002 110.483 179.696 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 99.25 32.83 5.65 Favored Glycine 0 N--CA 1.449 -0.486 0 C-N-CA 120.744 -0.741 . . . . 1.1599999999999999 113.02 175.96 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 120' ' ' HIS . . . . . 0.621 ' HB2' HG13 ' A' ' 115' ' ' VAL . 78.4 m-70 -119.54 -179.52 3.9 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 109.79 -0.448 . . . . 2.4199999999999999 109.79 177.692 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -117.46 149.27 40.85 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 120.956 0.408 . . . . 2.5299999999999998 111.166 -176.119 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 2.6 pp -108.3 143.53 27.62 Favored Pre-proline 0 C--N 1.324 -0.542 0 CA-C-N 115.516 -0.766 . . . . 1.3300000000000001 109.784 175.346 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -73.34 -13.9 25.41 Favored 'Trans proline' 0 C--N 1.343 0.261 0 C-N-CA 122.395 2.064 . . . . 1.3300000000000001 113.164 -176.338 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . 0.559 ' HA ' HD22 ' A' ' 92' ' ' LEU . . . 61.01 17.68 8.18 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 123.162 0.585 . . . . 1.25 111.392 -177.402 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -134.4 163.13 30.36 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 107.817 -1.179 . . . . 2.73 107.817 174.268 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 64.2 mt -109.2 93.88 14.11 Favored Pre-proline 0 C--N 1.322 -0.614 0 CA-C-O 120.724 0.297 . . . . 1.6599999999999999 111.515 -177.016 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 127' ' ' PRO . . . . . 0.432 ' HD2' HD12 ' A' ' 130' ' ' LEU . 63.5 Cg_endo -75.77 155.67 39.48 Favored 'Trans proline' 0 N--CA 1.459 -0.554 0 C-N-CA 122.571 2.181 . . . . 1.1699999999999999 111.141 173.667 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 90.0 Cg_exo -44.44 -37.2 10.48 Favored 'Trans proline' 0 CA--C 1.533 0.452 0 C-N-CA 123.478 2.785 . . . . 1.54 114.557 -177.874 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 41.0 p-80 -82.03 10.27 6.9 Favored 'General case' 0 N--CA 1.466 0.339 0 C-N-CA 120.793 -0.363 . . . . 1.0700000000000001 111.851 -175.503 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . 0.432 HD12 ' HD2' ' A' ' 127' ' ' PRO . 66.6 mt -126.99 1.57 6.57 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.514 0.197 . . . . 1.3600000000000001 111.48 176.335 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 43.0 t -85.06 122.9 74.09 Favored Pre-proline 0 C--N 1.326 -0.456 0 N-CA-C 110.515 -0.18 . . . . 1.28 110.515 -178.74 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 132' ' ' PRO . . . . . 0.407 ' HA ' ' HD3' ' A' ' 133' ' ' PRO . 47.9 Cg_exo -56.12 129.2 33.58 Favored 'Trans proline' 0 C--N 1.346 0.407 0 C-N-CA 122.99 2.46 . . . . 0.81000000000000005 112.329 178.881 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 133' ' ' PRO . . . . . 0.407 ' HD3' ' HA ' ' A' ' 132' ' ' PRO . 25.4 Cg_exo -62.01 -18.85 63.77 Favored 'Trans proline' 0 C--N 1.345 0.393 0 C-N-CA 122.884 2.39 . . . . 1.1699999999999999 112.692 -177.131 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 8.4 p -77.24 -21.5 53.66 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 116.061 -0.518 . . . . 1.6000000000000001 111.72 -179.317 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 135' ' ' LYS . . . . . 0.581 ' HE3' ' OE1' ' A' ' 105' ' ' GLU . 68.4 mttm . . . . . 0 C--N 1.328 -0.328 0 N-CA-C 111.721 0.267 . . . . 1.21 111.721 -175.074 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 149' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.445 -0.75 0 N-CA-C 111.748 -0.541 . . . . 0.47999999999999998 111.748 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' B' B ' 150' ' ' PRO . . . . . . . . . . . . . 90.0 Cg_endo -80.79 -0.69 10.78 Favored 'Trans proline' 0 N--CA 1.461 -0.389 0 C-N-CA 122.864 2.376 . . . . 0.33000000000000002 112.319 179.766 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 151' ' ' PHE . . . . . 0.594 ' CZ ' ' HA ' ' A' ' 73' ' ' LYS . 56.7 m-85 . . . . . 0 C--N 1.331 -0.207 0 N-CA-C 112.56 0.578 . . . . 0.75 112.56 -177.554 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 . . . . . 0 N--CA 1.455 -0.193 0 N-CA-C 109.755 -0.461 . . . . 3.1000000000000001 109.755 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 5.1 t90 -83.11 104.08 13.03 Favored 'General case' 0 N--CA 1.444 -0.764 0 N-CA-C 107.698 -1.223 . . . . 0.70999999999999996 107.698 168.93 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.422 ' HA ' ' HE3' ' A' ' 48' ' ' LYS . 29.7 m -69.82 4.89 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.234 0 CA-C-O 121.228 0.537 . . . . 1.45 111.628 -175.677 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.49 HG11 ' HA ' ' A' ' 108' ' ' LEU . 42.1 t -103.62 -29.48 2.9 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.818 0 CA-C-N 115.711 -0.677 . . . . 1.1000000000000001 109.874 172.239 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . 0.524 ' HA2' ' HB2' ' A' ' 50' ' ' LYS . . . -82.89 -10.12 83.47 Favored Glycine 0 N--CA 1.448 -0.54 0 CA-C-N 115.88 -0.6 . . . . 0.58999999999999997 113.023 -175.528 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . 0.422 ' HE3' ' HA ' ' A' ' 45' ' ' VAL . 17.2 ptpt -81.55 -25.89 35.48 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.772 0.32 . . . . 2.46 110.315 177.145 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 12.0 m-20 -110.11 33.21 4.58 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 108.948 -0.76 . . . . 1.6599999999999999 108.948 173.577 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . 0.667 ' N ' ' HD2' ' A' ' 51' ' ' PRO . 17.3 ttpp -77.35 -43.04 2.58 Favored Pre-proline 0 C--O 1.219 -0.538 0 CA-C-O 118.633 -0.699 . . . . 1.1499999999999999 112.067 -174.779 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . 0.667 ' HD2' ' N ' ' A' ' 50' ' ' LYS . 1.3 Cg_endo -44.74 -36.31 10.41 Favored 'Trans proline' 0 C--N 1.362 1.284 0 C-N-CA 123.0 2.467 . . . . 0.75 113.471 178.493 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 13.0 m -69.51 -45.49 68.75 Favored 'General case' 0 C--O 1.238 0.49 0 CA-C-O 121.111 0.481 . . . . 0.68000000000000005 110.459 178.657 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 21.7 m-85 -70.97 -22.35 62.21 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.027 -0.533 . . . . 0.68999999999999995 109.92 178.936 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -68.77 -45.03 72.44 Favored 'General case' 0 CA--C 1.513 -0.471 0 CA-C-N 116.163 -0.471 . . . . 2.1800000000000002 109.856 175.667 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -61.78 -44.85 96.07 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.79 -0.641 . . . . 2.3300000000000001 109.937 -179.821 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 45.0 mt -65.78 -40.95 89.17 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-N 115.798 -0.637 . . . . 0.64000000000000001 110.84 177.634 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 77.7 t80 -61.9 -39.34 91.66 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.677 -0.692 . . . . 0.28999999999999998 111.297 179.397 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 4.1 m-30 -79.79 -22.58 42.93 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.56 -0.291 . . . . 1.1699999999999999 111.2 -175.573 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 28.2 p -79.57 -10.15 59.75 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.72 0.295 . . . . 0.44 111.446 178.257 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 53.7 mt -88.92 -0.47 57.42 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.566 -0.288 . . . . 1.3700000000000001 110.246 175.274 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 55.7 m 62.43 81.04 0.24 Allowed Pre-proline 0 CA--C 1.533 0.313 0 O-C-N 123.788 0.68 . . . . 1.24 110.986 -176.86 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -76.61 157.54 36.02 Favored 'Trans proline' 0 N--CA 1.46 -0.482 0 C-N-CA 122.827 2.351 . . . . 0.46999999999999997 112.307 -179.011 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 15.4 m -123.96 115.64 45.61 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 CA-C-N 116.157 -0.474 . . . . 1.02 110.073 177.231 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 82.6 m-20 63.82 24.71 13.85 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 115.467 -0.788 . . . . 1.3400000000000001 111.375 179.809 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 88.69 10.52 67.19 Favored Glycine 0 C--N 1.33 0.224 0 C-N-CA 120.992 -0.623 . . . . 0.42999999999999999 112.957 178.334 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . 0.537 ' HE2' ' OD1' ' A' ' 102' ' ' ASP . 82.2 mttt -136.13 154.45 50.98 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 110.152 -0.314 . . . . 1.48 110.152 179.687 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 40.9 pt -116.77 159.16 16.93 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 C-N-CA 121.109 -0.236 . . . . 0.64000000000000001 110.397 174.942 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . 0.518 ' HA ' HD23 ' A' ' 100' ' ' LEU . 44.8 p -80.85 169.85 17.03 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.324 -0.398 . . . . 0.55000000000000004 110.148 -179.593 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . 0.541 ' O ' ' HB2' ' A' ' 73' ' ' LYS . . . -64.25 -16.98 61.0 Favored Glycine 0 N--CA 1.447 -0.626 0 C-N-CA 120.653 -0.784 . . . . 0.40999999999999998 112.503 177.314 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -68.86 -46.75 67.68 Favored 'General case' 0 C--O 1.235 0.325 0 CA-C-O 121.219 0.533 . . . . 0.38 111.743 -179.139 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 1.7 m120 -72.71 -43.17 63.35 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.815 -0.629 . . . . 1.8100000000000001 109.716 -174.575 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -64.1 -35.24 80.09 Favored 'General case' 0 N--CA 1.448 -0.568 0 CA-C-N 115.527 -0.761 . . . . 0.39000000000000001 110.137 176.061 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . 0.541 ' HB2' ' O ' ' A' ' 69' ' ' GLY . 34.3 tttp -56.23 -45.11 80.11 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 116.13 -0.486 . . . . 0.83999999999999997 110.194 176.259 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . 0.781 ' O ' ' HG2' ' A' ' 78' ' ' LYS . 45.8 mtpt -67.75 -31.38 71.26 Favored 'General case' 0 C--O 1.217 -0.651 0 CA-C-N 115.601 -0.727 . . . . 1.95 111.041 -178.742 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 13.9 tp10 -71.78 -47.52 52.89 Favored 'General case' 0 C--N 1.314 -0.971 0 CA-C-O 121.531 0.682 . . . . 1.6000000000000001 109.753 178.52 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' MET . . . . . 0.779 ' HG3' ' HZ ' ' B' ' 151' ' ' PHE . 16.0 mmt -55.52 -42.36 74.42 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.095 -0.957 . . . . 1.24 109.684 175.691 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.64 HG12 ' O ' ' A' ' 74' ' ' LYS . 1.1 p -74.12 -23.27 18.55 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.413 0 CA-C-N 115.276 -0.875 . . . . 1.5700000000000001 111.301 -177.226 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.781 ' HG2' ' O ' ' A' ' 74' ' ' LYS . 31.8 mmmt -73.56 -28.53 61.9 Favored 'General case' 0 CA--C 1.517 -0.319 0 CA-C-O 121.063 0.459 . . . . 2.79 109.872 176.165 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 45.1 m -81.91 -5.56 58.38 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.781 -0.645 . . . . 1.27 110.439 178.336 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 45.0 mttp 65.51 23.18 11.84 Favored 'General case' 0 N--CA 1.465 0.325 0 CA-C-N 115.418 -0.81 . . . . 2.9700000000000002 112.03 169.078 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.714 ' HB2' HD21 ' A' ' 86' ' ' LEU . 88.0 mt -85.59 148.65 49.64 Favored Pre-proline 0 C--N 1.322 -0.626 0 CA-C-N 116.413 -0.358 . . . . 0.52000000000000002 110.216 178.836 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . 0.534 ' O ' ' HG ' ' A' ' 86' ' ' LEU . 50.8 Cg_exo -54.91 137.34 75.46 Favored 'Trans proline' 0 C--N 1.344 0.294 0 C-N-CA 123.105 2.537 . . . . 0.44 112.206 179.043 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . 0.513 ' HA ' HD12 ' A' ' 86' ' ' LEU . 4.6 p30 -60.16 -34.81 74.09 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-N 115.954 -0.566 . . . . 1.8500000000000001 110.965 -174.225 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 63.3 m -63.39 -40.6 97.65 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.674 -0.694 . . . . 1.47 110.379 177.697 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.455 HG23 ' HB2' ' A' ' 82' ' ' PRO . 52.3 t -71.66 -34.49 52.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 115.835 -0.62 . . . . 0.45000000000000001 109.862 178.088 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.716 HD22 ' HB3' ' A' ' 76' ' ' MET . 77.1 mt -63.46 -33.9 76.57 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.969 -0.56 . . . . 0.90000000000000002 110.073 174.728 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -66.78 -38.05 92.78 Favored Glycine 0 N--CA 1.45 -0.423 0 N-CA-C 111.362 -0.695 . . . . 0.32000000000000001 111.362 176.064 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . 0.418 ' HB2' ' O ' ' A' ' 85' ' ' VAL . 71.7 mmtt -58.15 -49.48 76.87 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 109.974 -0.38 . . . . 1.8899999999999999 109.974 172.125 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 0.423 HG12 ' O ' ' A' ' 85' ' ' VAL . 40.3 mm -59.32 -48.4 87.15 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.197 0 CA-C-N 115.752 -0.658 . . . . 0.70999999999999996 111.294 -179.297 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' TRP . . . . . 0.414 ' HB2' ' HE2' ' B' ' 151' ' ' PHE . 41.8 t-105 -62.83 -45.16 93.9 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.937 0.398 . . . . 0.33000000000000002 111.087 -178.563 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 21.1 ttpp -64.27 -27.64 69.18 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.06 -0.518 . . . . 2.7000000000000002 111.285 -176.783 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.43 HD11 ' HG ' ' A' ' 126' ' ' LEU . 14.5 tp -93.9 -48.49 6.25 Favored 'General case' 0 N--CA 1.445 -0.696 0 N-CA-C 112.154 0.427 . . . . 1.6599999999999999 112.154 -175.946 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -73.3 -41.12 63.95 Favored 'General case' 0 N--CA 1.463 0.21 0 N-CA-C 111.847 0.314 . . . . 0.46999999999999997 111.847 -174.259 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . 0.622 ' OD2' ' HA ' ' A' ' 97' ' ' LYS . 21.9 t70 -78.08 96.34 5.11 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 108.965 -0.754 . . . . 0.79000000000000004 108.965 176.089 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 45.7 t -78.31 -36.22 20.51 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 CA-C-N 115.647 -0.706 . . . . 0.60999999999999999 111.08 -171.516 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 5.7 p30 -83.5 -11.39 57.51 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 116.042 -0.526 . . . . 0.95999999999999996 112.03 -174.942 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . 0.622 ' HA ' ' OD2' ' A' ' 94' ' ' ASP . 0.0 OUTLIER 59.08 30.89 20.8 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-O 121.26 0.552 . . . . 2.96 111.181 172.981 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . 0.643 ' OD2' ' HB2' ' A' ' 100' ' ' LEU . 8.6 p-10 -86.83 9.8 18.02 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 115.453 -0.794 . . . . 0.42999999999999999 111.24 -173.564 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 66.9 9.18 52.32 Favored Glycine 0 C--N 1.332 0.331 0 CA-C-N 116.089 -0.505 . . . . 0.44 112.476 -178.987 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.643 ' HB2' ' OD2' ' A' ' 98' ' ' ASP . 72.3 mt -135.18 161.45 35.32 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 109.145 -0.687 . . . . 1.1100000000000001 109.145 179.955 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 80.1 mt -117.86 125.5 50.64 Favored 'General case' 0 C--N 1.311 -1.09 0 C-N-CA 120.725 -0.39 . . . . 0.41999999999999998 110.035 176.73 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . 0.537 ' OD1' ' HE2' ' A' ' 66' ' ' LYS . 11.5 m-20 -68.94 172.51 6.5 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 108.111 -1.07 . . . . 1.72 108.111 172.939 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 2.0 p30 -63.16 -32.63 74.07 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 109.186 -0.672 . . . . 1.6000000000000001 109.186 177.113 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 51.9 mt-10 -72.16 -45.2 61.41 Favored 'General case' 0 N--CA 1.452 -0.336 0 CA-C-N 115.888 -0.596 . . . . 1.6599999999999999 110.956 175.463 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 29.7 mt-10 -64.89 -39.54 93.69 Favored 'General case' 0 N--CA 1.462 0.156 0 C-N-CA 120.818 -0.353 . . . . 0.44 110.449 -176.996 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 90.2 t80 -65.55 -40.87 93.33 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.298 -0.41 . . . . 0.41999999999999998 110.173 177.214 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -58.7 -47.42 84.62 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.246 -0.433 . . . . 0.22 110.688 176.158 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.49 ' HA ' HG11 ' A' ' 46' ' ' VAL . 60.4 tp -61.82 -45.94 91.65 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-N 116.32 -0.4 . . . . 1.3300000000000001 110.972 178.463 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . 0.677 ' O ' HG13 ' A' ' 113' ' ' ILE . . . -56.09 -57.16 13.32 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.052 -0.522 . . . . 0.32000000000000001 110.549 177.878 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' ASN . . . . . 0.515 ' HA ' HD12 ' A' ' 113' ' ' ILE . 1.1 t-20 -56.31 -36.27 68.5 Favored 'General case' 0 CA--C 1.521 -0.162 0 CA-C-N 116.049 -0.523 . . . . 1.2 111.395 179.684 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 13.3 t60 -63.67 -39.92 95.55 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.159 -0.473 . . . . 0.52000000000000002 110.174 -179.655 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 0.418 ' O ' HG12 ' A' ' 115' ' ' VAL . 94.6 mt -74.08 -39.86 63.15 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.27 -0.423 . . . . 0.55000000000000004 110.498 178.302 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.677 HG13 ' O ' ' A' ' 109' ' ' ALA . 54.0 mt -58.42 -49.53 81.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-O 121.531 0.681 . . . . 0.83999999999999997 110.361 177.647 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 114' ' ' LYS . . . . . 0.614 ' HE2' HD12 ' A' ' 117' ' ' LEU . 0.0 OUTLIER -71.31 -24.97 62.23 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.403 -0.817 . . . . 3.8300000000000001 110.827 -177.157 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . 0.418 HG12 ' O ' ' A' ' 112' ' ' LEU . 0.4 OUTLIER -72.78 -33.29 43.58 Favored 'Isoleucine or valine' 0 C--O 1.235 0.306 0 N-CA-C 109.75 -0.463 . . . . 1.1899999999999999 109.75 177.195 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 116' ' ' LYS . . . . . 0.458 ' HD2' ' O ' ' A' ' 120' ' ' HIS . 19.6 tptp -66.1 -39.5 90.03 Favored 'General case' 0 N--CA 1.442 -0.834 0 CA-C-N 116.125 -0.488 . . . . 1.3200000000000001 109.929 173.06 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . 0.614 HD12 ' HE2' ' A' ' 114' ' ' LYS . 80.1 mt -65.45 -23.54 66.96 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 116.066 -0.515 . . . . 0.95999999999999996 110.554 176.508 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 24.6 mm-40 -78.53 -7.01 57.05 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.918 -0.583 . . . . 2.1800000000000002 111.237 177.878 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 86.22 25.53 36.59 Favored Glycine 0 N--CA 1.448 -0.508 0 C-N-CA 120.652 -0.785 . . . . 1.1599999999999999 112.154 -179.277 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 120' ' ' HIS . . . . . 0.458 ' O ' ' HD2' ' A' ' 116' ' ' LYS . 97.5 m-70 -109.86 152.04 26.28 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 110.058 -0.349 . . . . 2.4199999999999999 110.058 178.029 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -108.12 155.75 20.05 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 116.015 -0.539 . . . . 2.5299999999999998 109.563 176.73 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -118.74 131.73 24.18 Favored Pre-proline 0 C--N 1.321 -0.653 0 CA-C-N 116.478 -0.328 . . . . 1.3300000000000001 110.33 -177.826 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_endo -71.19 -0.11 7.54 Favored 'Trans proline' 0 C--N 1.345 0.344 0 C-N-CA 123.274 2.649 . . . . 1.3300000000000001 113.438 -177.051 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . 62.92 21.25 12.75 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-O 121.526 0.679 . . . . 1.25 110.348 -175.405 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -103.74 142.78 33.76 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.107 -0.951 . . . . 2.73 108.53 178.552 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . 0.43 ' HG ' HD11 ' A' ' 92' ' ' LEU . 38.6 mt -115.27 90.96 26.22 Favored Pre-proline 0 C--N 1.321 -0.659 0 C-N-CA 120.943 -0.303 . . . . 1.6599999999999999 111.32 179.815 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 127' ' ' PRO . . . . . 0.497 ' HD2' HD12 ' A' ' 130' ' ' LEU . 41.7 Cg_endo -71.19 157.84 56.28 Favored 'Trans proline' 0 N--CA 1.46 -0.455 0 C-N-CA 122.678 2.252 . . . . 1.1699999999999999 111.45 173.248 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 128' ' ' PRO . . . . . 0.436 ' HA ' HG22 ' A' ' 131' ' ' VAL . 78.1 Cg_exo -52.41 -29.55 39.84 Favored 'Trans proline' 0 CA--C 1.535 0.527 0 C-N-CA 123.271 2.647 . . . . 1.54 114.155 -177.35 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 3.9 p-80 -83.36 1.85 39.25 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 120.476 -0.49 . . . . 1.0700000000000001 111.495 -178.988 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . 0.497 HD12 ' HD2' ' A' ' 127' ' ' PRO . 26.0 mt -113.98 -7.59 13.12 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 116.846 -0.161 . . . . 1.3600000000000001 111.304 175.149 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . 0.436 HG22 ' HA ' ' A' ' 128' ' ' PRO . 26.2 m -94.11 139.54 22.58 Favored Pre-proline 0 C--N 1.325 -0.471 0 CA-C-O 120.81 0.338 . . . . 1.28 110.145 177.452 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 132' ' ' PRO . . . . . 0.798 ' HG2' ' HB2' ' A' ' 135' ' ' LYS . 27.7 Cg_endo -63.08 143.95 91.55 Favored 'Trans proline' 0 C--O 1.234 0.285 0 C-N-CA 122.61 2.207 . . . . 0.81000000000000005 112.217 -178.111 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -54.19 -30.54 61.71 Favored 'Trans proline' 0 C--N 1.345 0.377 0 C-N-CA 123.142 2.562 . . . . 1.1699999999999999 112.961 179.254 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 50.2 p -75.36 -25.19 57.53 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 121.118 0.485 . . . . 1.6000000000000001 111.515 -178.097 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 135' ' ' LYS . . . . . 0.798 ' HB2' ' HG2' ' A' ' 132' ' ' PRO . 87.9 mttt . . . . . 0 C--N 1.325 -0.495 0 CA-C-N 116.243 -0.435 . . . . 1.21 110.976 -173.308 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 149' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.446 -0.67 0 N-CA-C 111.541 -0.623 . . . . 0.47999999999999998 111.541 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' B' B ' 150' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -77.59 -1.84 12.0 Favored 'Trans proline' 0 N--CA 1.463 -0.282 0 C-N-CA 122.753 2.302 . . . . 0.33000000000000002 112.712 -178.334 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 151' ' ' PHE . . . . . 0.779 ' HZ ' ' HG3' ' A' ' 76' ' ' MET . 48.1 m-85 . . . . . 0 C--N 1.324 -0.508 0 CA-C-N 116.574 -0.284 . . . . 0.75 110.813 -178.448 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 26.9 mt-10 . . . . . 0 C--O 1.235 0.293 0 CA-C-O 120.612 0.244 . . . . 3.1000000000000001 111.206 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' TRP . . . . . 0.553 ' CE3' ' HD3' ' A' ' 133' ' ' PRO . 5.1 t90 -83.84 111.04 18.85 Favored 'General case' 0 C--N 1.332 -0.191 0 N-CA-C 109.486 -0.561 . . . . 0.70999999999999996 109.486 179.451 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 12.0 p -60.85 -27.36 41.0 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-N 116.08 -0.509 . . . . 1.45 111.662 -176.911 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 21.5 t -85.17 -11.44 11.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 120.962 0.411 . . . . 1.1000000000000001 111.438 -177.367 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -66.38 -15.51 63.69 Favored Glycine 0 CA--C 1.518 0.231 0 C-N-CA 120.884 -0.674 . . . . 0.58999999999999997 113.565 -174.339 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 4.0 ptpp? -91.32 -27.64 18.26 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.787 0.294 . . . . 2.46 111.526 -179.201 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 27.5 m-20 -92.44 32.23 1.23 Allowed 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 120.648 -0.421 . . . . 1.6599999999999999 110.506 -175.692 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 7.8 mtpm? -79.78 -49.36 1.33 Allowed Pre-proline 0 C--O 1.214 -0.803 0 CA-C-O 118.544 -0.741 . . . . 1.1499999999999999 112.728 -175.377 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 82.8 Cg_exo -43.1 -37.2 6.4 Favored 'Trans proline' 0 C--N 1.354 0.822 0 C-N-CA 122.156 1.904 . . . . 0.75 113.502 -178.928 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -71.88 -45.97 59.48 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.012 0.434 . . . . 0.68000000000000005 111.878 179.238 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 12.8 m-85 -79.14 -22.31 45.3 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.508 -0.315 . . . . 0.68999999999999995 110.153 -175.585 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -70.93 -40.56 72.02 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 108.628 -0.879 . . . . 2.1800000000000002 108.628 173.553 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 20.6 tp10 -55.18 -48.34 73.94 Favored 'General case' 0 C--O 1.232 0.152 0 CA-C-N 114.988 -1.006 . . . . 2.3300000000000001 109.923 176.16 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 40.5 mt -71.77 -38.36 65.6 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-N 115.541 -0.754 . . . . 0.64000000000000001 110.907 178.968 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . 0.424 ' CE1' HG23 ' A' ' 67' ' ' ILE . 58.1 t80 -56.15 -34.96 66.63 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 116.022 -0.535 . . . . 0.28999999999999998 111.576 -177.773 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 9.8 m-85 -88.81 5.46 43.53 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 112.194 0.442 . . . . 1.1699999999999999 112.194 -175.871 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 80.4 p -98.98 -17.67 18.19 Favored 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 120.49 -0.484 . . . . 0.44 110.558 175.951 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.44 HD13 ' HA ' ' A' ' 60' ' ' LEU . 3.3 mm? -93.58 9.59 36.14 Favored 'General case' 0 N--CA 1.462 0.168 0 CA-C-N 116.225 -0.443 . . . . 1.3700000000000001 110.962 179.257 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 19.0 m 65.27 87.3 0.12 Allowed Pre-proline 0 N--CA 1.466 0.36 0 CA-C-N 115.538 -0.756 . . . . 1.24 111.647 179.061 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 95.3 Cg_endo -88.91 139.52 3.81 Favored 'Trans proline' 0 N--CA 1.456 -0.682 0 C-N-CA 122.754 2.303 . . . . 0.46999999999999997 113.39 -178.966 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 15.4 m -113.7 117.94 56.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 115.904 -0.589 . . . . 1.02 110.272 176.294 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 93.1 m-20 63.03 23.33 13.94 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 115.837 -0.62 . . . . 1.3400000000000001 110.827 -178.157 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 78.4 24.69 62.66 Favored Glycine 0 N--CA 1.448 -0.526 0 C-N-CA 120.72 -0.752 . . . . 0.42999999999999999 112.0 -177.367 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 24.4 mtpp -136.45 140.76 43.36 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 109.428 -0.582 . . . . 1.48 109.428 178.076 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . 0.424 HG23 ' CE1' ' A' ' 57' ' ' PHE . 45.8 pt -115.44 160.03 15.03 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 C-N-CA 120.614 -0.435 . . . . 0.64000000000000001 110.668 175.286 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . 0.401 ' HA ' HD23 ' A' ' 100' ' ' LEU . 24.0 p -79.26 158.99 27.47 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.664 -0.698 . . . . 0.55000000000000004 110.867 179.992 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . 0.44 ' O ' ' HB2' ' A' ' 73' ' ' LYS . . . -64.98 -18.06 64.05 Favored Glycine 0 C--O 1.221 -0.656 0 C-N-CA 120.895 -0.669 . . . . 0.40999999999999998 112.392 179.572 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.489 ' O ' ' HG3' ' A' ' 74' ' ' LYS . . . -62.33 -45.42 93.29 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.072 0.463 . . . . 0.38 111.385 179.818 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 48.1 m-80 -79.59 -34.84 40.42 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.216 -0.447 . . . . 1.8100000000000001 110.623 -176.494 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -61.62 -39.71 92.26 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 109.368 -0.605 . . . . 0.39000000000000001 109.368 173.054 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . 0.44 ' HB2' ' O ' ' A' ' 69' ' ' GLY . 78.9 tttt -57.87 -44.32 86.55 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 114.96 -1.018 . . . . 0.83999999999999997 110.141 176.099 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . 0.731 ' O ' ' HG2' ' A' ' 78' ' ' LYS . 96.0 mttt -55.73 -54.66 41.58 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.726 -0.67 . . . . 1.95 110.926 178.701 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . 0.473 ' HA ' ' OE1' ' A' ' 75' ' ' GLU . 12.6 tp10 -64.34 -40.05 95.11 Favored 'General case' 0 C--O 1.239 0.538 0 CA-C-O 121.125 0.488 . . . . 1.6000000000000001 111.151 -176.871 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' MET . . . . . 0.83 ' HB3' HD22 ' A' ' 86' ' ' LEU . 18.8 mmt -57.12 -47.05 82.05 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.892 -0.595 . . . . 1.24 111.358 179.607 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 25.4 m -74.29 -18.07 16.93 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.422 0 C-N-CA 120.798 -0.361 . . . . 1.5700000000000001 111.381 -178.861 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.731 ' HG2' ' O ' ' A' ' 74' ' ' LYS . 46.2 mmtm -76.25 -20.95 56.92 Favored 'General case' 0 N--CA 1.463 0.186 0 CA-C-O 121.265 0.555 . . . . 2.79 109.614 174.322 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 16.9 m -79.68 2.17 23.65 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-N 115.497 -0.774 . . . . 1.27 111.729 -178.174 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 7.3 mtpm? 65.98 22.39 11.26 Favored 'General case' 0 N--CA 1.471 0.575 0 C-N-CA 123.224 0.61 . . . . 2.9700000000000002 112.196 175.468 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.64 ' HB2' HD21 ' A' ' 86' ' ' LEU . 93.2 mt -95.58 147.18 32.61 Favored Pre-proline 0 C--N 1.325 -0.474 0 N-CA-C 110.012 -0.366 . . . . 0.52000000000000002 110.012 178.239 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . 0.484 ' O ' ' HG ' ' A' ' 86' ' ' LEU . 1.5 Cg_endo -73.2 156.22 51.33 Favored 'Trans proline' 0 N--CA 1.457 -0.619 0 C-N-CA 122.293 1.995 . . . . 0.44 112.178 -178.885 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 88.6 m-20 -55.16 -38.96 68.96 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-N 115.973 -0.558 . . . . 1.8500000000000001 111.503 -176.482 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . 0.599 ' O ' ' HG2' ' A' ' 88' ' ' LYS . 3.1 p -57.55 -51.38 69.72 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.119 -0.491 . . . . 1.47 111.121 178.323 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 93.0 t -63.37 -40.94 90.94 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 115.578 -0.737 . . . . 0.45000000000000001 110.834 -179.908 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.83 HD22 ' HB3' ' A' ' 76' ' ' MET . 83.5 mt -62.47 -37.37 85.7 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.138 -0.483 . . . . 0.90000000000000002 110.715 179.199 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -68.61 -35.45 80.91 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.889 -0.672 . . . . 0.32000000000000001 111.632 178.906 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . 0.599 ' HG2' ' O ' ' A' ' 84' ' ' THR . 74.8 mmtt -61.41 -52.75 63.29 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 109.419 -0.586 . . . . 1.8899999999999999 109.419 176.064 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 0.523 HG23 HD12 ' A' ' 112' ' ' LEU . 42.5 mt -62.7 -38.88 82.79 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.374 0 CA-C-N 115.396 -0.82 . . . . 0.70999999999999996 111.532 -177.093 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 64.7 t-105 -60.97 -45.77 93.44 Favored 'General case' 0 C--N 1.332 -0.19 0 C-N-CA 120.688 -0.405 . . . . 0.33000000000000002 110.731 177.134 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 39.3 ttpt -66.48 -24.46 66.41 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.295 -0.411 . . . . 2.7000000000000002 110.879 -177.319 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.455 ' HG ' ' O ' ' A' ' 88' ' ' LYS . 96.2 mt -86.03 -52.05 5.95 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.51 -0.314 . . . . 1.6599999999999999 111.657 -179.784 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . 0.436 ' HA ' HD23 ' A' ' 108' ' ' LEU . . . -64.86 -38.74 91.98 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.198 -0.455 . . . . 0.46999999999999997 111.687 -174.093 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . 0.439 ' OD2' ' HA ' ' A' ' 97' ' ' LYS . 25.6 t0 -81.71 97.11 7.77 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 109.44 -0.578 . . . . 0.79000000000000004 109.44 178.948 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 44.3 t -82.77 -36.86 13.58 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-N 115.119 -0.946 . . . . 0.60999999999999999 111.376 -173.969 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 1.9 p30 -87.0 -6.4 58.77 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.957 -0.565 . . . . 0.95999999999999996 111.166 -176.544 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . 0.439 ' HA ' ' OD2' ' A' ' 94' ' ' ASP . 23.9 mmmt 59.95 38.74 20.81 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 115.651 -0.704 . . . . 2.96 110.814 173.35 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 15.9 p-10 -98.52 9.06 44.05 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.131 -0.486 . . . . 0.42999999999999999 111.602 -173.817 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 66.07 6.72 33.55 Favored Glycine 0 C--N 1.333 0.389 0 C-N-CA 120.867 -0.682 . . . . 0.44 113.016 178.692 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.401 HD23 ' HA ' ' A' ' 68' ' ' THR . 90.0 mt -131.39 157.4 43.53 Favored 'General case' 0 N--CA 1.446 -0.659 0 N-CA-C 109.575 -0.528 . . . . 1.1100000000000001 109.575 -178.95 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 83.1 mt -116.23 115.96 26.92 Favored 'General case' 0 C--N 1.315 -0.928 0 C-N-CA 120.669 -0.412 . . . . 0.41999999999999998 110.481 177.491 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -70.55 173.19 7.33 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 108.672 -0.862 . . . . 1.72 108.672 171.85 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -57.85 -30.54 65.86 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 109.706 -0.479 . . . . 1.6000000000000001 109.706 175.978 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 38.2 mt-10 -66.31 -56.79 9.47 Favored 'General case' 0 C--O 1.235 0.294 0 CA-C-N 115.762 -0.654 . . . . 1.6599999999999999 111.192 175.242 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . 0.582 ' CG ' ' HE3' ' A' ' 135' ' ' LYS . 24.4 mt-10 -68.28 -34.93 77.07 Favored 'General case' 0 C--N 1.331 -0.202 0 C-N-CA 121.006 -0.278 . . . . 0.44 110.802 -173.561 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 84.8 t80 -69.15 -35.25 76.14 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 109.889 -0.412 . . . . 0.41999999999999998 109.889 178.247 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -60.47 -42.15 95.65 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.009 0.433 . . . . 0.22 109.96 175.452 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.436 HD23 ' HA ' ' A' ' 93' ' ' ALA . 53.2 tp -66.62 -45.88 77.68 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.183 -0.462 . . . . 1.3300000000000001 110.715 177.672 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -57.41 -50.38 73.17 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.24 -0.436 . . . . 0.32000000000000001 111.172 179.0 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -66.88 -30.61 70.83 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.161 -0.472 . . . . 1.2 110.979 179.349 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' HIS . . . . . 0.467 ' O ' HG23 ' A' ' 115' ' ' VAL . 55.6 t60 -64.51 -44.5 90.7 Favored 'General case' 0 C--O 1.22 -0.476 0 N-CA-C 109.749 -0.463 . . . . 0.52000000000000002 109.749 177.057 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 0.523 HD12 HG23 ' A' ' 89' ' ' ILE . 88.3 mt -63.81 -41.11 97.96 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.308 -0.406 . . . . 0.55000000000000004 110.494 178.534 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 81.2 mt -55.45 -51.76 53.76 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.308 0 CA-C-O 121.166 0.508 . . . . 0.83999999999999997 110.296 174.092 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 114' ' ' LYS . . . . . 0.401 ' HA ' ' HD2' ' A' ' 114' ' ' LYS . 14.3 tptm -60.12 -48.54 81.28 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.329 -0.85 . . . . 3.8300000000000001 110.809 -179.188 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . 0.498 HG12 ' HB2' ' A' ' 120' ' ' HIS . 54.4 t -62.75 -36.63 76.25 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-N 115.919 -0.582 . . . . 1.1899999999999999 111.091 -177.736 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 116' ' ' LYS . . . . . 0.411 ' HB3' ' HE3' ' A' ' 116' ' ' LYS . 23.2 mmmt -64.47 -50.88 65.75 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.627 -0.261 . . . . 1.3200000000000001 110.99 176.245 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 89.9 mt -69.06 -25.26 64.36 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.196 -0.457 . . . . 0.95999999999999996 110.91 -178.919 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 31.6 tt0 -72.0 -14.78 61.98 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.057 -0.519 . . . . 2.1800000000000002 110.583 179.504 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 107.47 28.51 4.83 Favored Glycine 0 N--CA 1.446 -0.635 0 C-N-CA 120.434 -0.889 . . . . 1.1599999999999999 113.042 176.774 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 120' ' ' HIS . . . . . 0.498 ' HB2' HG12 ' A' ' 115' ' ' VAL . 28.6 m-70 -121.38 156.75 31.97 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 109.397 -0.594 . . . . 2.4199999999999999 109.397 176.276 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -117.1 144.84 44.23 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 110.276 -0.268 . . . . 2.5299999999999998 110.276 177.327 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . 0.448 ' H ' ' HG ' ' A' ' 122' ' ' LEU . 2.1 pp -97.39 145.51 29.79 Favored Pre-proline 0 C--N 1.323 -0.569 0 CA-C-N 116.376 -0.374 . . . . 1.3300000000000001 110.756 -178.379 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 8.2 Cg_exo -73.31 -5.38 17.04 Favored 'Trans proline' 0 N--CA 1.465 -0.163 0 C-N-CA 122.927 2.418 . . . . 1.3300000000000001 112.636 -178.277 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . 69.9 19.05 7.15 Favored 'General case' 0 N--CA 1.464 0.275 0 O-C-N 123.734 0.646 . . . . 1.25 111.232 -179.265 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 20.7 m-20 -116.52 171.6 7.75 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 109.359 -0.608 . . . . 2.73 109.359 174.543 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 36.3 tp -115.62 97.42 48.73 Favored Pre-proline 0 C--N 1.325 -0.466 0 CA-C-O 120.965 0.412 . . . . 1.6599999999999999 110.486 177.582 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 127' ' ' PRO . . . . . 0.432 ' HD2' HD12 ' A' ' 130' ' ' LEU . 74.4 Cg_endo -75.97 156.03 38.63 Favored 'Trans proline' 0 CA--C 1.534 0.517 0 C-N-CA 122.962 2.442 . . . . 1.1699999999999999 112.417 178.232 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 11.3 Cg_endo -54.95 -34.7 87.42 Favored 'Trans proline' 0 C--N 1.347 0.482 0 C-N-CA 123.395 2.73 . . . . 1.54 113.677 -175.76 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 4.4 p-80 -79.96 7.63 8.58 Favored 'General case' 0 N--CA 1.465 0.302 0 C-N-CA 120.811 -0.356 . . . . 1.0700000000000001 111.76 -177.595 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . 0.432 HD12 ' HD2' ' A' ' 127' ' ' PRO . 29.3 mt -116.98 5.58 12.89 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.533 0.206 . . . . 1.3600000000000001 111.085 175.121 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 62.8 t -85.3 123.31 73.3 Favored Pre-proline 0 C--N 1.324 -0.51 0 CA-C-N 116.49 -0.323 . . . . 1.28 110.513 178.43 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 132' ' ' PRO . . . . . 0.483 ' HA ' ' HD3' ' A' ' 133' ' ' PRO . 53.6 Cg_exo -54.06 143.33 62.61 Favored 'Trans proline' 0 CA--C 1.534 0.521 0 C-N-CA 123.016 2.478 . . . . 0.81000000000000005 112.724 179.351 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 133' ' ' PRO . . . . . 0.553 ' HD3' ' CE3' ' A' ' 44' ' ' TRP . 23.7 Cg_exo -62.97 -35.27 67.32 Favored 'Trans proline' 0 C--N 1.347 0.454 0 C-N-CA 122.937 2.424 . . . . 1.1699999999999999 113.626 -175.005 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 23.2 t -87.44 0.01 56.15 Favored 'General case' 0 C--N 1.323 -0.573 0 C-N-CA 120.707 -0.397 . . . . 1.6000000000000001 111.249 -175.216 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 135' ' ' LYS . . . . . 0.582 ' HE3' ' CG ' ' A' ' 105' ' ' GLU . 62.6 mttm . . . . . 0 C--N 1.327 -0.4 0 CA-C-O 120.905 0.383 . . . . 1.21 111.342 -176.762 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 149' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.445 -0.752 0 N-CA-C 111.099 -0.8 . . . . 0.47999999999999998 111.099 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' B' B ' 150' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -74.93 -3.84 14.52 Favored 'Trans proline' 0 CA--C 1.53 0.293 0 C-N-CA 122.991 2.461 . . . . 0.33000000000000002 113.118 -173.888 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 151' ' ' PHE . . . . . 0.551 ' CZ ' ' HG3' ' A' ' 76' ' ' MET . 61.2 m-85 . . . . . 0 C--N 1.327 -0.396 0 CA-C-O 120.788 0.328 . . . . 0.75 110.955 -179.388 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.758 0 N-CA-C 111.602 -0.599 . . . . 10.970000000000001 111.602 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 9.0 Cg_endo -87.91 113.67 0.85 Allowed 'Trans proline' 0 N--CA 1.452 -0.93 0 C-N-CA 123.2 2.6 . . . . 9.0 112.11 179.263 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -92.34 -48.29 6.74 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.16 -0.473 . . . . 7.4199999999999999 109.732 177.157 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -84.75 60.67 4.79 Favored Glycine 0 N--CA 1.449 -0.482 0 C-N-CA 121.047 -0.596 . . . . 4.46 111.757 178.975 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 5.6 m -86.77 115.44 24.21 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 110.299 -0.26 . . . . 3.9700000000000002 110.299 179.698 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 10.9 m-20 -76.75 93.1 3.63 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.315 0.579 . . . . 3.46 110.261 175.853 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 7.0 t70 -125.63 106.87 10.06 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.466 -0.788 . . . . 1.9299999999999999 108.955 179.858 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 15.0 p -77.47 137.23 22.72 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-O 120.968 0.414 . . . . 1.8500000000000001 111.128 -174.978 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -66.92 128.81 37.74 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.399 -0.819 . . . . 3.1000000000000001 111.124 -177.587 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 6.4 t90 -82.39 106.01 13.92 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 109.333 -0.617 . . . . 0.70999999999999996 109.333 178.089 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.574 ' O ' ' HG2' ' A' ' 48' ' ' LYS . 9.7 p -67.5 -7.0 5.67 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.546 0 CA-C-N 115.562 -0.744 . . . . 1.45 112.236 -171.812 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 57.9 t -80.7 -24.81 11.02 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-O 120.742 0.306 . . . . 1.1000000000000001 110.759 178.393 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -74.0 -9.19 79.69 Favored Glycine 0 CA--C 1.519 0.284 0 C-N-CA 120.788 -0.72 . . . . 0.58999999999999997 113.215 -175.342 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . 0.574 ' HG2' ' O ' ' A' ' 45' ' ' VAL . 18.7 ptmt -74.23 -27.77 60.93 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 117.134 0.467 . . . . 2.46 111.175 -176.651 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 36.9 t0 -125.36 33.25 5.18 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.608 0.718 . . . . 1.6599999999999999 109.453 -179.671 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 0.644 ' N ' ' HD2' ' A' ' 51' ' ' PRO . 51.3 tttt -72.65 -43.86 8.97 Favored Pre-proline 0 C--N 1.321 -0.632 0 CA-C-N 115.471 -0.786 . . . . 1.1499999999999999 112.059 -175.481 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.644 ' HD2' ' N ' ' A' ' 50' ' ' LYS . 1.7 Cg_endo -45.77 -37.07 15.78 Favored 'Trans proline' 0 C--N 1.359 1.082 0 C-N-CA 123.122 2.548 . . . . 0.75 113.184 176.692 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 24.2 m -68.36 -46.61 69.64 Favored 'General case' 0 C--O 1.239 0.54 0 CA-C-O 121.198 0.523 . . . . 0.68000000000000005 110.304 -179.471 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 5.0 m-85 -75.11 -20.24 59.55 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.867 -0.606 . . . . 0.68999999999999995 109.423 -178.451 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 7.6 t70 -67.26 -45.23 77.29 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.42 -0.809 . . . . 2.1800000000000002 110.036 175.128 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 29.4 mt-10 -67.31 -29.17 68.68 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.229 -0.442 . . . . 2.3300000000000001 110.593 178.715 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 54.0 mt -78.87 -29.42 14.25 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-O 121.386 0.612 . . . . 0.64000000000000001 110.587 175.792 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . 0.554 ' CE2' ' HB3' ' A' ' 62' ' ' PRO . 72.8 t80 -71.2 -41.08 70.74 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.961 -0.563 . . . . 0.28999999999999998 110.623 178.765 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . 0.614 ' HA ' ' HG3' ' A' ' 62' ' ' PRO . 2.5 m-85 -78.23 -12.45 60.0 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.917 -0.583 . . . . 1.1699999999999999 111.656 -176.049 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 3.8 p -91.88 -7.61 48.81 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 120.96 0.409 . . . . 0.44 110.988 178.655 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 89.1 mt -100.77 11.49 39.45 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-N 116.015 -0.539 . . . . 1.3700000000000001 110.5 177.75 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 24.6 m 65.65 85.28 0.16 Allowed Pre-proline 0 N--CA 1.463 0.213 0 CA-C-N 115.363 -0.835 . . . . 1.24 111.8 178.347 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . 0.614 ' HG3' ' HA ' ' A' ' 58' ' ' TYR . 4.6 Cg_endo -85.59 130.87 3.87 Favored 'Trans proline' 0 N--CA 1.454 -0.795 0 C-N-CA 122.996 2.464 . . . . 0.46999999999999997 112.162 178.626 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 60.2 t -112.25 108.83 26.51 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 N-CA-C 109.755 -0.461 . . . . 1.02 109.755 177.477 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 92.0 m-20 62.15 30.03 17.65 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.664 -0.698 . . . . 1.3400000000000001 111.922 178.029 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 94.58 3.38 62.78 Favored Glycine 0 CA--C 1.519 0.296 0 C-N-CA 120.792 -0.718 . . . . 0.42999999999999999 113.817 173.668 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 55.5 mttm -129.37 150.53 50.69 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 117.135 0.467 . . . . 1.48 110.488 177.555 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 33.7 pt -117.66 159.67 17.72 Favored 'Isoleucine or valine' 0 C--O 1.24 0.605 0 CA-C-O 121.264 0.554 . . . . 0.64000000000000001 110.455 172.836 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 22.4 p -72.28 151.67 42.64 Favored 'General case' 0 N--CA 1.446 -0.64 0 CA-C-N 114.915 -1.038 . . . . 0.55000000000000004 110.784 179.046 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -71.05 -10.47 68.63 Favored Glycine 0 C--O 1.222 -0.63 0 C-N-CA 120.744 -0.741 . . . . 0.40999999999999998 111.609 179.957 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -70.52 -40.85 73.25 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.069 0.461 . . . . 0.38 111.181 178.65 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 30.2 m-80 -81.13 -33.09 33.43 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.971 -0.559 . . . . 1.8100000000000001 110.34 -178.409 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -62.95 -46.41 87.88 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 109.424 -0.584 . . . . 0.39000000000000001 109.424 171.558 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . 0.422 ' HA ' ' CE1' ' B' ' 151' ' ' PHE . 54.6 tttp -52.25 -43.38 64.33 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 115.248 -0.887 . . . . 0.83999999999999997 110.414 174.671 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . 0.54 ' O ' ' HG2' ' A' ' 78' ' ' LYS . 35.5 ttpt -59.16 -49.91 76.05 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.239 -0.891 . . . . 1.95 111.397 179.037 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 3.1 tp10 -59.32 -47.98 83.35 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.359 0.599 . . . . 1.6000000000000001 110.514 177.108 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' MET . . . . . 0.726 ' HB3' HD22 ' A' ' 86' ' ' LEU . 70.9 mmm -55.75 -47.09 77.57 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.383 -0.826 . . . . 1.24 111.457 -177.819 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 29.5 m -75.56 -20.7 15.95 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.362 0 N-CA-C 111.702 0.26 . . . . 1.5700000000000001 111.702 -177.641 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.54 ' HG2' ' O ' ' A' ' 74' ' ' LYS . 24.0 mmtp -72.96 -27.46 61.84 Favored 'General case' 0 CA--C 1.52 -0.196 0 CA-C-O 121.111 0.482 . . . . 2.79 110.151 174.723 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 66.1 m -85.59 5.09 33.22 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.831 -0.622 . . . . 1.27 111.291 179.286 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . 0.446 ' NZ ' ' HB3' ' A' ' 80' ' ' LYS . 5.0 mmmp? 62.9 31.92 16.0 Favored 'General case' 0 C--O 1.235 0.328 0 N-CA-C 113.343 0.868 . . . . 2.9700000000000002 113.343 170.188 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.432 ' HA ' ' HD3' ' A' ' 82' ' ' PRO . 87.0 mt -87.29 136.54 33.41 Favored Pre-proline 0 C--N 1.322 -0.624 0 C-N-CA 120.651 -0.42 . . . . 0.52000000000000002 110.335 176.813 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . 0.563 ' O ' ' HG ' ' A' ' 86' ' ' LEU . 32.0 Cg_exo -58.7 152.76 54.14 Favored 'Trans proline' 0 C--N 1.344 0.332 0 C-N-CA 122.795 2.33 . . . . 0.44 111.991 178.261 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . 0.551 ' HA ' HD12 ' A' ' 86' ' ' LEU . 17.6 m120 -55.21 -33.53 63.14 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-N 116.481 -0.327 . . . . 1.8500000000000001 111.658 -177.088 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 7.3 p -63.78 -46.64 84.31 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.255 0.55 . . . . 1.47 110.674 177.161 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.494 ' O ' HG12 ' A' ' 89' ' ' ILE . 47.8 t -69.1 -32.75 55.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 115.616 -0.72 . . . . 0.45000000000000001 110.61 -179.871 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.726 HD22 ' HB3' ' A' ' 76' ' ' MET . 79.7 mt -57.58 -46.67 83.72 Favored 'General case' 0 C--O 1.238 0.471 0 CA-C-N 116.119 -0.491 . . . . 0.90000000000000002 110.098 176.188 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -66.62 -35.39 89.82 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.821 -0.704 . . . . 0.32000000000000001 111.625 178.282 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 48.3 mmtt -57.21 -52.46 65.23 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-O 120.907 0.384 . . . . 1.8899999999999999 110.819 175.52 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.605 ' HB ' ' HE1' ' A' ' 76' ' ' MET . 50.6 mm -61.16 -47.0 95.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 115.581 -0.736 . . . . 0.70999999999999996 110.938 -177.675 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 50.0 t-105 -59.21 -46.87 87.3 Favored 'General case' 0 CA--C 1.53 0.198 0 CA-C-O 120.825 0.345 . . . . 0.33000000000000002 110.984 179.511 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 17.0 ttmm -54.42 -37.8 65.53 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 115.71 -0.677 . . . . 2.7000000000000002 112.025 178.319 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.749 HD11 ' HA ' ' A' ' 124' ' ' ALA . 96.9 mt -86.22 -29.95 22.77 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.5 -0.318 . . . . 1.6599999999999999 111.774 -176.907 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . 0.683 ' HA ' HD22 ' A' ' 108' ' ' LEU . . . -79.57 -42.31 25.29 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 116.458 -0.337 . . . . 0.46999999999999997 111.868 -175.659 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -102.99 95.14 5.95 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.186 0.517 . . . . 0.79000000000000004 110.197 -177.994 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 32.3 t -67.47 -40.52 84.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 115.388 -0.824 . . . . 0.60999999999999999 111.53 -174.27 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 13.2 p-10 -90.0 -20.09 23.68 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.24 -0.437 . . . . 0.95999999999999996 110.919 -175.994 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.513 ' NZ ' ' HB2' ' A' ' 97' ' ' LYS . 8.0 mtmp? 66.33 60.4 0.62 Allowed 'General case' 0 C--O 1.233 0.21 0 CA-C-N 115.848 -0.615 . . . . 2.96 111.038 177.164 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . 0.657 ' OD1' 'CA ' ' A' ' 141' ' ' ' CA' . 11.2 p-10 -94.3 9.57 37.61 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.211 -0.45 . . . . 0.42999999999999999 110.907 -179.598 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 73.99 -19.03 1.78 Allowed Glycine 0 CA--C 1.519 0.329 0 CA-C-N 116.025 -0.534 . . . . 0.44 113.346 175.592 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 94.7 mt -113.35 151.63 30.99 Favored 'General case' 0 C--N 1.318 -0.775 0 N-CA-C 108.889 -0.782 . . . . 1.1100000000000001 108.889 178.227 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 58.5 mt -104.04 119.99 40.12 Favored 'General case' 0 C--N 1.318 -0.796 0 C-N-CA 120.414 -0.514 . . . . 0.41999999999999998 110.519 178.762 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . 0.579 ' HB2' ' HG3' ' A' ' 105' ' ' GLU . 20.6 m-20 -69.38 168.61 14.03 Favored 'General case' 0 CA--C 1.513 -0.46 0 N-CA-C 108.721 -0.844 . . . . 1.72 108.721 171.586 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 12.7 p-10 -59.99 -35.89 76.0 Favored 'General case' 0 C--N 1.317 -0.845 0 N-CA-C 109.612 -0.514 . . . . 1.6000000000000001 109.612 176.094 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 37.5 mm-40 -65.57 -51.17 61.76 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-N 115.668 -0.697 . . . . 1.6599999999999999 110.288 176.138 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . 0.579 ' HG3' ' HB2' ' A' ' 102' ' ' ASP . 42.5 mt-10 -64.41 -42.78 95.89 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.75 -0.659 . . . . 0.44 111.074 -174.404 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 90.2 t80 -66.91 -34.89 78.78 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.245 -0.434 . . . . 0.41999999999999998 110.434 -179.574 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -60.8 -40.4 92.53 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.874 0.368 . . . . 0.22 110.326 175.667 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.683 HD22 ' HA ' ' A' ' 93' ' ' ALA . 6.9 tt -66.45 -50.21 64.11 Favored 'General case' 0 C--O 1.237 0.409 0 CA-C-N 116.217 -0.447 . . . . 1.3300000000000001 110.094 178.791 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . 0.64 ' O ' HG13 ' A' ' 113' ' ' ILE . . . -54.59 -55.98 23.76 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 115.961 -0.563 . . . . 0.32000000000000001 110.728 178.072 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' ASN . . . . . 0.625 ' HA ' HD12 ' A' ' 113' ' ' ILE . 0.7 OUTLIER -52.93 -39.91 63.22 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.662 -0.699 . . . . 1.2 111.176 179.98 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' HIS . . . . . 0.415 ' O ' HG23 ' A' ' 115' ' ' VAL . 37.2 t60 -60.54 -53.26 59.65 Favored 'General case' 0 C--O 1.223 -0.295 0 N-CA-C 110.115 -0.328 . . . . 0.52000000000000002 110.115 178.548 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 92.5 mt -54.87 -42.98 72.73 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-O 120.975 0.417 . . . . 0.55000000000000004 110.775 179.42 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.64 HG13 ' O ' ' A' ' 109' ' ' ALA . 70.6 mt -57.5 -56.63 14.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 115.542 -0.754 . . . . 0.83999999999999997 111.488 -179.374 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . 0.517 ' HG2' ' O ' ' A' ' 110' ' ' ASN . 63.2 mmtt -69.55 -32.99 72.12 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.69 -0.687 . . . . 3.8300000000000001 110.644 -174.261 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.529 HG12 ' HB2' ' A' ' 120' ' ' HIS . 51.5 t -62.96 -33.78 62.51 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-N 115.914 -0.585 . . . . 1.1899999999999999 110.679 174.212 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 3.5 mmmp? -68.27 -37.19 80.46 Favored 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 120.694 -0.402 . . . . 1.3200000000000001 110.19 173.225 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 98.1 mt -67.66 -27.78 67.14 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.201 -0.454 . . . . 0.95999999999999996 110.537 177.328 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . 0.408 ' HB2' ' O ' ' A' ' 115' ' ' VAL . 45.8 mt-10 -64.85 -22.41 66.99 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.06 -0.518 . . . . 2.1800000000000002 111.165 174.819 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 106.28 10.82 28.86 Favored Glycine 0 N--CA 1.445 -0.728 0 C-N-CA 120.417 -0.897 . . . . 1.1599999999999999 111.854 -176.906 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' HIS . . . . . 0.529 ' HB2' HG12 ' A' ' 115' ' ' VAL . 7.0 m170 -88.6 159.27 17.96 Favored 'General case' 0 C--O 1.235 0.318 0 N-CA-C 109.381 -0.6 . . . . 2.4199999999999999 109.381 177.32 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 18.2 mt-10 -114.04 163.28 15.37 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 110.285 -0.265 . . . . 2.5299999999999998 110.285 174.166 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . 0.766 ' H ' HD23 ' A' ' 122' ' ' LEU . 2.2 pt? -106.05 136.39 19.32 Favored Pre-proline 0 C--N 1.326 -0.422 0 CA-C-N 116.494 -0.321 . . . . 1.3300000000000001 110.588 -176.771 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . 0.44 ' HD3' ' HA ' ' A' ' 122' ' ' LEU . 10.7 Cg_exo -72.13 -14.91 28.95 Favored 'Trans proline' 0 N--CA 1.464 -0.238 0 C-N-CA 122.889 2.393 . . . . 1.3300000000000001 112.125 177.685 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . 0.749 ' HA ' HD11 ' A' ' 92' ' ' LEU . . . 64.72 18.99 11.69 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 115.417 -0.81 . . . . 1.25 112.106 179.238 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 24.4 t70 -128.45 152.16 48.55 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 108.921 -0.77 . . . . 2.73 108.921 174.767 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . 0.527 ' HG ' HG22 ' A' ' 131' ' ' VAL . 36.3 tp -105.75 105.44 53.0 Favored Pre-proline 0 C--N 1.322 -0.602 0 CA-C-O 120.747 0.308 . . . . 1.6599999999999999 111.588 -172.645 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' PRO . . . . . 0.482 ' HD2' HD12 ' A' ' 130' ' ' LEU . 71.9 Cg_endo -79.61 155.04 24.12 Favored 'Trans proline' 0 CA--C 1.534 0.508 0 C-N-CA 122.722 2.281 . . . . 1.1699999999999999 112.059 174.679 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 12.6 Cg_endo -56.7 -26.01 63.24 Favored 'Trans proline' 0 CA--C 1.534 0.504 0 C-N-CA 123.35 2.7 . . . . 1.54 114.32 -174.937 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 32.0 p-80 -87.14 3.34 46.72 Favored 'General case' 0 N--CA 1.462 0.169 0 C-N-CA 120.441 -0.504 . . . . 1.0700000000000001 111.148 -179.442 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . 0.482 HD12 ' HD2' ' A' ' 127' ' ' PRO . 24.2 mt -110.8 -17.86 13.25 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.453 -0.34 . . . . 1.3600000000000001 110.615 173.617 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . 0.527 HG22 ' HG ' ' A' ' 126' ' ' LEU . 6.7 t -75.73 122.41 87.02 Favored Pre-proline 0 C--N 1.328 -0.336 0 N-CA-C 109.844 -0.428 . . . . 1.28 109.844 178.832 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_exo -49.58 135.98 33.69 Favored 'Trans proline' 0 C--N 1.344 0.327 0 C-N-CA 122.851 2.367 . . . . 0.81000000000000005 112.078 177.153 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 133' ' ' PRO . . . . . 0.475 ' HA ' ' NE ' ' A' ' 136' ' ' ARG . 10.1 Cg_endo -51.23 -36.43 56.36 Favored 'Trans proline' 0 C--N 1.344 0.322 0 C-N-CA 123.762 2.974 . . . . 1.1699999999999999 113.815 -173.818 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 14.6 m -89.34 1.32 55.94 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 112.048 0.388 . . . . 1.6000000000000001 112.048 -176.783 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 66.0 mttm -120.4 3.42 10.79 Favored 'General case' 0 CA--C 1.532 0.278 0 O-C-N 122.313 -0.242 . . . . 1.21 111.198 -179.885 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . 0.475 ' NE ' ' HA ' ' A' ' 133' ' ' PRO . 35.7 ptt180 -103.78 151.37 23.13 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 113.037 0.754 . . . . 2.7599999999999998 113.037 -170.066 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 67.5 mtt180 -127.14 155.35 43.49 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 114.962 -1.017 . . . . 4.54 108.693 170.934 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 34.0 t60 -133.43 111.36 10.68 Favored 'General case' 0 C--N 1.318 -0.77 0 C-N-CA 120.397 -0.521 . . . . 5.9500000000000002 110.808 170.788 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 74.2 mm-40 . . . . . 0 C--O 1.244 0.809 0 CA-C-O 118.394 -0.813 . . . . 6.1500000000000004 109.868 176.172 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' B' B ' 143' ' ' PHE . . . . . . . . . . . . . 71.5 t80 . . . . . 0 N--CA 1.478 0.927 0 CA-C-O 120.766 0.317 . . . . 11.859999999999999 110.575 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' B' B ' 144' ' ' ASN . . . . . . . . . . . . . 27.7 t-20 -72.12 132.44 44.19 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.1 0.476 . . . . 8.1400000000000006 111.213 179.643 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 145' ' ' TYR . . . . . . . . . . . . . 72.7 t80 -151.49 139.21 19.76 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.804 -0.634 . . . . 6.71 109.786 -177.864 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 146' ' ' GLU . . . . . . . . . . . . . 2.2 pp20? -119.06 179.97 4.0 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.679 0.276 . . . . 6.6100000000000003 111.047 -178.987 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 147' ' ' SER . . . . . . . . . . . . . 33.2 p -121.25 -58.3 1.8 Allowed 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.309 0.576 . . . . 3.6499999999999999 111.07 -177.935 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 148' ' ' THR . . . . . . . . . . . . . 1.3 p -139.4 32.01 2.1 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.326 -0.852 . . . . 1.79 109.376 -179.76 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 149' ' ' GLY . . . . . . . . . . . . . . . 133.99 158.57 8.62 Favored Glycine 0 N--CA 1.437 -1.243 0 N-CA-C 110.832 -0.907 . . . . 0.47999999999999998 110.832 -171.318 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 150' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -73.21 -0.88 9.76 Favored 'Trans proline' 0 CA--C 1.53 0.323 0 C-N-CA 123.249 2.632 . . . . 0.33000000000000002 112.312 -177.009 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 151' ' ' PHE . . . . . 0.719 ' CZ ' ' HG3' ' A' ' 76' ' ' MET . 46.7 m-85 -106.96 -38.55 6.01 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.055 -0.52 . . . . 0.75 112.183 -178.617 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 152' ' ' THR . . . . . . . . . . . . . 4.5 p -87.43 24.01 1.75 Allowed 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 112.372 0.508 . . . . 2.2200000000000002 112.372 -170.871 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 153' ' ' ALA . . . . . . . . . . . . . . . -72.54 142.82 48.48 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 116.437 -0.347 . . . . 4.4000000000000004 110.473 178.079 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 154' ' ' LYS . . . . . . . . . . . . . 35.8 mmtp . . . . . 0 C--O 1.25 1.113 0 CA-C-O 118.481 -0.771 . . . . 6.75 110.19 -179.621 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 141' ' ' ' CA' . . . . . 0.657 'CA ' ' OD1' ' A' ' 98' ' ' ASP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.58 0 N-CA-C 112.139 -0.384 . . . . 10.970000000000001 112.139 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 16.5 Cg_endo -58.66 -35.59 98.42 Favored 'Trans proline' 0 C--N 1.344 0.307 0 C-N-CA 122.908 2.405 . . . . 9.0 112.308 178.881 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 1.2 tm? -135.98 -71.69 0.46 Allowed 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 109.883 -0.414 . . . . 7.4199999999999999 109.883 179.668 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 148.06 93.22 0.11 Allowed Glycine 0 N--CA 1.448 -0.533 0 C-N-CA 120.504 -0.855 . . . . 4.46 112.428 -179.009 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 46.3 m -150.53 25.84 0.77 Allowed 'General case' 0 C--N 1.318 -0.764 0 CA-C-O 121.787 0.803 . . . . 3.9700000000000002 108.849 178.166 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -109.74 108.41 18.77 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 114.597 -1.183 . . . . 3.46 110.569 -172.809 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -76.84 95.38 4.06 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.087 -0.506 . . . . 1.9299999999999999 111.316 -178.411 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 40.8 t -78.7 119.81 28.53 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 N-CA-C 109.525 -0.546 . . . . 1.8500000000000001 109.525 174.52 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 4.1 mp0 -66.82 150.04 49.72 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.356 0.598 . . . . 3.1000000000000001 111.887 -176.501 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' TRP . . . . . 0.523 ' HH2' ' O ' ' A' ' 104' ' ' GLU . 7.7 t90 -70.6 116.12 10.55 Favored 'General case' 0 N--CA 1.45 -0.436 0 CA-C-N 115.191 -0.913 . . . . 0.70999999999999996 109.025 178.533 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 9.9 p -67.38 -9.61 10.52 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-O 121.14 0.495 . . . . 1.45 111.371 -174.657 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 51.0 t -89.41 -20.76 7.01 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-O 121.262 0.553 . . . . 1.1000000000000001 110.317 176.866 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . 0.438 ' HA2' ' HG2' ' A' ' 50' ' ' LYS . . . -72.68 -19.34 79.15 Favored Glycine 0 N--CA 1.446 -0.635 0 CA-C-N 115.706 -0.679 . . . . 0.58999999999999997 112.897 -175.666 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 15.3 ptpt -76.61 -26.1 54.6 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.602 0.239 . . . . 2.46 111.138 -179.182 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -101.2 34.25 2.6 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.023 0.439 . . . . 1.6599999999999999 109.917 178.259 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 0.438 ' HG2' ' HA2' ' A' ' 47' ' ' GLY . 0.1 OUTLIER -67.73 -54.16 18.54 Favored Pre-proline 0 C--O 1.214 -0.775 0 CA-C-O 118.256 -0.878 . . . . 1.1499999999999999 113.156 -175.922 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_exo -42.66 -41.76 8.33 Favored 'Trans proline' 0 C--N 1.358 1.068 0 C-N-CA 122.798 2.332 . . . . 0.75 113.868 -173.245 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 90.7 m -69.97 -44.76 68.79 Favored 'General case' 0 C--O 1.238 0.449 0 CA-C-O 121.1 0.476 . . . . 0.68000000000000005 111.282 179.404 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 8.6 m-30 -74.23 -23.21 59.14 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.957 0.408 . . . . 0.68999999999999995 110.045 -177.491 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 84.2 m-20 -70.03 -44.23 69.69 Favored 'General case' 0 CA--C 1.511 -0.532 0 N-CA-C 108.961 -0.755 . . . . 2.1800000000000002 108.961 175.818 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 10.8 tp10 -57.26 -47.29 81.78 Favored 'General case' 0 N--CA 1.45 -0.444 0 CA-C-N 115.016 -0.993 . . . . 2.3300000000000001 110.225 178.541 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 39.8 mt -70.79 -37.54 69.14 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 CA-C-N 116.24 -0.437 . . . . 0.64000000000000001 111.552 -178.273 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . 0.461 ' HD2' ' CE1' ' A' ' 58' ' ' TYR . 86.6 t80 -66.29 -45.3 80.89 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.807 0.337 . . . . 0.28999999999999998 110.981 -178.689 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . 0.461 ' CE1' ' HD2' ' A' ' 57' ' ' PHE . 21.7 m-85 -79.81 -12.6 59.76 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.592 -0.276 . . . . 1.1699999999999999 111.429 -174.596 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 11.5 p -88.7 -8.65 54.16 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.716 0.293 . . . . 0.44 111.286 177.406 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.481 ' HB3' ' HB3' ' A' ' 71' ' ' ASN . 35.2 mt -94.69 9.38 39.07 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.665 -0.243 . . . . 1.3700000000000001 110.988 178.599 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 17.3 m 68.23 87.55 0.11 Allowed Pre-proline 0 CA--C 1.531 0.219 0 O-C-N 123.823 0.702 . . . . 1.24 110.854 -176.374 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -77.3 125.3 7.69 Favored 'Trans proline' 0 N--CA 1.458 -0.582 0 C-N-CA 122.586 2.191 . . . . 0.46999999999999997 112.199 -179.463 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 12.5 m -115.3 119.35 61.55 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 CA-C-O 121.091 0.472 . . . . 1.02 110.271 177.432 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 65.5 m-20 64.39 22.24 12.7 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-N 115.711 -0.677 . . . . 1.3400000000000001 110.742 -179.19 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 80.67 15.73 77.16 Favored Glycine 0 CA--C 1.52 0.352 0 C-N-CA 120.961 -0.638 . . . . 0.42999999999999999 112.579 -178.393 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 0.751 ' HG2' ' HB3' ' A' ' 102' ' ' ASP . 86.8 mttt -137.37 160.14 39.92 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 109.739 -0.467 . . . . 1.48 109.739 179.812 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . 0.454 HD11 ' HB2' ' A' ' 101' ' ' LEU . 2.8 pp -119.48 158.12 21.18 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 N-CA-C 109.907 -0.405 . . . . 0.64000000000000001 109.907 172.309 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . 0.401 ' HA ' ' CD2' ' A' ' 100' ' ' LEU . 63.8 p -89.5 173.11 8.52 Favored 'General case' 0 C--N 1.321 -0.63 0 CA-C-N 116.203 -0.453 . . . . 0.55000000000000004 110.898 -174.569 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -64.53 -19.29 64.56 Favored Glycine 0 N--CA 1.445 -0.726 0 C-N-CA 120.81 -0.709 . . . . 0.40999999999999998 111.997 176.962 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -66.61 -46.01 77.24 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.168 0.509 . . . . 0.38 111.154 179.061 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . 0.481 ' HB3' ' HB3' ' A' ' 60' ' ' LEU . 1.7 m120 -77.57 -41.09 40.13 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.654 -0.703 . . . . 1.8100000000000001 110.128 -175.148 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -62.78 -43.39 98.94 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.862 -0.608 . . . . 0.39000000000000001 110.263 177.194 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . 0.54 ' O ' HG22 ' A' ' 77' ' ' VAL . 21.3 ttmm -56.96 -47.28 81.08 Favored 'General case' 0 CA--C 1.516 -0.332 0 CA-C-N 116.255 -0.43 . . . . 0.83999999999999997 109.862 176.358 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 48.8 tttm -52.44 -50.65 62.17 Favored 'General case' 0 N--CA 1.451 -0.386 0 O-C-N 123.908 0.755 . . . . 1.95 111.209 -178.974 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 13.2 tp10 -70.7 -43.37 69.12 Favored 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 120.846 -0.341 . . . . 1.6000000000000001 111.15 -178.208 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 64.7 mtt -64.34 -38.67 91.85 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 111.656 0.243 . . . . 1.24 111.656 -175.729 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.54 HG22 ' O ' ' A' ' 73' ' ' LYS . 32.9 m -76.31 -28.55 18.34 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.302 0 C-N-CA 120.788 -0.365 . . . . 1.5700000000000001 110.621 177.271 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.456 ' HB3' ' HE3' ' A' ' 78' ' ' LYS . 19.8 mmmt -64.89 -25.78 68.04 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-N 116.18 -0.464 . . . . 2.79 110.727 173.58 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 20.3 m -75.16 -8.85 57.72 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.585 -0.734 . . . . 1.27 110.512 177.796 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 55.0 mtpt 62.34 42.64 8.95 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-N 115.903 -0.59 . . . . 2.9700000000000002 111.126 177.38 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.709 ' HB2' HD11 ' A' ' 86' ' ' LEU . 97.5 mt -100.32 169.2 8.25 Favored Pre-proline 0 C--N 1.325 -0.495 0 CA-C-N 115.704 -0.68 . . . . 0.52000000000000002 109.758 178.307 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . 0.407 ' CD ' ' HB3' ' A' ' 81' ' ' LEU . 2.0 Cg_endo -83.49 132.01 5.73 Favored 'Trans proline' 0 C--N 1.348 0.515 0 C-N-CA 123.274 2.65 . . . . 0.44 112.371 -178.478 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 5.0 p-10 -50.67 -38.67 47.95 Favored 'General case' 0 N--CA 1.472 0.638 0 N-CA-C 113.504 0.927 . . . . 1.8500000000000001 113.504 -171.532 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . 0.408 ' O ' ' HG2' ' A' ' 88' ' ' LYS . 75.7 m -65.79 -34.28 77.81 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 120.892 0.377 . . . . 1.47 110.925 -179.719 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.502 ' O ' HG12 ' A' ' 89' ' ' ILE . 95.6 t -71.12 -39.85 74.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.153 -0.476 . . . . 0.45000000000000001 109.789 178.485 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.709 HD11 ' HB2' ' A' ' 81' ' ' LEU . 9.8 mp -58.44 -34.83 71.24 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.18 -0.464 . . . . 0.90000000000000002 110.992 172.39 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . 0.417 ' HA2' ' HB2' ' B' ' 151' ' ' PHE . . . -65.66 -38.67 94.81 Favored Glycine 0 N--CA 1.447 -0.612 0 N-CA-C 111.072 -0.811 . . . . 0.32000000000000001 111.072 176.619 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . 0.408 ' HG2' ' O ' ' A' ' 84' ' ' THR . 70.0 mmtt -63.43 -49.73 72.57 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.147 -0.526 . . . . 1.8899999999999999 109.968 174.5 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.502 HG12 ' O ' ' A' ' 85' ' ' VAL . 40.8 mm -54.74 -49.82 65.46 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.097 0 CA-C-N 115.711 -0.677 . . . . 0.70999999999999996 110.699 179.686 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 53.5 t-105 -61.38 -50.55 72.42 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.323 -0.399 . . . . 0.33000000000000002 111.402 -178.671 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . 0.452 ' HE3' HG21 ' B' ' 152' ' ' THR . 26.4 ttmt -74.52 -10.76 59.87 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-O 121.009 0.433 . . . . 2.7000000000000002 111.359 -172.766 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.439 HD11 ' HA ' ' A' ' 124' ' ' ALA . 94.1 mt -94.36 -37.42 11.48 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.336 -0.393 . . . . 1.6599999999999999 111.08 172.7 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . 0.474 ' HA ' HD23 ' A' ' 108' ' ' LEU . . . -78.81 -36.85 42.08 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.224 -0.444 . . . . 0.46999999999999997 111.489 -176.787 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . 0.638 ' OD1' 'CA ' ' A' ' 141' ' ' ' CA' . 26.7 t0 -81.15 86.83 6.12 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.612 0.72 . . . . 0.79000000000000004 109.524 177.562 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.446 ' HB ' ' HD3' ' A' ' 135' ' ' LYS . 34.4 t -82.2 -30.74 9.83 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.587 0 CA-C-N 114.839 -1.073 . . . . 0.60999999999999999 110.352 -174.796 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . 0.595 ' OD1' 'CA ' ' A' ' 141' ' ' ' CA' . 43.5 p-10 -86.41 -7.57 58.34 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.22 -0.445 . . . . 0.95999999999999996 110.655 -179.461 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 88.9 mttt 59.06 44.62 15.85 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-N 115.716 -0.675 . . . . 2.96 111.129 172.974 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . 0.593 ' OD1' 'CA ' ' A' ' 141' ' ' ' CA' . 6.5 p-10 -107.08 9.06 30.56 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 116.246 -0.434 . . . . 0.42999999999999999 111.016 -175.872 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 67.58 12.84 62.27 Favored Glycine 0 CA--C 1.518 0.277 0 C-N-CA 121.053 -0.594 . . . . 0.44 112.481 178.746 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.536 ' HB2' ' OD2' ' A' ' 98' ' ' ASP . 87.0 mt -135.77 153.3 51.59 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 109.114 -0.699 . . . . 1.1100000000000001 109.114 178.817 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.454 ' HB2' HD11 ' A' ' 67' ' ' ILE . 89.9 mt -110.22 111.89 23.5 Favored 'General case' 0 C--N 1.315 -0.928 0 N-CA-C 109.166 -0.679 . . . . 0.41999999999999998 109.166 175.009 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . 0.751 ' HB3' ' HG2' ' A' ' 66' ' ' LYS . 2.1 p30 -75.99 -174.82 2.81 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 116.233 -0.44 . . . . 1.72 110.672 178.523 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -54.86 -40.33 69.56 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 115.604 -0.726 . . . . 1.6000000000000001 110.48 -179.215 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . 0.523 ' O ' ' HH2' ' A' ' 44' ' ' TRP . 54.5 mt-10 -73.62 -52.76 12.32 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.992 -0.549 . . . . 1.6599999999999999 110.253 179.408 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 36.1 mt-10 -63.12 -37.93 89.15 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.238 -0.437 . . . . 0.44 111.753 -173.833 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . 0.456 ' CD2' ' HD1' ' A' ' 57' ' ' PHE . 54.1 t80 -74.86 -34.94 62.35 Favored 'General case' 0 C--N 1.326 -0.436 0 C-N-CA 120.781 -0.368 . . . . 0.41999999999999998 110.098 -179.533 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -58.61 -42.43 88.13 Favored 'General case' 0 C--O 1.231 0.127 0 N-CA-C 109.714 -0.476 . . . . 0.22 109.714 173.215 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.474 HD23 ' HA ' ' A' ' 93' ' ' ALA . 64.8 tp -62.73 -43.77 97.95 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.842 -0.617 . . . . 1.3300000000000001 110.557 176.055 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . 0.519 ' O ' HG13 ' A' ' 113' ' ' ILE . . . -57.86 -46.03 85.41 Favored 'General case' 0 C--O 1.225 -0.237 0 CA-C-N 116.251 -0.431 . . . . 0.32000000000000001 110.869 178.562 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' ASN . . . . . 0.434 HD22 HD12 ' A' ' 113' ' ' ILE . 13.6 m120 -63.4 -36.71 84.61 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 116.5 -0.318 . . . . 1.2 111.146 179.037 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 9.6 t60 -64.4 -37.87 89.04 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 109.615 -0.513 . . . . 0.52000000000000002 109.615 178.838 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 94.3 mt -72.02 -39.19 69.33 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.793 -0.639 . . . . 0.55000000000000004 110.742 178.098 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.519 HG13 ' O ' ' A' ' 109' ' ' ALA . 59.4 mt -56.68 -47.54 82.24 Favored 'Isoleucine or valine' 0 C--O 1.233 0.211 0 N-CA-C 109.816 -0.439 . . . . 0.83999999999999997 109.816 175.247 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . 0.566 ' O ' ' HB2' ' A' ' 118' ' ' GLU . 4.6 mmmm -62.38 -44.11 97.23 Favored 'General case' 0 C--O 1.221 -0.413 0 CA-C-N 116.076 -0.511 . . . . 3.8300000000000001 111.622 179.223 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.567 HG13 ' HB2' ' A' ' 120' ' ' HIS . 42.9 t -58.01 -43.25 84.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-O 120.835 0.35 . . . . 1.1899999999999999 110.903 178.192 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . 0.472 ' HA ' ' HD2' ' A' ' 116' ' ' LYS . 18.3 tptt -65.75 -45.41 82.7 Favored 'General case' 0 N--CA 1.444 -0.754 0 CA-C-N 116.057 -0.519 . . . . 1.3200000000000001 110.786 -178.982 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 95.7 mt -78.95 -15.75 57.88 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.511 -0.313 . . . . 0.95999999999999996 111.78 -178.742 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . 0.566 ' HB2' ' O ' ' A' ' 114' ' ' LYS . 2.1 tp10 -79.4 -13.56 59.52 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 109.081 -0.711 . . . . 2.1800000000000002 109.081 177.063 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 93.78 31.02 8.46 Favored Glycine 0 N--CA 1.452 -0.287 0 CA-C-N 115.236 -0.893 . . . . 1.1599999999999999 112.318 178.293 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' HIS . . . . . 0.567 ' HB2' HG13 ' A' ' 115' ' ' VAL . 80.8 m-70 -117.09 176.8 4.97 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 109.843 -0.429 . . . . 2.4199999999999999 109.843 177.644 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 -126.41 155.07 42.75 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 120.789 0.328 . . . . 2.5299999999999998 110.255 -177.85 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . 0.481 ' HA ' ' HD3' ' A' ' 123' ' ' PRO . 0.7 OUTLIER -116.39 135.64 22.91 Favored Pre-proline 0 C--N 1.324 -0.521 0 N-CA-C 109.807 -0.442 . . . . 1.3300000000000001 109.807 177.931 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . 0.481 ' HD3' ' HA ' ' A' ' 122' ' ' LEU . 2.9 Cg_exo -76.45 10.31 2.23 Favored 'Trans proline' 0 C--O 1.234 0.315 0 C-N-CA 123.191 2.594 . . . . 1.3300000000000001 113.393 -175.49 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . 0.439 ' HA ' HD11 ' A' ' 92' ' ' LEU . . . 57.91 27.21 14.33 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-O 121.24 0.543 . . . . 1.25 111.367 -178.89 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 8.2 t70 -132.42 154.67 49.61 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 109.235 -0.654 . . . . 2.73 109.235 -179.887 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 95.2 mt -108.46 101.67 43.78 Favored Pre-proline 0 C--N 1.324 -0.527 0 CA-C-O 120.917 0.389 . . . . 1.6599999999999999 111.616 -177.078 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' PRO . . . . . 0.624 ' HG2' ' HB2' ' A' ' 130' ' ' LEU . 18.4 Cg_endo -62.64 151.95 80.68 Favored 'Trans proline' 0 CA--C 1.535 0.546 0 C-N-CA 122.821 2.347 . . . . 1.1699999999999999 111.767 173.344 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -53.11 -35.7 73.83 Favored 'Trans proline' 0 CA--C 1.533 0.461 0 C-N-CA 123.415 2.743 . . . . 1.54 113.622 -175.23 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 11.9 p-80 -86.93 3.26 46.36 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 111.669 0.248 . . . . 1.0700000000000001 111.669 -178.916 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . 0.624 ' HB2' ' HG2' ' A' ' 127' ' ' PRO . 16.5 tp -115.57 -1.14 12.83 Favored 'General case' 0 N--CA 1.446 -0.655 0 CA-C-O 120.965 0.412 . . . . 1.3600000000000001 110.279 -177.912 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . 0.413 HG23 ' O ' ' A' ' 127' ' ' PRO . 65.0 t -88.69 129.77 47.6 Favored Pre-proline 0 C--N 1.327 -0.391 0 CA-C-N 115.987 -0.551 . . . . 1.28 110.122 178.598 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 132' ' ' PRO . . . . . 0.463 ' HA ' ' HD3' ' A' ' 133' ' ' PRO . 83.1 Cg_exo -48.31 130.38 20.93 Favored 'Trans proline' 0 C--N 1.348 0.532 0 C-N-CA 122.891 2.394 . . . . 0.81000000000000005 112.306 177.685 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 133' ' ' PRO . . . . . 0.463 ' HD3' ' HA ' ' A' ' 132' ' ' PRO . 50.6 Cg_exo -54.27 -37.44 88.27 Favored 'Trans proline' 0 C--O 1.232 0.206 0 C-N-CA 123.446 2.764 . . . . 1.1699999999999999 113.369 -174.296 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 12.8 m -83.99 -2.05 55.85 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.55 -0.295 . . . . 1.6000000000000001 111.227 -177.05 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . 0.446 ' HD3' ' HB ' ' A' ' 95' ' ' VAL . 61.2 mttp -120.24 17.24 12.32 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 112.285 0.476 . . . . 1.21 112.285 -174.702 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 40.4 ptt180 -100.61 145.76 27.98 Favored 'General case' 0 C--N 1.324 -0.523 0 C-N-CA 120.748 -0.381 . . . . 2.7599999999999998 110.255 177.927 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 33.7 mtp180 -99.22 -176.26 3.25 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.637 0.732 . . . . 4.54 112.59 -175.098 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 31.2 m80 -120.91 140.82 51.31 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 114.707 -1.133 . . . . 5.9500000000000002 109.178 173.923 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 . . . . . 0 C--O 1.247 0.939 0 CA-C-O 118.218 -0.896 . . . . 6.1500000000000004 111.157 -179.732 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' B' B ' 143' ' ' PHE . . . . . . . . . . . . . 40.1 m-85 . . . . . 0 N--CA 1.477 0.895 0 CA-C-O 121.19 0.519 . . . . 11.859999999999999 111.145 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' B' B ' 144' ' ' ASN . . . . . . . . . . . . . 3.6 p-10 -169.15 168.89 9.69 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 107.797 -1.186 . . . . 8.1400000000000006 107.797 179.661 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 145' ' ' TYR . . . . . 0.437 ' HD2' ' H ' ' B' ' 147' ' ' SER . 36.0 t80 -103.21 159.3 15.66 Favored 'General case' 0 C--N 1.32 -0.692 0 C-N-CA 120.41 -0.516 . . . . 6.71 109.611 176.007 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 146' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -62.96 -23.3 67.34 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.719 -0.673 . . . . 6.6100000000000003 111.118 -178.874 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 147' ' ' SER . . . . . 0.437 ' H ' ' HD2' ' B' ' 145' ' ' TYR . 36.6 t -98.46 119.54 37.34 Favored 'General case' 0 N--CA 1.447 -0.594 0 CA-C-N 115.86 -0.609 . . . . 3.6499999999999999 109.417 178.704 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 148' ' ' THR . . . . . . . . . . . . . 2.6 p -105.78 19.5 20.46 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.342 0.591 . . . . 1.79 110.519 178.682 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 149' ' ' GLY . . . . . . . . . . . . . . . 161.29 157.54 8.86 Favored Glycine 0 N--CA 1.444 -0.778 0 CA-C-N 115.578 -0.737 . . . . 0.47999999999999998 111.542 177.723 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 150' ' ' PRO . . . . . . . . . . . . . 69.4 Cg_endo -73.86 -8.33 21.16 Favored 'Trans proline' 0 N--CA 1.465 -0.204 0 C-N-CA 122.423 2.082 . . . . 0.33000000000000002 112.106 -179.228 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 151' ' ' PHE . . . . . 0.43 ' CZ ' ' HA ' ' A' ' 73' ' ' LYS . 36.2 m-85 -108.59 -16.71 14.14 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.067 -0.515 . . . . 0.75 111.038 178.136 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 152' ' ' THR . . . . . 0.452 HG21 ' HE3' ' A' ' 91' ' ' LYS . 2.6 t -148.56 131.74 16.41 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.041 0.448 . . . . 2.2200000000000002 111.935 -167.32 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 153' ' ' ALA . . . . . . . . . . . . . . . -109.76 166.36 10.97 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.899 -0.592 . . . . 4.4000000000000004 109.806 176.26 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 154' ' ' LYS . . . . . . . . . . . . . 12.4 mptt . . . . . 0 C--O 1.247 0.94 0 CA-C-O 118.25 -0.881 . . . . 6.75 110.366 -177.696 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 141' ' ' ' CA' . . . . . 0.638 'CA ' ' OD1' ' A' ' 94' ' ' ASP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.723 0 N-CA-C 112.372 -0.291 . . . . 10.970000000000001 112.372 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 97.1 Cg_endo -84.4 68.78 6.34 Favored 'Trans proline' 0 N--CA 1.46 -0.444 0 C-N-CA 122.795 2.33 . . . . 9.0 112.084 178.414 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.488 HD23 ' H ' ' A' ' 37' ' ' LEU . 2.5 pt? -67.63 -25.12 65.58 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 116.109 -0.496 . . . . 7.4199999999999999 111.662 -177.659 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -78.43 -48.3 7.49 Favored Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 120.857 -0.687 . . . . 4.46 112.311 -177.848 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 16.5 m 66.58 -75.44 0.06 Allowed 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 122.977 0.511 . . . . 3.9700000000000002 110.596 -176.889 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -92.59 134.43 35.01 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 109.211 -0.662 . . . . 3.46 109.211 -179.502 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -114.57 138.73 50.28 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 120.646 0.26 . . . . 1.9299999999999999 111.379 -171.686 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 13.5 p -99.37 144.39 12.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.184 -0.462 . . . . 1.8500000000000001 110.718 -178.851 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.463 ' OE2' ' HA ' ' A' ' 45' ' ' VAL . 12.4 tt0 -74.01 143.04 45.73 Favored 'General case' 0 C--O 1.237 0.411 0 CA-C-O 120.879 0.371 . . . . 3.1000000000000001 110.814 179.775 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' TRP . . . . . 0.487 ' HH2' ' O ' ' A' ' 104' ' ' GLU . 6.1 t90 -83.39 102.14 11.82 Favored 'General case' 0 N--CA 1.448 -0.545 0 N-CA-C 107.503 -1.295 . . . . 0.70999999999999996 107.503 168.767 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.463 ' HA ' ' OE2' ' A' ' 43' ' ' GLU . 35.6 m -61.58 -9.66 3.24 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.532 0 N-CA-C 113.011 0.745 . . . . 1.45 113.011 -170.045 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 22.4 t -86.51 -20.17 7.91 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 CA-C-O 121.24 0.543 . . . . 1.1000000000000001 110.194 177.794 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . 0.553 ' HA2' ' HG3' ' A' ' 50' ' ' LYS . . . -73.27 -25.86 71.97 Favored Glycine 0 N--CA 1.449 -0.45 0 CA-C-N 115.71 -0.677 . . . . 0.58999999999999997 113.242 -175.145 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 6.4 ptpp? -74.06 -25.32 59.77 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 117.052 0.426 . . . . 2.46 111.051 -178.827 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 24.1 m-20 -105.67 33.75 3.6 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.114 0.483 . . . . 1.6599999999999999 109.96 179.37 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 0.553 ' HG3' ' HA2' ' A' ' 47' ' ' GLY . 48.9 mttt -70.16 -43.25 18.32 Favored Pre-proline 0 C--O 1.219 -0.521 0 CA-C-O 118.499 -0.762 . . . . 1.1499999999999999 112.657 178.042 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.512 ' O ' ' HG3' ' A' ' 55' ' ' GLU . 66.2 Cg_exo -39.64 -48.71 3.44 Favored 'Trans proline' 0 C--N 1.365 1.439 0 C-N-CA 122.82 2.346 . . . . 0.75 113.89 -179.243 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 18.4 m -69.54 -44.8 70.19 Favored 'General case' 0 C--O 1.239 0.509 0 CA-C-O 121.082 0.467 . . . . 0.68000000000000005 111.148 -177.626 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 9.8 m-30 -70.34 -21.49 62.9 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.873 -0.603 . . . . 0.68999999999999995 109.854 -178.238 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -74.88 -44.68 47.54 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.95 -0.568 . . . . 2.1800000000000002 109.734 177.782 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.512 ' HG3' ' O ' ' A' ' 51' ' ' PRO . 72.0 mt-10 -60.6 -29.8 69.44 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.453 -0.794 . . . . 2.3300000000000001 110.416 178.493 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.47 ' O ' HD13 ' A' ' 60' ' ' LEU . 52.4 mt -84.74 -48.72 16.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 116.148 -0.478 . . . . 0.64000000000000001 111.225 177.566 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . 0.497 ' HE1' HG12 ' A' ' 67' ' ' ILE . 82.9 t80 -56.24 -37.37 69.65 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 122.99 0.516 . . . . 0.28999999999999998 111.534 -176.699 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . 0.537 ' HA ' ' HG3' ' A' ' 62' ' ' PRO . 3.1 m-30 -80.44 -10.03 59.75 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.234 -0.439 . . . . 1.1699999999999999 111.59 -174.487 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 61.4 p -98.13 -2.38 40.12 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.113 0.482 . . . . 0.44 110.646 176.808 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.47 HD13 ' O ' ' A' ' 56' ' ' ILE . 8.9 mp -97.52 12.59 32.87 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.867 -0.606 . . . . 1.3700000000000001 110.526 179.439 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 44.6 t 64.32 73.5 0.45 Allowed Pre-proline 0 C--O 1.234 0.259 0 CA-C-N 115.595 -0.73 . . . . 1.24 111.407 -179.216 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . 0.537 ' HG3' ' HA ' ' A' ' 58' ' ' TYR . 61.2 Cg_endo -77.26 126.45 8.5 Favored 'Trans proline' 0 C--N 1.347 0.455 0 C-N-CA 122.212 1.942 . . . . 0.46999999999999997 112.4 178.88 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 15.7 m -109.42 113.1 43.24 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 CA-C-O 121.253 0.549 . . . . 1.02 110.438 177.633 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 95.2 m-20 61.33 34.65 18.35 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 115.617 -0.72 . . . . 1.3400000000000001 111.178 179.574 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 77.76 21.68 71.15 Favored Glycine 0 C--N 1.331 0.302 0 CA-C-N 115.89 -0.596 . . . . 0.42999999999999999 112.927 178.243 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 58.4 mttm -141.13 148.96 40.9 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 109.904 -0.406 . . . . 1.48 109.904 -179.015 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . 0.497 HG12 ' HE1' ' A' ' 57' ' ' PHE . 36.9 pt -117.5 160.61 16.92 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 N-CA-C 109.915 -0.402 . . . . 0.64000000000000001 109.915 171.103 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 54.8 p -86.18 170.71 11.91 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 120.921 0.391 . . . . 0.55000000000000004 110.623 -177.178 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -65.01 -21.13 67.55 Favored Glycine 0 N--CA 1.446 -0.687 0 C-N-CA 120.962 -0.637 . . . . 0.40999999999999998 112.36 178.687 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.617 ' O ' ' HG3' ' A' ' 74' ' ' LYS . . . -63.23 -52.42 62.26 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 121.027 0.441 . . . . 0.38 111.181 -179.754 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -71.23 -41.68 69.85 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.848 -0.614 . . . . 1.8100000000000001 109.93 -175.012 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -61.73 -38.07 86.56 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.472 -0.785 . . . . 0.39000000000000001 110.604 177.2 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . 0.636 ' HG3' ' HE1' ' B' ' 151' ' ' PHE . 79.9 tttt -64.41 -43.09 95.49 Favored 'General case' 0 CA--C 1.515 -0.37 0 CA-C-N 116.216 -0.447 . . . . 0.83999999999999997 110.43 178.462 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . 0.617 ' HG3' ' O ' ' A' ' 70' ' ' ALA . 29.1 mtpp -59.33 -44.58 92.59 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.54 0.21 . . . . 1.95 110.472 -179.41 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 14.6 tp10 -61.29 -48.41 81.51 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 116.337 -0.392 . . . . 1.6000000000000001 110.5 177.283 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' MET . . . . . 0.846 ' HB3' HD22 ' A' ' 86' ' ' LEU . 53.4 mtt -63.55 -33.38 75.46 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.155 0.502 . . . . 1.24 111.289 -179.682 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.487 HG23 ' O ' ' A' ' 73' ' ' LYS . 38.6 t -64.99 -30.8 51.44 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-N 116.123 -0.49 . . . . 1.5700000000000001 110.087 176.392 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 66.1 mmtt -79.6 -26.81 41.13 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.15 -0.477 . . . . 2.79 111.689 178.906 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 76.9 p -66.14 -14.97 62.7 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 120.867 -0.333 . . . . 1.27 110.501 178.422 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 31.7 mtmm 70.1 18.88 6.94 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-N 115.557 -0.747 . . . . 2.9700000000000002 111.572 176.135 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.605 ' HB2' HD21 ' A' ' 86' ' ' LEU . 97.0 mt -82.91 144.14 47.4 Favored Pre-proline 0 C--N 1.325 -0.498 0 N-CA-C 109.573 -0.528 . . . . 0.52000000000000002 109.573 174.363 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 41.2 Cg_exo -57.65 148.07 75.99 Favored 'Trans proline' 0 C--N 1.343 0.245 0 C-N-CA 122.605 2.204 . . . . 0.44 112.369 178.659 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 2.1 m-20 -50.61 -41.82 55.24 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-N 115.852 -0.613 . . . . 1.8500000000000001 111.293 -179.489 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -57.69 -47.62 81.82 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.942 -0.572 . . . . 1.47 110.878 179.37 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.529 ' O ' HG12 ' A' ' 89' ' ' ILE . 93.8 t -63.2 -37.89 80.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 115.699 -0.682 . . . . 0.45000000000000001 110.393 -179.761 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.846 HD22 ' HB3' ' A' ' 76' ' ' MET . 75.0 mt -65.73 -36.63 84.14 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.016 -0.538 . . . . 0.90000000000000002 110.672 179.704 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -65.23 -37.94 94.59 Favored Glycine 0 N--CA 1.449 -0.451 0 N-CA-C 110.857 -0.897 . . . . 0.32000000000000001 110.857 176.213 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 31.1 mmmt -61.91 -47.43 84.98 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.295 -0.452 . . . . 1.8899999999999999 109.976 174.739 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.529 HG12 ' O ' ' A' ' 85' ' ' VAL . 28.3 mm -58.97 -46.62 91.43 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.18 0 CA-C-N 115.471 -0.786 . . . . 0.70999999999999996 110.695 179.403 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 52.5 t-105 -60.09 -47.4 86.05 Favored 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 121.076 -0.25 . . . . 0.33000000000000002 110.915 -179.064 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 37.4 ttmt -62.91 -24.16 67.71 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 116.41 -0.359 . . . . 2.7000000000000002 111.319 -178.118 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.728 HD11 ' HA ' ' A' ' 124' ' ' ALA . 91.9 mt -93.38 -29.47 15.58 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.443 -0.344 . . . . 1.6599999999999999 111.51 179.903 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -85.94 -41.39 14.96 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.58 -0.282 . . . . 0.46999999999999997 111.35 -177.315 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . 0.659 ' OD1' 'CA ' ' A' ' 141' ' ' ' CA' . 39.8 t0 -84.5 79.34 9.61 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 108.858 -0.793 . . . . 0.79000000000000004 108.858 177.282 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.509 ' HB ' ' HG2' ' A' ' 135' ' ' LYS . 40.5 t -67.56 -37.51 78.91 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-N 115.292 -0.867 . . . . 0.60999999999999999 111.056 -171.63 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . 0.619 ' OD1' 'CA ' ' A' ' 141' ' ' ' CA' . 40.4 p-10 -83.54 -10.1 58.52 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.934 -0.575 . . . . 0.95999999999999996 110.973 -178.972 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 92.0 mttt 52.16 72.65 0.38 Allowed 'General case' 0 C--O 1.235 0.338 0 O-C-N 123.839 0.712 . . . . 2.96 110.843 179.789 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . 0.634 ' OD1' 'CA ' ' A' ' 141' ' ' ' CA' . 9.6 p-10 -127.27 9.02 6.64 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 120.916 0.389 . . . . 0.42999999999999999 110.694 -176.896 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 74.02 0.39 55.96 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.768 -0.729 . . . . 0.44 112.709 177.375 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.418 ' HB2' ' OD2' ' A' ' 98' ' ' ASP . 77.2 mt -128.79 147.41 50.79 Favored 'General case' 0 N--CA 1.446 -0.653 0 N-CA-C 109.417 -0.586 . . . . 1.1100000000000001 109.417 179.355 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 60.8 mt -105.17 120.1 40.68 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-N 115.992 -0.549 . . . . 0.41999999999999998 109.912 176.549 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . 0.444 ' HB2' ' HG3' ' A' ' 105' ' ' GLU . 9.8 m-20 -69.6 176.96 3.19 Favored 'General case' 0 CA--C 1.511 -0.533 0 N-CA-C 109.613 -0.514 . . . . 1.72 109.613 174.279 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -56.81 -42.7 80.01 Favored 'General case' 0 C--N 1.317 -0.808 0 N-CA-C 109.552 -0.536 . . . . 1.6000000000000001 109.552 172.967 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . 0.522 ' HB3' ' HB3' ' A' ' 132' ' ' PRO . 4.7 mp0 -61.94 -53.34 56.99 Favored 'General case' 0 N--CA 1.461 0.115 0 CA-C-N 115.895 -0.593 . . . . 1.6599999999999999 111.266 173.946 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . 0.444 ' HG3' ' HB2' ' A' ' 102' ' ' ASP . 22.9 mt-10 -67.1 -34.33 77.39 Favored 'General case' 0 C--N 1.327 -0.394 0 C-N-CA 120.947 -0.301 . . . . 0.44 111.471 -169.824 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . 0.437 ' CD1' HD11 ' A' ' 67' ' ' ILE . 84.4 t80 -71.29 -40.67 70.72 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 109.94 -0.393 . . . . 0.41999999999999998 109.94 176.335 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -57.31 -43.08 82.96 Favored 'General case' 0 N--CA 1.454 -0.239 0 CA-C-O 121.107 0.48 . . . . 0.22 110.393 175.698 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 6.3 tt -60.15 -50.6 73.03 Favored 'General case' 0 C--O 1.236 0.353 0 CA-C-N 115.504 -0.771 . . . . 1.3300000000000001 110.012 178.428 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . 0.466 ' O ' HG13 ' A' ' 113' ' ' ILE . . . -57.93 -45.38 86.64 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.108 -0.496 . . . . 0.32000000000000001 110.834 179.245 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -62.77 -34.12 76.58 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.04 -0.527 . . . . 1.2 110.674 -179.71 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 2.3 t60 -70.07 -35.85 74.52 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.197 -0.456 . . . . 0.52000000000000002 110.358 179.712 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 63.1 mt -68.65 -40.36 80.28 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.16 -0.473 . . . . 0.55000000000000004 110.077 176.597 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.466 HG13 ' O ' ' A' ' 109' ' ' ALA . 69.3 mt -57.58 -41.9 80.07 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.141 0 CA-C-N 115.959 -0.564 . . . . 0.83999999999999997 109.636 174.512 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . 0.685 ' O ' ' HG2' ' A' ' 118' ' ' GLU . 2.4 mmmt -58.08 -49.04 78.3 Favored 'General case' 0 C--O 1.22 -0.464 0 CA-C-N 115.406 -0.816 . . . . 3.8300000000000001 110.551 177.335 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.58 HG13 ' HB2' ' A' ' 120' ' ' HIS . 68.2 t -53.6 -40.86 43.9 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 O-C-N 123.408 0.443 . . . . 1.1899999999999999 111.604 177.63 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . 0.41 ' HA ' ' HD3' ' A' ' 116' ' ' LYS . 42.0 mmtt -70.16 -33.54 71.9 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 111.857 0.318 . . . . 1.3200000000000001 111.857 178.604 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 98.0 mt -71.38 -30.39 66.08 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.185 0.516 . . . . 0.95999999999999996 110.058 175.414 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . 0.685 ' HG2' ' O ' ' A' ' 114' ' ' LYS . 22.1 mm-40 -67.71 -25.9 65.89 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.345 -0.843 . . . . 2.1800000000000002 110.127 176.077 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 91.91 35.17 6.89 Favored Glycine 0 N--CA 1.447 -0.573 0 C-N-CA 120.593 -0.813 . . . . 1.1599999999999999 111.927 -176.65 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' HIS . . . . . 0.58 ' HB2' HG13 ' A' ' 115' ' ' VAL . 97.9 m-70 -119.51 164.82 15.22 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 109.91 -0.404 . . . . 2.4199999999999999 109.91 177.955 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 42.3 mm-40 -110.59 161.87 15.28 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 116.329 -0.396 . . . . 2.5299999999999998 110.882 -174.628 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . 0.513 ' H ' HD23 ' A' ' 122' ' ' LEU . 1.7 pt? -124.96 135.44 26.78 Favored Pre-proline 0 C--N 1.323 -0.553 0 CA-C-N 115.795 -0.638 . . . . 1.3300000000000001 109.492 176.331 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 62.9 Cg_endo -74.33 -1.76 11.43 Favored 'Trans proline' 0 CA--C 1.53 0.279 0 C-N-CA 122.877 2.385 . . . . 1.3300000000000001 113.557 -175.455 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . 0.728 ' HA ' HD11 ' A' ' 92' ' ' LEU . . . 68.97 18.89 8.35 Favored 'General case' 0 N--CA 1.467 0.38 0 C-N-CA 123.04 0.536 . . . . 1.25 110.769 -175.781 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -117.95 156.57 28.27 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.396 -0.82 . . . . 2.73 109.231 174.765 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . 0.51 HD21 ' HB3' ' A' ' 92' ' ' LEU . 90.8 mt -108.97 104.8 55.92 Favored Pre-proline 0 C--N 1.323 -0.566 0 CA-C-O 120.705 0.288 . . . . 1.6599999999999999 111.629 -176.858 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' PRO . . . . . 0.53 ' HD2' HD12 ' A' ' 130' ' ' LEU . 51.5 Cg_exo -54.81 146.72 54.42 Favored 'Trans proline' 0 C--O 1.235 0.356 0 C-N-CA 123.015 2.477 . . . . 1.1699999999999999 111.782 172.023 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 41.3 Cg_endo -67.14 3.14 1.76 Allowed 'Trans proline' 0 N--CA 1.475 0.426 0 C-N-CA 123.24 2.627 . . . . 1.54 114.258 -174.228 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 27.5 p-80 -117.16 7.51 13.02 Favored 'General case' 0 C--N 1.327 -0.382 0 C-N-CA 120.737 -0.385 . . . . 1.0700000000000001 110.577 177.877 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . 0.53 HD12 ' HD2' ' A' ' 127' ' ' PRO . 23.4 mt -108.08 0.99 22.03 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.833 0.349 . . . . 1.3600000000000001 111.345 178.785 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 3.5 m -77.31 121.06 83.94 Favored Pre-proline 0 C--N 1.322 -0.613 0 CA-C-N 116.373 -0.376 . . . . 1.28 110.401 173.825 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 132' ' ' PRO . . . . . 0.522 ' HB3' ' HB3' ' A' ' 104' ' ' GLU . 51.4 Cg_exo -53.29 148.64 31.87 Favored 'Trans proline' 0 C--N 1.342 0.205 0 C-N-CA 122.944 2.43 . . . . 0.81000000000000005 112.094 -179.404 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 133' ' ' PRO . . . . . 0.484 ' HD2' ' HG2' ' A' ' 104' ' ' GLU . 52.3 Cg_exo -55.27 -26.61 52.99 Favored 'Trans proline' 0 C--N 1.344 0.311 0 C-N-CA 122.816 2.344 . . . . 1.1699999999999999 112.554 -178.61 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 5.9 p -89.71 -13.05 37.71 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.113 -0.494 . . . . 1.6000000000000001 111.74 -179.32 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . 0.509 ' HG2' ' HB ' ' A' ' 95' ' ' VAL . 13.6 mptt -111.28 -14.99 13.72 Favored 'General case' 0 N--CA 1.464 0.228 0 N-CA-C 111.967 0.358 . . . . 1.21 111.967 -177.746 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 31.9 ptt180 -75.21 143.38 43.18 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.995 0.426 . . . . 2.7599999999999998 110.484 -177.774 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 18.9 ttm180 -88.71 100.39 13.09 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.029 0.443 . . . . 4.54 110.7 -177.415 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 52.9 t-80 -107.29 99.46 8.99 Favored 'General case' 0 C--N 1.318 -0.804 0 N-CA-C 109.491 -0.559 . . . . 5.9500000000000002 109.491 174.687 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 11.8 tp10 . . . . . 0 C--O 1.248 0.981 0 O-C-N 123.943 0.777 . . . . 6.1500000000000004 109.998 -178.056 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' B' B ' 143' ' ' PHE . . . . . . . . . . . . . 74.0 t80 . . . . . 0 N--CA 1.478 0.947 0 CA-C-O 120.577 0.227 . . . . 11.859999999999999 110.444 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' B' B ' 144' ' ' ASN . . . . . . . . . . . . . 8.3 t30 -78.01 99.36 6.05 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.019 0.438 . . . . 8.1400000000000006 110.52 -179.817 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 145' ' ' TYR . . . . . . . . . . . . . 27.7 p90 -92.76 133.71 35.77 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 116.07 -0.514 . . . . 6.71 109.659 177.453 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 146' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -138.64 -41.25 0.49 Allowed 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 109.831 -0.433 . . . . 6.6100000000000003 109.831 174.824 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 147' ' ' SER . . . . . . . . . . . . . 11.2 t 68.8 112.45 0.04 OUTLIER 'General case' 0 N--CA 1.463 0.179 0 O-C-N 123.999 0.812 . . . . 3.6499999999999999 111.319 175.509 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 148' ' ' THR . . . . . . . . . . . . . 2.8 m -113.41 1.6 15.15 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.751 -0.659 . . . . 1.79 110.336 -177.862 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 149' ' ' GLY . . . . . . . . . . . . . . . 168.85 -176.3 43.09 Favored Glycine 0 N--CA 1.447 -0.617 0 C-N-CA 120.647 -0.787 . . . . 0.47999999999999998 112.081 178.661 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 150' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -72.5 -2.25 11.49 Favored 'Trans proline' 0 C--O 1.235 0.345 0 C-N-CA 122.797 2.331 . . . . 0.33000000000000002 112.238 -179.188 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 151' ' ' PHE . . . . . 0.636 ' HE1' ' HG3' ' A' ' 73' ' ' LYS . 49.3 m-85 -102.8 1.66 34.48 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.006 -0.543 . . . . 0.75 111.236 -179.093 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 152' ' ' THR . . . . . . . . . . . . . 22.7 p -108.74 24.67 12.75 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.275 0.56 . . . . 2.2200000000000002 110.041 175.263 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 153' ' ' ALA . . . . . . . . . . . . . . . -120.13 -74.14 0.62 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.623 -0.717 . . . . 4.4000000000000004 110.051 177.778 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 154' ' ' LYS . . . . . . . . . . . . . 9.7 mptt . . . . . 0 C--O 1.248 0.976 0 CA-C-O 118.041 -0.98 . . . . 6.75 109.674 173.399 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 141' ' ' ' CA' . . . . . 0.659 'CA ' ' OD1' ' A' ' 94' ' ' ASP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.428 ' HA2' ' HD3' ' A' ' 36' ' ' PRO . . . . . . . . 0 N--CA 1.481 1.7 0 N-CA-C 111.658 -0.577 . . . . 10.970000000000001 111.658 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 0.428 ' HD3' ' HA2' ' A' ' 35' ' ' GLY . 22.7 Cg_exo -65.07 120.59 7.85 Favored 'Trans proline' 0 C--N 1.343 0.28 0 C-N-CA 122.904 2.403 . . . . 9.0 111.99 179.141 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 3.0 pp -106.88 -2.7 21.07 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.27 -0.423 . . . . 7.4199999999999999 111.253 -179.04 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -85.5 160.89 34.89 Favored Glycine 0 N--CA 1.448 -0.521 0 C-N-CA 120.525 -0.845 . . . . 4.46 112.362 -179.643 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 36.5 p -142.72 142.35 31.96 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 120.567 0.222 . . . . 3.9700000000000002 110.673 -179.591 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -77.63 92.62 4.12 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 109.923 -0.399 . . . . 3.46 109.923 174.982 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 9.1 m-20 -117.8 127.08 53.54 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.851 -0.613 . . . . 1.9299999999999999 110.838 -177.986 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.458 HG21 ' HA ' ' A' ' 129' ' ' HIS . 17.9 m -110.46 125.88 67.73 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.727 0 CA-C-N 115.717 -0.674 . . . . 1.8500000000000001 109.475 174.991 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 50.7 mt-10 -66.79 121.67 15.96 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 109.147 -0.686 . . . . 3.1000000000000001 109.147 177.523 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 1.5 t90 -71.16 107.61 4.27 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 109.444 -0.576 . . . . 0.70999999999999996 109.444 -176.375 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 31.2 m -66.48 -0.65 0.96 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 115.84 -0.618 . . . . 1.45 111.945 -177.444 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.416 HG13 ' HB2' ' A' ' 111' ' ' HIS . 46.5 t -97.73 -24.08 4.45 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-O 121.219 0.533 . . . . 1.1000000000000001 109.788 173.875 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . 0.785 ' HA2' ' HG2' ' A' ' 50' ' ' LYS . . . -73.25 -21.21 79.89 Favored Glycine 0 N--CA 1.45 -0.39 0 CA-C-N 115.81 -0.632 . . . . 0.58999999999999997 112.345 -178.483 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . 0.426 ' HB2' ' HE3' ' A' ' 48' ' ' LYS . 12.3 ptmt -75.13 -25.06 58.15 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 120.863 0.363 . . . . 2.46 110.633 178.847 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -102.67 31.87 3.91 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.205 -0.452 . . . . 1.6599999999999999 110.004 176.694 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 0.785 ' HG2' ' HA2' ' A' ' 47' ' ' GLY . 8.1 mmmm -72.82 -50.65 7.11 Favored Pre-proline 0 C--O 1.216 -0.673 0 CA-C-O 118.53 -0.747 . . . . 1.1499999999999999 112.253 -178.293 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.58 ' HD2' ' N ' ' A' ' 50' ' ' LYS . 1.4 Cg_endo -44.05 -42.01 12.66 Favored 'Trans proline' 0 C--N 1.36 1.181 0 C-N-CA 122.845 2.363 . . . . 0.75 112.593 -177.397 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 9.5 m -69.73 -45.4 68.24 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.952 -0.567 . . . . 0.68000000000000005 111.119 179.67 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' TYR . . . . . 0.48 ' OH ' ' HA ' ' A' ' 111' ' ' HIS . 12.1 m-30 -76.35 -22.69 54.57 Favored 'General case' 0 C--O 1.219 -0.535 0 CA-C-N 116.486 -0.324 . . . . 0.68999999999999995 110.607 -175.178 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -73.74 -45.05 54.37 Favored 'General case' 0 C--O 1.237 0.425 0 N-CA-C 108.68 -0.859 . . . . 2.1800000000000002 108.68 175.418 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 2.2 tp10 -53.61 -42.26 67.53 Favored 'General case' 0 N--CA 1.455 -0.186 0 CA-C-N 114.675 -1.148 . . . . 2.3300000000000001 110.495 178.2 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 66.1 mt -80.37 -47.09 21.33 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-N 115.668 -0.696 . . . . 0.64000000000000001 111.341 -179.134 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . 0.508 ' HE1' HG12 ' A' ' 67' ' ' ILE . 86.3 t80 -52.31 -37.2 55.2 Favored 'General case' 0 N--CA 1.468 0.457 0 C-N-CA 122.982 0.513 . . . . 0.28999999999999998 112.024 -176.076 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . 0.586 ' HA ' ' HG3' ' A' ' 62' ' ' PRO . 18.5 m-30 -77.24 -17.8 58.16 Favored 'General case' 0 C--N 1.326 -0.424 0 C-N-CA 120.743 -0.383 . . . . 1.1699999999999999 111.421 -174.485 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 41.0 p -85.83 -7.5 58.69 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.283 0.563 . . . . 0.44 110.386 -179.497 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 11.1 mp -95.47 19.16 11.35 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.58 -0.737 . . . . 1.3700000000000001 110.327 179.16 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 12.7 p 49.61 81.46 0.26 Allowed Pre-proline 0 N--CA 1.465 0.317 0 CA-C-N 115.558 -0.746 . . . . 1.24 111.836 -177.515 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . 0.586 ' HG3' ' HA ' ' A' ' 58' ' ' TYR . 72.6 Cg_endo -84.85 116.9 1.91 Allowed 'Trans proline' 0 N--CA 1.455 -0.767 0 C-N-CA 122.659 2.239 . . . . 0.46999999999999997 112.555 -177.744 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 18.7 m -88.76 113.46 25.53 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 CA-C-O 121.26 0.553 . . . . 1.02 110.134 178.011 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 11.7 m120 62.98 28.52 16.3 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 115.485 -0.78 . . . . 1.3400000000000001 111.472 179.4 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 82.01 22.98 58.38 Favored Glycine 0 N--CA 1.454 -0.146 0 C-N-CA 121.072 -0.585 . . . . 0.42999999999999999 112.326 179.404 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 0.539 ' HG2' ' HA ' ' A' ' 102' ' ' ASP . 26.8 mtpp -143.28 141.05 30.9 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 109.417 -0.586 . . . . 1.48 109.417 -177.886 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . 0.508 HG12 ' HE1' ' A' ' 57' ' ' PHE . 36.6 pt -108.66 154.77 9.86 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.812 0 CA-C-O 121.184 0.516 . . . . 0.64000000000000001 110.975 178.456 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . 0.52 ' HA ' ' CD2' ' A' ' 100' ' ' LEU . 32.2 p -77.6 161.28 27.95 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.171 -0.922 . . . . 0.55000000000000004 111.082 -179.474 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -63.6 -22.52 66.03 Favored Glycine 0 N--CA 1.444 -0.78 0 C-N-CA 121.05 -0.595 . . . . 0.40999999999999998 111.796 179.179 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -61.48 -47.52 85.29 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.898 0.38 . . . . 0.38 111.663 178.367 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 46.1 m-80 -81.29 -31.86 33.44 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.176 -0.465 . . . . 1.8100000000000001 110.976 -175.804 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 0.519 ' O ' ' HG2' ' A' ' 76' ' ' MET . . . -63.79 -45.21 90.73 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 109.378 -0.601 . . . . 0.39000000000000001 109.378 173.283 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 60.5 tttp -57.03 -37.9 72.4 Favored 'General case' 0 CA--C 1.52 -0.178 0 CA-C-N 115.24 -0.891 . . . . 0.83999999999999997 109.889 175.95 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . 0.415 ' O ' ' HG2' ' A' ' 78' ' ' LYS . 9.0 tptm -57.28 -57.05 14.32 Favored 'General case' 0 N--CA 1.453 -0.298 0 CA-C-N 115.41 -0.814 . . . . 1.95 110.509 177.968 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . 0.583 ' HA ' ' HG3' ' A' ' 78' ' ' LYS . 5.4 tp10 -64.61 -39.46 93.77 Favored 'General case' 0 C--O 1.237 0.434 0 CA-C-O 121.218 0.532 . . . . 1.6000000000000001 110.966 -177.168 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' MET . . . . . 0.638 ' HB3' HD22 ' A' ' 86' ' ' LEU . 96.3 mmm -64.91 -29.39 70.33 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.179 0.514 . . . . 1.24 109.882 178.775 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -75.04 -28.32 20.79 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 CA-C-N 115.985 -0.552 . . . . 1.5700000000000001 110.086 175.672 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.583 ' HG3' ' HA ' ' A' ' 75' ' ' GLU . 3.1 mmmm -68.86 -27.76 66.1 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.802 -0.635 . . . . 2.79 111.211 177.015 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 78.5 p -73.11 -15.67 61.48 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.32 -0.4 . . . . 1.27 111.643 -176.558 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 75.0 mmtt 66.75 16.43 10.38 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-N 115.9 -0.591 . . . . 2.9700000000000002 111.385 178.98 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.426 ' HB2' HD21 ' A' ' 86' ' ' LEU . 93.0 mt -83.82 150.3 58.72 Favored Pre-proline 0 C--N 1.327 -0.374 0 CA-C-N 116.483 -0.326 . . . . 0.52000000000000002 111.032 -179.633 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . 0.536 ' O ' ' HG ' ' A' ' 86' ' ' LEU . 51.2 Cg_exo -55.34 148.15 52.75 Favored 'Trans proline' 0 C--N 1.349 0.601 0 C-N-CA 123.113 2.542 . . . . 0.44 112.698 179.47 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 13.7 m120 -61.43 -36.12 79.48 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.939 -0.573 . . . . 1.8500000000000001 111.448 -174.109 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 15.0 t -66.03 -35.23 79.98 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.949 0.404 . . . . 1.47 110.254 179.243 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 57.4 t -72.29 -37.3 58.18 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.313 0 N-CA-C 109.68 -0.489 . . . . 0.45000000000000001 109.68 178.905 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.638 HD22 ' HB3' ' A' ' 76' ' ' MET . 62.1 mt -61.48 -39.72 91.94 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.883 -0.599 . . . . 0.90000000000000002 109.93 176.587 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -67.19 -39.93 92.45 Favored Glycine 0 N--CA 1.45 -0.378 0 N-CA-C 111.672 -0.571 . . . . 0.32000000000000001 111.672 177.29 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . 0.437 ' O ' ' HG ' ' A' ' 92' ' ' LEU . 29.9 mmmt -58.06 -47.92 81.68 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.996 0.427 . . . . 1.8899999999999999 110.67 175.69 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.774 HG23 HD12 ' A' ' 112' ' ' LEU . 74.9 mt -65.27 -40.35 88.32 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 115.811 -0.632 . . . . 0.70999999999999996 110.926 -177.785 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 39.0 t-105 -61.79 -45.16 95.08 Favored 'General case' 0 C--N 1.334 -0.083 0 N-CA-C 110.053 -0.351 . . . . 0.33000000000000002 110.053 175.392 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 4.9 tppp? -58.19 -28.15 64.53 Favored 'General case' 0 CA--C 1.531 0.232 0 CA-C-N 115.686 -0.688 . . . . 2.7000000000000002 111.561 -179.554 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.437 ' HG ' ' O ' ' A' ' 88' ' ' LYS . 73.6 mt -92.39 -36.19 13.28 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.708 0.289 . . . . 1.6599999999999999 111.056 179.396 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -75.22 -42.39 55.59 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.372 -0.377 . . . . 0.46999999999999997 111.404 -175.458 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . 0.653 ' OD1' 'CA ' ' A' ' 141' ' ' ' CA' . 45.2 t0 -86.73 75.45 9.64 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.549 0.69 . . . . 0.79000000000000004 109.446 178.954 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 42.8 t -63.56 -40.54 89.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 114.927 -1.033 . . . . 0.60999999999999999 111.255 -174.342 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 30.4 p30 -84.39 -7.47 59.29 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.369 -0.378 . . . . 0.95999999999999996 111.898 -177.838 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 48.0 mtmt 55.86 74.13 0.4 Allowed 'General case' 0 N--CA 1.466 0.369 0 O-C-N 123.503 0.502 . . . . 2.96 111.541 177.904 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . 0.626 ' OD1' 'CA ' ' A' ' 141' ' ' ' CA' . 7.3 p-10 -128.85 9.26 5.83 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.869 0.366 . . . . 0.42999999999999999 111.068 -177.557 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 69.73 -0.65 19.14 Favored Glycine 0 CA--C 1.522 0.487 0 C-N-CA 121.043 -0.598 . . . . 0.44 113.207 176.538 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.52 ' CD2' ' HA ' ' A' ' 68' ' ' THR . 83.8 mt -129.27 137.37 51.02 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 109.128 -0.693 . . . . 1.1100000000000001 109.128 177.617 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 72.3 mt -90.62 122.44 33.42 Favored 'General case' 0 C--N 1.312 -1.025 0 C-N-CA 120.3 -0.56 . . . . 0.41999999999999998 109.839 178.685 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . 0.539 ' HA ' ' HG2' ' A' ' 66' ' ' LYS . 23.4 m-20 -69.36 173.97 5.28 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 108.263 -1.014 . . . . 1.72 108.263 173.897 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -55.4 -41.44 72.7 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 121.081 0.467 . . . . 1.6000000000000001 110.133 173.755 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -72.54 -40.84 66.43 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.96 -0.564 . . . . 1.6599999999999999 111.406 179.508 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 28.2 mt-10 -70.13 -39.53 75.39 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 120.707 -0.397 . . . . 0.44 111.018 -176.017 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . 0.491 ' CD1' HD11 ' A' ' 67' ' ' ILE . 81.9 t80 -67.07 -37.64 84.37 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 109.952 -0.388 . . . . 0.41999999999999998 109.952 176.275 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -58.3 -43.91 88.31 Favored 'General case' 0 N--CA 1.452 -0.342 0 CA-C-N 116.147 -0.479 . . . . 0.22 110.406 175.885 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 6.3 tt -60.35 -48.11 83.17 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.154 -0.476 . . . . 1.3300000000000001 110.098 178.779 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -58.53 -49.47 77.29 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.082 -0.508 . . . . 0.32000000000000001 110.943 179.063 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' ASN . . . . . 0.471 HD21 ' HG2' ' A' ' 75' ' ' GLU . 0.5 OUTLIER -63.57 -31.42 72.58 Favored 'General case' 0 CA--C 1.519 -0.245 0 CA-C-N 115.915 -0.584 . . . . 1.2 111.201 179.737 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' HIS . . . . . 0.48 ' HA ' ' OH ' ' A' ' 53' ' ' TYR . 32.0 t60 -66.93 -40.57 87.65 Favored 'General case' 0 N--CA 1.453 -0.302 0 N-CA-C 109.952 -0.388 . . . . 0.52000000000000002 109.952 179.388 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.774 HD12 HG23 ' A' ' 89' ' ' ILE . 98.3 mt -65.29 -39.54 92.66 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.658 -0.246 . . . . 0.55000000000000004 110.448 177.519 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.526 HD11 ' SD ' ' A' ' 76' ' ' MET . 61.2 mt -60.3 -52.35 62.42 Favored 'Isoleucine or valine' 0 C--O 1.233 0.219 0 CA-C-O 121.104 0.478 . . . . 0.83999999999999997 110.192 175.424 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . 0.546 ' O ' ' HB2' ' A' ' 118' ' ' GLU . 0.4 OUTLIER -65.02 -39.45 93.4 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.492 -0.776 . . . . 3.8300000000000001 111.075 -174.804 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.401 HG23 ' O ' ' A' ' 111' ' ' HIS . 51.7 t -69.73 -45.03 78.67 Favored 'Isoleucine or valine' 0 C--O 1.234 0.248 0 CA-C-N 116.639 -0.255 . . . . 1.1899999999999999 111.567 -178.032 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 35.8 tptt -60.52 -45.76 92.64 Favored 'General case' 0 N--CA 1.454 -0.267 0 CA-C-O 120.981 0.42 . . . . 1.3200000000000001 110.676 176.92 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 94.4 mt -74.34 -16.06 60.92 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.306 -0.406 . . . . 0.95999999999999996 111.208 -179.4 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . 0.657 ' HB3' ' HD2' ' A' ' 120' ' ' HIS . 22.6 tt0 -80.02 0.89 29.82 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.914 -0.584 . . . . 2.1800000000000002 109.664 176.22 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 91.81 15.76 53.59 Favored Glycine 0 N--CA 1.451 -0.319 0 CA-C-N 115.839 -0.619 . . . . 1.1599999999999999 112.834 175.378 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' HIS . . . . . 0.657 ' HD2' ' HB3' ' A' ' 118' ' ' GLU . 61.6 m-70 -106.08 160.3 15.41 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 110.095 -0.335 . . . . 2.4199999999999999 110.095 179.903 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 8.0 tp10 -96.63 149.25 22.0 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 121.001 0.429 . . . . 2.5299999999999998 110.377 179.275 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . 0.434 ' O ' HD12 ' A' ' 122' ' ' LEU . 2.4 pp -114.06 143.67 30.11 Favored Pre-proline 0 C--N 1.321 -0.645 0 CA-C-N 115.92 -0.582 . . . . 1.3300000000000001 109.767 177.304 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 63.1 Cg_endo -74.09 -12.03 23.43 Favored 'Trans proline' 0 N--CA 1.465 -0.166 0 C-N-CA 122.298 1.998 . . . . 1.3300000000000001 113.036 -176.372 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . 62.92 18.07 10.53 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-N 115.823 -0.626 . . . . 1.25 110.337 -175.029 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -134.01 176.09 8.89 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.045 -0.98 . . . . 2.73 108.61 175.773 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . 0.469 ' HA ' ' HD2' ' A' ' 127' ' ' PRO . 4.2 tt -113.06 100.37 51.15 Favored Pre-proline 0 C--N 1.322 -0.61 0 C-N-CA 120.786 -0.365 . . . . 1.6599999999999999 110.542 -178.062 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' PRO . . . . . 0.755 ' HG2' ' HB2' ' A' ' 130' ' ' LEU . 19.5 Cg_endo -58.98 151.17 67.7 Favored 'Trans proline' 0 C--N 1.347 0.496 0 C-N-CA 123.435 2.757 . . . . 1.1699999999999999 112.645 176.624 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -58.38 -28.63 85.65 Favored 'Trans proline' 0 C--N 1.346 0.446 0 C-N-CA 123.329 2.686 . . . . 1.54 113.315 -175.608 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 129' ' ' HIS . . . . . 0.458 ' HA ' HG21 ' A' ' 42' ' ' VAL . 4.1 p-80 -91.34 4.9 51.25 Favored 'General case' 0 C--N 1.329 -0.316 0 C-N-CA 120.836 -0.346 . . . . 1.0700000000000001 111.226 -178.512 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . 0.755 ' HB2' ' HG2' ' A' ' 127' ' ' PRO . 41.7 tp -104.65 -2.95 24.35 Favored 'General case' 0 N--CA 1.444 -0.75 0 CA-C-O 121.185 0.517 . . . . 1.3600000000000001 110.248 -177.121 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . 0.445 ' HA ' ' HD2' ' A' ' 132' ' ' PRO . 29.9 t -72.84 125.99 90.85 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 115.779 -0.646 . . . . 1.28 109.907 177.562 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 132' ' ' PRO . . . . . 0.445 ' HD2' ' HA ' ' A' ' 131' ' ' VAL . 3.8 Cg_endo -47.69 136.02 21.76 Favored 'Trans proline' 0 C--O 1.236 0.414 0 C-N-CA 123.074 2.516 . . . . 0.81000000000000005 111.797 176.653 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 23.6 Cg_endo -60.81 -15.34 37.34 Favored 'Trans proline' 0 C--N 1.343 0.288 0 C-N-CA 123.222 2.615 . . . . 1.1699999999999999 112.633 -174.525 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 19.7 p -90.35 -21.63 21.9 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.166 -0.47 . . . . 1.6000000000000001 111.366 -179.451 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 62.8 mttt -119.5 23.34 11.26 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.782 0.325 . . . . 1.21 111.555 -172.23 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 21.1 ptt180 -87.11 132.62 33.78 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.942 0.401 . . . . 2.7599999999999998 111.504 -178.926 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 15.4 mtm180 -108.35 152.13 25.06 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 109.594 -0.521 . . . . 4.54 109.594 178.625 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 53.2 t-80 -133.59 137.21 45.35 Favored 'General case' 0 C--N 1.323 -0.562 0 C-N-CA 121.228 -0.189 . . . . 5.9500000000000002 110.539 177.665 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 7.4 tt0 . . . . . 0 C--O 1.25 1.11 0 O-C-N 124.301 1.0 . . . . 6.1500000000000004 111.245 176.488 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' B' B ' 143' ' ' PHE . . . . . . . . . . . . . 94.3 m-85 . . . . . 0 N--CA 1.483 1.202 0 CA-C-O 120.747 0.308 . . . . 11.859999999999999 110.247 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' B' B ' 144' ' ' ASN . . . . . . . . . . . . . 26.6 p-10 -86.48 166.42 15.51 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 109.411 -0.589 . . . . 8.1400000000000006 109.411 174.34 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 145' ' ' TYR . . . . . . . . . . . . . 62.6 t80 -122.55 107.71 12.31 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.178 0.513 . . . . 6.71 110.001 175.118 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 146' ' ' GLU . . . . . 0.459 ' H ' ' HG2' ' B' ' 146' ' ' GLU . 4.8 pt-20 -93.97 157.5 16.08 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.611 -0.722 . . . . 6.6100000000000003 110.51 -179.578 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 147' ' ' SER . . . . . . . . . . . . . 8.6 p -63.58 151.68 40.88 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.009 -0.542 . . . . 3.6499999999999999 112.062 -175.297 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 148' ' ' THR . . . . . . . . . . . . . 1.6 m -92.39 1.63 57.12 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.389 0.614 . . . . 1.79 110.37 -177.407 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 149' ' ' GLY . . . . . . . . . . . . . . . 143.67 157.62 7.25 Favored Glycine 0 N--CA 1.445 -0.726 0 CA-C-N 115.72 -0.673 . . . . 0.47999999999999998 111.712 -179.613 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 150' ' ' PRO . . . . . . . . . . . . . 91.8 Cg_endo -80.85 -1.52 11.28 Favored 'Trans proline' 0 CA--C 1.532 0.424 0 C-N-CA 123.176 2.584 . . . . 0.33000000000000002 112.571 -178.631 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 151' ' ' PHE . . . . . 0.571 ' CZ ' ' HG3' ' A' ' 76' ' ' MET . 37.8 m-85 -107.2 -58.45 1.94 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.996 -0.547 . . . . 0.75 111.327 -178.388 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 152' ' ' THR . . . . . . . . . . . . . 15.0 t -80.24 153.79 28.31 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.185 0.517 . . . . 2.2200000000000002 111.4 -174.692 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 153' ' ' ALA . . . . . . . . . . . . . . . -146.84 159.31 43.67 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.718 -0.674 . . . . 4.4000000000000004 109.529 179.562 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 154' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.245 0.836 0 CA-C-O 118.143 -0.932 . . . . 6.75 110.028 -178.886 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 141' ' ' ' CA' . . . . . 0.653 'CA ' ' OD1' ' A' ' 94' ' ' ASP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.598 0 N-CA-C 111.892 -0.483 . . . . 10.970000000000001 111.892 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 92.0 Cg_endo -76.64 10.18 2.34 Favored 'Trans proline' 0 CA--C 1.53 0.322 0 C-N-CA 123.019 2.48 . . . . 9.0 113.003 -178.015 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -123.7 92.37 3.67 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.138 0.494 . . . . 7.4199999999999999 109.919 179.108 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -94.61 57.56 1.92 Allowed Glycine 0 N--CA 1.447 -0.627 0 CA-C-N 115.712 -0.676 . . . . 4.46 112.465 -176.987 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 8.8 p -87.74 25.88 1.42 Allowed 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.05 0.452 . . . . 3.9700000000000002 110.85 -179.418 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -86.81 113.08 22.33 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.001 -0.545 . . . . 3.46 110.589 -178.611 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -75.3 127.56 33.42 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.281 -0.418 . . . . 1.9299999999999999 110.599 179.489 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 16.5 m -98.06 133.75 38.99 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-O 121.009 0.433 . . . . 1.8500000000000001 111.009 -179.915 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 16.8 pt-20 -66.56 147.41 53.32 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.214 0.53 . . . . 3.1000000000000001 111.386 -177.499 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' TRP . . . . . 0.433 ' HH2' ' O ' ' A' ' 104' ' ' GLU . 1.3 t90 -86.07 105.15 16.3 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 109.495 -0.557 . . . . 0.70999999999999996 109.495 -178.612 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 23.6 m -64.82 -11.33 11.01 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.335 0 CA-C-O 121.034 0.445 . . . . 1.45 111.961 -177.292 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.473 HG13 ' HB2' ' A' ' 111' ' ' HIS . 42.1 t -82.04 -16.43 11.89 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 CA-C-O 121.31 0.576 . . . . 1.1000000000000001 110.261 177.331 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . 0.53 ' HA2' ' HB2' ' A' ' 50' ' ' LYS . . . -74.25 -11.17 82.07 Favored Glycine 0 N--CA 1.446 -0.638 0 CA-C-N 115.684 -0.689 . . . . 0.58999999999999997 112.701 -178.68 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 17.2 pttt -82.95 -28.44 29.82 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 120.347 -0.541 . . . . 2.46 109.978 -179.041 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 12.9 m-20 -106.77 30.75 5.83 Favored 'General case' 0 CA--C 1.509 -0.622 0 N-CA-C 108.593 -0.892 . . . . 1.6599999999999999 108.593 176.972 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 0.598 ' H ' ' HD2' ' A' ' 51' ' ' PRO . 15.0 tttp -92.0 -52.86 0.28 Allowed Pre-proline 0 C--N 1.317 -0.827 0 N-CA-C 112.521 0.563 . . . . 1.1499999999999999 112.521 -171.207 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.598 ' HD2' ' H ' ' A' ' 50' ' ' LYS . 4.8 Cg_endo -47.03 -39.54 25.46 Favored 'Trans proline' 0 C--N 1.357 0.998 0 C-N-CA 122.738 2.292 . . . . 0.75 112.981 -178.078 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 18.8 m -70.14 -42.77 72.13 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 116.003 -0.544 . . . . 0.68000000000000005 110.55 -179.485 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 21.3 m-30 -71.74 -22.53 61.6 Favored 'General case' 0 CA--C 1.517 -0.312 0 CA-C-N 116.314 -0.403 . . . . 0.68999999999999995 110.222 179.558 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 86.8 m-20 -72.96 -36.26 67.09 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.183 -0.462 . . . . 2.1800000000000002 109.785 176.682 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.469 ' HG3' ' O ' ' A' ' 51' ' ' PRO . 48.1 mt-10 -66.12 -40.75 90.93 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.017 -0.538 . . . . 2.3300000000000001 110.472 176.659 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 44.8 mt -69.39 -37.38 75.25 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-O 121.582 0.706 . . . . 0.64000000000000001 109.964 175.781 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . 0.483 ' HE1' HG12 ' A' ' 67' ' ' ILE . 78.2 t80 -59.62 -36.79 77.03 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.171 -0.922 . . . . 0.28999999999999998 110.971 176.988 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . 0.519 ' HA ' ' HG3' ' A' ' 62' ' ' PRO . 14.2 m-30 -74.35 -23.38 59.01 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.481 -0.327 . . . . 1.1699999999999999 111.047 -178.689 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 19.0 p -89.76 6.77 40.13 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 120.978 0.418 . . . . 0.44 111.371 -179.15 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 59.9 mt -105.38 5.75 32.04 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.121 -0.49 . . . . 1.3700000000000001 110.193 173.956 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 19.2 m 66.42 82.7 0.2 Allowed Pre-proline 0 CA--C 1.532 0.276 0 CA-C-N 115.266 -0.879 . . . . 1.24 111.519 178.571 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . 0.519 ' HG3' ' HA ' ' A' ' 58' ' ' TYR . 36.7 Cg_endo -93.53 138.51 1.38 Allowed 'Trans proline' 0 N--CA 1.453 -0.885 0 C-N-CA 123.288 2.659 . . . . 0.46999999999999997 113.162 -178.837 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 18.9 m -119.42 134.06 64.22 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 115.892 -0.595 . . . . 1.02 109.555 174.816 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 83.6 m-20 59.27 30.65 20.43 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-O 121.015 0.436 . . . . 1.3400000000000001 110.986 -176.859 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 69.92 25.46 75.55 Favored Glycine 0 C--N 1.332 0.339 0 CA-C-N 115.959 -0.564 . . . . 0.42999999999999999 112.598 178.47 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 0.631 ' HA ' ' HA ' ' A' ' 102' ' ' ASP . 3.0 ptpp? -152.13 145.88 25.07 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.055 0.455 . . . . 1.48 111.425 179.528 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . 0.483 HG12 ' HE1' ' A' ' 57' ' ' PHE . 34.3 pt -107.9 142.77 19.73 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-N 116.078 -0.51 . . . . 0.64000000000000001 109.766 176.887 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . 0.703 ' HA ' ' HB2' ' A' ' 100' ' ' LEU . 23.2 p -64.51 161.4 17.37 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 116.382 -0.372 . . . . 0.55000000000000004 110.455 177.638 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -62.3 -12.43 38.44 Favored Glycine 0 N--CA 1.448 -0.548 0 C-N-CA 120.78 -0.724 . . . . 0.40999999999999998 112.24 -178.634 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.459 ' O ' ' HG3' ' A' ' 74' ' ' LYS . . . -68.16 -50.04 57.09 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.326 0.584 . . . . 0.38 110.63 179.573 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . 0.933 ' HA ' ' HE3' ' A' ' 74' ' ' LYS . 35.0 m-80 -72.92 -38.84 66.71 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.564 -0.743 . . . . 1.8100000000000001 110.32 -177.758 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -61.94 -41.63 98.17 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.69 -0.686 . . . . 0.39000000000000001 110.097 176.766 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . 0.513 ' HG3' ' CE1' ' B' ' 151' ' ' PHE . 86.0 tttt -59.21 -43.06 92.29 Favored 'General case' 0 CA--C 1.519 -0.234 0 CA-C-N 115.964 -0.562 . . . . 0.83999999999999997 110.216 176.639 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . 0.933 ' HE3' ' HA ' ' A' ' 71' ' ' ASN . 8.5 mtmp? -58.24 -42.03 85.45 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-N 116.318 -0.401 . . . . 1.95 111.091 179.114 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 15.4 tp10 -66.74 -44.92 80.24 Favored 'General case' 0 C--O 1.237 0.396 0 CA-C-O 121.476 0.655 . . . . 1.6000000000000001 110.732 179.154 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' MET . . . . . 0.591 ' HB3' HD22 ' A' ' 86' ' ' LEU . 84.8 mtp -73.11 -21.9 60.66 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.78 -0.645 . . . . 1.24 111.687 -174.423 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.404 HG22 ' O ' ' A' ' 73' ' ' LYS . 34.5 m -86.21 -12.32 11.08 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.455 0 C-N-CA 120.408 -0.517 . . . . 1.5700000000000001 110.363 171.054 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.75 ' HG2' ' O ' ' A' ' 74' ' ' LYS . 40.6 mmtm -75.78 -26.93 57.78 Favored 'General case' 0 N--CA 1.469 0.498 0 N-CA-C 110.244 -0.28 . . . . 2.79 110.244 170.439 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -72.88 -11.62 60.66 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-O 120.798 0.332 . . . . 1.27 110.39 172.069 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . 0.406 ' HG3' ' O ' ' A' ' 78' ' ' LYS . 73.3 mttt 65.38 24.28 12.03 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-N 115.596 -0.729 . . . . 2.9700000000000002 112.392 169.63 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.627 ' HB2' HD21 ' A' ' 86' ' ' LEU . 91.6 mt -83.77 161.86 54.57 Favored Pre-proline 0 C--N 1.325 -0.483 0 CA-C-N 116.302 -0.408 . . . . 0.52000000000000002 110.786 179.763 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . 0.433 ' O ' ' HG ' ' A' ' 86' ' ' LEU . 52.1 Cg_exo -57.73 142.16 95.87 Favored 'Trans proline' 0 C--N 1.349 0.576 0 C-N-CA 123.073 2.515 . . . . 0.44 112.812 177.558 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 31.4 m-80 -59.03 -43.62 91.65 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 115.769 -0.65 . . . . 1.8500000000000001 111.636 -175.237 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 2.9 p -63.64 -44.7 93.11 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.055 -0.52 . . . . 1.47 111.113 -179.208 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 60.6 t -64.18 -40.6 89.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 115.872 -0.604 . . . . 0.45000000000000001 110.241 178.886 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.627 HD21 ' HB2' ' A' ' 81' ' ' LEU . 92.3 mt -59.57 -38.43 81.13 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.178 -0.465 . . . . 0.90000000000000002 110.764 176.529 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -67.38 -37.61 90.57 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.686 -0.769 . . . . 0.32000000000000001 112.24 178.386 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.21 -43.3 95.42 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 120.766 -0.374 . . . . 1.8899999999999999 110.081 174.651 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 20.9 mt -62.37 -35.07 67.69 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.312 0 CA-C-N 116.07 -0.513 . . . . 0.70999999999999996 110.387 175.831 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 71.4 t-105 -57.44 -53.93 52.59 Favored 'General case' 0 N--CA 1.452 -0.342 0 CA-C-O 120.561 0.219 . . . . 0.33000000000000002 110.623 175.739 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . 0.819 ' HE2' ' HA ' ' A' ' 91' ' ' LYS . 0.6 OUTLIER -69.3 -15.57 63.37 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.989 0.423 . . . . 2.7000000000000002 111.1 -176.989 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.42 HD22 ' HA ' ' A' ' 124' ' ' ALA . 14.8 tp -88.4 -32.06 18.53 Favored 'General case' 0 N--CA 1.437 -1.09 0 CA-C-O 120.89 0.376 . . . . 1.6599999999999999 110.006 178.2 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . 0.761 ' HA ' HD12 ' A' ' 108' ' ' LEU . . . -87.89 -42.99 12.13 Favored 'General case' 0 C--O 1.232 0.184 0 CA-C-N 116.451 -0.34 . . . . 0.46999999999999997 111.583 -179.571 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . 0.641 ' OD1' 'CA ' ' A' ' 141' ' ' ' CA' . 28.1 t0 -82.81 99.9 9.98 Favored 'General case' 0 C--O 1.236 0.376 0 CA-C-O 121.555 0.693 . . . . 0.79000000000000004 110.029 179.667 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 45.3 t -83.09 -43.42 18.4 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.739 0 CA-C-N 115.282 -0.872 . . . . 0.60999999999999999 110.883 -174.512 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . 0.592 ' OD1' 'CA ' ' A' ' 141' ' ' ' CA' . 34.6 p-10 -82.63 -10.44 58.95 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.961 -0.563 . . . . 0.95999999999999996 111.779 -173.666 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.561 ' HA ' ' OD2' ' A' ' 94' ' ' ASP . 42.7 mtpt 57.91 73.0 0.49 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.402 0.62 . . . . 2.96 111.922 178.951 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . 0.582 ' OD1' 'CA ' ' A' ' 141' ' ' ' CA' . 16.9 p-10 -121.64 9.98 10.28 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 115.395 -0.82 . . . . 0.42999999999999999 110.196 176.334 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 64.2 18.05 62.27 Favored Glycine 0 C--N 1.333 0.401 0 CA-C-N 115.713 -0.676 . . . . 0.44 112.208 177.706 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.703 ' HB2' ' HA ' ' A' ' 68' ' ' THR . 1.7 pp -155.02 166.32 33.95 Favored 'General case' 0 N--CA 1.444 -0.748 0 N-CA-C 108.468 -0.938 . . . . 1.1100000000000001 108.468 -179.373 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 87.6 mt -126.44 123.66 38.36 Favored 'General case' 0 C--N 1.322 -0.615 0 C-N-CA 120.832 -0.347 . . . . 0.41999999999999998 111.228 -173.581 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . 0.631 ' HA ' ' HA ' ' A' ' 66' ' ' LYS . 2.3 p30 -79.75 -177.1 5.73 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 109.31 -0.626 . . . . 1.72 109.31 170.906 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 3.1 p30 -62.12 -29.39 70.3 Favored 'General case' 0 C--N 1.322 -0.63 0 C-N-CA 120.905 -0.318 . . . . 1.6000000000000001 111.503 -174.694 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . 0.515 ' HB3' ' HB3' ' A' ' 132' ' ' PRO . 78.3 mt-10 -70.97 -56.24 6.62 Favored 'General case' 0 C--O 1.232 0.178 0 N-CA-C 109.823 -0.436 . . . . 1.6599999999999999 109.823 177.545 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 25.3 mt-10 -65.52 -33.33 75.68 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.838 -0.619 . . . . 0.44 110.977 -174.645 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 90.8 t80 -69.23 -42.96 74.99 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.53 -0.305 . . . . 0.41999999999999998 110.235 178.13 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -59.95 -39.15 84.6 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-O 121.121 0.486 . . . . 0.22 110.092 176.35 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.761 HD12 ' HA ' ' A' ' 93' ' ' ALA . 2.5 tm? -59.99 -51.69 68.6 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.625 -0.716 . . . . 1.3300000000000001 109.492 176.862 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . 0.429 ' O ' HG13 ' A' ' 113' ' ' ILE . . . -57.61 -45.37 85.43 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 115.965 -0.562 . . . . 0.32000000000000001 111.62 179.456 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -69.38 -30.99 69.1 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.741 0.305 . . . . 1.2 111.244 -178.588 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' HIS . . . . . 0.473 ' HB2' HG13 ' A' ' 46' ' ' VAL . 30.3 t60 -64.55 -35.15 80.04 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 108.862 -0.792 . . . . 0.52000000000000002 108.862 175.426 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.498 ' HA ' HG12 ' A' ' 115' ' ' VAL . 74.8 mt -71.18 -42.63 68.79 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.399 -0.818 . . . . 0.55000000000000004 110.797 177.303 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.429 HG13 ' O ' ' A' ' 109' ' ' ALA . 24.6 mt -55.52 -50.28 67.51 Favored 'Isoleucine or valine' 0 C--O 1.234 0.26 0 CA-C-O 121.209 0.528 . . . . 0.83999999999999997 110.44 177.859 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 37.3 ttpt -69.95 -45.4 67.51 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.729 -0.669 . . . . 3.8300000000000001 110.997 -175.417 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.498 HG12 ' HA ' ' A' ' 112' ' ' LEU . 5.8 p -63.48 -30.61 50.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 120.95 0.405 . . . . 1.1899999999999999 110.207 -178.557 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . 0.477 ' HD2' ' O ' ' A' ' 120' ' ' HIS . 34.6 tptt -69.28 -45.81 68.72 Favored 'General case' 0 N--CA 1.447 -0.61 0 CA-C-N 116.204 -0.453 . . . . 1.3200000000000001 110.513 176.786 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 93.9 mt -74.56 -16.28 60.82 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.11 -0.496 . . . . 0.95999999999999996 111.305 -179.198 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -84.47 6.05 25.0 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.594 0.711 . . . . 2.1800000000000002 109.35 176.52 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 90.34 33.92 8.39 Favored Glycine 0 CA--C 1.518 0.272 0 CA-C-N 115.47 -0.786 . . . . 1.1599999999999999 113.927 172.666 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' HIS . . . . . 0.477 ' O ' ' HD2' ' A' ' 116' ' ' LYS . 33.4 m-70 -112.62 155.36 24.55 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 117.04 0.42 . . . . 2.4199999999999999 110.341 175.044 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 7.4 tp10 -111.52 127.98 55.88 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 109.864 -0.421 . . . . 2.5299999999999998 109.864 179.167 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . 0.436 ' H ' ' HG ' ' A' ' 122' ' ' LEU . 2.4 pp -92.86 136.92 24.27 Favored Pre-proline 0 C--N 1.321 -0.637 0 CA-C-O 121.108 0.48 . . . . 1.3300000000000001 111.761 -174.844 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_endo -73.42 -20.74 20.53 Favored 'Trans proline' 0 C--O 1.234 0.294 0 C-N-CA 123.147 2.564 . . . . 1.3300000000000001 112.423 179.266 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . 0.42 ' HA ' HD22 ' A' ' 92' ' ' LEU . . . 66.78 18.26 10.66 Favored 'General case' 0 N--CA 1.462 0.138 0 CA-C-N 115.297 -0.865 . . . . 1.25 110.092 -172.712 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 29.0 m-20 -106.14 159.74 15.85 Favored 'General case' 0 CA--C 1.516 -0.341 0 N-CA-C 108.015 -1.105 . . . . 2.73 108.015 172.445 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . 0.455 ' HA ' ' HD2' ' A' ' 127' ' ' PRO . 49.2 tp -114.44 91.98 26.44 Favored Pre-proline 0 C--N 1.322 -0.601 0 C-N-CA 120.609 -0.436 . . . . 1.6599999999999999 111.713 -176.982 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 127' ' ' PRO . . . . . 0.458 ' HA ' ' HD3' ' A' ' 128' ' ' PRO . 10.9 Cg_endo -58.5 146.45 90.64 Favored 'Trans proline' 0 CA--C 1.535 0.548 0 C-N-CA 122.836 2.357 . . . . 1.1699999999999999 112.138 171.883 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 128' ' ' PRO . . . . . 0.458 ' HD3' ' HA ' ' A' ' 127' ' ' PRO . 76.0 Cg_exo -51.77 -39.47 67.28 Favored 'Trans proline' 0 C--N 1.346 0.435 0 C-N-CA 123.842 3.028 . . . . 1.54 114.27 -175.31 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 41.6 p-80 -79.0 13.67 1.68 Allowed 'General case' 0 N--CA 1.469 0.513 0 N-CA-C 112.463 0.542 . . . . 1.0700000000000001 112.463 -175.368 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 41.3 mt -111.8 4.21 18.25 Favored 'General case' 0 C--N 1.324 -0.501 0 C-N-CA 121.181 -0.208 . . . . 1.3600000000000001 111.131 175.198 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 93.8 t -75.27 126.57 87.68 Favored Pre-proline 0 C--N 1.327 -0.37 0 CA-C-O 120.694 0.283 . . . . 1.28 110.923 -179.788 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 132' ' ' PRO . . . . . 0.515 ' HB3' ' HB3' ' A' ' 104' ' ' GLU . 54.4 Cg_exo -54.88 154.61 20.79 Favored 'Trans proline' 0 CA--C 1.533 0.455 0 C-N-CA 123.472 2.781 . . . . 0.81000000000000005 113.316 -179.583 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 133' ' ' PRO . . . . . 0.562 ' O ' ' HG2' ' A' ' 136' ' ' ARG . 50.7 Cg_exo -54.84 -54.55 4.3 Favored 'Trans proline' 0 C--N 1.347 0.468 0 C-N-CA 123.516 2.811 . . . . 1.1699999999999999 113.987 -175.979 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 72.6 p -84.87 8.04 18.82 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 120.676 -0.41 . . . . 1.6000000000000001 111.536 -175.464 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . 0.496 ' HD2' ' HG2' ' A' ' 132' ' ' PRO . 61.5 mttp -119.65 10.58 11.76 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 111.876 0.324 . . . . 1.21 111.876 -177.411 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . 0.562 ' HG2' ' O ' ' A' ' 133' ' ' PRO . 16.6 ptp180 -99.71 148.68 24.11 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.01 0.433 . . . . 2.7599999999999998 111.2 -178.647 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 22.6 mmm180 -78.44 111.72 14.74 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.997 -0.547 . . . . 4.54 111.366 -177.32 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 138' ' ' HIS . . . . . 0.469 ' ND1' ' HG2' ' A' ' 139' ' ' GLU . 8.2 p80 -111.1 144.31 40.43 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 108.847 -0.798 . . . . 5.9500000000000002 108.847 173.684 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . 0.469 ' HG2' ' ND1' ' A' ' 138' ' ' HIS . 17.6 mm-40 . . . . . 0 C--O 1.246 0.907 0 O-C-N 124.653 1.221 . . . . 6.1500000000000004 109.895 -175.786 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 143' ' ' PHE . . . . . . . . . . . . . 42.8 p90 . . . . . 0 N--CA 1.48 1.063 0 CA-C-O 120.596 0.236 . . . . 11.859999999999999 110.603 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' B' B ' 144' ' ' ASN . . . . . . . . . . . . . 9.8 t-20 -142.52 -47.2 0.33 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.275 -0.42 . . . . 8.1400000000000006 111.329 178.212 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 145' ' ' TYR . . . . . . . . . . . . . 47.5 p90 -129.76 6.09 5.1 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.372 -0.376 . . . . 6.71 111.088 -174.056 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 146' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -56.69 116.55 3.21 Favored 'General case' 0 C--N 1.329 -0.289 0 O-C-N 123.431 0.457 . . . . 6.6100000000000003 110.578 -172.115 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 147' ' ' SER . . . . . . . . . . . . . 10.7 p -72.44 -68.0 0.51 Allowed 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.702 -0.681 . . . . 3.6499999999999999 111.629 -175.39 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 148' ' ' THR . . . . . . . . . . . . . 25.1 m -132.86 -40.27 0.95 Allowed 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.909 -0.587 . . . . 1.79 109.651 178.662 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 149' ' ' GLY . . . . . . . . . . . . . . . -160.58 175.9 37.27 Favored Glycine 0 N--CA 1.443 -0.86 0 CA-C-N 115.251 -0.886 . . . . 0.47999999999999998 111.277 176.0 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 150' ' ' PRO . . . . . . . . . . . . . 76.0 Cg_endo -74.77 -8.13 20.01 Favored 'Trans proline' 0 N--CA 1.463 -0.28 0 C-N-CA 122.448 2.099 . . . . 0.33000000000000002 111.351 -179.187 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 151' ' ' PHE . . . . . 0.513 ' CE1' ' HG3' ' A' ' 73' ' ' LYS . 48.7 m-85 -89.47 -33.03 16.94 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.904 -0.589 . . . . 0.75 110.952 179.245 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 152' ' ' THR . . . . . . . . . . . . . 17.4 p -77.46 99.01 5.49 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.114 -0.494 . . . . 2.2200000000000002 111.05 -177.16 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 153' ' ' ALA . . . . . . . . . . . . . . . -138.04 167.23 22.22 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.015 -0.539 . . . . 4.4000000000000004 110.422 -179.957 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 154' ' ' LYS . . . . . . . . . . . . . 49.9 tptt . . . . . 0 C--O 1.251 1.146 0 CA-C-O 118.496 -0.764 . . . . 6.75 110.689 -178.356 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 141' ' ' ' CA' . . . . . 0.641 'CA ' ' OD1' ' A' ' 94' ' ' ASP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.401 ' HA2' ' HD3' ' A' ' 36' ' ' PRO . . . . . . . . 0 N--CA 1.482 1.735 0 N-CA-C 112.085 -0.406 . . . . 10.970000000000001 112.085 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 0.401 ' HD3' ' HA2' ' A' ' 35' ' ' GLY . 5.5 Cg_exo -78.3 137.79 15.33 Favored 'Trans proline' 0 N--CA 1.461 -0.422 0 C-N-CA 123.292 2.661 . . . . 9.0 112.057 179.522 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 95.0 mt -118.4 -56.34 2.15 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.051 0.453 . . . . 7.4199999999999999 110.755 -179.837 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -92.22 86.3 1.23 Allowed Glycine 0 N--CA 1.447 -0.604 0 C-N-CA 120.681 -0.771 . . . . 4.46 112.667 -178.482 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 28.3 m 65.94 -170.04 0.2 Allowed 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 122.888 0.475 . . . . 3.9700000000000002 111.118 177.151 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -100.02 134.05 43.5 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.207 -0.451 . . . . 3.46 110.423 179.69 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -105.1 131.11 53.02 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.047 -0.524 . . . . 1.9299999999999999 110.736 -177.64 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 13.8 p -123.52 150.64 27.81 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.45 0 CA-C-N 116.175 -0.466 . . . . 1.8500000000000001 111.345 -178.412 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -84.5 148.47 26.51 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 109.404 -0.591 . . . . 3.1000000000000001 109.404 174.142 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' TRP . . . . . 0.486 ' HH2' ' O ' ' A' ' 104' ' ' GLU . 3.2 t90 -85.6 109.41 18.53 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 120.967 0.413 . . . . 0.70999999999999996 110.095 -178.034 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 11.7 p -63.12 -17.62 19.91 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.433 0 CA-C-N 115.671 -0.695 . . . . 1.45 111.909 -175.822 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.4 HG11 ' HA ' ' A' ' 108' ' ' LEU . 46.9 t -82.06 -22.25 9.79 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-O 121.151 0.5 . . . . 1.1000000000000001 110.425 179.105 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . 0.711 ' HA2' ' HG3' ' A' ' 50' ' ' LYS . . . -73.31 -11.91 79.74 Favored Glycine 0 CA--C 1.517 0.161 0 CA-C-N 115.739 -0.664 . . . . 0.58999999999999997 113.481 -173.232 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 21.9 ptmt -77.83 -19.59 54.65 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.854 0.327 . . . . 2.46 111.158 -176.927 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 42.7 t0 -117.35 33.88 5.4 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.863 0.839 . . . . 1.6599999999999999 109.503 179.956 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 0.711 ' HG3' ' HA2' ' A' ' 47' ' ' GLY . 24.1 mtpt -69.18 -42.0 20.15 Favored Pre-proline 0 C--O 1.22 -0.454 0 CA-C-N 115.652 -0.704 . . . . 1.1499999999999999 112.793 -179.601 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_exo -44.21 -41.33 13.06 Favored 'Trans proline' 0 C--N 1.359 1.082 0 C-N-CA 122.202 1.935 . . . . 0.75 112.733 176.699 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 15.4 m -70.44 -45.5 65.69 Favored 'General case' 0 C--O 1.238 0.456 0 CA-C-N 116.203 -0.453 . . . . 0.68000000000000005 111.156 -179.277 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 7.2 m-85 -74.12 -22.01 59.64 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.534 -0.303 . . . . 0.68999999999999995 110.589 -176.998 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -76.09 -39.72 54.68 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 108.932 -0.766 . . . . 2.1800000000000002 108.932 178.007 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 44.4 tt0 -58.38 -47.86 82.48 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.241 -0.89 . . . . 2.3300000000000001 110.218 175.282 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 55.7 mt -67.45 -52.09 45.36 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 115.644 -0.707 . . . . 0.64000000000000001 111.384 179.697 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . 0.583 ' HE1' HG12 ' A' ' 67' ' ' ILE . 72.7 t80 -55.65 -32.57 63.3 Favored 'General case' 0 C--N 1.326 -0.435 0 C-N-CA 122.872 0.469 . . . . 0.28999999999999998 112.017 -176.695 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . 0.434 ' CE1' ' HD2' ' A' ' 57' ' ' PHE . 2.6 m-85 -88.52 -2.23 58.48 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 111.835 0.309 . . . . 1.1699999999999999 111.835 -176.416 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 79.0 p -100.36 -12.69 19.22 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.18 0.514 . . . . 0.44 109.99 173.476 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 10.4 mp -88.42 6.62 36.64 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.687 -0.688 . . . . 1.3700000000000001 110.768 177.885 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 52.0 m 62.87 83.6 0.2 Allowed Pre-proline 0 CA--C 1.531 0.212 0 CA-C-N 115.558 -0.746 . . . . 1.24 111.203 -178.6 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 75.2 Cg_endo -83.36 137.16 8.02 Favored 'Trans proline' 0 N--CA 1.458 -0.598 0 C-N-CA 122.763 2.309 . . . . 0.46999999999999997 112.893 -178.157 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 47.4 t -104.71 103.82 15.89 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 CA-C-N 116.105 -0.498 . . . . 1.02 110.25 178.191 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 93.2 m-20 60.57 25.78 15.47 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-N 116.042 -0.527 . . . . 1.3400000000000001 111.605 177.497 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 92.54 17.46 45.38 Favored Glycine 0 C--O 1.227 -0.303 0 C-N-CA 120.788 -0.72 . . . . 0.42999999999999999 112.712 178.533 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 0.636 ' HA ' ' HA ' ' A' ' 102' ' ' ASP . 59.4 mttm -141.41 134.64 29.42 Favored 'General case' 0 C--N 1.324 -0.532 0 C-N-CA 122.95 0.5 . . . . 1.48 110.242 177.734 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . 0.583 HG12 ' HE1' ' A' ' 57' ' ' PHE . 30.0 pt -103.25 150.57 6.7 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 N-CA-C 110.197 -0.297 . . . . 0.64000000000000001 110.197 173.321 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 59.3 p -73.62 166.3 23.51 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.272 -0.422 . . . . 0.55000000000000004 111.078 -176.307 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -68.06 -18.82 71.32 Favored Glycine 0 N--CA 1.447 -0.622 0 C-N-CA 120.801 -0.714 . . . . 0.40999999999999998 112.162 178.265 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -74.28 -39.52 62.9 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.374 0.607 . . . . 0.38 110.294 176.126 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 12.3 m120 -73.45 -41.36 63.3 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.686 -0.688 . . . . 1.8100000000000001 109.309 178.771 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -62.05 -37.63 85.68 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.232 -0.895 . . . . 0.39000000000000001 110.248 174.153 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . 0.452 ' O ' HG23 ' A' ' 77' ' ' VAL . 22.8 ttmm -55.74 -52.02 65.34 Favored 'General case' 0 C--O 1.221 -0.404 0 CA-C-N 115.86 -0.609 . . . . 0.83999999999999997 109.862 174.66 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . 0.438 ' O ' ' HG2' ' A' ' 78' ' ' LYS . 68.4 mttm -54.95 -46.23 74.99 Favored 'General case' 0 C--N 1.329 -0.321 0 O-C-N 123.38 0.425 . . . . 1.95 111.389 -179.395 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 20.7 tp10 -63.75 -49.72 71.9 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.838 0.352 . . . . 1.6000000000000001 110.895 -179.401 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' MET . . . . . 0.748 ' HB3' HD22 ' A' ' 86' ' ' LEU . 96.5 mmm -66.54 -27.91 68.12 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.247 0.546 . . . . 1.24 111.285 -178.34 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.452 HG23 ' O ' ' A' ' 73' ' ' LYS . 37.2 t -71.65 -34.53 52.64 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-N 115.907 -0.588 . . . . 1.5700000000000001 110.044 175.066 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.438 ' HG2' ' O ' ' A' ' 74' ' ' LYS . 29.5 mmmt -69.85 -22.46 63.26 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.925 -0.579 . . . . 2.79 110.277 174.872 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . 0.449 ' C ' ' HG2' ' A' ' 80' ' ' LYS . 15.7 m -76.02 -4.81 43.33 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.951 -0.568 . . . . 1.27 110.711 178.333 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . 0.449 ' HG2' ' C ' ' A' ' 79' ' ' SER . 18.5 ptmt 47.2 32.6 2.14 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 124.07 0.948 . . . . 2.9700000000000002 112.863 175.821 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.4 ' HB2' HD21 ' A' ' 86' ' ' LEU . 85.7 mt -97.22 150.16 36.51 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 116.094 -0.503 . . . . 0.52000000000000002 110.089 176.487 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . 0.508 ' O ' ' HG ' ' A' ' 86' ' ' LEU . 52.9 Cg_exo -55.51 145.39 69.27 Favored 'Trans proline' 0 C--O 1.234 0.293 0 C-N-CA 122.658 2.239 . . . . 0.44 112.347 179.636 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 21.1 p-10 -55.21 -41.71 72.39 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-N 116.35 -0.387 . . . . 1.8500000000000001 111.693 -177.046 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 9.4 m -55.06 -45.87 75.36 Favored 'General case' 0 N--CA 1.448 -0.542 0 CA-C-N 115.821 -0.627 . . . . 1.47 110.748 177.826 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 80.5 t -72.28 -32.04 41.22 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.177 0 CA-C-N 115.902 -0.59 . . . . 0.45000000000000001 110.891 -179.821 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.748 HD22 ' HB3' ' A' ' 76' ' ' MET . 80.4 mt -61.78 -43.66 98.42 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 110.079 -0.341 . . . . 0.90000000000000002 110.079 175.906 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -66.88 -34.35 86.87 Favored Glycine 0 N--CA 1.452 -0.299 0 N-CA-C 111.511 -0.635 . . . . 0.32000000000000001 111.511 178.09 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . 0.489 ' O ' HD23 ' A' ' 92' ' ' LEU . 35.5 mmtm -58.12 -58.69 7.35 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.946 0.403 . . . . 1.8899999999999999 110.124 174.189 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 56.0 mt -62.11 -35.22 67.57 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 115.747 -0.661 . . . . 0.70999999999999996 110.932 -177.483 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 50.7 t-105 -58.02 -49.03 78.28 Favored 'General case' 0 C--O 1.223 -0.325 0 C-N-CA 120.707 -0.397 . . . . 0.33000000000000002 110.293 175.287 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 20.8 ttmm -61.95 -39.84 93.48 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.298 -0.41 . . . . 2.7000000000000002 111.7 -177.526 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.83 HD12 ' HG ' ' A' ' 126' ' ' LEU . 4.3 mm? -76.74 -24.55 53.01 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 111.888 0.329 . . . . 1.6599999999999999 111.888 -179.253 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -93.05 -42.21 9.55 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.648 0.261 . . . . 0.46999999999999997 111.618 -178.291 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . 0.648 ' OD1' 'CA ' ' A' ' 141' ' ' ' CA' . 30.8 t0 -82.66 87.16 6.74 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.51 0.671 . . . . 0.79000000000000004 109.484 179.674 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 47.4 t -80.77 -34.75 14.27 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 CA-C-N 115.197 -0.911 . . . . 0.60999999999999999 110.718 -174.271 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . 0.634 ' OD1' 'CA ' ' A' ' 141' ' ' ' CA' . 48.4 p-10 -82.43 -13.92 55.99 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.503 -0.317 . . . . 0.95999999999999996 110.453 -179.294 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.476 ' HA ' ' OD2' ' A' ' 94' ' ' ASP . 31.7 mtmm 57.72 54.74 6.03 Favored 'General case' 0 C--O 1.231 0.118 0 O-C-N 123.778 0.674 . . . . 2.96 110.816 173.614 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . 0.606 ' OD1' 'CA ' ' A' ' 141' ' ' ' CA' . 16.2 p-10 -110.2 8.66 23.77 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.59 -0.732 . . . . 0.42999999999999999 110.891 -174.775 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 71.64 7.08 64.19 Favored Glycine 0 N--CA 1.453 -0.205 0 C-N-CA 120.633 -0.794 . . . . 0.44 112.429 179.717 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.413 HD12 ' O ' ' A' ' 98' ' ' ASP . 4.3 mp -135.04 155.18 51.2 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 109.516 -0.55 . . . . 1.1100000000000001 109.516 178.143 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 77.7 mt -109.68 114.09 27.4 Favored 'General case' 0 C--N 1.315 -0.933 0 N-CA-C 109.399 -0.593 . . . . 0.41999999999999998 109.399 175.831 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . 0.636 ' HA ' ' HA ' ' A' ' 66' ' ' LYS . 2.9 p30 -79.87 -176.05 5.24 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.255 -0.429 . . . . 1.72 110.65 179.698 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -55.07 -42.1 72.35 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.826 -0.624 . . . . 1.6000000000000001 111.277 -178.719 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . 0.486 ' O ' ' HH2' ' A' ' 44' ' ' TRP . 49.9 mt-10 -72.32 -52.78 14.69 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.193 -0.458 . . . . 1.6599999999999999 110.335 179.728 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 36.6 mt-10 -64.02 -37.77 88.63 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.106 -0.497 . . . . 0.44 111.193 -172.951 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . 0.488 ' CD2' ' HD1' ' A' ' 57' ' ' PHE . 49.5 t80 -74.79 -34.58 62.45 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.412 -0.358 . . . . 0.41999999999999998 110.3 -179.327 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -60.07 -42.64 94.99 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-O 121.075 0.465 . . . . 0.22 110.003 173.689 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.4 ' HA ' HG11 ' A' ' 46' ' ' VAL . 6.9 tt -62.1 -47.56 84.07 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-N 115.86 -0.609 . . . . 1.3300000000000001 109.74 176.643 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . 0.5 ' O ' HG13 ' A' ' 113' ' ' ILE . . . -55.82 -52.03 65.41 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 115.885 -0.598 . . . . 0.32000000000000001 111.195 179.2 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' ASN . . . . . 0.515 HD22 HD12 ' A' ' 113' ' ' ILE . 12.4 m120 -59.13 -35.14 72.95 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-O 120.721 0.296 . . . . 1.2 110.992 179.375 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' HIS . . . . . 0.478 ' O ' HG23 ' A' ' 115' ' ' VAL . 24.8 t60 -64.21 -39.94 95.02 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.282 -0.417 . . . . 0.52000000000000002 110.193 -179.49 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 59.7 mt -74.85 -34.29 62.26 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.297 -0.41 . . . . 0.55000000000000004 110.976 178.252 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.515 HD12 HD22 ' A' ' 110' ' ' ASN . 82.5 mt -59.32 -45.27 93.37 Favored 'Isoleucine or valine' 0 C--O 1.234 0.279 0 CA-C-O 121.242 0.544 . . . . 0.83999999999999997 109.61 173.955 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . 0.431 ' HA ' ' HE3' ' A' ' 114' ' ' LYS . 0.1 OUTLIER -60.54 -42.65 96.95 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.216 -0.902 . . . . 3.8300000000000001 110.163 177.808 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.635 HG13 ' HB2' ' A' ' 120' ' ' HIS . 40.6 t -53.53 -47.07 60.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.015 -0.539 . . . . 1.1899999999999999 110.978 176.103 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 27.6 mmmt -69.62 -38.75 77.36 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.403 -0.362 . . . . 1.3200000000000001 111.246 -179.42 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 94.7 mt -66.51 -29.09 69.11 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.128 0.489 . . . . 0.95999999999999996 111.009 177.805 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 5.4 tp10 -77.53 -22.11 51.61 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.47 0.652 . . . . 2.1800000000000002 110.044 178.858 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 99.57 19.71 19.5 Favored Glycine 0 N--CA 1.445 -0.702 0 CA-C-N 115.458 -0.792 . . . . 1.1599999999999999 112.657 179.919 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' HIS . . . . . 0.635 ' HB2' HG13 ' A' ' 115' ' ' VAL . 29.2 m-70 -97.4 167.07 11.23 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 109.425 -0.583 . . . . 2.4199999999999999 109.425 175.907 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 7.4 tp10 -114.86 145.77 41.81 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-O 120.717 0.294 . . . . 2.5299999999999998 110.223 -179.154 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . 0.496 ' HA ' ' HD3' ' A' ' 123' ' ' PRO . 3.1 pp -106.87 139.98 20.92 Favored Pre-proline 0 C--N 1.323 -0.545 0 N-CA-C 109.473 -0.566 . . . . 1.3300000000000001 109.473 177.133 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . 0.496 ' HD3' ' HA ' ' A' ' 122' ' ' LEU . 9.5 Cg_exo -72.58 0.17 7.95 Favored 'Trans proline' 0 C--O 1.232 0.19 0 C-N-CA 122.743 2.295 . . . . 1.3300000000000001 113.16 -176.55 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . 58.83 23.67 11.54 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-O 121.202 0.525 . . . . 1.25 110.592 -176.874 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 5.6 t0 -132.27 170.63 14.77 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 108.31 -0.996 . . . . 2.73 108.31 -179.87 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . 0.83 ' HG ' HD12 ' A' ' 92' ' ' LEU . 19.2 mt -116.76 105.93 48.91 Favored Pre-proline 0 C--N 1.321 -0.668 0 N-CA-C 112.116 0.413 . . . . 1.6599999999999999 112.116 -175.21 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 127' ' ' PRO . . . . . 0.423 ' HD2' ' HB2' ' A' ' 130' ' ' LEU . 12.1 Cg_exo -70.94 147.67 55.81 Favored 'Trans proline' 0 N--CA 1.459 -0.502 0 C-N-CA 122.611 2.207 . . . . 1.1699999999999999 110.778 169.919 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_exo -50.39 -37.87 51.81 Favored 'Trans proline' 0 CA--C 1.531 0.373 0 C-N-CA 122.944 2.429 . . . . 1.54 113.596 -178.311 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 44.3 p-80 -82.18 3.95 25.25 Favored 'General case' 0 CA--C 1.533 0.306 0 N-CA-C 111.961 0.356 . . . . 1.0700000000000001 111.961 -178.168 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . 0.423 ' HB2' ' HD2' ' A' ' 127' ' ' PRO . 2.4 mm? -101.06 -20.01 15.55 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.665 0.269 . . . . 1.3600000000000001 110.582 174.35 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 43.4 t -74.85 126.54 88.24 Favored Pre-proline 0 C--N 1.325 -0.459 0 CA-C-N 116.127 -0.488 . . . . 1.28 110.606 -178.989 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_exo -55.64 134.0 61.39 Favored 'Trans proline' 0 C--N 1.345 0.391 0 C-N-CA 122.587 2.191 . . . . 0.81000000000000005 111.722 177.224 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -58.31 -23.32 62.31 Favored 'Trans proline' 0 CA--C 1.529 0.256 0 C-N-CA 122.961 2.441 . . . . 1.1699999999999999 112.955 -176.64 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 5.5 m -82.01 -16.77 49.14 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.413 -0.358 . . . . 1.6000000000000001 111.304 -179.72 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 6.2 mptt -119.93 22.11 11.63 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 111.776 0.287 . . . . 1.21 111.776 -176.404 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 33.9 ptt180 -86.99 101.68 13.67 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.662 0.744 . . . . 2.7599999999999998 112.035 -174.702 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 15.2 tpp180 -132.21 131.7 42.41 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.343 -0.844 . . . . 4.54 109.463 175.343 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 28.0 t60 -85.36 99.65 11.31 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 120.709 0.29 . . . . 5.9500000000000002 110.528 179.432 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 52.1 mt-10 . . . . . 0 C--O 1.249 1.039 0 CA-C-O 118.616 -0.707 . . . . 6.1500000000000004 109.93 175.877 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' B' B ' 143' ' ' PHE . . . . . . . . . . . . . 86.1 m-85 . . . . . 0 N--CA 1.479 0.993 0 N-CA-C 110.175 -0.306 . . . . 11.859999999999999 110.175 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' B' B ' 144' ' ' ASN . . . . . . . . . . . . . 48.3 t30 -145.61 117.65 8.3 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 109.888 -0.412 . . . . 8.1400000000000006 109.888 176.498 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 145' ' ' TYR . . . . . . . . . . . . . 12.9 t80 -126.32 100.58 6.34 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.134 0.492 . . . . 6.71 110.106 179.066 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 146' ' ' GLU . . . . . 0.545 ' H ' ' CD ' ' B' ' 146' ' ' GLU . 0.7 OUTLIER -80.63 121.5 25.92 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.652 -0.704 . . . . 6.6100000000000003 110.486 -179.918 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 147' ' ' SER . . . . . . . . . . . . . 4.9 p -140.56 40.86 1.88 Allowed 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.767 -0.651 . . . . 3.6499999999999999 110.788 -176.655 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 148' ' ' THR . . . . . 0.533 ' HB ' ' HB ' ' B' ' 152' ' ' THR . 18.0 p -78.64 -33.83 46.93 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.191 -0.459 . . . . 1.79 111.027 -178.059 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 149' ' ' GLY . . . . . . . . . . . . . . . 106.89 160.0 21.7 Favored Glycine 0 N--CA 1.443 -0.84 0 C-N-CA 120.561 -0.828 . . . . 0.47999999999999998 112.395 177.555 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 150' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -73.83 -2.14 11.81 Favored 'Trans proline' 0 C--O 1.232 0.191 0 C-N-CA 122.844 2.362 . . . . 0.33000000000000002 112.318 -178.272 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 151' ' ' PHE . . . . . . . . . . . . . 26.9 m-85 -102.84 -27.14 12.84 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.961 -0.563 . . . . 0.75 110.409 178.491 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 152' ' ' THR . . . . . 0.533 ' HB ' ' HB ' ' B' ' 148' ' ' THR . 6.0 m -90.61 -31.76 16.54 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.935 -0.575 . . . . 2.2200000000000002 110.386 -179.743 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 153' ' ' ALA . . . . . . . . . . . . . . . 67.05 -165.06 0.22 Allowed 'General case' 0 C--O 1.234 0.285 0 CA-C-N 115.363 -0.835 . . . . 4.4000000000000004 111.661 177.523 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 154' ' ' LYS . . . . . . . . . . . . . 51.2 mtmt . . . . . 0 C--O 1.245 0.846 0 CA-C-O 118.423 -0.798 . . . . 6.75 109.985 -178.732 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 141' ' ' ' CA' . . . . . 0.648 'CA ' ' OD1' ' A' ' 94' ' ' ASP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.406 ' HA3' ' HD3' ' A' ' 36' ' ' PRO . . . . . . . . 0 N--CA 1.483 1.797 0 N-CA-C 111.528 -0.629 . . . . 10.970000000000001 111.528 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 0.742 ' HA ' ' HB2' ' A' ' 40' ' ' ASP . 7.6 Cg_exo -72.44 97.15 0.85 Allowed 'Trans proline' 0 N--CA 1.46 -0.441 0 C-N-CA 122.658 2.239 . . . . 9.0 111.3 177.125 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 56.0 tp -109.89 -47.3 3.36 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.13 -0.486 . . . . 7.4199999999999999 110.211 -178.263 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -90.38 -126.64 3.29 Favored Glycine 0 N--CA 1.446 -0.674 0 N-CA-C 110.617 -0.993 . . . . 4.46 110.617 177.671 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 3.8 t -94.52 40.56 1.09 Allowed 'General case' 0 C--N 1.318 -0.784 0 N-CA-C 109.253 -0.647 . . . . 3.9700000000000002 109.253 176.832 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . 0.742 ' HB2' ' HA ' ' A' ' 36' ' ' PRO . 13.7 m-20 -76.35 95.1 3.72 Favored 'General case' 0 CA--C 1.519 -0.216 0 CA-C-N 115.506 -0.77 . . . . 3.46 109.887 -179.029 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 9.9 t0 -93.03 90.52 6.95 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 109.536 -0.542 . . . . 1.9299999999999999 109.536 179.347 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 26.9 m -77.32 146.75 8.03 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-N 115.904 -0.589 . . . . 1.8500000000000001 110.512 -178.842 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -69.54 136.12 50.95 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 116.088 -0.505 . . . . 3.1000000000000001 110.547 178.682 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 9.8 t90 -83.44 122.02 27.95 Favored 'General case' 0 C--N 1.318 -0.803 0 N-CA-C 108.796 -0.816 . . . . 0.70999999999999996 108.796 179.834 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 33.6 m -61.48 -15.9 13.87 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.521 0 N-CA-C 114.316 1.228 . . . . 1.45 114.316 -166.793 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.469 HG23 ' HB2' ' A' ' 111' ' ' HIS . 11.5 p -92.45 -14.06 8.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 C-N-CA 120.033 -0.667 . . . . 1.1000000000000001 110.541 178.346 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -64.55 -25.41 70.17 Favored Glycine 0 CA--C 1.519 0.305 0 C-N-CA 120.964 -0.636 . . . . 0.58999999999999997 112.955 -177.115 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . 0.5 ' HG3' ' OD2' ' A' ' 49' ' ' ASP . 11.5 ptmm? -76.63 -19.44 57.8 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.599 0.238 . . . . 2.46 111.149 -179.226 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . 0.5 ' OD2' ' HG3' ' A' ' 48' ' ' LYS . 10.5 m-20 -127.14 34.56 4.72 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 109.362 -0.607 . . . . 1.6599999999999999 109.362 179.571 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 0.436 ' HG2' ' OD1' ' A' ' 54' ' ' ASP . 56.7 tttm -86.61 -48.13 0.51 Allowed Pre-proline 0 C--N 1.324 -0.541 0 CA-C-N 115.862 -0.608 . . . . 1.1499999999999999 112.308 -172.725 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.411 ' HD3' ' HB3' ' A' ' 50' ' ' LYS . 84.3 Cg_exo -49.61 -31.22 24.11 Favored 'Trans proline' 0 C--N 1.361 1.202 0 C-N-CA 122.158 1.905 . . . . 0.75 113.003 -179.88 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 11.0 m -70.14 -45.43 66.81 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.252 -0.431 . . . . 0.68000000000000005 110.502 177.763 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 19.9 m-30 -73.67 -23.25 59.82 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.395 -0.366 . . . . 0.68999999999999995 110.291 -177.81 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . 0.436 ' OD1' ' HG2' ' A' ' 50' ' ' LYS . 0.9 OUTLIER -72.59 -40.6 66.44 Favored 'General case' 0 CA--C 1.517 -0.305 0 N-CA-C 109.683 -0.488 . . . . 2.1800000000000002 109.683 174.657 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 2.6 mm-40 -58.76 -36.93 75.18 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.039 -0.528 . . . . 2.3300000000000001 110.58 176.012 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 35.3 mt -75.65 -40.29 40.31 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-O 121.119 0.485 . . . . 0.64000000000000001 110.298 177.183 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . 0.411 ' HD2' ' CD1' ' A' ' 58' ' ' TYR . 86.5 t80 -57.1 -38.18 73.01 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.685 -0.689 . . . . 0.28999999999999998 111.409 179.132 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . 0.546 ' HA ' ' HG3' ' A' ' 62' ' ' PRO . 19.8 m-30 -80.32 -3.77 50.77 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.383 -0.372 . . . . 1.1699999999999999 111.578 -174.208 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 75.3 p -100.2 -2.4 34.04 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.878 0.371 . . . . 0.44 111.034 179.609 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 74.6 mt -102.09 16.7 25.28 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.393 -0.367 . . . . 1.3700000000000001 110.615 179.753 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 48.3 t 63.06 80.89 0.24 Allowed Pre-proline 0 CA--C 1.532 0.283 0 CA-C-N 115.53 -0.759 . . . . 1.24 111.237 -179.209 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . 0.578 ' HA ' HG22 ' A' ' 67' ' ' ILE . 6.2 Cg_exo -78.59 143.88 19.4 Favored 'Trans proline' 0 N--CA 1.461 -0.427 0 C-N-CA 122.899 2.399 . . . . 0.46999999999999997 112.007 178.84 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 16.7 m -122.86 117.43 51.78 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-N 116.284 -0.416 . . . . 1.02 110.191 176.161 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 13.7 m120 62.07 23.35 13.77 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-N 115.984 -0.553 . . . . 1.3400000000000001 111.182 -179.823 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 90.57 5.77 68.79 Favored Glycine 0 C--O 1.229 -0.201 0 C-N-CA 120.961 -0.638 . . . . 0.42999999999999999 113.043 178.375 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 0.645 ' HG2' ' HA ' ' A' ' 102' ' ' ASP . 37.0 mtpt -135.52 157.93 45.64 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 109.952 -0.388 . . . . 1.48 109.952 -178.692 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . 0.578 HG22 ' HA ' ' A' ' 62' ' ' PRO . 48.8 pt -124.95 164.07 24.38 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-O 120.988 0.423 . . . . 0.64000000000000001 110.943 177.416 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . 0.409 ' HA ' HD23 ' A' ' 100' ' ' LEU . 37.5 p -82.25 165.57 20.31 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.339 -0.846 . . . . 0.55000000000000004 110.893 179.992 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -72.1 -12.98 76.17 Favored Glycine 0 N--CA 1.447 -0.614 0 C-N-CA 120.988 -0.625 . . . . 0.40999999999999998 112.56 179.599 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.413 ' O ' ' HG3' ' A' ' 74' ' ' LYS . . . -64.46 -58.97 4.93 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.079 0.466 . . . . 0.38 111.068 -179.216 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 39.4 m-80 -68.89 -38.54 79.72 Favored 'General case' 0 C--O 1.238 0.454 0 CA-C-N 115.809 -0.632 . . . . 1.8100000000000001 110.451 -178.06 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -59.25 -43.2 92.45 Favored 'General case' 0 N--CA 1.45 -0.425 0 CA-C-N 115.608 -0.723 . . . . 0.39000000000000001 109.951 176.542 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -62.23 -39.54 93.16 Favored 'General case' 0 C--O 1.224 -0.276 0 CA-C-N 116.362 -0.381 . . . . 0.83999999999999997 110.906 177.85 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . 0.464 ' O ' HG12 ' A' ' 77' ' ' VAL . 57.6 mtpt -59.14 -33.43 70.87 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-O 121.008 0.432 . . . . 1.95 110.693 178.731 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . 0.478 ' O ' ' HG3' ' A' ' 78' ' ' LYS . 40.9 tt0 -81.34 -50.67 9.22 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 116.172 -0.467 . . . . 1.6000000000000001 110.368 -179.496 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' MET . . . . . 0.749 ' HB3' HD22 ' A' ' 86' ' ' LEU . 75.1 mmm -57.4 -27.49 62.39 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.803 -0.635 . . . . 1.24 110.327 178.672 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.464 HG12 ' O ' ' A' ' 74' ' ' LYS . 1.5 p -86.95 -28.01 5.8 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.535 0 CA-C-N 115.942 -0.572 . . . . 1.5700000000000001 110.968 -179.082 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.478 ' HG3' ' O ' ' A' ' 75' ' ' GLU . 0.0 OUTLIER -82.28 -14.38 55.51 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-O 120.886 0.374 . . . . 2.79 110.26 -179.096 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 2.0 p -78.6 4.43 13.53 Favored 'General case' 0 CA--C 1.531 0.214 0 CA-C-N 116.323 -0.399 . . . . 1.27 110.396 170.343 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 52.3 mtpt 63.5 32.81 14.0 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 115.403 -0.817 . . . . 2.9700000000000002 112.247 172.535 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.671 ' HB2' HD21 ' A' ' 86' ' ' LEU . 88.7 mt -102.17 141.39 22.44 Favored Pre-proline 0 C--N 1.318 -0.778 0 CA-C-N 116.417 -0.356 . . . . 0.52000000000000002 110.118 176.956 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . 0.537 ' O ' ' HG ' ' A' ' 86' ' ' LEU . 51.7 Cg_exo -56.14 136.74 76.69 Favored 'Trans proline' 0 C--N 1.344 0.306 0 C-N-CA 122.821 2.347 . . . . 0.44 112.706 179.52 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . 0.411 ' HA ' HD12 ' A' ' 86' ' ' LEU . 18.2 p30 -51.93 -34.9 43.79 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-N 115.846 -0.616 . . . . 1.8500000000000001 112.437 -179.866 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 30.1 m -69.48 -39.07 77.89 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 121.006 0.432 . . . . 1.47 110.608 -179.553 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.414 HG23 ' HB2' ' A' ' 82' ' ' PRO . 58.8 t -67.69 -36.23 75.33 Favored 'Isoleucine or valine' 0 C--O 1.234 0.277 0 N-CA-C 109.325 -0.62 . . . . 0.45000000000000001 109.325 176.573 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.749 HD22 ' HB3' ' A' ' 76' ' ' MET . 65.4 mt -63.84 -33.47 75.75 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.348 -0.842 . . . . 0.90000000000000002 109.876 175.807 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -68.58 -38.28 86.07 Favored Glycine 0 N--CA 1.451 -0.363 0 N-CA-C 111.57 -0.612 . . . . 0.32000000000000001 111.57 178.931 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . 0.418 ' O ' ' HG ' ' A' ' 92' ' ' LEU . 73.1 mmtt -57.7 -52.82 63.86 Favored 'General case' 0 C--O 1.24 0.563 0 CA-C-O 121.638 0.733 . . . . 1.8899999999999999 109.582 173.814 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.43 HG23 HD12 ' A' ' 112' ' ' LEU . 45.4 mt -65.12 -34.88 73.59 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.453 0 CA-C-N 114.924 -1.034 . . . . 0.70999999999999996 111.389 -178.148 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' TRP . . . . . 0.462 ' HB2' ' CE2' ' B' ' 151' ' ' PHE . 55.0 t-105 -60.45 -46.09 91.33 Favored 'General case' 0 C--N 1.333 -0.118 0 CA-C-O 120.795 0.331 . . . . 0.33000000000000002 110.149 175.814 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 30.8 ttpt -66.39 -20.86 66.18 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.846 -0.615 . . . . 2.7000000000000002 110.807 -178.611 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.782 HD11 ' HA ' ' A' ' 124' ' ' ALA . 82.6 mt -92.35 -31.56 15.3 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.437 -0.347 . . . . 1.6599999999999999 111.682 177.4 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -86.54 -41.49 14.28 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.506 -0.315 . . . . 0.46999999999999997 111.835 -174.39 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . 0.65 ' OD1' 'CA ' ' A' ' 141' ' ' ' CA' . 36.3 t0 -80.86 81.26 7.16 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 108.982 -0.747 . . . . 0.79000000000000004 108.982 178.137 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.714 ' HB ' ' HD3' ' A' ' 135' ' ' LYS . 46.2 t -75.35 -34.7 31.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 115.027 -0.988 . . . . 0.60999999999999999 111.083 -173.519 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . 0.634 ' OD1' 'CA ' ' A' ' 141' ' ' ' CA' . 15.5 p-10 -82.58 -8.46 59.61 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 109.514 -0.551 . . . . 0.95999999999999996 109.514 179.05 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 97.0 mttt 49.65 73.06 0.27 Allowed 'General case' 0 C--O 1.235 0.314 0 CA-C-N 115.403 -0.817 . . . . 2.96 111.455 175.229 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . 0.484 ' OD2' ' HB2' ' A' ' 100' ' ' LEU . 9.5 p-10 -134.69 9.5 3.63 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.624 -0.716 . . . . 0.42999999999999999 111.067 -173.837 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 73.75 -4.64 28.14 Favored Glycine 0 C--N 1.331 0.288 0 C-N-CA 120.791 -0.719 . . . . 0.44 112.407 178.699 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.484 ' HB2' ' OD2' ' A' ' 98' ' ' ASP . 89.2 mt -120.86 154.35 35.93 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 109.051 -0.722 . . . . 1.1100000000000001 109.051 178.401 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 75.3 mt -108.32 122.77 47.67 Favored 'General case' 0 C--N 1.31 -1.138 0 C-N-CA 120.487 -0.485 . . . . 0.41999999999999998 110.146 178.011 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . 0.674 ' HB2' ' HG3' ' A' ' 105' ' ' GLU . 16.0 m-20 -68.83 168.36 13.63 Favored 'General case' 0 CA--C 1.512 -0.508 0 N-CA-C 108.113 -1.069 . . . . 1.72 108.113 170.111 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -61.53 -29.82 70.24 Favored 'General case' 0 C--N 1.317 -0.81 0 N-CA-C 109.202 -0.666 . . . . 1.6000000000000001 109.202 174.527 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 50.7 mt-10 -64.64 -55.52 19.69 Favored 'General case' 0 C--O 1.231 0.092 0 CA-C-N 115.762 -0.654 . . . . 1.6599999999999999 110.148 173.495 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . 0.674 ' HG3' ' HB2' ' A' ' 102' ' ' ASP . 14.4 mt-10 -62.4 -39.85 94.6 Favored 'General case' 0 N--CA 1.463 0.207 0 CA-C-N 115.454 -0.793 . . . . 0.44 110.956 -173.914 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 79.7 t80 -64.21 -47.86 78.09 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.671 -0.695 . . . . 0.41999999999999998 110.524 178.193 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -57.67 -45.61 85.36 Favored 'General case' 0 N--CA 1.454 -0.258 0 CA-C-N 116.278 -0.419 . . . . 0.22 110.754 178.704 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 55.1 tp -59.48 -47.37 85.75 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.486 -0.325 . . . . 1.3300000000000001 110.735 -179.906 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . 0.579 ' O ' HG12 ' A' ' 113' ' ' ILE . . . -58.61 -46.85 86.14 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.224 -0.444 . . . . 0.32000000000000001 110.595 177.974 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' ASN . . . . . 0.437 ' HA ' HG12 ' A' ' 113' ' ' ILE . 0.6 OUTLIER -60.59 -36.5 78.7 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 115.903 -0.589 . . . . 1.2 111.388 179.044 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' HIS . . . . . 0.731 ' O ' HG23 ' A' ' 115' ' ' VAL . 24.8 t60 -62.94 -48.13 80.26 Favored 'General case' 0 CA--C 1.513 -0.449 0 N-CA-C 108.78 -0.822 . . . . 0.52000000000000002 108.78 177.192 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.43 HD12 HG23 ' A' ' 89' ' ' ILE . 97.8 mt -58.16 -34.64 70.53 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.527 -0.76 . . . . 0.55000000000000004 110.795 177.521 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.579 HG12 ' O ' ' A' ' 109' ' ' ALA . 36.9 mm -56.46 -52.32 54.11 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.235 0 CA-C-O 121.515 0.674 . . . . 0.83999999999999997 110.309 173.605 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 18.4 tppt? -63.13 -45.83 90.11 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.016 -0.993 . . . . 3.8300000000000001 111.523 -177.416 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.731 HG23 ' O ' ' A' ' 111' ' ' HIS . 2.2 t -73.89 -23.82 19.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-O 120.82 0.343 . . . . 1.1899999999999999 110.294 -176.499 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 14.6 tppt? -64.89 -49.48 70.31 Favored 'General case' 0 CA--C 1.52 -0.175 0 N-CA-C 109.487 -0.56 . . . . 1.3200000000000001 109.487 170.264 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 86.2 mt -70.41 -15.15 62.81 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.553 -0.749 . . . . 0.95999999999999996 110.88 -179.804 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 7.2 tp10 -71.35 -16.44 62.43 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.104 0.478 . . . . 2.1800000000000002 109.784 175.331 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 98.67 23.97 11.46 Favored Glycine 0 N--CA 1.451 -0.36 0 N-CA-C 111.124 -0.79 . . . . 1.1599999999999999 111.124 179.443 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 18.2 t60 -117.84 121.57 41.09 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 121.122 0.487 . . . . 2.4199999999999999 110.867 -177.584 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 47.9 mm-40 -83.59 119.88 25.28 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.361 -0.836 . . . . 2.5299999999999998 110.725 177.55 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . 0.821 ' H ' HD23 ' A' ' 122' ' ' LEU . 1.3 pt? -78.58 139.37 58.87 Favored Pre-proline 0 C--N 1.322 -0.626 0 N-CA-C 109.019 -0.734 . . . . 1.3300000000000001 109.019 172.948 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . 0.455 ' HD3' ' HA ' ' A' ' 122' ' ' LEU . 7.8 Cg_exo -72.78 10.03 1.16 Allowed 'Trans proline' 0 C--N 1.345 0.374 0 C-N-CA 123.205 2.604 . . . . 1.3300000000000001 112.792 -176.055 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . 0.782 ' HA ' HD11 ' A' ' 92' ' ' LEU . . . 59.14 29.94 19.61 Favored 'General case' 0 C--O 1.232 0.141 0 CA-C-N 116.239 -0.437 . . . . 1.25 110.946 -179.771 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 37.8 t70 -132.53 156.92 45.95 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.819 -0.628 . . . . 2.73 109.882 -179.688 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . 0.659 ' HG ' HD22 ' A' ' 92' ' ' LEU . 84.3 mt -110.46 103.34 53.94 Favored Pre-proline 0 C--N 1.327 -0.41 0 N-CA-C 112.055 0.391 . . . . 1.6599999999999999 112.055 -175.814 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 127' ' ' PRO . . . . . 0.539 ' HD2' HD12 ' A' ' 130' ' ' LEU . 56.6 Cg_endo -72.21 161.46 44.48 Favored 'Trans proline' 0 C--O 1.234 0.321 0 C-N-CA 122.803 2.335 . . . . 1.1699999999999999 111.085 171.249 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 75.5 Cg_exo -50.49 -40.39 54.22 Favored 'Trans proline' 0 C--N 1.346 0.446 0 C-N-CA 123.178 2.585 . . . . 1.54 113.836 -176.672 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 23.4 p-80 -81.29 14.56 2.35 Favored 'General case' 0 CA--C 1.533 0.324 0 N-CA-C 112.828 0.677 . . . . 1.0700000000000001 112.828 -174.381 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . 0.539 HD12 ' HD2' ' A' ' 127' ' ' PRO . 12.7 mt -114.39 2.41 14.69 Favored 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 120.791 -0.363 . . . . 1.3600000000000001 111.072 174.69 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 46.3 t -84.39 121.48 75.16 Favored Pre-proline 0 C--N 1.324 -0.539 0 CA-C-N 116.326 -0.397 . . . . 1.28 110.492 -178.455 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 44.7 Cg_exo -56.77 142.75 91.96 Favored 'Trans proline' 0 C--N 1.347 0.484 0 C-N-CA 123.097 2.531 . . . . 0.81000000000000005 112.804 -179.974 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 133' ' ' PRO . . . . . 0.445 ' O ' ' HG2' ' A' ' 136' ' ' ARG . 11.8 Cg_endo -55.45 -36.16 93.53 Favored 'Trans proline' 0 CA--C 1.531 0.345 0 C-N-CA 123.739 2.959 . . . . 1.1699999999999999 113.62 -176.682 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 4.4 m -83.82 -9.59 58.66 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.012 0.434 . . . . 1.6000000000000001 110.885 -178.19 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . 0.714 ' HD3' ' HB ' ' A' ' 95' ' ' VAL . 49.5 mttp -119.67 17.62 12.76 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.056 -0.52 . . . . 1.21 110.843 -173.867 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . 0.445 ' HG2' ' O ' ' A' ' 133' ' ' PRO . 41.0 ptt180 -103.59 142.12 34.86 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.867 0.365 . . . . 2.7599999999999998 110.621 -179.978 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 55.5 mtm180 -105.67 111.91 24.77 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.301 -0.408 . . . . 4.54 111.501 -179.87 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 61.6 t-80 -132.8 99.18 4.53 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 109.096 -0.705 . . . . 5.9500000000000002 109.096 170.361 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 . . . . . 0 C--O 1.246 0.914 0 CA-C-O 118.135 -0.936 . . . . 6.1500000000000004 110.074 -179.006 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' B' B ' 143' ' ' PHE . . . . . 0.411 ' N ' ' OE2' ' B' ' 146' ' ' GLU . 92.7 m-85 . . . . . 0 N--CA 1.481 1.088 0 CA-C-O 120.868 0.366 . . . . 11.859999999999999 110.423 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 144' ' ' ASN . . . . . 0.465 ' O ' ' HB3' ' B' ' 145' ' ' TYR . 5.8 t-20 -160.2 131.07 5.64 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.465 -0.334 . . . . 8.1400000000000006 110.293 -175.191 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 145' ' ' TYR . . . . . 0.465 ' HB3' ' O ' ' B' ' 144' ' ' ASN . 64.3 t80 76.91 -30.55 0.18 Allowed 'General case' 0 N--CA 1.478 0.937 0 N-CA-C 112.515 0.561 . . . . 6.71 112.515 173.179 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 146' ' ' GLU . . . . . 0.411 ' OE2' ' N ' ' B' ' 143' ' ' PHE . 6.3 mt-10 -56.42 106.9 0.32 Allowed 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 122.935 0.494 . . . . 6.6100000000000003 111.87 -178.673 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 147' ' ' SER . . . . . . . . . . . . . 79.0 p -98.91 131.06 45.28 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.048 -0.524 . . . . 3.6499999999999999 109.756 175.883 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 148' ' ' THR . . . . . . . . . . . . . 7.5 p -84.46 -43.43 14.63 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 120.831 0.348 . . . . 1.79 111.734 -177.886 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 149' ' ' GLY . . . . . . . . . . . . . . . -175.28 -178.85 45.44 Favored Glycine 0 N--CA 1.446 -0.675 0 C-N-CA 120.627 -0.797 . . . . 0.47999999999999998 111.878 -179.212 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 150' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -74.72 -2.02 11.91 Favored 'Trans proline' 0 CA--C 1.533 0.465 0 C-N-CA 123.053 2.502 . . . . 0.33000000000000002 113.159 -176.585 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 151' ' ' PHE . . . . . 0.462 ' CE2' ' HB2' ' A' ' 90' ' ' TRP . 30.2 m-85 -94.03 -14.02 26.29 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 112.119 0.414 . . . . 0.75 112.119 -174.344 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 152' ' ' THR . . . . . 0.408 ' HB ' ' HG2' ' B' ' 154' ' ' LYS . 1.2 p -84.06 -15.22 48.26 Favored 'General case' 0 C--N 1.327 -0.395 0 C-N-CA 121.036 -0.266 . . . . 2.2200000000000002 111.679 179.957 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 153' ' ' ALA . . . . . . . . . . . . . . . 58.86 50.23 8.82 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 115.847 -0.615 . . . . 4.4000000000000004 111.201 -179.948 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 154' ' ' LYS . . . . . 0.408 ' HG2' ' HB ' ' B' ' 152' ' ' THR . 72.0 mmtt . . . . . 0 C--O 1.247 0.969 0 CA-C-N 115.736 -0.665 . . . . 6.75 109.215 178.642 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 141' ' ' ' CA' . . . . . 0.65 'CA ' ' OD1' ' A' ' 94' ' ' ASP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.787 0 N-CA-C 111.576 -0.61 . . . . 10.970000000000001 111.576 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 88.4 Cg_endo -83.09 150.14 13.73 Favored 'Trans proline' 0 N--CA 1.464 -0.248 0 C-N-CA 122.448 2.099 . . . . 9.0 112.338 179.179 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 40.8 tp -111.46 -38.0 5.08 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.934 0.397 . . . . 7.4199999999999999 110.582 177.561 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -159.29 49.03 0.4 Allowed Glycine 0 N--CA 1.449 -0.472 0 C-N-CA 120.439 -0.886 . . . . 4.46 112.173 179.002 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . 0.461 ' HA ' ' CE1' ' A' ' 138' ' ' HIS . 44.1 m 54.12 74.24 0.34 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.969 0.89 . . . . 3.9700000000000002 109.589 -175.05 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -75.59 101.01 4.77 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 114.56 -1.2 . . . . 3.46 110.383 -170.021 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -82.38 94.49 7.4 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.519 -0.764 . . . . 1.9299999999999999 110.264 -176.627 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.436 HG11 ' HA ' ' A' ' 129' ' ' HIS . 13.7 p -96.64 148.25 5.59 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-N 115.829 -0.623 . . . . 1.8500000000000001 110.922 -177.733 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 17.9 mm-40 -67.47 126.84 30.57 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.861 -0.609 . . . . 3.1000000000000001 110.474 177.142 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 5.7 t90 -81.91 103.14 11.36 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 109.243 -0.651 . . . . 0.70999999999999996 109.243 176.912 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.493 ' O ' ' HG2' ' A' ' 48' ' ' LYS . 21.2 m -60.2 -19.86 18.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 N-CA-C 112.978 0.733 . . . . 1.45 112.978 -173.172 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 28.3 t -78.94 -16.79 13.41 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-O 121.177 0.513 . . . . 1.1000000000000001 110.856 -178.834 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -74.08 -9.54 80.36 Favored Glycine 0 N--CA 1.448 -0.526 0 C-N-CA 120.851 -0.69 . . . . 0.58999999999999997 113.414 -175.476 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . 0.493 ' HG2' ' O ' ' A' ' 45' ' ' VAL . 1.1 ptpm? -83.93 -27.66 28.4 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 117.3 0.55 . . . . 2.46 111.112 -178.787 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 21.5 m-20 -100.6 33.83 2.62 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.824 0.345 . . . . 1.6599999999999999 110.266 -179.465 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 0.554 ' N ' ' HD2' ' A' ' 51' ' ' PRO . 14.9 mmtp -69.35 -51.03 17.99 Favored Pre-proline 0 C--N 1.324 -0.53 0 N-CA-C 112.83 0.678 . . . . 1.1499999999999999 112.83 -177.017 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.643 ' HA ' ' OD2' ' A' ' 54' ' ' ASP . 4.6 Cg_endo -48.34 -42.04 34.69 Favored 'Trans proline' 0 C--N 1.356 0.966 0 C-N-CA 122.707 2.271 . . . . 0.75 113.217 -177.966 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . 0.486 ' O ' ' HB3' ' A' ' 55' ' ' GLU . 21.9 m -70.93 -39.93 72.36 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.375 0.607 . . . . 0.68000000000000005 110.932 -179.419 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 21.2 m-30 -79.25 -22.09 45.23 Favored 'General case' 0 C--N 1.324 -0.51 0 C-N-CA 120.603 -0.439 . . . . 0.68999999999999995 111.114 -175.857 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . 0.643 ' OD2' ' HA ' ' A' ' 51' ' ' PRO . 0.6 OUTLIER -82.1 -25.48 34.45 Favored 'General case' 0 CA--C 1.52 -0.18 0 N-CA-C 108.945 -0.761 . . . . 2.1800000000000002 108.945 175.166 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.486 ' HB3' ' O ' ' A' ' 52' ' ' THR . 9.5 tp10 -59.37 -43.14 92.9 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.478 -0.783 . . . . 2.3300000000000001 109.102 169.598 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.447 HG12 ' O ' ' A' ' 52' ' ' THR . 27.6 mm -76.18 -34.82 26.91 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.331 0 CA-C-N 115.841 -0.618 . . . . 0.64000000000000001 110.521 178.092 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . 0.509 ' CE2' ' HB3' ' A' ' 62' ' ' PRO . 74.0 t80 -65.72 -46.6 78.32 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.122 -0.49 . . . . 0.28999999999999998 111.372 -176.725 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . 0.428 ' HA ' ' HG3' ' A' ' 62' ' ' PRO . 15.1 m-85 -80.33 -7.94 59.28 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.382 -0.372 . . . . 1.1699999999999999 111.922 -174.493 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 15.5 p -92.65 -4.34 53.44 Favored 'General case' 0 C--N 1.323 -0.572 0 C-N-CA 120.717 -0.393 . . . . 0.44 110.693 177.064 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.466 ' HB3' ' HB3' ' A' ' 71' ' ' ASN . 73.0 mt -108.08 13.24 26.16 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.299 -0.41 . . . . 1.3700000000000001 111.266 178.026 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 15.8 m 68.53 87.42 0.11 Allowed Pre-proline 0 N--CA 1.469 0.525 0 CA-C-N 116.03 -0.532 . . . . 1.24 112.171 175.698 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . 0.509 ' HB3' ' CE2' ' A' ' 57' ' ' PHE . 5.6 Cg_exo -80.69 138.89 12.18 Favored 'Trans proline' 0 N--CA 1.46 -0.47 0 C-N-CA 122.862 2.375 . . . . 0.46999999999999997 112.635 178.206 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 11.0 m -127.94 117.83 47.05 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-N 115.819 -0.628 . . . . 1.02 110.216 175.168 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 49.3 m-80 66.39 24.27 10.5 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-N 115.694 -0.684 . . . . 1.3400000000000001 111.389 178.661 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 92.96 8.15 62.01 Favored Glycine 0 C--N 1.331 0.275 0 C-N-CA 121.018 -0.611 . . . . 0.42999999999999999 112.788 176.847 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 0.804 ' HG2' ' HA ' ' A' ' 102' ' ' ASP . 55.1 mtmt -143.28 153.96 43.31 Favored 'General case' 0 C--N 1.326 -0.422 0 C-N-CA 122.381 0.272 . . . . 1.48 110.397 -177.165 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . 0.449 HD11 ' CD1' ' A' ' 106' ' ' PHE . 41.0 pt -110.68 153.92 12.36 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.763 0 N-CA-C 110.011 -0.366 . . . . 0.64000000000000001 110.011 174.957 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 18.6 p -72.7 152.5 41.65 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.285 -0.416 . . . . 0.55000000000000004 111.151 179.589 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -61.8 -15.93 49.96 Favored Glycine 0 N--CA 1.448 -0.54 0 C-N-CA 121.071 -0.585 . . . . 0.40999999999999998 112.947 -179.434 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -60.36 -50.46 73.51 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.133 0.492 . . . . 0.38 111.213 177.636 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . 0.559 ' HA ' ' HD3' ' A' ' 74' ' ' LYS . 39.9 m-80 -74.93 -34.23 62.08 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.826 -0.624 . . . . 1.8100000000000001 110.38 -175.778 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -61.42 -45.28 94.99 Favored 'General case' 0 N--CA 1.449 -0.489 0 CA-C-N 115.929 -0.578 . . . . 0.39000000000000001 109.528 173.961 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . 0.594 ' HA ' ' CZ ' ' B' ' 151' ' ' PHE . 54.9 tttp -56.08 -38.43 70.67 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.777 -0.647 . . . . 0.83999999999999997 110.383 177.296 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . 0.559 ' HD3' ' HA ' ' A' ' 71' ' ' ASN . 26.8 mtpp -65.49 -32.88 74.73 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.952 -0.567 . . . . 1.95 111.256 178.671 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 18.2 tp10 -76.31 -39.39 54.27 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.164 0.507 . . . . 1.6000000000000001 110.039 177.701 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' MET . . . . . 0.517 ' HB3' HD22 ' A' ' 86' ' ' LEU . 1.1 mpt? -60.71 -36.43 78.78 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 116.378 -0.374 . . . . 1.24 111.471 176.386 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.426 HG22 ' HA ' ' A' ' 74' ' ' LYS . 17.9 m -82.38 -13.88 12.2 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.507 0 C-N-CA 120.701 -0.4 . . . . 1.5700000000000001 110.978 177.455 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 46.7 mmtt -74.29 -29.74 61.77 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-O 120.867 0.365 . . . . 2.79 111.029 171.396 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -83.9 -13.61 53.09 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.155 -0.475 . . . . 1.27 111.122 -178.931 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 56.2 mttp 68.29 33.01 4.43 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 115.639 -0.709 . . . . 2.9700000000000002 111.927 171.788 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.715 ' HB2' HD21 ' A' ' 86' ' ' LEU . 97.2 mt -86.32 151.6 53.98 Favored Pre-proline 0 C--N 1.326 -0.453 0 N-CA-C 109.68 -0.489 . . . . 0.52000000000000002 109.68 175.682 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -54.46 142.91 69.11 Favored 'Trans proline' 0 C--N 1.35 0.628 0 C-N-CA 122.887 2.391 . . . . 0.44 112.65 179.336 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 39.9 m-80 -52.36 -48.05 65.76 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 115.615 -0.72 . . . . 1.8500000000000001 112.141 -175.61 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . 0.436 ' O ' ' HD3' ' A' ' 88' ' ' LYS . 38.8 p -63.76 -42.73 97.77 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.912 0.387 . . . . 1.47 110.757 -178.837 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 84.7 t -59.85 -39.24 79.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 115.85 -0.614 . . . . 0.45000000000000001 110.584 179.247 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.715 HD21 ' HB2' ' A' ' 81' ' ' LEU . 93.6 mt -65.75 -29.37 69.87 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.435 -0.348 . . . . 0.90000000000000002 110.521 177.333 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . 0.492 ' HA3' ' HA ' ' B' ' 153' ' ' ALA . . . -65.77 -41.41 95.73 Favored Glycine 0 CA--C 1.502 -0.753 0 N-CA-C 111.086 -0.806 . . . . 0.32000000000000001 111.086 175.151 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . 0.911 ' HD2' ' HB1' ' B' ' 153' ' ' ALA . 2.5 mptp? -75.06 -28.33 60.32 Favored 'General case' 0 N--CA 1.443 -0.808 0 CA-C-N 115.464 -0.368 . . . . 1.8899999999999999 110.846 178.605 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 16.4 mm -60.15 -49.44 84.08 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.254 0 CA-C-N 116.325 -0.398 . . . . 0.70999999999999996 110.222 173.153 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' TRP . . . . . 0.424 ' HB2' ' CD2' ' B' ' 151' ' ' PHE . 52.4 t-105 -62.38 -45.33 93.62 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.917 0.389 . . . . 0.33000000000000002 110.578 178.073 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 17.4 ttmm -54.85 -32.33 60.49 Favored 'General case' 0 C--O 1.237 0.447 0 CA-C-N 115.665 -0.698 . . . . 2.7000000000000002 111.585 179.276 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.559 HD22 ' HA ' ' A' ' 124' ' ' ALA . 13.0 tp -93.93 -36.92 11.96 Favored 'General case' 0 N--CA 1.442 -0.846 0 CA-C-N 115.906 -0.588 . . . . 1.6599999999999999 111.782 -176.439 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -81.36 -42.48 20.44 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.753 0.311 . . . . 0.46999999999999997 111.718 -174.53 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . 0.654 ' OD2' ' HA ' ' A' ' 97' ' ' LYS . 50.0 t0 -78.03 96.72 5.16 Favored 'General case' 0 C--O 1.237 0.417 0 N-CA-C 108.689 -0.856 . . . . 0.79000000000000004 108.689 178.049 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 38.3 t -68.86 -45.16 81.14 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-N 115.481 -0.781 . . . . 0.60999999999999999 110.965 -172.497 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 29.0 p-10 -88.6 -17.96 29.04 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 116.092 -0.504 . . . . 0.95999999999999996 111.694 -176.779 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.654 ' HA ' ' OD2' ' A' ' 94' ' ' ASP . 53.0 mttp 58.07 72.89 0.5 Allowed 'General case' 0 CA--C 1.518 -0.278 0 CA-C-O 122.063 0.935 . . . . 2.96 111.32 177.838 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . 0.628 ' OD1' 'CA ' ' A' ' 141' ' ' ' CA' . 11.5 p-10 -122.83 9.05 9.41 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 114.589 -1.187 . . . . 0.42999999999999999 110.868 -173.169 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 78.19 -3.78 60.92 Favored Glycine 0 CA--C 1.52 0.369 0 C-N-CA 121.001 -0.619 . . . . 0.44 112.468 -179.554 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.417 ' HB2' ' OD2' ' A' ' 98' ' ' ASP . 4.6 mp -128.86 166.23 19.47 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 109.726 -0.472 . . . . 1.1100000000000001 109.726 175.922 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 81.7 mt -123.75 127.52 48.26 Favored 'General case' 0 C--N 1.314 -0.951 0 CA-C-N 116.128 -0.487 . . . . 0.41999999999999998 109.799 176.999 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . 0.804 ' HA ' ' HG2' ' A' ' 66' ' ' LYS . 2.6 m-20 -69.72 168.42 14.99 Favored 'General case' 0 CA--C 1.509 -0.631 0 N-CA-C 108.799 -0.815 . . . . 1.72 108.799 174.334 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -57.61 -30.28 65.2 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 108.46 -0.941 . . . . 1.6000000000000001 108.46 171.772 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 6.4 mm-40 -66.97 -58.81 4.23 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-N 115.11 -0.95 . . . . 1.6599999999999999 111.851 177.195 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . 0.581 ' OE1' ' HE3' ' A' ' 135' ' ' LYS . 2.4 pt-20 -78.91 -18.09 54.44 Favored 'General case' 0 CA--C 1.53 0.187 0 C-N-CA 120.283 -0.567 . . . . 0.44 112.236 -173.822 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . 0.449 ' CD1' HD11 ' A' ' 67' ' ' ILE . 50.3 t80 -76.64 -34.17 58.31 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 109.164 -0.68 . . . . 0.41999999999999998 109.164 173.603 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -62.23 -44.49 96.44 Favored 'General case' 0 N--CA 1.452 -0.363 0 CA-C-N 115.672 -0.694 . . . . 0.22 109.262 171.663 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.435 ' O ' ' HG ' ' A' ' 112' ' ' LEU . 4.8 tt -60.39 -46.28 90.54 Favored 'General case' 0 CA--C 1.533 0.305 0 CA-C-N 115.491 -0.777 . . . . 1.3300000000000001 109.847 178.326 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -56.17 -49.65 73.41 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 116.484 -0.326 . . . . 0.32000000000000001 111.363 178.361 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 22.5 m-80 -65.06 -32.53 74.28 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.423 -0.353 . . . . 1.2 111.31 179.626 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' HIS . . . . . 0.408 ' O ' HG23 ' A' ' 115' ' ' VAL . 11.9 t60 -68.28 -35.59 78.09 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 109.689 -0.485 . . . . 0.52000000000000002 109.689 178.091 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.435 ' HG ' ' O ' ' A' ' 108' ' ' LEU . 95.8 mt -65.61 -46.88 77.65 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 116.323 -0.398 . . . . 0.55000000000000004 110.324 175.713 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 62.7 mt -56.7 -45.03 82.63 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.177 0 CA-C-N 115.767 -0.651 . . . . 0.83999999999999997 109.709 177.254 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 17.1 tppt? -56.85 -49.99 73.78 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.054 -0.975 . . . . 3.8300000000000001 110.919 178.191 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.621 HG13 ' HB2' ' A' ' 120' ' ' HIS . 45.9 t -58.68 -42.87 86.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.194 -0.457 . . . . 1.1899999999999999 111.57 -178.716 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 17.5 tppt? -70.02 -41.51 74.19 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 116.628 -0.26 . . . . 1.3200000000000001 110.698 -179.257 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 74.5 mt -68.61 -30.69 69.48 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.881 0.372 . . . . 0.95999999999999996 111.04 179.287 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -74.96 -16.7 60.63 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.917 -0.583 . . . . 2.1800000000000002 110.483 179.696 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 99.25 32.83 5.65 Favored Glycine 0 N--CA 1.449 -0.486 0 C-N-CA 120.744 -0.741 . . . . 1.1599999999999999 113.02 175.96 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' HIS . . . . . 0.621 ' HB2' HG13 ' A' ' 115' ' ' VAL . 78.4 m-70 -119.54 -179.52 3.9 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 109.79 -0.448 . . . . 2.4199999999999999 109.79 177.692 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -117.46 149.27 40.85 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 120.956 0.408 . . . . 2.5299999999999998 111.166 -176.119 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 2.6 pp -108.3 143.53 27.62 Favored Pre-proline 0 C--N 1.324 -0.542 0 CA-C-N 115.516 -0.766 . . . . 1.3300000000000001 109.784 175.346 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -73.34 -13.9 25.41 Favored 'Trans proline' 0 C--N 1.343 0.261 0 C-N-CA 122.395 2.064 . . . . 1.3300000000000001 113.164 -176.338 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . 0.559 ' HA ' HD22 ' A' ' 92' ' ' LEU . . . 61.01 17.68 8.18 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 123.162 0.585 . . . . 1.25 111.392 -177.402 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -134.4 163.13 30.36 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 107.817 -1.179 . . . . 2.73 107.817 174.268 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 64.2 mt -109.2 93.88 14.11 Favored Pre-proline 0 C--N 1.322 -0.614 0 CA-C-O 120.724 0.297 . . . . 1.6599999999999999 111.515 -177.016 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 127' ' ' PRO . . . . . 0.432 ' HD2' HD12 ' A' ' 130' ' ' LEU . 63.5 Cg_endo -75.77 155.67 39.48 Favored 'Trans proline' 0 N--CA 1.459 -0.554 0 C-N-CA 122.571 2.181 . . . . 1.1699999999999999 111.141 173.667 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 90.0 Cg_exo -44.44 -37.2 10.48 Favored 'Trans proline' 0 CA--C 1.533 0.452 0 C-N-CA 123.478 2.785 . . . . 1.54 114.557 -177.874 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 129' ' ' HIS . . . . . 0.436 ' HA ' HG11 ' A' ' 42' ' ' VAL . 41.0 p-80 -82.03 10.27 6.9 Favored 'General case' 0 N--CA 1.466 0.339 0 C-N-CA 120.793 -0.363 . . . . 1.0700000000000001 111.851 -175.503 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . 0.432 HD12 ' HD2' ' A' ' 127' ' ' PRO . 66.6 mt -126.99 1.57 6.57 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.514 0.197 . . . . 1.3600000000000001 111.48 176.335 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 43.0 t -85.06 122.9 74.09 Favored Pre-proline 0 C--N 1.326 -0.456 0 N-CA-C 110.515 -0.18 . . . . 1.28 110.515 -178.74 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 132' ' ' PRO . . . . . 0.407 ' HA ' ' HD3' ' A' ' 133' ' ' PRO . 47.9 Cg_exo -56.12 129.2 33.58 Favored 'Trans proline' 0 C--N 1.346 0.407 0 C-N-CA 122.99 2.46 . . . . 0.81000000000000005 112.329 178.881 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 133' ' ' PRO . . . . . 0.408 ' HA ' ' HG2' ' A' ' 136' ' ' ARG . 25.4 Cg_exo -62.01 -18.85 63.77 Favored 'Trans proline' 0 C--N 1.345 0.393 0 C-N-CA 122.884 2.39 . . . . 1.1699999999999999 112.692 -177.131 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 8.4 p -77.24 -21.5 53.66 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 116.061 -0.518 . . . . 1.6000000000000001 111.72 -179.317 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . 0.581 ' HE3' ' OE1' ' A' ' 105' ' ' GLU . 68.4 mttm -115.94 0.19 13.0 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 111.721 0.267 . . . . 1.21 111.721 -175.074 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . 0.425 ' O ' ' HG3' ' A' ' 136' ' ' ARG . 36.1 ptt180 -84.74 110.08 18.52 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 121.61 0.719 . . . . 2.7599999999999998 110.951 -176.364 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 65.6 mtm180 -100.84 130.4 46.85 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.702 -0.681 . . . . 4.54 109.502 174.038 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 138' ' ' HIS . . . . . 0.461 ' CE1' ' HA ' ' A' ' 39' ' ' SER . 5.2 t-80 -117.83 139.68 50.76 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 120.725 0.298 . . . . 5.9500000000000002 110.761 -174.716 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 . . . . . 0 C--O 1.245 0.865 0 CA-C-O 118.209 -0.901 . . . . 6.1500000000000004 109.65 -179.639 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' B' B ' 143' ' ' PHE . . . . . . . . . . . . . 98.6 m-85 . . . . . 0 N--CA 1.481 1.085 0 N-CA-C 109.825 -0.435 . . . . 11.859999999999999 109.825 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' B' B ' 144' ' ' ASN . . . . . . . . . . . . . 27.0 p-10 -120.17 -8.65 9.69 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 112.22 0.452 . . . . 8.1400000000000006 112.22 -175.223 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 145' ' ' TYR . . . . . . . . . . . . . 28.8 p90 -131.24 165.18 23.95 Favored 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 120.688 -0.405 . . . . 6.71 110.578 -177.973 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 146' ' ' GLU . . . . . . . . . . . . . 30.9 tt0 -158.34 27.39 0.24 Allowed 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 122.02 0.914 . . . . 6.6100000000000003 108.613 177.877 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 147' ' ' SER . . . . . . . . . . . . . 1.4 m -65.3 -14.29 60.43 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 114.556 -1.202 . . . . 3.6499999999999999 112.295 -172.42 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 148' ' ' THR . . . . . 0.403 ' HB ' ' HA ' ' B' ' 152' ' ' THR . 4.7 m -134.92 32.02 3.25 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.796 0.808 . . . . 1.79 109.366 176.795 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 149' ' ' GLY . . . . . . . . . . . . . . . 83.55 -172.49 50.57 Favored Glycine 0 N--CA 1.445 -0.75 0 CA-C-N 115.282 -0.872 . . . . 0.47999999999999998 111.748 -179.13 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 150' ' ' PRO . . . . . . . . . . . . . 90.0 Cg_endo -80.79 -0.69 10.78 Favored 'Trans proline' 0 N--CA 1.461 -0.389 0 C-N-CA 122.864 2.376 . . . . 0.33000000000000002 112.319 179.766 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 151' ' ' PHE . . . . . 0.594 ' CZ ' ' HA ' ' A' ' 73' ' ' LYS . 56.7 m-85 -101.28 -47.72 4.62 Favored 'General case' 0 C--N 1.331 -0.207 0 N-CA-C 112.56 0.578 . . . . 0.75 112.56 -177.554 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 152' ' ' THR . . . . . 0.415 ' HB ' ' O ' ' B' ' 151' ' ' PHE . 81.6 m 72.01 101.59 0.07 Allowed 'General case' 0 CA--C 1.532 0.28 0 CA-C-O 121.57 0.7 . . . . 2.2200000000000002 109.896 -170.934 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 153' ' ' ALA . . . . . 0.911 ' HB1' ' HD2' ' A' ' 88' ' ' LYS . . . -85.68 -33.78 21.47 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 113.31 0.855 . . . . 4.4000000000000004 113.31 -169.047 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 154' ' ' LYS . . . . . 0.446 ' NZ ' ' HB3' ' B' ' 154' ' ' LYS . 9.5 mtpm? . . . . . 0 C--O 1.251 1.135 0 CA-C-O 118.423 -0.798 . . . . 6.75 109.789 -169.434 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 141' ' ' ' CA' . . . . . 0.63 'CA ' ' OD1' ' A' ' 94' ' ' ASP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.818 0 N-CA-C 111.972 -0.451 . . . . 10.970000000000001 111.972 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 33.2 Cg_exo -61.83 -63.2 0.1 Allowed 'Trans proline' 0 C--N 1.343 0.265 0 C-N-CA 122.751 2.301 . . . . 9.0 112.151 -179.758 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 47.4 tp 51.29 81.14 0.07 Allowed 'General case' 0 N--CA 1.463 0.221 0 O-C-N 123.904 0.752 . . . . 7.4199999999999999 111.744 178.861 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -178.14 -153.09 10.83 Favored Glycine 0 N--CA 1.446 -0.674 0 C-N-CA 120.759 -0.734 . . . . 4.46 112.312 179.859 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 7.6 p -145.47 143.24 29.9 Favored 'General case' 0 C--N 1.322 -0.598 0 C-N-CA 122.288 0.235 . . . . 3.9700000000000002 110.443 179.692 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -103.51 114.57 28.94 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.426 -0.352 . . . . 3.46 110.285 178.486 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -105.89 111.08 23.58 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.04 -0.527 . . . . 1.9299999999999999 109.636 177.33 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 35.8 m -77.17 154.21 5.52 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 CA-C-N 115.355 -0.839 . . . . 1.8500000000000001 111.813 -173.019 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -68.88 144.3 54.27 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.015 -0.539 . . . . 3.1000000000000001 109.755 175.072 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 5.1 t90 -83.11 104.08 13.03 Favored 'General case' 0 N--CA 1.444 -0.764 0 N-CA-C 107.698 -1.223 . . . . 0.70999999999999996 107.698 168.93 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.422 ' HA ' ' HE3' ' A' ' 48' ' ' LYS . 29.7 m -69.82 4.89 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.234 0 CA-C-O 121.228 0.537 . . . . 1.45 111.628 -175.677 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.49 HG11 ' HA ' ' A' ' 108' ' ' LEU . 42.1 t -103.62 -29.48 2.9 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.818 0 CA-C-N 115.711 -0.677 . . . . 1.1000000000000001 109.874 172.239 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . 0.524 ' HA2' ' HB2' ' A' ' 50' ' ' LYS . . . -82.89 -10.12 83.47 Favored Glycine 0 N--CA 1.448 -0.54 0 CA-C-N 115.88 -0.6 . . . . 0.58999999999999997 113.023 -175.528 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . 0.422 ' HE3' ' HA ' ' A' ' 45' ' ' VAL . 17.2 ptpt -81.55 -25.89 35.48 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.772 0.32 . . . . 2.46 110.315 177.145 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 12.0 m-20 -110.11 33.21 4.58 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 108.948 -0.76 . . . . 1.6599999999999999 108.948 173.577 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 0.667 ' N ' ' HD2' ' A' ' 51' ' ' PRO . 17.3 ttpp -77.35 -43.04 2.58 Favored Pre-proline 0 C--O 1.219 -0.538 0 CA-C-O 118.633 -0.699 . . . . 1.1499999999999999 112.067 -174.779 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.667 ' HD2' ' N ' ' A' ' 50' ' ' LYS . 1.3 Cg_endo -44.74 -36.31 10.41 Favored 'Trans proline' 0 C--N 1.362 1.284 0 C-N-CA 123.0 2.467 . . . . 0.75 113.471 178.493 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 13.0 m -69.51 -45.49 68.75 Favored 'General case' 0 C--O 1.238 0.49 0 CA-C-O 121.111 0.481 . . . . 0.68000000000000005 110.459 178.657 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 21.7 m-85 -70.97 -22.35 62.21 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.027 -0.533 . . . . 0.68999999999999995 109.92 178.936 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -68.77 -45.03 72.44 Favored 'General case' 0 CA--C 1.513 -0.471 0 CA-C-N 116.163 -0.471 . . . . 2.1800000000000002 109.856 175.667 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -61.78 -44.85 96.07 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.79 -0.641 . . . . 2.3300000000000001 109.937 -179.821 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 45.0 mt -65.78 -40.95 89.17 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-N 115.798 -0.637 . . . . 0.64000000000000001 110.84 177.634 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 77.7 t80 -61.9 -39.34 91.66 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.677 -0.692 . . . . 0.28999999999999998 111.297 179.397 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 4.1 m-30 -79.79 -22.58 42.93 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.56 -0.291 . . . . 1.1699999999999999 111.2 -175.573 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 28.2 p -79.57 -10.15 59.75 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.72 0.295 . . . . 0.44 111.446 178.257 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 53.7 mt -88.92 -0.47 57.42 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.566 -0.288 . . . . 1.3700000000000001 110.246 175.274 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 55.7 m 62.43 81.04 0.24 Allowed Pre-proline 0 CA--C 1.533 0.313 0 O-C-N 123.788 0.68 . . . . 1.24 110.986 -176.86 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -76.61 157.54 36.02 Favored 'Trans proline' 0 N--CA 1.46 -0.482 0 C-N-CA 122.827 2.351 . . . . 0.46999999999999997 112.307 -179.011 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 15.4 m -123.96 115.64 45.61 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 CA-C-N 116.157 -0.474 . . . . 1.02 110.073 177.231 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 82.6 m-20 63.82 24.71 13.85 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 115.467 -0.788 . . . . 1.3400000000000001 111.375 179.809 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 88.69 10.52 67.19 Favored Glycine 0 C--N 1.33 0.224 0 C-N-CA 120.992 -0.623 . . . . 0.42999999999999999 112.957 178.334 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 0.537 ' HE2' ' OD1' ' A' ' 102' ' ' ASP . 82.2 mttt -136.13 154.45 50.98 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 110.152 -0.314 . . . . 1.48 110.152 179.687 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 40.9 pt -116.77 159.16 16.93 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 C-N-CA 121.109 -0.236 . . . . 0.64000000000000001 110.397 174.942 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . 0.518 ' HA ' HD23 ' A' ' 100' ' ' LEU . 44.8 p -80.85 169.85 17.03 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.324 -0.398 . . . . 0.55000000000000004 110.148 -179.593 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . 0.541 ' O ' ' HB2' ' A' ' 73' ' ' LYS . . . -64.25 -16.98 61.0 Favored Glycine 0 N--CA 1.447 -0.626 0 C-N-CA 120.653 -0.784 . . . . 0.40999999999999998 112.503 177.314 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -68.86 -46.75 67.68 Favored 'General case' 0 C--O 1.235 0.325 0 CA-C-O 121.219 0.533 . . . . 0.38 111.743 -179.139 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 1.7 m120 -72.71 -43.17 63.35 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.815 -0.629 . . . . 1.8100000000000001 109.716 -174.575 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -64.1 -35.24 80.09 Favored 'General case' 0 N--CA 1.448 -0.568 0 CA-C-N 115.527 -0.761 . . . . 0.39000000000000001 110.137 176.061 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . 0.541 ' HB2' ' O ' ' A' ' 69' ' ' GLY . 34.3 tttp -56.23 -45.11 80.11 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 116.13 -0.486 . . . . 0.83999999999999997 110.194 176.259 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . 0.781 ' O ' ' HG2' ' A' ' 78' ' ' LYS . 45.8 mtpt -67.75 -31.38 71.26 Favored 'General case' 0 C--O 1.217 -0.651 0 CA-C-N 115.601 -0.727 . . . . 1.95 111.041 -178.742 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 13.9 tp10 -71.78 -47.52 52.89 Favored 'General case' 0 C--N 1.314 -0.971 0 CA-C-O 121.531 0.682 . . . . 1.6000000000000001 109.753 178.52 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' MET . . . . . 0.779 ' HG3' ' HZ ' ' B' ' 151' ' ' PHE . 16.0 mmt -55.52 -42.36 74.42 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.095 -0.957 . . . . 1.24 109.684 175.691 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.64 HG12 ' O ' ' A' ' 74' ' ' LYS . 1.1 p -74.12 -23.27 18.55 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.413 0 CA-C-N 115.276 -0.875 . . . . 1.5700000000000001 111.301 -177.226 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.781 ' HG2' ' O ' ' A' ' 74' ' ' LYS . 31.8 mmmt -73.56 -28.53 61.9 Favored 'General case' 0 CA--C 1.517 -0.319 0 CA-C-O 121.063 0.459 . . . . 2.79 109.872 176.165 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 45.1 m -81.91 -5.56 58.38 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.781 -0.645 . . . . 1.27 110.439 178.336 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 45.0 mttp 65.51 23.18 11.84 Favored 'General case' 0 N--CA 1.465 0.325 0 CA-C-N 115.418 -0.81 . . . . 2.9700000000000002 112.03 169.078 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.714 ' HB2' HD21 ' A' ' 86' ' ' LEU . 88.0 mt -85.59 148.65 49.64 Favored Pre-proline 0 C--N 1.322 -0.626 0 CA-C-N 116.413 -0.358 . . . . 0.52000000000000002 110.216 178.836 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . 0.534 ' O ' ' HG ' ' A' ' 86' ' ' LEU . 50.8 Cg_exo -54.91 137.34 75.46 Favored 'Trans proline' 0 C--N 1.344 0.294 0 C-N-CA 123.105 2.537 . . . . 0.44 112.206 179.043 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . 0.513 ' HA ' HD12 ' A' ' 86' ' ' LEU . 4.6 p30 -60.16 -34.81 74.09 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-N 115.954 -0.566 . . . . 1.8500000000000001 110.965 -174.225 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 63.3 m -63.39 -40.6 97.65 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.674 -0.694 . . . . 1.47 110.379 177.697 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.455 HG23 ' HB2' ' A' ' 82' ' ' PRO . 52.3 t -71.66 -34.49 52.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 115.835 -0.62 . . . . 0.45000000000000001 109.862 178.088 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.716 HD22 ' HB3' ' A' ' 76' ' ' MET . 77.1 mt -63.46 -33.9 76.57 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.969 -0.56 . . . . 0.90000000000000002 110.073 174.728 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -66.78 -38.05 92.78 Favored Glycine 0 N--CA 1.45 -0.423 0 N-CA-C 111.362 -0.695 . . . . 0.32000000000000001 111.362 176.064 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . 0.418 ' HB2' ' O ' ' A' ' 85' ' ' VAL . 71.7 mmtt -58.15 -49.48 76.87 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 109.974 -0.38 . . . . 1.8899999999999999 109.974 172.125 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.423 HG12 ' O ' ' A' ' 85' ' ' VAL . 40.3 mm -59.32 -48.4 87.15 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.197 0 CA-C-N 115.752 -0.658 . . . . 0.70999999999999996 111.294 -179.297 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' TRP . . . . . 0.414 ' HB2' ' HE2' ' B' ' 151' ' ' PHE . 41.8 t-105 -62.83 -45.16 93.9 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.937 0.398 . . . . 0.33000000000000002 111.087 -178.563 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 21.1 ttpp -64.27 -27.64 69.18 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.06 -0.518 . . . . 2.7000000000000002 111.285 -176.783 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.43 HD11 ' HG ' ' A' ' 126' ' ' LEU . 14.5 tp -93.9 -48.49 6.25 Favored 'General case' 0 N--CA 1.445 -0.696 0 N-CA-C 112.154 0.427 . . . . 1.6599999999999999 112.154 -175.946 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -73.3 -41.12 63.95 Favored 'General case' 0 N--CA 1.463 0.21 0 N-CA-C 111.847 0.314 . . . . 0.46999999999999997 111.847 -174.259 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . 0.622 ' OD2' ' HA ' ' A' ' 97' ' ' LYS . 21.9 t70 -78.08 96.34 5.11 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 108.965 -0.754 . . . . 0.79000000000000004 108.965 176.089 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 45.7 t -78.31 -36.22 20.51 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 CA-C-N 115.647 -0.706 . . . . 0.60999999999999999 111.08 -171.516 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . 0.607 ' OD1' 'CA ' ' A' ' 141' ' ' ' CA' . 5.7 p30 -83.5 -11.39 57.51 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 116.042 -0.526 . . . . 0.95999999999999996 112.03 -174.942 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.622 ' HA ' ' OD2' ' A' ' 94' ' ' ASP . 0.0 OUTLIER 59.08 30.89 20.8 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-O 121.26 0.552 . . . . 2.96 111.181 172.981 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . 0.643 ' OD2' ' HB2' ' A' ' 100' ' ' LEU . 8.6 p-10 -86.83 9.8 18.02 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 115.453 -0.794 . . . . 0.42999999999999999 111.24 -173.564 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 66.9 9.18 52.32 Favored Glycine 0 C--N 1.332 0.331 0 CA-C-N 116.089 -0.505 . . . . 0.44 112.476 -178.987 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.643 ' HB2' ' OD2' ' A' ' 98' ' ' ASP . 72.3 mt -135.18 161.45 35.32 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 109.145 -0.687 . . . . 1.1100000000000001 109.145 179.955 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 80.1 mt -117.86 125.5 50.64 Favored 'General case' 0 C--N 1.311 -1.09 0 C-N-CA 120.725 -0.39 . . . . 0.41999999999999998 110.035 176.73 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . 0.537 ' OD1' ' HE2' ' A' ' 66' ' ' LYS . 11.5 m-20 -68.94 172.51 6.5 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 108.111 -1.07 . . . . 1.72 108.111 172.939 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 2.0 p30 -63.16 -32.63 74.07 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 109.186 -0.672 . . . . 1.6000000000000001 109.186 177.113 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 51.9 mt-10 -72.16 -45.2 61.41 Favored 'General case' 0 N--CA 1.452 -0.336 0 CA-C-N 115.888 -0.596 . . . . 1.6599999999999999 110.956 175.463 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 29.7 mt-10 -64.89 -39.54 93.69 Favored 'General case' 0 N--CA 1.462 0.156 0 C-N-CA 120.818 -0.353 . . . . 0.44 110.449 -176.996 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 90.2 t80 -65.55 -40.87 93.33 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.298 -0.41 . . . . 0.41999999999999998 110.173 177.214 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -58.7 -47.42 84.62 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.246 -0.433 . . . . 0.22 110.688 176.158 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.49 ' HA ' HG11 ' A' ' 46' ' ' VAL . 60.4 tp -61.82 -45.94 91.65 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-N 116.32 -0.4 . . . . 1.3300000000000001 110.972 178.463 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . 0.677 ' O ' HG13 ' A' ' 113' ' ' ILE . . . -56.09 -57.16 13.32 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.052 -0.522 . . . . 0.32000000000000001 110.549 177.878 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' ASN . . . . . 0.515 ' HA ' HD12 ' A' ' 113' ' ' ILE . 1.1 t-20 -56.31 -36.27 68.5 Favored 'General case' 0 CA--C 1.521 -0.162 0 CA-C-N 116.049 -0.523 . . . . 1.2 111.395 179.684 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 13.3 t60 -63.67 -39.92 95.55 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.159 -0.473 . . . . 0.52000000000000002 110.174 -179.655 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.418 ' O ' HG12 ' A' ' 115' ' ' VAL . 94.6 mt -74.08 -39.86 63.15 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.27 -0.423 . . . . 0.55000000000000004 110.498 178.302 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.677 HG13 ' O ' ' A' ' 109' ' ' ALA . 54.0 mt -58.42 -49.53 81.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-O 121.531 0.681 . . . . 0.83999999999999997 110.361 177.647 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . 0.614 ' HE2' HD12 ' A' ' 117' ' ' LEU . 0.0 OUTLIER -71.31 -24.97 62.23 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.403 -0.817 . . . . 3.8300000000000001 110.827 -177.157 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.418 HG12 ' O ' ' A' ' 112' ' ' LEU . 0.4 OUTLIER -72.78 -33.29 43.58 Favored 'Isoleucine or valine' 0 C--O 1.235 0.306 0 N-CA-C 109.75 -0.463 . . . . 1.1899999999999999 109.75 177.195 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . 0.458 ' HD2' ' O ' ' A' ' 120' ' ' HIS . 19.6 tptp -66.1 -39.5 90.03 Favored 'General case' 0 N--CA 1.442 -0.834 0 CA-C-N 116.125 -0.488 . . . . 1.3200000000000001 109.929 173.06 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . 0.614 HD12 ' HE2' ' A' ' 114' ' ' LYS . 80.1 mt -65.45 -23.54 66.96 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 116.066 -0.515 . . . . 0.95999999999999996 110.554 176.508 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 24.6 mm-40 -78.53 -7.01 57.05 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.918 -0.583 . . . . 2.1800000000000002 111.237 177.878 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 86.22 25.53 36.59 Favored Glycine 0 N--CA 1.448 -0.508 0 C-N-CA 120.652 -0.785 . . . . 1.1599999999999999 112.154 -179.277 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' HIS . . . . . 0.458 ' O ' ' HD2' ' A' ' 116' ' ' LYS . 97.5 m-70 -109.86 152.04 26.28 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 110.058 -0.349 . . . . 2.4199999999999999 110.058 178.029 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -108.12 155.75 20.05 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 116.015 -0.539 . . . . 2.5299999999999998 109.563 176.73 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -118.74 131.73 24.18 Favored Pre-proline 0 C--N 1.321 -0.653 0 CA-C-N 116.478 -0.328 . . . . 1.3300000000000001 110.33 -177.826 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_endo -71.19 -0.11 7.54 Favored 'Trans proline' 0 C--N 1.345 0.344 0 C-N-CA 123.274 2.649 . . . . 1.3300000000000001 113.438 -177.051 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . 62.92 21.25 12.75 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-O 121.526 0.679 . . . . 1.25 110.348 -175.405 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -103.74 142.78 33.76 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.107 -0.951 . . . . 2.73 108.53 178.552 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . 0.43 ' HG ' HD11 ' A' ' 92' ' ' LEU . 38.6 mt -115.27 90.96 26.22 Favored Pre-proline 0 C--N 1.321 -0.659 0 C-N-CA 120.943 -0.303 . . . . 1.6599999999999999 111.32 179.815 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 127' ' ' PRO . . . . . 0.497 ' HD2' HD12 ' A' ' 130' ' ' LEU . 41.7 Cg_endo -71.19 157.84 56.28 Favored 'Trans proline' 0 N--CA 1.46 -0.455 0 C-N-CA 122.678 2.252 . . . . 1.1699999999999999 111.45 173.248 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 128' ' ' PRO . . . . . 0.436 ' HA ' HG22 ' A' ' 131' ' ' VAL . 78.1 Cg_exo -52.41 -29.55 39.84 Favored 'Trans proline' 0 CA--C 1.535 0.527 0 C-N-CA 123.271 2.647 . . . . 1.54 114.155 -177.35 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 3.9 p-80 -83.36 1.85 39.25 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 120.476 -0.49 . . . . 1.0700000000000001 111.495 -178.988 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . 0.497 HD12 ' HD2' ' A' ' 127' ' ' PRO . 26.0 mt -113.98 -7.59 13.12 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 116.846 -0.161 . . . . 1.3600000000000001 111.304 175.149 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . 0.436 HG22 ' HA ' ' A' ' 128' ' ' PRO . 26.2 m -94.11 139.54 22.58 Favored Pre-proline 0 C--N 1.325 -0.471 0 CA-C-O 120.81 0.338 . . . . 1.28 110.145 177.452 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 132' ' ' PRO . . . . . 0.798 ' HG2' ' HB2' ' A' ' 135' ' ' LYS . 27.7 Cg_endo -63.08 143.95 91.55 Favored 'Trans proline' 0 C--O 1.234 0.285 0 C-N-CA 122.61 2.207 . . . . 0.81000000000000005 112.217 -178.111 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -54.19 -30.54 61.71 Favored 'Trans proline' 0 C--N 1.345 0.377 0 C-N-CA 123.142 2.562 . . . . 1.1699999999999999 112.961 179.254 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 50.2 p -75.36 -25.19 57.53 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 121.118 0.485 . . . . 1.6000000000000001 111.515 -178.097 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . 0.798 ' HB2' ' HG2' ' A' ' 132' ' ' PRO . 87.9 mttt -116.71 22.4 12.72 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.243 -0.435 . . . . 1.21 110.976 -173.308 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 11.4 ptp180 -110.42 139.45 45.62 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.96 0.41 . . . . 2.7599999999999998 111.109 178.949 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 63.5 mtp180 -134.19 120.85 20.56 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.025 -0.534 . . . . 4.54 110.211 173.859 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 84.1 t60 -133.58 104.59 6.44 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.061 0.458 . . . . 5.9500000000000002 111.199 177.02 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--O 1.247 0.932 0 CA-C-N 115.419 -0.809 . . . . 6.1500000000000004 109.59 176.673 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 143' ' ' PHE . . . . . . . . . . . . . 86.5 t80 . . . . . 0 N--CA 1.476 0.844 0 N-CA-C 109.96 -0.385 . . . . 11.859999999999999 109.96 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' B' B ' 144' ' ' ASN . . . . . . . . . . . . . 51.0 t30 -105.02 142.77 34.22 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.324 -0.398 . . . . 8.1400000000000006 109.996 -178.566 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 145' ' ' TYR . . . . . 0.633 ' HD2' ' H ' ' B' ' 146' ' ' GLU . 5.9 p90 -142.84 -95.07 0.12 Allowed 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.318 -0.401 . . . . 6.71 110.498 -179.713 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 146' ' ' GLU . . . . . 0.633 ' H ' ' HD2' ' B' ' 145' ' ' TYR . 42.6 mt-10 -130.4 -156.96 0.79 Allowed 'General case' 0 C--N 1.318 -0.782 0 N-CA-C 107.697 -1.223 . . . . 6.6100000000000003 107.697 173.953 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 147' ' ' SER . . . . . . . . . . . . . 13.2 p -121.6 131.64 54.23 Favored 'General case' 0 C--N 1.319 -0.73 0 C-N-CA 119.785 -0.766 . . . . 3.6499999999999999 112.396 -176.449 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 148' ' ' THR . . . . . . . . . . . . . 8.0 p -90.95 -43.92 9.68 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.463 -0.79 . . . . 1.79 110.567 175.684 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 149' ' ' GLY . . . . . . . . . . . . . . . 163.26 157.79 9.4 Favored Glycine 0 N--CA 1.446 -0.67 0 CA-C-N 115.403 -0.817 . . . . 0.47999999999999998 111.541 178.832 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 150' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -77.59 -1.84 12.0 Favored 'Trans proline' 0 N--CA 1.463 -0.282 0 C-N-CA 122.753 2.302 . . . . 0.33000000000000002 112.712 -178.334 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 151' ' ' PHE . . . . . 0.779 ' HZ ' ' HG3' ' A' ' 76' ' ' MET . 48.1 m-85 -92.14 -57.03 2.85 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.574 -0.284 . . . . 0.75 110.813 -178.448 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 152' ' ' THR . . . . . . . . . . . . . 8.8 t -119.49 133.87 55.49 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 121.317 0.579 . . . . 2.2200000000000002 111.156 178.654 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 153' ' ' ALA . . . . . . . . . . . . . . . -157.94 10.6 0.18 Allowed 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.449 -0.796 . . . . 4.4000000000000004 110.189 -179.893 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 154' ' ' LYS . . . . . . . . . . . . . 11.9 tptt . . . . . 0 C--O 1.248 1.011 0 CA-C-O 118.423 -0.799 . . . . 6.75 110.408 -174.704 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 141' ' ' ' CA' . . . . . 0.607 'CA ' ' OD1' ' A' ' 96' ' ' ASP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.734 0 N-CA-C 111.984 -0.446 . . . . 10.970000000000001 111.984 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 25.6 Cg_exo -63.95 140.07 71.0 Favored 'Trans proline' 0 C--O 1.234 0.301 0 C-N-CA 122.816 2.344 . . . . 9.0 111.764 177.189 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 81.4 mt -113.18 119.95 39.56 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.1 -0.5 . . . . 7.4199999999999999 111.17 -175.435 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -168.33 87.58 0.09 OUTLIER Glycine 0 N--CA 1.447 -0.61 0 CA-C-N 115.627 -0.715 . . . . 4.46 111.44 177.823 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 26.6 t -101.51 138.09 38.97 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.768 0.284 . . . . 3.9700000000000002 110.348 -176.923 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 35.2 t70 -117.7 134.82 54.5 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.473 -0.33 . . . . 3.46 110.487 178.441 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -134.94 146.01 48.71 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.344 -0.389 . . . . 1.9299999999999999 110.047 -179.456 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 17.9 m -123.9 146.1 29.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 120.757 0.313 . . . . 1.8500000000000001 111.148 -179.896 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 26.9 mt-10 -68.71 142.83 54.9 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.392 -0.367 . . . . 3.1000000000000001 111.206 -176.816 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' TRP . . . . . 0.553 ' CE3' ' HD3' ' A' ' 133' ' ' PRO . 5.1 t90 -83.84 111.04 18.85 Favored 'General case' 0 C--N 1.332 -0.191 0 N-CA-C 109.486 -0.561 . . . . 0.70999999999999996 109.486 179.451 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 12.0 p -60.85 -27.36 41.0 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-N 116.08 -0.509 . . . . 1.45 111.662 -176.911 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 21.5 t -85.17 -11.44 11.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 120.962 0.411 . . . . 1.1000000000000001 111.438 -177.367 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -66.38 -15.51 63.69 Favored Glycine 0 CA--C 1.518 0.231 0 C-N-CA 120.884 -0.674 . . . . 0.58999999999999997 113.565 -174.339 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 4.0 ptpp? -91.32 -27.64 18.26 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.787 0.294 . . . . 2.46 111.526 -179.201 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 27.5 m-20 -92.44 32.23 1.23 Allowed 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 120.648 -0.421 . . . . 1.6599999999999999 110.506 -175.692 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 7.8 mtpm? -79.78 -49.36 1.33 Allowed Pre-proline 0 C--O 1.214 -0.803 0 CA-C-O 118.544 -0.741 . . . . 1.1499999999999999 112.728 -175.377 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 82.8 Cg_exo -43.1 -37.2 6.4 Favored 'Trans proline' 0 C--N 1.354 0.822 0 C-N-CA 122.156 1.904 . . . . 0.75 113.502 -178.928 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -71.88 -45.97 59.48 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.012 0.434 . . . . 0.68000000000000005 111.878 179.238 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 12.8 m-85 -79.14 -22.31 45.3 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.508 -0.315 . . . . 0.68999999999999995 110.153 -175.585 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -70.93 -40.56 72.02 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 108.628 -0.879 . . . . 2.1800000000000002 108.628 173.553 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 20.6 tp10 -55.18 -48.34 73.94 Favored 'General case' 0 C--O 1.232 0.152 0 CA-C-N 114.988 -1.006 . . . . 2.3300000000000001 109.923 176.16 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 40.5 mt -71.77 -38.36 65.6 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-N 115.541 -0.754 . . . . 0.64000000000000001 110.907 178.968 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . 0.424 ' CE1' HG23 ' A' ' 67' ' ' ILE . 58.1 t80 -56.15 -34.96 66.63 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 116.022 -0.535 . . . . 0.28999999999999998 111.576 -177.773 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 9.8 m-85 -88.81 5.46 43.53 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 112.194 0.442 . . . . 1.1699999999999999 112.194 -175.871 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 80.4 p -98.98 -17.67 18.19 Favored 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 120.49 -0.484 . . . . 0.44 110.558 175.951 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.44 HD13 ' HA ' ' A' ' 60' ' ' LEU . 3.3 mm? -93.58 9.59 36.14 Favored 'General case' 0 N--CA 1.462 0.168 0 CA-C-N 116.225 -0.443 . . . . 1.3700000000000001 110.962 179.257 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 19.0 m 65.27 87.3 0.12 Allowed Pre-proline 0 N--CA 1.466 0.36 0 CA-C-N 115.538 -0.756 . . . . 1.24 111.647 179.061 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 95.3 Cg_endo -88.91 139.52 3.81 Favored 'Trans proline' 0 N--CA 1.456 -0.682 0 C-N-CA 122.754 2.303 . . . . 0.46999999999999997 113.39 -178.966 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 15.4 m -113.7 117.94 56.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 115.904 -0.589 . . . . 1.02 110.272 176.294 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 93.1 m-20 63.03 23.33 13.94 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 115.837 -0.62 . . . . 1.3400000000000001 110.827 -178.157 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 78.4 24.69 62.66 Favored Glycine 0 N--CA 1.448 -0.526 0 C-N-CA 120.72 -0.752 . . . . 0.42999999999999999 112.0 -177.367 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 24.4 mtpp -136.45 140.76 43.36 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 109.428 -0.582 . . . . 1.48 109.428 178.076 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . 0.424 HG23 ' CE1' ' A' ' 57' ' ' PHE . 45.8 pt -115.44 160.03 15.03 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 C-N-CA 120.614 -0.435 . . . . 0.64000000000000001 110.668 175.286 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . 0.401 ' HA ' HD23 ' A' ' 100' ' ' LEU . 24.0 p -79.26 158.99 27.47 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.664 -0.698 . . . . 0.55000000000000004 110.867 179.992 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . 0.44 ' O ' ' HB2' ' A' ' 73' ' ' LYS . . . -64.98 -18.06 64.05 Favored Glycine 0 C--O 1.221 -0.656 0 C-N-CA 120.895 -0.669 . . . . 0.40999999999999998 112.392 179.572 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.489 ' O ' ' HG3' ' A' ' 74' ' ' LYS . . . -62.33 -45.42 93.29 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.072 0.463 . . . . 0.38 111.385 179.818 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 48.1 m-80 -79.59 -34.84 40.42 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.216 -0.447 . . . . 1.8100000000000001 110.623 -176.494 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -61.62 -39.71 92.26 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 109.368 -0.605 . . . . 0.39000000000000001 109.368 173.054 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . 0.44 ' HB2' ' O ' ' A' ' 69' ' ' GLY . 78.9 tttt -57.87 -44.32 86.55 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 114.96 -1.018 . . . . 0.83999999999999997 110.141 176.099 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . 0.731 ' O ' ' HG2' ' A' ' 78' ' ' LYS . 96.0 mttt -55.73 -54.66 41.58 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.726 -0.67 . . . . 1.95 110.926 178.701 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . 0.473 ' HA ' ' OE1' ' A' ' 75' ' ' GLU . 12.6 tp10 -64.34 -40.05 95.11 Favored 'General case' 0 C--O 1.239 0.538 0 CA-C-O 121.125 0.488 . . . . 1.6000000000000001 111.151 -176.871 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' MET . . . . . 0.83 ' HB3' HD22 ' A' ' 86' ' ' LEU . 18.8 mmt -57.12 -47.05 82.05 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.892 -0.595 . . . . 1.24 111.358 179.607 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 25.4 m -74.29 -18.07 16.93 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.422 0 C-N-CA 120.798 -0.361 . . . . 1.5700000000000001 111.381 -178.861 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.731 ' HG2' ' O ' ' A' ' 74' ' ' LYS . 46.2 mmtm -76.25 -20.95 56.92 Favored 'General case' 0 N--CA 1.463 0.186 0 CA-C-O 121.265 0.555 . . . . 2.79 109.614 174.322 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 16.9 m -79.68 2.17 23.65 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-N 115.497 -0.774 . . . . 1.27 111.729 -178.174 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 7.3 mtpm? 65.98 22.39 11.26 Favored 'General case' 0 N--CA 1.471 0.575 0 C-N-CA 123.224 0.61 . . . . 2.9700000000000002 112.196 175.468 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.64 ' HB2' HD21 ' A' ' 86' ' ' LEU . 93.2 mt -95.58 147.18 32.61 Favored Pre-proline 0 C--N 1.325 -0.474 0 N-CA-C 110.012 -0.366 . . . . 0.52000000000000002 110.012 178.239 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . 0.484 ' O ' ' HG ' ' A' ' 86' ' ' LEU . 1.5 Cg_endo -73.2 156.22 51.33 Favored 'Trans proline' 0 N--CA 1.457 -0.619 0 C-N-CA 122.293 1.995 . . . . 0.44 112.178 -178.885 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 88.6 m-20 -55.16 -38.96 68.96 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-N 115.973 -0.558 . . . . 1.8500000000000001 111.503 -176.482 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . 0.599 ' O ' ' HG2' ' A' ' 88' ' ' LYS . 3.1 p -57.55 -51.38 69.72 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.119 -0.491 . . . . 1.47 111.121 178.323 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 93.0 t -63.37 -40.94 90.94 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 115.578 -0.737 . . . . 0.45000000000000001 110.834 -179.908 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.83 HD22 ' HB3' ' A' ' 76' ' ' MET . 83.5 mt -62.47 -37.37 85.7 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.138 -0.483 . . . . 0.90000000000000002 110.715 179.199 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -68.61 -35.45 80.91 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.889 -0.672 . . . . 0.32000000000000001 111.632 178.906 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . 0.599 ' HG2' ' O ' ' A' ' 84' ' ' THR . 74.8 mmtt -61.41 -52.75 63.29 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 109.419 -0.586 . . . . 1.8899999999999999 109.419 176.064 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.523 HG23 HD12 ' A' ' 112' ' ' LEU . 42.5 mt -62.7 -38.88 82.79 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.374 0 CA-C-N 115.396 -0.82 . . . . 0.70999999999999996 111.532 -177.093 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 64.7 t-105 -60.97 -45.77 93.44 Favored 'General case' 0 C--N 1.332 -0.19 0 C-N-CA 120.688 -0.405 . . . . 0.33000000000000002 110.731 177.134 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 39.3 ttpt -66.48 -24.46 66.41 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.295 -0.411 . . . . 2.7000000000000002 110.879 -177.319 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.455 ' HG ' ' O ' ' A' ' 88' ' ' LYS . 96.2 mt -86.03 -52.05 5.95 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.51 -0.314 . . . . 1.6599999999999999 111.657 -179.784 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . 0.436 ' HA ' HD23 ' A' ' 108' ' ' LEU . . . -64.86 -38.74 91.98 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.198 -0.455 . . . . 0.46999999999999997 111.687 -174.093 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . 0.641 ' OD1' 'CA ' ' A' ' 141' ' ' ' CA' . 25.6 t0 -81.71 97.11 7.77 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 109.44 -0.578 . . . . 0.79000000000000004 109.44 178.948 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 44.3 t -82.77 -36.86 13.58 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-N 115.119 -0.946 . . . . 0.60999999999999999 111.376 -173.969 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . 0.596 ' OD1' 'CA ' ' A' ' 141' ' ' ' CA' . 1.9 p30 -87.0 -6.4 58.77 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.957 -0.565 . . . . 0.95999999999999996 111.166 -176.544 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.439 ' HA ' ' OD2' ' A' ' 94' ' ' ASP . 23.9 mmmt 59.95 38.74 20.81 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 115.651 -0.704 . . . . 2.96 110.814 173.35 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . 0.626 ' OD1' 'CA ' ' A' ' 141' ' ' ' CA' . 15.9 p-10 -98.52 9.06 44.05 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.131 -0.486 . . . . 0.42999999999999999 111.602 -173.817 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 66.07 6.72 33.55 Favored Glycine 0 C--N 1.333 0.389 0 C-N-CA 120.867 -0.682 . . . . 0.44 113.016 178.692 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.401 HD23 ' HA ' ' A' ' 68' ' ' THR . 90.0 mt -131.39 157.4 43.53 Favored 'General case' 0 N--CA 1.446 -0.659 0 N-CA-C 109.575 -0.528 . . . . 1.1100000000000001 109.575 -178.95 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 83.1 mt -116.23 115.96 26.92 Favored 'General case' 0 C--N 1.315 -0.928 0 C-N-CA 120.669 -0.412 . . . . 0.41999999999999998 110.481 177.491 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -70.55 173.19 7.33 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 108.672 -0.862 . . . . 1.72 108.672 171.85 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -57.85 -30.54 65.86 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 109.706 -0.479 . . . . 1.6000000000000001 109.706 175.978 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 38.2 mt-10 -66.31 -56.79 9.47 Favored 'General case' 0 C--O 1.235 0.294 0 CA-C-N 115.762 -0.654 . . . . 1.6599999999999999 111.192 175.242 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . 0.582 ' CG ' ' HE3' ' A' ' 135' ' ' LYS . 24.4 mt-10 -68.28 -34.93 77.07 Favored 'General case' 0 C--N 1.331 -0.202 0 C-N-CA 121.006 -0.278 . . . . 0.44 110.802 -173.561 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 84.8 t80 -69.15 -35.25 76.14 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 109.889 -0.412 . . . . 0.41999999999999998 109.889 178.247 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -60.47 -42.15 95.65 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.009 0.433 . . . . 0.22 109.96 175.452 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.436 HD23 ' HA ' ' A' ' 93' ' ' ALA . 53.2 tp -66.62 -45.88 77.68 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.183 -0.462 . . . . 1.3300000000000001 110.715 177.672 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -57.41 -50.38 73.17 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.24 -0.436 . . . . 0.32000000000000001 111.172 179.0 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -66.88 -30.61 70.83 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.161 -0.472 . . . . 1.2 110.979 179.349 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' HIS . . . . . 0.467 ' O ' HG23 ' A' ' 115' ' ' VAL . 55.6 t60 -64.51 -44.5 90.7 Favored 'General case' 0 C--O 1.22 -0.476 0 N-CA-C 109.749 -0.463 . . . . 0.52000000000000002 109.749 177.057 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.523 HD12 HG23 ' A' ' 89' ' ' ILE . 88.3 mt -63.81 -41.11 97.96 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.308 -0.406 . . . . 0.55000000000000004 110.494 178.534 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 81.2 mt -55.45 -51.76 53.76 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.308 0 CA-C-O 121.166 0.508 . . . . 0.83999999999999997 110.296 174.092 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . 0.401 ' HA ' ' HD2' ' A' ' 114' ' ' LYS . 14.3 tptm -60.12 -48.54 81.28 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.329 -0.85 . . . . 3.8300000000000001 110.809 -179.188 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.498 HG12 ' HB2' ' A' ' 120' ' ' HIS . 54.4 t -62.75 -36.63 76.25 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-N 115.919 -0.582 . . . . 1.1899999999999999 111.091 -177.736 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . 0.411 ' HB3' ' HE3' ' A' ' 116' ' ' LYS . 23.2 mmmt -64.47 -50.88 65.75 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.627 -0.261 . . . . 1.3200000000000001 110.99 176.245 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 89.9 mt -69.06 -25.26 64.36 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.196 -0.457 . . . . 0.95999999999999996 110.91 -178.919 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 31.6 tt0 -72.0 -14.78 61.98 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.057 -0.519 . . . . 2.1800000000000002 110.583 179.504 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 107.47 28.51 4.83 Favored Glycine 0 N--CA 1.446 -0.635 0 C-N-CA 120.434 -0.889 . . . . 1.1599999999999999 113.042 176.774 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' HIS . . . . . 0.498 ' HB2' HG12 ' A' ' 115' ' ' VAL . 28.6 m-70 -121.38 156.75 31.97 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 109.397 -0.594 . . . . 2.4199999999999999 109.397 176.276 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -117.1 144.84 44.23 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 110.276 -0.268 . . . . 2.5299999999999998 110.276 177.327 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . 0.448 ' H ' ' HG ' ' A' ' 122' ' ' LEU . 2.1 pp -97.39 145.51 29.79 Favored Pre-proline 0 C--N 1.323 -0.569 0 CA-C-N 116.376 -0.374 . . . . 1.3300000000000001 110.756 -178.379 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 8.2 Cg_exo -73.31 -5.38 17.04 Favored 'Trans proline' 0 N--CA 1.465 -0.163 0 C-N-CA 122.927 2.418 . . . . 1.3300000000000001 112.636 -178.277 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . 69.9 19.05 7.15 Favored 'General case' 0 N--CA 1.464 0.275 0 O-C-N 123.734 0.646 . . . . 1.25 111.232 -179.265 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 20.7 m-20 -116.52 171.6 7.75 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 109.359 -0.608 . . . . 2.73 109.359 174.543 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 36.3 tp -115.62 97.42 48.73 Favored Pre-proline 0 C--N 1.325 -0.466 0 CA-C-O 120.965 0.412 . . . . 1.6599999999999999 110.486 177.582 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 127' ' ' PRO . . . . . 0.432 ' HD2' HD12 ' A' ' 130' ' ' LEU . 74.4 Cg_endo -75.97 156.03 38.63 Favored 'Trans proline' 0 CA--C 1.534 0.517 0 C-N-CA 122.962 2.442 . . . . 1.1699999999999999 112.417 178.232 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 11.3 Cg_endo -54.95 -34.7 87.42 Favored 'Trans proline' 0 C--N 1.347 0.482 0 C-N-CA 123.395 2.73 . . . . 1.54 113.677 -175.76 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 4.4 p-80 -79.96 7.63 8.58 Favored 'General case' 0 N--CA 1.465 0.302 0 C-N-CA 120.811 -0.356 . . . . 1.0700000000000001 111.76 -177.595 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . 0.432 HD12 ' HD2' ' A' ' 127' ' ' PRO . 29.3 mt -116.98 5.58 12.89 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.533 0.206 . . . . 1.3600000000000001 111.085 175.121 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 62.8 t -85.3 123.31 73.3 Favored Pre-proline 0 C--N 1.324 -0.51 0 CA-C-N 116.49 -0.323 . . . . 1.28 110.513 178.43 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 132' ' ' PRO . . . . . 0.483 ' HA ' ' HD3' ' A' ' 133' ' ' PRO . 53.6 Cg_exo -54.06 143.33 62.61 Favored 'Trans proline' 0 CA--C 1.534 0.521 0 C-N-CA 123.016 2.478 . . . . 0.81000000000000005 112.724 179.351 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 133' ' ' PRO . . . . . 0.553 ' HD3' ' CE3' ' A' ' 44' ' ' TRP . 23.7 Cg_exo -62.97 -35.27 67.32 Favored 'Trans proline' 0 C--N 1.347 0.454 0 C-N-CA 122.937 2.424 . . . . 1.1699999999999999 113.626 -175.005 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 23.2 t -87.44 0.01 56.15 Favored 'General case' 0 C--N 1.323 -0.573 0 C-N-CA 120.707 -0.397 . . . . 1.6000000000000001 111.249 -175.216 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . 0.582 ' HE3' ' CG ' ' A' ' 105' ' ' GLU . 62.6 mttm -119.82 9.67 11.39 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.905 0.383 . . . . 1.21 111.342 -176.762 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . 0.467 ' HG2' ' O ' ' A' ' 133' ' ' PRO . 15.8 ptp180 -103.61 132.62 49.71 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.356 -0.384 . . . . 2.7599999999999998 110.409 -178.987 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 85.5 mtm180 -142.72 149.98 39.5 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.477 -0.329 . . . . 4.54 110.942 -178.197 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 48.2 m-70 -119.24 100.78 7.53 Favored 'General case' 0 C--N 1.319 -0.72 0 N-CA-C 109.542 -0.54 . . . . 5.9500000000000002 109.542 171.584 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 16.5 tp10 . . . . . 0 C--O 1.251 1.138 0 CA-C-O 118.194 -0.907 . . . . 6.1500000000000004 109.999 -178.248 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' B' B ' 143' ' ' PHE . . . . . . . . . . . . . 54.1 t80 . . . . . 0 N--CA 1.482 1.173 0 N-CA-C 110.031 -0.359 . . . . 11.859999999999999 110.031 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' B' B ' 144' ' ' ASN . . . . . . . . . . . . . 44.3 t30 -100.52 -28.18 13.03 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.329 0.585 . . . . 8.1400000000000006 109.447 177.606 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 145' ' ' TYR . . . . . . . . . . . . . 5.6 t80 -96.56 -152.86 0.39 Allowed 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 108.868 -0.79 . . . . 6.71 108.868 179.156 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 146' ' ' GLU . . . . . . . . . . . . . 11.8 mm-40 63.38 36.69 11.34 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-O 121.162 0.506 . . . . 6.6100000000000003 110.654 179.856 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 147' ' ' SER . . . . . . . . . . . . . 6.7 m -68.79 139.09 55.27 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.704 -0.68 . . . . 3.6499999999999999 111.435 -178.574 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 148' ' ' THR . . . . . . . . . . . . . 2.0 p -93.44 6.46 48.11 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.497 0.665 . . . . 1.79 110.907 177.268 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 149' ' ' GLY . . . . . . . . . . . . . . . 130.62 155.74 8.38 Favored Glycine 0 N--CA 1.445 -0.752 0 CA-C-N 115.205 -0.907 . . . . 0.47999999999999998 111.099 179.326 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 150' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -74.93 -3.84 14.52 Favored 'Trans proline' 0 CA--C 1.53 0.293 0 C-N-CA 122.991 2.461 . . . . 0.33000000000000002 113.118 -173.888 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 151' ' ' PHE . . . . . 0.551 ' CZ ' ' HG3' ' A' ' 76' ' ' MET . 61.2 m-85 -102.13 -6.11 23.67 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.788 0.328 . . . . 0.75 110.955 -179.388 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 152' ' ' THR . . . . . . . . . . . . . 6.6 t -137.98 1.11 2.24 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.2 0.524 . . . . 2.2200000000000002 110.607 179.951 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 153' ' ' ALA . . . . . . . . . . . . . . . -149.72 101.4 3.06 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.791 -0.64 . . . . 4.4000000000000004 110.226 178.197 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 154' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--O 1.251 1.141 0 CA-C-N 115.562 -0.744 . . . . 6.75 110.766 178.07 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 141' ' ' ' CA' . . . . . 0.641 'CA ' ' OD1' ' A' ' 94' ' ' ASP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 stop_ save_